Our,O
data,O
suggest,O
that,O
lipoxygenase,B
metabolites,I
activate,O
ROI,B
formation,I
which,O
then,O
induce,O
IL,B
-,I
2,I
expression,O
via,O
NF,B
-,I
kappa,I
B,I
activation,O
.,O
Human,O
immunodeficiency,O
virus,O
type,O
2,O
(,O
HIV,B
-,I
2,I
),O
",",O
like,O
HIV,B
-,I
1,I
",",O
causes,O
AIDS,O
and,O
is,O
associated,O
with,O
AIDS,O
cases,O
primarily,O
in,O
West,O
Africa,O
.,O
This,O
is,O
the,O
first,O
description,O
of,O
an,O
HIV,B
-,I
2,I
enhancer,O
element,O
which,O
displays,O
such,O
monocyte,B
specificity,O
",",O
and,O
no,O
comparable,O
enhancer,O
element,O
has,O
been,O
clearly,O
defined,O
for,O
HIV,B
-,I
1,I
.,O
While,O
a,O
nuclear,B
factor,I
(,O
s,O
),O
from,O
both,O
peripheral,B
blood,I
monocytes,I
and,O
T,B
cells,I
binds,O
the,O
peri,O
-,O
kappa,O
B,O
site,O
",",O
electrophoretic,O
mobility,O
shift,O
assays,O
suggest,O
that,O
either,O
a,O
different,O
protein,B
binds,O
to,O
this,O
site,O
in,O
monocytes,B
versus,O
T,B
cells,I
or,O
that,O
the,O
protein,B
recognizing,O
this,O
enhancer,O
element,O
undergoes,O
differential,O
modification,O
in,O
monocytes,B
and,O
T,B
cells,I
",",O
thus,O
supporting,O
the,O
transfection,O
data,O
.,O
Understanding,O
the,O
monocyte,B
-,I
specific,I
function,O
of,O
the,O
peri,O
-,O
kappa,O
B,O
factor,O
may,O
ultimately,O
provide,O
insight,O
into,O
the,O
different,O
role,O
monocytes,B
and,O
T,B
cells,I
play,O
in,O
HIV,O
pathogenesis,O
.,O
Distinct,O
signaling,O
properties,O
identify,O
functionally,O
different,O
CD4,B
epitopes,I
.,O
Whereas,O
different,O
anti,O
-,O
CD4,B
mAb,I
or,O
HIV,O
-,O
1,O
gp120,O
could,O
all,O
trigger,O
activation,O
of,O
the,O
protein,B
tyrosine,I
kinases,I
p56lck,I
and,O
p59fyn,I
and,O
phosphorylation,O
of,O
the,O
Shc,B
adaptor,I
protein,I
",",O
which,O
mediates,O
signals,O
to,O
Ras,B
",",O
they,O
differed,O
significantly,O
in,O
their,O
ability,O
to,O
activate,O
NF,B
-,I
AT,I
.,O
To,O
address,O
potential,O
mechanisms,O
by,O
which,O
estrogens,O
suppress,O
erythropoiesis,O
",",O
we,O
have,O
examined,O
their,O
effects,O
on,O
GATA,B
-,I
1,I
",",O
an,O
erythroid,O
transcription,O
factor,O
that,O
participates,O
in,O
the,O
regulation,O
of,O
the,O
majority,O
of,O
erythroid,O
cell,O
-,O
specific,O
genes,O
and,O
is,O
necessary,O
for,O
full,O
maturation,O
of,O
erythrocytes,O
.,O
ER,B
-,I
mediated,I
repression,I
of,I
GATA,B
-,I
1,I
activity,O
occurs,O
on,O
an,O
artificial,O
promoter,O
containing,O
a,O
single,O
GATA,B
-,I
binding,I
site,I
",",O
as,O
well,O
as,O
in,O
the,O
context,O
of,O
an,O
intact,O
promoter,O
which,O
is,O
normally,O
regulated,O
by,O
GATA,B
-,I
1,I
.,O
In,O
coimmunoprecipitatio,O
experiments,O
using,O
transfected,O
COS,B
cells,I
",",O
GATA,B
-,I
1,I
and,O
ER,B
associate,O
in,O
a,O
ligand,O
-,O
dependent,O
manner,O
.,O
(,O
ABSTRACT,O
TRUNCATED,O
AT,O
250,O
WORDS,O
),O
The,O
transcriptional,O
response,O
of,O
the,O
IL,B
-,I
2R,I
alpha,I
gene,I
to,O
stimulation,O
by,O
IL,B
-,I
1,I
+,I
IL,B
-,I
2,I
is,O
biphasic,O
.,O
It,O
also,O
primes,O
cells,O
to,O
become,O
IL,B
-,I
2,I
responsive,I
and,O
thereby,O
prepares,O
the,O
second,O
phase,O
",",O
in,O
which,O
IL,B
-,I
2,I
induces,O
a,O
100,O
-,O
fold,O
further,O
increase,O
in,O
IL,B
-,I
2R,I
alpha,I
transcripts,I
.,O
Transient,O
transfection,O
experiments,O
show,O
that,O
several,O
elements,O
in,O
the,O
promoter,B
-,I
proximal,I
region,I
of,O
the,O
IL,B
-,I
2R,I
alpha,I
gene,I
contribute,O
to,O
IL,B
-,I
1,I
responsiveness,O
",",O
most,O
importantly,O
an,O
NF,B
-,I
kappa,I
B,I
site,I
conserved,O
in,O
the,O
human,B
and,O
mouse,B
gene,I
.,O
IL,B
-,I
2,I
responsiveness,O
",",O
on,O
the,O
other,O
hand,O
",",O
depends,O
on,O
a,O
78,O
-,O
nucleotide,O
segment,O
1,O
.,O
3,O
kilobases,O
upstream,O
of,O
the,O
major,O
transcription,O
start,O
site,O
.,O
Epstein,O
-,O
Barr,O
virus,O
(,O
EBV,B
),O
is,O
known,O
to,O
infect,O
B,B
cells,I
and,O
epithelial,B
cells,I
.,O
The,O
appearance,O
of,O
the,O
BamHI,O
ZLF,O
-,O
1,O
gene,O
product,O
",",O
ZEBRA,B
",",O
by,O
RT,O
-,O
PCR,O
",",O
was,O
observed,O
within,O
8,O
hr,O
of,O
infection,O
.,O
Transcripts,O
encoding,O
gp350,B
/,I
220,I
",",O
the,O
major,O
coat,O
protein,O
of,O
EBV,B
",",O
were,O
identified,O
",",O
but,O
we,O
did,O
not,O
find,O
any,O
evidence,O
of,O
transcription,O
from,O
the,O
LMP,B
-,I
2A,I
or,O
EBER,B
-,I
1,I
loci,O
in,O
infected,O
thymocytes,O
.,O
The,O
main,O
difference,O
is,O
that,O
with,O
thymocytes,B
",",O
no,O
evidence,O
could,O
be,O
found,O
that,O
the,O
virus,O
ever,O
circularizes,O
.,O
Rather,O
",",O
EBV,B
remains,O
in,O
a,O
linear,O
configuration,O
from,O
which,O
replicative,O
genes,O
are,O
transcribed,O
.,O
Several,O
recent,O
studies,O
have,O
implicated,O
Jak,B
kinases,I
in,O
the,O
signaling,O
pathway,O
induced,O
by,O
IL,B
-,I
2,I
.,O
We,O
demonstrate,O
",",O
through,O
the,O
deletion,O
of,O
the,O
human,O
UDG,B
promoter,I
sequences,I
",",O
that,O
expression,O
of,O
E2F,B
-,I
1,I
activates,O
the,O
UDG,B
promoter,I
through,O
several,O
E2F,B
sites,I
.,O
Overexpression,O
of,O
UDG,B
in,O
Saos,B
2,I
cells,O
was,O
observed,O
to,O
delay,O
growth,O
late,O
in,O
G1,O
phase,O
and,O
transiently,O
arrest,O
these,O
cells,O
from,O
progressing,O
into,O
the,O
S,B
phase,I
.,O
Cellular,O
and,O
molecular,O
mechanisms,O
of,O
IFN,B
-,I
gamma,I
production,O
induced,O
by,O
IL,B
-,I
2,I
and,O
IL,B
-,I
12,I
in,O
a,O
human,B
NK,I
cell,I
line,I
.,O
In,O
addition,O
",",O
when,O
used,O
together,O
IL,B
-,I
2,I
and,O
IL,B
-,I
12,I
synergized,O
in,O
the,O
induction,O
of,O
IFN,B
-,I
gamma,I
and,O
GM,B
-,I
CSF,I
and,O
this,O
synergy,O
was,O
attributed,O
to,O
an,O
increased,O
accumulation,O
and,O
stability,O
of,O
the,O
IFN,B
-,I
gamma,I
and,O
GM,B
-,I
CSF,I
mRNAs,O
.,O
To,O
investigate,O
the,O
signaling,O
pathways,O
involved,O
in,O
the,O
gene,O
induction,O
",",O
five,O
inhibitors,O
",",O
cyclosporin,B
A,I
(,I
CsA,I
),I
",",O
transforming,O
growth,O
factor,O
-,O
beta,O
",",O
cycloheximide,B
",",O
genistein,B
",",O
and,O
staurosporine,B
A,I
",",O
were,O
used,O
in,O
analyzing,O
the,O
effects,O
of,O
IL,O
-,O
2,O
and,O
IL,O
-,O
12,O
on,O
NK3,B
0.3,I
cells,I
.,O
In,O
addition,O
",",O
IL,O
-,O
2,O
but,O
not,O
IL,O
-,O
12,O
induced,O
nuclear,O
factors,O
NF,B
-,I
kappa,I
B,I
and,O
AP1,B
",",O
and,O
regulation,O
of,O
the,O
nuclear,O
levels,O
of,O
these,O
two,O
DNA,B
binding,I
protein,I
complexes,I
is,O
correlated,O
with,O
IFN,O
-,O
gamma,O
and,O
GM,O
-,O
CSF,O
gene,O
expression,O
.,O
One,O
substrate,O
is,O
p95vav,B
",",O
which,O
is,O
expressed,O
exclusively,O
in,O
hematopoietic,B
and,O
trophoblast,B
cells,I
.,O
Furthermore,O
",",O
p95vav,B
synergizes,O
with,O
TCR,O
stimulation,O
in,O
inducing,O
NFAT,B
-,I
and,I
interleukin,B
-,I
2,I
-,I
dependent,I
transcription,I
.,O
Furthermore,O
",",O
the,O
activating,O
function,O
of,O
p95vav,B
is,O
blocked,O
by,O
FK506,O
",",O
suggesting,O
that,O
its,O
activity,O
also,O
depends,O
on,O
calcineurin,B
.,O
alpha,B
B,I
is,O
the,O
mouse,O
homologue,O
of,O
human,O
AML1,B
gene,I
detected,O
at,O
the,O
breakpoints,O
of,O
t,O
(,O
8,O
;,O
21,O
),O
and,O
t,O
(,O
3,O
;,O
21,O
),O
myeloid,O
leukemias,O
.,O
We,O
examined,O
alpha,B
A1,I
(,O
an,O
alpha,B
A,I
-,I
gene,I
product,I
),O
and,O
alpha,B
B1,I
and,O
alpha,B
B2,I
(,O
two,O
alpha,B
B,I
-,I
encoded,I
isomers,I
),O
for,O
their,O
effects,O
on,O
the,O
GM,B
-,I
CSF,I
promoter,I
.,O
Although,O
further,O
studies,O
are,O
required,O
to,O
determine,O
the,O
precise,O
role,O
of,O
PEBP2,B
in,O
the,O
GM,B
-,I
CSF,I
promoter,I
activity,I
",",O
the,O
present,O
findings,O
suggested,O
the,O
importance,O
of,O
the,O
relative,O
ratio,O
of,O
different,O
PEBP2,B
isoforms,I
in,O
regulating,O
the,O
levels,O
of,O
the,O
promoter,O
activity,O
.,O
IFN,O
-,O
gamma,O
priming,O
of,O
monocytes,B
enhances,O
LPS,O
-,O
induced,O
TNF,B
production,O
by,O
augmenting,O
both,O
transcription,O
and,O
MRNA,B
stability,O
.,O
The,O
induction,O
of,O
cytokine,O
expression,O
in,O
monocytes,B
/,I
macrophages,I
by,O
bacterial,O
endotoxin,O
or,O
lipopolysaccharide,O
is,O
a,O
critical,O
",",O
highly,O
regulated,O
host,O
defence,O
response,O
The,O
increased,O
transcriptional,O
rate,O
correlated,O
with,O
a,O
marked,O
increase,O
in,O
nuclear,O
factor,O
-,O
kappa,O
B,O
activity,O
in,O
these,O
cells,O
as,O
determined,O
by,O
electrophoretic,O
mobility,O
shift,O
assay,O
using,O
a,O
consensus,O
NF,B
-,I
kappa,I
B,I
oligonucleotide,I
.,O
Consistent,O
with,O
the,O
increased,O
mRNA,B
stability,O
",",O
the,O
duration,O
of,O
mRNA,B
accumulation,O
was,O
longer,O
following,O
LPS,O
stimulation,O
in,O
primed,O
monocytes,O
",",O
in,O
addition,O
to,O
being,O
of,O
greater,O
magnitude,O
.,O
H,O
-,O
89,O
substantially,O
suppressed,O
LPS,O
-,O
induced,O
TNF,B
mRNA,I
accumulation,O
in,O
unprimed,O
cells,O
",",O
but,O
had,O
no,O
effect,O
on,O
primed,O
monocytes,O
following,O
LPS,O
stimulation,O
.,O
A,O
Myc,B
-,I
associated,I
zinc,I
finger,I
protein,I
binding,I
site,I
is,O
one,O
of,O
four,O
important,O
functional,O
regions,O
in,O
the,O
CD4,B
promoter,I
.,O
Since,O
the,O
terminal,O
events,O
of,O
erythropoiesis,O
are,O
controlled,O
by,O
the,O
glycoprotein,B
hormone,I
erythropoietin,I
(,O
Epo,B
),O
",",O
we,O
investigated,O
whether,O
the,O
expression,O
or,O
activity,O
of,O
the,O
TAL1,B
gene,I
and,O
its,O
protein,B
products,I
were,O
affected,O
by,O
Epo,B
in,O
splenic,B
erythroblasts,I
from,O
mice,O
infected,O
with,O
an,O
anemia,O
-,O
inducing,O
strain,O
of,O
Friend,O
virus,O
(,O
FVA,B
cells,I
),O
.,O
The,O
role,O
of,O
shared,O
receptor,B
motifs,I
and,O
common,O
Stat,B
proteins,I
in,O
the,O
generation,O
of,O
cytokine,O
pleiotropy,O
and,O
redundancy,O
by,O
IL,B
-,I
2,I
",",O
IL,B
-,I
4,I
",",O
IL,B
-,I
7,I
",",O
IL,B
-,I
13,I
",",O
and,O
IL,B
-,I
15,I
.,O
IL,B
-,I
13,I
Induced,O
the,O
same,O
complexes,O
as,O
IL,B
-,I
4,I
",",O
a,O
finding,O
explained,O
by,O
our,O
studies,O
implicating,O
IL,B
-,I
4R,I
as,O
a,O
shared,O
component,O
of,O
the,O
receptors,O
.,O
Control,O
of,O
I,B
kappa,I
B,I
-,I
alpha,I
proteolysis,O
by,O
site,O
-,O
specific,O
",",O
signal,O
-,O
induced,O
phosphorylation,O
.,O
When,O
either,O
serine,B
-,I
32,I
or,O
serine,B
-,I
36,I
of,O
I,B
kappa,I
B,I
-,I
alpha,I
was,O
mutated,O
",",O
the,O
protein,O
did,O
not,O
undergo,O
signal,O
-,O
induced,O
phosphorylation,O
or,O
degradation,O
",",O
and,O
NF,B
-,I
kappa,I
B,I
could,O
not,O
be,O
activated,O
.,O
Regulation,O
of,O
transcription,O
of,O
the,O
human,O
erythropoietin,B
receptor,I
gene,I
by,O
proteins,O
binding,O
to,O
GATA,B
-,I
1,I
and,O
Sp1,B
motifs,O
.,O
Erythropoietin,B
(,O
Epo,B
),O
",",O
the,O
primary,O
regulator,O
of,O
the,O
production,O
of,O
erythroid,B
cells,I
",",O
acts,O
by,O
binding,O
to,O
a,O
cell,B
surface,I
receptor,I
(,O
EpoR,B
),O
on,O
erythroid,B
progenitors,I
.,O
Interestingly,O
",",O
when,O
we,O
mutated,O
the,O
Sp1,B
site,I
",",O
resulting,O
in,O
a,O
marked,O
decrease,O
in,O
hEpoR,B
promoter,I
activity,I
",",O
we,O
could,O
restore,O
transactivation,O
by,O
increasing,O
GATA,B
-,I
1,I
levels,I
in,O
OCIM1,B
cells,I
.,O
These,O
data,O
suggest,O
that,O
while,O
GATA,B
-,I
1,I
can,O
transactivate,O
the,O
EpoR,B
promoter,I
",",O
the,O
level,O
of,O
hEpoR,B
gene,I
expression,I
does,O
not,O
depend,O
on,O
GATA,B
-,I
1,I
alone,O
.,O
The,O
deduced,O
amino,O
acid,O
sequence,O
similarity,O
to,O
the,O
proteins,O
encoded,O
by,O
these,O
two,O
latter,O
genes,O
is,O
approximately,O
65,O
%,O
and,O
includes,O
domains,O
and,O
amino,O
acid,O
residues,O
(,O
the,O
leucine,O
zipper,O
-,O
like,O
and,O
the,O
RGD,B
domain,I
",",O
a,O
serine,O
and,O
a,O
histidine,O
residue,O
in,O
the,O
NH2,B
-,I
and,I
in,I
the,I
COOH,B
-,I
terminal,I
portion,I
of,I
the,I
protein,I
",",O
respectively,O
),O
postulated,O
to,O
be,O
important,O
for,O
nm23,B
function,I
.,O
Treatment,O
of,O
U937,B
with,O
IFN,B
-,I
gamma,I
for,O
9,O
hr,O
in,O
the,O
presence,O
of,O
cycloheximide,O
led,O
to,O
super,O
-,O
induction,O
of,O
Fc,B
gamma,I
RI,I
expression,O
.,O
Genomic,O
sequence,O
upstream,O
of,O
the,O
Fc,B
gamma,I
RIC,I
gene,I
was,O
cloned,O
and,O
subjected,O
to,O
primer,O
extension,O
analysis,O
",",O
which,O
demonstrated,O
a,O
single,O
transcription,O
initiation,O
site,O
without,O
a,O
TATA,B
box,I
.,O
Double,O
-,O
stranded,O
GIRE,B
sequence,I
",",O
but,O
not,O
a,O
scrambled,O
sequence,O
",",O
was,O
specifically,O
bound,O
by,O
nuclear,O
proteins,O
from,O
IFN,O
-,O
gamma,O
treated,O
U937,B
cells,I
.,O
The,O
Fc,B
gamma,I
RIC,I
GIRE,I
is,O
homologous,O
to,O
the,O
IFN,O
-,O
gamma,O
activation,O
sequence,O
(,O
GAS,B
),O
of,O
the,O
guanylate,B
binding,I
protein,I
and,O
to,O
X,B
box,I
elements,I
of,O
class,O
II,O
MHC,B
genes,I
.,O
In,O
HTLV,B
-,I
I,I
-,I
infected,O
cord,O
blood,O
lymphocytes,O
",",O
the,O
transition,O
from,O
IL,B
-,I
2,I
-,I
dependent,O
to,O
IL,B
-,I
2,I
-,I
independent,O
growth,O
correlated,O
with,O
the,O
acquisition,O
of,O
a,O
constitutively,O
activated,O
Jak,B
-,I
STAT,I
pathway,I
",",O
which,O
suggests,O
that,O
this,O
pathway,O
participates,O
in,O
HTLV,B
-,I
I,I
-,I
mediated,O
T,O
cell,O
transformation,O
.,O
**Nitric,O
oxide,O
selectively,O
reduces,O
endothelial,O
expression,O
of,O
adhesion,O
molecules,O
and,O
proinflammatory,O
cytokines,O
.,O
In,O
a,O
concentration,O
-,O
dependent,O
manner,O
",",O
NO,B
inhibited,O
interleukin,B
(,O
IL,B
),O
-,O
1,O
alpha,O
-,O
stimulated,O
VCAM,B
-,I
1,I
expression,O
by,O
35,O
-,O
55,O
%,O
as,O
determined,O
by,O
cell,O
surface,O
enzyme,O
immunoassays,O
and,O
flow,O
cytometry,O
.,O
Inhibition,O
of,O
endogenous,O
NO,B
production,O
by,O
L,O
-,O
N,O
-,O
monomethyl,O
-,O
arginine,O
also,O
induced,O
the,O
expression,O
of,O
VCAM,B
-,I
1,I
",",O
but,O
did,O
not,O
augment,O
cytokine,O
-,O
induced,O
VCAM,B
-,I
1,I
expression,O
.,O
Murine,O
macrophage,O
inflammatory,O
protein,B
1,I
alpha,I
(,O
MIP,B
-,I
1,I
alpha,I
),O
and,O
its,O
human,O
equivalent,O
(,O
GOS19,B
",",O
LD78,B
",",O
or,O
AT464,B
),O
are,O
members,O
of,O
the,O
-,O
C,O
-,O
C,O
family,O
of,O
low,O
-,O
molecular,O
-,O
weight,O
chemokines,O
.,O
It,O
also,O
induces,O
chemotaxis,O
and,O
inflammatory,O
responses,O
in,O
mature,O
cell,B
types,I
.,O
One,O
member,O
",",O
ICK,B
-,I
1A,I
",",O
behaves,O
as,O
a,O
strong,O
negative,O
regulator,O
.,O
We,O
provide,O
evidence,O
for,O
an,O
additional,O
binding,O
site,O
",",O
the,O
MIP,B
-,I
1,I
alpha,I
nuclear,I
protein,I
(,O
MNP,B
),O
site,O
",",O
which,O
overlaps,O
the,O
ICK,B
-,I
1,I
site,I
.,O
The,O
signal,O
is,O
subsequently,O
propagated,O
through,O
the,O
activation,O
of,O
Raf,B
-,I
1,I
",",O
MEK,B
",",O
and,O
MAP,B
kinases,I
as,O
shown,O
by,O
their,O
increased,O
autophosphorylation,O
in,O
vitro,O
and,O
phosphorylation,O
in,O
situ,O
.,O
We,O
conclude,O
that,O
IL,B
-,I
5,I
induced,O
signals,O
are,O
propagated,O
through,O
two,O
distinct,O
pathways,O
:,O
(,O
1,O
),O
Lyn,B
-,I
-,I
>,I
Ras,B
-,I
-,I
>,I
Raf,B
-,I
1,I
-,I
-,I
>,I
MEK,B
-,I
-,I
>,I
MAP,B
kinase,I
and,O
(,O
2,O
),O
Jak2,B
-,I
-,I
>,I
STAT1,B
.,O
The,O
retinoblastoma,B
gene,I
product,I
negatively,O
regulates,O
transcriptional,O
activation,O
mediated,O
by,O
the,O
human,B
cytomegalovirus,I
IE2,I
protein,I
.,O
We,O
found,O
that,O
the,O
retinoblastoma,B
susceptibility,I
gene,I
product,I
(,O
Rb,B
),O
dramatically,O
suppressed,O
this,O
IE2,O
transactivation,O
of,O
various,O
promoters,O
.,O
However,O
",",O
the,O
relationship,O
remains,O
controversial,O
according,O
to,O
the,O
tumor,O
cell,B
types,I
and,O
experimental,O
system,O
",",O
with,O
conflicting,O
results,O
from,O
different,O
research,O
groups,O
.,O
And,O
there,O
was,O
no,O
statistically,O
significant,O
difference,O
in,O
NDP,B
kinase,I
expression,O
between,O
SCC,B
with,O
metastasis,O
and,O
SCC,B
without,O
metastasis,O
.,O
Retinoblastoma,B
protein,I
(,O
RB,B
),O
is,O
a,O
tumor,O
suppressor,O
and,O
functions,O
as,O
a,O
transcriptional,O
repressor,O
by,O
binding,O
and,O
inactivating,O
the,O
transactivator,O
E2F,B
-,I
I,I
.,O
RB,B
-,I
defective,O
tumor,O
lines,O
are,O
non,O
-,O
inducible,O
for,O
MHC,B
class,I
II,I
by,O
IFN,O
-,O
gamma,O
",",O
or,O
very,O
weakly,O
inducible,O
",",O
but,O
transfection,O
of,O
2,O
different,O
lines,O
with,O
RB,B
expression,O
vectors,O
re,O
-,O
establishes,O
or,O
substantially,O
enhances,O
class,O
II,O
inducibility,O
.,O
We,O
also,O
examined,O
the,O
IFN,B
-,I
gamma,I
induction,O
of,O
CIITA,B
in,O
RB,O
-,O
defective,O
lines,O
.,O
We,O
have,O
recently,O
demonstrated,O
that,O
stimulation,O
of,O
human,O
T,B
and,O
natural,O
killer,O
cells,O
with,O
IL,B
-,I
12,I
induces,O
tyrosine,O
phosphorylation,O
of,O
the,O
Janus,O
family,O
tyrosine,O
kinase,O
JAK2,B
and,O
Tyk2,B
",",O
implicating,O
these,O
kinases,O
in,O
the,O
immediate,O
biochemical,O
response,O
to,O
IL,B
-,I
12,I
.,O
Furthermore,O
",",O
we,O
show,O
that,O
IL,B
-,I
12,I
stimulates,O
formation,O
of,O
a,O
DNA,B
-,I
binding,I
complex,I
that,O
recognizes,O
a,O
DNA,B
sequence,I
previously,O
shown,O
to,O
bind,O
STAT,B
proteins,I
and,O
that,O
this,O
complex,O
contains,O
STAT4,B
.,O
DESIGN,O
:,O
The,O
effects,O
of,O
hypercortisolaemia,O
",",O
hyperthermia,O
and,O
cellular,O
composition,O
on,O
number,O
of,O
glucocorticoid,B
receptors,I
per,O
cell,O
and,O
their,O
affinity,O
were,O
evaluated,O
",",O
both,O
in,O
vitro,O
and,O
in,O
vivo,O
",",O
in,O
peripheral,O
blood,O
mononuclear,B
leucocytes,I
of,O
control,O
subjects,O
and,O
in,O
patients,O
with,O
sepsis,O
or,O
septic,O
shock,O
.,O
RESULTS,O
:,O
Hypercortisolaemia,O
",",O
in,O
vitro,O
",",O
resulted,O
in,O
a,O
decreased,O
affinity,O
and,O
a,O
decreased,O
binding,O
capacity,O
of,O
the,O
glucocorticoid,B
receptor,I
.,O
Integrin,O
-,O
mediated,O
tyrosine,O
phosphorylation,O
and,O
cytokine,O
message,O
induction,O
in,O
monocytic,B
cells,I
.,O
The,O
tyrosine,O
kinase,O
inhibitors,O
genistein,O
and,O
herbimycin,O
A,O
block,O
both,O
integrin,O
-,O
mediated,O
tyrosine,O
phosphorylation,O
and,O
increases,O
in,O
IL,B
-,I
1,I
beta,I
message,I
levels,I
",",O
indicating,O
a,O
causal,O
relationship,O
between,O
the,O
two,O
events,O
.,O
These,O
observations,O
indicate,O
that,O
the,O
Syk,B
tyrosine,I
kinase,I
may,O
be,O
an,O
important,O
component,O
of,O
an,O
integrin,O
signaling,O
pathway,O
in,O
monocytic,B
cells,I
",",O
leading,O
to,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
and,O
to,O
increased,O
levels,O
of,O
cytokine,B
messages,I
.,O
To,O
determine,O
if,O
New,O
World,O
primates,O
express,O
an,O
inhibitor,O
that,O
influences,O
glucocorticoid,B
receptor,I
(,I
GR,I
),I
binding,O
characteristics,O
",",O
we,O
examined,O
[,O
3H,O
],O
dexamethasone,O
binding,O
in,O
cytosol,O
prepared,O
from,O
B95,B
-,I
8,I
lymphoid,I
cells,I
",",O
derived,O
from,O
the,O
cotton,O
top,O
tamarin,O
(,O
Saguinus,O
oedipus,O
),O
",",O
in,O
combination,O
with,O
cytosol,O
prepared,O
from,O
human,O
or,O
rat,O
tissues,O
.,O
Kinetic,O
studies,O
using,O
mixed,O
cytosol,O
indicated,O
that,O
B95,B
-,I
8,I
cytosol,I
did,O
not,O
affect,O
the,O
apparent,O
dissociation,O
rate,O
of,O
[,O
3H,B
],I
dexamethasone,I
.,O
The,O
results,O
further,O
demonstrated,O
the,O
activation,O
of,O
S6,B
kinase,I
(,O
pp90rsk,B
),O
",",O
evidenced,O
by,O
phosphorylation,O
of,O
S6,B
and,O
serum,B
response,I
factor,I
(,O
SRF,B
),O
peptides,O
",",O
in,O
PWM,O
treated,O
B,B
cells,I
.,O
We,O
have,O
recently,O
found,O
a,O
novel,O
conserved,B
motif,I
in,O
the,O
promoters,O
of,O
several,O
T,B
-,I
cell,I
-,I
expressed,O
cytokines,O
[,O
human,B
interleukin,I
-,I
2,I
",",O
-,O
4,I
",",O
-,O
5,I
and,O
-,O
13,I
and,O
human,B
and,O
mouse,O
granulocyte,B
/,I
macrophage,I
-,I
colony,I
stimulating,I
factor,I
(,I
GM,I
-,I
CSF,I
),I
],O
. In,O
transfection,O
assays,O
",",O
the,O
human,B
GM,I
-,I
CSF,I
element,I
has,O
a,O
strong,O
positive,O
effect,O
on,O
the,O
expression,O
of,O
a,O
reporter,O
gene,O
by,O
the,O
human,B
T,B
cell,I
line,I
Jurkat,I
J6,I
upon,O
stimulation,O
.,O
In,O
different,O
genes,O
",",O
the,O
core,O
sequences,O
are,O
separated,O
by,O
integer,O
numbers,O
of,O
helical,O
turns,O
.,O
Aspirin,O
inhibits,O
nuclear,O
factor,O
-,O
kappa,O
B,B
mobilization,O
and,O
monocyte,O
adhesion,O
in,O
stimulated,O
human,O
endothelial,O
cells,O
.,O
These,O
effects,O
of,O
aspirin,O
were,O
not,O
related,O
to,O
the,O
inhibition,O
of,O
cyclooxygenase,O
activity,O
",",O
since,O
indomethacin,O
was,O
ineffective,O
.,O
Activation,O
of,O
NF,B
-,I
kappa,I
B,I
by,O
various,O
cellular,O
stimuli,O
involves,O
the,O
phosphorylation,O
and,O
subsequent,O
degradation,O
of,O
its,O
inhibitor,O
",",O
I,B
kappa,I
B,I
alpha,I
",",O
although,O
the,O
underlying,O
mechanism,O
remains,O
unclear,O
.,O
Together,O
",",O
these,O
results,O
suggest,O
that,O
phosphorylation,O
of,O
I,B
kappa,I
B,I
alpha,I
",",O
mediated,O
through,O
both,O
the,O
TNF,O
-,O
alpha,O
-,O
inducible,O
and,O
the,O
PP,O
-,O
2A,O
-,O
opposing,O
kinases,O
",",O
may,O
serve,O
to,O
target,O
I,B
kappa,I
B,I
alpha,I
for,O
proteasome,O
-,O
mediated,O
degradation,O
.,O
The,O
5,O
',O
flanking,O
region,O
of,O
the,O
human,O
alpha,B
-,I
globin,I
gene,I
is,O
highly,O
G,B
+,I
C,I
rich,I
and,O
contains,O
multiple,O
copies,O
of,O
the,O
consensus,O
sequence,O
for,O
the,O
Sp1,B
binding,I
site,I
.,O
Finally,O
",",O
we,O
show,O
by,O
both,O
footprint,O
analysis,O
and,O
functional,O
assays,O
that,O
the,O
ability,O
of,O
the,O
G,B
+,I
C,I
-,I
rich,I
region,I
to,O
increase,O
alpha,B
-,I
globin,I
promoter,I
activity,O
from,O
a,O
stably,O
integrated,O
alpha,B
-,I
globin,I
gene,I
is,O
mediated,O
by,O
its,O
multiple,O
binding,O
sites,O
for,O
the,O
transcription,O
factor,O
Sp1,B
.,O
LFA,O
-,O
3,O
induced,O
moderate,O
levels,O
of,O
AP,B
-,I
1,I
",",O
but,O
did,O
not,O
influence,O
the,O
levels,O
of,O
NF,B
-,I
kappa,I
B,I
",",O
while,O
B7,O
costimulation,O
strongly,O
induced,O
both,O
AP,B
-,I
1,I
and,O
substantially,O
enhanced,O
NF,B
-,I
kappa,I
B,I
binding,I
proteins,I
.,O
The,O
Ah,O
receptor,O
recognizes,O
DNA,B
binding,I
sites,I
for,O
the,O
B,B
cell,I
transcription,I
factor,I
",",O
BSAP,O
:,O
a,O
possible,O
mechanism,O
for,O
dioxin,O
-,O
mediated,O
alteration,O
of,O
CD19,O
gene,O
expression,O
in,O
human,O
B,B
lymphocytes,I
.,O
In,O
addition,O
",",O
the,O
Ah,B
receptor,I
complex,I
recognized,O
a,O
DNA,B
binding,I
site,I
for,O
B,B
cell,I
lineage,I
-,I
specific,I
activator,I
protein,I
(,O
BSAP,B
),O
in,O
the,O
promoter,O
region,O
of,O
the,O
human,O
CD19,B
gene,I
which,O
is,O
similar,O
to,O
the,O
consensus,O
Ah,B
receptor,I
DNA,B
binding,I
site,I
.,O
We,O
recently,O
identified,O
a,O
differentiation,O
inhibitory,O
factor,O
(,O
I,B
-,I
factor,I
),O
in,O
mouse,O
myeloid,O
leukemia,O
M1,O
cells,O
as,O
a,O
murine,O
homolog,O
of,O
the,O
human,O
nm23,B
-,I
H2,I
gene,I
product,I
.,O
In,O
the,O
present,O
experiment,O
",",O
we,O
examined,O
the,O
effect,O
of,O
nm23,B
proteins,I
on,O
various,O
differentiation,O
induction,O
systems,O
of,O
human,O
leukemic,O
cells,O
including,O
HL,B
-,I
60,I
",",O
U937,B
",",O
HEL,B
/,I
S,I
",",O
KU812F,B
",",O
K562,B
",",O
and,O
HEL,B
cells,I
. ,O
Delayed,O
administration,O
of,O
rBPI21,O
also,O
affected,O
LPS,B
-,I
mediated,I
activation,O
of,O
the,O
nuclear,O
factor,O
",",O
NF,B
-,I
kappa,I
B,I
. ,O
Two,O
to,O
4,O
h,O
following,O
LPS,B
addition,O
to,O
endothelial,B
cells,I
",",O
when,O
NF,B
-,I
kappa,I
B,I
was,O
already,O
activated,O
",",O
addition,O
of,O
rBPI21,O
resulted,O
in,O
marked,O
reduction,O
of,O
NF,B
-,I
kappa,I
B,I
detectable,O
at,O
4,O
or,O
6,O
h,O
.,O
GM,B
-,I
CSF,I
and,O
IL,B
-,I
2,I
share,O
common,O
control,O
mechanisms,O
in,O
response,O
to,O
costimulatory,O
signals,O
in,O
T,B
cells,I
.,O
Antigen,B
complexed,O
with,O
major,B
histocompatibility,I
complex,I
class,I
I,I
or,O
II,O
molecules,O
on,O
the,O
surface,O
of,O
antigen,O
presenting,O
cells,I
interacts,O
with,O
the,O
T,B
cell,I
receptor,I
(,O
TCR,B
),O
on,O
the,O
surface,O
of,O
T,B
cells,I
and,O
initiates,O
an,O
activation,O
cascade,O
.,O
Costimulatory,O
signals,O
",",O
such,O
as,O
activation,O
of,O
the,O
CD28,B
cell,I
surface,I
molecule,I
on,O
T,B
cells,I
",",O
lead,O
to,O
activation,O
through,O
a,O
distinct,O
region,O
of,O
the,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
(,O
GM,B
-,I
CSF,I
),O
promoter,O
.,O
Human,O
T,B
leukemia,I
virus,I
type,I
1,I
(,O
HTLV,B
-,I
1,I
),O
infects,O
T,B
cells,I
and,O
can,O
lead,O
to,O
increase,O
GM,B
-,I
CSF,I
expression,O
.,O
This,O
observation,O
",",O
together,O
with,O
the,O
fact,O
that,O
both,O
GM,B
-,I
CSF,I
and,O
IL,B
-,I
2,I
respond,O
to,O
TCR,O
signals,O
via,O
NFAT,O
",",O
implies,O
a,O
high,O
degree,O
of,O
conservation,O
in,O
the,O
regulation,O
of,O
cytokine,O
gene,O
expression,O
in,O
T,B
cells,I
.,O
3,O
.,O
Danazol,O
decreased,O
the,O
transcription,O
rate,O
of,O
ER,B
gene,I
to,O
approximately,O
50,O
%,O
in,O
monocytes,O
in,O
a,O
run,O
-,O
on,O
assay,O
.,O
Formation,O
of,O
the,O
NFAT,B
-,I
1,I
transcriptional,O
complex,O
on,O
the,O
IL,B
-,I
2,I
promoter,O
is,O
essential,O
for,O
IL,B
-,I
2,I
transcription,O
.,O
WIN,O
53071,O
inhibited,O
IL,B
-,I
2,I
production,O
induced,O
in,O
the,O
calcium,O
-,O
dependent,O
PMA,O
and,O
ionomycin,O
pathway,O
.,O
We,O
examined,O
mRNA,O
levels,O
of,O
various,O
V,B
-,I
ATPase,I
subunits,O
during,O
differentiation,O
of,O
both,O
native,O
monocytes,O
and,O
the,O
cell,B
line,I
THP,I
-,I
1,I
",",O
and,O
found,O
that,O
transcriptional,O
and,O
post,O
-,O
transcriptional,O
mechanisms,O
could,O
account,O
for,O
increases,O
in,O
cell,B
V,I
-,I
ATPase,I
content,O
.,O
From,O
nuclear,O
runoff,O
experiments,O
",",O
we,O
found,O
that,O
one,O
subunit,O
in,O
particular,O
",",O
the,O
B2,B
isoform,I
(,O
Mr,O
=,O
56,O
",",O
0,O
),O
",",O
was,O
amplified,O
primarily,O
by,O
transcriptional,O
means,O
.,O
Primer,O
extension,O
and,O
ribonuclease,O
protection,O
analyses,O
indicate,O
a,O
single,O
major,O
transcriptional,O
start,O
site,O
.,O
We,O
transfected,O
promoter,O
-,O
luciferase,O
reporter,O
plasmids,O
into,O
THP,O
-,O
1,O
cells,O
to,O
define,O
sequences,O
that,O
mediate,O
transcriptional,O
control,O
during,O
monocyte,O
differentiation,O
.,O
We,O
have,O
examined,O
the,O
function,O
of,O
these,O
elements,O
in,O
Burkitt,O
',O
s,O
lymphoma,O
cells,O
(,O
Ramos,O
and,O
Daudi,O
),O
as,O
well,O
as,O
a,O
T,O
lymphocytic,O
cell,O
line,O
(,O
Jurkat,O
),O
.,O
Okadaic,O
acid,O
augments,O
PMA,O
-,O
as,O
well,O
as,O
calcium,O
-,O
mediated,O
activation,O
of,O
c,O
-,O
fos,O
",",O
and,O
has,O
little,O
or,O
no,O
effect,O
when,O
combined,O
with,O
cAMP,O
.,O
The,O
main,O
difference,O
between,O
Ramos,O
(,O
B,O
cells,O
),O
and,O
Jurkat,O
(,O
T,O
cells,O
),O
in,O
the,O
regulation,O
of,O
c,O
-,O
fos,O
is,O
that,O
cAMP,O
plus,O
calcium,O
is,O
strongly,O
synergistic,O
in,O
Jurkat,O
and,O
is,O
without,O
effect,O
in,O
Ramos,O
.,O
These,O
results,O
suggest,O
that,O
cell,B
-,I
specific,I
patterns,O
of,O
synergy,O
are,O
an,O
essential,O
feature,O
for,O
c,O
-,O
fos,O
induction,O
and,O
may,O
be,O
relevant,O
for,O
c,O
-,O
fos,O
control,O
through,O
B,B
and,O
T,B
cell,I
antigen,I
receptors,I
.,O
Multiple,O
signals,O
are,O
required,O
for,O
function,O
of,O
the,O
human,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
gene,I
promoter,I
in,O
T,B
cells,I
.,O
These,O
results,O
imply,O
that,O
at,O
least,O
three,O
signals,O
are,O
required,O
to,O
activate,O
the,O
GM,B
-,I
CSF,I
proximal,I
promoter,I
",",O
and,O
that,O
the,O
signals,O
impinge,O
on,O
distinct,O
transcription,O
factors,O
that,O
bind,O
to,O
the,O
hCLEO,B
and,O
NF,B
-,I
kappa,I
B,I
regions,I
of,O
the,O
promoter,O
.,O
In,O
this,O
report,O
",",O
we,O
show,O
that,O
in,O
monocytes,B
and,O
T,B
cells,I
IL,B
-,I
10,I
stimulates,O
tyrosine,O
phosphorylation,O
of,O
the,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
",",O
STAT1,B
alpha,I
and,O
STAT3,B
",",O
in,O
a,O
differential,O
manner,O
such,O
that,O
the,O
relative,O
formation,O
of,O
homo,O
-,O
and,O
heterodimers,O
varies,O
between,O
the,O
two,O
cell,B
types,I
.,O
IL,O
-,O
10,O
treatment,O
of,O
both,O
T,B
cells,I
and,O
monocytes,B
results,O
in,O
the,O
ligand,O
-,O
induced,O
tyrosine,O
phosphorylation,O
of,O
tyk2,B
and,O
Jak1,B
",",O
but,O
not,O
Jak2,B
or,O
Jak3,B
.,O
Selective,O
modulation,O
of,O
immune,O
responsiveness,O
by,O
IL,O
-,O
10,O
in,O
cells,O
such,O
as,O
monocytes,B
and,O
T,B
cells,I
may,O
result,O
in,O
part,O
from,O
the,O
differential,O
activation,O
of,O
STAT,B
protein,I
pairs,I
.,O
However,O
",",O
the,O
real,O
effect,O
of,O
hormones,O
involved,O
in,O
ovulation,O
is,O
expressed,O
by,O
biological,O
modifications,O
on,O
target,O
tissues,O
.,O
They,O
also,O
display,O
constitutively,O
high,O
levels,O
of,O
p59fyn,B
and,O
CD3,B
zeta,I
tyrosine,I
phosphorylation,I
.,O
The,O
generation,O
of,O
second,O
messengers,O
in,O
T,B
cells,I
normally,O
leads,O
to,O
downstream,O
signaling,O
that,O
results,O
in,O
transcriptional,O
activation,O
of,O
the,O
IL,B
-,I
2,I
gene,I
.,O
Levels,O
of,O
the,O
octamer,O
",",O
NF,B
-,I
kappa,I
B,I
(,O
p50,B
-,I
p65,I
heterodimer,I
),O
",",O
and,O
AP,B
-,I
1,I
transcriptional,I
factors,I
are,O
constitutively,O
elevated,O
in,O
freshly,O
isolated,O
Ipr,B
CD4,I
-,I
8,I
-,I
T,I
cells,I
",",O
consistent,O
with,O
the,O
activated,O
phenotype,O
of,O
these,O
cells,O
.,O
We,O
demonstrate,O
that,O
cross,O
-,O
linking,O
CD30,B
with,O
an,O
anti,O
-,O
CD30,B
-,I
specific,I
monoclonal,I
antibody,I
",",O
which,O
mimics,O
the,O
described,O
biological,O
activities,O
of,O
the,O
CD30,B
ligand,I
(,I
CD30L,I
),O
",",O
results,O
in,O
HIV,B
expression,I
.,O
Type,O
II,O
major,O
histocompatibility,O
complex,O
combined,O
immune,O
deficiency,O
(,O
type,O
II,O
MHC,B
CID,I
or,O
bare,O
lymphocyte,O
syndrome,O
),O
is,O
a,O
congenital,O
immunodeficiency,O
disease,O
characterized,O
by,O
absent,O
MHC,B
class,I
II,I
expression,O
.,O
Here,O
",",O
we,O
demonstrate,O
that,O
CIITA,O
is,O
an,O
MHC,B
class,I
II,I
gene,I
-,I
specific,I
transcription,I
activator,I
.,O
The,O
transcription,O
activation,O
function,O
is,O
provided,O
by,O
the,O
N,O
-,O
terminal,O
acidic,O
domain,O
(,O
amino,O
acids,O
26,O
-,O
137,O
),O
",",O
which,O
is,O
experimentally,O
exchangeable,O
with,O
a,O
heterologous,O
viral,O
transcription,O
-,O
activating,O
domain,O
.,O
These,O
results,O
demonstrate,O
that,O
P,B
-,I
selectin,I
",",O
through,O
its,O
ligands,O
on,O
monocytes,O
",",O
may,O
locally,O
regulate,O
cytokine,O
secretion,O
in,O
inflamed,O
tissues,O
.,O
Here,O
",",O
we,O
report,O
that,O
nitric,O
oxide,O
(,O
NO,B
),O
activates,O
p21ras,B
in,O
human,O
T,B
cells,I
as,O
evidenced,O
by,O
an,O
increase,O
in,O
GTP,B
-,I
bound,I
p21ras,I
.,O
In,O
vitro,O
studies,O
using,O
pure,O
recombinant,O
p21ras,B
demonstrate,O
that,O
the,O
activation,O
is,O
direct,O
and,O
reversible,O
.,O
Circular,O
dichroism,O
analysis,O
reveals,O
that,O
NO,B
induces,O
a,O
profound,O
conformational,O
change,O
in,O
p21ras,B
in,O
association,O
with,O
GDP,O
/,O
GTP,O
exchange,O
.,O
Furthermore,O
",",O
we,O
demonstrate,O
that,O
p21ras,B
is,O
essential,O
for,O
NO,B
-,O
induced,O
downstream,O
signaling,O
",",O
such,O
as,O
NF,B
-,I
kappa,I
B,I
activation,O
",",O
and,O
that,O
endogenous,O
NO,B
can,O
activate,O
p21ras,B
in,O
the,O
same,O
cell,O
.,O
These,O
studies,O
identify,O
p21ras,B
as,O
a,O
target,O
of,O
the,O
same,O
cell,B
.,O
These,O
studies,O
identify,O
p21ras,B
as,O
a,O
target,O
of,O
NO,O
in,O
T,O
cells,B
and,O
suggest,O
that,O
NO,O
activates,O
p21ras,B
by,O
an,O
action,O
which,O
mimics,O
that,O
of,O
guanine,B
nucleotide,I
exchange,I
factors,I
.,O
In,O
the,O
present,O
study,O
we,O
analyzed,O
the,O
control,O
of,O
IL,B
-,I
2,I
promoter,I
activity,O
in,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
)-,O
transformed,O
B,B
cell,I
clones,I
which,O
are,O
capable,O
of,O
secreting,O
IL,B
-,I
2,I
at,O
a,O
low,O
level,O
after,O
stimulation,O
with,O
phorbol,O
12,O
-,O
myristate,O
13,O
-,O
acetate,O
and,O
the,O
Ca2,B
+,I
ionophore,I
ionomycin,I
.,O
Transient,O
transfections,O
using,O
reporter,O
constructs,O
with,O
multiples,O
of,O
transcription,O
factor,O
binding,O
sites,O
from,O
the,O
IL,O
-,O
2,O
promoter,O
[,O
distal,O
nuclear,O
factor,O
(,O
NF,B
)-24,O
AT,O
",",O
proximal,O
NF,B
-,I
AT,I
",",O
AP,B
-,I
1,I
/,I
Octamer,I
(,I
UPS,I
),I
or,O
NF,B
-,I
chi,I
B,I
(,I
TCEd,I
),I
sites,O
],O
were,O
performed,O
.,O
In,O
EBV,O
-,O
transformed,O
B,O
clones,O
",",O
the,O
chi,B
B,I
site,I
exerted,O
the,O
strongest,O
inducible,O
activity,O
;,O
the,O
NF,B
-,I
AT,I
binding,I
sites,O
showed,O
either,O
no,O
or,O
only,O
weak,O
activity,O
compared,O
to,O
Jurkat,O
T,O
cells,O
.,O
In,O
seven,O
EBV,B
-,I
B,I
cell,I
clones,I
or,O
lines,O
differing,O
in,O
their,O
capacity,O
to,O
secrete,O
IL,B
-,I
2,I
",",O
the,O
activity,O
of,O
the,O
IL,B
-,I
2,I
promoter,I
correlated,O
well,O
with,O
the,O
status,O
of,O
IL,B
-,I
2,I
secretion,I
.,O
Latent,O
membrane,O
protein,B
-,I
1,I
induces,O
cyclin,B
D2,I
expression,I
",",O
pRb,B
hyperphosphorylation,I
",",O
and,O
loss,O
of,O
TGF,B
-,I
beta,I
1,I
-,I
mediated,I
growth,I
inhibition,I
in,O
EBV,B
-,I
positive,I
B,I
cells,I
.,O
Here,O
",",O
we,O
show,O
that,O
the,O
presence,O
of,O
either,O
wild,O
-,O
type,O
EBV,B
or,O
its,O
transforming,O
latent,O
membrane,O
protein,B
-,I
1,I
(,O
LMP,B
-,I
1,I
),O
results,O
in,O
the,O
loss,O
of,O
TGF,B
-,I
beta,I
1,I
-,I
mediated,I
growth,I
inhibition,I
in,O
human,O
B,B
cells,I
.,O
Does,O
thyroidectomy,O
",",O
radioactive,O
iodine,O
therapy,O
",",O
or,O
antithyroid,O
drug,O
treatment,O
alter,O
reactivity,O
of,O
patients,O
',O
T,B
cells,I
to,O
epitopes,O
of,O
thyrotropin,B
receptor,I
in,O
autoimmune,O
thyroid,B
diseases,I
?,O
A,O
further,O
decrease,O
in,O
the,O
T,B
cell,I
reactivity,I
to,O
TSHR,B
peptides,I
was,O
observed,O
3,O
-,O
6,O
months,O
after,O
surgery,O
.,O
Six,O
to,O
8,O
weeks,O
after,O
RAI,O
therapy,O
",",O
the,O
number,O
of,O
patients,O
responding,O
to,O
any,O
peptide,O
and,O
the,O
average,O
number,O
of,O
recognized,O
peptides,O
increased,O
.,O
The,O
reactivity,O
of,O
T,B
cell,I
lines,I
in,O
different,O
groups,O
reflected,O
a,O
pattern,O
similar,O
to,O
PBMC,O
after,O
treatment,O
.,O
TSHR,B
antibody,I
and,O
microsomal,B
antibody,I
levels,O
decreased,O
after,O
surgery,O
",",O
but,O
increased,O
after,O
RAI,O
therapy,O
.,O
We,O
have,O
identified,O
an,O
in,O
vivo,O
footprint,O
over,O
the,O
PuF,B
site,I
on,O
the,O
translocated,O
c,O
-,O
myc,B
allele,I
in,O
Burkitt,O
',O
s,O
lymphoma,O
cells,O
.,O
Transfection,O
experiments,O
with,O
c,O
-,O
myc,B
promoter,I
constructs,I
in,O
both,O
DHL,B
-,I
9,I
and,O
Raji,B
cells,I
revealed,O
that,O
the,O
PuF,B
site,I
functioned,O
as,O
a,O
positive,O
regulatory,O
element,O
in,O
B,B
cells,I
with,O
a,O
drop,O
in,O
activity,O
with,O
mutation,O
of,O
this,O
site,O
.,O
Electromobility,O
shift,O
assays,O
utilizing,O
this,O
sequence,O
demonstrated,O
binding,O
of,O
a,O
fetal,O
and,O
erythroid,O
-,O
specific,O
protein,B
.,O
These,O
results,O
indicate,O
that,O
the,O
5,O
',O
-,O
UTR,O
of,O
the,O
gamma,B
-,I
gene,I
contains,O
sequences,O
that,O
may,O
be,O
important,O
for,O
its,O
transcriptional,O
and,O
developmental,O
regulation,O
.,O
However,O
",",O
this,O
deletion,O
mutation,O
prevented,O
the,O
induced,O
phosphorylation,O
",",O
degradative,O
loss,O
",",O
and,O
functional,O
release,O
of,O
I,B
kappa,I
B,I
alpha,I
from,O
NF,B
-,I
kappa,I
B,I
in,O
Tax,O
-,O
expressing,O
cells,O
.,O
Alanine,O
substitutions,O
introduced,O
at,O
two,O
serine,B
residues,I
positioned,O
within,O
this,O
N,O
-,O
terminal,O
regulatory,O
region,O
of,O
I,O
kappa,O
B,O
alpha,O
also,O
yielded,O
constitutive,O
repressors,O
that,O
escaped,O
from,O
Tax,O
-,O
induced,O
turnover,O
and,O
that,O
potently,O
inhibited,O
immune,O
activation,O
pathways,O
for,O
NF,O
-,O
kappa,O
B,O
induction,O
",",O
including,O
those,O
initiated,O
from,O
antigen,O
and,O
cytokine,O
receptors,O
.,O
In,O
contrast,O
",",O
introduction,O
of,O
a,O
phosphoserine,B
mimetic,I
at,O
these,O
sites,O
rectified,O
this,O
functional,B
defect,I
",",O
a,O
finding,O
consistent,O
with,O
a,O
causal,O
linkage,O
between,O
the,O
phosphorylation,O
status,O
and,O
proteolytic,O
stability,O
of,O
this,O
cytoplasmic,O
inhibitor,O
.,O
Together,O
",",O
these,O
in,O
vivo,O
studies,O
define,O
a,O
critical,O
signal,O
response,O
domain,O
in,O
I,B
kappa,I
B,I
alpha,I
that,O
coordinately,O
controls,O
the,O
biologic,O
activities,O
of,O
I,B
kappa,I
B,I
alpha,I
and,O
NF,B
-,I
kappa,I
B,I
in,O
response,O
to,O
viral,O
and,O
immune,O
stimuli,O
.,O
Human,O
prostatic,B
epithelial,I
cells,I
from,O
an,O
androgen,O
-,O
dependent,O
LNCaP,B
cell,I
line,I
were,O
examined,O
in,O
response,O
to,O
conditioned,O
medium,O
(,O
CM,B
),O
derived,O
from,O
phytohemagglutinin,O
(,O
PHA,B
),O
-,O
stimulated,O
lymphocytes,O
.,O
Cell,B
morphology,I
showed,O
dendritic,O
processes,O
extending,O
from,O
cytoplasm,O
and,O
other,O
neuroendocrine,B
cell,I
characteristics,I
.,O
These,O
included,O
vimentin,B
",",O
correlating,O
to,O
cell,O
shape,O
changes,O
",",O
cytokeratins,B
8,I
and,O
18,I
",",O
associated,O
with,O
differentiated,O
cell,O
types,O
of,O
prostate,B
epithelia,I
",",O
and,O
neuron,B
-,I
specific,I
enolase,I
and,O
serotonin,B
",",O
associated,O
with,O
neuroendocrine,B
cells,I
.,O
Human,O
peripheral,O
blood,O
monocytes,O
responded,O
to,O
stimulation,O
of,O
platelet,B
-,I
activating,I
factor,I
(,O
PAF,O
),O
with,O
up,O
-,O
regulation,O
of,O
the,O
transcript,O
for,O
heparin,B
-,I
binding,I
epidermal,I
growth,I
factor,I
-,I
like,I
growth,I
factor,I
(,O
HB,O
-,O
EGF,O
),O
",",O
a,O
potent,O
mitogen,O
for,O
vascular,B
smooth,I
muscle,I
cells,I
.,O
This,O
function,O
of,O
PAF,B
was,O
observed,O
at,O
nanomolar,O
concentrations,O
of,O
the,O
ligand,O
",",O
starting,O
at,O
30,O
min,O
after,O
stimulation,O
.,O
These,O
functions,O
of,O
PAF,B
appeared,O
to,O
be,O
mediated,O
through,O
the,O
cell,B
surface,I
PAF,B
receptors,I
",",O
as,O
two,O
PAF,B
receptor,I
antagonists,I
",",O
WEB,O
2086,O
and,O
L,O
-,O
659,O
",",O
989,O
",",O
blocked,O
both,O
the,O
up,O
-,O
regulation,O
of,O
HB,B
-,I
EGF,I
mRNA,I
and,O
kappa,B
B,I
binding,I
activity,I
induced,O
by,O
PAF,B
.,O
The,O
antagonists,O
",",O
however,O
",",O
had,O
no,O
effect,O
on,O
phorbol,O
ester,O
-,O
induced,O
up,O
-,O
regulation,O
of,O
HB,B
-,I
EGF,I
mRNA,I
and,O
kappa,O
B,B
binding,I
activity,I
.,O
Several,O
criteria,O
indicated,O
that,O
the,O
defect,O
in,O
this,O
cell,O
line,O
influences,O
the,O
activity,O
of,O
an,O
isotype,O
-,O
specific,O
transcription,O
factor,O
.,O
The,O
DQB,B
X2,I
-,I
box,I
was,O
able,O
to,O
restore,O
expression,O
to,O
the,O
silent,O
DRA,B
reporter,I
construct,I
.,O
Moreover,O
",",O
replacement,O
of,O
the,O
DQB,B
X2,I
-,I
box,I
with,O
the,O
DRA,B
X2,I
-,I
box,I
markedly,O
diminished,O
the,O
activity,O
of,O
the,O
DQB,B
promoter,I
in,O
the,O
mutant,O
cell,O
.,O
ZEBRA,B
is,O
a,O
bZIP,B
transcriptional,I
activator,I
which,O
binds,O
as,O
a,O
dimer,O
to,O
7,O
-,O
bp,O
response,O
elements,O
within,O
EBV,B
promoters,I
and,O
is,O
directly,O
involved,O
in,O
the,O
stimulation,O
of,O
virus,O
replication,O
at,O
the,O
EBV,B
lytic,I
origin,I
.,O
Both,O
chimeras,O
were,O
found,O
to,O
transactivate,O
model,O
and,O
native,O
promoters,O
at,O
equivalent,O
or,O
better,O
levels,O
than,O
ZEBRA,B
itself,O
.,O
These,O
activation,O
domains,O
restored,O
ZEBRA,B
',O
s,O
ability,O
to,O
induce,O
early,O
antigen,O
and,O
to,O
stimulate,O
origin,O
replication,O
to,O
levels,O
that,O
were,O
equal,O
to,O
or,O
greater,O
than,O
those,O
of,O
wild,O
type,O
.,O
Because,O
these,O
are,O
the,O
characteristics,O
of,O
a,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
(,O
Stat,B
),O
protein,O
",",O
we,O
determined,O
whether,O
antibodies,O
to,O
Stat,B
proteins,I
will,O
interfere,O
with,O
gel,O
mobility,O
shift,O
and,O
found,O
that,O
antibodies,O
to,O
IL,B
-,I
4,I
Stat,B
",",O
also,O
known,O
as,O
Stat6,B
",",O
but,O
not,O
antibodies,O
to,O
other,O
Stat,B
proteins,I
",",O
interfere,O
with,O
the,O
formation,O
of,O
the,O
IL,B
-,I
4,I
NAF,I
complex,I
.,O
Monoallelic,O
expression,O
of,O
TAL1,B
was,O
observed,O
in,O
the,O
leukemic,O
cells,O
of,O
all,O
patients,O
(,O
8,O
of,O
8,O
),O
bearing,O
a,O
TAL1,B
gene,I
rearrangement,I
.,O
In,O
the,O
leukemic,O
cells,O
of,O
patients,O
without,O
detectable,O
TAL1,B
rearrangements,I
",",O
TAL1,B
transcription,O
occurred,O
in,O
either,O
a,O
monoallelic,O
(,O
3,O
of,O
7,O
patients,O
),O
or,O
a,O
biallelic,O
(,O
4,O
of,O
7,O
patients,O
),O
fashion,O
.,O
Expression,O
of,O
erythroid,B
-,I
specific,I
genes,I
in,O
acute,O
megakaryoblastic,B
leukaemia,I
and,O
transient,O
myeloproliferative,B
disorder,I
in,O
Down,O
',O
s,O
syndrome,O
.,O
Acute,O
megakaryoblastic,B
leukaemia,I
(,O
M7,O
),O
and,O
transient,O
myeloproliferative,B
disorder,I
in,O
Down,O
',O
s,O
syndrome,O
(,O
TMD,O
),O
are,O
characterized,O
by,O
rapid,O
growth,O
of,O
abnormal,O
blast,O
cells,O
which,O
express,O
megakaryocytic,B
markers,I
.,O
Erythroid,B
-,I
specific,I
mRNAs,O
encoding,O
gamma,B
-,I
globin,I
and,O
erythroid,B
delta,I
-,I
aminolevulinate,I
synthase,I
were,O
found,O
to,O
be,O
expressed,O
in,O
blasts,O
from,O
most,O
of,O
these,O
cases,O
",",O
indicating,O
that,O
majorities,O
of,O
the,O
blasts,O
in,O
M7,O
and,O
TMD,O
cases,O
have,O
erythroid,B
and,O
megakaryocytic,B
phenotypes,O
.,O
These,O
results,O
suggest,O
that,O
M7,O
blasts,O
and,O
TMD,O
blasts,O
correspond,O
to,O
the,O
erythroid,B
/,I
megakaryocytic,B
bipotential,I
progenitor,I
cells,I
.,O
In,O
this,O
paper,O
",",O
the,O
expression,O
of,O
this,O
gene,O
in,O
blood,O
cells,O
was,O
first,O
investigated,O
in,O
fractions,O
of,O
nucleated,O
cells,O
",",O
revealing,O
predominant,O
expression,O
of,O
the,O
Ah,B
receptor,I
gene,I
in,O
the,O
monocyte,B
fraction,I
.,O
The,O
incubation,O
with,O
transforming,O
growth,O
factor,O
beta,O
1,O
and,O
1,O
alpha,O
",",O
25,O
-,O
dihydroxyvitamin,O
D3,O
resulted,O
in,O
a,O
5,O
-,O
to,O
7,O
-,O
fold,O
increase,O
of,O
AhR,B
mRNA,I
.,O
In,O
vitro,O
translated,O
Spi,B
-,I
B,I
protein,I
can,O
bind,O
to,O
PU,B
. 11,O
1,O
binding,O
sites,O
in,O
myeloid,B
promoters,I
and,O
transactivate,O
these,O
promoters,O
in,O
nonmyeloid,B
cells,I
. 25,O
In,O
contrast,O
",",O
PU,B
. 30,O
1,O
is,O
expressed,O
at,O
high,O
levels,O
not,O
only,O
in,O
monocytes,B
and,O
macrophages,B
but,O
also,O
in,O
neutrophils,B
",",O
indicating,O
that,O
PU,B
. 51,O
1,O
can,O
activate,O
gene,O
expression,O
in,O
both,O
major,O
myeloid,B
lineages,I
. 62,O
The,O
promoters,O
were,O
used,O
without,O
enhancers,O
",",O
or,O
with,O
enhancers,O
derived,O
from,O
the,O
beta,B
-,I
globin,I
locus,I
control,I
region,I
and,O
the,O
alpha,B
-,I
globin,I
HS,I
-,I
40,I
enhancer,I
.,O
When,O
transfected,O
into,O
K562,B
cells,I
",",O
which,O
express,O
zeta,B
-,I
globin,I
",",O
comparable,O
amounts,O
of,O
activity,O
were,O
obtained,O
from,O
the,O
-,O
557,O
and,O
-,O
417,O
zeta,B
-,I
luciferase,I
constructs,I
and,O
the,O
alpha,B
-,I
luciferase,I
constructs,I
when,O
no,O
enhancers,O
or,O
the,O
alpha,B
-,I
globin,I
locus,I
enhancers,I
were,O
used,O
.,O
This,O
element,O
requires,O
GATA,B
-,I
1,I
and,O
additional,O
unknown,O
factors,O
for,O
maximal,O
activity,O
.,O
To,O
address,O
this,O
issue,O
",",O
mutationally,O
active,O
PKC,B
-,I
alpha,I
",",O
-,O
epsilon,B
",",O
or,O
-,O
zeta,B
have,O
been,O
transfected,O
into,O
T,B
cells,I
and,O
the,O
consequences,O
for,O
T,B
cell,I
activation,I
determined,O
.,O
Accordingly,O
",",O
the,O
effects,O
of,O
the,O
constitutively,O
active,O
PKCs,B
were,O
compared,O
to,O
the,O
effects,O
of,O
mutationally,O
activated,O
p21ras,B
.,O
The,O
ability,O
of,O
PKC,B
-,I
epsilon,I
to,O
induce,O
transactivation,O
of,O
NF,B
-,I
AT,I
-,I
1,I
and,O
AP,B
-,I
1,I
was,O
similar,O
to,O
the,O
stimulatory,O
effect,O
of,O
a,O
constitutively,O
activated,O
p21ras,B
.,O
These,O
results,O
indicate,O
selective,O
functions,O
for,O
different,O
PKC,B
isotypes,O
in,O
T,B
cells,I
.,O
Moreover,O
",",O
the,O
data,O
comparing,O
the,O
effects,O
of,O
activated,O
Ras,B
and,O
PKC,B
mutants,O
suggest,O
that,O
PKC,B
-,I
alpha,I
",",O
p21ras,B
",",O
and,O
PKC,B
-,I
epsilon,I
are,O
not,O
positioned,O
linearly,O
on,O
a,O
single,O
signal,O
transduction,O
pathway,O
.,O
Differences,O
in,O
binding,O
of,O
glucocorticoid,B
receptor,I
to,O
DNA,B
in,O
steroid,O
-,O
resistant,O
asthma,O
.,O
We,O
examined,O
the,O
ability,O
of,O
nuclear,O
translocated,O
glucocorticoid,B
receptors,I
to,O
bind,O
to,O
their,O
DNA,B
binding,O
sites,O
(,O
GRE,B
),O
using,O
electrophoretic,O
mobility,O
shift,O
assays,O
in,O
PBMC,O
from,O
patients,O
with,O
steroid,O
-,O
sensitive,O
and,O
steroid,O
-,O
resistant,O
asthma,O
.,O
Scatchard,O
analysis,O
of,O
glucocorticoid,B
receptor,I
-,I
GRE,I
binding,O
showed,O
no,O
change,O
in,O
binding,O
affinity,O
but,O
did,O
show,O
a,O
reduced,O
number,O
of,O
receptors,O
available,O
for,O
DNA,B
binding,O
in,O
the,O
steroid,O
-,O
resistant,O
patients,O
.,O
Interleukin,B
-,I
5,I
signaling,O
in,O
human,O
eosinophils,O
involves,O
JAK2,B
tyrosine,I
kinase,I
and,O
Stat1,B
alpha,I
.,O
Signaling,O
by,O
a,O
wide,O
variety,O
of,O
cytokines,O
",",O
including,O
interferons,B
",",O
interleukins,B
",",O
and,O
growth,O
factors,O
",",O
involves,O
activation,O
of,O
JAK,B
kinases,I
and,O
Stat,B
(,O
Signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
),O
proteins,O
.,O
From,O
supershift,O
experiments,O
it,O
was,O
concluded,O
that,O
one,O
DNA,B
-,I
binding,I
complex,I
contained,O
Stat1,B
alpha,I
",",O
probably,O
as,O
a,O
homodimer,O
.,O
It,O
was,O
found,O
that,O
the,O
propagation,O
of,O
the,O
Tat,B
mutants,I
containing,O
wild,O
-,O
type,O
LTRs,O
was,O
less,O
efficient,O
than,O
that,O
of,O
the,O
LTR,B
-,I
modified,I
Tat,B
mutants,I
.,O
Here,O
we,O
show,O
that,O
the,O
lymphoid,B
-,I
specific,I
transcription,I
factor,I
Oct,B
-,I
2A,I
plays,O
a,O
critical,O
role,O
in,O
HLA,B
-,I
DRA,I
gene,I
expression,I
in,O
class,O
II,O
-,O
positive,O
B,B
cell,I
lines,I
",",O
and,O
that,O
the,O
high,O
mobility,O
group,O
protein,O
(,O
HMG,B
),O
I,O
/,O
Y,O
binds,O
to,O
multiple,O
sites,O
within,O
the,O
DRA,B
promoter,I
",",O
including,O
the,O
Oct,B
-,I
2A,I
binding,I
site,I
.,O
We,O
conclude,O
that,O
distinct,O
sets,O
of,O
transcription,O
factors,O
are,O
involved,O
in,O
the,O
two,O
modes,O
of,O
HLA,B
-,I
DRA,I
expression,O
",",O
and,O
that,O
HMG,B
I,I
/,I
Y,I
may,O
be,O
important,O
for,O
B,B
cell,I
-,I
specific,I
expression,O
",",O
and,O
is,O
essential,O
for,O
IFN,B
-,I
gamma,I
induction,O
.,O
In,O
lymphoblastoid,B
cell,I
lines,I
",",O
six,O
EBV,B
-,I
encoded,I
nuclear,I
antigens,I
(,O
EBNA1,B
",",O
2,O
",",O
3A,B
",",O
3B,B
",",O
3C,B
",",O
-,O
LP,B
),O
",",O
three,O
latent,B
membrane,I
proteins,I
(,O
LMP1,B
",",O
2A,B
",",O
2B,B
),O
",",O
and,O
two,O
nuclear,B
RNAs,I
(,O
EBERs,B
),O
are,O
expressed,O
.,O
In,O
EBV,B
-,I
positive,O
cases,O
of,O
Hodgkin,O
',O
s,O
disease,O
",",O
the,O
EBERs,B
",",O
EBNA1,B
",",O
and,O
the,O
LMPs,B
are,O
expressed,O
(,O
latency,O
II,O
),O
",",O
whereas,O
in,O
Burkitt,O
',O
s,O
lymphoma,O
(,O
BL,O
),O
only,O
the,O
EBERs,B
and,O
EBNA1,B
have,O
been,O
detected,O
(,O
latency,O
I,O
),O
. Expression,O
of,O
LMP1,B
was,O
seen,O
in,O
variable,O
proportions,O
of,O
tumor,O
cells,O
in,O
two,O
cases,O
and,O
EBNA2,B
was,O
detected,O
in,O
some,O
tumor,O
cells,O
in,O
three,O
other,O
cases,O
.,O
Also,O
",",O
the,O
BZLF1,B
trans,I
-,I
activator,I
protein,I
was,O
expressed,O
in,O
a,O
few,O
tumor,O
cells,O
in,O
6,O
cases,O
",",O
indicating,O
entry,O
into,O
the,O
lytic,O
cycle,O
.,O
A,O
phenotypic,O
drift,O
from,O
latency,O
I,O
to,O
latency,O
III,O
has,O
been,O
observed,O
previously,O
in,O
some,O
BL,O
cell,O
lines,O
.,O
Our,O
results,O
suggest,O
that,O
a,O
similar,O
phenomenon,O
may,O
occur,O
in,O
BL,O
in,O
vivo,O
and,O
indicate,O
that,O
the,O
operational,O
definition,O
of,O
EBV,O
latencies,O
is,O
not,O
easily,O
applied,O
to,O
human,O
tumors,O
.,O
Eosinophils,B
were,O
purified,O
from,O
peripheral,O
blood,O
by,O
discontinuous,O
Percoll,O
gradients,O
and,O
stimulated,O
with,O
IL,O
-,O
5,O
.,O
Immunosuppression,O
has,O
been,O
often,O
associated,O
with,O
the,O
course,O
of,O
malignant,O
diseases,O
.,O
Whereas,O
PHA,O
-,O
induced,O
proliferation,O
of,O
PBMCs,O
derived,O
from,O
patients,O
with,O
breast,B
cancer,I
preoperatively,O
was,O
significantly,O
decreased,O
when,O
compared,O
with,O
data,O
obtained,O
in,O
healthy,O
control,O
individuals,O
(,O
P,O
<,O
0,O
.,O
1,O
),O
",",O
the,O
degree,O
of,O
the,O
defect,O
in,O
PHA,B
-,I
induced,I
proliferation,I
of,I
PBMCs,I
depended,O
upon,O
the,O
tumour,O
burden,O
as,O
manifested,O
by,O
tumour,O
size,O
and,O
axillary,O
lymph,O
node,O
involvement,O
(,O
P,O
<,O
0,O
0.33,O
in,O
each,O
case,O
),O
0.38,O
PHA,B
-,I
induced,I
proliferation,I
of,I
PBMCs,I
dropped,O
significantly,O
in,O
patients,O
who,O
received,O
adjuvant,O
chemotherapy,O
consisting,O
of,O
cyclophosphamide,O
",",O
methotrexate,O
and,O
fluorouracil,O
(,O
CMF,O
),O
after,O
an,O
observation,O
period,O
of,O
6,O
months,O
(,O
P,O
<,O
0,O
0.74,O
1,O
),O
",",O
but,O
not,O
in,O
patients,O
under,O
adjuvant,O
treatment,O
with,O
tamoxifen,O
only,O
.,O
We,O
thus,O
conclude,O
that,O
PHA,O
-,O
induced,O
proliferation,O
of,O
PBMCs,O
derived,O
from,O
patients,O
with,O
breast,B
cancer,I
depends,O
upon,O
the,O
tumour,O
load,O
and,O
is,O
a,O
good,O
clinical,O
predictor,O
for,O
the,O
further,O
course,O
of,O
the,O
disease,O
.,O
A,O
previously,O
unrecognized,O
element,O
",",O
located,O
downstream,O
of,O
the,O
start,O
site,O
of,O
transcription,O
in,O
the,O
first,O
exon,O
of,O
the,O
DR,B
alpha,I
gene,I
",",O
has,O
been,O
defined,O
that,O
enhances,O
promoter,O
activity,O
up,O
to,O
eightfold,O
in,O
a,O
position,O
-,O
dependent,O
manner,O
.,O
The,O
nuclear,O
factor,O
binds,O
to,O
the,O
DR,B
alpha,I
and,O
DP,B
alpha,I
element,O
but,O
not,O
to,O
the,O
element,O
in,O
the,O
DQ,B
alpha,I
gene,O
.,O
One,O
of,O
the,O
genes,O
that,O
encodes,O
a,O
CBF,B
alpha,I
subunit,O
is,O
AML1,O
",",O
also,O
called,O
Cbf,B
alpha,I
2,I
.,O
Three,O
different,O
isoforms,O
of,O
CBF,B
beta,I
were,O
also,O
tested,O
for,O
transcriptional,O
activity,O
on,O
the,O
SL3,O
enhancer,O
.,O
These,O
results,O
indicated,O
that,O
at,O
least,O
in,O
certain,O
cell,O
types,O
",",O
the,O
maximum,O
activity,O
of,O
CBF,B
required,O
both,O
subunits,O
.,O
We,O
also,O
examined,O
whether,O
CBF,B
could,O
distinguish,O
a,O
1,O
-,O
bp,O
difference,O
between,O
the,O
enhancer,O
core,O
of,O
SL3,O
and,O
the,O
core,O
of,O
the,O
nonleukemogenic,O
virus,O
",",O
Akv,O
.,O
However,O
",",O
no,O
combination,O
of,O
CBF,B
alpha,I
and,O
CBF,B
beta,I
subunits,I
that,O
we,O
tested,O
was,O
able,O
to,O
distinguish,O
the,O
1,O
-,O
bp,O
difference,O
in,O
transcription,O
assays,O
.,O
Using,O
electrophoretic,O
mobility,O
shift,O
assays,O
(,O
EMSA,O
),O
",",O
we,O
now,O
show,O
that,O
",",O
in,O
monocytes,O
stimulated,O
with,O
LPS,O
or,O
TNF,O
alpha,O
",",O
IL,O
-,O
10,O
inhibits,O
nuclear,O
stimulation,O
of,O
nuclear,O
factor,O
kappa,O
B,O
(,O
NF,B
kappa,I
B,I
),O
",",O
a,O
transcription,O
factor,O
involved,O
in,O
the,O
expression,O
of,O
inflammatory,O
cytokine,O
genes,O
.,O
Several,O
other,O
transcription,O
factors,O
including,O
NF,B
-,I
IL,I
-,I
6,I
",",O
AP,B
-,I
1,I
",",O
AP,B
-,I
2,I
",",O
GR,B
",",O
CREB,B
",",O
Oct,B
-,I
1,I
",",O
and,O
Sp,B
-,I
1,I
are,O
not,O
affected,O
by,O
IL,B
-,I
10,I
.,O
Furthermore,O
",",O
compounds,O
such,O
as,O
tosylphenylalanyl,O
chloromethyl,O
ketone,O
and,O
pyrrolidinedithiocar,O
that,O
are,O
known,O
to,O
selectively,O
inhibit,O
NF,B
kappa,I
B,I
activation,O
block,O
cytokine,O
gene,O
transcription,O
in,O
LPS,O
-,O
stimulated,O
monocytes,O
.,O
Taken,O
together,O
",",O
these,O
results,O
suggest,O
that,O
inhibition,O
of,O
NF,B
kappa,I
B,I
activation,O
may,O
be,O
an,O
important,O
mechanism,O
for,O
IL,B
-,I
10,I
suppression,O
of,O
cytokine,O
gene,O
transcription,O
in,O
human,B
monocytes,I
.,O
In,O
addition,O
",",O
this,O
TR2RE,O
-,O
SV40,O
can,O
function,O
as,O
a,O
repressor,O
to,O
suppress,O
the,O
transcriptional,O
activities,O
of,O
both,O
SV40,O
early,O
and,O
late,O
promoters,O
.,O
We,O
have,O
analyzed,O
CBF,B
beta,I
-,I
MYH11,I
fusion,I
transcripts,I
by,O
RT,O
-,O
PCR,O
in,O
myelomonocytic,B
leukemias,I
",",O
with,O
or,O
without,O
eosinophilia,B
",",O
to,O
determine,O
whether,O
their,O
presence,O
correlates,O
with,O
morphology,O
. 30,O
Fifty,O
-,O
three,O
cases,O
(,O
11,O
AML,B
M4Eo,I
;,O
1,O
AML,B
M4,I
with,O
atypical,O
abnormal,O
eosinophils,B
(,O
AML,B
M4,I
`,O
`,O
Eo,O
',O
',O
),O
;,O
29,O
AML,B
M4,I
;,O
8,O
AML,B
M5,I
;,O
3,O
CMML,B
;,O
and,O
1,O
AML,B
M2,I
with,O
eosinophilia,B
),O
were,O
analyzed,O
. 77,O
Both,O
cases,O
tested,O
also,O
showed,O
MYH11,B
genomic,I
rearrangement,I
.,O
Follow,O
-,O
up,O
of,O
three,O
patient,O
showed,O
residual,O
positivity,O
in,O
apparent,O
complete,O
remission,O
.,O
HIV,B
-,I
1,I
Tat,I
potentiates,O
TNF,B
-,I
induced,I
NF,B
-,I
kappa,I
B,I
activation,I
and,O
cytotoxicity,O
by,O
altering,O
the,O
cellular,O
redox,O
state,O
.,O
In,O
HeLa,B
cells,I
stably,O
transfected,O
with,O
the,O
HIV,B
-,I
1,I
tat,I
gene,I
(,O
HeLa,B
-,I
tat,I
cells,I
),O
",",O
expression,O
of,O
the,O
Tat,B
protein,I
enhanced,O
both,O
TNF,B
-,I
induced,I
activation,I
of,O
NF,B
-,I
kappa,I
B,I
and,O
TNF,B
-,I
mediated,I
cytotoxicity,O
.,O
Thus,O
",",O
Mn,O
-,O
SOD,B
RNA,B
protein,I
levels,O
and,O
activity,O
were,O
markedly,O
reduced,O
in,O
the,O
presence,O
of,O
Tat,O
.,O
The,O
use,O
of,O
glucocorticoids,O
in,O
acute,O
lymphoblastic,O
leukemia,O
of,O
childhood,O
.,O
Glucocorticoids,O
have,O
been,O
included,O
in,O
almost,O
all,O
treatment,O
regimens,O
for,O
childhood,O
acute,O
lymphoblastic,O
leukemia,O
for,O
decades,O
.,O
New,O
data,O
on,O
the,O
pharmacokinetics,O
",",O
pharmacodynamics,O
",",O
and,O
molecular,O
mechanisms,O
of,O
action,O
of,O
glucocorticoids,O
have,O
suggested,O
alternative,O
approaches,O
in,O
ALL,O
.,O
Blast,O
sensitivity,O
to,O
glucocorticoids,B
correlates,O
closely,O
with,O
sensitivity,O
to,O
other,O
",",O
putatively,O
non,O
-,O
cross,O
-,O
resisting,O
agents,O
and,O
with,O
outcome,O
after,O
multi,O
-,O
agent,O
therapy,O
",",O
suggesting,O
overlapping,O
mechanisms,O
of,O
action,O
",",O
and,O
focusing,O
attention,O
on,O
the,O
determinants,O
of,O
the,O
threshold,O
for,O
apoptosis,O
.,O
Expression,O
of,O
the,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
),O
latent,O
membrane,O
protein,O
1,O
(,O
LMP,B
-,I
1,I
),O
oncogene,O
is,O
regulated,O
by,O
the,O
EBV,B
nuclear,I
protein,I
2,I
(,O
EBNA,B
-,I
2,I
),O
transactivator,O
.,O
EBNA,B
-,I
2,I
is,O
known,O
to,O
interact,O
with,O
the,O
cellular,O
DNA,B
-,I
binding,I
protein,I
J,B
kappa,I
and,O
is,O
recruited,O
to,O
promoters,O
containing,O
the,O
GTGGGAA,O
J,B
kappa,I
recognition,I
sequence,I
.,O
The,O
minimal,O
EBNA,B
-,I
2,I
-,I
responsive,I
LMP,B
-,I
1,I
promoter,I
includes,O
one,O
J,B
kappa,I
-,I
binding,I
site,I
",",O
and,O
we,O
now,O
show,O
that,O
mutation,O
of,O
that,O
site,O
",",O
such,O
that,O
J,B
kappa,I
can,O
not,O
bind,O
",",O
reduces,O
EBNA,B
-,I
2,I
responsiveness,I
by,O
60,O
%,O
.,O
To,O
identify,O
other,O
factors,O
which,O
interact,O
with,O
the,O
LMP,B
-,I
1,I
EBNA,B
-,I
2,I
response,O
element,O
(,O
E2RE,O
),O
",",O
a,O
-,O
236,O
/,O
-,O
145,O
minimal,O
E2RE,O
was,O
used,O
as,O
a,O
probe,O
in,O
an,O
electrophoretic,O
mobility,O
shift,O
assay,O
.,O
LBF4,O
is,O
B,O
-,O
and,O
T,O
-,O
cell,O
specific,O
and,O
recognizes,O
the,O
PU,O
.,O
1,O
GGAA,O
core,O
sequence,O
as,O
shown,O
by,O
methylation,O
interference,O
.,O
The,O
efficacy,O
of,O
serotonin,B
reuptake,I
inhibitors,I
(,O
SRIs,B
),O
is,O
uncertain,O
",",O
and,O
response,O
predictors,O
are,O
unavailable,O
.,O
Abnormal,O
fast,O
feedback,O
and,O
negative,O
feedback,O
of,O
the,O
hypothalamic,B
-,I
pituitary,I
-,I
adrenal,I
axis,I
implicates,O
a,O
dampened,O
limbic,B
-,I
hippocampal,I
glucocorticoid,I
type,I
II,I
receptor,I
(,O
GCII,B
),O
.,O
We,O
hypothesized,O
that,O
lymphocyte,B
GCII,I
is,O
altered,O
in,O
adolescent,O
MDD,O
and,O
could,O
serve,O
as,O
a,O
marker,O
for,O
response,O
to,O
SRIs,B
.,O
The,O
role,O
of,O
NFATp,B
in,O
cyclosporin,O
A,O
-,O
sensitive,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
gene,O
transcription,O
.,O
Thus,O
",",O
although,O
the,O
kappa,O
3,O
element,O
has,O
little,O
sequence,O
similarity,O
to,O
other,O
NFATp,B
-,O
binding,O
sites,O
",",O
it,O
appears,O
to,O
function,O
as,O
a,O
cyclosporin,O
-,O
sensitive,O
promoter,O
element,O
in,O
T,O
cells,O
by,O
virtue,O
of,O
its,O
ability,O
to,O
bind,O
NFATp,B
.,O
By,O
contrast,O
",",O
three,O
lymphoblastoid,B
cell,I
lines,I
(,O
immortalized,O
in,O
vitro,O
with,O
Epstein,O
-,O
Barr,O
virus,O
),O
were,O
weakly,O
positive,O
and,O
MNDA,B
was,O
up,O
-,O
regulated,O
by,O
interferon,O
-,O
alpha,O
(,O
IFN,B
-,I
alpha,I
),O
treatment,O
.,O
The,O
results,O
varied,O
with,O
the,O
agent,O
",",O
cell,O
type,O
",",O
and,O
stage,O
of,O
differentiation,O
.,O
Changes,O
in,O
MNDA,B
expression,O
occurred,O
slowly,O
(,O
hours,O
to,O
days,O
),O
",",O
suggesting,O
that,O
MNDA,B
could,O
mediate,O
changes,O
realized,O
over,O
a,O
long,O
period,O
.,O
EBNA,B
-,I
2,I
is,O
able,O
to,O
trans,O
-,O
activate,O
the,O
expression,O
of,O
the,O
LMP,B
gene,I
in,O
several,O
cell,B
lines,I
.,O
Various,O
reports,O
have,O
delineated,O
the,O
cis,O
-,O
acting,O
elements,O
of,O
the,O
LMP,B
promoter,I
through,O
which,O
EBNA,B
-,I
2,I
mediates,O
trans,O
-,O
activation,O
.,O
These,O
complexes,O
were,O
destroyed,O
by,O
detergent,O
.,O
Enhanced,O
Ig,B
synthesis,I
is,O
a,O
result,O
of,O
coordinated,O
transcriptional,O
activation,O
of,O
Ig,B
genes,I
without,O
promoter,O
or,O
isotype,O
specificity,O
",",O
and,O
differential,O
accumulation,O
of,O
the,O
mRNA,O
encoding,O
the,O
secreted,O
form,O
of,O
Ig,B
heavy,I
chain,I
.,O
It,O
is,O
saturable,O
and,O
subject,O
to,O
negative,O
control,O
when,O
IL,B
-,I
6,I
stimulation,O
is,O
prolonged,O
.,O
Thus,O
",",O
differentiation,O
of,O
B,B
cells,I
with,O
IL,B
-,I
6,I
in,O
vitro,O
recapitulates,O
the,O
hallmarks,O
of,O
terminal,O
B,B
differentiation,I
in,O
vivo,O
;,O
Oct,O
-,O
2,O
may,O
have,O
a,O
role,O
in,O
this,O
process,O
.,O
We,O
have,O
previously,O
shown,O
that,O
treatment,O
of,O
Jurkat,B
T,I
cells,I
with,O
phytohemaglutinin,O
(,O
PHA,B
),O
and,O
the,O
phorbol,O
ester,O
",",O
PMA,B
",",O
activated,O
transcription,O
initiation,O
from,O
the,O
IL,B
-,I
3,I
gene,I
.,O
We,O
also,O
examined,O
the,O
function,O
of,O
the,O
IL,B
-,I
3,I
CK,I
-,I
1,I
/,I
CK,I
-,I
2,I
elements,O
that,O
are,O
present,O
in,O
many,O
cytokine,B
genes,I
and,O
found,O
that,O
they,O
acted,O
as,O
a,O
repressor,O
of,O
basal,O
level,O
expression,O
when,O
cloned,O
upstream,O
of,O
a,O
heterologous,O
promoter,O
but,O
were,O
also,O
inducible,O
by,O
PMA,O
/,O
PHA,O
.,O
Glucocorticoids,O
have,O
an,O
inhibitory,O
effect,O
on,O
inflammatory,O
and,O
immune,O
responses,O
",",O
and,O
this,O
may,O
be,O
through,O
the,O
modulation,O
of,O
transcription,O
factor,O
binding,O
to,O
DNA,B
.,O
TNF,B
-,I
alpha,I
",",O
IL,B
-,I
1,I
beta,I
and,O
phorbol,O
myristate,O
acetate,O
(,O
PMA,O
),O
treatment,O
increased,O
AP,B
-,I
1,I
and,O
NF,B
kappa,I
B,I
DNA,I
binding,I
by,O
up,O
to,O
200,O
%,O
but,O
decreased,O
CREB,B
binding,I
(,O
38,O
%,O
),O
over,O
a,O
60,O
-,O
min,O
time,O
course,O
.,O
This,O
may,O
be,O
an,O
important,O
molecular,O
site,O
of,O
steroid,O
action,O
.,O
During,O
the,O
induction,O
of,O
anergy,O
",",O
T,B
cells,I
are,O
phenotypically,O
similar,O
to,O
cells,O
responding,O
to,O
an,O
immunogenic,O
stimulus,O
.,O
When,O
restimulated,O
",",O
however,O
",",O
anergic,O
T,B
cells,I
fail,O
to,O
up,O
-,O
regulate,O
transcription,O
of,O
the,O
IL,B
-,I
2,I
gene,I
and,O
in,O
consequence,O
do,O
not,O
produce,O
IL,B
-,I
2,I
.,O
The,O
effect,O
of,O
BDP,O
was,O
greatly,O
dependent,O
on,O
the,O
presence,O
of,O
Zn,B
+,I
+,I
ions,I
in,O
the,O
preparation,O
",",O
since,O
the,O
augmenting,O
effect,O
was,O
abolished,O
if,O
BDP,O
did,O
not,O
contain,O
zinc,O
.,O
The,O
receptor,B
concentration,O
",",O
as,O
measured,O
by,O
staining,O
and,O
steroid,B
binding,I
test,O
",",O
varied,O
considerably,O
but,O
showed,O
no,O
clear,O
correlation,O
to,O
clinical,O
response,O
.,O
Using,O
a,O
highly,O
sensitive,O
mutation,O
screening,O
assay,O
of,O
the,O
DNA,B
-,I
and,O
the,O
steroid,B
-,I
binding,I
region,I
",",O
none,O
of,O
the,O
treated,O
patients,O
revealed,O
any,O
mutation,O
",",O
suggesting,O
that,O
the,O
glucocorticoid,B
receptor,I
in,O
the,O
CLL,O
patients,O
tested,O
is,O
not,O
altered,O
in,O
these,O
domains,O
.,O
Expression,O
of,O
the,O
kappa,B
immunoglobulin,I
light,I
chain,I
gene,I
requires,O
developmental,O
-,O
and,O
tissue,O
-,O
specific,O
regulation,O
by,O
trans,O
-,O
acting,O
factors,O
which,O
interact,O
with,O
two,O
distinct,O
enhancer,O
elements,O
.,O
Methylation,O
studies,O
indicated,O
that,O
the,O
tal,O
-,O
15,O
',O
GC,O
-,O
rich,O
region,O
behaves,O
like,O
a,O
CpG,O
island,O
",",O
hypomethylated,O
in,O
normal,O
cells,O
",",O
and,O
methylated,O
de,O
novo,O
on,O
transcriptionally,O
inactive,O
alleles,O
in,O
established,O
cell,B
lines,I
.,O
M,B
-,I
TAT,I
is,O
a,O
cytokine,O
-,O
dependent,O
cell,O
line,O
with,O
the,O
potential,O
to,O
differentiate,O
along,O
the,O
erythroid,B
and,O
megakaryocytic,B
lineages,I
.,O
In,O
contrast,O
",",O
the,O
addition,O
of,O
GM,B
-,I
CSF,I
to,O
the,O
M,B
-,I
TAT,I
/,I
EPO,I
cell,O
culture,O
decreased,O
the,O
amount,O
of,O
hemoglobin,B
",",O
even,O
in,O
the,O
presence,O
of,O
EPO,B
",",O
indicating,O
that,O
the,O
EPO,B
signal,I
for,O
erythroid,B
differentiation,I
is,O
suppressed,O
by,O
GM,B
-,I
CSF,I
.,O
Transient,O
chloramphenicol,B
acetyltransferase,I
assay,O
revealed,O
that,O
the,O
region,O
containing,O
E2F,B
binding,I
site,I
had,O
a,O
strong,O
promoter,O
activity,O
",",O
and,O
introduction,O
of,O
the,O
mutation,O
at,O
the,O
E2F,B
binding,I
site,I
resulted,O
in,O
a,O
significant,O
loss,O
of,O
the,O
activity,O
.,O
E2F,B
-,I
1,I
and,O
DP,B
-,I
1,I
mRNAs,O
were,O
not,O
detectable,O
in,O
granulocytes,O
",",O
monocytes,O
and,O
resting,O
T,B
-,I
lymphocytes,I
but,O
were,O
induced,O
after,O
the,O
mitogenic,O
stimulation,O
of,O
T,B
-,I
lymphocytes,I
.,O
Association,O
of,O
alterations,O
in,O
NF,B
-,I
kappa,I
B,I
moieties,O
with,O
HIV,B
type,I
1,I
proviral,I
latency,O
in,O
certain,O
monocytic,O
cells,O
.,O
Human,O
immunodeficiency,O
virus,O
type,O
1,O
(,O
HIV,B
-,I
1,I
),O
replication,O
is,O
controlled,O
by,O
a,O
complex,O
array,O
of,O
virally,O
encoded,O
and,O
cellular,O
proteins,O
.,O
The,O
NFATd,B
element,I
",",O
which,O
binds,O
the,O
transcription,O
factor,O
NFAT,B
-,I
1,I
and,O
is,O
very,O
active,O
in,O
T,O
cells,O
",",O
is,O
only,O
weakly,O
active,O
in,O
one,O
B,O
clone,O
and,O
not,O
at,O
all,O
in,O
another,O
.,O
This,O
parallels,O
the,O
increased,O
I,B
kappa,I
B,I
alpha,I
synthesis,O
secondary,O
to,O
increased,O
I,B
kappa,I
B,I
alpha,I
gene,O
transcription,O
",",O
i,O
.,O
e,O
.,O
",",O
increased,O
RNA,B
and,O
transcriptional,O
activity,O
of,O
its,O
promoter,O
-,O
enhancer,O
.,O
Transcriptional,O
activity,O
of,O
p105,B
is,O
also,O
increased,O
in,O
infected,O
cells,O
and,O
is,O
also,O
mediated,O
by,O
NF,B
-,I
kappa,I
B,I
through,O
a,O
specific,O
kappa,I
B,I
motif,O
.,O
In,O
this,O
study,O
",",O
we,O
show,O
that,O
an,O
activation,O
-,O
deficient,O
glucocorticoid,B
receptor,I
mutant,I
is,O
as,O
effective,O
as,O
the,O
wild,O
-,O
type,O
receptor,O
in,O
repression,O
of,O
AP,O
-,O
1,O
activity,O
",",O
inhibition,O
of,O
interleukin,B
-,I
2,I
production,I
",",O
inhibition,O
of,O
c,O
-,O
myc,O
expression,O
and,O
induction,O
of,O
apoptosis,O
.,O
HIV,O
type,O
1,O
protease,O
activation,O
of,O
NF,O
-,O
kappa,O
B,O
within,O
T,O
lymphoid,O
cells,O
.,O
It,O
has,O
been,O
reported,O
that,O
HIV,B
-,I
1,I
protease,O
may,O
cleave,O
the,O
NF,B
-,I
kappa,I
B,I
precursor,O
to,O
its,O
active,O
form,O
in,O
vitro,O
.,O
Insertion,O
of,O
this,O
chimeric,O
promoter,O
(,O
ISG15,B
LTR,I
),O
upstream,O
of,O
the,O
human,O
IFNA2,B
gene,O
directed,O
high,O
levels,O
of,O
IFN,B
synthesis,O
in,O
Tat,O
-,O
expressing,O
cells,O
",",O
while,O
this,O
promoter,O
was,O
not,O
responsive,O
to,O
tumor,O
necrosis,O
factor,O
alpha,O
-,O
mediated,O
activation,O
.,O
Selected,O
transfected,O
clones,O
produced,O
low,O
levels,O
of,O
IFN,B
A,I
(,O
IFNA,B
),O
constitutively,O
",",O
and,O
their,O
abilities,O
to,O
express,O
interleukin,B
-,I
2,I
and,O
interleukin,B
-,I
2,I
receptor,I
upon,O
stimulation,O
with,O
phytohemagglutinin,O
and,O
phorbol,O
myristate,O
acetate,O
were,O
retained,O
.,O
Flow,O
cytometric,O
analysis,O
also,O
showed,O
that,O
at,O
72,O
h,O
of,O
virus,O
exposure,O
fewer,O
T,O
cells,O
from,O
the,O
elderly,O
produced,O
interferon,B
-,I
gamma,I
(,O
IFN,B
-,I
gamma,I
),O
",",O
suggesting,O
a,O
link,O
between,O
the,O
magnitude,O
of,O
the,O
Fos,O
and,O
Jun,O
and,O
IFN,B
-,I
gamma,I
responses,O
.,O
The,O
regulation,O
of,O
HIV,B
by,O
retinoic,B
acid,I
correlates,O
with,O
cellular,O
expression,O
of,O
the,O
retinoic,B
acid,I
receptors,I
.,O
Even,O
a,O
moderate,O
increase,O
in,O
the,O
cellular,O
cysteine,B
supply,I
elevates,O
the,O
intracellular,O
glutathione,B
(,O
GSH,B
),O
and,O
glutathione,B
disulfide,I
(,O
GSSG,B
),O
levels,O
and,O
potentiates,O
immunological,O
functions,O
of,O
lymphocytes,O
in,O
vitro,O
.,O
As,O
signal,O
transduction,O
is,O
facilitated,O
by,O
prooxidant,O
conditions,O
",",O
we,O
propose,O
that,O
the,O
well,O
-,O
known,O
immunological,O
consequences,O
of,O
GSH,B
depletion,I
ultimately,O
may,O
be,O
results,O
of,O
the,O
accompanying,O
GSSG,B
deficiency,I
.,O
The,O
second,O
abnormality,O
in,O
kappa,O
B,O
-,O
binding,O
activity,O
in,O
T,O
cells,O
from,O
these,O
patients,O
is,O
that,O
RelA,B
",",O
a,O
member,O
of,O
the,O
Rel,O
homology,O
family,O
which,O
is,O
part,O
of,O
the,O
normal,O
NF,O
-,O
kappa,O
B,O
complex,O
",",O
was,O
not,O
induced,O
in,O
the,O
nucleus,O
following,O
activation,O
.,O
Cord,O
blood,O
cultures,O
showed,O
an,O
additive,O
combination,O
of,O
`,O
`,O
adult,B
',I
',O
and,O
`,O
`,O
fetal,B
',I
',O
patterns,O
.,O
Our,O
studies,O
also,O
demonstrate,O
that,O
under,O
anemic,O
stress,O
",",O
recruitment,O
of,O
fetal,B
progenitors,O
may,O
occur,O
in,O
adulthood,O
.,O
Taken,O
together,O
",",O
our,O
data,O
suggest,O
that,O
two,O
interactive,O
mechanisms,O
regulate,O
monocytic,O
I,O
kappa,O
B,O
alpha,O
/,O
MAD,O
-,O
3,O
mRNA,O
levels,O
.,O
In,O
extracts,O
from,O
nonstimulated,O
cells,O
the,O
receptor,B
is,O
recovered,O
in,O
an,O
inducible,O
cytoplasmic,O
form,O
associated,O
with,O
the,O
90,O
-,O
kDa,O
heat,B
shock,I
protein,I
(,O
hsp90,B
),O
",",O
a,O
molecular,O
chaperone,O
.,O
It,O
was,O
not,O
possible,O
to,O
reconstitute,O
dioxin,B
receptor,I
function,O
with,O
proteins,O
expressed,O
in,O
wheat,B
germ,I
lysate,I
.,O
In,O
line,O
with,O
these,O
observations,O
",",O
reticulocyte,B
lysate,I
but,O
not,O
wheat,B
germ,I
lysate,I
promoted,O
the,O
association,O
of,O
de,O
novo,O
synthesized,O
dioxin,B
receptor,I
with,O
hsp90,B
.,O
Induction,O
of,O
transcription,O
factors,O
in,O
human,O
T,B
lymphocytes,I
by,O
aspirin,O
-,O
like,O
drugs,O
.,O
Protein,B
kinase,I
C,I
is,O
not,O
a,O
downstream,O
effector,O
of,O
p21ras,O
in,O
activated,O
T,B
cells,I
.,O
Data,O
is,O
presented,O
",",O
using,O
the,O
potent,O
and,O
selective,O
PKC,B
inhibitor,I
Ro,I
31,I
-,I
8425,I
and,O
transient,O
expression,O
of,O
a,O
constitutively,O
active,O
ras,O
mutant,O
",",O
which,O
clearly,O
shows,O
that,O
PKC,B
is,O
not,O
downstream,O
of,O
p21ras,O
in,O
the,O
induction,O
of,O
NF,B
-,I
AT,I
and,O
AP,B
-,I
1,I
transcriptional,I
activity,I
and,O
in,O
the,O
expression,O
of,O
IL,B
-,I
2,I
in,O
human,O
Jurkat,B
T,I
cells,I
.,O
The,O
signaling,O
pathways,O
involving,O
PKC,B
activation,I
",",O
calcium,B
mobilization,I
and,O
ras,B
activation,I
combine,O
to,O
provide,O
the,O
necessary,O
components,O
for,O
production,O
of,O
IL,B
-,I
2,I
during,O
T,B
cell,I
activation,I
.,O
Here,O
",",O
we,O
report,O
that,O
stimulation,O
through,O
the,O
IL,B
-,I
2R,I
induced,O
tyrosine,B
phosphorylation,I
and,O
subsequent,O
nuclear,B
translocation,I
of,O
stat3,B
",",O
a,O
newly,O
identified,O
member,O
of,O
the,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
STAT,B
),O
family,O
of,O
proteins,O
.,O
Apart,O
from,O
stat3,B
",",O
another,O
cytoplasmic,O
protein,B
was,O
tyrosine,O
phosphorylated,O
and,O
subsequently,O
translocated,O
to,O
the,O
nucleus,O
in,O
response,O
to,O
IL,O
-,O
2,O
.,O
This,O
protein,B
had,O
an,O
apparent,O
molecular,O
mass,O
of,O
84,O
kDa,O
and,O
was,O
not,O
recognized,O
by,O
stat3,B
or,O
stat1,B
mAb,I
or,O
antisera,B
.,O
Taken,O
together,O
",",O
we,O
report,O
that,O
IL,O
-,O
2,O
induces,O
tyrosine,O
phosphorylation,O
and,O
subsequent,O
nuclear,O
translocation,O
of,O
stat3,B
and,O
an,O
as,O
yet,O
undefined,O
84,O
-,O
kDa,O
protein,B
in,O
antigen,O
-,O
specific,O
human,O
T,O
cell,B
lines,I
.,O
Human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
Tax,B
activation,O
of,O
NF,B
-,I
kappa,I
B,I
/,O
Rel,B
involves,O
phosphorylation,O
and,O
degradation,O
of,O
I,B
kappa,I
B,I
alpha,I
and,O
RelA,B
(,O
p65,I
),O
-,O
mediated,O
induction,O
of,O
the,O
c,B
-,I
rel,I
gene,I
.,O
The,O
tax,O
gene,O
product,O
of,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
(,O
HTLV,B
-,I
I,I
),O
is,O
a,O
potent,O
transcriptional,O
activator,O
that,O
both,O
stimulates,O
viral,O
gene,O
expression,O
and,O
activates,O
an,O
array,O
of,O
cellular,O
genes,O
involved,O
in,O
T,B
-,I
cell,I
growth,O
.,O
In,O
contrast,O
to,O
prior,O
in,O
vitro,O
studies,O
",",O
at,O
least,O
a,O
fraction,O
of,O
the,O
phosphorylated,O
form,O
of,O
I,B
kappa,I
B,I
alpha,I
remains,O
physically,O
associated,O
with,O
the,O
NF,B
-,I
kappa,I
B,I
complex,I
in,O
vivo,O
but,O
is,O
subject,O
to,O
rapid,O
degradation,O
",",O
thereby,O
promoting,O
the,O
nuclear,O
translocation,O
of,O
the,O
active,O
NF,B
-,I
kappa,I
B,I
complex,I
.,O
Therefore,O
we,O
investigated,O
the,O
modifications,O
imposed,O
on,O
NF,B
-,I
kappa,I
B,I
/,I
I,B
kappa,I
B,I
components,I
following,O
stimulation,O
and,O
show,O
that,O
the,O
final,O
step,O
of,O
NF,B
-,I
kappa,I
B,I
induction,O
in,O
vivo,O
involves,O
phosphorylation,O
of,O
several,O
members,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
/,I
I,B
kappa,I
B,I
protein,I
families,I
.,O
Isolation,O
of,O
differentially,O
expressed,O
sequence,O
tags,O
from,O
steroid,B
-,I
responsive,I
cells,I
using,O
mRNA,B
differential,I
display,I
.,O
Although,O
much,O
is,O
known,O
about,O
the,O
structure,O
and,O
function,O
of,O
steroid,B
receptors,I
",",O
relatively,O
few,O
cell,B
-,I
specific,I
steroid,B
-,I
regulated,I
genes,I
have,O
been,O
isolated,O
and,O
characterized,O
.,O
In,O
this,O
paper,O
we,O
describe,O
results,O
using,O
mRNA,B
differential,I
display,I
reverse,I
transcriptase,I
PCR,I
(,O
DDPCR,B
),O
to,O
identify,O
and,O
isolate,O
short,O
cDNA,B
sequence,I
tags,I
from,O
thymocyte,B
and,O
prostate,B
cells,I
under,O
various,O
hormone,O
conditions,O
.,O
GIG10,O
is,O
a,O
novel,O
sequence,O
and,O
GIG18,O
is,O
the,O
mouse,O
homologue,O
of,O
a,O
human,O
expressed,O
sequence,O
tag,O
isolated,O
from,O
activated,O
B,B
lymphocytes,I
.,O
We,O
have,O
shown,O
that,O
",",O
within,O
the,O
thymus,O
",",O
a,O
population,O
of,O
large,O
",",O
immature,O
cells,O
expresses,O
CD21,B
.,O
EBV,O
altered,O
the,O
activation,O
responses,O
of,O
immature,O
thymocytes,O
in,O
vitro,O
.,O
This,O
function,O
was,O
a,O
result,O
of,O
the,O
interaction,O
of,O
EBV,O
with,O
its,O
receptor,O
",",O
CD21,B
",",O
but,O
was,O
caused,O
by,O
infection,O
rather,O
than,O
surface,O
signaling,O
",",O
because,O
neither,O
specific,O
mAb,O
nor,O
the,O
P3HR,O
-,O
1,O
strain,O
of,O
virus,O
mimicked,O
the,O
effect,O
of,O
B95,O
-,O
8,O
.,O
Consistent,O
with,O
the,O
activity,O
of,O
B95,B
-,I
8,I
",",O
EBNA,B
-,I
2,I
transcripts,O
were,O
identified,O
within,O
infected,O
thymocyte,O
populations,O
.,O
A,O
second,O
transcript,O
was,O
identified,O
as,O
encoding,O
the,O
recently,O
characterized,O
RAZ,B
",",O
which,O
also,O
is,O
associated,O
with,O
replicative,O
infection,O
.,O
The,O
regulation,O
of,O
nuclear,O
factor,O
(,O
NF,B
),O
-,O
kappa,O
B,I
activation,O
by,O
the,O
T,B
cell,I
receptor,I
(,O
TcR,B
),O
/,O
CD3,B
complex,I
in,O
primary,O
human,O
T,B
cells,I
has,O
been,O
studied,O
at,O
various,O
times,O
after,O
activation,O
.,O
p50,B
.,O
c,B
-,I
rel,I
heterodimers,O
were,O
also,O
detected,O
bound,O
to,O
this,O
sequence,O
at,O
early,O
time,O
points,O
(,O
7,O
-,O
16,O
h,O
;,O
early,O
),O
",",O
and,O
both,O
remained,O
active,O
at,O
later,O
time,O
points,O
(,O
40,O
h,O
;,O
late,O
),O
after,O
activation,O
.,O
These,O
results,O
indicate,O
that,O
the,O
regulation,O
of,O
NF,B
-,I
kappa,I
B,I
activation,O
during,O
T,B
cell,I
activation,O
by,O
TcR,B
/,I
CD3,I
signals,O
is,O
biphasic,O
:,O
TcR,B
/,I
CD3,I
triggers,O
its,O
immediate,O
translocation,O
",",O
which,O
is,O
transient,O
if,O
no,O
TNF,B
-,I
alpha,I
is,O
present,O
.,O
The,O
cis,O
-,O
acting,O
region,O
",",O
GM,B
-,I
kappa,I
B,I
/,I
GC,I
-,I
box,I
(,O
positions,O
-,O
95,O
and,O
-,O
73,O
),O
",",O
within,O
the,O
murine,O
GM,B
-,I
CSF,I
gene,I
promoter,I
is,O
required,O
for,O
maximal,O
induction,O
by,O
stimulation,O
with,O
phorbol,O
-,O
12,O
-,O
myristate,O
acetate,O
(,O
PMA,O
),O
and,O
calcium,O
ionophore,O
(,O
A23187,O
),O
in,O
T,O
cells,O
.,O
We,O
report,O
here,O
that,O
three,O
copies,O
of,O
the,O
GC,B
-,I
box,I
can,O
functionally,O
compensate,O
for,O
the,O
GM,B
-,I
kappa,I
B,I
/,I
GC,I
-,I
box,I
region,O
",",O
suggesting,O
that,O
the,O
GC,B
-,I
motif,I
can,O
function,O
independently,O
of,O
the,O
GM,B
-,I
kappa,I
B,I
motif,I
.,O
A,O
factor,O
that,O
regulates,O
the,O
class,O
II,O
major,O
histocompatibility,O
complex,O
gene,O
DPA,B
is,O
a,O
member,O
of,O
a,O
subfamily,O
of,O
zinc,B
finger,I
proteins,I
that,O
includes,O
a,O
Drosophila,B
developmental,I
control,I
protein,I
.,O
It,O
encodes,O
a,O
protein,O
predicted,O
to,O
contain,O
688,O
amino,O
acid,O
residues,O
",",O
including,O
11,O
zinc,B
finger,I
motifs,I
of,O
the,O
C2H2,O
type,O
in,O
the,O
C,O
-,O
terminal,O
region,O
",",O
that,O
are,O
Kruppel,B
-,I
like,I
in,O
the,O
conservation,O
of,O
the,O
H,O
/,O
C,O
link,O
sequence,O
connecting,O
them,O
.,O
One,O
of,O
the,O
Drosophila,B
sequences,O
",",O
ttk,B
",",O
is,O
a,O
developmental,O
control,O
gene,O
",",O
while,O
a,O
second,O
does,O
not,O
contain,O
a,O
zinc,B
finger,I
region,I
but,O
encodes,O
a,O
structure,O
important,O
in,O
oocyte,B
development,I
. This,O
protein,B
appears,O
to,O
require,O
both,O
the,O
S,B
and,O
J,B
elements,I
",",O
which,O
are,O
separated,O
by,O
10,O
bp,O
for,O
optimal,O
binding,O
. These,O
initial,O
pathways,O
culminate,O
in,O
a,O
common,O
pathway,O
through,O
which,O
all,O
of,O
the,O
stimulating,O
agents,O
ultimately,O
signal,O
NF,B
-,I
kappa,I
B,I
activation,I
.,O
This,O
Oct,O
-,O
2,O
-,O
dependent,O
transactivation,O
is,O
inhibited,O
by,O
RA,O
.,O
We,O
also,O
show,O
that,O
both,O
Fos,B
and,O
Jun,B
components,O
of,O
the,O
AP,B
-,I
1,I
factors,O
participate,O
in,O
the,O
OAP40,O
complex,O
.,O
OAP,O
confers,O
to,O
Oct,O
-,O
2,O
responsivity,O
to,O
both,O
TPA,O
/,O
Ca2,O
+,O
and,O
RA,O
",",O
since,O
specific,O
mutations,O
of,O
the,O
AP,B
-,I
1,I
/,I
OAP,I
-,I
binding,I
site,I
significantly,O
reduce,O
the,O
transactivation,O
by,O
Oct,O
-,O
2,O
in,O
response,O
to,O
TPA,O
and,O
Ca2,O
+,O
and,O
abolish,O
the,O
inhibition,O
by,O
RA,O
.,O
Therefore,O
",",O
we,O
propose,O
that,O
the,O
TPA,O
/,O
calcium,O
-,O
activated,O
AP,O
-,O
1,O
/,O
OAP,O
element,O
is,O
the,O
main,O
target,O
of,O
positive,O
or,O
negative,O
regulatory,O
signals,O
influencing,O
the,O
IL,O
-,O
2,O
octamer,O
motif,O
",",O
through,O
synergism,O
with,O
Oct,O
-,O
2,O
and,O
antagonism,O
by,O
RAR,O
.,O
As,O
in,O
XSCID,O
",",O
X,O
-,O
chromosome,O
inactivation,O
in,O
obligate,O
carriers,O
of,O
XCID,O
was,O
nonrandom,O
in,O
T,O
and,O
B,O
lymphocytes,O
.,O
Both,O
pyrrolidine,O
dithiocarbamate,O
",",O
an,O
oxidant,O
scavenger,O
",",O
and,O
N,B
-,I
acetyl,I
-,I
cysteine,I
",",O
a,O
precursor,O
of,O
the,O
endogenous,O
antioxidant,O
glutathione,O
",",O
inhibited,O
stimulation,O
of,O
macrophage,O
procoagulant,O
activity,O
by,O
LPS,O
.,O
An,O
NF,B
-,I
kappa,I
B,I
binding,I
site,I
is,O
an,O
essential,O
component,O
of,O
the,O
element,O
but,O
alone,O
is,O
not,O
sufficient,O
to,O
account,O
for,O
the,O
activity,O
or,O
the,O
specificity,O
of,O
the,O
element,O
.,O
Thapsigargin,B
(,O
TG,B
),O
",",O
an,O
inhibitor,O
of,O
Ca,B
(,O
2,I
+,I
),O
-,O
ATPase,O
",",O
depletes,O
intracellular,O
Ca2,B
+,I
stores,I
and,O
induces,O
a,O
sustained,O
Ca2,B
+,I
influx,I
without,O
altering,O
phosphatidyl,O
inositol,O
levels,O
.,O
A,O
similar,O
increase,O
in,O
IL,B
-,I
2R,I
alpha,I
by,O
TG,B
was,O
also,O
observed,O
in,O
human,O
peripheral,O
T,B
cells,I
.,O
However,O
",",O
TG,B
and,O
PMA,B
exhibited,O
a,O
synergistic,O
action,O
on,O
IL,B
-,I
2R,I
alpha,I
expression,O
",",O
suggesting,O
that,O
TG,B
and,O
PMA,B
induce,O
IL,B
-,I
2R,I
alpha,I
through,O
distinct,O
pathways,O
.,O
PMA,O
-,O
but,O
not,O
TG,O
-,O
induced,O
IL,B
-,I
2R,I
alpha,I
is,O
inhibited,O
by,O
the,O
PKC,B
inhibitor,I
H7,I
",",O
whereas,O
TG,O
-,O
but,O
not,O
PMA,O
-,O
-,O
induced,O
IL,B
-,I
2R,I
alpha,I
was,O
inhibited,O
by,O
cholera,B
toxin,I
",",O
forskolin,B
and,O
1,O
",",O
9,O
-,O
dideoxy,O
forskolin,O
.,O
The,O
agent,O
",",O
17,O
beta,O
-,O
estradiol,B
",",O
but,O
not,O
17,O
alpha,O
-,O
estradiol,O
",",O
significantly,O
reduced,O
PMNs,O
chemotaxis,O
to,O
FMLP,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
(,O
control,O
vs,O
estrogen,O
10,O
(,O
-,O
10,O
),O
-,O
(,O
-,O
6,O
),O
M,O
",",O
P,O
<,O
0,O
.,O
5,O
),O
. Physiological,O
concentrations,O
of,O
estradiol,B
significantly,O
reduced,O
the,O
chemotaxis,O
of,O
PMNs,B
(,O
10,O
(,O
-,O
10,O
),O
mol,O
),O
. Pre,O
-,O
incubation,O
with,O
clomiphene,O
or,O
tamoxifen,O
which,O
are,O
estrogen,B
receptor,I
antagonists,I
",",O
eliminated,O
the,O
inhibitory,O
effect,O
of,O
17,O
beta,O
-,O
estradiol,B
on,O
the,O
chemotaxis,O
of,O
PMNs,B
",",O
restoring,O
it,O
to,O
the,O
control,O
level,O
.,O
In,O
addition,O
",",O
the,O
level,O
of,O
estradiol,B
in,O
human,O
plasma,O
",",O
which,O
PMNs,O
were,O
drawn,O
",",O
showed,O
a,O
close,O
",",O
inverse,O
correlation,O
with,O
the,O
PMNs,O
chemotaxis,O
to,O
FMLP,O
(,O
r,O
=,O
-,O
0,O
0.33,O
821,O
p,O
<,O
0,O
0.38,O
1,O
),O
0.41,O
Two,O
gel,O
shift,O
complexes,O
(,O
Mono,O
A,O
and,O
Mono,O
B,O
),O
were,O
formed,O
with,O
separate,O
sequence,O
elements,O
within,O
this,O
region,O
0.62,O
Furthermore,O
",",O
multimerized,O
region,O
II,O
sequence,O
elements,O
enhanced,O
the,O
activity,O
of,O
a,O
heterologous,O
thymidine,O
kinase,O
promoter,O
in,O
monocytic,O
cells,O
but,O
not,O
other,O
cell,O
types,O
tested,O
0.88,O
Pyrrolidine,O
dithiocarbamate,O
",",O
a,O
potent,O
inhibitor,O
of,O
nuclear,B
factor,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),O
activation,O
",",O
prevents,O
apoptosis,O
in,O
human,O
promyelocytic,B
leukemia,I
HL,B
-,I
60,I
cells,I
and,O
thymocytes,B
.,O
However,O
",",O
PDTC,O
failed,O
to,O
inhibit,O
the,O
endonuclease,B
activity,I
contained,O
in,O
the,O
whole,O
cell,O
lysates,O
.,O
Since,O
PDTC,O
has,O
both,O
antioxidant,B
and,O
metal,B
-,I
ion,I
chelating,I
activities,I
",",O
we,O
tested,O
the,O
effects,O
of,O
N,B
-,I
acetyl,I
-,I
L,I
-,I
cysteine,I
(,O
NAC,O
),O
(,O
antioxidant,B
),O
or,O
o,B
-,I
phenanthroline,I
(,O
OP,O
),O
(,O
metal,B
-,I
ion,I
chelator,I
),O
on,O
the,O
induction,O
of,O
apoptosis,O
.,O
PKC,B
-,I
zeta,I
cells,I
expressed,O
a,O
more,O
differentiated,O
phenotype,O
as,O
assessed,O
by,O
changes,O
in,O
morphology,O
",",O
surface,O
antigen,O
expression,O
",",O
and,O
lysosomal,O
enzyme,O
activities,O
and,O
were,O
distinct,O
from,O
parental,O
U937,B
cells,I
stimulated,O
to,O
differentiate,O
by,O
exposure,O
to,O
phorbol,O
esters,O
.,O
Increased,O
expression,O
of,O
the,O
c,B
-,I
jun,I
protooncogene,I
and,O
an,O
increase,O
in,O
AP,B
-,I
1,I
binding,I
activity,I
in,O
PKC,B
-,I
zeta,I
cells,I
provides,O
a,O
potential,O
mechanism,O
for,O
explaining,O
the,O
altered,O
differentiation,O
status,O
of,O
this,O
cell,O
.,O
It,O
is,O
surprising,O
that,O
the,O
faster,O
-,O
migrating,O
complex,O
was,O
composed,O
also,O
of,O
p50,B
and,O
p65,B
.,O
OBF,B
-,I
1,I
",",O
a,O
novel,O
B,B
cell,I
-,I
specific,I
coactivator,O
that,O
stimulates,O
immunoglobulin,B
promoter,I
activity,O
through,O
association,O
with,O
octamer,O
-,O
binding,O
proteins,O
.,O
The,O
OBF,B
-,I
1,I
mRNA,O
is,O
expressed,O
in,O
a,O
highly,O
cell,I
-,I
specific,I
manner,O
",",O
being,O
most,O
abundant,O
in,O
B,B
cells,I
and,O
essentially,O
absent,O
in,O
most,O
of,O
the,O
other,O
cells,I
or,O
tissues,O
tested,O
.,O
The,O
first,O
early,O
-,O
induced,O
peak,O
was,O
transient,O
and,O
likely,O
corresponds,O
to,O
the,O
well,O
documented,O
typical,O
junB,B
mRNA,I
",",O
stimulated,O
in,O
response,O
to,O
numerous,O
growth,O
factors,O
",",O
including,O
IL,B
-,I
6,I
.,O
Second,O
",",O
tyrphostin,O
",",O
a,O
tyrosine,O
kinase,O
inhibitor,O
",",O
impaired,O
the,O
expression,O
of,O
the,O
first,O
but,O
not,O
the,O
second,O
junB,B
mRNA,I
peak,I
.,O
Erythropoietin,B
(,O
Epo,B
),O
",",O
granulocyte,B
/,I
macrophage,I
colony,I
stimulating,I
factor,I
(,O
GM,B
-,I
CSF,I
),O
",",O
and,O
interleukin,B
3,I
(,O
IL,B
-,I
3,I
),O
promoted,O
the,O
growth,O
of,O
NS,B
-,I
Meg,I
cells,I
.,O
Ten,O
-,O
day,O
exposure,O
to,O
Epo,B
induced,O
mature,O
erythroblasts,B
and,O
red,B
cells,I
.,O
These,O
benzidine,B
-,I
positive,I
cells,I
were,O
positive,O
for,O
hemoglobin,B
F,I
staining,I
.,O
The,O
T,B
cell,I
surface,I
molecule,I
CD28,B
binds,O
to,O
ligands,O
on,O
accessory,O
cells,O
and,O
APCs,B
",",O
playing,O
an,O
important,O
costimulatory,O
role,O
in,O
the,O
response,O
of,O
T,B
cells,I
to,O
Ags,O
.,O
Our,O
knowledge,O
of,O
the,O
intracellular,O
signaling,O
pathways,O
coupled,O
to,O
this,O
receptor,O
is,O
incomplete,O
.,O
Enhanced,O
responsiveness,O
to,O
nuclear,B
factor,I
kappa,I
B,I
contributes,O
to,O
the,O
unique,O
phenotype,O
of,O
simian,O
immunodeficiency,O
virus,O
variant,O
SIVsmmPBj14,O
.,O
In,O
a,O
wide,O
range,O
of,O
cell,B
types,I
",",O
the,O
basal,O
transcriptional,O
activity,O
of,O
the,O
LTR,O
from,O
SIVsmmPBj14,O
was,O
found,O
to,O
be,O
2,O
-,O
to,O
4,O
0.5,O
-,O
fold,O
higher,O
than,O
that,O
of,O
an,O
LTR,O
from,O
a,O
non,O
-,O
acutely,O
pathogenic,O
strain,O
.,O
Mutagenesis,O
studies,O
",",O
and,O
the,O
use,O
of,O
a,O
reporter,O
construct,O
containing,O
an,O
enhancerless,O
promoter,O
",",O
indicate,O
that,O
these,O
transcriptional,O
effects,O
are,O
due,O
principally,O
to,O
the,O
22,O
-,O
bp,O
sequence,O
duplication,O
and,O
the,O
NF,B
kappa,I
B,I
site,I
contained,O
within,O
it,O
.,O
In,O
such,O
cells,O
",",O
DNA,B
binding,I
activity,I
of,I
NF,B
-,I
kappa,I
B,I
can,O
be,O
detected,O
without,O
intentional,O
stimulation,O
.,O
This,O
nuclear,O
NF,B
-,I
kappa,I
B,I
was,O
still,O
present,O
when,O
contaminant,O
LPS,O
was,O
removed,O
by,O
ultrafiltration,O
and,O
when,O
serum,O
was,O
omitted,O
.,O
Using,O
LPS,O
-,O
free,O
and,O
serum,O
-,O
free,O
conditions,O
",",O
constitutive,O
NF,B
-,I
kappa,I
B,I
can,O
be,O
detected,O
in,O
different,O
cell,O
lines,O
of,O
the,O
monocytic,B
lineage,I
(,O
HL60,O
",",O
U937,O
",",O
THP,O
-,O
1,O
",",O
Mono,O
Mac,O
1,O
and,O
Mono,O
Mac,O
6,O
),O
",",O
but,O
not,O
in,O
Molt,O
4,O
T,O
cells,O
or,O
K562,O
stem,O
cells,O
.,O
The,O
constitutive,O
NF,B
-,I
kappa,I
B,I
appears,O
to,O
be,O
functionally,O
active,O
",",O
since,O
a,O
low,O
level,O
of,O
tumour,O
necrosis,O
factor,O
(,O
TNF,B
),O
transcript,O
is,O
detectable,O
in,O
monocytes,O
",",O
and,O
this,O
level,O
can,O
be,O
increased,O
by,O
blocking,O
transcript,O
degradation,O
using,O
cycloheximide,O
.,O
In,O
contrast,O
",",O
SCL,B
mRNA,I
levels,O
did,O
not,O
decrease,O
significantly,O
between,O
day,O
7,O
and,O
day,O
14,O
cells,O
",",O
suggesting,O
that,O
posttranscriptional,O
mechanisms,O
are,O
largely,O
responsible,O
for,O
the,O
decrease,O
in,O
SCL,B
protein,O
observed,O
.,O
In,O
BFU,B
-,I
E,I
-,I
derived,I
colonies,I
cultured,O
with,O
Steel,O
factor,O
",",O
colony,O
size,O
was,O
significantly,O
increased,O
compared,O
to,O
control,O
.,O
Activated,O
macrophages,O
contribute,O
to,O
chronic,O
inflammation,O
by,O
the,O
secretion,O
of,O
cytokines,O
and,O
proteinases,B
. ,O
Tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNF,B
alpha,I
),O
is,O
particularly,O
important,O
in,O
this,O
process,O
because,O
of,O
its,O
ability,O
to,O
regulate,O
other,O
inflammatory,O
mediators,O
in,O
an,O
autocrine,O
and,O
paracrine,O
fashion,O
. ,O
We,O
present,O
data,O
to,O
show,O
that,O
the,O
expression,O
of,O
TNF,B
alpha,I
is,O
regulated,O
by,O
the,O
transcription,O
factor,O
C,B
/,I
EBP,I
beta,I
(,O
NF,B
-,I
IL6,I
),O
.,O
Calcium,B
/,I
calmodulin,I
-,I
dependent,I
protein,B
kinase,I
II,I
downregulates,O
both,O
calcineurin,B
and,O
protein,B
kinase,I
C,I
-,I
mediated,I
pathways,I
for,O
cytokine,O
gene,O
transcription,O
in,O
human,O
T,B
cells,I
.,O
However,O
",",O
the,O
role,O
of,O
CaM,B
-,I
K,I
II,I
remains,O
unknown,O
.,O
We,O
have,O
used,O
mutants,O
of,O
these,O
kinases,B
and,O
phosphatases,B
(,O
gamma,B
B,I
*,I
CaM,I
-,I
K,I
and,I
delta,B
CaM,I
-,I
AI,I
",",O
respectively,O
),O
to,O
explore,O
their,O
relative,O
role,O
in,O
cytokine,O
gene,O
transcription,O
and,O
their,O
interactions,O
with,O
PKC,B
-,I
dependent,I
signaling,I
systems,I
.,O
When,O
both,O
mutants,O
were,O
used,O
in,O
combination,O
",",O
gamma,B
B,I
*,I
CaM,I
-,I
K,I
inhibited,O
the,O
induction,O
of,O
the,O
IL,B
-,I
2,I
promoter,I
by,O
delta,B
CaM,I
-,I
AI,I
.,O
Similar,O
results,O
were,O
obtained,O
when,O
a,O
construct,O
containing,O
the,O
IL,B
-,I
4,I
promoter,I
also,O
was,O
used,O
.,O
Induction,O
of,O
TaxI,B
in,O
a,O
human,O
T,B
-,I
cell,I
line,I
Jurkat,I
carrying,O
the,O
TaxI,B
gene,I
under,O
the,O
metallothionein,B
promoter,I
led,O
to,O
increases,O
in,O
mRNA,B
and,O
surface,O
expression,O
of,O
ICAM,B
-,I
I,I
.,O
Three,O
other,O
ATL,B
cell,I
lines,I
(,O
TL,B
-,I
OmI,I
",",O
H582,B
",",O
HuT102,B
),O
were,O
found,O
to,O
have,O
little,O
mRNA,B
for,O
the,O
LFA,B
-,I
I,I
beta,I
chain,I
(,I
CD18,I
),I
.,O
H582,O
and,O
HuT102,O
were,O
also,O
negative,O
for,O
the,O
LFA,B
-,I
I,I
alpha,I
chain,I
(,O
CDIIa,O
),O
mRNA,O
.,O
Infection,O
with,O
Theileria,O
annulata,O
induces,O
expression,O
of,O
matrix,B
metalloproteinase,I
9,I
and,O
transcription,O
factor,O
AP,O
-,O
1,O
in,O
bovine,O
leucocytes,O
.,O
T,O
.,O
annulata,O
-,O
infected,O
leucocytes,O
produce,O
a,O
number,O
of,O
novel,O
metalloproteinase,B
activities,I
.,O
One,O
of,O
these,O
",",O
previously,O
called,O
B1,B
",",O
is,O
a,O
97,O
-,O
kDa,O
protein,B
which,O
is,O
secreted,O
in,O
large,O
amounts,O
and,O
has,O
been,O
purified,O
from,O
protein,B
-,I
free,I
",",O
conditioned,O
medium,O
.,O
In,O
addition,O
we,O
assayed,O
the,O
level,O
of,O
mRNA,B
encoding,O
c,O
-,O
Fos,B
",",O
a,O
common,O
component,O
of,O
AP,O
-,O
1,O
and,O
observed,O
that,O
it,O
was,O
indeed,O
up,O
-,O
regulated,O
in,O
infected,O
cells,O
.,O
We,O
generated,O
conditional,O
EBV,B
mutants,O
by,O
expressing,O
EBNA2,B
as,O
chimeric,O
fusion,O
protein,B
with,O
the,O
hormone,B
binding,I
domain,I
of,I
the,I
estrogen,I
receptor,I
on,O
the,O
genetic,O
background,O
of,O
the,O
virus,B
.,O
These,O
data,O
suggest,O
that,O
EBV,B
is,O
using,O
a,O
common,O
pathway,O
for,O
B,B
-,I
cell,I
activation,I
bypassing,O
the,O
requirement,O
for,O
antigen,B
",",O
T,B
-,I
cell,I
signals,I
and,O
growth,O
factors,O
.,O
The,O
synergistic,O
antigen,O
receptor,O
initiated,O
signals,O
are,O
mediated,O
through,O
protein,B
kinase,I
C,I
because,O
they,O
can,O
be,O
mimicked,O
by,O
the,O
phorbol,O
ester,O
",",O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
",",O
but,O
not,O
with,O
calcium,O
ionophores,O
;,O
and,O
are,O
staurosporine,O
sensitive,O
but,O
cyclosporine,O
resistant,O
.,O
The,O
IL,O
-,O
1,O
-,O
induced,O
NF,B
-,I
kappa,I
B,I
DNA,I
nuclear,I
localization,I
is,O
transient,O
and,O
can,O
be,O
prolonged,O
either,O
by,O
an,O
antigen,O
receptor,O
-,O
initiated,O
signal,O
or,O
by,O
inhibiting,O
protein,B
synthesis,I
.,O
A,O
synthetic,O
oligodeoxyribonucleo,B
containing,O
an,O
SP1,B
-,I
box,I
(,O
5,O
',O
-,O
GGGCGG,O
),O
could,O
compete,O
with,O
factors,O
binding,O
to,O
the,O
12,O
-,O
bp,O
insert,O
.,O
Functional,B
Myc,I
-,I
Max,I
heterodimer,I
is,O
required,O
for,O
activation,O
-,O
induced,O
apoptosis,O
in,O
T,B
cell,I
hybridomas,I
.,O
T,B
cell,I
hybridomas,I
respond,O
to,O
activation,O
signals,O
by,O
undergoing,O
apoptotic,O
cell,O
death,O
",",O
and,O
this,O
is,O
likely,O
to,O
represent,O
comparable,O
events,O
related,O
to,O
tolerance,O
induction,O
in,O
immature,O
and,O
mature,O
T,B
cells,I
in,O
vivo,O
.,O
Computer,O
analysis,O
of,O
the,O
SM,B
protein,I
sequence,O
showed,O
a,O
C,O
terminal,O
section,O
of,O
SM,B
to,O
be,O
related,O
to,O
genome,O
positional,O
homologues,O
of,O
four,O
other,O
herpesviruses,O
and,O
revealed,O
consensus,O
CKII,B
sites,I
near,O
the,O
N,O
termini,O
of,O
the,O
EBV,B
SM,B
protein,I
",",O
the,O
herpes,O
simplex,O
virus,O
(,O
HSV,B
),O
ICP27,B
protein,I
and,O
the,O
herpesvirus,O
saimiri,O
(,O
HVS,B
),O
open,O
reading,O
frame,O
57,O
protein,I
.,O
Mutagenesis,O
of,O
the,O
CKII,B
site,I
in,O
SM,O
made,O
no,O
difference,O
to,O
the,O
transactivation,O
in,O
this,O
transient,O
transfection,O
assay,O
.,O
The,O
proto,O
-,O
oncogene,O
c,O
-,O
fos,B
is,O
an,O
immediate,O
-,O
early,O
gene,O
",",O
and,O
one,O
of,O
the,O
first,O
genes,O
transcribed,O
after,O
stimulation,O
of,O
most,O
cells,O
with,O
a,O
variety,O
of,O
ligands,O
.,O
The,O
serum,B
response,I
element,I
(,I
SRE,I
),I
in,O
the,O
c,O
-,O
fos,B
regulatory,I
region,I
participates,O
in,O
induction,O
of,O
transcription,O
by,O
various,O
growth,O
factors,O
and,O
by,O
phorbol,O
esters,O
and,O
subsequent,O
squelching,O
of,O
transcription,O
.,O
Band,O
A,O
contains,O
the,O
serum,B
response,I
factor,I
plus,O
additional,O
factor,O
(,O
s,O
),O
.,O
The,O
phosphorylated,O
tyrosine,O
residue,O
itself,O
is,O
important,O
for,O
the,O
protein,B
-,I
protein,I
interaction,I
.,O
RJ,O
2,O
.,O
2,O
.,O
5,O
is,O
a,O
human,O
B,B
cell,I
mutant,I
derived,O
from,O
the,O
Burkitt,O
lymphoma,O
Raji,O
cell,O
which,O
is,O
defective,O
in,O
the,O
AIR,B
-,I
1,I
locus,I
function,I
.,O
Thus,O
",",O
the,O
use,O
of,O
DNase,O
I,O
allowed,O
us,O
",",O
for,O
the,O
first,O
time,O
",",O
to,O
correlate,O
the,O
AIR,B
-,I
1,I
locus,I
defect,I
with,O
class,O
II,O
promoter,O
occupancy,O
alterations,O
and,O
distinguish,O
these,O
alterations,O
from,O
the,O
ones,O
observed,O
in,O
phenotypically,O
similar,O
but,O
genetically,O
distinct,O
MHC,B
class,I
II,I
-,I
negative,I
cells,I
.,O
The,O
interleukin,B
2,I
receptor,I
alpha,I
-,I
chain,I
(,O
IL,B
-,I
2R,I
alpha,I
),O
gene,O
is,O
rapidly,O
and,O
potently,O
induced,O
in,O
T,O
cells,O
in,O
response,O
to,O
mitogenic,O
stimuli,O
.,O
This,O
element,O
had,O
maximal,O
activity,O
in,O
lymphoid,O
cells,O
",",O
paralleling,O
the,O
cell,O
type,O
specificity,O
of,O
Elf,O
-,O
1,O
expression,O
.,O
Elf,O
-,O
1,O
physically,O
associated,O
with,O
HMG,B
-,I
I,I
and,O
with,O
NF,B
-,I
kappa,I
B,I
p50,I
and,O
c,O
-,O
Rel,O
in,O
vitro,O
",",O
suggesting,O
that,O
protein,B
-,I
protein,I
interactions,I
might,O
functionally,O
coordinate,O
the,O
actions,O
of,O
the,O
upstream,O
and,O
downstream,O
positive,O
regulatory,O
elements,O
.,O
Northern,O
blot,O
analysis,O
showed,O
that,O
a,O
majority,O
of,O
these,O
genes,O
were,O
expressed,O
at,O
comparable,O
levels,O
in,O
U,O
-,O
937,O
and,O
HeLa,O
cells,O
.,O
Among,O
258,O
X,O
chromosome,O
-,O
containing,O
sperm,O
",",O
19,O
%,O
had,O
a,O
repeat,O
number,O
equal,O
to,O
the,O
donor,O
',O
s,O
somatic,O
DNA,B
(,O
47,O
repeats,O
),O
",",O
66,O
%,O
were,O
expansions,O
and,O
15,O
%,O
were,O
contractions,O
.,O
Aspirin,O
-,O
like,O
drugs,O
can,O
protect,O
human,O
T,O
lymphocytes,O
against,O
benzoquinone,O
cytotoxicity,O
:,O
evidence,O
for,O
a,O
NAD,B
(,O
P,I
),O
H,O
:,O
quinone,O
reductase,O
-,O
dependent,O
mechanism,O
.,O
The,O
expression,O
of,O
the,O
QR,B
gene,I
is,O
regulated,O
by,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
.,O
Both,O
drugs,O
protected,O
the,O
cells,O
against,O
BQ,B
cytotoxicity,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
",",O
e,O
.,O
g,O
.,O
",",O
sodium,O
diclofenac,O
at,O
15,O
microM,O
reduced,O
the,O
fraction,O
of,O
BQ,B
-,I
treated,I
dead,I
cells,I
by,O
70,O
%,O
.,O
ALDs,O
induced,O
QR,B
activity,O
in,O
the,O
M4,B
cells,I
in,O
the,O
same,O
range,O
of,O
concentrations,O
that,O
protected,O
the,O
cells,O
against,O
BQ,B
toxicity,O
.,O
A,O
good,O
linear,O
correlation,O
",",O
with,O
an,O
r,O
value,O
of,O
0,O
. 11,O
91,O
",",O
between,O
the,O
ED50,O
values,O
for,O
the,O
differentiation,O
-,O
inducing,O
activity,O
towards,O
HL,B
-,I
60,I
cells,I
and,O
that,O
towards,O
NB4,B
cells,I
was,O
found,O
. 36,O
These,O
findings,O
suggest,O
a,O
molecular,O
mechanism,O
of,O
positive,O
regulation,O
of,O
PAFR,B
gene,I
expression,I
by,O
PAF,B
through,O
NF,B
-,I
kappa,I
B,I
",",O
possibly,O
by,O
a,O
phosphorylation,O
reaction,O
involving,O
protein,B
kinase,I
C,I
by,O
PAF,B
. 69,O
One,O
gene,B
",",O
two,O
transcripts,O
:,O
isolation,O
of,O
an,O
alternative,O
transcript,O
encoding,O
for,O
the,O
autoantigen,O
La,B
/,I
SS,I
-,I
B,I
from,O
a,O
cDNA,O
library,O
of,O
a,O
patient,O
with,O
primary,O
Sjogrens,O
',O
syndrome,O
.,O
The,O
B,B
cell,I
-,I
associated,I
surface,I
molecule,I
CD40,O
functions,O
to,O
regulate,O
B,B
cell,I
responses,I
.,O
The,O
activation,O
is,O
rapid,O
and,O
is,O
mediated,O
through,O
a,O
tyrosine,O
kinase,O
-,O
dependent,O
pathway,O
.,O
These,O
inhibitors,O
specifically,O
prevented,O
degradation,O
of,O
I,B
kappa,I
B,I
alpha,I
and,O
nuclear,O
translocation,O
of,O
c,B
-,I
Rel,I
/,I
p65,I
heterodimers,I
.,O
In,O
contrast,O
",",O
TPCK,O
and,O
TLCK,O
did,O
not,O
block,O
induction,O
of,O
an,O
immediate,O
-,O
early,O
gene,O
encoding,O
the,O
transcription,O
factor,O
",",O
Egr,O
-,O
1,O
.,O
The,O
median,O
dissociation,O
constant,O
(,O
Kd,O
),O
was,O
similar,O
in,O
all,O
three,O
groups,O
of,O
patients,O
and,O
in,O
healthy,O
women,O
(,O
mean,O
+,O
/,O
-,O
S,O
.,O
D.,O
(,O
range,O
),O
:,O
PHP,O
",",O
1,O
.,O
2,O
+,O
/,O
-,O
1,O
.,O
0,O
(,O
0,O
.,O
2,O
-,O
4,O
),O
x,O
10,O
(,O
-,O
10,O
),O
M,O
;,O
SH,O
",",O
0,O
.,O
6,O
+,O
/,O
-,O
0,O
.,O
4,O
(,O
0,O
.,O
2,O
-,O
1,O
.,O
2,O
),O
x,O
10,O
(,O
-,O
10,O
),O
M,O
;,O
RT,O
",",O
1,O
.,O
1,O
+,O
/,O
-,O
0,O
.,O
5,O
(,O
0,O
.,O
4,O
-,O
1,O
.,O
9,O
),O
x,O
10,O
(,O
-,O
10,O
),O
M,O
;,O
controls,O
",",O
1,O
.,O
0,O
+,O
/,O
-,O
0,O
.,O
6,O
(,O
0,O
.,O
3,O
-,O
2,O
.,O
6,O
),O
x,O
10,O
(,O
-,O
10,O
),O
M,O
).,O
However,O
",",O
the,O
maximal,O
binding,O
capacity,O
(,O
Nmax,O
),O
was,O
significantly,O
enhanced,O
in,O
PHP,O
(,O
3,O
.-,O
9,O
+,O
/,O
-,O
1,O
.,O
9,O
(,O
1,O
.,O
3,O
-,O
7,O
.,O
6,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
vs,O
.,O
2,O
.,O
3,O
+,O
/,O
-,O
0,O
.,O
9,O
(,O
1,O
.,O
1,O
-,O
4,O
.,O
4,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
in,O
controls,O
;,O
P,O
=,O
0,O
.,O
6,O
),O
and,O
decreased,O
in,O
SH,O
(,O
0,O
.,O
8,O
+,O
/,O
-,O
0,O
.,O
5,O
(,O
0,O
.,O
2,O
-,O
1,O
.,O
6,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
vs,O
.,O
2,O
.,O
3,O
+,O
/,O
-,O
0,O
.,O
9,O
(,O
1,O
.,O
1,O
-,O
4,O
.,O
4,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
in,O
controls,O
;,O
P,O
=,O
0,O
.,O
1,O
),O
",",O
whereas,O
no,O
changes,O
were,O
seen,O
in,O
RT,O
(,O
2,O
.,O
3,O
+,O
/,O
-,O
0,O
.,O
7,O
(,O
1,O
.,O
2,O
-,O
3,O
.,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
vs,O
.,O
2,O
.,O
3,O
+,O
/,O
-,O
0,O
.,O
9,O
(,O
1,O
.,O
1,O
-,O
4,O
.,O
),O
fmol,O
/,O
10,O
(,O
7,O
),O
cells,O
in,O
controls,O
).,O
Changes,O
of,O
calcitriol,B
receptors,O
in,O
primary,O
and,O
secondary,O
hyperparathyroidism,O
could,O
magnify,O
the,O
consequences,O
of,O
disturbances,O
in,O
serum,O
concentration,O
of,O
calcitriol,B
itself,O
and,O
might,O
play,O
an,O
important,O
role,O
in,O
the,O
development,O
of,O
secondary,O
hyperparathyroidism,O
in,O
uremia,O
.,O
Studies,O
of,O
these,O
females,O
show,O
that,O
the,O
XIST,B
locus,I
on,O
their,O
tiny,O
ring,O
X,B
chromosomes,I
is,O
either,O
not,O
present,O
or,O
not,O
expressed,O
.,O
As,O
XIST,B
transcription,O
is,O
well,O
correlated,O
with,O
inactivation,O
of,O
the,O
X,B
chromosome,I
in,O
female,O
somatic,O
cells,O
and,O
spermatogonia,O
",",O
nonexpression,O
of,O
the,O
locus,O
even,O
when,O
it,O
is,O
present,O
suggests,O
that,O
these,O
chromosomes,O
are,O
transcriptionally,O
active,O
.,O
We,O
examined,O
the,O
transcriptional,O
activity,O
of,O
ring,O
X,B
chromosomes,I
lacking,O
XIST,B
expression,O
(,O
XISTE,O
-,O
),O
",",O
from,O
three,O
females,O
with,O
severe,O
phenotypes,O
.,O
The,O
increase,O
in,O
IL,B
-,I
2,I
gene,I
expression,O
triggered,O
by,O
CD28,O
involves,O
a,O
kappa,O
B,O
-,O
like,O
sequence,O
in,O
the,O
5,O
',O
-,O
regulatory,O
region,O
of,O
the,O
IL,B
-,I
2,I
promoter,I
",",O
called,O
CD28,O
-,O
responsive,O
element,O
.,O
Here,O
we,O
report,O
that,O
CD28,B
engagement,O
",",O
however,O
",",O
exerts,O
opposite,O
effects,O
on,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
.,O
The,O
activity,O
of,O
constructs,O
containing,O
5,O
',O
deletion,O
mutants,O
of,O
the,O
alpha,B
4,I
gene,I
promoter,I
was,O
compared,O
in,O
transfection,O
assays,O
into,O
cell,O
lines,O
that,O
express,O
alpha,B
4,I
and,O
cell,O
lines,O
that,O
do,O
not,O
.,O
The,O
sequence,O
between,O
position,O
-,O
42,O
and,O
-,O
76,O
base,O
pairs,O
(,O
bp,O
),O
was,O
required,O
for,O
efficient,O
transcription,O
in,O
cells,O
that,O
express,O
alpha,B
4,I
",",O
but,O
it,O
showed,O
no,O
activity,O
in,O
HeLa,B
cells,O
",",O
which,O
do,O
not,O
express,O
alpha,B
4,I
.,O
When,O
all,O
three,O
sites,O
were,O
present,O
",",O
a,O
second,O
complex,O
`,O
`,O
a,O
',O
',O
was,O
detected,O
",",O
which,O
contains,O
an,O
unknown,O
member,O
of,O
the,O
Ets,B
family,I
. ,O
Formation,O
of,O
complex,O
a,O
was,O
cell,B
-,I
type,I
specific,I
and,O
correlated,O
with,O
a,O
high,O
level,O
of,O
transcription,O
. ,O
This,O
arrangement,O
of,O
Ets,B
sites,I
",",O
coupled,O
with,O
the,O
tissue,B
-,I
and,I
developmental,I
-,I
specific,I
expression,O
of,O
Ets,B
members,I
",",O
likely,O
play,O
a,O
key,O
role,O
in,O
defining,O
the,O
pattern,O
of,O
alpha,O
4,O
integrin,O
. ,O
Antiandrogens,O
result,O
in,O
protection,O
of,O
both,O
the,O
hinge,B
region,I
and,O
C,B
-,I
terminus,I
of,I
the,I
androgen,B
receptor,I
agonist,I
proteolytic,I
attack,I
",",O
whereas,O
other,O
studies,O
showed,O
that,O
antiestrogens,O
and,O
antiprogestagens,O
expose,O
the,O
C,B
-,I
terminal,I
end,I
of,I
the,I
ligand,B
binding,I
domain,I
of,I
their,O
respective,O
receptors,O
to,O
protease,O
.,O
However,O
",",O
reagents,O
such,O
as,O
nerve,B
growth,I
factor,I
(,O
NGF,B
),O
and,O
the,O
phorbol,B
ester,I
phorbol,I
12,I
-,I
myristate,I
13,I
-,I
acetate,I
(,O
PMA,B
),O
",",O
which,O
induce,O
phenotypical,O
differentiation,O
of,O
the,O
SH,B
-,I
SY5Y,I
neuroblastoma,I
cell,I
line,I
",",O
activated,O
NF,B
-,I
kappa,I
B,I
",",O
but,O
only,O
in,O
that,O
particular,O
cell,O
line,O
.,O
To,O
identify,O
ets,B
-,I
related,I
transcriptional,I
regulators,I
expressed,O
in,O
pre,O
-,O
B,O
lymphocytes,O
that,O
may,O
interact,O
with,O
either,O
the,O
pi,O
or,O
the,O
microB,O
site,O
",",O
we,O
have,O
used,O
a,O
PCR,O
approach,O
with,O
degenerate,O
oligonucleotides,O
encoding,O
conserved,B
sequences,I
in,O
all,O
members,O
of,O
the,O
ets,B
family,I
.,O
We,O
have,O
cloned,O
the,O
gene,O
for,O
a,O
new,O
ets,O
-,O
related,O
transcription,O
factor,O
",",O
ERP,B
(,O
ets,O
-,O
related,O
protein,B
),O
",",O
from,O
the,O
murine,O
pre,O
-,O
B,O
cell,O
line,O
BASC,B
6C2,I
and,O
from,O
mouse,O
lung,O
tissue,O
.,O
Full,O
-,O
length,O
ERP,B
expresses,O
only,O
negligible,O
DNA,B
-,I
binding,I
activity,I
by,O
itself,O
.,O
Two,O
cis,O
-,O
acting,O
elements,O
GM,B
-,I
kappa,I
B,I
/,I
GC,I
-,I
box,I
and,O
CLE0.00,O
",",O
of,O
the,O
granulocyte,O
-,O
macrophage,O
colony,O
-,O
stimulating,O
factor,O
(,O
GM,B
-,I
CSF,I
),O
gene,O
are,O
required,O
for,O
maximal,O
induction,O
in,O
Jurkat,B
T,I
cells,O
by,O
costimulation,O
with,O
phorbol,O
-,O
12,O
-,O
myristate,O
acetate,O
(,O
PMA,O
),O
and,O
Ca2,B
+,I
ionophore,O
(,O
A23187,O
),O
.,O
Nonpituitary,O
human,O
prolactin,B
gene,I
transcription,O
is,O
independent,O
of,O
Pit,B
-,I
1,I
and,O
differentially,O
controlled,O
in,O
lymphocytes,B
and,O
in,O
endometrial,B
stroma,I
.,O
Our,O
experiments,O
also,O
show,O
that,O
activated,O
PR,B
does,O
not,O
confer,O
direct,O
transcriptional,O
control,O
on,O
the,O
dPRL,B
promoter,I
.,O
One,O
of,O
the,O
nuclear,B
factors,I
(,O
NFs,B
),O
that,O
regulates,O
the,O
response,O
of,O
the,O
IL,B
-,I
5,I
promoter,I
to,O
cAMP,B
and,O
PMA,B
has,O
properties,O
similar,O
to,O
NF,B
for,O
activated,O
t,B
cell,I
.,O
JNK,B
is,O
involved,O
in,O
signal,O
integration,O
during,O
costimulation,O
of,O
T,B
lymphocytes,I
.,O
T,B
lymphocyte,I
activation,O
and,O
interleukin,O
-,O
2,O
(,O
IL,B
-,I
2,I
),O
production,O
require,O
at,O
least,O
two,O
signals,O
",",O
generated,O
by,O
phorbol,O
ester,O
(,O
TPA,B
),O
and,O
Ca2,B
+,I
ionophore,I
or,O
costimulation,O
of,O
the,O
T,B
cell,I
receptor,I
(,O
TCR,B
),O
and,O
the,O
CD28,B
auxiliary,I
receptor,I
.,O
Full,O
activation,O
of,O
the,O
MAP,B
kinases,I
that,O
phosphorylate,O
the,O
Jun,B
activation,I
domain,I
",",O
JNK1,B
and,O
JNK2,B
",",O
required,O
costimulation,O
of,O
T,B
cells,I
with,O
either,O
TPA,B
and,O
Ca2,B
+,I
ionophore,I
or,O
antibodies,O
to,O
TCR,B
and,O
CD28,B
.,O
The,O
effect,O
of,O
a,O
liposomal,O
formulation,O
of,O
methylprednisolone,B
(,O
MPL,B
),O
on,O
the,O
inhibition,O
of,O
lymphocyte,B
proliferation,I
in,O
spleen,B
cells,I
was,O
investigated,O
following,O
IV,B
dosing,I
in,O
rats,O
.,O
Liposomes,O
do,O
not,O
alter,O
the,O
suppressive,O
action,O
of,O
MPL,B
when,O
placed,O
in,O
lymphocyte,B
culture,I
.,O
Inhibition,O
effects,O
versus,O
time,O
were,O
described,O
by,O
a,O
pharmacodynamic,O
model,O
using,O
MPL,B
concentrations,O
in,O
plasma,O
as,O
an,O
input,O
function,O
.,O
In,O
vivo,O
protein,B
-,I
DNA,I
contacts,O
are,O
detectable,O
at,O
Ii,B
kappa,I
B,I
-,I
1,I
in,O
cell,B
lines,I
in,O
which,O
this,O
site,O
is,O
functional,O
as,O
either,O
a,O
positive,O
or,O
negative,O
regulator,O
.,O
Ii,O
kappa,O
B,O
-,O
2,O
is,O
a,O
site,O
of,O
positive,O
regulation,O
in,O
B,B
-,I
cell,I
lines,I
and,O
a,O
site,O
of,O
negative,O
regulation,O
in,O
H9,B
T,I
cells,I
",",O
myelomonocytic,B
",",O
and,O
glial,B
cell,I
lines,I
.,O
Again,O
",",O
in,O
vitro,O
supershift,O
studies,O
indicate,O
that,O
the,O
presence,O
of,O
p50,B
",",O
p52,B
",",O
p65,B
",",O
and,O
cRel,B
correlates,O
with,O
positive,O
function,O
whereas,O
the,O
presence,O
of,O
only,O
p50,B
and,O
p52,B
correlates,O
with,O
negative,O
function,O
.,O
OBJECTIVE,O
:,O
To,O
determine,O
whether,O
activation,O
of,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
),O
replication,O
in,O
tumour,O
cells,O
of,O
AIDS,O
-,O
related,O
non,O
-,O
Hodgkin,O
',O
s,O
lymphoma,O
(,O
ARNHL,O
),O
is,O
correlated,O
with,O
CD4,B
+,I
cell,I
counts,I
and,O
influences,O
antibody,O
response,O
to,O
EBV,B
[,O
anti,O
-,O
Z,O
Epstein,B
-,I
Barr,I
replicative,I
activator,I
(,O
ZEBRA,O
),O
",",O
anti,O
-,O
early,O
antigen,O
(,O
EA,O
),O
",",O
anti,O
-,O
viral,O
capsid,O
antigen,O
(,O
VCA,O
),O
],O
.,O
DESIGN,O
:,O
Retrospective,O
study,O
based,O
on,O
immunohistochemistry,O
and,O
in,O
situ,O
hybridization,O
to,O
detect,O
EBV,B
replicative,I
gene,I
products,I
in,O
tissue,O
samples,O
from,O
patients,O
affected,O
by,O
ARNHL,O
and,O
correlation,O
with,O
CD4,B
+,I
cell,I
counts,I
and,O
results,O
of,O
EBV,B
serology,I
(,O
including,O
anti,O
-,O
ZEBRA,B
activity,I
),O
in,O
sera,O
from,O
the,O
same,O
patients,O
.,O
In,O
cells,O
stimulated,O
with,O
anti,O
-,O
CD3,B
mAb,I
",",O
PGE2,B
inhibited,O
cell,O
proliferation,O
and,O
the,O
production,O
of,O
all,O
the,O
cytokines,O
examined,O
. Addition,O
of,O
rIL,B
-,I
2,I
fully,O
restored,O
the,O
proliferative,O
response,O
and,O
partially,O
restored,O
the,O
production,O
of,O
IL,B
-,I
4,I
and,O
IL,B
-,I
5,I
",",O
but,O
not,O
that,O
of,O
other,O
cytokines,O
. It,O
seems,O
therefore,O
that,O
PGE2,B
",",O
by,O
elevating,O
cAMP,B
levels,I
",",O
interferes,O
with,O
the,O
activation,O
pathway,O
for,O
NF,B
-,I
kappa,I
B,I
but,O
not,O
for,O
NF,B
-,I
AT,I
",",O
AP,B
-,I
1,I
or,O
CLE0.00,O
binding,O
protein,O
.,O
Moreover,O
",",O
rapamycin,O
",",O
an,O
inhibitor,O
of,O
pp70S6K,B
activation,O
",",O
had,O
no,O
effect,O
on,O
induction,O
of,O
EGR,B
-,I
1,I
expression,O
.,O
In,O
contrast,O
",",O
analysis,O
of,O
pp90rsk,B
activity,O
by,O
phosphorylation,O
of,O
a,O
peptide,O
derived,O
from,O
S6,B
protein,I
demonstrated,O
stimulation,O
of,O
this,O
kinase,O
in,O
TPA,O
-,O
treated,O
U,B
-,I
937,I
",",O
and,O
not,O
TUR,B
",",O
cells,O
.,O
PDTC,B
or,O
N,B
-,I
acetylcysteine,I
dose,O
dependently,O
reduced,O
TNF,B
-,I
induced,I
VCAM,I
-,I
1,I
but,O
not,O
ICAM,B
-,I
1,I
surface,O
protein,O
(,O
also,O
in,O
human,B
umbilical,I
arterial,I
endothelial,I
cells,O
),O
and,O
mRNA,O
expression,O
(,O
by,O
70,O
%,O
at,O
100,O
mumol,O
/,O
L,O
PDTC,B
),O
in,O
HUVECs,O
as,O
assessed,O
by,O
flow,O
cytometry,O
and,O
polymerase,O
chain,O
reaction,O
.,O
We,O
have,O
identified,O
a,O
`,O
`,O
two,O
-,O
handed,O
',O
',O
zinc,B
finger,I
protein,I
",",O
denoted,O
ZEB,B
",",O
the,O
DNA,B
-,I
binding,I
specificity,I
of,O
which,O
mimics,O
that,O
of,O
the,O
cellular,O
repressor,O
.,O
By,O
employing,O
a,O
derivative,O
E,O
box,O
that,O
binds,O
ZEB,B
but,O
not,O
E2A,O
",",O
we,O
have,O
shown,O
that,O
the,O
repressor,O
is,O
active,O
in,O
B,O
cells,O
and,O
the,O
IgH,B
enhancer,I
is,O
silenced,O
in,O
the,O
absence,O
of,O
binding,O
competition,O
by,O
bHLH,O
proteins,O
.,O
Effects,O
of,O
the,O
antisense,O
myb,B
expression,O
on,O
hemin,B
-,I
and,O
erythropoietin,B
-,I
induced,O
erythroid,O
differentiation,O
of,O
K562,B
cells,I
.,O
In,O
order,O
to,O
elucidate,O
the,O
role,O
of,O
c,O
-,O
myb,B
gene,I
in,O
erythroid,O
differentiation,O
of,O
K562,B
cell,I
induced,O
by,O
hemin,B
(,O
Hm,B
),O
and,O
erythropoietin,B
(,O
Epo,B
),O
",",O
we,O
constructed,O
recombinant,O
plasmid,O
that,O
could,O
produce,O
antisense,O
myb,B
RNA,I
after,O
induction,O
with,O
dexamethasone,O
.,O
During,O
treatment,O
with,O
Hm,O
",",O
K562,B
cells,I
constitutively,O
expressed,O
c,O
-,O
myb,B
mRNA,I
",",O
and,O
50,O
%,O
of,O
them,O
began,O
to,O
synthesize,O
hemoglobin,B
(,O
Hb,I
),O
.,O
We,O
investigated,O
whether,O
non,O
-,O
abortive,O
maternal,O
infections,O
would,O
compromise,O
fetal,O
brain,O
development,O
and,O
alter,O
hypothalamic,B
-,I
pituitary,I
-,I
adrenocortical,I
(,I
HPA,I
),O
axis,O
functioning,O
when,O
adult,O
.,O
The,O
adult,O
male,O
progeny,O
(,O
3,O
mo,O
old,O
),O
of,O
both,O
experimental,O
groups,O
showed,O
increased,O
basal,O
plasma,O
corticosterone,B
levels,O
0.19,O
Both,O
groups,O
showed,O
substantial,O
decreases,O
in,O
mineralocorticoid,B
(,O
MR,B
),O
and,O
glucocorticoid,B
receptor,I
(,O
GR,B
),O
levels,O
in,O
the,O
hippocampus,O
",40",O
a,O
limbic,O
brain,O
structure,O
critical,O
for,O
HPA,O
axis,O
regulation,O
",50",O
whereas,O
GR,B
concentrations,O
in,O
the,O
hypothalamus,O
were,O
unchanged,O
and,O
in,O
anterior,O
pituitary,O
were,O
slightly,O
increased,O
0.66,O
HRBC,B
and,O
LPS,B
indeed,O
stimulated,O
the,O
maternal,O
immune,O
system,O
as,O
revealed,O
by,O
specific,O
anti,O
-,O
HRBC,B
antibody,I
production,I
and,O
enhanced,O
IL,B
-,I
1,I
beta,I
mRNA,I
expression,I
in,O
splenocytes,O
",",O
respectively,O
.,O
NM23,B
was,O
identified,O
in,O
a,O
system,O
of,O
murine,O
melanoma,B
cell,I
lines,I
",",O
in,O
which,O
an,O
inverse,O
relationship,O
was,O
found,O
between,O
NM23,B
expression,I
and,O
metastatic,O
ability,O
.,O
The,O
transmission,O
of,O
signals,O
from,O
the,O
membrane,O
to,O
the,O
nucleus,O
is,O
mediated,O
principally,O
through,O
the,O
action,O
of,O
protein,B
tyrosine,I
and,O
serine,B
/,I
threonine,I
kinases,I
.,O
Fos,B
kinase,I
may,O
play,O
a,O
role,O
in,O
transcriptional,O
regulation,O
through,O
its,O
capacity,O
to,O
phosphorylate,O
c,O
-,O
Fos,B
at,O
a,O
site,O
required,O
for,O
expression,O
of,O
the,O
transcriptional,O
transrepressive,O
activity,O
of,O
this,O
molecule,O
.,O
Each,O
of,O
the,O
remaining,O
four,O
patients,O
also,O
yielded,O
at,O
least,O
one,O
type,O
-,O
specific,O
T,B
-,I
cell,I
clone,I
reactive,O
with,O
an,O
HSV,B
-,I
2,I
epitope,I
mapping,O
to,O
approximately,O
0,O
.,O
67,O
to,O
0,O
.,O
73,O
map,O
units,O
.,O
Human,O
T,B
-,I
cell,I
clones,I
reactive,O
with,O
gC,B
and,O
VP16,B
are,O
reported,O
here,O
for,O
the,O
first,O
time,O
.,O
We,O
studied,O
genomic,O
DNA,B
and,O
RNA,B
extracted,O
from,O
the,O
patient,O
',O
s,O
peripheral,O
leucocytes,O
in,O
order,O
to,O
determine,O
the,O
origin,O
of,O
the,O
basophils,O
.,O
The,O
RAR,B
alpha,I
rearranged,O
band,O
in,O
the,O
Southern,O
blot,O
analysis,O
and,O
a,O
chimaeric,O
product,O
of,O
PML,B
-,I
RAR,I
alpha,I
by,O
polymerase,O
chain,O
reaction,O
were,O
strongly,O
visible,O
before,O
ATRA,O
treatment,O
",",O
but,O
at,O
the,O
time,O
of,O
maximal,O
basophilia,O
both,O
of,O
them,O
were,O
markedly,O
diminished,O
.,O
Activation,O
of,O
the,O
interleukin,B
6,I
gene,I
by,O
Mycobacterium,B
tuberculosis,I
or,O
lipopolysaccharide,O
is,O
mediated,O
by,O
nuclear,O
factors,O
NF,B
-,I
IL6,I
and,O
NF,B
-,I
kappa,I
B,I
[,O
published,O
erratum,O
appears,O
in,O
Proc,O
Natl,O
Acad,O
Sci,O
U,O
S,O
A,O
1995,O
Apr,O
11,O
;,O
92,O
(,O
8,O
):,O
3632,O
].,O
In,O
this,O
regard,O
",",O
the,O
cytokine,O
interleukin,B
6,I
(,O
IL,B
-,I
6,I
),O
may,O
play,O
a,O
role,O
in,O
the,O
clinical,O
manifestations,O
and,O
pathological,O
events,O
of,O
tuberculosis,O
infection,O
.,O
LAM,O
and,O
LPS,O
were,O
potent,O
inducers,O
of,O
IL,B
-,I
6,I
gene,I
expression,I
in,O
peripheral,O
blood,O
monocytes,O
.,O
Two,O
nuclear,O
factor,O
NF,B
-,I
IL6,I
(,O
positions,O
-,O
153,O
to,O
-,O
145,O
and,O
-,O
83,O
to,O
-,O
75,O
),O
and,O
one,O
nuclear,O
factor,O
NF,B
-,I
kappa,I
B,I
(,O
positions,O
-,O
72,O
to,O
-,O
63,O
),O
motifs,O
are,O
present,O
within,O
this,O
fragment,O
.,O
We,O
conclude,O
that,O
the,O
NF,B
-,I
IL6,I
and,O
NF,B
-,I
kappa,I
B,I
sites,O
mediate,O
IL,B
-,I
6,I
induction,I
in,O
response,O
to,O
both,O
LPS,O
and,O
LAM,O
",",O
acting,O
as,O
bacterial,O
or,O
mycobacterial,O
response,O
elements,O
.,O
Using,O
FACS,O
",",O
Northern,O
blotting,O
",",O
and,O
nuclear,O
run,O
-,O
on,O
analyses,O
",",O
we,O
demonstrate,O
that,O
the,O
up,O
-,O
regulation,O
of,O
CD14,B
expression,I
during,O
monocytic,O
cell,O
maturation,O
is,O
regulated,O
mainly,O
at,O
the,O
level,O
of,O
gene,O
transcription,O
",",O
and,O
that,O
new,O
protein,B
synthesis,I
is,O
required,O
for,O
CD14,B
induction,I
.,O
This,O
region,O
contains,O
two,O
binding,O
sites,O
for,O
the,O
Sp1,B
transcription,I
factor,I
.,O
UV,O
irradiation,O
and,O
H2O2,O
treatment,O
of,O
T,B
lymphocytes,I
induce,O
protein,B
tyrosine,I
phosphorylation,I
and,O
Ca2,B
+,I
signals,O
similar,O
to,O
those,O
observed,O
following,O
biological,O
stimulation,O
.,O
Similarly,O
",",O
Jurkat,B
T,I
cell,I
lines,I
deficient,O
in,O
CD3,B
or,O
CD45,B
expression,O
also,O
gave,O
impaired,O
UV,B
responses,O
.,O
Inhibition,O
of,O
the,O
differentiation,O
of,O
human,O
myeloid,B
cell,I
lines,I
by,O
redox,O
changes,O
induced,O
through,O
glutathione,O
depletion,O
.,O
The,O
glutathione,B
-,I
depleting,I
agent,I
diethyl,I
maleate,I
(,O
DEM,B
),O
prevented,O
the,O
development,O
of,O
differentiated,O
features,O
in,O
response,O
to,O
phorbol,O
esters,O
",",O
including,O
adherence,O
of,O
the,O
cells,O
to,O
plastic,O
surfaces,O
and,O
repression,O
of,O
the,O
myeloperoxidase,B
and,O
CD34,B
genes,I
.,O
This,O
nuclear,O
complex,O
was,O
activated,O
by,O
LPS,O
with,O
kinetics,O
that,O
preceded,O
induction,O
of,O
the,O
TF,B
gene,I
.,O
Human,O
immunodeficiency,O
virus,O
type,O
1,O
Nef,B
protein,I
down,O
-,O
regulates,O
transcription,O
factors,O
NF,B
-,I
kappa,I
B,I
and,O
AP,B
-,I
1,I
in,O
human,O
T,B
cells,I
in,O
vitro,O
after,O
T,B
-,I
cell,I
receptor,I
stimulation,I
.,O
To,O
define,O
the,O
mechanism,O
of,O
action,O
of,O
the,O
Nef,B
protein,I
",",O
the,O
signal,O
transduction,O
pathways,O
which,O
may,O
be,O
affected,O
in,O
T,B
cells,I
by,O
constitutive,O
expression,O
of,O
the,O
nef,O
gene,O
were,O
examined,O
.,O
Stimulation,O
of,O
T,B
cells,I
with,O
tumor,O
necrosis,O
factor,O
",",O
interleukin,O
-,O
1,O
",",O
or,O
lipopolysaccharide,O
resulted,O
in,O
the,O
recruitment,O
of,O
transcriptional,O
factors,O
to,O
a,O
similar,O
level,O
whether,O
or,O
not,O
the,O
cells,B
expressed,O
the,O
nef,O
gene,O
.,O
When,O
cells,B
were,O
preincubated,O
with,O
dihydrolipoic,O
acid,O
(,O
0,O
.,O
2,O
mM,O
),O
the,O
expression,O
of,O
c,B
-,I
fos,I
mRNA,I
was,O
suppressed,O
at,O
30,O
min,O
after,O
stimulation,O
of,O
TPA,O
(,O
0,O
.,O
5,O
microM,O
),O
whereas,O
in,O
the,O
case,O
of,O
preincubation,O
of,O
alpha,B
-,I
lipoic,I
acid,I
(,O
0,O
.,O
2,O
microM,O
),O
",",O
the,O
expression,O
was,O
enhanced,O
at,O
30,O
min,O
.,O
This,O
resulted,O
in,O
only,O
a,O
partial,O
inhibition,O
of,O
TNF,O
-,O
or,O
PMA,O
-,O
induced,O
HIV,B
replication,I
in,O
U1,B
cells,I
",",O
and,O
no,O
detectable,O
effect,O
on,O
HIV,B
replication,I
in,O
chronically,O
infected,O
U937,B
cells,I
.,O
Another,O
limitation,O
is,O
that,O
antioxidant,O
concentrations,O
high,O
enough,O
to,O
block,O
NK,B
-,I
kappa,I
B,I
activation,O
were,O
shown,O
to,O
have,O
a,O
suppressive,O
effect,O
on,O
immune,O
functions,O
in,O
vitro,O
",",O
because,O
NAC,O
and,O
BHA,O
blocked,O
IL,B
-,I
2,I
-,I
induced,O
PBMC,O
proliferation,O
.,O
We,O
have,O
developed,O
a,O
three,O
-,O
layer,O
Percoll,O
density,O
gradient,O
that,O
allows,O
separation,O
of,O
the,O
different,O
granules,O
and,O
vesicles,O
from,O
human,O
neutrophils,O
;,O
in,O
particular,O
",",O
it,O
allows,O
separation,O
of,O
specific,O
and,O
gelatinase,O
granules,O
.,O
This,O
allows,O
us,O
to,O
characterize,O
these,O
two,O
granule,O
populations,O
with,O
regard,O
to,O
their,O
content,O
of,O
membrane,B
proteins,I
",",O
which,O
become,O
incorporated,O
into,O
the,O
plasma,B
membrane,I
during,O
exocytosis,O
.,O
Furthermore,O
",",O
we,O
found,O
that,O
20,O
%,O
to,O
25,O
%,O
of,O
both,O
the,O
adhesion,B
protein,I
Mac,I
-,I
1,I
and,O
the,O
NADPH,B
-,I
oxidase,I
component,I
cytochrome,I
b558,I
is,O
localized,O
in,O
gelatinase,O
granules,O
.,O
This,O
shows,O
that,O
gelatinase,B
granules,I
are,O
functionally,O
important,O
relative,O
to,O
specific,O
granules,B
in,O
mediating,O
early,O
inflammatory,O
responses,O
.,O
Treatment,O
of,O
human,O
resting,O
T,B
cells,I
with,O
phorbol,O
esters,O
strongly,O
induced,O
the,O
expression,O
of,O
IL,B
-,I
2R,I
alpha,I
and,O
the,O
activation,O
of,O
NF,B
.,O
kappa,I
B,I
.,O
Rather,O
",",O
the,O
data,O
indicate,O
that,O
mitogen,O
increases,O
the,O
levels,O
of,O
a,O
nuclear,O
factor,O
(,O
s,O
),O
that,O
dimerizes,O
with,O
CREB,B
.,O
We,O
have,O
examined,O
the,O
effect,O
of,O
alpha,B
-,I
tocopherol,I
(,O
alpha,B
-,I
tcp,I
),O
on,O
one,O
cellular,O
event,O
in,O
atherosclerotic,O
plaque,O
development,O
",",O
monocyte,B
adhesion,O
to,O
stimulated,O
endothelial,B
cells,I
(,O
ECs,B
),O
.,O
Agonist,O
-,O
induced,O
monocytic,B
cell,I
adhesion,O
",",O
but,O
not,O
basal,O
adhesion,O
",",O
was,O
inhibited,O
in,O
a,O
time,O
-,O
and,O
concentration,O
-,O
dependent,O
manner,O
by,O
alpha,B
-,I
tcp,I
.,O
Central,O
nervous,O
system,O
-,O
derived,O
cells,O
express,O
a,O
kappa,B
B,I
-,I
binding,I
activity,I
that,O
enhances,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
transcription,O
in,O
vitro,O
and,O
facilitates,O
TAR,O
-,O
independent,O
transactivation,O
by,O
Tat,O
.,O
Tat,O
transactivation,O
mediated,O
by,O
the,O
kappa,B
B,I
domain,I
is,O
sufficient,O
to,O
allow,O
replication,O
of,O
TAR,O
-,O
deleted,O
mutant,O
HIV,O
-,O
1,O
in,O
astrocytes,O
.,O
For,O
one,O
of,O
these,O
proteins,B
",",O
p57,B
",",O
binding,O
to,O
the,O
IRES,O
correlates,O
with,O
translation,O
.,O
Retinoid,O
-,O
like,O
receptors,B
play,O
a,O
central,O
role,O
in,O
hormonal,O
responses,O
by,O
forming,O
heterodimers,O
with,O
other,O
nuclear,O
hormone,O
receptors,O
.,O
Hence,O
",",O
PPAR,B
can,O
positively,O
or,O
negatively,O
influence,O
TH,B
action,O
depending,O
on,O
TRE,O
structure,O
and,O
THR,B
isotype,O
.,O
Comparison,O
of,O
retinoic,B
acid,I
and,O
phorbol,B
myristate,I
acetate,I
as,O
inducers,O
of,O
monocytic,B
differentiation,I
.,O
Several,O
human,O
myeloid,B
leukemia,I
cell,I
lines,I
growing,O
in,O
vitro,O
can,O
be,O
induced,O
to,O
differentiate,O
to,O
more,O
mature,O
monocyte,B
/,I
macrophage,I
-,I
like,I
cells,I
by,O
treatment,O
with,O
protein,B
kinase,I
C,I
-,I
activating,I
phorbol,B
esters,I
",",O
such,O
as,O
PMA,O
.,O
Lymphoid,O
cells,O
transformed,O
by,O
Abelson,O
murine,O
leukemia,O
virus,O
have,O
provided,O
one,O
of,O
the,O
classic,O
models,O
for,O
study,O
of,O
early,O
B,B
-,I
cell,I
development,I
and,O
immunoglobulin,B
rearrangement,I
.,O
To,O
test,O
this,O
hypothesis,O
",",O
light,O
-,O
chain,O
gene,O
structure,O
was,O
examined,O
in,O
pre,O
-,O
B,B
cells,I
transformed,O
by,O
temperature,O
-,O
sensitive,O
mutants,O
of,O
the,O
Abelson,O
virus,O
and,O
in,O
derivatives,O
that,O
survive,O
at,O
the,O
nonpermissive,O
temperature,O
because,O
they,O
express,O
a,O
human,O
BCL,B
-,I
2,I
gene,I
.,O
Our,O
studies,O
reveal,O
that,O
inactivation,O
of,O
the,O
v,B
-,I
abl,I
protein,I
tyrosine,I
kinase,I
triggers,O
high,O
-,O
frequency,O
rearrangement,O
of,O
kappa,B
and,O
lambda,B
light,I
-,I
chain,I
genes,I
.,O
Expression,O
and,O
genomic,O
configuration,O
of,O
GM,B
-,I
CSF,I
",",O
IL,B
-,I
3,I
",",O
M,B
-,I
CSF,I
receptor,I
(,O
C,B
-,I
FMS,I
),O
",",O
early,O
growth,O
response,O
gene,O
-,O
1,O
(,O
EGR,B
-,I
1,I
),O
and,O
M,B
-,I
CSF,I
genes,I
in,O
primary,O
myelodysplastic,O
syndromes,O
.,O
The,O
expression,O
of,O
the,O
M,B
-,I
CSF,I
gene,I
",",O
that,O
has,O
been,O
recently,O
reassigned,O
to,O
the,O
short,O
arm,O
of,O
chromosome,O
1,O
(,O
lp,O
),O
",",O
was,O
also,O
investigated,O
.,O
Similar,O
analysis,O
of,O
poly,O
(,O
A,O
),O
RNA,B
from,O
a,O
variety,O
of,O
adult,O
tissues,O
demonstrated,O
HB9,B
transcripts,I
in,O
pancreas,O
",",O
small,O
intestine,O
",",O
and,O
colon,O
. The,O
observed,O
increase,O
in,O
IL,B
-,I
2,I
levels,I
might,O
facilitate,O
virus,O
spread,O
from,O
or,O
to,O
T,B
cells,I
.,O
Recent,O
reports,O
demonstrated,O
that,O
ionizing,O
radiation,O
in,O
the,O
dose,O
range,O
of,O
2,O
-,O
50,O
Gy,O
results,O
in,O
expression,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
human,O
KG,B
-,I
1,I
myeloid,I
leukemia,I
cells,I
and,O
human,O
B,B
-,I
lymphocyte,I
precursor,I
cells,I
;,O
the,O
precise,O
mechanism,O
involved,O
and,O
the,O
significance,O
are,O
not,O
yet,O
known,O
. The,O
present,O
report,O
demonstrates,O
that,O
even,O
lower,O
doses,O
of,O
ionizing,O
radiation,O
",",O
0,O
0.63,O
25,O
-,O
2,O
.,O
0,O
Gy,O
",",O
are,O
capable,O
of,O
inducing,O
expression,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
EBV,O
-,O
transformed,O
244B,O
human,O
lymphoblastoid,O
cells,O
.,O
The,O
expression,O
of,O
the,O
p50,B
and,O
p65,B
NF,B
-,I
kappa,I
B,I
subunits,I
was,O
also,O
shown,O
to,O
be,O
regulated,O
differentially,O
after,O
exposures,O
to,O
1,O
.,O
0,O
and,O
2,O
.,O
0,O
Gy,O
.,O
The,O
two,O
human,O
GATA3,B
zinc,I
fingers,I
are,O
encoded,O
by,O
two,O
separate,O
exons,O
highly,O
conserved,B
with,O
those,O
of,O
GATA1,B
",",O
but,O
no,O
other,O
structural,O
homologies,O
between,O
these,O
two,O
genes,O
can,O
be,O
found,O
.,O
The,O
human,O
and,O
mouse,O
GATA3,B
transcription,O
units,O
start,O
at,O
a,O
major,O
initiation,O
site,O
.,O
Retinoic,O
acid,O
-,O
induced,O
expression,O
of,O
CD38,B
antigen,O
in,O
myeloid,O
cells,O
is,O
mediated,O
through,O
retinoic,O
acid,O
receptor,O
-,O
alpha,O
.,O
CD38,B
is,O
a,O
leukocyte,O
differentiation,O
antigen,O
that,O
has,O
been,O
thought,O
to,O
be,O
a,O
phenotypic,O
marker,O
of,O
different,O
subpopulations,O
of,O
T,B
-,I
and,I
B,I
-,I
lymphocytes,I
.,O
In,O
myeloid,B
cells,I
",",O
CD38,B
is,O
expressed,O
during,O
early,O
stages,O
of,O
differentiation,O
.,O
Some,O
antioxidants,O
inhibit,O
",",O
in,O
a,O
co,O
-,O
ordinate,O
fashion,O
",",O
the,O
production,O
of,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
",",O
IL,B
-,I
beta,I
",",O
and,O
IL,B
-,I
6,I
by,O
human,O
peripheral,O
blood,O
mononuclear,O
cells,O
.,O
Inhibition,O
of,O
cytokine,O
production,O
was,O
gene,O
selective,O
and,O
not,O
due,O
to,O
general,O
effects,O
on,O
protein,B
synthesis,O
.,O
Much,O
higher,O
concentrations,O
of,O
other,O
antioxidants,O
-,O
-,O
including,O
ascorbic,O
acid,O
",",O
trolox,O
",",O
alpha,O
-,O
tocopherol,O
",",O
butylated,O
hydroxytoluene,O
",",O
and,O
the,O
5,O
-,O
lipoxygenase,O
inhibitor,O
zileuton,O
-,O
-,O
did,O
not,O
affect,O
the,O
production,O
of,O
these,O
cytokines,O
.,O
Thus,O
antioxidants,O
vary,O
widely,O
in,O
potency,O
as,O
inhibitors,O
of,O
the,O
activation,O
of,O
transcription,O
factors,O
and,O
of,O
the,O
transcription,O
of,O
genes,O
for,O
pro,O
-,O
inflammatory,O
cytokines,O
.,O
This,O
protein,B
has,O
now,O
been,O
purified,O
and,O
its,O
encoding,O
gene,O
cloned,O
.,O
Examination,O
of,O
the,O
primary,O
amino,O
acid,O
sequence,O
of,O
this,O
protein,B
indicates,O
that,O
it,O
is,O
a,O
member,O
of,O
the,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
Stat,B
),O
family,O
of,O
DNA,B
binding,I
proteins,I
",",O
hereby,O
designated,O
IL,B
-,I
4,I
Stat,I
.,O
Such,O
observations,O
indicate,O
that,O
IL,B
-,I
4,I
Stat,I
has,O
the,O
same,O
functional,B
domain,I
for,O
both,O
receptor,O
coupling,O
and,O
dimerization,O
.,O
Lung,B
disease,I
associated,O
with,O
disorders,O
such,O
as,O
cystic,B
fibrosis,I
(,O
CF,B
),O
may,O
be,O
amenable,O
to,O
somatic,O
gene,B
therapy,I
in,O
which,O
there,O
is,O
delivery,O
of,O
the,O
normal,O
gene,B
directly,O
to,O
the,O
respiratory,B
epithelium,I
using,O
E1a,B
-,I
adenovirus,I
(,O
Ad,B
),O
type,O
2,O
-,O
or,O
5,O
-,O
based,O
vectors,O
.,O
In,O
the,O
E1a,B
-,I
positive,I
samples,O
",",O
the,O
average,O
of,O
E1a,B
copy,I
number,I
was,O
55,O
+,O
/,O
-,O
18,O
/,O
10,O
(,O
3,O
),O
recovered,O
cells,O
.,O
Tumor,O
cells,O
showed,O
an,O
overexpression,O
of,O
p53,B
protein,I
and,O
were,O
estrogen,B
receptor,I
-,I
positive,I
.,O
The,O
magnitude,O
and,O
time,O
kinetics,O
of,O
the,O
LIF,B
effects,I
were,O
similar,O
to,O
interleukin,B
1,I
(,O
IL,B
-,I
1,I
),O
",",O
IL,B
-,I
6,I
",",O
and,O
tumor,O
necrosis,O
factor,O
(,O
TNF,B
),O
",",O
other,O
cytokines,O
known,O
to,O
induce,O
HIV,O
replication,O
in,O
this,O
cell,O
line,O
.,O
To,O
characterize,O
mechanisms,O
responsible,O
for,O
these,O
LIF,B
effects,I
",",O
levels,O
of,O
HIV,O
mRNA,O
",",O
activation,O
of,O
the,O
DNA,B
binding,I
protein,I
nuclear,I
factor,I
(,O
NF,B
),O
-,O
kB,O
",",O
signal,O
transduction,O
pathways,O
",",O
and,O
potential,O
interactions,O
with,O
other,O
cytokines,O
were,O
analyzed,O
.,O
In,O
both,O
cell,O
lines,O
LIF,O
increased,O
NF,B
-,I
kB,I
activity,O
.,O
Induction,O
of,O
NF,B
-,I
kB,I
and,O
HIV,B
replication,O
by,O
cytokines,O
are,O
at,O
least,O
in,O
part,O
dependent,O
on,O
reactive,O
oxygen,O
intermediates,O
.,O
The,O
mechanisms,O
involved,O
in,O
the,O
inhibition,O
of,O
growth,O
of,O
a,O
human,O
B,B
lymphoma,I
cell,I
line,I
",",O
B104,B
",",O
by,O
anti,O
-,O
MHC,B
class,I
II,I
antibodies,I
(,O
Ab,O
),O
were,O
compared,O
with,O
those,O
in,O
anti,O
-,O
IgM,O
Ab,O
-,O
induced,O
B104,B
growth,O
inhibition,O
.,O
In,O
order,O
to,O
study,O
CD14,B
gene,I
regulation,I
",",O
the,O
human,O
CD14,B
gene,I
was,O
cloned,O
from,O
a,O
partial,O
EcoRI,O
digested,O
chromosome,O
5,O
library,O
.,O
Four,O
regions,O
in,O
this,O
DNA,B
fragment,I
interact,O
with,O
nuclear,O
proteins,O
isolated,O
from,O
monocytic,B
cells,I
.,O
The,O
Sp1,B
transcription,I
factor,I
bound,O
to,O
three,O
different,O
regions,O
in,O
the,O
CD14,B
promoter,I
.,O
Binding,O
data,O
were,O
derived,O
from,O
Scatchard,O
analysis,O
.,O
In,O
fertile,O
women,O
remarkable,O
changes,O
in,O
androgen,B
binding,I
sites,I
were,O
seen,O
in,O
the,O
course,O
of,O
the,O
menstrual,O
cycle,O
",",O
with,O
a,O
significant,O
increase,O
in,O
the,O
immediate,O
preovulatory,O
period,O
.,O
The,O
immunological,O
implications,O
of,O
these,O
results,O
are,O
discussed,O
.,O
Stimulation,O
of,O
the,O
CD28,B
cell,I
surface,I
molecule,I
delivers,O
costimulatory,O
signals,O
essential,O
for,O
lymphokine,B
production,O
in,O
activated,O
T,B
cells,I
via,O
a,O
conserved,B
sequence,I
element,I
found,O
in,O
the,O
promoter,O
of,O
several,O
lymphokine,B
genes,I
.,O
Diminished,O
glucocorticoid,B
receptors,I
do,O
not,O
result,O
in,O
glucocorticoid,B
resistance,O
.,O
Corticosteroid,B
Type,I
I,I
and,O
Type,B
II,I
receptors,I
are,O
inversely,O
correlated,O
with,O
age,O
.,O
All,O
-,O
trans,O
retinoic,O
acid,O
and,O
1,O
alpha,O
",",O
25,O
-,O
dihydroxyvitamin,O
D3,O
co,O
-,O
operate,O
to,O
promote,O
differentiation,O
of,O
the,O
human,O
promyeloid,O
leukemia,O
cell,O
line,O
HL60,B
to,O
monocytes,O
.,O
A,O
basis,O
for,O
differentiation,O
therapy,O
of,O
leukemias,O
is,O
provided,O
by,O
knowledge,O
of,O
agents,O
which,O
induce,O
specific,O
lineage,O
maturation,O
.,O
That,O
RA,B
promotes,O
both,O
neutrophil,B
and,O
monocyte,B
differentiation,O
has,O
implications,O
for,O
the,O
use,O
of,O
RA,B
and,O
D3,B
in,O
treatment,O
of,O
leukemias,O
and,O
provides,O
insight,O
into,O
mechanisms,O
whereby,O
RAR,B
",",O
VDR,B
and,O
RXR,B
facilitate,O
monocyte,B
differentiation,O
.,O
Thrombin,B
and,O
thrombin,B
receptor,I
agonist,I
peptide,I
induce,O
early,O
events,O
of,O
T,B
cell,I
activation,I
and,O
synergize,O
with,O
TCR,B
cross,I
-,I
linking,I
for,O
CD69,B
expression,I
and,O
interleukin,B
2,I
production,I
.,O
There,O
was,O
a,O
good,O
correlation,O
between,O
thrombin,B
-,I
induced,I
tyrosine,B
phosphorylation,I
of,O
the,O
latter,O
three,O
proteins,O
and,O
Ca2,B
+,I
mobilization,I
.,O
Stress,O
response,O
of,O
senescent,O
T,B
lymphocytes,I
:,O
reduced,O
hsp70,B
is,O
independent,O
of,O
the,O
proliferative,O
block,O
.,O
Senescent,O
human,O
T,B
lymphocyte,I
cultures,O
are,O
unable,O
to,O
undergo,O
proliferation,O
",",O
but,O
show,O
no,O
difference,O
from,O
early,O
passage,O
cells,O
in,O
cytotoxic,O
function,O
or,O
surface,O
antigenic,O
profile,O
.,O
Interestingly,O
",",O
the,O
progressive,O
decline,O
in,O
the,O
heat,O
shock,O
response,O
of,O
cultured,O
T,B
cells,I
correlates,O
with,O
the,O
percent,O
proliferative,O
life,O
span,O
completed,O
rather,O
than,O
with,O
the,O
actual,O
proliferative,O
activity,O
at,O
the,O
time,O
of,O
heat,O
shock,O
.,O
Wortmannin,O
",",O
an,O
inhibitor,O
of,O
receptor,O
-,O
coupled,O
PLD,B
activation,O
",",O
blocked,O
the,O
anti,O
-,O
CD3,O
-,O
induced,O
increases,O
in,O
both,O
PLD,B
activity,O
and,O
AP,B
-,I
1,I
enhancer,I
activity,O
.,O
We,O
found,O
a,O
good,O
correlation,O
in,O
the,O
transfected,O
cells,O
between,O
PLD,B
activation,O
and,O
induction,O
of,O
AP,B
-,I
1,I
enhancer,I
activity,O
under,O
different,O
experimental,O
conditions,O
.,O
We,O
therefore,O
reexamined,O
this,O
issue,O
by,O
using,O
two,O
different,O
experimental,O
approaches,O
that,O
allowed,O
LMP1,B
-,I
induced,O
effects,O
to,O
be,O
monitored,O
immediately,O
following,O
expression,O
of,O
the,O
viral,O
protein,B
and,O
in,O
the,O
absence,O
of,O
selective,O
pressures,O
;,O
activation,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
transcription,O
factor,O
and,O
upregulation,O
of,O
the,O
cell,B
adhesion,I
molecule,I
ICAM,I
-,I
1,I
were,O
used,O
as,O
early,O
indices,O
of,O
LMP1,B
function,O
.,O
In,O
the,O
second,O
approach,O
",",O
we,O
tested,O
the,O
generality,O
of,O
this,O
phenomenon,O
by,O
transiently,O
expressing,O
LMP1,B
from,O
a,O
strong,O
constitutively,O
active,O
promoter,O
in,O
a,O
range,O
of,O
different,O
cell,B
types,I
.,O
In,O
the,O
same,O
experiments,O
",",O
all,O
three,O
non,O
-,O
B,O
-,O
cell,B
lines,I
showed,O
NF,B
-,I
kappa,I
B,I
activation,I
and,O
ICAM,B
-,I
1,I
upregulation,O
but,O
never,O
any,O
effect,O
upon,O
Bcl,B
-,I
2,I
.,O
We,O
found,O
that,O
tyrosine,B
kinase,I
activity,I
was,O
similar,O
for,O
both,O
mAbs,O
over,O
a,O
period,O
of,O
hours,O
.,O
However,O
",",O
the,O
inositol,B
phosphate,I
response,I
was,O
stronger,O
for,O
64,O
0.1,O
than,O
for,O
OKT3,O
.,O
To,O
tie,O
these,O
events,O
to,O
gene,O
activation,O
",",O
we,O
measured,O
NF,B
-,I
kappa,I
B,I
and,O
NF,B
-,I
AT,I
activity,I
in,O
the,O
nucleus,O
after,O
anti,O
-,O
CD3,O
stimulation,O
.,O
Both,O
stimuli,O
induced,O
the,O
appearance,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
components,I
(,O
c,B
-,I
Rel,I
",",O
p65,B
(,O
RelA,B
),O
",",O
and,O
p50,B
(,O
NF,B
-,I
kappa,I
B1,I
),O
and,O
NF,B
-,I
kappa,I
B,I
DNA,B
binding,I
activity,I
in,O
the,O
nucleus,O
.,O
From,O
a,O
consecutive,O
series,O
of,O
350,O
cases,O
of,O
adult,O
de,O
novo,O
acute,O
myeloid,O
leukemia,O
(,O
AML,O
),O
",",O
we,O
identified,O
20,O
cases,O
(,O
6,O
%,O
),O
with,O
a,O
unique,O
immunophenotype,O
:,O
CD33,B
+,O
",",O
CD56,B
+,O
",",O
CD11a,B
+,O
",",O
CD13lo,B
",",O
CD15lo,B
",",O
CD34,B
+,O
/,O
-,O
",",O
HLA,B
-,I
DR,I
-,I
",",O
CD16,B
-,I
.,O
This,O
was,O
supported,O
by,O
the,O
observation,O
that,O
the,O
down,O
-,O
regulatory,O
capacity,O
of,O
IL,B
-,I
4,I
appeared,O
to,O
be,O
dependent,O
on,O
de,O
novo,O
protein,B
synthesis,I
.,O
Although,O
these,O
data,O
suggest,O
AP,O
-,O
1,O
regulated,O
cytokine,O
mRNA,O
expression,O
",",O
results,O
from,O
PBMo,O
are,O
not,O
in,O
accordance,O
with,O
this,O
notion,O
.,O
These,O
differences,O
may,O
represent,O
different,O
regulatory,O
pathways,O
of,O
the,O
two,O
cell,B
systems,I
.,O
Furthermore,O
",",O
the,O
present,O
results,O
demonstrate,O
clearly,O
that,O
mycoplasma,O
products,O
can,O
have,O
a,O
profound,O
impact,O
on,O
the,O
activation,O
status,O
of,O
eukaryotic,O
cells,O
.,O
Novel,O
membrane,O
receptors,O
for,O
aldosterone,B
in,O
human,O
lymphocytes,O
:,O
a,O
50,O
kDa,O
protein,B
on,O
SDS,O
-,O
PAGE,O
.,O
The,O
novel,O
aldosterone,B
membrane,O
receptor,O
was,O
analyzed,O
on,O
SDS,O
-,O
PAGE,O
after,O
labeling,O
of,O
microsomal,O
membranes,O
from,O
human,O
mononuclear,O
leukocytes,O
with,O
a,O
[,O
125I,O
].,O
-,O
aldosterone,B
-,O
derivative,O
by,O
use,O
of,O
BASED,O
as,O
a,O
photoactivatable,O
crosslinker,O
.,O
Binding,O
of,O
1,O
nM,O
[,O
125I,B
],O
-,O
aldosterone,O
was,O
found,O
at,O
a,O
molecular,O
weight,O
of,O
approximately,O
50,O
kDa,O
which,O
was,O
absent,O
with,O
1,O
microM,O
cold,O
aldosterone,O
",",O
but,O
not,O
cortisol,O
in,O
the,O
binding,O
media,O
.,O
It,O
",",O
thus,O
",",O
appears,O
as,O
an,O
integral,O
membrane,O
protein,B
.,O
Analysis,O
of,O
the,O
chromatin,O
organization,O
of,O
the,O
integrated,O
human,B
immunodeficiency,I
virus,I
type,I
1,I
(,O
HIV,B
-,I
1,I
),O
genome,O
has,O
previously,O
revealed,O
a,O
major,O
constitutive,O
DNase,B
I,I
-,I
hypersensitive,I
site,I
associated,O
with,O
the,O
pol,B
gene,I
(,O
E,B
Verdin,O
",",O
J,O
.,O
Virol,O
.,O
65,O
:,O
6790,O
-,O
6799,O
",",O
1991,O
.,O
Site,O
D,O
(,O
nt,O
4816,O
to,O
4851,O
),O
specifically,O
bound,O
a,O
ubiquitously,O
expressed,O
factor,O
.,O
NF,B
-,I
kappa,I
B,I
is,O
a,O
rapidly,O
inducible,O
transcriptional,O
activator,O
that,O
responds,O
to,O
a,O
variety,O
of,O
signals,O
and,O
influences,O
the,O
expression,O
of,O
many,O
genes,O
involved,O
in,O
the,O
immune,O
response,O
.,O
Human,B
herpesvirus,I
6,I
(,O
HHV,B
-,I
6,I
),O
is,O
a,O
lymphotropic,O
herpesvirus,O
",",O
and,O
in,O
vitro,O
",",O
it,O
can,O
productively,O
infect,O
human,O
CD4,B
+,I
T,I
cells,I
as,O
HIV,B
-,I
1,I
.,O
Sequence,O
analyses,O
show,O
that,O
this,O
protein,B
has,O
significant,O
homology,O
with,O
the,O
human,O
cytomegalovirus,B
UL44,I
gene,I
coding,O
for,O
the,O
ICP36,B
family,I
of,I
early,I
-,I
late,I
-,I
class,I
phosphoprotein,I
.,O
Sequence,O
analyses,O
of,O
pCD41,O
indicate,O
that,O
there,O
are,O
two,O
potential,O
open,O
reading,O
frames,O
(,O
ORFs,O
),O
",",O
A,O
and,O
B,O
",",O
which,O
are,O
homologous,O
to,O
the,O
ORFs,O
found,O
in,O
the,O
genomic,O
clone,O
pGD41,O
.,O
CD14,O
-,O
mediated,O
translocation,O
of,O
nuclear,O
factor,O
-,O
kappa,O
B,B
induced,O
by,O
lipopolysaccharide,O
does,O
not,O
require,O
tyrosine,O
kinase,O
activity,O
.,O
Nuclear,O
translocation,O
of,O
cytosolic,O
NF,B
-,I
kappa,I
B,I
is,O
correlated,O
with,O
a,O
number,O
of,O
LPS,O
-,O
inducible,O
responses,O
.,O
LPS,O
-,O
stimulated,O
translocation,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
CHO,O
/,O
CD14,O
cells,O
resembled,O
the,O
same,O
response,O
in,O
the,O
murine,O
macrophage,O
-,O
like,O
cell,O
line,O
RAW,O
264,O
.,O
7,O
.,O
The,O
stimulatory,O
effects,O
of,O
gp160,O
are,O
mediated,O
through,O
the,O
CD4,O
molecule,O
",",O
since,O
pretreatment,O
with,O
soluble,O
CD4,O
abrogates,O
its,O
activity,O
.,O
The,O
stimulatory,O
effect,O
of,O
gp160,B
on,O
NF,B
-,I
kappa,I
B,I
activation,O
is,O
protein,O
synthesis,O
independent,O
",",O
is,O
dependent,O
upon,O
protein,O
tyrosine,O
phosphorylation,O
",",O
and,O
abrogated,O
by,O
inhibitors,O
of,O
protein,O
kinase,O
C,O
.,O
No,O
evidence,O
for,O
the,O
expression,O
of,O
the,O
progesterone,O
receptor,O
on,O
peripheral,O
blood,O
lymphocytes,O
during,O
pregnancy,O
[,O
see,O
comments,O
],O
A,O
role,O
for,O
the,O
progesterone,O
receptor,O
in,O
the,O
mechanism,O
of,O
the,O
known,O
effect,O
of,O
progesterone,O
on,O
peripheral,O
blood,O
lymphocytes,O
is,O
also,O
excluded,O
.,O
In,O
nuclear,B
run,I
-,I
on,I
analysis,I
",",O
such,O
tolerant,O
cells,O
show,O
only,O
a,O
low,O
degree,O
of,O
transcription,O
",",O
indicating,O
that,O
tolerance,O
operates,O
at,O
or,O
upstream,O
of,O
the,O
transcription,O
level,O
.,O
The,O
CD14,B
LPS,I
receptor,I
is,O
",",O
however,O
",",O
up,O
-,O
regulated,O
(,O
not,O
down,O
-,O
regulated,O
),O
in,O
tolerant,O
cells,O
",",O
and,O
LPS,B
can,O
",",O
in,O
fact,O
",",O
still,O
lead,O
to,O
activation,O
of,O
tolerant,O
cells,O
as,O
evidenced,O
by,O
mobilization,O
of,O
the,O
transcription,O
factor,O
nuclear,B
factor,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),I
.,O
Resolution,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
complex,I
in,O
gel,O
shift,O
analysis,O
shows,O
that,O
the,O
binding,O
protein,B
",",O
mobilized,O
in,O
naive,O
Mono,B
Mac,I
6,I
cells,I
",",O
consists,O
mainly,O
of,O
p50,B
-,I
p65,I
heterodimers,I
",",O
while,O
in,O
tolerant,O
cells,I
",",O
the,O
p50,B
homodimer,I
is,O
predominant,O
.,O
This,O
increase,O
in,O
p50,B
homodimers,I
coincides,O
with,O
an,O
increase,O
in,O
p105,B
mRNA,I
",",O
suggestive,O
of,O
a,O
transcriptional,O
up,O
-,O
regulation,O
of,O
p50,B
.,O
Analysis,O
of,O
Oct2,B
-,I
isoform,I
expression,O
in,O
lipopolysaccharide,O
-,O
stimulated,O
B,B
lymphocytes,I
.,O
Oct2,B
-,I
isoform,I
expression,O
in,O
splenic,O
B,B
cells,I
stimulated,O
with,O
lipopolysaccharide,O
or,O
lipopolysaccharide,O
plus,O
phorbol,O
-,O
di,O
-,O
butyrate,O
was,O
analysed,O
by,O
cDNA,B
cloning,I
.,O
A,O
new,O
exon,O
containing,O
a,O
highly,O
basic,O
region,O
(,O
4c,O
),O
was,O
characterized,O
",",O
between,O
exons,O
4,O
and,O
5,O
.,O
In,O
addition,O
",",O
a,O
new,O
combination,O
isoform,O
containing,O
Oct2a,O
',O
s,O
amino,O
terminal,O
insert,O
(,O
exon,O
7a,O
),O
and,O
Oct2b,O
',O
s,O
carboxy,O
terminal,O
insert,O
(,O
exon,O
13,O
),O
was,O
found,O
that,O
created,O
a,O
novel,O
large,O
isoform,O
",",O
Oct2ab,O
.,O
Positive,O
regulators,O
of,O
the,O
lineage,O
-,O
specific,O
transcription,O
factor,O
GATA,O
-,O
1,O
in,O
differentiating,O
erythroid,O
cells,O
.,O
Analyses,O
with,O
cultured,O
cells,O
and,O
cell,O
-,O
free,O
systems,O
have,O
provided,O
strong,O
evidence,O
that,O
GATA,B
-,I
1,I
is,O
involved,O
in,O
control,O
of,O
globin,B
gene,I
expression,I
during,O
erythroid,B
differentiation,I
.,O
The,O
role,O
of,O
the,O
human,O
immunodeficiency,O
virus,O
(,O
HIV,B
-,I
1,I
),O
Nef,B
protein,I
in,O
T,B
cell,I
activation,I
pathways,I
was,O
investigated,O
using,O
a,O
Jurkat,B
CD4,I
+,I
cell,I
line,I
stably,O
transfected,O
with,O
a,O
Nef,B
expression,I
vector,I
.,O
The,O
response,O
of,O
mammalian,B
cells,I
to,O
stress,O
is,O
controlled,O
by,O
transcriptional,O
regulatory,O
proteins,O
such,O
as,O
nuclear,B
factor,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),O
to,O
induce,O
a,O
wide,O
variety,O
of,O
early,O
response,O
genes,O
.,O
In,O
comparison,O
to,O
other,O
activators,O
of,O
NF,B
-,I
kappa,I
B,I
such,O
as,O
phorbol,O
myristate,O
acetate,O
or,O
tumor,O
necrosis,O
factor,O
",",O
we,O
did,O
not,O
detect,O
changes,O
in,O
the,O
tyrosine,O
phosphorylation,O
status,O
of,O
I,B
kappa,I
B,I
alpha,I
following,O
treatment,O
with,O
either,O
of,O
these,O
agents,O
.,O
Molecular,O
",",O
biochemical,O
and,O
epidemiological,O
evidence,O
implicate,O
HTLV,B
-,I
I,I
as,O
an,O
etiologic,O
agent,O
of,O
adult,O
T,B
cell,I
leukemia,I
(,O
ATL,B
),O
.,O
Furthermore,O
",",O
the,O
NFKB2,B
precursor,I
is,O
physically,O
associated,O
with,O
c,O
-,O
Rel,B
and,O
with,O
Tax,B
in,O
HTLV,B
-,I
I,I
infected,O
cells,O
.,O
We,O
have,O
examined,O
the,O
effects,O
of,O
RA,O
on,O
normal,O
hematopoiesis,O
by,O
using,O
early,O
hematopoietic,O
progenitor,O
cells,O
(,O
HPC,B
),O
stringently,O
purified,O
from,O
adult,O
peripheral,O
blood,O
.,O
This,O
phenomenon,O
is,O
correlated,O
with,O
inhibition,O
of,O
GATA1,B
induction,O
in,O
the,O
early,O
stages,O
of,O
erythropoietic,O
differentiation,O
.,O
We,O
have,O
previously,O
shown,O
that,O
a,O
human,O
B,B
lymphoma,I
cell,I
line,I
",",O
B104,O
",",O
expressed,O
surface,O
IgM,B
(,O
sIgM,O
),O
and,O
surface,O
IgD,B
(,O
sIgD,O
),O
",",O
and,O
that,O
crosslinking,O
of,O
sIgM,O
and,O
sIgD,O
by,O
anti,O
-,O
IgM,O
antibody,O
(,O
Ab,O
),O
and,O
anti,O
-,O
IgD,O
Ab,O
",",O
respectively,O
",",O
induced,O
Ca2,O
+,O
influx,O
to,O
almost,O
the,O
same,O
degree,O
",",O
whereas,O
only,O
sIgM,O
-,O
crosslinking,O
caused,O
B104,O
cell,O
death,O
.,O
Phorbol,O
myristate,O
acetate,O
induced,O
Egr,B
-,I
1,I
mRNA,O
expression,O
but,O
forskolin,O
and,O
dibutyryl,O
cyclic,O
AMP,O
did,O
not,O
.,O
Treatment,O
of,O
human,B
erythrocytes,I
with,O
10,O
microM,O
sodium,O
orthovanadate,O
(,O
NaOV,B
),O
",",O
an,O
inhibitor,O
of,O
plasma,B
membrane,I
Ca,I
-,I
ATPase,I
and,O
phosphotyrosine,O
phosphatase,O
",",O
decreased,O
parasitemia,O
by,O
30,O
%,O
.,O
Because,O
erythrocytes,B
are,O
anucleated,O
",",O
these,O
results,O
are,O
discussed,O
as,O
evidence,O
for,O
biochemical,O
changes,O
by,O
TCDD,O
without,O
requiring,O
the,O
activation,O
of,O
gene,O
products,O
.,O
Irrespective,O
of,O
the,O
human,B
cell,I
partner,I
used,O
for,O
fusion,O
",",O
a,O
certain,O
number,O
of,O
hybrids,O
lost,O
CD5,B
surface,I
expression,I
over,O
a,O
period,O
of,O
time,O
in,O
culture,O
.,O
Electrophoretic,O
mobility,O
shift,O
assays,O
indicate,O
that,O
MS,B
-,I
2beta,I
and,O
MS,B
-,I
2gamma,I
interact,O
with,O
nuclear,B
factors,I
that,O
are,O
induced,O
during,O
U937,B
differentiation,I
.,O
These,O
factors,O
are,O
detected,O
at,O
the,O
time,O
the,O
CD11b,B
promoter,I
is,O
activated,O
.,O
The,O
presence,O
of,O
multiple,O
potential,O
binding,O
sites,O
for,O
MS,O
-,O
2,O
in,O
the,O
promoter,B
regions,I
of,O
a,O
wide,O
range,O
of,O
genes,O
expressed,O
in,O
mature,O
myeloid,B
cells,I
suggests,O
this,O
factor,O
plays,O
a,O
general,O
role,O
in,O
myeloid,B
differentiation,I
.,O
Acetylsalicylic,O
acid,O
and,O
sodium,O
salicylate,O
inhibit,O
LPS,O
-,O
induced,O
NF,B
-,I
kappa,I
B,I
/,I
c,I
-,I
Rel,I
nuclear,I
translocation,I
",",O
and,O
synthesis,O
of,O
tissue,O
factor,B
(,I
TF,I
),I
and,O
tumor,O
necrosis,O
factor,O
alfa,O
(,O
TNF,B
-,I
alpha,I
),I
in,O
human,O
monocytes,B
.,O
Interferon,B
augments,O
PML,B
and,O
PML,B
/,I
RAR,I
alpha,I
expression,O
in,O
normal,O
myeloid,O
and,O
acute,O
promyelocytic,O
cells,O
and,O
cooperates,O
with,O
all,O
-,O
trans,O
retinoic,O
acid,O
to,O
induce,O
maturation,O
of,O
a,O
retinoid,O
-,O
resistant,O
promyelocytic,O
cell,O
line,O
.,O
PML,B
is,O
expressed,O
in,O
diverse,O
tissues,O
and,O
cell,O
lines,O
and,O
localized,O
in,O
the,O
nucleus,O
with,O
a,O
typical,O
speckled,O
pattern,O
.,O
Neutral,O
sphingomyelinase,B
(,O
SMase,B
),O
can,O
be,O
activated,O
by,O
extracellular,O
signals,O
to,O
produce,O
ceramide,B
",",O
which,O
may,O
affect,O
mitogen,O
-,O
activated,O
protein,B
kinase,I
(,I
MAPK,I
),I
activities,O
.,O
PMA,O
acted,O
synergistically,O
with,O
ionomycin,O
to,O
activate,O
JNK,B
MAPKs,I
in,O
Jurkat,O
and,O
EL4,O
within,O
10,O
minutes,O
.,O
Ara,O
-,O
C,O
activated,O
JNKs,B
only,O
after,O
prolonged,O
incubation,O
(,O
90,O
-,O
120,O
minutes,O
),O
.,O
The,O
transmembrane,B
domains,I
are,O
well,O
conserved,O
",",O
but,O
there,O
is,O
striking,O
sequence,O
divergence,O
of,O
the,O
carboxy,B
-,I
terminal,I
cytoplasmic,I
domain,I
essential,O
for,O
B,B
-,I
cell,I
immortalization,I
and,O
interaction,O
with,O
the,O
tumor,O
necrosis,O
factor,O
receptor,O
signaling,O
pathway,O
.,O
Distinct,O
patterns,O
of,O
chromosome,B
1,I
abnormalities,I
were,O
found,O
among,O
the,O
histologic,B
types,I
of,I
breast,I
carcinoma,I
.,O
These,O
results,O
indicate,O
the,O
utility,O
of,O
this,O
FISH,O
technique,O
for,O
a,O
better,O
definition,O
of,O
the,O
biological,O
characteristics,O
of,O
ductal,O
carcinomas,O
.,O
Increased,O
proliferation,O
",",O
cytotoxicity,O
",",O
and,O
gene,O
expression,O
after,O
stimulation,O
of,O
human,O
peripheral,O
blood,O
T,B
lymphocytes,I
through,O
a,O
surface,O
ganglioside,B
(,O
GD3,B
),O
[,O
published,O
erratum,O
appears,O
in,O
J,O
Immunol,O
1994,O
Jul,O
15,O
;,O
153,O
(,O
2,O
),O
:,O
910,O
],O
However,O
",",O
their,O
specific,O
function,O
in,O
these,O
processes,O
has,O
not,O
been,O
clearly,O
defined,O
.,O
In,O
this,O
study,O
",",O
we,O
have,O
investigated,O
the,O
mechanisms,O
by,O
which,O
the,O
R24,B
mAb,I
affects,O
T,B
cell,I
functions,O
.,O
We,O
have,O
observed,O
that,O
the,O
R24,B
mAb,I
stimulates,O
GD3,B
+,I
T,I
cell,I
proliferation,O
",",O
cytotoxicity,O
",",O
and,O
surface,O
marker,O
expression,O
of,O
IL,B
-,I
2R,I
alpha,I
-,I
chain,I
",",O
IL,B
-,I
2R,I
beta,I
-,I
chain,I
",",O
HLA,B
-,I
DR,I
",",O
CD11a,B
",",O
and,O
CD11c,B
.,O
R24,B
-,I
stimulated,O
increases,O
in,O
proliferation,O
",",O
cytotoxicity,O
",",O
and,O
cell,O
surface,O
protein,B
expression,I
could,O
be,O
blocked,O
by,O
cyclosporin,B
and,O
staurosporin,B
",",O
indicating,O
that,O
cyclophilin,B
/,I
calcineurin,I
and,O
protein,B
kinase,I
C,I
may,O
be,O
involved,O
in,O
the,O
R24,B
signaling,O
pathway,O
.,O
Additionally,O
",",O
herbimycin,O
A,O
",",O
a,O
tyrosine,B
kinase,I
inhibitor,O
",",O
blocked,O
the,O
R24,O
-,O
stimulated,O
increase,O
in,O
proliferation,O
but,O
not,O
cytotoxicity,O
at,O
concentrations,O
consistent,O
with,O
specificity,O
for,O
tyrosine,B
kinases,I
.,O
Using,O
fluorescence,O
in,O
situ,O
hybridization,O
(,O
FISH,O
),O
",",O
we,O
show,O
here,O
that,O
the,O
genes,O
encoding,O
the,O
TATA,B
-,I
box,I
binding,I
protein,I
(,O
TBP,B
),O
",",O
TFIIB,B
",",O
TFIIE,B
alpha,I
",",O
TFIIE,B
beta,I
",",O
RAP30,B
",",O
RAP74,B
and,O
the,O
62,O
kDa,O
subunit,O
",",O
of,O
TFIIH,B
are,O
located,O
at,O
the,O
human,O
chromosomal,O
bands,O
6q26,O
-,O
27,O
",",O
1p21,O
-,O
22,O
",",O
3q21,O
-,O
24,O
",",O
8p12,O
",",O
13q14,O
",",O
19p13,O
.,O
3,O
and,O
11p14,O
-,O
15,O
.,O
1,O
",",O
respectively,O
.,O
Although,O
no,O
proof,O
yet,O
exists,O
of,O
a,O
role,O
for,O
these,O
lesions,O
in,O
DLCL,O
pathogenesis,O
",",O
the,O
feature,O
of,O
the,O
BCL,B
-,I
6,I
gene,I
product,I
",",O
its,O
specific,O
pattern,O
of,O
expression,O
in,O
B,B
cells,I
",",O
and,O
the,O
clustering,O
of,O
lesions,O
disrupting,O
its,O
regulatory,O
domain,O
strongly,O
suggest,O
that,O
deregulation,O
of,O
BCL,B
-,I
6,I
expression,O
may,O
contribute,O
to,O
DLCL,O
development,O
.,O
DLCL,B
represent,O
a,O
heterogeneous,O
group,O
of,O
neoplasms,O
which,O
are,O
treated,O
homogeneously,O
despite,O
the,O
fact,O
that,O
only,O
50,O
%,O
of,O
patients,O
experience,O
long,O
-,O
term,O
disease,O
-,O
free,O
survival,O
(,O
Schneider,O
et,O
al,O
.,O
1990,O
),O
.,O
It,O
is,O
thus,O
generally,O
believed,O
that,O
the,O
pancreatic,O
endocrine,O
-,O
lineage,O
possesses,O
the,O
ability,O
to,O
mature,O
along,O
a,O
differentiation,O
pathway,O
that,O
shares,O
many,O
characteristics,O
with,O
those,O
of,O
neuronal,O
differentiation,O
.,O
Octamer,O
independent,O
activation,O
of,O
transcription,O
from,O
the,O
kappa,B
immunoglobulin,I
germline,I
promoter,I
.,O
To,O
further,O
elucidate,O
the,O
role,O
of,O
this,O
variant,O
octamer,B
motif,O
in,O
the,O
regulation,O
of,O
germline,I
transcription,I
from,O
the,O
unrearranged,O
kappa,B
locus,O
",",O
we,O
have,O
quantitated,O
the,O
relative,O
binding,O
affinity,O
of,O
Oct,O
-,O
1,O
and,O
Oct,O
-,O
2,O
for,O
the,O
variant,O
octamer,B
motif,O
and,O
determined,O
the,O
functional,B
role,I
of,I
this,I
octamer,I
motif,I
in,I
transcriptional,I
activation,I
.,O
In,O
the,O
present,O
study,O
",",O
we,O
showed,O
that,O
CD14,B
+,I
adherent,I
human,I
monocytes,I
can,O
differentiate,O
into,O
CD1,B
+,I
relB,B
+,I
dendritic,I
cells,I
(,O
DC,B
),O
by,O
the,O
combination,O
of,O
GM,O
-,O
CSF,O
plus,O
interleukin,O
-,O
4,O
(,O
IL,B
-,I
4,I
),O
and,O
that,O
they,O
differentiate,O
into,O
tartrate,B
-,I
resistant,I
acid,I
phosphatase,I
(,O
TRAP,B
),O
-,O
positive,O
osteoclast,B
-,I
like,I
multinucleated,I
giant,I
cells,I
(,O
MGC,B
),O
by,O
the,O
combination,O
of,O
M,O
-,O
CSF,O
plus,O
IL,B
-,I
4,I
.,O
The,O
mechanism,O
of,O
inhibition,O
is,O
related,O
to,O
the,O
surface,O
expression,O
of,O
several,O
cell,O
adhesion,O
molecules,O
.,O
Flow,O
cytometry,O
analyses,O
on,O
cultured,O
cells,O
that,O
were,O
treated,O
with,O
tepoxalin,O
or,O
antisense,O
oligonucleotides,O
to,O
the,O
P65,B
/,I
p50,I
subunit,I
of,O
NF,B
-,I
kappa,I
B,I
",",O
and,O
then,O
stimulated,O
with,O
PMA,O
",",O
revealed,O
a,O
reduced,O
expression,O
of,O
CD11b,B
/,I
CD18,I
on,O
monocytic,O
HL60,B
cells,O
",",O
and,O
endothelial,B
adhesion,I
molecule,I
-,I
1,I
(,O
CD62E,B
),O
and,O
vascular,B
adhesion,I
molecule,I
-,I
1,I
(,O
CD106,B
),O
on,O
human,O
umbilical,O
vein,O
endothelial,B
cells,O
.,O
Tepoxalin,O
also,O
inhibited,O
the,O
secretion,O
of,O
a,O
NF,B
-,I
kappa,I
B,I
regulated,O
chemokine,O
",",O
IL,B
-,I
8,I
",",O
a,O
known,O
inducer,O
of,O
CD11b,B
/,I
CD18,I
expression,O
.,O
Thus,O
the,O
suppression,O
of,O
CD11b,B
/,I
CD18,I
expression,O
by,O
tepoxalin,O
may,O
involve,O
IL,B
-,I
8,I
.,O
Characterization,O
of,O
a,O
CD43,B
/,I
leukosialin,I
-,I
mediated,O
pathway,O
for,O
inducing,O
apoptosis,O
in,O
human,O
T,B
-,I
lymphoblastoid,I
cells,I
.,O
The,O
monoclonal,B
antibody,I
(,O
mAb,B
),O
J393,B
induces,O
apoptosis,O
in,O
Jurkat,B
T,I
-,I
cells,I
.,O
NH2,O
-,O
terminal,O
amino,O
acid,O
sequence,O
analysis,O
identified,O
the,O
140,O
-,O
kDa,O
surface,O
antigen,O
for,O
mAb,B
J393,I
as,O
CD43,B
/,I
leukosialin,I
",",O
the,O
major,O
sialoglycoprotein,O
of,O
leukocytes,O
.,O
While,O
Jurkat,B
cells,I
co,O
-,O
expressed,O
two,O
discrete,O
cell,O
-,O
surface,O
isoforms,O
of,O
CD43,B
",",O
recognized,O
by,O
mAb,B
J393,I
and,O
mAb,B
G10,I
-,I
2,I
",",O
respectively,O
",",O
only,O
J393,B
/,I
CD43,B
signaled,O
apoptosis,O
.,O
Tyrosine,B
kinase,I
inhibition,I
by,O
herbimycin,O
A,O
diminished,O
J393,B
/,I
CD43,I
-,I
mediated,O
apoptosis,O
",",O
whereas,O
inhibition,O
of,O
phosphotyrosine,B
phosphatase,I
activity,I
by,O
bis,O
(,O
maltolato,O
),O
oxovanadium,O
-,O
IV,O
enhanced,O
cell,O
death,O
.,O
Consequently,O
",",O
the,O
present,O
study,O
was,O
addressed,O
to,O
understand,O
this,O
phenomenon,O
and,O
revealed,O
the,O
existence,O
of,O
a,O
unique,O
47,O
kDa,O
protein,B
factor,I
having,O
affinity,O
for,O
this,O
SRE,O
sequence,O
in,O
lymphocytes,B
from,O
normal,O
subjects,O
as,O
well,O
as,O
its,O
absence,O
in,O
lymphocytes,B
from,O
untreated,O
CML,O
patients,O
.,O
To,O
understand,O
the,O
mechanism,O
by,O
which,O
PRL,B
regulates,O
the,O
biphasic,O
expression,O
of,O
IRF,B
-,I
1,I
",",O
we,O
cloned,O
the,O
rat,O
IRF,B
-,I
1,I
gene,I
and,O
functionally,O
characterized,O
the,O
IRF,B
-,I
1,I
promoter,I
.,O
Hence,O
",",O
the,O
PRL,B
-,I
induced,O
biphasic,O
expression,O
of,O
the,O
IRF,B
-,I
1,I
gene,I
appears,O
to,O
be,O
controlled,O
by,O
separate,O
PRL,B
-,I
responsive,O
elements,O
:,O
elements,O
in,O
the,O
first,O
0,O
.,O
2,O
kb,O
of,O
the,O
IRF,B
-,I
1,I
promoter,I
region,I
act,O
during,O
early,O
activation,O
",",O
and,O
elements,O
between,O
0,O
.,O
2,O
and,O
1,O
.,O
7,O
kb,O
act,O
in,O
concert,O
with,O
the,O
proximal,O
0,O
.,O
2,O
-,O
kb,O
region,O
during,O
S,O
phase,O
progression,O
.,O
The,O
SCL,B
protein,I
displays,O
cell,O
-,O
specific,O
heterogeneity,O
in,O
size,O
.,O
In,O
most,O
cell,O
lines,O
",",O
proteins,O
of,O
molecular,O
weight,O
49,B
and,O
44,B
kDa,I
were,O
found,O
",",O
however,O
two,O
myeloid,O
cell,O
lines,O
expressed,O
only,O
lower,O
molecular,O
weight,O
species,O
of,O
24,B
and,O
22,B
kDa,I
.,O
The,O
restricted,O
pattern,O
of,O
SCL,B
protein,I
synthesis,O
is,O
consistent,O
with,O
the,O
restricted,O
expression,O
of,O
SCL,B
mRNA,I
documented,O
previously,O
.,O
This,O
effect,O
required,O
surface,O
expression,O
of,O
the,O
CD45,B
PTPase,I
and,O
was,O
not,O
observed,O
in,O
CD45,B
-,I
deficient,I
variants,I
of,O
Jurkat,B
cells,I
.,O
Pervanadate,O
activated,O
NF,B
-,I
kappa,I
B,I
",",O
as,O
shown,O
by,O
an,O
increase,O
in,O
DNA,B
-,I
binding,I
activity,O
of,O
this,O
transcription,O
factor,O
.,O
Signals,O
transduced,O
via,O
the,O
TCR,B
activate,O
the,O
transcription,O
factor,O
nuclear,O
factor,O
-,O
kappaB,B
(,O
NF,B
-,I
kappaB,I
),O
",",O
which,O
",",O
in,O
turn,O
",",O
is,O
critical,O
to,O
the,O
transcriptional,O
induction,O
of,O
many,O
genes,O
important,O
for,O
the,O
proliferation,O
and,O
expression,O
of,O
a,O
differentiated,O
phenotype,O
.,O
Here,O
we,O
identify,O
intracellular,O
signaling,O
components,O
involved,O
in,O
activation,O
of,O
NF,B
-,I
kappaB,I
following,O
TCR,B
stimulation,O
.,O
We,O
have,O
shown,O
elsewhere,O
that,O
both,O
the,O
major,O
immediate,O
-,O
early,O
gene,O
(,O
MIE,B
),O
and,O
lytic,O
cycle,O
infectious,O
progeny,O
virus,O
expression,O
can,O
be,O
induced,O
in,O
otherwise,O
nonpermissive,O
monocyte,B
-,I
like,I
U,B
-,I
937,I
cell,I
cultures,O
infected,O
with,O
either,O
human,B
CMV,I
(,I
HCMV,I
),I
or,O
simian,B
CMV,I
(,I
SCMV,I
),I
by,O
treatment,O
with,O
the,O
phorbol,O
ester,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
(,O
TPA,B
),O
.,O
Therefore,O
",",O
to,O
evaluate,O
the,O
mechanism,O
of,O
TPA,O
responsiveness,O
of,O
the,O
SNE,B
motifs,I
and,O
of,O
a,O
related,O
16,O
-,O
bp,O
SEE,B
(,O
SRF,B
/,I
ETS,I
element,I
),O
motif,O
found,O
in,O
the,O
HCMV,O
and,O
chimpanzee,O
CMV,O
MIE,O
enhancers,O
",",O
we,O
have,O
examined,O
the,O
functional,B
responses,I
and,O
protein,B
binding,I
properties,I
of,O
multimerized,O
wild,O
-,O
type,O
and,O
mutant,O
elements,O
added,O
upstream,O
to,O
the,O
SCMV,O
MIE,O
or,O
simian,O
virus,O
40,O
minimal,O
promoter,O
regions,O
in,O
the,O
U,O
-,O
937,O
",",O
K,O
-,O
562,O
",",O
HL,O
-,O
60,O
",",O
THP,O
-,O
1,O
",",O
and,O
Jurkat,O
cell,O
lines,O
.,O
T,B
-,I
cell,I
-,I
directed,O
TAL,B
-,I
1,I
expression,O
induces,O
T,B
-,I
cell,I
malignancies,O
in,O
transgenic,O
mice,O
.,O
The,O
survival,O
rate,O
of,O
tal,B
-,I
1,I
transgenic,O
animals,O
was,O
much,O
lower,O
as,O
compared,O
with,O
control,O
mice,O
.,O
To,O
further,O
unravel,O
the,O
tal,B
-,I
1,I
oncogenic,O
potential,O
",",O
a,O
strain,O
of,O
tal,B
-,I
1,I
transgenic,O
mice,O
was,O
crossbred,O
with,O
p53,B
-,I
/,I
-,I
mice,O
;,O
the,O
survival,O
rate,O
in,O
these,O
animals,O
was,O
reduced,O
by,O
more,O
than,O
one,O
-,O
half,O
when,O
compared,O
with,O
that,O
of,O
tal,B
-,I
1,I
mice,O
",",O
and,O
histopathological,O
analysis,O
revealed,O
exclusively,O
T,B
-,I
cell,I
lymphomas,O
.,O
TSC2,B
is,O
a,O
gene,O
on,O
chromosome,O
16p13,O
.,O
3,O
associated,O
with,O
the,O
autosomal,O
dominant,O
neurocutaneous,O
disorder,O
",",O
tuberous,O
sclerosis,O
complex,O
(,O
TSC,B
),O
.,O
TSC2,B
messenger,O
RNA,B
was,O
widely,O
expressed,O
in,O
various,O
cell,B
types,I
throughout,O
the,O
body,O
",",O
including,O
epithelia,B
",",O
lymphocytes,B
",",O
and,O
cells,B
with,O
endocrine,B
functions,I
",",O
e,O
.,O
g,O
.,O
",",O
adrenal,B
cortex,I
and,O
anterior,B
pituitary,I
.,O
Fas,B
-,I
mediated,I
apoptosis,I
plays,O
an,O
important,O
role,O
in,O
regulating,O
the,O
immune,B
response,I
in,O
peripheral,B
T,I
cells,I
.,O
In,O
contrast,O
",",O
interleukin,B
-,I
1beta,I
-,I
converting,I
enzyme,I
family,I
protease,I
inhibitors,I
Ac,O
-,O
DEVD,O
-,O
CHO,O
and,O
CrmA,O
blocked,O
Fas,B
-,I
mediated,I
apoptosis,I
.,O
These,O
results,O
suggest,O
that,O
peripheral,B
T,I
cells,I
use,O
distinct,O
apoptosis,O
signaling,O
pathways,O
with,O
differential,O
sensitivity,O
to,O
Bcl,O
-,O
2,O
and,O
interleukin,B
-,I
1beta,I
-,I
converting,I
enzyme,I
family,I
protease,I
inhibitors,I
.,O
However,O
",",O
in,O
contrast,O
to,O
human,B
lymphocytes,I
",",O
IFN,B
-,I
gamma,I
production,O
was,O
inhibited,O
and,O
IFN,B
-,I
gamma,I
mRNA,O
levels,O
were,O
unaffected,O
at,O
24,O
h,O
and,O
only,O
slightly,O
upregulated,O
at,O
48,O
and,O
72,O
h,O
of,O
culture,O
in,O
murine,B
splenocytes,I
incubated,O
with,O
cipro,O
(,O
20,O
micrograms,O
/,O
ml,O
),O
.,O
Cipro,O
did,O
not,O
affect,O
the,O
nuclear,O
transcription,O
factors,O
AP,B
-,I
1,I
or,O
NFIL,B
-,I
2A,I
.,O
An,O
additional,O
distinguishing,O
characteristic,O
of,O
HTLV,B
-,I
I,I
infection,O
is,O
the,O
profound,O
state,O
of,O
viral,O
latency,O
that,O
is,O
present,O
in,O
circulating,O
primary,O
leukemic,O
T,B
cells,I
.,O
Furthermore,O
",",O
the,O
physical,O
interaction,O
of,O
Tax,B
with,O
p100,B
leads,O
to,O
the,O
inhibition,O
of,O
Tax,B
-,I
induced,I
activation,I
of,O
the,O
HTLV,B
-,I
I,I
and,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
long,O
terminal,O
repeats,O
",",O
reflecting,O
p100,B
-,I
mediated,I
cytoplasmic,I
sequestration,I
of,O
the,O
normally,O
nuclearly,O
expressed,O
Tax,B
protein,I
.,O
Selection,O
against,O
such,O
mutations,O
may,O
be,O
the,O
result,O
of,O
functional,B
redundancy,I
of,I
these,I
myogenic,I
transcription,I
factors,I
.,O
In,O
vertebrates,O
",",O
five,O
distinct,O
DNA,B
binding,I
subunits,I
are,O
currently,O
known,O
which,O
might,O
extensively,O
heterodimerize,O
",",O
thereby,O
forming,O
complexes,O
with,O
distinct,O
transcriptional,O
activity,O
",",O
DNA,B
sequence,I
specificity,I
",",O
and,O
cell,B
type,I
-,I
and,I
cell,I
stage,I
-,I
specific,I
distribution,I
.,O
Other,O
I,B
kappa,I
B,I
proteins,O
are,O
rather,O
involved,O
in,O
terminating,O
NF,B
-,I
kappa,I
B,I
',O
s,O
activity,O
in,O
the,O
nucleus,O
.,O
The,O
intracellular,O
events,O
that,O
lead,O
to,O
the,O
inactivation,O
of,O
I,B
kappa,I
B,I
",",O
i,O
.e,O
.,O
the,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
",",O
are,O
complex,O
.,O
In,O
previous,O
studies,O
",",O
it,O
was,O
shown,O
that,O
the,O
fusion,O
region,O
of,O
the,O
pml,O
/,O
RAR,O
-,O
alpha,O
protein,O
",",O
expressed,O
by,O
acute,O
promyelocytic,O
leukemia,O
(,O
APL,O
),O
cells,O
",",O
can,O
be,O
specifically,O
recognized,O
in,O
vitro,O
by,O
donor,O
(,O
D,O
0.88,O
E,O
.,O
),O
CD4,B
T,I
cells,I
in,O
a,O
HLA,B
class,I
II,I
DR11,I
-,I
restricted,I
fashion,I
.,O
We,O
present,O
here,O
the,O
results,O
on,O
the,O
recognition,O
of,O
several,O
pml,O
/,O
RAR,O
-,O
alpha,O
peptides,O
by,O
APL,O
patients,O
expressing,O
HLA,B
DR11,I
.,O
These,O
clones,O
were,O
tested,O
for,O
their,O
recognition,O
of,O
BCR1,O
/,O
25,O
.,O
APL,O
blasts,O
",",O
available,O
only,O
from,O
patients,O
F,O
.,O
R,O
.,O
and,O
P,O
.,O
G,O
.,O
",",O
were,O
not,O
lysed,O
by,O
C3,B
/,I
5,I
and,O
were,O
unable,O
to,O
present,O
peptide,O
BCR1,O
/,O
25,O
.,O
No,O
peptide,O
-,O
specific,O
T,B
-,I
cell,I
line,I
or,O
clone,O
could,O
be,O
generated,O
from,O
both,O
donors,O
and,O
patients,O
.,O
Interferon,B
-,I
gamma,I
(,O
IFN,B
-,I
gamma,I
),O
is,O
produced,O
by,O
natural,O
killer,O
cells,O
and,O
certain,O
subsets,O
of,O
T,B
cells,I
",",O
but,O
the,O
basis,O
for,O
its,O
selective,O
expression,O
is,O
unknown,O
.,O
The,O
proximal,O
element,O
is,O
a,O
composite,O
site,O
that,O
binds,O
members,O
of,O
the,O
CREB,B
/,I
ATF,I
",",O
AP,B
-,I
1,I
",",O
and,O
octamer,O
families,O
of,O
transcription,O
factors,O
.,O
S107,B
plasmacytoma,I
cells,I
",",O
which,O
express,O
CD40,B
but,O
are,O
defective,O
for,O
the,O
nuclear,O
appearance,O
of,O
p50,B
/,I
p65,I
-,I
NF,I
-,I
kappaB,I
",",O
do,O
not,O
express,O
RelB,B
after,O
CD40,B
stimulation,O
.,O
The,O
nuclear,O
body,O
(,O
NB,B
),O
is,O
a,O
cellular,O
organelle,O
that,O
is,O
involved,O
in,O
the,O
pathogenesis,O
of,O
acute,O
promyelocytic,O
leukemia,O
and,O
viral,O
infection,O
.,O
The,O
predicted,O
amino,B
acid,I
sequence,I
of,I
the,I
amino,I
-,I
terminal,I
portion,I
of,I
Sp140,B
was,O
similar,O
to,O
Sp100,B
",",O
a,O
previously,O
identified,O
NB,O
protein,O
.,O
B,B
lymphocyte,I
stimulation,I
via,O
both,O
CD40,B
and,O
surface,O
Ig,B
(,O
sIg,I
),O
receptors,O
substantially,O
induced,O
fra,B
-,I
1,I
expression,I
",",O
and,O
for,O
both,O
receptors,O
",",O
induction,O
was,O
protein,B
kinase,I
C,I
(,I
PKC,I
),O
dependent,O
.,O
Induction,O
of,O
fra,B
-,I
1,I
following,O
engagement,O
of,O
CD40,B
did,O
not,O
require,O
protein,O
synthesis,O
",",O
suggesting,O
that,O
the,O
PKC,B
-,I
dependent,I
linkage,O
between,O
CD40,B
and,O
fra,B
-,I
1,I
is,O
direct,O
.,O
Pentoxifylline,O
for,O
the,O
treatment,O
of,O
infection,O
with,O
human,B
immunodeficiency,I
virus,I
.,O
Cytokine,O
dysregulation,O
in,O
human,B
immunodeficiency,I
virus,I
type,I
1,I
(,O
HIV,B
-,I
1,I
),O
infection,O
has,O
been,O
documented,O
in,O
numerous,O
studies,O
and,O
has,O
been,O
cited,O
as,O
an,O
important,O
component,O
in,O
the,O
pathogenesis,O
of,O
this,O
retroviral,O
infection,O
.,O
Pentoxifylline,O
",",O
a,O
trisubstituted,O
xanthine,O
derivative,O
",",O
has,O
been,O
used,O
to,O
decrease,O
blood,O
viscosity,O
and,O
is,O
reasonably,O
well,O
tolerated,O
by,O
most,O
recipients,O
of,O
the,O
drug,O
.,O
(,O
ABSTRACT,O
TRUNCATED,O
AT,O
250,O
WORDS,O
),O
The,O
other,O
two,O
SR,O
patients,O
had,O
an,O
abnormally,O
low,O
GR,B
number,O
with,O
normal,O
binding,O
affinity,O
that,O
was,O
not,O
limited,O
to,O
T,O
cells,O
.,O
This,O
may,O
be,O
due,O
to,O
the,O
low,O
prevalence,O
of,O
overexpressed,O
ER,B
and,O
the,O
small,O
number,O
of,O
controls,O
.,O
A,O
large,O
prospective,O
trial,O
is,O
needed,O
to,O
determine,O
if,O
one,O
or,O
more,O
of,O
these,O
biomarkers,O
",",O
is,O
predictive,O
of,O
breast,B
cancer,I
development,O
.,O
Inhibition,O
of,O
RANTES,B
expression,O
did,O
not,O
appear,O
to,O
be,O
secondary,O
to,O
IL,B
-,I
2,I
inhibition,O
and,O
required,O
binding,O
to,O
the,O
intracellular,O
glucocorticoid,B
receptor,I
.,O
Association,O
of,O
TRAF1,B
",",O
TRAF2,B
",",O
and,O
TRAF3,B
with,O
an,O
Epstein,O
-,O
Barr,O
virus,O
LMP1,O
domain,O
important,O
for,O
B,O
-,O
lymphocyte,O
transformation,O
:,O
role,O
in,O
NF,O
-,O
kappaB,O
activation,O
.,O
The,O
Epstein,O
-,O
Barr,O
virus,O
(,O
EBV,O
),O
transforming,O
protein,O
LMP1,O
appears,O
to,O
be,O
a,O
constitutively,O
activated,O
tumor,O
necrosis,O
factor,O
receptor,O
(,O
TNFR,O
),O
on,O
the,O
basis,O
of,O
an,O
intrinsic,O
ability,O
to,O
aggregate,O
in,O
the,O
plasma,O
membrane,O
and,O
an,O
association,O
of,O
its,O
cytoplasmic,O
carboxyl,O
terminus,O
(,O
CT,O
),O
with,O
TNFR,O
-,O
associated,O
factors,O
(,O
TRAFs,O
),O
.,O
TRAF1,B
",",O
TRAF2,B
",",O
and,O
TRAF3,B
bind,O
to,O
a,O
single,O
site,O
in,O
the,O
LMP1,B
CT,I
corresponding,O
to,O
amino,O
acids,O
(,O
aa,O
),O
199,O
to,O
214,O
",",O
within,O
a,O
domain,O
which,O
is,O
important,O
for,O
B,B
-,I
lymphocyte,I
growth,I
transformation,I
(,O
aa,O
187,O
to,O
231,O
),O
.,O
NF,B
-,I
kappaB,I
activation,I
by,O
LMP1,B
(,O
1,O
-,O
231,O
),O
is,O
likely,O
to,O
be,O
mediated,O
by,O
TRAF1,B
/,O
TRAF2,B
heteroaggregates,O
since,O
TRAF1,B
is,O
unique,O
among,O
the,O
TRAFs,O
in,O
coactivating,O
NF,B
-,I
kappaB,I
with,O
LMP1,B
(,O
1,O
-,O
231,O
),O
",",O
a,O
TRAF2,B
dominant,O
-,O
negative,O
mutant,O
can,O
block,O
LMP1,B
(,O
1,O
-,O
231,O
),O
-,O
mediated,O
NF,B
-,I
kappaB,I
activation,I
as,O
well,O
as,O
TRAF1,B
coactivation,O
",",O
and,O
30,O
%,O
of,O
TRAF2,B
is,O
associated,O
with,O
TRAF1,B
in,O
EBV,B
-,I
transformed,I
B,I
cells,I
.,O
The,O
gene,O
encoding,O
the,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
)-10,O
-,O
specific,O
dUTPase,B
was,O
amplified,O
from,O
virus,O
DNA,B
by,O
PCR,O
.,O
Preliminary,O
experiments,O
yielded,O
a,O
Km,O
value,O
of,O
about,O
0,O
.,O
8,O
microM,O
for,O
dUTP,B
.,O
This,O
indicated,O
that,O
the,O
dUTPase,B
is,O
expressed,O
during,O
EBV,B
replication,O
and,O
reactivation,O
.,O
Two,O
pp56,O
(,O
lck,O
),O
mutants,O
lacking,O
either,O
the,O
entire,O
catalytic,O
domain,O
or,O
the,O
entire,O
NH2,O
regulatory,O
domain,O
were,O
generated,O
and,O
their,O
abilities,O
to,O
trigger,O
transactivation,O
of,O
the,O
TCR,O
-,O
regulated,O
nuclear,O
factor,O
of,O
activated,O
T,O
cells,O
(,O
NF,O
-,O
AT,O
),O
region,O
of,O
the,O
IL,O
-,O
2,O
promoter,O
were,O
compared,O
.,O
The,O
results,O
showed,O
that,O
the,O
average,O
number,O
of,O
GCR,B
in,O
asthmatics,O
was,O
significantly,O
lower,O
than,O
that,O
in,O
healthy,O
subjects,O
(,O
P,O
<,O
0,O
.,O
1,O
),O
",",O
and,O
there,O
was,O
a,O
linear,O
correlation,O
between,O
the,O
number,O
of,O
GCR,B
and,O
the,O
course,O
of,O
asthma,O
.,O
These,O
findings,O
suggest,O
that,O
there,O
is,O
no,O
primary,O
and,O
general,O
impairment,O
of,O
glucocorticoid,B
metabolism,I
in,O
the,O
asthmatics,O
",",O
but,O
the,O
number,O
of,O
GCR,B
in,O
the,O
asthmatics,O
is,O
lower,O
than,O
that,O
in,O
healthy,O
controls,O
.,O
Subsequently,O
binding,O
sites,O
have,O
been,O
demonstrated,O
in,O
the,O
plasma,O
membrane,O
of,O
human,O
lymphocytes,O
which,O
show,O
pharmacological,O
(,O
aldosterone,B
specificity,O
),O
and,O
kinetic,O
(,O
high,O
turnover,O
),O
properties,O
identical,O
with,O
those,O
of,O
the,O
rapid,O
aldosterone,B
effects,O
in,O
the,O
same,O
cells,O
.,O
The,O
macrophage,B
colony,I
-,I
stimulating,I
factor,I
(,O
M,B
-,I
CSF,I
),O
receptor,O
is,O
expressed,O
in,O
a,O
tissue,O
-,O
specific,O
fashion,O
from,O
two,O
distinct,O
promoters,O
in,O
monocytes,O
/,O
macrophages,O
and,O
the,O
placenta,O
.,O
CONCLUSION,O
.,O
The,O
number,O
of,O
GCR,B
may,O
be,O
improved,O
by,O
inhalation,O
of,O
oxygen,O
.,O
Signaling,O
via,O
IL,B
-,I
2,I
and,O
IL,B
-,I
4,I
in,O
JAK3,B
-,I
deficient,I
severe,I
combined,I
immunodeficiency,I
lymphocytes,I
:,O
JAK3,B
-,I
dependent,I
and,O
independent,O
pathways,O
.,O
However,O
",",O
IL,B
-,I
4,I
-,I
induced,I
effects,O
were,O
clearly,O
improved,O
following,O
JAK3,B
expression,O
.,O
Interleukin,B
2,I
(,I
IL,I
-,I
2R,I
alpha,I
.,O
We,O
identified,O
an,O
86,O
-,O
nucleotide,O
fragment,O
that,O
is,O
90,O
%,O
identical,O
to,O
the,O
recently,O
characterized,O
murine,O
IL,B
-,I
2,I
-,I
responsive,I
element,I
(,O
mIL,B
-,I
2rE,I
),O
.,O
Tumor,O
necrosis,O
factor,O
receptor,O
-,O
1,O
(,O
TNFR,B
-,I
1,I
),O
and,O
CD95,B
(,O
also,O
called,O
Fas,B
or,O
APO,B
-,I
1,I
),O
are,O
cytokine,O
receptors,O
that,O
engage,O
the,O
apoptosis,O
pathway,O
through,O
a,O
region,O
of,O
intracellular,O
homology,O
",",O
designated,O
the,O
`,O
`,O
death,O
domain,O
.,O
Another,O
death,O
domain,O
-,O
containing,O
member,O
of,O
the,O
TNFR,B
family,I
",",O
death,O
receptor,O
3,O
(,O
DR3,B
),O
",",O
was,O
identified,O
and,O
was,O
shown,O
to,O
induce,O
both,O
apoptosis,O
and,O
activation,O
of,O
nuclear,O
factor,O
kappaB,O
.,O
Differential,O
nuclear,O
localization,O
of,O
p50,B
",",O
p52,B
",",O
and,O
RelB,B
proteins,O
in,O
human,O
accessory,O
cells,O
of,O
the,O
immune,O
response,O
in,O
situ,O
.,O
The,O
different,O
patterns,O
of,O
p50,B
",",O
p52,B
and,O
RelB,B
protein,I
nuclear,I
localization,I
may,O
provide,O
insight,O
into,O
their,O
different,O
roles,O
during,O
the,O
immune,O
response,O
in,O
vivo,O
.,O
Although,O
mutation,O
of,O
either,O
Y113,B
and,O
Y128,B
has,O
a,O
minimal,O
effect,O
on,O
SLP,B
-,I
76,I
function,O
",",O
mutation,O
of,O
both,O
residues,O
decreases,O
significantly,O
the,O
ability,O
of,O
SLP,B
-,I
76,I
to,O
promote,O
T,B
cell,I
activation,O
.,O
The,O
IRF,B
-,I
2,I
promoter,I
region,I
contains,O
a,O
CpG,O
island,O
",",O
with,O
several,O
GC,O
boxes,O
",",O
a,O
putative,O
NF,B
-,I
kappa,I
B,I
-,I
binding,I
site,I
",",O
and,O
a,O
CAAT,O
box,O
",",O
but,O
no,O
TATA,O
box,O
.,O
When,O
the,O
promoter,B
region,I
was,O
linked,O
with,O
a,O
heterologous,O
reporter,O
gene,O
",",O
we,O
found,O
that,O
the,O
promoter,B
region,I
is,O
inducible,O
by,O
both,O
interferons,O
(,O
interferon,B
-,I
alpha,I
and,O
-,O
gamma,I
),O
and,O
interferon,B
regulatory,I
factor,I
1,I
.,O
Interferon,B
alpha,I
selectively,O
affects,O
expression,O
of,O
the,O
human,O
myeloid,B
cell,I
nuclear,I
differentiation,I
antigen,I
in,O
late,O
stage,O
cells,O
in,O
the,O
monocytic,B
but,O
not,O
the,O
granulocytic,B
lineage,I
.,O
Although,O
",",O
the,O
level,O
of,O
MNDA,B
mRNA,I
in,O
primary,O
monocytes,B
is,O
very,O
low,O
it,O
was,O
up,O
-,O
regulated,O
at,O
6,O
h,O
following,O
the,O
addition,O
of,O
interferon,B
alpha,I
.,O
This,O
reduced,O
level,O
of,O
mRNA,B
could,O
then,O
be,O
elevated,O
with,O
subsequent,O
interferon,B
alpha,I
treatment,O
.,O
We,O
identified,O
a,O
protein,B
",",O
p37,O
",",O
which,O
specifically,O
bound,O
to,O
DRE,B
1,I
.,O
Binding,O
of,O
the,O
cDNA,B
fusion,I
protein,I
",",O
similarly,O
to,O
the,O
results,O
obtained,O
with,O
purified,O
Jurkat,B
protein,I
",",O
was,O
decreased,O
by,O
introduction,O
of,O
site,O
-,O
specific,O
mutations,O
in,O
the,O
DRE,B
1,I
regulatory,I
sequence,I
.,O
Cotransfection,O
of,O
a,O
YB,B
-,I
1,I
expression,I
plasmid,I
increases,O
HTLV,B
-,I
I,I
basal,I
transcription,I
approximately,O
14,O
-,O
fold,O
in,O
Jurkat,B
T,I
lymphocytes,I
.,O
The,O
subjects,O
were,O
exposed,O
to,O
cold,O
air,O
(,O
4,O
degrees,O
C,O
),O
twice,O
/,O
d,O
",",O
30,O
min,O
/,O
exposure,O
",",O
for,O
a,O
total,O
of,O
80,O
exposures,O
.,O
These,O
results,O
describe,O
for,O
the,O
first,O
time,O
the,O
rapid,O
modulation,O
of,O
the,O
NT3R,B
in,O
response,O
to,O
the,O
combined,O
influence,O
of,O
cold,O
exposure,O
and,O
reduced,O
circulating,O
T4,B
and,O
TSH,B
.,O
HIV,B
-,I
1,I
LTR,I
activity,O
in,O
human,B
CD40,I
-,I
activated,I
B,I
lymphocytes,I
is,O
dependent,O
on,O
NF,B
-,I
kappaB,I
.,O
In,O
these,O
cells,O
",",O
nuclear,O
factors,O
involved,O
in,O
activation,O
of,O
the,O
HIV,B
-,I
1,I
LTR,I
",",O
which,O
contains,O
the,O
transcriptional,O
control,O
elements,O
of,O
the,O
virus,O
",",O
are,O
unknown,O
.,O
In,O
preincubated,O
cells,O
",",O
the,O
cycloheximide,O
response,O
is,O
decreased,O
",",O
especially,O
in,O
the,O
case,O
of,O
FOSB,B
.,O
Regions,O
of,O
low,O
base,O
order,O
-,O
dependent,O
stem,O
-,O
loop,O
potential,O
in,O
the,O
region,O
of,O
the,O
gene,O
are,O
defined,O
.,O
Susceptibility,O
of,O
these,O
transformed,O
cell,O
lines,O
to,O
NK,B
cells,I
was,O
determined,O
by,O
cytolytic,O
assays,O
.,O
Cell,O
specific,O
expression,O
of,O
human,O
Bruton,B
',I
s,I
agammaglobulinemia,I
tyrosine,I
kinase,I
gene,I
(,O
Btk,B
),O
is,O
regulated,O
by,O
Sp1,B
-,I
and,I
Spi,B
-,I
1,I
/,I
PU,I
.,O
1,O
-,O
family,O
members,O
.,O
In,O
vitro,O
footprinting,O
analysis,O
within,O
this,O
part,O
of,O
the,O
promoter,O
revealed,O
two,O
Sp1,B
binding,I
sites,I
as,O
well,O
as,O
a,O
PU,B
-,I
box,I
.,O
In,O
addition,O
Spi,O
-,O
B,O
as,O
well,O
as,O
PU,B
.,O
1,O
were,O
able,O
to,O
transactivate,O
Btk,O
expression,O
.,O
They,O
also,O
demonstrate,O
for,O
the,O
first,O
time,O
the,O
occurrence,O
of,O
T,B
cell,I
responses,I
against,O
EBV,O
transactivating,O
factors,O
",",O
which,O
might,O
be,O
central,O
in,O
the,O
control,O
of,O
virus,O
reactivation,O
.,O
CD14,B
-,I
mediated,I
signal,I
pathway,I
of,I
Porphyromonas,O
gingivalis,O
lipopolysaccharide,O
in,O
human,B
gingival,I
fibroblasts,I
.,O
In,O
this,O
study,O
",",O
we,O
observed,O
unexpectedly,O
by,O
immunohistochemical,O
",",O
Western,O
blotting,O
(,O
immunoblotting,O
),O
",",O
and,O
Northern,B
(,I
RNA,I
),I
blotting,I
assays,I
that,O
CD14,B
is,O
expressed,O
at,O
high,O
density,O
in,O
human,B
gingival,I
fibroblasts,I
.,O
The,O
inhibitor,O
also,O
dramatically,O
inhibited,O
monocyte,B
chemotactic,I
activity,I
of,O
and,O
MCP,B
-,I
1,I
production,O
by,O
the,O
cells,O
.,O
Thus,O
",",O
the,O
tyrosine,B
kinase,I
activated,O
by,O
G,B
-,I
CSF,I
appears,O
to,O
directly,O
transduce,O
a,O
signal,O
to,O
a,O
protein,B
which,O
functions,O
as,O
a,O
transcriptional,O
regulator,O
.,O
Thus,O
",",O
we,O
focused,O
our,O
study,O
on,O
isolated,O
FDC,B
clusters,I
from,O
normal,O
tonsils,O
.,O
As,O
showed,O
on,O
tissue,O
sections,O
",",O
we,O
detected,O
the,O
p50,B
in,O
both,O
cytoplasm,O
and,O
nucleus,O
of,O
FDC,B
.,O
Now,O
that,O
these,O
proteins,B
are,O
purified,O
and,O
cloned,O
",",O
the,O
major,O
goals,O
will,O
be,O
to,O
understand,O
their,O
role,O
and,O
the,O
roles,O
of,O
other,O
family,O
members,O
in,O
thymic,O
development,O
.,O
This,O
effect,O
is,O
blocked,O
by,O
anti,O
-,O
VCAM,B
antibodies,I
.,O
This,O
activity,O
seems,O
to,O
be,O
due,O
to,O
increased,O
cAMP,B
levels,I
because,O
forskolin,O
and,O
IBMX,O
mimic,O
the,O
effects,O
of,O
PGE2,O
.,O
These,O
data,O
support,O
the,O
positive,O
role,O
for,O
PGE2,B
on,O
some,O
immune,O
functions,O
.,O
In,O
addition,O
",",O
analysis,O
of,O
EBV,B
protein,I
expression,O
by,O
IH,O
revealed,O
a,O
heterogeneous,O
pattern,O
of,O
EBV,B
gene,I
expression,O
at,O
the,O
single,O
-,O
cell,B
level,I
consisting,O
of,O
both,O
LMP1,B
+,I
and,O
LMP1,B
-,I
tumour,O
cells,O
",",O
suggesting,O
a,O
mixture,O
of,O
latency,O
I,O
and,O
II,O
.,O
This,O
made,O
the,O
need,O
for,O
VD,B
analogues,O
with,O
selectively,O
increased,O
cell,B
regulatory,I
properties,I
.,O
Studies,O
with,O
20,O
-,O
epi,O
analogues,O
pointed,O
out,O
the,O
importance,O
of,O
the,O
carbon,O
-,O
20,O
position,O
and,O
led,O
to,O
the,O
development,O
of,O
20,O
-,O
methyl,O
derivatives,O
of,O
VD,B
.,O
Moreover,O
",",O
ZK161422,O
",",O
but,O
not,O
ZK157202,O
",",O
showed,O
preference,O
for,O
gene,O
activation,O
from,O
a,O
promoter,O
carrying,O
a,O
VD,B
response,I
element,I
with,O
a,O
palindromic,O
arrangement,O
of,O
two,O
hexameric,O
receptor,O
binding,O
sites,O
spaced,O
by,O
9,O
nucleotides,O
(,O
IP9,O
),O
rather,O
than,O
for,O
activation,O
from,O
a,O
response,O
element,O
formed,O
by,O
a,O
direct,O
repeat,O
spaced,O
by,O
3,O
nucleotides,O
(,O
DR3,O
),O
.,O
This,O
observation,O
supports,O
a,O
model,O
",",O
in,O
which,O
promoter,O
selectivity,O
reflects,O
the,O
selectively,O
increased,O
antiproliferative,O
effect,O
of,O
VD,B
analogues,O
.,O
The,O
process,O
of,O
activation,O
involves,O
calcium,B
mobilization,I
",",O
activation,O
of,O
protein,B
kinase,I
C,I
(,O
PKC,B
),O
",",O
and,O
phosphorylation,O
of,O
tyrosine,B
kinases,I
.,O
The,O
involvement,O
of,O
p21,B
(,O
ras,I
),O
in,O
the,O
regulation,O
of,O
calcium,B
-,I
dependent,I
signals,I
has,O
been,O
suggested,O
through,O
analysis,O
of,O
its,O
role,O
in,O
the,O
activation,O
of,O
NF,B
-,I
AT,I
.,O
The,O
expression,O
of,O
activated,O
p21,B
(,O
ras,B
),O
negatively,O
regulated,O
the,O
induction,O
of,O
IE,O
genes,O
by,O
calcium,O
ionophore,O
.,O
A,O
later,O
result,O
of,O
inhibition,O
of,O
this,O
activation,O
pathway,O
by,O
p21,B
(,O
ras,B
),O
was,O
down,O
-,O
regulation,O
of,O
the,O
activity,O
of,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
and,O
subsequent,O
coordinate,O
reductions,O
in,O
IL,B
-,I
2,I
gene,I
expression,O
and,O
protein,B
production,O
.,O
Calcineurin,B
acts,O
in,O
synergy,O
with,O
PMA,O
to,O
inactivate,O
I,B
kappa,I
B,I
/,I
MAD3.00,I
",",O
an,O
inhibitor,O
of,O
NF,B
-,I
kappa,I
B,I
.,O
Calcineurin,B
stimulates,O
the,O
NF,B
-,I
kappa,I
B,I
element,O
by,O
enhancing,O
inactivation,O
of,O
I,B
kappa,I
B,I
/,I
MAD3.00,I
",",O
an,O
inhibitor,O
of,O
NF,B
-,I
kappa,I
B,I
",",O
thereby,O
increasing,O
the,O
amount,O
of,O
nuclear,O
NF,B
-,I
kappa,I
B,I
DNA,I
binding,O
activity,O
.,O
Inhibition,O
of,O
membrane,O
IL,B
-,I
2R,I
alpha,I
and,O
IL,B
-,I
2R,I
beta,I
expression,O
by,O
10,O
(,O
-,O
6,O
),O
M,O
DM,O
was,O
partially,O
reversible,O
by,O
recombinant,O
human,O
IL,B
-,I
2,I
(,O
rhIL,O
-,O
2,O
),O
.,O
The,O
mechanism,O
of,O
action,O
of,O
DM,O
on,O
IL,B
-,I
2R,I
alpha,I
transcription,O
was,O
examined,O
by,O
determining,O
the,O
mRNA,O
levels,O
of,O
the,O
p50,O
subunit,O
of,O
nuclear,O
factor,O
kappa,O
B,O
(,O
NF,O
-,O
kappa,O
B,O
),O
",",O
a,O
transcription,O
factor,O
that,O
stimulates,O
IL,B
-,I
2R,I
alpha,I
gene,I
expression,O
.,O
However,O
",",O
simultaneous,O
incubation,O
of,O
RU,B
486,I
with,O
dexamethasone,O
caused,O
a,O
distinct,O
interference,O
of,O
RU,B
486,I
with,O
dexamethasone,O
.,O
The,O
protein,B
-,I
tyrosine,I
kinase,I
ZAP,B
-,I
70,I
is,O
implicated,O
",",O
together,O
with,O
the,O
Src,B
kinase,I
p56,I
(,O
lck,B
),O
",",O
in,O
controlling,O
the,O
early,O
steps,O
of,O
the,O
T,B
-,I
cell,I
antigen,I
receptor,I
(,O
TCR,B
),O
signaling,O
cascade,O
.,O
To,O
help,O
elucidate,O
further,O
the,O
mechanism,O
by,O
which,O
ZAP,B
-,I
70,I
regulates,O
these,O
initial,O
events,O
",",O
we,O
used,O
a,O
dominant,O
-,O
negative,O
mutant,O
approach,O
.,O
ZAP,B
-,I
70,I
will,O
then,O
be,O
able,O
to,O
effectively,O
control,O
phosphorylation,O
of,O
its,O
substrates,O
and,O
lead,O
to,O
gene,O
activation,O
.,O
Peripheral,O
blood,O
mononuclear,O
cell,O
GCR,B
binding,I
affinities,I
for,O
dexamethasone,O
and,O
budesonide,O
were,O
also,O
determined,O
for,O
both,O
patient,O
groups,O
by,O
using,O
a,O
radioligand,O
binding,I
assay,I
and,O
Scatchard,O
analysis,O
.,O
The,O
GCR,B
binding,I
affinity,I
for,O
budesonide,O
was,O
significantly,O
higher,O
in,O
both,O
groups,O
(,O
i,O
.,O
e,O
.,O
",",O
lower,O
dissociation,O
constant,O
),O
than,O
that,O
obtained,O
for,O
dexamethasone,O
.,O
Characterization,O
of,O
the,O
murine,O
cyclin,O
-,O
dependent,O
kinase,O
inhibitor,O
gene,O
p27Kip1,O
.,O
The,O
gene,O
consists,O
of,O
at,O
least,O
three,O
exons,O
and,O
spans,O
more,O
than,O
5,O
.,O
6,O
kb,O
of,O
DNA,B
.,O
Primer,O
extension,O
and,O
nuclease,O
S1,O
protection,O
analysis,O
revealed,O
two,O
major,O
transcription,O
initiation,O
sites,O
.,O
The,O
-,O
326,O
to,O
-,O
615,O
region,O
contained,O
positive,O
regulatory,O
elements,O
.,O
Constitutive,O
nuclear,O
appearance,O
was,O
also,O
observed,O
for,O
NF,B
-,I
kB2,I
/,I
p52,I
.,O
These,O
findings,O
indicate,O
that,O
T,O
cells,O
representing,O
different,O
activation,O
and,O
/,O
or,O
differentiation,O
stages,O
can,O
be,O
differentially,O
responsive,O
to,O
ROI,O
-,O
mediated,O
signals,O
.,O
Furthermore,O
",",O
overexpression,O
and,O
constitutive,O
nuclear,O
localization,O
of,O
NF,B
-,I
AT,I
",",O
but,O
not,O
Jun,O
",",O
Fos,O
",",O
NF,B
-,I
kappaB,I
",",O
Oct,O
or,O
Ets,O
family,O
members,O
",",O
renders,O
the,O
interleukin,B
-,I
2,I
enhancer,I
in,O
Jurkat,B
T,I
lymphocytes,I
resistant,O
to,O
FK506,O
and,O
cyclosporin,O
A,O
.,O
These,O
findings,O
thus,O
reveal,O
the,O
presence,O
of,O
a,O
second,O
inducible,O
autoregulated,O
inhibitory,O
pathway,O
that,O
helps,O
ensure,O
the,O
rapid,O
but,O
transient,O
action,O
of,O
nuclear,O
NF,B
-,I
kappa,I
B,I
.,O
Implications,O
for,O
replication,O
of,O
HIV,B
-,I
1,I
.,O
First,O
",",O
anti,O
-,O
CD45,B
antibodies,I
did,O
not,O
affect,O
basal,O
but,O
decreased,O
activated,O
levels,O
of,O
expression,O
from,O
the,O
HIV,B
-,I
1,I
LTR,I
.,O
The,O
expression,O
of,O
GM,B
-,I
CSF,I
and,O
IL,B
-,I
2,I
is,O
inhibited,O
by,O
immunosuppressive,O
drugs,O
such,O
as,O
cyclosporin,O
A,O
(,O
CsA,O
),O
and,O
FK506,O
.,O
The,O
constitutively,O
active,O
type,O
of,O
the,O
CN,B
A,I
subunit,I
",",O
which,O
lacks,O
the,O
auto,O
-,O
inhibitory,O
and,O
calmodulin,O
-,O
binding,O
domains,O
",",O
acts,O
in,O
synergy,O
with,O
PMA,O
to,O
activate,O
transcription,O
from,O
the,O
GM,B
-,I
CSF,I
promoter,I
.,O
Alternate,O
immune,O
system,O
targets,O
for,O
TCDD,B
:,O
lymphocyte,B
stem,I
cells,I
and,O
extrathymic,B
T,I
-,I
cell,I
development,I
.,O
TCDD,B
mediates,O
atrophy,O
induction,O
through,O
its,O
specific,O
receptor,O
(,O
the,O
AhR,B
),O
and,O
not,O
through,O
effects,O
on,O
the,O
estrogen,B
receptor,I
.,O
Both,O
TCDD,B
and,O
estradiol,B
induce,O
extrathymic,B
T,I
-,I
cell,I
differentiation,I
in,O
the,O
liver,O
.,O
It,O
predicts,O
for,O
two,O
open,O
reading,O
frames,O
(,O
ORFs,O
),O
.,O
ORF1,B
consists,O
of,O
240,O
bp,O
that,O
would,O
encode,O
80,O
amino,B
acids,I
",",O
while,O
the,O
major,O
ORF2,B
consists,O
of,O
648,O
bp,O
capable,O
of,O
coding,O
for,O
216,O
amino,B
acids,I
.,O
To,O
investigate,O
the,O
mechanisms,O
of,O
transcriptional,O
activation,O
of,O
interleukin,B
-,I
1beta,I
(,O
IL,B
-,I
1beta,I
),O
in,O
non,O
-,O
monocytic,O
cells,O
",",O
we,O
constructed,O
a,O
series,O
of,O
reporter,O
plasmids,O
with,O
the,O
bacterial,O
chloramphenicol,O
acetyltransferase,O
gene,O
linked,O
to,O
various,O
parts,O
of,O
the,O
human,O
IL,B
-,I
1beta,I
promoter,I
and,O
performed,O
transient,O
transfection,O
experiments,O
.,O
Egr,B
-,I
1,I
expression,O
correlates,O
with,O
the,O
cellular,B
phenotype,I
and,O
the,O
specific,O
pattern,O
of,O
viral,O
latency,O
established,O
within,O
the,O
individual,O
cell,B
lines,I
.,O
Several,O
forms,O
of,O
EGR,B
-,I
1,I
protein,O
are,O
found,O
within,O
the,O
different,O
groups,O
of,O
cell,B
lines,I
",",O
and,O
the,O
binding,O
activity,O
to,O
DNA,B
consensus,I
sequences,I
was,O
investigated,O
.,O
In,O
all,O
cells,O
tested,O
",",O
IL,O
-,O
10,O
activated,O
Stat1,B
and,O
Stat3,B
and,O
induced,O
the,O
formation,O
of,O
three,O
distinct,O
DNA,B
binding,I
complexes,I
that,O
contained,O
different,O
combinations,O
of,O
these,O
two,O
transcription,O
factors,O
. Using,O
a,O
structure,O
-,O
function,O
mutagenesis,O
approach,O
",",O
two,O
tyrosine,O
residues,O
(,O
Tyr427,B
and,O
Tyr477,B
),O
in,O
the,O
intracellular,O
domain,O
of,O
the,O
murine,O
IL,O
-,O
10,O
receptor,O
were,O
found,O
to,O
be,O
redundantly,O
required,O
for,O
receptor,O
function,O
and,O
for,O
activation,O
of,O
Stat3,B
but,O
not,O
for,O
Stat1,B
or,O
Stat5,B
.,O
This,O
study,O
thus,O
supports,O
the,O
concept,O
that,O
utilization,O
of,O
distinct,O
STAT,B
proteins,I
by,O
different,O
cytokine,O
receptors,O
is,O
dependent,O
on,O
the,O
expression,O
of,O
particular,O
ligand,O
-,O
activatable,O
",",O
tyrosine,O
-,O
containing,O
STAT,B
docking,I
sites,I
in,O
receptor,O
intracellular,O
domains,O
.,O
Silencing,O
of,O
human,O
fetal,O
globin,B
expression,O
is,O
impaired,O
in,O
the,O
absence,O
of,O
the,O
adult,O
beta,B
-,I
globin,I
gene,I
activator,I
protein,I
EKLF,B
.,O
Globin,B
genes,I
are,O
subject,O
to,O
tissue,O
-,O
specific,O
and,O
developmental,O
stage,O
-,O
specific,O
regulation,O
.,O
Stimulation,O
of,O
human,O
peripheral,O
blood,O
mononuclear,O
cells,O
by,O
zinc,B
and,O
related,O
cations,O
.,O
Therefore,O
",",O
monokine,O
induction,O
is,O
a,O
zinc,B
-,I
specific,I
effect,I
influenced,O
by,O
the,O
physicochemical,O
properties,O
of,O
the,O
ion,O
.,O
Confirmation,O
of,O
the,O
unique,O
significance,O
of,O
zinc,B
for,O
immune,O
function,O
provides,O
a,O
better,O
understanding,O
of,O
the,O
mechanisms,O
of,O
specific,O
zinc,B
-,I
mediated,I
immune,I
modulation,I
.,O
E3,B
",",O
a,O
hematopoietic,B
-,I
specific,I
transcript,I
directly,O
regulated,O
by,O
the,O
retinoic,O
acid,O
receptor,O
alpha,O
.,O
E3,B
",",O
one,O
of,O
nine,O
sequences,O
identified,O
",",O
was,O
upregulated,O
in,O
an,O
immediate,O
-,O
early,O
manner,O
",",O
with,O
transcript,O
levels,O
peaking,O
after,O
60,O
minutes,O
exposure,O
to,O
RA,O
.,O
E3,B
transcripts,I
were,O
RA,O
-,O
inducible,O
in,O
HL60,B
cells,I
",",O
but,O
not,O
in,O
an,O
RA,O
-,O
resistant,O
subclone,O
",",O
HL60R,B
",",O
that,O
harbors,O
a,O
mutated,O
RAR,B
alpha,I
gene,I
.,O
These,O
results,O
indicate,O
that,O
E3,B
is,O
a,O
hematopoietic,B
-,I
specific,I
gene,I
that,O
is,O
an,O
immediate,O
target,O
for,O
the,O
activated,O
RAR,B
alpha,I
during,O
myelopoiesis,O
.,O
The,O
molecular,O
mechanism,O
underlying,O
IL,B
-,I
2,I
transcriptional,I
blockade,I
in,O
anergic,O
T,B
cell,I
clones,I
is,O
not,O
fully,O
understood,O
.,O
To,O
examine,O
whether,O
an,O
active,O
negative,O
regulatory,O
process,O
occurs,O
",",O
we,O
created,O
a,O
reporter,O
construct,O
containing,O
as,O
an,O
enhancer,O
four,O
copies,O
of,O
the,O
NF,B
-,I
AT,I
site,I
and,O
one,O
copy,O
of,O
the,O
octamer,O
site,O
(,O
4X,O
NF,B
-,I
AT,I
-,I
Oct,I
),O
.,O
The,O
simplest,O
model,O
to,O
explain,O
these,O
results,O
is,O
that,O
anergy,O
is,O
mediated,O
by,O
a,O
complex,O
of,O
multiple,O
transcription,O
factors,O
that,O
exert,O
a,O
cis,O
-,O
acting,O
dominant,O
negative,O
regulatory,O
effect,O
on,O
the,O
trans,O
-,O
activation,O
of,O
the,O
IL,B
-,I
2,I
gene,I
.,O
In,O
contrast,O
",",O
expression,O
of,O
the,O
activation,O
-,O
dependent,O
cell,O
surface,O
markers,O
CD25,B
and,O
CD69,B
was,O
within,O
normal,O
limits,O
.,O
Whereas,O
AP,B
-,I
1,I
",",O
NF,B
-,I
kappa,I
B,I
",",O
Oct,B
",",O
CREB,B
and,O
SP1,B
displayed,O
normal,O
binding,O
activities,O
in,O
nuclear,O
extracts,O
",",O
the,O
binding,O
of,O
NF,B
-,I
AT,I
to,O
its,O
IL,O
-,O
2,O
promoter,O
response,O
element,O
was,O
barely,O
detectable,O
both,O
before,O
and,O
after,O
T,O
cell,O
stimulation,O
.,O
Our,O
results,O
strongly,O
suggest,O
that,O
this,O
NF,B
-,I
AT,I
/,I
DNA,B
binding,O
defect,O
is,O
responsible,O
for,O
the,O
multiple,O
cytokine,O
deficiency,O
and,O
the,O
SCID,O
phenotype,O
observed,O
in,O
the,O
two,O
infant,O
brothers,O
.,O
During,O
Epstein,B
-,I
Barr,I
virus,I
latent,I
infection,I
of,I
B,I
lymphocytes,I
in,I
vitro,I
",",O
six,O
viral,O
nuclear,O
antigens,O
(,O
EBNAs,B
),O
are,O
expressed,O
from,O
one,O
of,O
two,O
promoters,O
",",O
Cp,B
or,O
Wp,B
",",O
whose,O
activities,O
are,O
mutually,O
exclusive,O
.,O
Deletion,O
of,O
the,O
EBNA2,B
-,I
dependent,I
enhancer,I
located,I
upstream,I
of,I
Cp,B
resulted,O
in,O
a,O
ca,O
.,O
two,O
-,O
to,O
fivefold,O
reduction,O
in,O
Cp,B
activity,O
in,O
the,O
LCLs,B
assayed,O
.,O
Deletion,O
of,O
the,O
glucocorticoid,B
response,I
elements,I
located,O
at,O
ca,O
.,O
bp,O
-,O
850,O
upstream,O
of,O
Cp,O
did,O
not,O
result,O
in,O
a,O
significant,O
loss,O
in,O
activity,O
.,O
The,O
identification,O
of,O
oriP,O
and,O
the,O
EBNA2,O
-,O
dependent,O
enhancer,O
as,O
the,O
major,O
positive,O
cis,O
elements,I
involved,O
in,O
regulating,O
Cp,O
activity,O
in,O
LCL,O
suggests,O
that,O
EBNA,O
gene,O
transcription,O
is,O
largely,O
autoregulated,O
by,O
EBNA,O
1,O
and,O
EBNA,O
2,O
.,O
Expression,O
of,O
interleukin,B
1beta,I
and,O
other,O
cytokines,O
",",O
such,O
as,O
interleukin,B
6,I
and,O
tumor,O
necrosis,O
factor,O
alpha,O
",",O
has,O
been,O
shown,O
to,O
be,O
dependent,O
on,O
the,O
activation,O
of,O
the,O
transcription,O
factor,O
",",O
NFkappaB,B
.,O
HIV,O
-,O
1,O
infection,O
resulted,O
in,O
constitutive,O
",",O
low,O
-,O
level,O
expression,O
of,O
type,O
1,O
interferon,B
(,O
IFN,B
),O
at,O
the,O
mRNA,O
level,O
.,O
We,O
suggest,O
that,O
HIV,B
-,I
1,I
infection,O
of,O
myeloid,B
cells,I
induces,O
IFN,B
production,O
and,O
PKR,B
activity,O
",",O
which,O
in,O
turn,O
contribute,O
to,O
enhanced,O
IkappaBalpha,B
phosphorylation,O
and,O
subsequent,O
degradation,O
.,O
Nuclear,O
translocation,O
of,O
NF,B
-,I
kappaB,I
subunits,O
may,O
ultimately,O
increase,O
the,O
intracellular,O
pool,O
of,O
NF,B
-,I
kappaB,I
/,I
IkappaBalpha,I
by,O
an,O
autoregulatory,O
mechanism,O
.,O
The,O
transcription,O
and,O
transformation,O
activity,O
of,O
c,B
-,I
Jun,I
is,O
governed,O
by,O
a,O
27,O
-,O
amino,O
acid,O
regulatory,O
motif,O
",",O
labeled,O
the,O
delta,O
-,O
domain,O
",",O
which,O
is,O
deleted,O
in,O
v,O
-,O
Jun,O
.,O
Here,O
",",O
we,O
report,O
that,O
differentiated,O
B,B
cells,I
contain,O
a,O
novel,O
substoichiometric,O
TAF,B
of,O
105,O
kDa,O
not,O
found,O
associated,O
with,O
TFIID,B
isolated,O
from,O
other,O
cell,B
types,I
.,O
All,O
cells,O
tested,O
express,O
TAFII105,B
mRNA,O
",",O
but,O
only,O
B,B
cells,O
contain,O
significant,O
levels,O
of,O
protein,B
associated,O
with,O
TFIID,B
.,O
The,O
association,O
of,O
20q,O
deletions,O
with,O
myeloid,O
`,O
`,O
stem,O
cell,O
',O
',O
disorders,O
suggests,O
that,O
the,O
deletions,O
mark,O
the,O
site,O
of,O
one,O
or,O
more,O
genes,O
",",O
loss,O
or,O
inactivation,O
of,O
which,O
plays,O
a,O
role,O
in,O
the,O
regulation,O
of,O
normal,O
hematopoietic,O
progenitors,O
.,O
Seventeen,O
microsatellite,O
markers,O
that,O
span,O
the,O
common,O
deleted,O
region,O
were,O
used,O
to,O
search,O
for,O
loss,O
of,O
heterozygosity,O
in,O
granulocyte,B
DNA,I
.,O
Therefore,O
",",O
the,O
human,O
androgen,O
receptor,O
assay,O
(,O
HUMARA,B
),O
was,O
used,O
to,O
determine,O
granulocyte,B
clonality,O
.,O
These,O
results,O
show,O
that,O
",",O
in,O
the,O
vast,O
majority,O
of,O
patients,O
presented,O
here,O
",",O
the,O
failure,O
to,O
detect,O
loss,O
of,O
heterozygosity,O
can,O
not,O
be,O
attributed,O
to,O
the,O
presence,O
of,O
normal,O
polyclonal,O
granulocytes,B
.,O
In,O
contrast,O
to,O
MM,B
cells,I
",",O
normal,O
splenic,O
B,B
cells,I
express,O
dephosphorylated,O
pRB,B
. Although,O
CD40,B
ligand,I
(,O
CD40L,B
),O
triggers,O
a,O
shift,O
from,O
dephosphorylated,O
to,O
phosphorylated,O
pRB,B
and,O
proliferation,O
of,O
B,B
cells,I
",",O
the,O
addition,O
of,O
exogenous,O
IL,B
-,I
6,I
to,O
CD40L,B
-,I
treated,O
B,B
cells,I
does,O
not,O
alter,O
either,O
pRB,B
or,O
proliferation,O
",",O
as,O
observed,O
in,O
MM,B
cells,I
.,O
Soluble,O
factors,O
secreted,O
by,O
activated,O
T,B
-,I
lymphocytes,I
modulate,O
the,O
transcription,O
of,O
the,O
immunosuppressive,B
cytokine,I
TGF,B
-,I
beta,I
2,I
in,O
glial,B
cells,I
.,O
These,O
data,O
along,O
with,O
previous,O
observations,O
demonstrating,O
the,O
potent,O
immunosuppressive,B
activity,I
of,O
TGF,B
-,I
beta,I
2,I
",",O
support,O
a,O
model,O
for,O
a,O
feedback,O
mechanism,O
between,O
the,O
activated,O
T,B
-,I
lymphocytes,I
and,O
astrocytes,B
via,O
TGF,B
-,I
beta,I
2,I
to,O
regulate,O
the,O
immune,O
response,O
.,O
The,O
transcriptionally,O
regulatory,O
regions,O
of,O
the,O
lymphomagenic,O
Akv,O
and,O
SL3,O
-,O
3,O
murine,O
leukemia,O
retroviruses,O
(,O
MLVs,O
),O
contain,O
two,O
types,O
of,O
E,B
-,I
box,I
consensus,I
motifs,I
",",O
CAGATG,O
.,O
We,O
have,O
examined,O
the,O
requirements,O
of,O
the,O
individual,O
E,B
-,I
boxes,I
in,O
MLV,O
transcriptional,O
regulation,O
.,O
In,O
lymphoid,O
cell,O
lines,O
only,O
",",O
the,O
E,B
(,O
gre,O
),O
-,O
binding,O
protein,O
complexes,O
included,O
ALF1,O
or,O
HEB,O
and,O
E2A,O
basic,O
helix,O
-,O
loop,O
-,O
helix,O
proteins,O
.,O
ALF1,O
transactivated,O
transcription,O
of,O
Akv,B
MLV,I
through,O
the,O
two,O
E,B
(,O
gre,I
),O
motifs,O
equally,O
",",O
whereas,O
E2A,B
protein,O
required,O
the,O
promoter,O
-,O
proximal,O
E,B
(,O
gre,I
),O
motif,O
.,O
Moreover,O
",",O
ectopic,O
Id1,O
repressed,O
E,B
(,O
gre,I
),O
-,O
directed,O
but,O
not,O
EA,O
/,O
S,O
-,O
directed,O
MLV,I
transcription,O
in,O
lymphoid,B
cell,I
lines,I
.,O
In,O
conclusion,O
",",O
E,B
(,O
gre,I
),O
motifs,O
and,O
interacting,O
basic,O
helix,O
-,O
loop,O
-,O
helix,O
proteins,O
are,O
important,O
determinants,O
for,O
MLV,B
transcriptional,O
activity,O
in,O
lymphocytic,B
cell,I
lines,I
.,O
Reversal,O
of,O
apoptosis,O
by,O
the,O
leukaemia,O
-,O
associated,O
E2A,O
-,O
HLF,O
chimaeric,O
transcription,O
factor,O
.,O
We,O
cloned,O
human,O
nur77,B
beta,I
cDNA,I
",",O
called,O
TINUR,O
.,O
Although,O
NGFI,O
-,O
B,O
/,O
nur77,B
is,O
essential,O
for,O
TCR,O
-,O
mediated,O
apoptosis,O
in,O
T,O
-,O
cell,B
hybridomas,I
",",O
the,O
reports,O
on,O
nur77,B
knock,O
-,O
out,O
mice,O
and,O
nur77,B
dominant,I
negative,I
transgenic,I
mice,O
suggest,O
that,O
there,O
is,O
a,O
functional,O
redundancy,O
among,O
NGFI,O
-,O
B,O
/,O
nur77,B
family,O
.,O
Correlations,O
were,O
found,O
between,O
plasma,O
IFN,B
alpha,I
and,O
receptor,O
Kd,O
on,O
monocytes,O
of,O
AIDS,O
-,O
GR,B
(,O
r,O
=,O
0,O
.,O
77,O
),O
and,O
between,O
IFN,B
alpha,I
and,O
plasma,O
cortisol,O
in,O
the,O
same,O
group,O
(,O
r,O
=,O
0,O
.,O
74,O
),O
.,O
By,O
contrast,O
",",O
glucocorticoids,O
failed,O
to,O
inhibit,O
IFNalpha,B
production,O
from,O
AIDS,O
-,O
GR,B
monocytes,O
(,O
approximately,O
20,O
%,O
inhibition,O
),O
.,O
This,O
activation,O
differed,O
substantially,O
from,O
that,O
mediated,O
by,O
phorbol,O
12,O
-,O
myristate,O
13,O
-,O
acetate,O
(,O
PMA,O
),O
and,O
Ca2,B
+,I
ionophore,O
or,O
produced,O
by,O
costimulation,O
with,O
antibodies,O
against,O
the,O
T,B
cell,I
receptor,I
-,I
CD3,I
complex,I
and,O
to,O
CD28,B
.,O
The,O
age,O
-,O
associated,O
immune,O
dysfunction,O
may,O
be,O
implicated,O
to,O
some,O
degree,O
in,O
the,O
extreme,O
susceptibility,O
of,O
the,O
elderly,O
to,O
infection,O
and,O
neoplasia,O
and,O
may,O
even,O
participate,O
in,O
various,O
aspects,O
of,O
senescence,O
.,O
The,O
biochemical,B
modifications,I
responsible,O
for,O
the,O
defect,O
in,O
transduction,O
and,O
execution,O
of,O
the,O
proliferative,O
signal,O
are,O
analyzed,O
as,O
a,O
function,O
of,O
age,O
.,O
The,O
multiple,O
alterations,O
observed,O
on,O
the,O
various,O
biochemical,B
pathways,I
may,O
appear,O
as,O
a,O
consequence,O
of,O
a,O
unique,O
deleterious,O
mechanism,O
more,O
fundamentally,O
related,O
to,O
the,O
process,O
of,O
senescence,O
such,O
as,O
the,O
inability,O
to,O
cope,O
with,O
oxidative,O
stress,O
.,O
Induction,O
of,O
bcl,B
expression,O
by,O
phosphorylated,O
CREB,B
proteins,I
during,O
B,B
-,I
cell,I
activation,O
and,O
rescue,O
from,O
apoptosis,O
.,O
Engagement,O
of,O
surface,O
immunoglobulin,B
on,O
mature,O
B,B
cells,I
leads,O
to,O
rescue,O
from,O
apoptosis,O
and,O
to,O
proliferation,O
.,O
These,O
stimuli,O
result,O
in,O
phosphorylation,O
of,O
CREB,B
at,O
serine,O
133,O
.,O
It,O
is,O
possible,O
that,O
the,O
CRE,B
site,I
is,O
responsible,O
for,O
induction,O
of,O
bcl,B
expression,I
in,O
other,O
cell,B
types,I
",",O
particularly,O
those,O
in,O
which,O
protein,O
kinase,O
C,O
is,O
involved,O
.,O
MNDA,B
(,O
myeloid,B
cell,I
nuclear,I
differentiation,I
antigen,I
),O
is,O
an,O
interferon,O
alpha,O
regulated,O
nuclear,O
protein,O
expressed,O
only,O
in,O
cells,O
of,O
the,O
human,O
myelomonocytic,B
lineage,I
.,O
In,O
addition,O
",",O
DNA,B
methylation,I
was,O
revealed,O
as,O
one,O
of,O
the,O
possible,O
factors,O
in,O
establishing,O
MNDA,B
expression,O
.,O
This,O
abnormality,O
was,O
not,O
seen,O
in,O
resting,O
T,B
cells,I
nor,O
T,B
cells,I
from,O
patients,O
with,O
systemic,O
lupus,O
erythematosus,O
",",O
rheumatoid,O
arthritis,O
(,O
RA,B
),O
",",O
or,O
SS,B
accompanied,O
by,O
RA,B
.,O
Characterization,O
of,O
a,O
new,O
isoform,O
of,O
the,O
NFAT,B
(,O
nuclear,I
factor,I
of,I
activated,I
T,I
cells,I
),O
gene,O
family,O
member,O
NFATc,B
[,O
published,O
erratum,O
appears,O
in,O
J,O
Biol,O
Chem,O
1996,O
Dec,O
27,O
;,O
271,O
(,O
52,O
),O
:,O
33705,O
],O
The,O
amino,O
acid,O
sequence,O
of,O
NFATc,B
.,O
beta,B
differs,O
from,O
that,O
of,O
NFATc,B
.,O
Transient,O
expression,O
of,O
NFATc,B
.,O
beta,B
was,O
capable,O
of,O
activating,O
an,O
interleukin,O
-,O
2,O
NFAT,B
-,I
driven,I
reporter,I
gene,I
in,O
stimulated,O
Jurkat,B
cells,I
in,O
a,O
CsA,B
-,I
sensitive,I
manner,I
.,O
However,O
",",O
NFATc,B
.,O
beta,O
neither,O
bound,O
to,O
the,O
kappa3,O
element,O
(,O
an,O
NFAT,B
-,I
binding,I
site,I
),O
in,O
the,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
promoter,O
nor,O
activated,O
the,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
promoter,O
in,O
cotransfection,O
assays,O
.,O
In,O
this,O
study,O
",",O
we,O
examined,O
seven,O
EBV,B
-,I
positive,I
gastric,I
carcinoma,I
tissues,O
for,O
viral,O
gene,O
expression,O
at,O
the,O
mRNA,B
level,I
",",O
from,O
which,O
studies,O
on,O
the,O
EBV,B
oncogenicity,O
in,O
human,O
epithelial,O
cells,O
will,O
benefit,O
.,O
Both,O
are,O
located,O
in,O
the,O
particulate,O
fraction,O
following,O
platelet,B
activation,O
and,O
are,O
also,O
able,O
to,O
bind,O
to,O
a,O
GST,B
-,I
construct,I
containing,O
the,O
SH2,B
and,O
SH3,B
domains,I
of,O
phospholipase,B
C,I
gamma,I
1,I
.,O
Constitutive,O
expression,O
of,O
specific,O
interferon,B
isotypes,I
in,O
peripheral,B
blood,I
leukocytes,I
from,O
normal,O
individuals,O
and,O
in,O
promonocytic,B
U937,I
cells,I
.,O
Constitutive,O
expression,O
of,O
IFN,B
-,I
alpha5,I
and,O
IFN,B
-,I
beta,I
was,O
detected,O
in,O
different,O
lymphoid,B
cells,I
including,O
peripheral,B
blood,I
mononuclear,I
cells,I
from,O
normal,O
individuals,O
following,O
amplification,O
of,O
IFN,B
mRNA,I
by,O
reverse,O
transcriptase,O
-,O
polymerase,O
chain,O
reaction,O
and,O
direct,O
sequencing,O
of,O
the,O
amplified,O
product,O
.,O
These,O
results,O
suggest,O
that,O
IFN,B
-,I
alpha5,I
and,O
IFN,B
-,I
beta,I
are,O
produced,O
at,O
low,O
levels,O
in,O
normal,O
tissues,O
and,O
play,O
an,O
important,O
role,O
in,O
the,O
regulation,O
of,O
cell,B
function,I
and,O
in,O
the,O
maintenance,O
of,O
homeostasis,O
.,O
Thus,O
",",O
IL,B
-,I
2,I
-,I
induced,O
IL,B
-,I
2R,I
alpha,I
promoter,I
activity,O
requires,O
a,O
complex,O
upstream,O
element,O
",",O
which,O
appears,O
to,O
contain,O
binding,O
sites,O
for,O
both,O
positive,O
and,O
negative,O
regulatory,O
factors,O
.,O
Lymphocytes,O
from,O
CML,O
patients,O
lack,O
a,O
47,O
kDa,O
factor,O
having,O
affinity,O
for,O
a,O
genomic,O
sterol,O
regulatory,O
sequence,O
.,O
The,O
proximal,O
sequence,O
element,O
(,O
PSE,B
),O
-,O
binding,O
transcription,O
factor,O
(,O
PTF,B
),O
",",O
which,O
binds,O
the,O
PSE,B
of,O
both,O
RNA,B
polymerase,I
II,I
-,I
and,O
RNA,B
polymerase,I
III,I
-,I
transcribed,O
mammalian,O
small,O
nuclear,O
RNA,B
(,O
snRNA,B
),O
genes,O
",",O
is,O
essential,O
for,O
their,O
transcription,O
.,O
Here,O
we,O
describe,O
the,O
isolation,O
and,O
expression,O
of,O
a,O
cDNA,B
encoding,O
PTF,B
beta,I
",",O
as,O
well,O
as,O
functional,O
studies,O
using,O
anti,O
-,O
PTF,B
beta,I
antibodies,I
.,O
We,O
report,O
here,O
on,O
the,O
identification,O
of,O
a,O
17,O
kDa,O
variant,O
of,O
the,O
14,O
kDa,O
Id,B
-,I
3,I
protein,I
termed,O
Id,B
-,I
3L,I
(,O
long,O
version,O
),O
which,O
possesses,O
a,O
unique,O
60,O
amino,O
acid,O
carboxy,O
-,O
terminus,O
generated,O
by,O
read,O
through,O
of,O
a,O
',O
coding,O
intron,O
',O
and,O
alternative,O
splicing,O
.,O
Tyloxapol,B
inhibits,O
NF,B
-,I
kappa,I
B,I
and,O
cytokine,B
release,I
",",O
scavenges,O
HOCI,O
",",O
and,O
reduces,O
viscosity,O
of,O
cystic,B
fibrosis,I
sputum,I
.,O
In,O
the,O
search,O
for,O
a,O
potential,O
treatment,O
",",O
we,O
have,O
tested,O
tyloxapol,B
",",O
an,O
alkylaryl,O
polyether,O
alcohol,O
polymer,O
detergent,O
previously,O
used,O
as,O
a,O
mucolytic,O
agent,O
in,O
adult,O
chronic,O
bronchitis,O
.,O
Tyloxapol,O
inhibits,O
activation,O
of,O
the,O
transcription,O
factor,O
nuclear,O
factor,O
-,O
kappa,O
B,B
(,O
NK,B
-,I
kappa,I
B,I
),O
",",O
reduces,O
resting,O
secretion,O
of,O
the,O
cytokine,O
interleukin,B
-,I
8,I
(,O
IL,B
-,I
8,I
),O
in,O
cultured,O
human,O
monocytes,O
",",O
and,O
inhibits,O
lipopolysaccharide,B
(,O
LPS,B
),O
-,O
stimulated,O
release,O
of,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
(,O
TNF,B
-,I
alpha,I
),O
",",O
IL,B
-,I
1,I
beta,I
",",O
IL,B
-,I
6,I
",",O
IL,B
-,I
8,I
",",O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
(,O
GM,B
-,I
CSF,I
),O
",",O
and,O
the,O
eiconsanoids,O
thromboxane,B
A2,I
and,O
leukotriene,B
B4,I
(,O
LTB4,B
),O
.,O
In,O
this,O
study,O
",",O
we,O
examined,O
the,O
molecular,O
mechanism,O
by,O
which,O
agents,O
that,O
elevate,O
intracellular,O
cAMP,B
inhibit,O
the,O
expression,O
of,O
the,O
tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNFalpha,O
),O
",",O
tissue,O
factor,O
",",O
endothelial,O
leukocyte,O
adhesion,O
molecule,O
-,O
1,O
",",O
and,O
vascular,O
cell,O
adhesion,O
molecule,O
-,O
1,O
genes,O
.,O
We,O
propose,O
that,O
direct,O
interaction,O
between,O
the,O
glucocorticoid,B
receptor,I
and,O
nuclear,O
factor,O
-,O
kappa,O
B,O
factors,O
is,O
at,O
least,O
a,O
partial,O
explanation,O
for,O
the,O
effects,O
of,O
this,O
hormone,O
in,O
inflammatory,O
diseases,O
.,O
Abnormalities,O
in,O
the,O
p16,B
",",O
p15,B
and,O
CDK4,B
genes,I
that,O
regulate,O
transition,O
through,O
the,O
G1,O
phase,O
of,O
the,O
cell,B
cycle,I
have,O
been,O
implicated,O
in,O
the,O
malignant,O
progression,O
of,O
astrocytomas,O
.,O
The,O
primary,O
and,O
recurrent,O
tumors,O
in,O
Group,O
A,O
did,O
not,O
show,O
structural,O
alterations,O
in,O
the,O
p16,B
",",O
p15,B
or,O
CDK4,B
genes,I
",",O
whereas,O
homozygous,O
codeletion,O
of,O
p16,B
and,O
p15,B
was,O
observed,O
in,O
both,O
primary,O
and,O
recurrent,O
tumors,O
in,O
Group,O
B,O
.,O
The,O
primary,O
tumors,O
in,O
Group,O
C,O
had,O
a,O
normal,O
profile,O
of,O
p16,B
",",O
p15,B
and,O
CDK4,B
at,O
presentation,O
.,O
Approximately,O
40,O
%,O
of,O
diffuse,O
large,O
cell,O
lymphoma,O
are,O
associated,O
with,O
chromosomal,O
translocations,O
that,O
deregulate,O
the,O
expression,O
of,O
the,O
BCL6,B
gene,I
by,O
juxtaposing,O
heterologous,O
promoters,O
to,O
the,O
BCL,B
-,I
6,I
coding,I
domain,I
.,O
In,O
transient,O
transfectin,O
experiments,O
",",O
BCL6,B
can,O
repress,O
transcription,O
from,O
promoters,O
linked,O
to,O
its,O
DNA,B
target,I
sequence,I
and,O
this,O
activity,O
is,O
dependent,O
upon,O
specific,O
DNA,B
-,I
binding,I
and,O
the,O
presence,O
of,O
an,O
intact,O
N,B
-,I
terminal,I
half,I
of,I
the,O
protein,B
.,O
As,O
the,O
NF,B
-,I
kappa,I
B,I
transcription,O
factor,O
has,O
a,O
central,O
role,O
in,O
the,O
control,O
of,O
transcription,O
of,O
several,O
genes,O
involved,O
in,O
immune,O
and,O
inflammatory,O
responses,O
",",O
the,O
authors,O
have,O
analysed,O
the,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
human,O
umbilical,O
cord,O
T,B
lymphocytes,I
.,O
The,O
key,O
role,O
of,O
erythropoietin,B
(,O
Epo,B
),O
for,O
colony,O
formation,O
by,O
early,O
erythroid,B
progenitors,O
(,O
burst,O
-,O
forming,O
units,O
-,O
erythroid,B
[,O
BFU,B
-,I
E,I
],O
),O
has,O
been,O
confirmed,O
.,O
High,O
concentrations,O
of,O
either,O
compound,O
(,O
1,O
),O
drastically,O
reduced,O
the,O
number,O
of,O
primary,O
HPP,B
-,I
CFC,I
colonies,O
and,O
totally,O
abolished,O
their,O
recloning,O
capacity,O
and,O
(,O
2,O
),O
inhibited,O
HSC,B
proliferation,O
.,O
Altogether,O
",",O
these,O
results,O
suggest,O
that,O
ATRA,B
/,O
9,O
-,O
cis,O
RA,B
may,O
play,O
a,O
key,O
role,O
in,O
FL,O
hematopoiesis,O
via,O
a,O
dual,O
effect,O
hypothetically,O
mediated,O
by,O
interaction,O
with,O
the,O
RAR,B
/,O
RXR,B
heterodimer,O
",",O
ie,O
",",O
inhibition,O
of,O
HSC,B
/,O
primitive,O
HPC,B
proliferation,O
and,O
induction,O
of,O
CFU,B
-,O
GEMM,I
/,O
BFU,B
-,O
E,I
/,O
CFU,B
-,O
M,I
shift,O
from,O
the,O
multipotent,O
/,O
erythroid,B
/,O
monocytic,B
to,O
the,O
granulocytic,B
-,O
neutrophilic,B
differentiation,O
program,O
.,O
We,O
previously,O
suggested,O
that,O
the,O
measurement,O
of,O
corticosteroid,B
receptors,I
in,O
lymphocytes,B
is,O
an,O
index,O
of,O
an,O
analogous,O
pattern,O
in,O
brain,B
0.20,O
Receptors,O
were,O
measured,O
by,O
radioreceptor,O
assay,O
0.27,O
Analysis,O
of,O
the,O
ligand,O
-,O
binding,O
domain,O
of,O
human,O
retinoic,B
acid,I
receptor,I
alpha,I
by,O
site,O
-,O
directed,O
mutagenesis,O
0.46,O
Three,O
subtypes,O
of,O
retinoic,B
acid,I
receptors,I
(,O
RAR,B
),O
",56",O
termed,O
RAR,B
alpha,I
",60",O
RAR,B
beta,I
",63",O
and,O
RAR,B
gamma,I
",67",O
have,O
been,O
described,O
0.71,O
RARs,B
specifically,O
bind,O
all,O
-,O
trans,O
-,O
retinoic,B
acid,I
(,O
RA,B
),O
",",O
9,O
-,O
cis,O
-,O
RA,B
",",O
and,O
retinoid,B
analogs,I
.,O
Interestingly,O
",",O
residue,O
C,O
-,O
235,O
is,O
specifically,O
important,O
in,O
antagonist,B
binding,I
.,O
With,O
respect,O
to,O
arginine,B
residues,I
",",O
only,O
the,O
two,O
single,O
mutations,O
of,O
R,B
-,O
276,O
and,O
R,B
-,O
394,O
to,O
alanine,O
showed,O
a,O
dramatic,O
decrease,O
of,O
agonist,B
and,O
antagonist,B
binding,I
whereas,O
the,O
R272A,O
mutation,O
showed,O
only,O
a,O
slight,O
effect,O
.,O
For,O
all,O
other,O
arginine,B
mutations,I
",",O
no,O
differences,O
in,O
affinity,O
were,O
detectable,O
.,O
The,O
two,O
mutations,O
R217A,B
and,O
R294A,B
caused,O
an,O
increased,O
binding,O
efficiency,O
for,O
antagonists,O
but,O
no,O
change,O
in,O
agonist,O
binding,O
.,O
From,O
these,O
results,O
",",O
we,O
can,O
conclude,O
that,O
electrostatic,O
interactions,O
of,O
retinoids,O
with,O
the,O
RAR,B
alpha,I
-,I
LBD,I
play,O
a,O
significant,O
role,O
in,O
ligand,O
binding,O
.,O
In,O
spite,O
of,O
this,O
similar,O
downstream,O
signalling,O
",",O
IL4,B
and,O
IL13,B
used,O
a,O
different,O
set,O
of,O
Janus,O
kinases,O
:,O
IL13,B
is,O
unable,O
to,O
activate,O
JAK1,B
and,O
JAK3,B
.,O
Our,O
findings,O
support,O
the,O
recently,O
determined,O
calcineurin,B
X,I
-,I
ray,I
crystal,I
structure,I
",",O
provide,O
evidence,O
that,O
calcineurin,B
is,O
the,O
only,O
CsA,B
-,I
sensitive,I
component,I
limiting,I
signaling,I
from,O
the,O
T,B
cell,I
receptor,I
to,O
the,O
nucleus,O
",",O
and,O
suggest,O
a,O
means,O
to,O
render,O
cells,O
and,O
tissues,O
resistant,O
to,O
the,O
toxic,O
side,O
effects,O
of,O
CsA,B
and,O
FK506,B
.,O
Epstein,B
-,I
Barr,I
viral,I
latency,I
is,O
disrupted,O
by,O
the,O
immediate,O
-,O
early,O
BRLF1,B
protein,I
through,O
a,O
cell,B
-,I
specific,I
mechanism,I
.,O
Epithelial,B
cells,I
are,O
the,O
major,O
site,O
of,O
lytic,O
EBV,B
replication,I
within,O
the,O
human,O
host,O
",",O
and,O
viral,O
reactivation,O
occurs,O
in,O
EBV,B
-,I
associated,I
nasopharyngeal,I
carcinomas,I
.,O
Eosinophils,B
play,O
an,O
important,O
role,O
in,O
the,O
effector,O
phase,O
of,O
allergic,O
inflammation,O
.,O
The,O
extent,O
to,O
which,O
peptides,O
containing,O
chemically,O
and,O
post,O
-,O
translationally,O
modified,O
amino,O
acid,O
side,O
chains,O
are,O
recognized,O
by,O
primed,O
CTL,B
has,O
not,O
been,O
clearly,O
defined,O
.,O
The,O
CTL,B
specifically,O
recognized,O
the,O
succinimide,O
-,O
containing,O
peptide,O
showing,O
only,O
weak,O
cross,O
-,O
reactivity,O
at,O
high,O
concentrations,O
of,O
the,O
parent,O
peptide,O
containing,O
unmodified,O
asparagine,O
.,O
Moreover,O
",",O
since,O
succinimide,O
intermediates,O
of,O
deamidated,O
peptides,O
can,O
occasionally,O
be,O
very,O
stable,O
",",O
these,O
peptides,O
have,O
the,O
potential,O
to,O
act,O
as,O
altered,O
self,O
-,O
Ags,O
with,O
significant,O
implications,O
for,O
autoimmunity,O
.,O
A,O
3,O
',O
-,O
>,O
5,O
',O
XPB,B
helicase,I
defect,O
in,O
repair,O
/,O
transcription,O
factor,O
TFIIH,O
of,O
xeroderma,B
pigmentosum,I
group,I
B,I
affects,O
both,O
DNA,B
repair,I
and,O
transcription,O
.,O
Although,O
identical,O
in,O
composition,O
and,O
stoichiometry,O
to,O
TFIIHwt,B
",",O
TFIIHmut,B
shows,O
a,O
reduced,O
3,O
',O
-,O
-,O
>,O
5,O
',O
XPB,B
helicase,I
activity,I
.,O
The,O
XPB,B
mutation,I
causes,O
a,O
severe,O
NER,B
defect,I
.,O
The,O
latter,O
defect,O
may,O
provide,O
an,O
explanation,O
for,O
many,O
of,O
the,O
XP,B
and,O
CS,B
symptoms,O
that,O
are,O
difficult,O
to,O
rationalize,O
based,O
solely,O
on,O
an,O
NER,B
defect,I
.,O
PU,O
.,O
1,O
is,O
completely,O
absent,O
from,O
peripheral,O
T,B
cells,I
and,O
most,O
T,B
cell,I
lines,I
based,O
on,O
sensitive,O
RT,O
-,O
PCR,O
assays,O
.,O
In,O
contrast,O
",",O
Spi,O
-,O
B,B
is,O
expressed,O
exclusively,O
in,O
lymphoid,B
cells,I
and,O
can,O
be,O
detected,O
in,O
early,O
fetal,O
thymus,O
and,O
spleen,O
.,O
In,O
situ,O
hybridization,O
and,O
Northern,O
blot,O
analysis,O
suggest,O
that,O
Spi,O
-,O
B,B
gene,I
expression,I
increases,O
during,O
B,B
cell,I
maturation,I
and,O
decreases,O
during,O
T,B
cell,I
maturation,I
.,O
Taken,O
together,O
",",O
these,O
data,O
suggest,O
that,O
differences,O
in,O
patterns,O
of,O
expression,O
between,O
Spi,B
-,I
B,I
and,O
PU,B
.,O
1,O
distinguish,O
the,O
function,O
of,O
each,O
protein,B
during,O
development,O
of,O
the,O
immune,B
system,I
.,O
DNase,B
I,I
hypersensitive,I
site,I
(,O
DHS,B
),O
mapping,O
revealed,O
that,O
the,O
perforin,B
locus,I
contained,O
six,O
DHS,B
within,O
7,O
.,O
0,O
kb,O
of,O
the,O
5,O
',O
upstream,O
sequence,O
(,O
-,O
7,O
.-63,O
0,O
kb,O
),O
and,O
two,O
DHS,O
in,O
intron,O
2,O
.,O
Chloramphenicol,B
acetyltransferase,I
(,O
CAT,B
),O
activities,O
directed,O
by,O
5,O
',O
upstream,O
promoter,O
were,O
detected,O
preferentially,O
in,O
perforin,O
-,O
expressing,O
cell,O
lines,O
.,O
When,O
single,O
-,O
point,O
mutation,O
was,O
introduced,O
to,O
each,O
GC,B
box,I
",",O
EBS,B
",",O
and,O
GT,B
box,I
in,O
PFP9a20,O
",",O
at,O
least,O
3,O
-,O
fold,O
less,O
CAT,B
activity,O
was,O
observed,O
in,O
CTLL,B
-,I
R8,I
cells,O
.,O
The,O
results,O
suggest,O
that,O
a,O
combination,O
of,O
the,O
three,O
proximal,O
cis,O
-,O
acting,O
elements,O
may,O
constitute,O
a,O
minimal,O
region,O
responsible,O
for,O
CTL,B
-,I
specific,I
expression,I
of,O
perforin,O
.,O
Thus,O
Oct,B
-,I
2,I
plays,O
an,O
important,O
role,O
in,O
the,O
regulation,O
of,O
cellular,O
gene,O
expression,O
in,O
both,O
B,B
cells,I
and,O
neuronal,B
cells,I
as,O
well,O
as,O
in,O
the,O
control,O
of,O
viral,O
latency,O
.,O
Instead,O
",",O
ATF,B
-,I
2,I
and,O
Jun,B
proteins,I
bind,O
to,O
the,O
composite,O
kappa,B
3,I
/,I
CRE,I
site,I
and,O
NFATp,B
binds,O
to,O
a,O
newly,O
identified,O
second,O
NFAT,B
site,I
centered,O
at,O
-,O
76,O
nucleotides,O
relative,O
to,O
the,O
TNF,O
-,O
alpha,O
transcription,O
start,O
site,O
.,O
Consistent,O
with,O
these,O
results,O
",",O
quantitative,O
DNase,B
footprinting,I
of,O
the,O
TNF,O
-,O
alpha,O
promoter,O
using,O
increasing,O
amounts,O
of,O
recombinant,O
NFATp,B
demonstrated,O
that,O
the,O
-,O
76,O
site,O
binds,O
to,O
NFATp,B
with,O
a,O
higher,O
affinity,O
than,O
the,O
kappa,B
3,I
site,I
.,O
Thus,O
",",O
through,O
the,O
differential,O
use,O
of,O
the,O
same,O
promoter,B
element,I
",",O
the,O
composite,O
kappa,B
3,I
/,I
CRE,I
site,I
",",O
the,O
TNF,B
-,I
alpha,I
gene,I
is,O
regulated,O
in,O
a,O
cell,B
-,I
type,I
-,I
specific,I
manner,I
in,O
response,O
to,O
the,O
same,O
extracellular,O
signal,O
.,O
To,O
address,O
possible,O
mechanisms,O
that,O
could,O
explain,O
this,O
selective,O
activity,O
of,O
c,B
-,I
ErbB,I
",",O
we,O
analyzed,O
the,O
ability,O
of,O
these,O
receptors,O
to,O
activate,O
the,O
different,O
members,O
of,O
the,O
Stat,B
transcription,I
factor,I
family,I
.,O
Ligand,O
activation,O
of,O
c,O
-,O
ErbB,B
induced,O
the,O
tyrosine,O
phosphorylation,O
",",O
DNA,B
-,I
binding,I
",",O
and,O
reporter,O
gene,O
transcription,O
of,O
Stat,O
5b,O
in,O
erythroblasts,O
.,O
In,O
contrast,O
",",O
ligand,O
activation,O
of,O
c,O
-,O
Kit,B
was,O
unable,O
to,O
induce,O
any,O
of,O
these,O
effects,O
in,O
the,O
same,O
cells,O
.,O
Sequence,O
-,O
specific,O
DNA,B
binding,I
of,O
the,O
B,B
-,I
cell,I
-,I
specific,I
coactivator,I
OCA,I
-,I
B,I
.,O
While,O
one,O
of,O
the,O
twins,O
was,O
clinically,O
affected,O
",",O
the,O
other,O
was,O
asymptomatic,O
.,O
This,O
is,O
the,O
first,O
documented,O
case,O
of,O
female,O
twins,O
discordant,O
for,O
Fabry,O
disease,O
.,O
Precise,O
alignment,O
of,O
sites,O
required,O
for,O
mu,B
enhancer,I
activation,I
in,O
B,B
cells,I
.,O
The,O
lymphocyte,B
-,I
specific,I
immunoglobulin,B
mu,I
heavy,I
-,I
chain,I
gene,I
intronic,I
enhancer,I
is,O
regulated,O
by,O
multiple,O
nuclear,O
factors,O
.,O
The,O
previously,O
defined,O
minimal,O
enhancer,O
containing,O
the,O
muA,B
",",O
muE3,B
",",O
and,O
muB,B
sites,O
is,O
transactivated,O
by,O
a,O
combination,O
of,O
the,O
ETS,B
-,I
domain,I
proteins,I
PU,B
.,O
1,O
and,O
Ets,B
-,I
1,I
in,O
nonlymphoid,O
cells,O
.,O
The,O
core,O
GGAAs,O
of,O
the,O
muA,B
and,O
muB,B
sites,O
are,O
separated,O
by,O
30,O
nucleotides,O
",",O
suggesting,O
that,O
ETS,B
proteins,I
bind,O
to,O
these,O
sites,O
from,O
these,O
same,O
side,O
of,O
the,O
DNA,B
helix,O
.,O
In,O
allergic,O
bronchial,O
asthma,O
",",O
inflammation,O
seems,O
to,O
be,O
orchestrated,O
predominantly,O
by,O
a,O
subset,O
of,O
T,B
lymphocytes,I
",",O
with,O
a,O
phenotype,O
similar,O
to,O
the,O
Th2,B
subset,I
able,O
to,O
produce,O
IL,B
-,I
4,I
and,O
IL,B
-,I
5,I
.,O
Some,O
criteria,O
which,O
can,O
be,O
used,O
to,O
define,O
steroid,B
-,I
resistant,I
bronchial,I
asthma,I
are,O
listed,O
here,O
.,O
Mechanisms,O
of,O
transactivation,O
by,O
nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
-,I
1,I
.,O
Nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
-,I
family,I
proteins,I
(,O
NFAT1,B
/,I
NFATp,I
",",O
NFATc,B
",",O
NFAT3,B
",",O
and,O
NFAT4,B
/,I
NFATx,I
/,I
NFATc3,I
),O
play,O
a,O
key,O
role,O
in,O
the,O
transcription,O
of,O
cytokine,O
genes,O
and,O
other,O
genes,O
during,O
the,O
immune,O
response,O
.,O
Our,O
results,O
emphasize,O
the,O
multiple,O
levels,O
at,O
which,O
NFAT,B
-,I
dependent,I
transactivation,I
is,O
regulated,O
",",O
and,O
predict,O
significant,O
differences,O
in,O
the,O
architecture,O
of,O
cooperative,O
transcription,O
complexes,O
containing,O
different,O
NFAT,B
-,I
family,I
proteins,I
.,O
A,O
major,O
obstacle,O
in,O
understanding,O
the,O
signaling,O
events,O
that,O
follow,O
CD28,B
receptor,I
ligation,I
arises,O
from,O
the,O
fact,O
that,O
CD28,B
acts,O
as,O
a,O
costimulus,O
to,O
TCR,B
engagement,O
",",O
making,O
it,O
difficult,O
to,O
assess,O
the,O
relative,O
contribution,O
of,O
CD28,B
signals,O
as,O
distinct,O
from,O
those,O
of,O
the,O
TCR,B
.,O
This,O
revealed,O
that,O
NF,B
-,I
kappaB,I
generation,O
was,O
sensitive,O
to,O
chloroquine,O
",",O
an,O
inhibitor,O
of,O
acidic,O
sphingomyelinase,O
",",O
but,O
not,O
to,O
the,O
phosphatidylinositol,B
3,I
-,I
kinase,I
inhibitor,I
",",O
wortmannin,O
.,O
To,O
investigate,O
the,O
presence,O
of,O
various,O
isoforms,O
of,O
the,O
estrogen,B
receptor,I
(,O
ER,B
),O
in,O
SLE,O
we,O
isolated,O
RNA,B
from,O
mononuclear,B
cells,I
of,O
lupus,O
patients,O
and,O
normal,O
controls,O
.,O
It,O
is,O
expressed,O
on,O
a,O
subpopulation,O
of,O
macrophages,B
in,O
lymphoid,B
tissues,I
and,O
in,O
chronic,O
inflammation,O
(,O
e,O
.,O
g,O
.,O
.,O
",",O
during,O
autoimmune,O
diseases,O
),O
.,O
Sialoadhesin,B
expression,O
was,O
functional,O
as,O
shown,O
by,O
cell,B
adhesion,I
assays,O
with,O
human,O
RBCs,B
.,O
Northern,O
blotting,O
experiments,O
indicated,O
that,O
regulation,O
predominantly,O
occurred,O
at,O
the,O
mRNA,B
level,I
.,O
The,O
results,O
suggest,O
a,O
new,O
option,O
for,O
HIV,B
gene,I
therapy,I
;,O
bcl,O
-,O
2,O
muteins,O
that,O
have,O
noncleavable,O
alterations,O
surrounding,O
the,O
HIV,B
protease,I
cleavage,I
site,I
.,O
In,O
contrast,O
to,O
freshly,O
isolated,O
T,B
cells,I
",",O
in,O
vitro,O
-,O
cultured,O
T,B
cells,I
did,O
not,O
require,O
costimulation,O
for,O
cytokine,O
secretion,O
in,O
response,O
to,O
anti,O
-,O
CD3,O
alone,O
. The,O
induction,O
of,O
T,B
cell,I
proliferation,O
requires,O
signals,O
from,O
the,O
TCR,O
and,O
a,O
co,O
-,O
receptor,O
molecule,O
",",O
such,O
as,O
CD28,O
",",O
that,O
activate,O
parallel,O
and,O
partially,O
cross,O
-,O
reactive,O
signaling,O
pathways,O
.,O
Our,O
results,O
suggest,O
that,O
PKA,B
inhibits,O
T,B
cell,I
activation,I
by,O
interfering,O
with,O
multiple,O
events,O
along,O
the,O
two,O
signaling,O
pathways,O
operating,O
downstream,O
of,O
the,O
TCR,B
and,O
the,O
CD28,B
co,I
-,I
receptor,I
molecules,I
.,O
This,O
pattern,O
of,O
STAT,B
activation,I
was,O
seen,O
in,O
all,O
BCP,B
-,I
ALL,I
cases,I
that,O
respond,O
to,O
IL,B
-,I
7,I
in,O
proliferation,O
assays,O
.,O
To,O
determine,O
the,O
contribution,O
of,O
the,O
cytoplasmic,O
domain,O
of,O
the,O
IL,B
-,I
7,I
receptor,I
alpha,I
chain,I
(,O
IL,B
-,I
7R,I
alpha,I
),O
to,O
activation,O
of,O
STAT,B
proteins,I
",",O
transfectants,O
of,O
the,O
murine,O
pro,O
-,O
B,O
cell,O
line,O
BAF3,B
were,O
made,O
that,O
express,O
chimeric,O
receptors,O
consisting,O
of,O
the,O
extracellular,O
domain,O
of,O
human,O
granulocyte,B
colony,I
-,I
stimulating,I
factor,I
receptor,I
(,O
G,B
-,I
CSF,I
-,I
R,I
),O
and,O
the,O
transmembrane,O
and,O
intracellular,O
domains,O
of,O
human,O
IL,B
-,I
7R,I
alpha,I
.,O
The,O
oligo,O
sequence,O
I,O
stimulated,O
proliferation,O
of,O
both,O
T,B
and,O
",",O
to,O
a,O
lesser,O
extent,O
",",O
B,B
cells,I
.,O
The,O
percentage,O
of,O
cells,O
expressing,O
CD40,B
in,O
T,B
and,O
B,B
cell,I
co,I
-,I
cultures,I
increased,O
from,O
4,O
.,O
2,O
%,O
to,O
13,O
.,O
8,O
%,O
after,O
oligo,O
stimulation,O
in,O
patients,O
",",O
while,O
it,O
increased,O
form,O
4,O
.,O
7,O
%,O
to,O
48,O
.,O
6,O
%,O
in,O
healthy,O
controls,O
.,O
We,O
demonstrate,O
that,O
CaMKIV,B
/,I
Gr,I
reconstitutes,O
the,O
capacity,O
of,O
the,O
cytosolic,O
component,O
of,O
NFAT,B
to,O
direct,O
transcription,O
from,O
NFAT,B
sites,I
in,O
non,O
-,O
T,B
cells,I
.,O
This,O
was,O
identified,O
as,O
the,O
mRNA,B
encoding,O
the,O
transcription,O
factor,O
egr,B
-,I
1,I
",",O
which,O
is,O
expressed,O
with,O
fast,O
kinetics,O
in,O
T,B
and,O
NK,B
cells,I
upon,O
IL,B
-,I
2,I
",",O
but,O
not,O
IL,B
-,I
12,I
",",O
stimulation,O
.,O
Increasing,O
the,O
levels,O
of,O
BCL,B
-,I
2,I
retarded,O
the,O
G0,B
-,I
-,I
>,I
S,I
transition,O
",",O
sustained,O
the,O
levels,O
of,O
cyclin,B
-,I
dependent,I
kinase,I
inhibitor,I
p27Kip1,I
",",O
and,O
repressed,O
postactivation,O
death,O
.,O
However,O
",",O
the,O
transcription,O
and,O
synthesis,O
of,O
interleukin,B
2,I
and,O
other,O
delayed,O
early,O
cytokines,O
were,O
markedly,O
attenuated,O
by,O
BCL,O
-,O
2,O
.,O
On,O
the,O
basis,O
of,O
several,O
independent,O
assays,O
",",O
we,O
now,O
report,O
a,O
physical,O
and,O
functional,O
interaction,O
between,O
Tax,O
and,O
the,O
transcription,O
factor,O
",",O
TFIIA,O
.,O
Finally,O
",",O
TFIIA,O
facilitates,O
Tax,O
transactivation,O
in,O
vitro,O
and,O
in,O
vivo,O
.,O
Inhibition,O
of,O
transcription,O
factor,O
Stat1,B
activity,O
in,O
mononuclear,B
cell,I
cultures,I
and,O
T,B
cells,I
by,O
the,O
cyclic,O
AMP,B
signaling,I
pathway,I
0.19,O
Suppression,O
of,O
c,O
-,O
jun,B
by,O
antisense,O
oligonucleotides,O
inhibits,O
cell,B
adhesion,I
but,O
not,O
respiratory,B
burst,I
during,O
phorbol,O
ester,O
-,O
induced,O
differentiation,O
of,O
U937,B
human,I
monoblastic,I
cells,I
0.46,O
GM,B
-,I
CSF,I
gene,I
activation,O
in,O
T,B
cells,I
is,O
known,O
to,O
involve,O
the,O
transcription,O
factors,O
nuclear,B
factor,I
-,I
kappa,I
B,I
",",O
AP,B
-,I
1,I
",",O
NFAT,B
",",O
and,O
Sp1,B
.,O
A,O
2,O
-,O
bp,O
mutation,O
within,O
the,O
CBF,B
site,I
resulted,O
in,O
a,O
2,O
-,O
3,O
-,O
fold,O
decrease,O
in,O
the,O
activities,O
of,O
both,O
a,O
69,O
-,O
bp,O
proximal,O
promoter,O
fragment,O
and,O
a,O
627,O
-,O
bp,O
full,O
-,O
length,O
promoter,O
fragment,O
.,O
The,O
AML1,B
and,O
CBF,B
beta,I
genes,I
that,O
encode,O
CBF,B
each,O
have,O
the,O
ability,O
to,O
influence,O
cell,O
growth,O
and,O
differentiation,O
and,O
have,O
been,O
implicated,O
as,O
proto,O
-,O
oncogenes,O
in,O
acute,O
myeloid,O
leukemia,O
.,O
The,O
GM,B
-,I
CSF,I
locus,O
may,O
represent,O
one,O
of,O
several,O
target,O
genes,I
that,O
are,O
dysregulated,O
in,O
acute,O
myeloid,O
leukemia,O
.,O
The,O
preferential,O
induction,O
of,O
c,B
-,I
jun,I
by,O
H2O2,O
did,O
not,O
represent,O
redox,O
stabilization,O
of,O
mRNA,B
transcripts,I
",",O
and,O
oxidative,O
signals,O
closely,O
resembled,O
PHA,O
/,O
PMA,O
stimulation,O
by,O
effectively,O
transactivating,O
the,O
full,O
length,O
c,B
-,I
jun,I
promoter,I
via,O
the,O
proximal,O
jun1,O
tumor,O
promoter,O
-,O
responsive,O
element,O
(,O
TRE,O
),O
-,O
like,O
promoter,O
element,O
.,O
Furthermore,O
",",O
sublethal,O
levels,O
of,O
H2O2,B
actively,O
suppressed,O
the,O
transcriptional,O
activation,O
of,O
NF,B
-,I
AT,I
and,O
IL,B
-,I
2,I
reporters,O
as,O
well,O
as,O
the,O
expression,O
of,O
IL,B
-,I
2,I
mRNA,O
in,O
cells,O
stimulated,O
with,O
PHA,O
/,O
PMA,O
.,O
These,O
results,O
suggest,O
that,O
oxidative,O
signals,O
can,O
positively,O
and,O
negatively,O
regulate,O
T,O
cell,O
transcriptional,O
events,O
and,O
that,O
changes,O
in,O
cellular,O
redox,O
can,O
uncouple,O
AP,O
-,O
1,O
regulation,O
of,O
c,O
-,O
jun,O
from,O
transcriptional,O
up,O
-,O
regulation,O
of,O
IL,B
-,I
2,I
via,O
NF,B
-,I
AT,I
.,O
Many,O
of,O
Pb,O
',O
s,O
effects,O
on,O
the,O
immune,B
system,I
could,O
be,O
explained,O
through,O
activation,O
of,O
the,O
transcription,O
factor,O
",",O
NF,B
-,I
kappa,I
B,I
.,O
Tyrosine,O
kinase,O
and,O
cAMP,B
-,I
dependent,I
protein,I
kinase,I
activities,O
in,O
CD40,B
-,I
activated,I
human,B
B,I
lymphocytes,I
.,O
In,O
vitro,O
",",O
human,B
B,I
lymphocytes,I
undergo,O
long,O
-,O
term,O
proliferation,O
when,O
activated,O
through,O
CD40,B
",",O
a,O
protein,O
expressed,O
on,O
their,O
cell,O
surface,O
.,O
Rather,O
",",O
tyrosine,B
phosphorylation,I
was,O
shown,O
to,O
be,O
directly,O
involved,O
in,O
mediating,O
CD40,O
-,O
dependent,O
signals,O
.,O
To,O
examine,O
the,O
potential,O
effects,O
of,O
stress,O
on,O
TH1,O
/,O
TH2,O
balance,O
",",O
we,O
studied,O
the,O
ability,O
of,O
three,O
prototype,O
stress,O
hormones,O
-,O
dexamethasone,O
(,O
a,O
synthetic,O
glucocorticoid,O
),O
and,O
the,O
catecholamines,O
norepinephrine,O
and,O
epinephrine,O
-,O
to,O
alter,O
the,O
production,O
of,O
IL,B
-,I
12,I
(,O
p70,O
),O
and,O
IL,B
-,I
10,I
induced,O
by,O
bacterial,O
lipopolysaccharide,O
(,O
LPS,O
),O
in,O
human,O
whole,O
blood,O
.,O
The,O
effects,O
of,O
either,O
catecholamine,O
on,O
IL,B
-,I
12,I
or,O
IL,B
secretion,O
were,O
blocked,O
completely,O
by,O
propranolol,O
",",O
a,O
beta,B
-,I
adrenoreceptor,I
antagonist,I
",",O
indicating,O
that,O
they,O
were,O
mediated,O
by,O
the,O
beta,B
-,I
adrenergic,I
receptor,I
.,O
These,O
findings,O
suggest,O
that,O
the,O
central,O
nervous,O
system,O
may,O
regulate,O
IL,B
-,I
12,I
and,O
IL,B
-,I
10,I
secretion,O
and,O
",",O
hence,O
",",O
TH1,O
/,O
TH2,O
balance,O
via,O
the,O
peripheral,O
end,O
-,O
effectors,O
of,O
the,O
stress,O
system,O
.,O
There,O
is,O
increasing,O
evidence,O
that,O
lipoproteins,B
of,O
Treponema,B
pallidum,I
and,O
Borrelia,B
burgdorferi,I
are,O
key,O
inflammatory,O
mediators,O
during,O
syphilis,O
and,O
Lyme,B
disease,I
.,O
Acylation,O
of,O
OspA,B
and,O
the,O
synthetic,O
peptides,O
was,O
requisite,O
for,O
cell,B
activation,O
.,O
Polymyxin,B
B,I
abrogated,O
only,O
the,O
response,O
to,O
LPS,B
.,O
Finally,O
",",O
the,O
biological,O
relevance,O
of,O
the,O
observation,O
that,O
T,B
pallidum,O
lipoproteins,B
-,I
lipopeptides,I
induce,O
both,O
NF,B
-,I
kappa,I
B,I
and,O
cytokine,B
production,O
in,O
monocytes,B
was,O
supported,O
by,O
the,O
ability,O
of,O
the,O
synthetic,B
analogs,I
to,O
promote,O
human,B
immunodeficiency,I
virus,I
replication,O
in,O
chronically,O
infected,O
U1,B
monocytoid,I
cells,I
;,O
these,O
observations,O
also,O
suggest,O
a,O
potential,O
mechanism,O
whereby,O
a,O
syphilitic,O
chancre,O
can,O
serve,O
as,O
a,O
cofactor,O
for,O
human,B
immunodeficiency,I
virus,I
transmission,O
.,O
The,O
present,O
study,O
describes,O
the,O
cloning,O
of,O
a,O
lymphoid,B
-,I
restricted,I
gene,I
",",O
LYSP100,B
",",O
that,O
is,O
homologous,O
to,O
another,O
protein,B
that,O
localizes,O
to,O
PML,B
NBs,I
",",O
SP100,B
0.28,O
We,O
term,O
the,O
LYSP100,B
structures,O
`,O
`,O
LANDs,O
",",O
',O
',O
for,O
LYSP100,B
-,O
associated,O
nuclear,O
domains,O
0.46,O
Immunoelectron,O
microscopy,O
revealed,O
LANDs,O
to,O
be,O
globular,O
",",O
electron,O
-,O
dense,O
structures,O
morphologically,O
distinct,O
from,O
the,O
annular,O
structures,O
characteristic,O
of,O
PML,B
NBs,I
0.69,O
Transcriptional,O
control,O
of,O
steroid,B
-,I
regulated,I
apoptosis,I
in,O
murine,O
thymoma,O
cells,O
.,O
Early,O
studies,O
in,O
murine,O
T,B
cell,I
lines,I
indicated,O
that,O
transcriptional,O
transactivation,O
functions,O
encoded,O
in,O
the,O
glucocorticoid,B
receptor,I
(,O
GR,B
),O
N,O
-,O
terminal,O
domain,O
are,O
required,O
for,O
glucocorticoid,B
-,I
mediated,I
apoptosis,I
.,O
To,O
better,O
understand,O
the,O
contribution,O
of,O
the,O
GR,B
N,O
-,O
terminal,O
transactivation,O
domain,O
in,O
mediating,O
murine,O
thymocyte,O
apoptosis,O
",",O
we,O
stably,O
transfected,O
GR,B
",",O
GR,B
variants,I
",",O
and,O
the,O
androgen,B
receptor,I
(,O
AR,B
),O
into,O
receptor,O
-,O
negative,O
S49,B
murine,O
thymoma,O
cells,O
.,O
One,O
p21ras,B
effector,I
pathway,I
involves,O
the,O
MAP,B
kinase,I
ERK,I
-,I
2,I
",",O
and,O
we,O
have,O
examined,O
its,O
role,O
in,O
NFAT,B
regulation,O
.,O
In,O
vivo,O
differentiation,O
therapy,O
with,O
retinoids,O
in,O
APL,B
patients,O
follows,O
strict,O
guidelines,O
related,O
both,O
to,O
the,O
APL,B
cell,I
and,O
the,O
biodisposal,O
of,O
all,O
-,O
trans,O
retinoic,O
acid,O
.,O
IL,B
-,I
2,I
-,I
",",O
IL,B
-,I
12,I
-,I
",",O
and,O
IFN,B
-,I
alpha,I
-,I
mediated,O
signaling,O
pathways,O
were,O
analyzed,O
in,O
primary,O
NK,B
cells,I
and,O
in,O
the,O
NK3,B
.,O
3,O
cell,B
line,I
.,O
Gel,O
mobility,O
shift,O
and,O
immunoprecipitation,O
analyses,O
revealed,O
that,O
in,O
addition,O
to,O
activating,O
STAT3,B
(,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
-,O
3,O
),O
and,O
STAT5,B
",",O
IL,O
-,O
2,O
induced,O
tyrosine,O
and,O
serine,O
phosphorylation,O
of,O
STAT1,B
alpha,I
",",O
which,O
formed,O
IFN,B
-,I
gamma,I
-,I
activated,I
sequence,I
-,I
binding,I
complexes,I
by,O
itself,O
and,O
with,O
STAT3,B
.,O
Although,O
IL,B
-,I
2,I
and,O
IFN,B
-,I
alpha,I
activated,O
STAT1,B
alpha,I
and,O
STAT5,B
",",O
IL,B
-,I
2,I
predominantly,O
activated,O
STAT5,B
",",O
while,O
IFN,B
-,I
alpha,I
predominantly,O
activated,O
STAT1,B
alpha,I
.,O
STAT1,B
alpha,I
activation,O
by,O
IL,B
-,I
12,I
correlated,O
with,O
increased,O
phosphorylation,O
of,O
serine,O
",",O
but,O
not,O
tyrosine,O
.,O
Direct,O
evidence,O
that,O
N,B
-,I
acetylcysteine,I
(,O
NAC,B
),O
enhances,O
the,O
immune,O
response,O
of,O
peripheral,O
blood,O
T,B
cells,I
at,O
the,O
level,O
of,O
NF,B
(,O
kappa,I
),O
B,I
is,O
presented,O
.,O
In,O
addition,O
",",O
NAC,B
blocks,O
the,O
suppression,O
of,O
T,B
cell,I
mitogenesis,I
and,O
cytokine,O
production,O
by,O
protease,O
inhibitors,O
such,O
as,O
N,B
-,I
tosylphenylalanine,I
chloromethyl,I
ketone,I
(,O
TPCK,B
),O
.,O
Strikingly,O
",",O
the,O
immunosuppressive,O
effects,O
of,O
TPCK,B
are,O
blocked,O
when,O
T,B
cells,I
are,O
pretreated,O
for,O
15,O
min,O
with,O
5,O
mM,O
NAC,B
.,O
Our,O
data,O
support,O
the,O
notion,O
that,O
NF,B
(,O
kappa,I
),O
B,I
and,O
I,B
(,O
kappa,I
),O
B,I
proteases,O
play,O
obligate,O
roles,O
in,O
T,B
cell,I
activation,I
and,O
mitogenesis,I
",",O
roles,O
that,O
are,O
enhanced,O
significantly,O
by,O
NAC,B
.,O
Recently,O
it,O
has,O
become,O
clear,O
that,O
these,O
cytokines,B
activate,O
a,O
number,O
of,O
important,O
intracellular,O
signaling,O
molecules,O
",",O
including,O
the,O
Janus,B
kinases,I
JAK1,B
and,O
JAK3,B
and,O
members,O
of,O
the,O
transcription,O
factor,O
family,O
of,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
STATs,B
),O
.In,O
this,O
review,O
we,O
examine,O
the,O
structure,O
and,O
function,O
of,O
cytokine,B
receptors,I
and,O
the,O
signaling,O
pathways,O
involved,O
in,O
their,O
regulation,O
of,O
gene,O
expression,O
.,O
Retinoic,B
acid,I
(,O
RA,B
),O
and,O
1,O
",",O
25,O
alpha,O
-,O
dihydroxycholecalcif,O
(,O
VitD3,B
),O
are,O
potent,O
regulators,O
of,O
hematopoletic,O
differentiation,O
.,O
Yet,O
",",O
little,O
is,O
known,O
as,O
to,O
how,O
the,O
RA,B
and,O
VitD3,B
receptor,O
network,O
operates,O
in,O
hematopoietic,O
cells,O
",",O
and,O
whether,O
receptor,O
interactions,O
can,O
explain,O
the,O
interplay,O
between,O
the,O
RA,B
-,I
and,O
VitD3,B
-,I
signaling,O
pathways,O
during,O
differentiation,O
.,O
Therefore,O
",",O
we,O
analyzed,O
the,O
expression,O
",",O
DNA,B
binding,O
",",O
and,O
transcriptional,O
activity,O
of,O
the,O
endogenous,O
RA,B
and,O
VitD3,B
receptors,O
[,O
retinoic,B
acid,I
receptors,I
(,O
RARs,B
),O
",",O
retinoid,B
X,I
receptors,I
(,O
RXRs,B
),O
",",O
and,O
VitD3,B
receptor,O
(,O
VDR,B
),O
],O
in,O
the,O
U,O
-,O
937,O
cell,O
line,O
",",O
in,O
which,O
RA,B
and,O
VitD3,B
induce,O
distinct,O
monocytic,B
differentiation,I
pathways,I
.,O
However,O
",",O
transcriptional,O
activation,O
was,O
only,O
observed,O
from,O
a,O
VitD3,B
response,I
element,I
-,I
driven,I
reporter,I
construct,I
.,O
Also,O
",",O
VitD3,B
inhibited,O
the,O
expression,O
of,O
CD23,B
and,O
CD49f,B
",",O
characteristic,O
markers,O
of,O
retinoid,O
-,O
induced,O
U,B
-,I
937,I
cell,I
differentiation,I
.,O
Freshly,O
isolated,O
monocytes,O
expressed,O
94,O
-,O
kD,O
STAT5A,B
",",O
92,O
-,O
kD,O
STAT5B,B
",",O
and,O
an,O
80,O
-,O
kD,O
STAT5A,B
molecule,I
.,O
STAT5A,B
-,I
STAT5A,I
homodimers,O
and,O
STAT5A,B
-,I
STAT5B,I
heterodimers,O
formed,O
in,O
response,O
to,O
GM,O
-,O
CSF,O
.,O
Translocation,O
(,O
3,O
;,O
14,O
),O
(,O
q27,O
;,O
q11,O
),O
:,O
a,O
new,O
variant,O
translocation,O
in,O
a,O
patient,O
with,O
non,O
-,O
Hodgkin,O
',O
s,O
lymphoma,O
of,O
B,B
-,I
cell,I
type,I
with,O
BCL6,B
rearrangement,I
.,O
Southern,O
blot,O
analysis,O
showed,O
rearrangement,O
of,O
BCL6,B
",",O
JH,B
",",O
and,O
TCR,B
beta,I
but,O
not,O
of,O
TCR,B
delta,I
.,O
Basal,O
total,O
white,B
blood,I
cell,I
and,O
granulocyte,B
counts,I
did,O
not,O
appreciably,O
differ,O
between,O
PML,O
/,O
RARalpha,O
transgenic,O
and,O
control,O
mice,O
.,O
As,O
expected,O
",",O
nearly,O
all,O
control,O
mice,O
(,O
94,O
.,O
4,O
%,O
),O
survived,O
irradiation,O
",",O
yet,O
this,O
irradiation,O
was,O
lethal,O
to,O
45,O
.,O
8,O
%,O
of,O
PML,O
/,O
RARalpha,O
transgenic,O
mice,O
.,O
B,B
-,I
cell,I
immortalization,I
by,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,O
),O
is,O
dependent,O
on,O
permanent,O
control,O
of,O
the,O
cellular,O
processes,O
which,O
normally,O
regulate,O
cell,B
division,I
and,O
apoptosis,O
",",O
functions,O
possessed,O
by,O
p53,O
in,O
a,O
number,O
of,O
normal,O
cell,B
types,I
.,O
Latent,O
membrane,O
protein,B
1,I
and,O
",",O
to,O
a,O
lesser,O
extent,O
",",O
EBV,B
nuclear,I
antigen,I
2,I
mediated,O
the,O
increase,O
in,O
p53,B
levels,I
via,O
activation,O
of,O
the,O
NF,B
-,I
kappaB,I
transcription,I
factor,I
.,O
Tissue,O
-,O
specific,O
expression,O
of,O
interleukin,B
-,I
3,I
(,O
IL,B
-,I
3,I
),O
is,O
mediated,O
via,O
cis,O
-,O
acting,O
elements,O
located,O
within,O
315,O
base,O
pairs,O
of,O
the,O
transcription,O
start,O
.,O
In,O
addition,O
to,O
the,O
already,O
identified,O
NIP,B
repressor,I
site,I
",",O
evidence,O
is,O
presented,O
for,O
a,O
second,O
repressor,O
region,O
that,O
restricts,O
promoter,O
activity,O
in,O
fibroblasts,O
.,O
In,O
the,O
current,O
studies,O
",",O
IL,B
-,I
2,I
production,O
by,O
T,B
cells,I
from,O
elderly,O
(,O
mean,O
78,O
years,O
),O
and,O
young,O
(,O
mean,O
37,O
years,O
),O
humans,O
was,O
measured,O
in,O
cultures,O
stimulated,O
with,O
PHA,O
",",O
PHA,O
plus,O
PMA,O
",",O
crosslinked,O
anti,O
-,O
CD3,B
mAB,I
OKT3,I
plus,O
PMA,O
",",O
or,O
PMA,O
plus,O
ionomycin,O
.,O
By,O
contrast,O
",",O
T,B
cells,I
from,O
elderly,O
subjects,O
with,O
normal,O
levels,O
of,O
IL,B
-,I
2,I
production,O
exhibited,O
normal,O
activation,O
of,O
AP,B
-,I
1,I
and,O
NF,B
-,I
AT,I
.,O
IL,B
-,I
13,I
caused,O
rapid,O
phosphorylation,O
of,O
the,O
three,O
out,O
of,O
four,O
members,O
of,O
the,O
known,O
Janus,B
family,I
of,I
kinases,I
(,O
JAKs,B
),O
.,O
IL,B
-,I
4,I
also,O
stimulated,O
all,O
three,O
kinases,I
and,O
substrates,O
",",O
but,O
unlike,O
in,O
immune,O
cells,O
",",O
IL,B
-,I
4,I
did,O
not,O
involve,O
JAK3,B
activation,O
for,O
its,O
signaling,O
in,O
colon,O
cancer,O
cell,B
lines,I
.,O
Furthermore,O
",",O
JAK2,B
associated,O
with,O
the,O
IL,B
-,I
4R,I
p140,I
before,O
and,O
after,O
stimulation,O
with,O
IL,B
-,I
13,I
.,O
Differential,O
regulation,O
of,O
IL,B
-,I
6,I
gene,I
transcription,O
and,O
expression,O
by,O
IL,B
-,I
4,I
and,O
IL,B
-,I
10,I
in,O
human,O
monocytic,B
cell,I
lines,I
.,O
To,O
investigate,O
the,O
molecular,O
mechanism,O
of,O
the,O
inhibitory,O
effect,O
on,O
transcriptional,O
or,O
post,O
-,O
transcriptional,O
regulation,O
of,O
IL,B
-,I
6,I
gene,I
expression,O
by,O
IL,B
-,I
4,I
and,O
IL,B
-,I
10,I
",",O
we,O
studied,O
IL,B
-,I
6,I
production,O
",",O
expression,O
level,O
of,O
IL,B
-,I
6,I
mRNA,I
",",O
IL,B
-,I
6,I
promoter,I
activity,O
",",O
transcriptional,O
activity,O
of,O
NF,B
-,I
kappaB,I
and,O
NF,B
-,I
IL,B
-,I
6,I
",",O
and,O
IL,B
-,I
6,I
mRNA,I
stability,O
in,O
human,O
monocytic,B
cell,I
lines,I
",",O
THP,B
-,I
1,I
and,O
U937,B
",",O
stimulated,O
by,O
PMA,B
and,O
LPS,B
in,O
the,O
absence,O
or,O
the,O
presence,O
of,O
IL,B
-,I
4,I
or,O
IL,B
-,I
10,I
.,O
In,O
chloramphenicol,B
acetyltransferase,I
assays,O
",",O
utilizing,O
the,O
transient,O
transfection,O
of,O
a,O
chloramphenicol,B
acetyltransferase,I
reporter,I
plasmid,I
containing,O
the,O
IL,B
-,I
6,I
gene,I
promoter,I
",",O
IL,B
-,I
4,I
",",O
but,O
not,O
IL,B
-,I
10,I
",",O
suppressed,O
the,O
transcriptional,O
activity,O
of,O
the,O
IL,B
-,I
6,I
gene,I
promoter,I
stimulated,O
by,O
PMA,O
and,O
LPS,O
. On,O
the,O
other,O
hand,O
",",O
IL,B
-,I
10,I
enhanced,O
the,O
degradation,O
of,O
IL,B
-,I
6,I
mRNA,I
in,O
a,O
mRNA,I
stability,I
assay,O
.,O
These,O
results,O
suggest,O
that,O
IL,B
-,I
may,O
inhibit,O
the,O
transcription,O
of,O
the,O
IL,B
gene,I
by,O
affecting,O
NF,B
-,I
kappaB,I
binding,I
activity,I
",",O
while,O
IL,B
may,O
inhibit,O
the,O
IL,B
mRNA,I
levels,I
post,O
-,O
transcriptionally,O
",",O
without,O
suppressing,O
promoter,O
activity,O
.,O
IL,B
-,I
2,I
production,O
by,O
CsA,O
-,O
treated,O
cells,O
is,O
therefore,O
dramatically,O
reduced,O
.,O
Electrophoretic,O
mobility,O
shift,O
assay,O
showed,O
the,O
induction,O
of,O
a,O
CsA,B
-,I
resistant,I
NFAT,B
complex,I
in,O
the,O
nuclear,O
extracts,O
of,O
peripheral,O
blood,O
T,B
cells,I
stimulated,O
with,O
PMA,O
plus,O
alphaCD28,O
.,O
Deactivation,O
of,O
mononuclear,O
phagocytes,O
is,O
critical,O
to,O
limit,O
the,O
inflammatory,O
response,O
but,O
can,O
be,O
detrimental,O
in,O
the,O
face,O
of,O
progressive,O
infection,O
.,O
We,O
compared,O
the,O
effects,O
of,O
the,O
deactivating,O
cytokine,O
interleukin,B
10,I
(,O
IL,B
-,I
10,I
),O
on,O
human,B
peripheral,I
blood,I
mononuclear,I
cell,I
(,O
PBMC,B
),O
responses,O
to,O
lipopolysaccharide,O
(,O
LPS,B
),O
",",O
Cryptococcus,B
neoformans,I
",",O
and,O
Candida,B
albicans,I
.,O
Characterization,O
and,O
purification,O
of,O
a,O
protein,B
kinase,I
C,I
substrate,I
in,O
human,B
B,I
cells,I
.,O
These,O
findings,O
",",O
therefore,O
",",O
could,O
have,O
clinical,O
significance,O
to,O
AIDS,O
patients,O
with,O
malignancies,O
who,O
are,O
undergoing,O
radiotherapy,O
and,O
chemotherapy,O
.,O
To,O
determine,O
whether,O
the,O
IL,B
-,I
10R,I
has,O
signaling,O
functions,O
similar,O
to,O
IL,B
-,I
6R,I
in,O
cells,O
normally,O
expressing,O
these,O
receptors,O
",",O
leukocytes,O
of,O
the,O
B,B
-,I
",",I
T,B
-,I
",",I
and,O
NK,B
-,I
cell,I
lineages,I
were,O
treated,O
with,O
either,O
cytokine,O
.,O
The,O
IL,B
-,I
10R,I
",",O
together,O
with,O
reporter,O
gene,O
constructs,O
containing,O
different,O
IL,B
-,I
6,I
-,I
responsive,I
gene,I
elements,I
",",O
reconstituted,O
in,O
hepatoma,O
cells,O
an,O
induction,O
of,O
transcription,O
by,O
IL,B
-,I
10,I
that,O
was,O
comparable,O
to,O
that,O
by,O
IL,B
-,I
6,I
.,O
These,O
receptor,O
functions,O
required,O
the,O
presence,O
of,O
the,O
box,O
3,O
motifs,O
",",O
as,O
shown,O
by,O
the,O
analysis,O
of,O
the,O
mouse,O
IL,B
-,I
10R,I
constructs,O
containing,O
progressively,O
truncated,O
cytoplasmic,O
domains,O
.,O
These,O
results,O
suggest,O
that,O
both,O
common,O
mechanisms,O
",",O
such,O
as,O
the,O
one,O
mediated,O
by,O
the,O
CIITA,B
trans,I
-,I
activator,I
",",O
and,O
distinct,O
tissue,O
-,O
specific,O
constraints,O
contribute,O
to,O
the,O
transcriptional,O
control,O
of,O
constitutive,O
and,O
IFN,O
-,O
gamma,O
-,O
induced,O
MHC,B
class,I
II,I
gene,I
expression,I
.,O
E3330,O
inhibited,O
this,O
induced,O
promoter,O
activity,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
.,O
There,O
are,O
four,O
putative,O
NF,B
-,I
kappa,I
B,I
binding,I
sites,I
(,O
kappa,B
B,I
-,I
1,I
",",O
kappa,B
B,I
-,I
2,I
",",O
kappa,B
B,I
-,I
3,I
",",O
kappa,B
B,I
-,I
4,I
),O
in,O
human,O
TNF,B
-,I
alpha,I
promoter,I
.,O
In,O
this,O
study,O
we,O
have,O
analysed,O
the,O
structural,O
requirements,O
for,O
transcriptional,O
activation,O
by,O
BSAP,O
.,O
We,O
have,O
demonstrated,O
that,O
the,O
level,O
of,O
CRE,B
binding,I
protein,I
(,O
CREB,B
),O
was,O
the,O
same,O
in,O
all,O
cell,B
lines,I
and,O
that,O
the,O
putative,O
AR,B
-,I
CRE,I
forms,O
specific,O
and,O
compatible,O
protein,O
interactions,O
with,O
CREB,B
.,O
Structural,O
and,O
functional,O
characterization,O
of,O
the,O
human,O
CD36,B
gene,I
promoter,I
:,O
identification,O
of,O
a,O
proximal,O
PEBP2,B
/,I
CBF,I
site,O
.,O
In,O
these,O
cells,O
",",O
CD36,B
is,O
involved,O
in,O
phagocytosis,O
of,O
apoptotic,O
cells,O
",",O
and,O
foam,O
cell,O
formation,O
by,O
uptake,O
of,O
oxidized,O
low,O
density,O
lipoprotein,O
.,O
Biochemical,O
analysis,O
of,O
the,O
region,O
-,O
158,O
/,O
-,O
90,O
revealed,O
a,O
binding,O
site,O
for,O
transcription,O
factors,O
of,O
the,O
polyomavirus,O
enhancer,O
-,O
binding,O
protein,O
2,O
/,O
core,O
-,O
binding,O
factor,O
(,O
PEBP2,B
/,I
CBF,I
),O
family,O
at,O
position,O
-,O
103,O
.,O
Disruption,O
of,O
the,O
PEBP2,B
/,I
CBF,I
site,O
markedly,O
diminished,O
the,O
role,O
of,O
the,O
PEBP2,B
/,I
CBF,I
factors,O
in,O
the,O
constitutive,O
transcription,O
of,O
the,O
CD36,B
gene,I
.,O
The,O
association,O
of,O
specific,O
HLA,B
-,I
DQ,I
alleles,O
with,O
autoimmunity,O
is,O
correlated,O
with,O
discrete,O
polymorphisms,O
in,O
the,O
HLA,B
-,I
DQ,I
sequence,O
that,O
are,O
localized,O
within,O
sites,O
suitable,O
for,O
peptide,O
recognition,O
.,O
Appearance,O
of,O
the,O
STAT1,B
factor,I
is,O
significantly,O
reduced,O
in,O
the,O
presence,O
of,O
cyclosporin,O
A,O
",",O
and,O
blocked,O
by,O
cycloheximide,O
",",O
indicating,O
that,O
its,O
activation,O
is,O
dependent,O
upon,O
a,O
protein,B
(,O
s,O
),O
synthesized,O
in,O
response,O
to,O
initial,O
signaling,O
events,O
.,O
Neutralizing,O
antiserum,O
against,O
IFN,B
-,I
gamma,I
",",O
but,O
not,O
other,O
cytokines,O
tested,O
",",O
blocked,O
activation,O
of,O
the,O
factor,O
almost,O
completely,O
",",O
and,O
IFN,B
-,I
gamma,I
was,O
found,O
in,O
the,O
culture,O
supernatants,O
of,O
stimulated,O
cells,O
at,O
levels,O
at,O
which,O
recombinant,O
IFN,B
-,I
gamma,I
could,O
activate,O
the,O
factor,O
in,O
naive,O
cells,O
.,O
Therefore,O
",",O
a,O
STAT1,B
transcription,I
factor,I
is,O
activated,O
by,O
IFN,B
-,I
gamma,I
synthesized,O
and,O
released,O
upon,O
stimulation,O
of,O
T,B
lymphocyte,I
populations,O
.,O
While,O
Jurkat,B
cells,I
both,O
secrete,O
and,O
respond,O
to,O
IFN,B
-,I
gamma,I
in,O
an,O
autocrine,O
loop,O
",",O
it,O
seems,O
likely,O
that,O
the,O
responding,O
cells,O
may,O
differ,O
from,O
those,O
synthesizing,O
this,O
cytokine,O
in,O
the,O
mononuclear,O
cell,O
cultures,O
in,O
the,O
light,O
of,O
the,O
recent,O
report,O
that,O
Th1,B
cells,I
lack,O
the,O
IFN,B
-,I
gamma,I
receptor,I
chain,I
necessary,O
for,O
activation,O
of,O
STAT1,B
(,O
Pernis,O
",",O
A,O
.,O
",",O
Gupta,O
",",O
S,O
.,O
",",O
Gollob,O
",",O
K,O
.,O
J,O
.,O
",",O
Garfein,O
",",O
E,O
.,O
",",O
Coffman,O
",",O
R,O
.,O
L,O
.,O
",",O
Schindler,O
",",O
C,O
.,O
",",O
and,O
Rothman,O
",",O
P,O
.,O
",",O
Science,O
1995,O
.,O
269,O
:,O
245,O
),O
.,O
Based,O
on,O
the,O
presence,O
of,O
T,B
cell,I
receptor,I
-,I
beta,I
(,O
TcR,B
-,I
beta,I
),O
gene,O
rearrangements,O
in,O
L428,O
and,O
HDLM,O
-,O
1,O
cells,O
",",O
the,O
expression,O
of,O
CD2,O
in,O
HDLM,O
-,O
1,O
cells,O
",",O
and,O
the,O
presence,O
of,O
immunoglobulin,B
heavy,I
-,I
chain,I
(,I
IgH,I
),O
gene,O
rearrangement,O
in,O
KM,O
-,O
H2,O
cells,O
",",O
some,O
researchers,O
have,O
concluded,O
that,O
these,O
long,O
-,O
term,O
cell,O
lines,O
derived,O
from,O
patients,O
with,O
Hodgkin,O
',O
s,O
disease,O
are,O
lymphoid,O
in,O
nature,O
.,O
Expression,O
of,O
the,O
MAP,B
kinase,I
-,I
specific,I
phosphatase,I
",",O
MKP,B
-,I
1,I
",",O
which,O
blocks,O
ERK,B
activation,I
",",O
inhibited,O
IL,B
-,I
2,I
promoter,I
and,O
NF,B
-,I
AT,I
-,I
driven,I
transcription,I
stimulated,O
by,O
a,O
calcium,B
ionophore,I
and,O
PMA,B
",",O
and,O
in,O
addition,O
",",O
MKP,B
-,I
1,I
neutralized,O
the,O
transcriptional,B
enhancement,I
caused,O
by,O
active,O
Raf,B
-,I
1,I
and,O
MEK1,B
expression,I
.,O
Although,O
GM,B
-,I
CSF,I
does,O
not,O
appear,O
to,O
be,O
essential,O
for,O
normal,O
hemopoiesis,O
",",O
overexpression,O
of,O
GM,B
-,I
CSF,I
has,O
been,O
implicated,O
in,O
the,O
pathogenesis,O
of,O
some,O
diseases,O
such,O
as,O
myeloid,B
leukemia,I
and,O
chronic,B
inflammation,I
.,O
We,O
investigated,O
oligonucleotide,O
-,O
directed,O
triple,O
helix,O
formation,O
across,O
this,O
regulatory,O
sequence,O
as,O
a,O
potential,O
tool,O
to,O
inhibit,O
GM,B
-,I
CSF,I
gene,I
transcription,I
.,O
Triplex,O
formation,O
by,O
GM3,B
blocked,O
recombinant,O
and,O
nuclear,O
NF,B
-,I
kappaB,I
proteins,I
binding,O
to,O
the,O
GM,B
-,I
CSF,I
element,I
.,O
Finally,O
",",O
GM3,B
greatly,O
reduced,O
the,O
concentration,O
of,O
endogenous,O
GM,B
-,I
CSF,I
mRNA,I
induced,O
by,O
different,O
stimuli,O
in,O
Jurkat,B
T,I
cells,I
but,O
did,O
not,O
affect,O
interleukin,B
3,I
mRNA,I
levels,O
in,O
the,O
same,O
cells,I
.,O
We,O
conclude,O
that,O
the,O
kappaB,B
element,I
in,O
the,O
GM,B
-,I
CSF,I
promoter,I
plays,O
a,O
central,O
role,O
in,O
the,O
transcriptional,O
activation,O
of,O
the,O
endogenous,O
GM,B
-,I
CSF,I
gene,I
.,O
Colinear,O
triplex,O
formation,O
acts,O
as,O
a,O
selective,O
transcriptional,O
repressor,O
of,O
the,O
GM,B
-,I
CSF,I
gene,O
and,O
may,O
have,O
potential,O
therapeutic,O
application,O
in,O
cases,O
of,O
undesirable,O
overexpression,O
of,O
this,O
protein,B
.,O
ML,O
-,O
9,O
induced,O
nitroblue,O
tetrazolium,O
(,O
NBT,B
),O
-,O
reducing,O
activity,O
of,O
U937,B
cell,I
more,O
rapidly,O
than,O
VD3,B
:,O
This,O
differentiation,O
marker,O
was,O
induced,O
significantly,O
after,O
incubation,O
with,O
ML,O
-,O
9,O
and,O
VD3,B
for,O
4,O
hours,O
and,O
1,O
day,O
",",O
respectively,O
.,O
These,O
results,O
suggest,O
that,O
ML,B
-,I
9,I
should,O
be,O
useful,O
for,O
studying,O
the,O
mechanisms,O
of,O
monocytic,B
differentiation,I
.,O
Modulation,O
of,O
endogenous,O
IL,B
-,I
1,I
beta,I
and,O
IL,B
-,I
1,I
receptor,I
antagonist,I
results,O
in,O
opposing,O
effects,O
on,O
HIV,B
expression,I
in,O
chronically,O
infected,O
monocytic,B
cells,I
.,O
The,O
present,O
study,O
examines,O
the,O
mechanisms,O
involved,O
in,O
LPS,B
-,I
mediated,I
induction,I
of,O
HIV,B
expression,I
in,O
U1,B
cells,I
",",O
a,O
promonocytic,B
cell,I
line,I
chronically,O
infected,O
with,O
HIV,B
.,O
Costimulation,O
of,O
U1,B
cells,I
with,O
LPS,O
plus,O
GM,O
-,O
CSF,O
resulted,O
in,O
the,O
accumulation,O
of,O
steady,O
-,O
state,O
levels,O
of,O
HIV,B
RNA,I
;,O
however,O
",",O
only,O
a,O
weak,O
induction,O
of,O
HIV,B
long,I
terminal,I
repeat,I
-,I
driven,I
transcription,I
",",O
which,O
was,O
not,O
associated,O
with,O
the,O
activation,O
of,O
the,O
cellular,O
transcription,O
factor,O
nuclear,O
factor,O
-,O
kappa,O
B,O
",",O
was,O
noted,O
.,O
IL,B
-,I
12,I
is,O
a,O
novel,O
heterodimeric,O
cytokine,O
important,O
for,O
the,O
regulation,O
and,O
differentiation,O
of,O
lymphocytes,B
and,O
NK,B
cells,I
.,O
Using,O
these,O
T,B
cells,I
as,O
a,O
model,O
of,O
IL,B
-,I
12,I
signal,O
transduction,O
",",O
we,O
confirmed,O
that,O
these,O
events,O
involve,O
members,O
of,O
the,O
Janus,B
kinase,I
family,I
of,O
nonreceptor,O
tyrosine,O
kinases,O
JAK2,B
",",O
TYK2,B
",",O
and,O
signal,B
transducer,I
and,I
activator,I
of,I
transcription,I
4,I
.,O
These,O
mechanisms,O
include,O
the,O
assembly,O
of,O
higher,O
order,O
nucleoprotein,B
complexes,I
and,O
other,O
protein,B
-,I
protein,I
interactions,O
that,O
enhance,O
the,O
functional,O
specificity,O
of,O
transcriptional,O
regulators,O
in,O
lymphocytes,B
.,O
Patients,O
with,O
HIV,O
infections,O
often,O
show,O
elevated,O
circulating,O
levels,O
of,O
cortisol,B
",",O
suggesting,O
some,O
misfunction,O
in,O
the,O
regulatory,O
systems,O
that,O
maintain,O
the,O
levels,O
of,O
this,O
critical,O
hormone,O
.,O
At,O
the,O
cellular,O
level,O
",",O
it,O
is,O
known,O
that,O
both,O
acute,O
HIV,B
infection,I
and,O
glucocorticoids,O
can,O
cause,O
apoptotic,O
cell,O
death,O
in,O
thymic,O
lymphocytes,O
.,O
In,O
vitro,O
",",O
chronically,O
HIV,B
-,I
infected,I
cells,I
of,O
the,O
lymphoid,O
CEM,B
line,I
displayed,O
resistance,O
to,O
glucocorticoid,O
-,O
induced,O
apoptosis,O
.,O
Thus,O
it,O
appears,O
that,O
there,O
may,O
often,O
be,O
malfunction,O
of,O
the,O
normal,O
glucocorticoid,O
response,O
in,O
HIV,B
-,I
infected,I
cells,I
probably,O
due,O
to,O
altered,O
interactions,O
between,O
the,O
glucocorticoid,O
receptor,O
and,O
its,O
hormone,O
.,O
Nuclei,O
of,O
unstimulated,O
PBL,B
from,O
different,O
donors,O
expressed,O
p62c,B
-,I
fos,I
and,O
p39c,B
-,I
jun,I
",",O
but,O
AP,B
-,I
1,I
was,O
not,O
detected,O
in,O
the,O
majority,O
of,O
samples,O
.,O
Following,O
PHA,B
stimulation,O
of,O
PBL,B
",",O
the,O
increase,O
in,O
AP,B
-,I
1,I
activity,O
was,O
delayed,O
with,O
respect,O
to,O
the,O
augmentation,O
of,O
p39c,B
-,I
jun,I
expression,O
.,O
However,O
",",O
no,O
cytoplasmic,O
p62c,B
-,I
fos,I
was,O
detected,O
in,O
unstimulated,O
PBL,B
",",O
although,O
in,O
some,O
cases,O
cytoplasmic,O
p39c,B
-,I
jun,I
was,O
detected,O
",",O
suggesting,O
that,O
subcellular,O
compartmentalization,O
of,O
these,O
proteins,O
may,O
occur,O
under,O
certain,O
circumstances,O
.,O
However,O
",",O
the,O
inducible,O
degradation,O
of,O
p105,B
is,O
not,O
coupled,O
with,O
the,O
generation,O
of,O
p50,B
.,O
Together,O
",",O
these,O
studies,O
demonstrate,O
that,O
the,O
processing,O
and,O
inducible,O
degradation,O
of,O
p105,B
are,O
differentially,O
regulated,O
.,O
However,O
",",O
synthesis,O
of,O
the,O
26,O
-,O
kDa,O
membrane,O
form,O
of,O
TNF,B
was,O
effectively,O
blocked,O
by,O
CNI,O
-,O
1493,O
.,O
r,O
-,O
hTBP,B
-,I
1,I
and,O
rhu,O
TNFR,B
:,O
Fc,I
also,O
decreased,O
p24,O
antigen,O
synthesized,O
by,O
U1,B
cells,I
in,O
response,O
to,O
other,O
stimuli,O
",",O
including,O
phytohemagglutinin,O
(,O
PHA,B
),O
-,O
induced,O
supernatant,O
",",O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
",",O
interleukin,B
-,I
6,I
",",O
and,O
TNF,B
.,O
Addition,O
of,O
r,O
-,O
hTBP,B
-,I
1,I
to,O
U1,B
cells,I
during,O
the,O
last,O
4,O
h,O
of,O
a,O
24,O
h,O
incubation,O
with,O
PMA,O
still,O
inhibited,O
p24,O
antigen,O
production,O
by,O
15,O
%,O
.,O
r,O
-,O
hTBP,B
-,I
1,O
also,O
partially,O
reversed,O
inhibition,O
of,O
U1,B
cellular,I
proliferation,I
caused,O
by,O
PMA,O
.,O
Transcriptional,O
activation,O
of,O
RNA,B
polymerase,I
III,I
-,I
dependent,I
genes,I
by,O
the,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
1,I
tax,I
protein,I
.,O
The,O
viral,O
protein,B
Tax,I
was,O
likely,O
responsible,O
for,O
this,O
higher,O
level,O
of,O
class,O
II,O
gene,O
transcription,O
",",O
as,O
purified,O
Tax,B
was,O
found,O
to,O
stimulate,O
both,O
genes,O
when,O
added,O
to,O
the,O
uninfected,O
cell,O
extract,O
or,O
in,O
reconstituted,O
systems,O
.,O
Expression,O
of,O
Retinoid,B
X,I
Receptor,I
alpha,I
is,O
increased,O
upon,O
monocytic,B
cell,I
differentiation,I
.,O
Efficient,O
gene,O
activation,O
requires,O
the,O
heterodimerization,O
of,O
VDR,B
with,O
Retinoid,B
X,I
Receptors,I
(,O
RXR,B
),O
.,O
Combinations,O
of,O
all,O
-,O
trans,O
retinoic,O
acid,O
(,O
RA,B
),O
and,O
VD,B
",",O
in,O
some,O
cases,O
",",O
increased,O
this,O
effect,O
.,O
We,O
have,O
generated,O
rabbit,O
antisera,O
against,O
this,O
putative,O
p13MTCP1,B
protein,I
and,O
screened,O
for,O
expression,O
of,O
p13MTCP1,B
normal,O
lymphoid,B
tissues,I
and,O
33,O
cases,O
of,O
immature,B
and,O
mature,O
lymphoid,B
T,I
-,I
cell,I
proliferations,I
using,O
a,O
sensitive,O
Western,O
blot,O
assay,O
.,O
The,O
p13MTCP1,B
protein,I
was,O
detected,O
in,O
the,O
three,O
T,B
-,I
cell,I
proliferations,I
with,O
MTCP1,O
rearrangements,O
because,O
of,O
t,O
(,O
X,O
;,O
14,O
),O
translocations,O
",",O
but,O
neither,O
in,O
normal,O
resting,O
and,O
activated,O
lymphocytes,O
nor,O
in,O
the,O
other,O
T,B
-,I
cell,I
leukemias,I
.,O
A,O
variety,O
of,O
cytokines,O
and,O
growth,O
factors,O
act,O
through,O
an,O
induction,O
of,O
gene,O
expression,O
mediated,O
by,O
a,O
family,O
of,O
latent,O
transcription,O
factors,O
called,O
STAT,B
(,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
),O
proteins,O
.,O
Electrophoretic,O
mobility,O
shift,O
assays,O
(,O
EMSAs,O
),O
demonstrated,O
that,O
unstimulated,O
monocytes,O
predominantly,O
expressed,O
p50,B
NF,I
-,I
kappa,I
B,I
.,O
However,O
",",O
the,O
combined,O
stimulation,O
did,O
not,O
result,O
in,O
enhanced,O
p50,B
and,O
p65,B
protein,I
expression,O
.,O
The,O
effects,O
of,O
IFN,O
-,O
gamma,O
on,O
the,O
transcription,O
factors,O
were,O
specific,O
",",O
since,O
no,O
change,O
was,O
observed,O
in,O
the,O
expression,O
of,O
NF,B
-,I
IL,I
-,I
6,I
or,O
I,B
kappa,I
B,I
alpha,I
",",O
the,O
inhibitor,O
of,O
NF,B
-,I
kappa,I
B,I
.,O
We,O
conclude,O
that,O
the,O
effects,O
of,O
IFN,B
-,I
gamma,I
on,O
the,O
expression,O
of,O
the,O
transcription,O
factors,O
AP,B
-,I
1,I
and,O
NF,B
-,I
kappa,I
B,I
may,O
be,O
important,O
for,O
the,O
modulatory,O
effects,O
of,O
IFN,B
-,I
gamma,I
on,O
the,O
cytokine,O
expression,O
in,O
activated,O
human,B
monocytes,I
.,O
The,O
expression,O
of,O
MIP,B
-,I
1,I
alpha,I
is,O
induced,O
during,O
cellular,O
activation,O
of,O
CD4,B
+,I
T,I
-,I
cells,I
and,O
monocytes,I
.,O
It,O
is,O
also,O
expressed,O
in,O
transformed,O
B,B
-,I
cells,I
.,O
We,O
have,O
previously,O
identified,O
a,O
new,O
transcription,O
factor,O
family,O
(,O
the,O
MNP,B
family,I
),O
whose,O
expression,O
is,O
crucial,O
for,O
the,O
induction,O
of,O
MIP,O
-,O
1,O
alpha,O
transcription,O
during,O
cellular,O
activation,O
and,O
in,O
transformed,O
B,B
cells,I
.,O
In,O
this,O
report,O
we,O
show,O
induction,O
of,O
MNP,B
-,I
1,I
in,O
Jurkat,B
T,I
-,I
cells,I
expressing,O
HIV,O
-,O
1,O
tat,O
.,O
Differentiation,O
of,O
T,B
-,I
helper,I
lymphocytes,I
:,O
selective,O
regulation,O
by,O
members,O
of,O
the,O
STAT,B
family,I
of,I
transcription,I
factors,I
.,O
Specific,O
docking,O
sites,O
within,O
individual,O
cytokine,B
receptors,I
have,O
been,O
identified,O
for,O
almost,O
all,O
Stat,B
proteins,I
.,O
The,O
direct,O
coupling,O
between,O
cytokine,B
receptor,I
and,O
transcription,O
factor,O
helps,O
to,O
explain,O
how,O
different,O
cytokines,B
elicit,O
distinct,O
patterns,O
of,O
gene,O
expression,O
.,O
Here,O
we,O
identify,O
the,O
gene,B
encoding,O
the,O
lymphocyte,B
homing,I
and,I
migration,I
protein,I
CD44,B
as,O
a,O
target,O
of,O
EGR1,O
regulation,O
in,O
B,B
cells,I
.,O
The,O
EGR1,O
binding,O
motif,O
was,O
shown,O
to,O
be,O
necessary,O
for,O
stimulus,O
-,O
induced,O
expression,O
of,O
a,O
CD44,B
promoter,I
-,I
chloramphenicol,I
acetyltransferase,I
reporter,I
construct,I
in,O
nontransformed,O
B,B
lymphocytes,I
and,O
was,O
required,O
for,O
transactivation,O
by,O
an,O
EGR1,O
expression,O
vector,O
in,O
a,O
B,B
-,I
cell,I
line,I
.,O
These,O
studies,O
identify,O
EGR1,B
as,O
an,O
intermediary,O
linking,O
BCR,B
-,I
derived,I
signals,O
to,O
the,O
induction,O
of,O
CD44,B
.,O
In,O
Jurkat,B
cells,I
that,O
are,O
not,O
sensitive,O
to,O
H2O2,B
-,I
induced,I
NF,B
-,I
kappaB,I
activation,I
",",O
H2O2,B
potentiated,O
NF,B
-,I
kappaB,I
activation,I
in,O
the,O
presence,O
of,O
sustained,O
high,O
[,O
Ca2,B
+,I
],O
i,O
following,O
thapsigargin,O
treatment,O
.,O
A,O
mutant,O
Tax,B
protein,I
deficient,O
in,O
transactivation,O
of,O
genes,O
by,O
the,O
nuclear,B
factor,I
(,O
NF,B
),O
-,O
kappaB,I
pathway,I
was,O
unable,O
to,O
induce,O
transcriptional,O
activity,O
of,O
IL,B
-,I
1alpha,I
promoter,I
-,I
CAT,I
constructs,I
",",O
but,O
was,O
rescued,O
by,O
exogenous,O
provision,O
of,O
p65,B
/,I
p50,I
NF,I
-,I
kappaB,I
.,O
mRNA,O
for,O
c,B
-,I
fes,I
has,O
been,O
detected,O
exclusively,O
in,O
myeloid,B
cells,I
and,O
vascular,B
endothelial,I
cells,I
in,O
adult,O
mammals,O
.,O
Although,O
a,O
13,O
-,O
kilobase,O
-,O
pair,O
(,O
kb,O
),O
human,B
c,I
-,I
fes,I
transgene,O
exhibits,O
high,O
levels,O
of,O
expression,O
in,O
mice,O
",",O
the,O
sequences,O
that,O
confer,O
myeloid,B
-,I
cell,I
-,I
specific,I
expression,O
of,O
the,O
human,B
c,I
-,I
fes,I
gene,I
have,O
not,O
been,O
defined,O
.,O
However,O
",",O
the,O
first,O
two,O
footprints,O
resided,O
in,O
sequences,O
that,O
were,O
largely,O
dispensable,O
for,O
transient,O
activity,O
.,O
Electrophoretic,O
mobility,O
shift,O
analyses,O
demonstrated,O
that,O
the,O
151,O
-,O
bp,O
region,O
contains,O
nuclear,B
protein,I
binding,I
sites,I
for,O
Sp1,B
",",O
PU,B
.,O
1,O
",",O
and,O
/,O
or,O
Elf,B
-,I
1,I
",",O
and,O
a,O
novel,O
factor,O
.,O
IL,B
-,I
10,I
markedly,O
reduces,O
nuclear,B
factor,I
(,I
NF,I
),I
-,I
kappa,I
B,I
/,I
Rel,I
nuclear,I
activity,I
induced,O
in,O
PBMC,B
by,O
stimulation,O
with,O
the,O
anti,O
-,O
CD3,B
mAb,I
OKT3,I
.,O
As,O
judged,O
by,O
supershifting,O
the,O
DNA,B
-,I
protein,I
complexes,I
with,O
Abs,O
recognizing,O
specific,O
components,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
/,I
Rel,I
protein,I
family,I
",",O
the,O
p50,B
/,I
p65,I
(,O
Rel,B
A,I
),O
heterodimeric,O
form,O
of,O
NF,B
-,I
kappa,I
B,I
is,O
primarily,O
affected,O
.,O
The,O
maximal,O
effect,O
is,O
observed,O
at,O
the,O
IL,B
-,I
10,I
concentration,O
of,O
20,O
U,O
/,O
ml,O
.,O
Our,O
results,O
demonstrate,O
that,O
IL,B
-,I
10,I
can,O
inhibit,O
the,O
induction,O
of,O
NF,B
-,I
kappa,I
B,I
/,I
Rel,I
nuclear,O
activity,O
in,O
CD3,B
-,I
stimulated,I
T,I
lymphocytes,I
.,O
In,O
a,O
panel,O
of,O
32,O
B,B
-,I
cell,I
lines,I
",",O
A,O
-,O
myb,B
was,O
very,O
strongly,O
expressed,O
in,O
most,O
Burkitt,B
',I
s,I
lymphoma,I
(,O
BL,B
),O
cell,O
lines,O
",",O
but,O
weak,O
or,O
negative,O
in,O
2,O
pre,O
-,O
B,B
acute,I
lymphoblastic,I
leukemia,I
(,O
ALL,B
),O
",",O
4,O
non,O
-,O
Hodgkin,B
',I
s,I
lymphoma,I
(,O
NHL,B
),O
",",O
6,O
Epstein,B
-,I
Barr,I
virus,I
-,I
immortalized,I
lymphoblastoid,I
cell,I
lines,I
",",O
and,O
6,O
myeloma,B
lines,I
.,O
C,O
-,O
myb,B
and,O
B,O
-,O
myb,B
were,O
expressed,O
in,O
all,O
neoplastic,O
groups,O
",",O
except,O
in,O
CLL,O
cells,O
.,O
Thus,O
",",O
A,O
-,O
myb,B
expression,O
",",O
unlike,O
that,O
of,O
c,O
-,O
myb,B
and,O
B,O
-,O
myb,B
",",O
is,O
restricted,O
to,O
a,O
subset,O
of,O
B,O
-,O
cell,B
neoplasias,I
(,O
in,O
particular,O
BL,O
and,O
slg,O
+,O
B,O
-,O
ALL,O
),O
representative,O
of,O
a,O
specific,O
stage,O
of,O
B,O
-,O
cell,B
differentiation,I
.,O
Here,O
we,O
provide,O
evidence,O
that,O
this,O
transformation,O
is,O
the,O
result,O
of,O
double,O
infection,O
of,O
a,O
cell,O
with,O
two,O
virions,O
",",O
the,O
P3HR1,O
virus,O
genome,O
and,O
a,O
mini,O
-,O
EBV,B
plasmid,O
carrying,O
the,O
chimeric,O
EBNA2,B
gene,O
.,O
It,O
remains,O
open,O
whether,O
the,O
growth,O
retarding,O
property,O
of,O
the,O
EBNA2,B
-,I
oestrogen,I
receptor,I
fusion,I
protein,I
in,O
B,B
cell,I
lymphoma,I
lines,I
is,O
due,O
to,O
unphysiologically,O
high,O
expression,O
of,O
the,O
chimeric,O
protein,I
or,O
to,O
interference,O
with,O
a,O
cellular,O
programme,O
driving,O
proliferation,O
in,O
these,O
cell,O
lines,O
.,O
These,O
results,O
indicate,O
that,O
",",O
as,O
already,O
reported,O
for,O
the,O
IL2Rbeta,O
promoter,O
",",O
GA,B
-,I
binding,I
protein,I
is,O
an,O
essential,O
component,O
of,O
gammac,O
basal,O
promoter,O
activity,O
.,O
Detection,O
of,O
intracellular,O
signal,O
transduction,O
molecules,O
in,O
PBMC,O
from,O
rhesus,O
macaques,O
and,O
sooty,O
mangabeys,O
.,O
The,O
molecular,O
mechanisms,O
associated,O
with,O
the,O
T,O
-,O
cell,B
dysfunction,I
remain,O
to,O
be,O
elucidated,O
.,O
Because,O
relatively,O
little,O
is,O
known,O
about,O
these,O
events,O
in,O
nonhuman,O
primates,O
",",O
our,O
laboratory,O
defined,O
optimal,O
conditions,O
",",O
reagents,O
",",O
and,O
assays,O
for,O
the,O
study,O
of,O
signal,O
transduction,O
events,O
in,O
cells,O
from,O
nonhuman,O
primates,O
.,O
The,O
protein,B
phosphorylation,I
patterns,I
in,O
the,O
two,O
monkeys,O
exhibited,O
quantitative,O
",",O
qualitative,O
",",O
and,O
kinetic,O
differences,O
.,O
Expression,O
of,O
ATF,B
-,I
2,I
in,O
S,O
.,O
cerevisiae,O
did,O
not,O
activate,O
TRE,B
-,I
1,I
in,O
the,O
presence,O
of,O
Tax,O
.,O
This,O
shows,O
that,O
in,O
a,O
eukaryotic,O
nucleus,O
",",O
Tax,O
specifically,O
interacts,O
with,O
the,O
basic,O
domain,O
-,O
leucine,O
zipper,O
region,O
of,O
ATF,B
-,I
1,I
",",O
CREB,B
",",O
and,O
CREM,B
.,O
Trapoxin,O
is,O
a,O
microbially,O
derived,O
cyclotetrapeptide,O
that,O
inhibits,O
histone,B
deacetylation,I
in,O
vivo,O
and,O
causes,O
mammalian,O
cells,O
to,O
arrest,O
in,O
the,O
cell,B
cycle,I
.,O
The,O
mechanisms,O
by,O
which,O
these,O
promoters,O
of,O
cell,B
growth,I
exert,O
their,O
inhibitory,O
effects,O
vary,O
",",O
but,O
in,O
most,O
instances,O
they,O
involve,O
a,O
disruption,O
of,O
the,O
IFN,B
-,I
alpha,I
/,I
beta,I
-,I
induced,I
transcription,I
complex,I
ISGF3,I
such,O
that,O
the,O
DNA,B
-,I
binding,I
component,I
of,O
this,O
complex,O
(,O
the,O
48,O
-,O
kDa,O
ISGF3gamma,B
protein,I
),O
does,O
not,O
bind,O
to,O
the,O
interferon,B
-,I
stimulated,I
response,I
element,I
(,O
ISRE,O
),O
.,O
Phorbol,O
ester,O
treatment,O
of,O
monocytes,B
inhibited,O
IFN,B
alpha,I
-,I
stimulated,O
tyrosine,O
phosphorylation,O
of,O
the,O
transcription,O
factors,O
Stat1alpha,B
",",O
Stat2,B
",",O
and,O
Stat3,B
and,O
of,O
the,O
tyrosine,O
kinase,O
Tyk2,B
but,O
had,O
no,O
effect,O
on,O
IFN,B
-,I
gamma,I
activation,O
of,O
Stat1alpha,B
.,O
Pretreatment,O
of,O
cells,B
with,O
vanadate,B
prevented,O
the,O
effects,O
of,O
PMA,B
with,O
regard,O
to,O
PMA,B
-,I
induced,O
Tyk2,B
dephosphorylation,O
.,O
Interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
promoter,O
-,O
reporter,O
gene,O
behavior,O
closely,O
parallels,O
the,O
endogenous,O
gene,O
in,O
response,O
to,O
T,O
cell,O
receptor,O
and,O
costimulatory,O
signals,O
.,O
The,O
RAR,B
-,I
RXR,I
as,O
well,O
as,O
the,O
RXR,B
-,I
RXR,I
pathway,I
is,O
involved,O
in,O
signaling,O
growth,O
inhibition,O
of,O
human,O
CD34,B
+,I
erythroid,I
progenitor,I
cells,I
.,O
Previous,O
studies,O
have,O
shown,O
that,O
retinoic,O
acid,O
(,O
RA,B
),O
",",O
similar,O
to,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
(,O
TNF,B
-,I
alpha,I
),O
",",O
can,O
act,O
as,O
a,O
bifunctional,O
regulator,O
of,O
the,O
growth,O
of,O
bone,O
marrow,O
progenitors,O
",",O
in,O
that,O
it,O
can,O
stimulate,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
(,O
GM,B
-,I
CSF,I
),O
-,O
or,O
interleukin,B
-,I
3,I
(,O
IL,B
-,I
3,I
),O
-,O
induced,O
GM,B
colony,I
formation,I
",",O
but,O
potently,O
inhibit,O
G,O
-,O
CSF,O
-,O
induced,O
growth,O
.,O
Erythroid,B
colony,I
growth,I
was,O
also,O
inhibited,O
when,O
CD34,B
+,I
progenitors,I
were,O
seeded,O
at,O
one,O
cell,O
per,O
well,O
",",O
suggesting,O
a,O
direct,O
action,O
of,O
RA,B
.,O
At,O
this,O
concentration,O
",",O
Ro,B
13,I
-,I
7410,I
potently,O
inhibited,O
G,B
-,I
CSF,I
-,I
stimulated,I
myeloid,I
as,O
well,O
as,O
SCF,B
+,I
Epo,I
-,I
induced,I
erythroid,I
colony,I
growth,I
.,O
At,O
the,O
same,O
concentration,O
",",O
Ro,B
25,I
-,I
6603,I
and,O
Ro,B
25,I
-,I
7386,I
had,O
little,O
or,O
no,O
effect,O
on,O
G,B
-,I
CSF,I
-,I
induced,I
colony,I
formation,I
",",O
whereas,O
they,O
inhibited,O
75,O
%,O
and,O
53,O
%,O
",",O
respectively,O
",",O
of,O
SCF,B
+,I
Epo,I
-,I
stimulated,I
BFU,I
-,I
E,I
colony,I
growth,I
.,O
Thus,O
",",O
the,O
RAR,B
-,I
RXR,B
response,O
pathway,O
can,O
signal,O
growth,O
inhibition,O
of,O
normal,O
bone,O
marrow,O
myeloid,O
and,O
erythroid,O
progenitor,O
cells,O
.,O
After,O
treatment,O
of,O
APL,O
cells,O
with,O
AM580,O
either,O
alone,O
or,O
in,O
combination,O
with,O
granulocyte,B
colony,I
-,I
stimulating,I
factor,I
(,O
G,B
-,I
CSF,I
),O
",",O
the,O
compound,O
induces,O
granulocytic,O
maturation,O
",",O
as,O
assessed,O
by,O
determination,O
of,O
the,O
levels,O
of,O
leukocyte,B
alkaline,I
phosphatase,I
",",O
CD11b,B
",",O
CD33,B
",",O
and,O
G,B
-,I
CSF,I
receptor,I
mRNA,I
",",O
at,O
concentrations,O
that,O
are,O
10,O
-,O
to,O
100,O
-,O
fold,O
lower,O
than,O
those,O
of,O
ATRA,O
necessary,O
to,O
produce,O
similar,O
effects,O
.,O
By,O
contrast,O
",",O
AM580,B
is,O
not,O
effective,O
as,O
ATRA,B
in,O
modulating,O
the,O
expression,O
of,O
these,O
differentiation,O
markers,O
in,O
the,O
HL,B
-,I
60,I
cell,I
line,I
and,O
in,O
freshly,O
isolated,O
granulocytes,O
obtained,O
from,O
the,O
peripheral,O
blood,O
of,O
chronic,O
myelogenous,O
leukemia,O
patients,O
during,O
the,O
stable,O
phase,O
of,O
the,O
disease,O
.,O
In,O
NB4,B
cells,I
",",O
two,O
other,O
synthetic,O
nonselective,O
RAR,B
ligands,I
are,O
capable,O
of,O
inducing,O
LAP,B
as,O
much,O
as,O
AM580,B
",",O
whereas,O
RAR,B
beta,I
-,I
or,O
RAR,B
gamma,I
-,I
specific,I
ligands,I
are,O
totally,O
ineffective,O
.,O
These,O
results,O
show,O
that,O
AM580,B
is,O
more,O
powerful,O
than,O
ATRA,B
in,O
modulating,O
the,O
expression,O
of,O
differentiation,O
antigens,O
only,O
in,O
cells,O
in,O
which,O
PML,B
-,I
RAR,I
is,O
present,O
.,O
Binding,O
experiments,O
",",O
using,O
COS,O
-,O
7,O
cells,O
transiently,O
transfected,O
with,O
PML,B
-,I
RAR,I
and,O
the,O
normal,O
RAR,B
alpha,I
",",O
show,O
that,O
AM580,B
has,O
a,O
lower,O
affinity,O
than,O
ATRA,B
for,O
both,O
receptors,O
.,O
Inhibition,O
of,O
vitamin,B
D,I
receptor,I
-,I
retinoid,I
X,I
receptor,I
-,I
vitamin,I
D,I
response,I
element,I
complex,I
formation,I
by,O
nuclear,O
extracts,O
of,O
vitamin,B
D,I
-,I
resistant,I
New,I
World,I
primate,I
cells,I
.,O
Nuclear,O
and,O
post,O
-,O
nuclear,O
extracts,O
were,O
prepared,O
from,O
two,O
B,O
-,O
lymphoblastoid,O
cell,O
lines,O
known,O
to,O
be,O
representative,O
of,O
the,O
vitamin,B
D,I
-,I
resistant,I
and,O
wild,O
type,O
phenotypes,O
",",O
respectively,O
.,O
In,O
addition,O
",",O
vitamin,O
D,B
-,I
resistant,I
cell,I
nuclear,I
extract,I
contained,O
a,O
protein,B
(,O
s,O
),O
which,O
was,O
bound,O
specifically,O
to,O
the,O
VDRE,O
and,O
was,O
capable,O
of,O
completely,O
inhibiting,O
VDR,B
-,I
RXR,I
-,I
VDRE,I
complex,I
formation,I
;,O
these,O
effects,O
were,O
not,O
demonstrated,O
with,O
nuclear,O
extract,O
from,O
the,O
wild,O
type,O
cell,O
line,O
or,O
with,O
the,O
post,O
-,O
nuclear,O
extract,O
of,O
the,O
vitamin,O
D,B
-,I
resistant,I
cell,I
line,I
.,O
We,O
conclude,O
that,O
a,O
VDRE,B
-,I
binding,I
protein,I
(,O
s,O
),O
",",O
distinct,O
from,O
IDBP,O
and,O
present,O
in,O
nuclear,O
extract,O
of,O
cells,O
from,O
a,O
prototypical,O
vitamin,O
D,O
-,O
resistant,O
NWP,O
",",O
is,O
capable,O
of,O
inhibiting,O
normal,O
VDR,B
-,I
RXR,I
heterodimer,I
binding,I
to,O
the,O
VDRE,B
.,O
Finally,O
",",O
the,O
activation,O
-,O
induced,O
changes,O
in,O
one,O
set,O
of,O
phosphoproteins,B
were,O
dramatically,O
inhibited,O
by,O
cyclosporin,O
A,O
.,O
Like,O
IkappaBalpha,B
",",O
Tax,O
-,O
mediated,O
breakdown,O
of,O
IkappaBbeta,B
in,O
transfected,O
T,B
lymphocytes,I
is,O
blocked,O
either,O
by,O
cell,B
-,I
permeable,I
proteasome,I
inhibitors,I
or,O
by,O
mutation,O
Of,O
IkappaBbeta,B
at,O
two,O
serine,B
residues,I
present,O
within,O
its,O
N,B
-,I
terminal,I
region,I
.,O
Although,O
a,O
role,O
of,O
p16,B
in,O
this,O
regulation,O
has,O
been,O
presumed,O
",",O
there,O
is,O
no,O
proof,O
so,O
far,O
that,O
loss,O
of,O
this,O
tumor,B
suppressor,I
gene,I
really,O
affects,O
E2F,B
-,I
mediated,I
regulations,I
.,O
Nuclear,O
factors,O
from,O
unstimulated,O
",",O
but,O
not,O
from,O
activated,O
cells,O
",",O
bound,O
a,O
site,O
",",O
META,B
(,O
D,I
-,I
),I
",",O
adjacent,O
to,O
META,B
(,O
D,I
+,I
),I
.,O
We,O
have,O
isolated,O
a,O
novel,O
cDNA,O
clone,O
encoding,O
interferon,B
(,O
IFN,B
),I
consensus,I
sequence,I
-,I
binding,I
protein,I
in,O
adult,O
T,B
-,I
cell,I
leukemia,I
cell,I
line,I
or,O
activated,O
T,B
cells,I
(,O
ICSAT,O
),I
;,O
this,O
protein,O
is,O
the,O
human,O
homolog,O
of,O
the,O
recently,O
cloned,O
Pip,O
/,O
LSIRF,O
.,O
Here,O
",",O
we,O
describe,O
the,O
effect,O
of,O
383,O
-,O
bp,O
(,O
delta383,O
),O
and,O
99,O
-,O
bp,O
(,O
delta99,O
),O
sequences,O
containing,O
the,O
PYBF,B
-,I
binding,I
site,I
on,O
transcription,O
from,O
various,O
globin,B
and,O
non,O
-,O
globin,B
promoters,I
",",O
using,O
a,O
transient,O
assay,O
with,O
the,O
cat,O
reporter,O
gene,O
in,O
murine,B
erythroleukemia,I
(,O
MEL,B
),O
cells,O
",",O
a,O
cell,O
line,O
with,O
abundant,O
PYBF,B
activity,O
.,O
Translocation,O
breakpoints,O
in,O
three,O
patients,O
with,O
campomelic,O
dysplasia,O
and,O
autosomal,O
sex,O
reversal,O
map,O
more,O
than,O
130,O
kb,O
from,O
SOX9,B
.,O
Campomelic,O
dysplasia,O
(,O
CMPD1,O
),O
and,O
autosomal,O
XY,O
sex,O
reversal,O
(,O
SRA1,O
),O
are,O
caused,O
by,O
mutations,O
in,O
the,O
SRY,O
-,O
related,O
gene,O
SOX9,B
on,O
17q,O
.,O
Unexpectedly,O
",",O
the,O
17q,O
breakpoints,O
in,O
four,O
CMPD1,O
translocation,O
cases,O
previously,O
analyzed,O
by,O
us,O
and,O
others,O
map,O
50,O
kb,O
or,O
more,O
from,O
SOX9,B
.,O
DeltaSpi,B
-,I
B,I
product,O
was,O
not,O
able,O
to,O
bind,O
DNA,B
and,O
was,O
recovered,O
in,O
cytoplasmic,B
cellular,I
extracts,I
.,O
Both,O
CIITA,B
and,O
Bob1,O
increase,O
the,O
expression,O
from,O
the,O
DRA,O
promoter,I
",",O
which,O
is,O
a,O
prototypic,O
class,O
II,O
promoter,I
.,O
However,O
",",O
the,O
growth,O
of,O
most,O
mutated,O
viruses,O
was,O
suppressed,O
in,O
primary,O
rhesus,O
monkey,O
alveolar,O
macrophages,O
(,O
SIVmacMER,O
approximately,O
2xNFkappaB,O
approximately,O
substNFkappaB,O
>,O
deltaNFkappaB,O
>,O
deltaNFkappaB,O
deltaSpl234,O
approximately,O
deltaNFkappaBdeltaSp,O
>,O
deltaSpl234,O
approximately,O
substSpl2,O
>,O
substSp23,O
approximately,O
substSp34,O
approximately,O
substSpl234,O
>,O
or,O
=,O
SIVmac239,O
).,O
The,O
ability,O
of,O
T,B
cells,I
to,O
form,O
high,O
intracellular,O
levels,O
of,O
cAMP,B
is,O
acquired,O
during,O
development,O
in,O
the,O
human,O
thymus,O
and,O
is,O
retained,O
by,O
the,O
majority,O
of,O
mature,O
peripheral,O
T,B
lymphocytes,I
.,O
A,O
hydrophobic,O
domain,O
of,O
Ca2,B
+,I
-,I
modulating,I
cyclophilin,I
ligand,I
modulates,O
calcium,B
influx,I
signaling,I
in,O
T,B
lymphocytes,I
.,O
Ca2,B
+,I
-,I
modulating,I
cyclophilin,I
ligand,I
(,O
CAML,B
),O
was,O
originally,O
described,O
as,O
a,O
cyclophilin,I
B,I
-,I
binding,I
protein,I
whose,O
overexpression,O
in,O
T,B
cells,I
causes,O
a,O
rise,O
in,O
intracellular,O
calcium,B
",",O
thus,O
activating,O
transcription,O
factors,O
responsible,O
for,O
the,O
early,O
immune,O
response,O
.,O
The,O
Epstein,B
-,I
Barr,I
virus,I
-,I
encoded,O
nuclear,O
antigen,O
EBNA,B
-,I
5,I
accumulates,O
in,O
PML,B
-,I
containing,I
bodies,I
.,O
The,O
chromosome,O
17,O
breakpoint,O
was,O
localized,O
to,O
intron,O
2,O
of,O
RARA,B
by,O
Southern,O
blotting,O
",",O
and,O
there,O
was,O
no,O
evidence,O
at,O
the,O
molecular,O
level,O
for,O
rearrangement,O
at,O
PML,B
locus,I
.,O
Immunocytochemistry,O
identified,O
the,O
cells,O
in,O
the,O
infiltrate,O
as,O
cytotoxic,B
T,I
cells,I
.,O
In,O
these,O
same,O
animals,O
",",O
E1A,B
protein,I
was,O
detected,O
20,O
days,O
after,O
infection,O
in,O
two,O
and,O
47,O
days,O
after,O
infection,O
in,O
one,O
while,O
persistent,O
bronchiolitis,O
was,O
observed,O
in,O
four,O
and,O
three,O
animals,O
20,O
and,O
47,O
days,O
after,O
infection,O
",",O
respectively,O
.,O
Cyclic,O
AMP,B
-,I
responsive,I
element,I
-,I
dependent,I
activation,I
of,I
Epstein,B
-,I
Barr,I
virus,I
zebra,I
promoter,I
by,O
human,O
herpesvirus,O
6,O
.,O
Mutation,O
of,O
the,O
consensus,O
AP,B
-,I
1,I
/,I
CRE,I
site,I
within,O
ZII,B
abolished,O
the,O
inducibility,O
of,O
Zp,O
by,O
HHV,O
-,O
6,O
",",O
whereas,O
positioning,O
of,O
the,O
ZII,B
domain,I
upstream,O
of,O
the,O
beta,B
-,I
globin,I
minimal,I
promoter,I
conferred,O
responsiveness,O
following,O
HHV,O
-,O
6,O
infection,O
.,O
Antibodies,O
against,O
CRE,B
-,I
binding,I
(,I
CREB,I
),I
protein,I
but,O
not,O
against,O
c,O
-,O
Fos,B
or,O
c,O
-,O
Jun,B
were,O
able,O
to,O
supershift,O
the,O
DNA,B
-,I
protein,I
complex,I
",",O
identifying,O
the,O
nature,O
of,O
the,O
transcription,O
factor,O
which,O
binds,O
to,O
ZII,B
as,O
a,O
member,O
of,O
the,O
CREB,B
family,I
of,I
proteins,I
.,O
Regulation,O
of,O
the,O
nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
in,O
stably,O
transfected,O
Jurkat,B
cell,I
clones,I
.,O
Glucocorticoids,B
induced,O
down,O
-,O
regulation,O
of,O
glucocorticoid,B
receptor,I
mRNA,I
expression,I
in,O
asthma,O
.,O
The,O
lymphoid,B
-,I
specific,I
transcription,I
factor,I
Oct,B
-,I
2a,I
is,O
implicated,O
in,O
B,B
cell,I
-,I
specific,I
transcriptional,I
activity,I
via,O
the,O
octamer,O
motif,O
.,O
Structure,O
/,O
function,O
analysis,O
of,O
various,O
Oct,O
-,O
2a,O
effector,O
regions,O
in,O
the,O
context,O
of,O
the,O
GAL4,B
DNA,I
-,I
binding,I
domain,I
revealed,O
that,O
Oct,O
-,O
2a,O
contains,O
two,O
functionally,O
different,O
activation,O
domains,O
at,O
the,O
N,O
and,O
the,O
C,O
termini,O
.,O
When,O
this,O
domain,O
was,O
transferred,O
to,O
a,O
potent,O
activator,O
",",O
transcription,O
was,O
strongly,O
inhibited,O
.,O
In,O
this,O
study,O
we,O
present,O
a,O
deletion,O
analysis,O
of,O
the,O
N,B
-,I
terminal,I
region,I
of,O
Oct,O
-,O
2a,O
to,O
determine,O
the,O
minimal,O
repression,O
domain,O
.,O
The,O
possibility,O
that,O
Oct,O
-,O
2a,O
can,O
act,O
as,O
an,O
activator,O
and,O
/,O
or,O
a,O
repressor,O
may,O
have,O
important,O
consequences,O
for,O
the,O
function,O
of,O
Oct,O
-,O
2a,O
in,O
B,O
cell,O
differentiation,O
and,O
other,O
developmental,O
processes,O
.,O
Although,O
there,O
have,O
been,O
a,O
number,O
of,O
reports,O
demonstrating,O
that,O
glucocorticoids,B
(,O
in,O
particular,O
dexamethasone,B
),O
antagonize,O
the,O
eosinophil,B
life,I
-,I
prolonging,I
effects,O
of,O
hemopoietins,O
",",O
direct,O
effects,O
of,O
dexamethasone,B
on,O
eosinophil,B
apoptosis,O
have,O
not,O
been,O
documented,O
.,O
In,O
contrast,O
",",O
dexamethasone,B
was,O
a,O
potent,O
inhibitor,O
of,O
neutrophil,B
apoptosis,O
.,O
For,O
this,O
purpose,O
",",O
we,O
used,O
three,O
main,O
approaches,O
.,O
The,O
first,O
was,O
to,O
abruptly,O
terminate,O
tumor,B
necrosis,I
factor,I
-,I
induced,I
NF,B
-,I
kappaB,I
binding,O
to,O
the,O
enhancer,O
sequences,O
in,O
U1,B
monocytic,I
cells,I
",",O
using,O
a,O
short,O
pulse,O
of,O
exogenous,O
tumor,B
necrosis,I
factor,I
.,O
Together,O
",",O
our,O
results,O
indicate,O
that,O
occupancy,O
of,O
the,O
viral,O
enhancer,O
by,O
NF,B
-,I
kappaB,I
(,O
p50,B
/,I
p65,I
),O
heterodimers,O
is,O
required,O
for,O
ongoing,O
transcription,O
of,O
integrated,O
HIV,B
provirus,I
in,O
monocytes,B
",",O
even,O
in,O
cells,O
chronically,O
infected,O
and,O
permanently,O
producing,O
functional,B
HIV,I
Tat,I
protein,I
.,O
In,O
an,O
attempt,O
to,O
identify,O
changes,O
in,O
gene,B
expression,I
that,O
accompany,O
the,O
T,B
-,I
cell,I
stimulation,I
defects,I
associated,O
with,O
the,O
loss,O
of,O
Rel,B
",",O
we,O
have,O
examined,O
the,O
expression,O
of,O
cell,B
surface,I
activation,I
markers,I
and,O
cytokine,B
production,I
in,O
mitogen,O
-,O
stimulated,O
Rel,B
-,I
/,I
-,I
T,I
cells,I
. ,O
Exogenous,O
IL,B
-,I
2,I
",",O
which,O
restitutes,O
the,O
proliferative,O
response,O
of,O
the,O
anti,O
-,O
CD3,B
-,I
and,I
anti,I
-,I
CD28,I
-,I
treated,I
Rel,B
-,I
/,I
-,I
T,I
cells,I
",",O
restores,O
production,O
of,O
IL,B
-,I
5,I
",",O
TNF,B
-,I
alpha,I
",",O
and,O
IFN,B
-,I
gamma,I
",",O
but,O
not,O
IL,B
-,I
3,I
and,O
GM,B
-,I
CSF,I
expression,I
to,O
approximately,O
normal,O
levels,O
. ,O
These,O
findings,O
establish,O
that,O
Rel,B
can,O
function,O
as,O
an,O
activator,O
or,O
repressor,O
of,O
gene,O
expression,O
and,O
is,O
required,O
by,O
T,B
lymphocytes,I
for,O
production,O
of,O
IL,B
-,I
3,I
and,O
GM,B
-,I
CSF,I
.,O
Nuclear,O
appearance,O
of,O
a,O
factor,O
that,O
binds,O
the,O
CD28,B
response,I
element,I
within,O
the,O
interleukin,B
-,I
2,I
enhancer,I
correlates,O
with,O
interleukin,B
-,I
2,I
production,O
.,O
These,O
results,O
indicate,O
that,O
mitogenic,O
combinations,O
of,O
T,B
cell,I
activation,I
signals,I
are,O
integrated,O
at,O
the,O
level,O
of,O
NF,B
-,I
MATp35,I
induction,I
.,O
Transcriptional,O
basis,O
for,O
hyporesponsiveness,O
of,O
the,O
human,O
inducible,O
nitric,O
oxide,O
synthase,O
gene,O
to,O
lipopolysaccharide,O
/,O
interferon,O
-,O
gamma,O
.,O
Two,O
explanations,O
for,O
hyporesponsiveness,O
of,O
the,O
human,O
iNOS,B
promoter,I
to,O
LPS,O
+,O
/,O
-,O
IFN,O
-,O
gamma,O
were,O
found,O
:,O
(,O
1,O
),O
multiple,O
inactivating,O
nucleotide,O
substitutions,O
in,O
the,O
human,O
counterpart,O
of,O
the,O
enhancer,O
element,O
that,O
has,O
been,O
shown,O
to,O
regulate,O
LPS,O
/,O
IFN,O
-,O
gamma,O
induced,O
expression,O
of,O
the,O
mouse,O
iNOS,B
gene,I
;,O
and,O
(,O
2,O
),O
and,O
absence,O
of,O
one,O
or,O
more,O
nuclear,O
factors,O
in,O
human,O
macrophages,O
(,O
e,O
.,O
g,O
.,O
",",O
an,O
LPS,O
-,O
inducible,O
nuclear,O
factor,O
-,O
kappa,O
B,B
/,O
Rel,O
complex,O
),O
",",O
that,O
is,O
(,O
are,O
),O
required,O
for,O
maximal,O
expression,O
of,O
the,O
gene,O
.,O
Severe,O
skewing,O
of,O
X,B
inactivation,O
resulting,O
in,O
inactivity,O
of,O
the,O
intact,O
X,B
was,O
found,O
in,O
blood,O
and,O
cultures,O
of,O
both,O
types,O
of,O
skin,O
",",O
but,O
analysis,O
of,O
DNA,B
prepared,O
directly,O
from,O
hypopigmented,O
skin,O
showed,O
significant,O
inactivation,O
of,O
the,O
translocated,O
X,B
",",O
inconsistent,O
with,O
the,O
usual,O
mechanism,O
of,O
phenotypic,O
expression,O
in,O
X,B
;,O
autosome,O
translocations,O
.,O
While,O
partial,O
variable,O
monosomy,O
of,O
loci,O
on,O
chromosome,O
17p,O
can,O
not,O
be,O
excluded,O
as,O
contributing,O
to,O
the,O
phenotype,O
in,O
this,O
patient,O
",",O
it,O
is,O
argued,O
that,O
the,O
major,O
likely,O
factor,O
is,O
partial,O
functional,B
disomy,I
of,O
sequences,O
on,O
Xp,O
in,O
cell,O
lineages,O
that,O
have,O
failed,O
to,O
inactivate,O
the,O
intact,O
X,B
chromosome,I
.,O
After,O
several,O
round,O
of,O
subcloning,O
followed,O
by,O
transfection,O
",",O
oriP,B
was,O
mapped,O
to,O
a,O
1,O
.,O
955,O
-,O
kb,O
viral,O
segment,O
.,O
Large,O
amounts,O
of,O
AP,B
-,I
1,I
and,O
NF,B
-,I
kappa,I
B,I
and,O
significant,O
quantities,O
of,O
NF,B
-,I
AT,I
were,O
induced,O
in,O
SEA,O
-,O
activated,O
CD4,B
+,I
spleen,O
T,B
cells,I
",",O
whereas,O
Oct,O
-,O
1,O
and,O
Oct,O
-,O
2,O
DNA,B
binding,I
activity,I
was,O
similar,O
in,O
both,O
resting,O
and,O
activated,O
T,B
cells,I
.,O
Fas,B
ligation,I
induces,O
apoptosis,O
and,O
Jun,B
kinase,I
activation,I
independently,O
of,O
CD45,B
and,O
Lck,B
in,O
human,O
T,B
cells,I
.,O
More,O
is,O
known,O
regarding,O
signal,O
transduction,O
events,O
that,O
occur,O
after,O
ligation,O
of,O
the,O
T,B
-,I
cell,I
antigen,I
receptor,I
(,O
TCR,B
),O
.,O
Although,O
prior,O
studies,O
suggest,O
a,O
role,O
for,O
protein,B
tyrosine,I
kinases,I
and,O
phosphatases,B
in,O
Fas,B
signaling,I
",",O
we,O
report,O
here,O
that,O
Fas,B
ligation,O
induces,O
apoptosis,O
in,O
T,B
cells,I
deficient,O
in,O
either,O
CD45,B
or,O
Lck,B
.,O
Globin,B
gene,I
switching,I
.,O
In,O
contrast,O
",",O
in,O
vivo,O
footprints,O
on,O
GT,B
(,O
CACCC,I
),O
motifs,O
differed,O
between,O
the,O
cells,O
expressing,O
the,O
fetal,B
or,O
the,O
adult,B
globin,I
program,I
.,O
The,O
active,O
vitamin,B
D3,I
metabolite,I
1,O
",",O
25,O
-,O
dihydroxycholecalcif,O
(,O
1,O
",",O
25,O
(,O
OH,B
),I
2D3,I
),O
acts,O
as,O
an,O
antiproliferative,O
and,O
differentiating,O
agent,O
for,O
the,O
monoblastoid,B
cell,I
line,I
U937,I
and,O
as,O
an,O
important,O
immunologic,O
mediator,O
implicated,O
particularly,O
in,O
the,O
function,O
of,O
cells,O
belonging,O
to,O
the,O
monocyte,B
/,I
macrophage,I
lineage,I
.,O
Cell,B
cycle,I
analysis,I
showed,O
shifts,O
in,O
the,O
distribution,O
of,O
cells,B
from,O
G1,B
to,O
S,B
phase,I
",",O
which,O
were,O
more,O
pronounced,O
after,O
cadmium,O
treatment,O
.,O
These,O
data,O
indicate,O
that,O
",",O
in,O
contrast,O
to,O
most,O
LPS,O
effects,O
",",O
AP,O
-,O
1,O
",",O
but,O
not,O
nuclear,O
factor,O
-,O
kappaB,O
",",O
mediates,O
LPS,O
induction,O
of,O
collagenase,B
transcription,I
in,O
macrophagelike,O
cells,B
.,O
Activation,O
of,O
macrophages,B
by,O
bacterial,O
lipopolysaccharide,O
(,O
LPS,B
),O
induces,O
transcription,O
of,O
genes,O
that,O
encode,O
for,O
proinflammatory,O
regulators,O
of,O
the,O
immune,O
response,O
.,O
LPS,B
treatment,O
of,O
RAW,B
264,I
.,O
7,O
cells,O
",",O
murine,O
bone,O
marrow,O
-,O
derived,O
macrophages,O
",",O
and,O
the,O
human,O
monocyte,B
cell,I
line,I
THP,B
-,I
1,I
resulted,O
in,O
rapid,O
activation,O
of,O
the,O
p46,B
and,O
p54,B
isoforms,O
of,O
JNK,B
.,O
These,O
results,O
suggest,O
that,O
LPS,B
activation,O
of,O
JNK,B
in,O
monocyte,B
/,I
macrophage,I
cells,I
is,O
a,O
CD14,B
-,I
and,O
protein,B
tyrosine,I
phosphorylation,I
-,I
dependent,I
event,O
that,O
may,O
mediate,O
the,O
early,O
activation,O
of,O
AP,B
-,I
1,I
in,O
regulating,O
LPS,B
-,I
triggered,I
gene,I
induction,I
.,O
A,O
cell,O
type,O
-,O
specific,O
enhancer,O
in,O
the,O
human,O
B7,B
.,O
1,I
gene,I
regulated,O
by,O
NF,B
-,I
kappaB,I
.,O
This,O
183,O
-,O
bp,O
region,O
was,O
both,O
cell,B
type,I
specific,O
and,O
responsive,O
to,O
two,O
distinct,O
stimuli,O
",",O
lipopolysaccharide,O
and,O
dibutyryl,O
cAMP,O
",",O
known,O
to,O
regulate,O
B7,O
0.1,O
expression,O
.,O
Deletional,O
and,O
site,O
-,O
directed,O
mutagenesis,O
revealed,O
the,O
presence,O
of,O
multiple,O
functionally,O
critical,O
cis,O
elements,O
within,O
this,O
region,O
",",O
one,O
of,O
which,O
was,O
a,O
nuclear,B
factor,I
(,O
NF,B
),O
-,O
kappaB,I
consensus,I
sequence,I
.,O
This,O
is,O
the,O
first,O
description,O
",",O
to,O
our,O
knowledge,O
",",O
of,O
regulatory,O
elements,O
that,O
control,O
expression,O
of,O
a,O
gene,O
encoding,O
a,O
B7,B
costimulatory,I
molecule,I
.,O
Recombinant,O
c,O
-,O
Jun,B
and,O
c,O
-,O
Fos,B
were,O
ubiquitinylated,O
by,O
the,O
ubiquitin,B
carrier,I
enzymes,I
E214K,O
",",O
E220K,O
",",O
or,O
E232K,O
in,O
the,O
presence,O
of,O
the,O
ubiquitin,B
-,I
activating,I
enzyme,I
",",O
E1,O
.,O
We,O
have,O
also,O
characterized,O
the,O
genomic,O
mBob1,B
clone,O
.,O
Analysis,O
of,O
its,O
intron,O
-,O
exon,O
structure,O
has,O
allowed,O
identification,O
of,O
a,O
C,B
-,I
terminal,I
splice,I
variant,I
.,O
mBob1,B
interacts,O
with,O
the,O
octamer,O
transcription,O
factors,O
Oct,B
-,I
1,I
and,O
Oct,B
-,I
2,I
and,O
stimulates,O
transcription,O
mediated,O
by,O
these,O
factors,O
.,O
It,O
is,O
well,O
established,O
that,O
the,O
two,O
major,O
glial,O
cells,O
in,O
the,O
central,O
nervous,O
system,O
(,O
CNS,O
),O
",",O
astrocytes,O
and,O
microglia,O
",",O
are,O
key,O
participants,O
in,O
mediating,O
the,O
neurologic,O
dysfunction,O
associated,O
with,O
HIV,O
infection,O
of,O
the,O
CNS,O
.,O
Moreover,O
",",O
gp120,B
induces,O
tyrosine,O
phosphorylation,O
of,O
signal,O
transducer,O
and,O
activator,O
of,O
stat,B
-,I
1,I
alpha,I
),O
as,O
well,O
as,O
the,O
janus,B
kinase,I
(,O
jak2,B
),O
in,O
glial,B
cells,I
.,O
Northern,O
blot,O
analysis,O
as,O
well,O
as,O
ab,O
blocking,O
and,O
cytokine,O
secretion,O
studies,O
indicated,O
that,O
the,O
induction,O
of,O
either,O
endogenous,O
tnf,B
-,I
alpha,I
or,O
il,B
-,I
10,I
was,O
not,O
involved,O
in,O
the,O
cooperativity,O
",",O
nor,O
was,O
an,O
up,O
-,O
regulation,O
of,O
tnf,B
-,I
alpha,I
receptors,I
.,O
Interaction,O
of,O
HTLV,B
-,I
I,I
Tax,I
with,O
the,O
human,O
proteasome,B
:,O
implications,O
for,O
NF,B
-,I
kappa,I
B,I
induction,O
.,O
We,O
identified,O
a,O
physical,O
interaction,O
between,O
Tax,B
and,O
the,O
HsN3,B
subunit,O
of,O
the,O
human,O
proteasome,B
.,O
This,O
raises,O
the,O
intriguing,O
possibility,O
that,O
physical,O
association,O
of,O
the,O
HsN3,B
proteasome,I
subunit,O
with,O
HTLV,B
-,I
I,I
Tax,I
coupled,O
with,O
the,O
independent,O
interaction,O
of,O
Tax,B
with,O
either,O
p100,O
or,O
p65,O
-,O
I,O
kappa,O
B,O
alpha,O
targets,O
these,O
cytoplasmic,O
NF,B
-,I
kappa,I
B,I
/,O
Rel,O
complexes,O
to,O
the,O
proteasome,B
for,O
processing,O
.,O
Basement,O
membrane,O
immunoreactivity,O
for,O
type,O
IV,B
collagen,I
and,O
laminin,B
was,O
discontinuous,O
in,O
most,O
examples,O
of,O
IDC,O
regardless,O
of,O
type,O
",",O
with,O
a,O
trend,O
toward,O
more,O
intense,O
staining,O
in,O
comedo,O
than,O
in,O
noncomedo,O
carcinomas,O
.,O
Periductal,O
angiogenesis,O
was,O
not,O
significantly,O
related,O
to,O
the,O
type,O
of,O
IDC,O
but,O
was,O
more,O
pronounced,O
with,O
comedo,O
carcinomas,O
.,O
They,O
correlated,O
with,O
markers,O
of,O
tumor,O
aggressivity,O
(,O
axillary,O
node,O
involvement,O
and,O
especially,O
with,O
markers,O
of,O
high,O
mitotic,O
rate,O
as,O
Ki,B
-,I
67,I
staining,O
",",O
histological,O
grade,O
),O
.,O
OBJECTIVE,O
:,O
We,O
sought,O
to,O
investigate,O
the,O
molecular,O
mechanisms,O
regulating,O
this,O
early,O
inflammatory,O
response,O
.,O
We,O
have,O
focused,O
on,O
the,O
study,O
of,O
the,O
signal,O
transduction,O
pathways,O
triggered,O
by,O
CD23,O
in,O
human,O
monocytes,O
and,O
the,O
promonocytic,O
cell,O
line,B
U937,O
.,O
IkappaBalpha,B
phosphorylation,O
and,O
degradation,O
was,O
analyzed,O
by,O
Western,O
blot,O
.,O
Paclitaxel,B
and,O
other,O
drugs,O
that,O
disturb,O
microtubule,B
dynamics,I
kill,O
cells,O
in,O
a,O
Fas,B
/,I
Fas,I
ligand,I
(,O
FasL,B
),O
-,O
dependent,O
manner,O
;,O
antibody,O
to,O
FasL,B
inhibits,O
paclitaxel,O
-,O
induced,O
apoptosis,O
.,O
Without,O
NFAT,B
nuclear,I
translocation,I
",",O
the,O
FasL,B
gene,I
is,O
not,O
transcribed,O
.,O
The,O
effects,O
of,O
Bcl,B
-,I
2,I
can,O
be,O
overcome,O
",",O
at,O
least,O
partially,O
",",O
through,O
phosphorylation,O
of,O
Bcl,B
-,I
2,I
.,O
MHC,B
-,I
peptide,I
ligand,I
interactions,I
establish,O
a,O
functional,O
threshold,O
for,O
antigen,O
-,O
specific,O
T,B
cell,I
recognition,I
.,O
Regulatory,O
effects,O
of,O
interleukin,B
-,I
11,I
during,O
acute,O
lung,O
inflammatory,O
injury,O
.,O
IL,B
-,I
11,I
mRNA,I
and,O
protein,O
were,O
both,O
up,O
-,O
regulated,O
during,O
the,O
course,O
of,O
this,O
inflammatory,O
response,O
.,O
Recently,O
",",O
we,O
and,O
others,O
have,O
shown,O
that,O
thrombopoietin,B
induces,O
rapid,O
tyrosine,O
phosphorylation,O
of,O
Jak2,B
and,O
other,O
proteins,O
in,O
human,O
platelets,B
and,O
BaF3,B
cells,I
",",O
genetically,O
engineered,O
to,O
express,O
c,B
-,I
Mpl,I
",",O
a,O
receptor,O
for,O
thrombopoietin,B
.,O
Thus,O
",",O
our,O
data,O
indicate,O
that,O
Stat3,B
and,O
Stat5,B
may,O
be,O
involved,O
in,O
signal,O
transduction,O
after,O
ligand,O
binding,O
to,O
c,B
-,I
Mpl,I
and,O
that,O
this,O
event,O
may,O
have,O
a,O
role,O
in,O
megakaryopoiesis,O
/,O
thrombopoiesis,O
or,O
possibly,O
a,O
mature,O
platelet,B
function,O
such,O
as,O
aggregation,O
.,O
Damage,O
to,O
the,O
genes,B
encoding,O
proteins,O
that,O
function,O
in,O
intracellular,O
signaling,O
",",O
transcription,O
",",O
or,O
regulation,O
of,O
the,O
cell,B
cycle,I
has,O
been,O
identified,O
and,O
linked,O
at,O
varying,O
degrees,O
to,O
the,O
progression,O
of,O
certain,O
lymphoid,B
malignancies,I
.,O
One,O
such,O
example,O
is,O
the,O
excessive,O
expression,O
of,O
`,O
`,O
normal,O
',O
',O
lymphokines,O
of,O
cytokines,O
which,O
accompanies,O
many,O
lymphoproliferative,O
diseases,O
.,O
The,O
dysregulated,O
expression,O
of,O
cytokines,B
during,O
malignancy,O
can,O
result,O
in,O
the,O
augmentation,O
of,O
growth,O
of,O
transformed,O
lymphocytes,O
",",O
as,O
well,O
as,O
an,O
alteration,O
of,O
the,O
anti,O
-,O
tumor,O
immune,O
response,O
.,O
In,O
addition,O
to,O
its,O
role,O
as,O
a,O
precursor,O
for,O
other,O
steroid,O
hormones,O
",",O
DHEA,B
has,O
been,O
proposed,O
to,O
play,O
an,O
important,O
role,O
in,O
immunity,O
.,O
Monocytes,B
stimulated,O
with,O
LPS,B
concentrations,O
of,O
1,O
.,O
0,O
micrograms,O
/,O
ml,O
displayed,O
the,O
above,O
cytotoxic,O
markers,O
",",O
whereas,O
monocytes,B
stimulated,O
with,O
DHEA,B
alone,O
or,O
with,O
LPS,B
at,O
a,O
lower,O
concentration,O
of,O
0,O
.,O
2,O
ng,O
/,O
ml,O
did,O
not,O
.,O
Finally,O
",",O
Scatchard,O
plot,O
analysis,O
demonstrated,O
the,O
presence,O
of,O
a,O
DHEA,B
receptor,O
in,O
monocytes,B
",",O
suggesting,O
that,O
DHEA,B
effects,O
on,O
LPS,B
-,I
stimulated,O
monocytes,B
are,O
mediated,O
through,O
a,O
receptor,O
-,I
dependent,O
process,O
.,O
IL,O
-,O
4,O
activates,O
gene,O
expression,O
by,O
inducing,O
tyrosine,O
phosphorylation,O
",",O
homodimerization,O
",",O
and,O
nuclear,O
translocation,O
of,O
the,O
latent,O
transcription,O
factor,O
",",O
STAT6,B
(,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
-,O
6,O
),O
.,O
Because,O
STAT6,B
activation,O
is,O
essential,O
for,O
IL,O
-,O
4,O
-,O
induced,O
gene,O
expression,O
",",O
we,O
examined,O
the,O
ability,O
of,O
type,O
I,O
and,O
type,O
II,O
IFNs,O
to,O
regulate,O
activation,O
of,O
STAT6,B
by,O
IL,O
-,O
4,O
in,O
primary,O
human,O
monocytes,O
.,O
The,O
shift,O
from,O
complex,O
I,O
to,O
complex,O
II,O
seen,O
only,O
in,O
SCM,B
-,I
1,I
-,I
producer,O
T,B
cell,I
lines,I
upon,O
activation,O
was,O
completely,O
suppressed,O
by,O
cyclosporin,O
A,O
.,O
One,O
-,O
hybrid,O
assays,O
in,O
yeast,O
isolated,O
NF,B
-,I
ATp,I
as,O
an,O
E1,O
binding,O
protein,O
",",O
and,O
transfection,O
of,O
NF,B
-,I
ATp,I
into,O
T,B
and,O
B,B
cell,I
lines,I
strongly,O
enhanced,O
the,O
activation,O
-,O
dependent,O
SCM,B
-,I
1,I
promoter,I
activity,O
.,O
Recent,O
studies,O
have,O
reported,O
that,O
lymphocytes,B
produce,O
",",O
transport,O
and,O
bind,O
dopamine,B
present,O
in,O
plasma,O
.,O
The,O
importance,O
of,O
NF,B
-,I
kappaB,I
sites,I
was,O
confirmed,O
by,O
using,O
vectors,O
containing,O
wild,O
-,O
type,O
or,O
mutant,O
kappaB,B
sites,I
in,O
a,O
heterologous,O
promoter,O
.,O
Consistent,O
with,O
the,O
role,O
of,O
NF,B
-,I
kappaB,I
in,O
mediating,O
dopamine,B
responsiveness,O
",",O
the,O
proteasome,B
inhibitor,I
MG132,I
abolished,O
dopamine,B
-,O
induced,O
transcriptional,O
activation,O
.,O
A,O
significant,O
correlation,O
between,O
high,O
lymphocytic,B
infiltration,I
(,O
2,O
. ,O
5,O
points,O
),O
",",O
low,O
body,B
mass,I
and,O
fat,O
was,O
identified,O
. ,O
Moderate,O
body,B
mass,I
",",O
relatively,O
low,O
fat,O
level,O
and,O
positive,O
receptor,B
status,O
are,O
among,O
factors,O
of,O
good,O
prognosis,O
in,O
breast,B
cancer,I
of,I
early,I
stages,I
. ,O
In,O
this,O
study,O
",",O
we,O
analyzed,O
the,O
binding,O
activity,O
of,O
IL,B
-,I
10,I
-,I
and,O
IFN,B
-,I
gamma,I
-,I
activated,O
STAT,B
molecules,I
to,O
two,O
kinds,O
of,O
GAS,O
-,O
motif,O
sequences,O
. ,O
This,O
may,O
explain,O
the,O
difference,O
between,O
IL,B
-,I
10,I
and,O
IFN,B
-,I
gamma,I
in,O
biological,O
activity,O
",",O
and,O
the,O
inhibitory,O
effect,O
of,O
IL,B
-,I
10,I
on,O
IFN,B
-,I
gamma,I
activities,O
.,O
Peptides,O
derived,O
from,O
the,O
HSV,B
-,I
2,I
VP16,I
protein,I
were,O
utilized,O
for,O
studies,O
of,O
peptide,O
binding,O
to,O
DQ0302,B
molecules,I
and,O
T,B
cell,I
activation,I
at,O
both,O
neutral,O
and,O
acidic,O
pH,O
.,O
The,O
short,O
truncated,O
analog,O
433,O
-,O
442A,O
binds,O
very,O
poorly,O
at,O
both,O
acidic,O
and,O
neutral,O
pH,O
.,O
Much,O
higher,O
concentrations,O
of,O
wild,O
type,O
peptides,O
were,O
needed,O
to,O
activate,O
T,O
cells,O
at,O
neutral,O
pH,O
.,O
To,O
investigate,O
a,O
potential,O
role,O
of,O
E2F,B
-,I
1,I
in,O
differentiation,O
",",O
we,O
assayed,O
the,O
ability,O
of,O
megakaryocytes,O
to,O
form,O
platelets,O
in,O
an,O
in,O
vivo,O
transgenic,O
model,O
.,O
Administration,O
of,O
megakaryocyte,B
growth,I
and,I
development,I
factor,I
or,O
interleukin,B
6,I
could,O
not,O
overcome,O
the,O
differentiation,O
block,O
.,O
A,O
recent,O
sib,O
-,O
pair,O
analysis,O
revealed,O
a,O
tight,O
linkage,O
between,O
markers,O
on,O
5q31,O
.,O
1,O
and,O
a,O
major,O
susceptibility,O
gene,O
controlling,O
total,O
serum,B
IgE,I
levels,I
.,O
Evidence,O
for,O
lowered,O
induction,O
of,O
nuclear,B
factor,I
kappa,I
B,I
in,O
activated,O
human,B
T,I
lymphocytes,I
during,O
aging,O
.,O
Inhibition,O
of,O
lipopolysaccharide,O
-,O
induced,O
monocyte,O
interleukin,O
-,O
1,O
receptor,O
antagonist,O
synthesis,O
by,O
cortisol,B
:,O
involvement,O
of,O
the,O
mineralocorticoid,O
receptor,O
.,O
The,O
mineralocorticoid,O
aldosterone,O
exerted,O
a,O
significant,O
decrease,O
in,O
LPS,O
-,O
induced,O
monocyte,O
IL,O
-,O
1ra,O
secretion,O
in,O
vitro,O
",",O
which,O
was,O
blocked,O
by,O
coincubation,O
with,O
spironolactone,O
.,O
Moreover,O
",",O
we,O
provide,O
evidence,O
that,O
",",O
in,O
addition,O
to,O
a,O
glucocorticoid,B
receptor,I
-,I
mediated,I
effect,I
",",O
the,O
mineralocorticoid,B
receptor,I
is,O
involved,O
in,O
the,O
inhibition,O
of,O
monocyte,B
IL,I
-,I
1ra,I
secretion,I
by,O
cortisol,B
.,O
Cell,B
-,I
mediated,I
immunity,I
plays,O
an,O
essential,O
role,O
in,O
the,O
control,O
of,O
infection,O
with,O
the,O
human,B
cytomegalovirus,I
(,I
HCMV,I
),I
.,O
Here,O
",",O
we,O
have,O
readdressed,O
the,O
issue,O
of,O
CD8,B
(,O
+,O
),O
T,B
cells,I
specific,O
for,O
the,O
72,O
-,O
kDa,O
major,O
immediate,O
-,O
early,O
protein,B
(,O
IE,B
-,I
1,I
),O
",",O
which,O
is,O
nonstructural,O
but,O
is,O
found,O
very,O
early,O
and,O
throughout,O
the,O
replicative,O
cycle,O
.,O
In,O
summary,O
",",O
our,O
results,O
suggest,O
that,O
IE,B
-,I
1,I
is,O
far,O
more,O
important,O
as,O
a,O
CD8,B
(,O
+,O
),O
-,O
T,B
-,I
cell,I
target,I
than,O
current,O
opinion,O
suggests,O
.,O
E1A,B
oncogene,I
induction,O
of,O
cellular,O
susceptibility,O
to,O
killing,O
by,O
cytolytic,O
lymphocytes,O
through,O
target,O
cell,O
sensitization,O
to,O
apoptotic,O
injury,O
.,O
Since,O
CLs,O
can,O
induce,O
either,O
apoptotic,O
or,O
necrotic,O
cell,O
death,O
",",O
we,O
asked,O
whether,O
E1A,B
sensitization,O
to,O
injury,O
-,O
induced,O
apoptosis,O
is,O
sufficient,O
to,O
explain,O
E1A,B
-,I
induced,I
cytolytic,I
susceptibility,I
.,O
Copyright,O
1999,O
Academic,O
Press,O
.,O
TCL1,B
oncogene,I
expression,O
in,O
AIDS,O
-,O
related,O
lymphomas,O
and,O
lymphoid,O
tissues,O
.,O
We,O
find,O
that,O
TCL1,B
is,O
expressed,O
in,O
the,O
majority,O
of,O
AIDS,O
IBLP,O
tumors,O
examined,O
.,O
They,O
also,O
indicate,O
that,O
abundant,O
TCL1,B
expression,O
in,O
quiescent,O
mantle,O
zone,O
B,O
cells,O
is,O
down,O
-,O
regulated,O
in,O
activated,O
germinal,O
center,O
follicular,O
B,O
cells,O
in,O
parallel,O
to,O
the,O
known,O
expression,O
pattern,O
of,O
BCL,B
-,I
2,I
.,O
High,O
-,O
level,O
expression,O
in,O
nonproliferating,O
B,B
cells,I
suggests,O
that,O
TCL1,B
may,O
function,O
in,O
protecting,O
naive,O
preactivated,O
B,B
cells,I
from,O
apoptosis,O
.,O
Here,O
",",O
we,O
report,O
a,O
model,O
of,O
CD28,B
costimulation,O
using,O
PMA,O
plus,O
the,O
natural,O
ligand,O
CD80,B
that,O
resulted,O
in,O
very,O
limited,O
stimulation,O
of,O
IL,B
-,I
2,I
",",O
as,O
evidenced,O
by,O
both,O
cytokine,O
production,O
and,O
IL,B
-,I
2,I
promoter,I
stimulation,O
.,O
We,O
have,O
determined,O
that,O
the,O
JAK,B
/,I
STAT,I
pathway,O
positively,O
regulates,O
Qp,B
activity,O
.,O
In,O
transient,O
-,O
transfection,O
assays,O
",",O
a,O
Qp,B
-,I
CAT,I
reporter,I
was,O
activated,O
by,O
cotransfected,O
JAK,B
-,I
1,I
and,O
by,O
treatment,O
of,O
cells,O
with,O
the,O
cytokine,O
IL,B
-,I
6,I
.,O
Consistent,O
with,O
a,O
role,O
for,O
STATs,B
in,O
Qp,B
function,O
",",O
Qp,B
using,O
Burkitt,B
',I
s,I
lymphoma,I
Rael,I
cells,I
and,O
cultured,O
nasopharyngeal,B
carcinoma,I
(,I
NPC,I
),I
cells,I
contained,O
nuclear,O
STAT,B
protein,O
.,O
This,O
negative,O
regulation,O
required,O
Zta,B
DNA,I
-,I
binding,I
activity,I
.,O
We,O
provide,O
evidence,O
that,O
Zta,B
up,O
-,O
regulation,O
of,O
p53,B
leads,O
to,O
p53,B
-,I
mediated,I
interference,O
with,O
JAK,B
/,I
STAT,I
activation,I
of,O
Qp,B
.,O
Reactive,O
oxygen,O
intermediate,O
-,O
release,O
of,O
fibre,O
-,O
exposed,O
monocytes,B
increases,O
inflammatory,O
cytokine,O
-,O
mRNA,O
level,O
",",O
protein,B
tyrosine,I
kinase,I
and,O
NF,B
-,I
kappaB,I
activity,I
in,O
co,O
-,O
cultured,O
bronchial,B
epithelial,I
cells,I
(,O
BEAS,B
-,I
2B,I
),O
.,O
We,O
show,O
here,O
that,O
the,O
response,O
of,O
the,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,O
LTR,B
),O
to,O
mitogenic,O
or,O
Tat,B
-,I
mediated,I
activation,I
is,O
sensitive,O
to,O
the,O
suppressive,O
action,O
of,O
a,O
Herpesvirus,B
saimiri,I
(,O
HVS,B
),O
-,O
transformed,O
CD8,B
+,I
T,I
cell,I
clone,I
from,O
an,O
HIV,B
-,I
infected,I
individual,I
and,O
supernatants,O
from,O
CD8,B
+,I
T,I
cells,I
of,O
HIV,B
-,I
1,I
-,I
infected,I
asymptomatic,I
subjects,I
(,O
CD4,B
+,I
>,I
350,I
/,I
microliters,I
),O
.,O
Mutagenesis,O
of,O
NF,B
kappa,I
B,I
or,O
Sp,O
-,O
1,O
elements,O
within,O
the,O
LTR,O
resulted,O
in,O
no,O
change,O
in,O
the,O
ability,O
of,O
CD8,B
+,I
T,I
cell,I
supernatants,I
to,O
inhibit,O
Tat,O
-,O
or,O
mitogen,O
-,O
mediated,O
LTR,O
transcription,O
.,O
Taken,O
together,O
",",O
these,O
observations,O
suggest,O
that,O
mitogenic,O
activation,O
",",O
mediated,O
primarily,O
through,O
the,O
NF,B
kappa,I
B,I
enhancer,I
",",O
is,O
susceptible,O
to,O
CD8,B
-,I
mediated,I
inhibition,I
",",O
however,O
",",O
inhibition,O
of,O
Tat,O
-,O
mediated,O
activation,O
may,O
rely,O
upon,O
a,O
different,O
pathway,O
that,O
is,O
NFAT,B
-,I
1,I
dependent,I
.,O
Nuclear,B
factor,I
(,O
NF,B
),O
kappa,O
B,O
is,O
a,O
redox,O
sensitive,O
cytosolic,O
transcription,O
factor,O
.,O
Induction,O
of,O
endothelial,B
adhesion,I
molecules,I
by,O
the,O
cytokine,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
(,O
TNF,B
),O
can,O
occur,O
independently,O
of,O
protein,B
kinase,I
C,I
and,O
activation,O
of,O
a,O
protein,B
tyrosine,I
kinase,I
(,O
PTK,B
),O
has,O
recently,O
been,O
implicated,O
in,O
the,O
upregulation,O
of,O
vascular,O
cell,B
adhesion,I
molecule,I
1,I
(,O
VCAM,B
-,I
1,I
),O
by,O
interleukin,O
-,O
4,O
(,O
IL,B
-,I
4,I
),O
on,O
endothelial,B
cells,I
.,O
In,O
this,O
study,O
",",O
we,O
demonstrate,O
that,O
constitutive,O
expression,O
of,O
bcl,B
-,I
xl,I
but,O
not,O
bcl,B
-,I
2,I
",",O
bcl,B
-,I
xs,I
",",O
bak,B
",",O
bad,B
",",O
or,O
bax,B
was,O
associated,O
with,O
apoptosis,O
resistance,O
after,O
IL,O
-,O
2,O
deprivation,O
in,O
CTLL,B
-,I
2,I
cells,I
that,O
expressed,O
Tax,O
. Transient,O
-,O
transfection,O
assays,O
showed,O
that,O
bcl,B
-,I
x,I
promoter,I
was,O
transactivated,O
by,O
wild,O
-,O
type,O
Tax,O
.,O
We,O
find,O
that,O
recruitment,O
of,O
EKLF,B
to,O
5,O
',O
HS2,B
requires,O
the,O
TATA,B
box,I
",",O
but,O
recruitment,O
to,O
5,O
',O
HS3,B
depends,O
on,O
the,O
CACCC,B
and,O
TATA,B
boxes,I
of,O
the,O
beta,B
-,I
globin,I
promoter,I
.,O
We,O
have,O
found,O
that,O
the,O
recruitment,O
of,O
EKLF,B
to,O
5,O
',O
HS3,B
depends,O
on,O
the,O
presence,O
of,O
5,O
',O
HS2,B
in,O
cis,O
",",O
but,O
the,O
recruitment,O
to,O
5,O
',O
HS2,B
does,O
not,O
depend,O
on,O
5,O
',O
HS3,B
.,O
Based,O
on,O
these,O
results,O
",",O
we,O
present,O
a,O
model,O
that,O
illustrates,O
how,O
EKLF,B
may,O
be,O
recruited,O
to,O
the,O
beta,B
-,I
globin,I
locus,I
.,O
We,O
also,O
report,O
that,O
in,O
RAW,B
264,I
.,I
7,I
cells,I
",",O
an,O
E,B
(,O
2,O
),O
receptor,O
-,O
positive,O
murine,O
monocytic,O
line,O
",",O
E,B
(,O
2,O
),O
downregulates,O
cytokine,O
-,O
induced,O
TNF,B
gene,I
expression,I
by,O
decreasing,O
the,O
activity,O
of,O
the,O
Jun,B
NH,I
(,I
2,I
),I
-,I
terminal,I
kinase,I
(,I
JNK,I
),I
.,O
The,O
resulting,O
diminished,O
phosphorylation,O
of,O
c,B
-,I
Jun,I
and,I
JunD,I
at,O
their,O
NH,O
(,O
2,O
),O
-,O
termini,O
decreases,O
the,O
ability,O
of,O
these,O
nuclear,O
proteins,O
to,O
autostimulate,O
the,O
expression,O
of,O
the,O
c,B
-,I
Jun,I
and,I
JunD,I
genes,O
",",O
thus,O
leading,O
to,O
lower,O
production,O
of,O
c,B
-,I
Jun,I
and,I
JunD,I
.,O
Recent,O
data,O
show,O
that,O
TCR,O
/,O
CD3,O
stimulation,O
induces,O
activation,O
of,O
Stat5,B
in,O
murine,O
T,B
cells,O
.,O
In,O
conclusion,O
",",O
we,O
show,O
that,O
CD3,B
ligation,O
by,O
mAb,O
and,O
SE,O
triggers,O
a,O
rapid,O
",",O
PP1,O
-,O
sensitive,O
tyrosine,B
and,O
serine,B
phosphorylation,O
of,O
Stat3,B
in,O
human,O
CD4,B
+,I
T,I
cells,I
.,O
Clusters,O
of,O
genes,O
expressed,O
by,O
stromal,B
cells,I
and,O
lymphocytes,B
in,O
the,O
breast,B
tumors,I
also,O
were,O
identified,O
in,O
this,O
analysis,O
.,O
Stimulation,O
of,O
T,B
cells,I
with,O
calcium,B
ionophore,I
induced,O
a,O
shift,O
in,O
the,O
molecular,O
weight,O
of,O
NFATp,B
that,O
is,O
due,O
to,O
its,O
dephosphorylation,O
.,O
This,O
dephosphorylation,O
was,O
inhibited,O
by,O
treatment,O
of,O
T,B
cells,I
with,O
cyclosporin,O
A,O
or,O
FK506,O
prior,O
to,O
stimulation,O
.,O
The,O
B,B
cell,I
-,I
associated,I
surface,I
molecule,I
CD40,B
plays,O
a,O
key,O
role,O
in,O
T,B
cell,I
-,I
dependent,I
B,B
cell,I
maturation,O
",",O
as,O
individuals,O
with,O
defects,O
in,O
either,O
CD40,B
or,O
its,O
ligand,O
are,O
impaired,O
in,O
immunoglobulin,B
isotype,I
class,I
switching,O
and,O
germinal,O
center,O
formation,O
.,O
CD40,B
signaling,O
activates,O
downstream,O
effectors,O
",",O
including,O
the,O
tyrosine,B
protein,I
kinase,I
",",O
Lyn,B
",",O
the,O
phosphatidylinositol,B
-,I
3,I
-,I
kinase,I
(,O
PI,B
-,I
3,I
kinase,I
),O
",",O
and,O
the,O
transcription,O
factor,O
",",O
NF,B
-,I
kappa,I
B,I
.,O
In,O
this,O
study,O
",",O
we,O
demonstrate,O
that,O
stress,O
-,O
activated,O
protein,B
kinases,I
(,O
SAPK,B
),O
are,O
activated,O
after,O
CD40,B
cross,O
-,O
linking,O
on,O
various,O
B,B
cell,I
lines,I
or,O
human,O
tonsillar,O
B,B
cells,I
.,O
In,O
summary,O
",",O
CD40,B
signaling,O
preferentially,O
induces,O
SAPK,B
but,O
not,O
MAPK,B
.,O
Using,O
CD45,B
-,I
or,O
CD3,B
-,I
negative,O
variants,O
of,O
the,O
Jurkat,B
leukemic,I
T,I
-,I
cell,I
line,I
we,O
show,O
that,O
the,O
different,O
biochemical,O
events,O
induced,O
by,O
pervanadate,O
appeared,O
to,O
be,O
dependent,O
on,O
the,O
presence,O
at,O
the,O
cell,O
surface,O
of,O
either,O
CD45,B
or,O
CD3,B
.,O
CD45,B
-,I
dependent,O
events,O
such,O
as,O
tyrosine,O
phosphorylation,O
of,O
Shc,B
",",O
activation,O
of,O
nuclear,O
factor,O
-,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),O
",",O
activator,O
protein,O
-,I
1,I
(,O
AP,B
-,I
1,I
),O
",",O
transcription,O
factors,O
",",O
and,O
stimulation,O
of,O
interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
promoter,O
and,O
of,O
CD69,B
and,O
CD25,B
surface,O
expression,O
paralleled,O
activation,O
of,O
the,O
tyrosine,O
kinases,O
lck,B
and,O
fyn,B
.,O
Previously,O
",",O
the,O
action,O
of,O
MC903,B
and,O
KH1060,B
was,O
presumed,O
to,O
be,O
mediated,O
by,O
the,O
nuclear,O
vitamin,O
D,B
receptor,I
(,O
VDRnuc,B
),O
.,O
These,O
data,O
suggest,O
that,O
although,O
MC903,B
and,O
KH1060,B
may,O
bind,O
the,O
VDRnuc,B
",",O
that,O
the,O
differentiative,O
activities,O
of,O
these,O
agents,O
requires,O
nongenomic,O
signaling,O
pathways,O
.,O
Here,O
we,O
show,O
that,O
1alpha,O
",",O
25,O
(,O
OH,O
),O
2,O
-,O
d5,O
-,O
previtamin,O
D3,B
(,O
HF,O
),O
",",O
JN,O
",",O
KH1060,B
",",O
and,O
MC903,B
induce,O
expression,O
of,O
PKC,B
alpha,I
and,O
PKC,B
delta,I
and,O
translocation,O
of,O
both,O
isoforms,O
to,O
the,O
particulate,O
fraction,O
",",O
and,O
PKC,B
alpha,I
to,O
the,O
nuclear,O
fraction,O
.,O
Retinoic,O
acid,O
can,O
directly,O
modulate,O
gene,B
expression,I
via,O
binding,O
to,O
its,O
nuclear,B
receptors,I
",",O
which,O
can,O
",",O
in,O
turn,O
",",O
activate,O
transcription,O
of,O
target,O
genes,B
.,O
Tax,O
has,O
been,O
shown,O
to,O
transactivate,O
several,O
cellular,B
genes,I
.,O
Induced,O
MIP,B
-,I
1alpha,I
expression,O
and,O
secretion,O
in,O
PMA,O
/,O
PHA,O
stimulated,O
tax,O
transfected,O
cells,O
correlate,O
with,O
the,O
noninduction,O
of,O
MNP,O
-,O
1,O
transcription,O
factor,O
",",O
which,O
is,O
intimately,O
involved,O
in,O
downmodulating,O
the,O
MIP,B
-,I
1alpha,I
gene,I
.,O
Copyright,O
1999,O
Academic,O
Press,O
.,O
Like,O
a,O
delayed,O
-,O
type,O
hypersensitivity,O
response,O
",",O
the,O
rheumatoid,O
synovium,O
represents,O
an,O
effector,O
site,O
.,O
The,O
other,O
major,O
subpopulation,O
expressing,O
the,O
CD4,B
receptor,I
",",O
namely,O
",",O
the,O
double,O
-,O
positive,O
(,O
DP,B
),O
CD4,B
(,O
+,O
),O
CD8,B
(,O
+,O
),O
CD3,B
(,O
+,O
/,O
-,O
),O
thymocytes,O
",",O
despite,O
the,O
entry,O
of,O
the,O
virus,O
",",O
do,O
not,O
produce,O
a,O
significant,O
level,O
of,O
virus,O
",",O
presumably,O
because,O
they,O
are,O
unresponsive,O
to,O
TNF,B
and,O
IL,B
-,I
7,I
.,O
Activation,O
of,O
CD40,B
is,O
essential,O
for,O
thymus,B
-,I
dependent,I
humoral,I
immune,I
responses,I
and,O
rescuing,O
B,B
cells,I
from,O
apoptosis,O
.,O
MBP,B
over,O
the,O
concentration,O
range,O
of,O
0,O
.,O
1,O
to,O
10,O
microM,O
stimulated,O
the,O
release,O
of,O
up,O
to,O
approximately,O
8,O
ng,O
/,O
ml,O
IL,B
-,I
8,I
.,O
MBP,B
also,O
induced,O
transient,O
increases,O
in,O
mRNA,B
for,O
macrophage,B
inflammatory,I
protein,I
(,I
MIP,I
),I
-,I
1alpha,I
and,O
MIP,B
-,I
1beta,I
",",O
but,O
did,O
not,O
stimulate,O
the,O
release,O
of,O
either,O
chemokine,O
.,O
Patients,O
with,O
the,O
recessively,O
inherited,O
disorder,O
ataxia,O
telangiectasia,O
(,O
A,B
-,I
T,I
),O
have,O
a,O
high,O
level,O
of,O
specific,O
chromosome,O
translocations,O
which,O
can,O
be,O
easily,O
observed,O
in,O
peripheral,O
T,B
cells,I
and,O
show,O
a,O
greatly,O
increased,O
predisposition,O
to,O
leukaemia,O
/,O
lymphoma,O
",",O
mainly,O
of,O
T,B
cell,I
origin,O
.,O
On,O
the,O
average,O
",",O
no,O
correlation,O
was,O
established,O
between,O
degree,O
of,O
lymphocyte,O
infiltration,O
in,O
breast,O
tumor,O
and,O
age,O
and,O
menopause,O
onset,O
.,O
A,O
high,O
-,O
affinity,O
calcineurin,B
-,I
binding,I
peptide,I
was,O
selected,O
from,O
combinatorial,O
peptide,O
libraries,O
based,O
on,O
the,O
calcineurin,B
docking,I
motif,I
of,O
NFAT,O
.,O
Substitution,O
of,O
the,O
optimized,O
peptide,O
sequence,O
into,O
the,O
natural,O
calcineurin,B
docking,I
site,I
increased,O
the,O
calcineurin,B
responsiveness,I
of,O
NFAT,O
.,O
Compounds,O
that,O
interfere,O
selectively,O
with,O
the,O
calcineurin,B
-,I
NFAT,I
interaction,I
without,O
affecting,O
calcineurin,B
phosphatase,I
activity,I
may,O
be,O
useful,O
as,O
therapeutic,O
agents,O
that,O
are,O
less,O
toxic,O
than,O
current,O
drugs,O
.,O
9,O
-,O
cis,O
retinoic,O
acid,O
induces,O
monocyte,O
chemoattractant,O
protein,B
-,I
1,I
secretion,O
in,O
human,O
monocytic,O
THP,B
-,I
1,I
cells,O
.,O
Thus,O
",",O
both,O
copies,O
of,O
BRCA1,B
were,O
retained,O
in,O
tumor,O
.,O
The,O
DNA,B
variation,O
",",O
233G,O
-,O
-,O
>,O
A,O
",",O
does,O
not,O
result,O
in,O
an,O
amino,O
acid,O
change,O
",",O
and,O
is,O
considered,O
a,O
benign,O
polymorphism,O
.,O
Therefore,O
",",O
we,O
investigated,O
whether,O
IVS1,O
-,O
10T,O
-,O
-,O
>,O
C,O
deleteriously,O
affected,O
BRCA1,B
splicing,O
or,O
expression,O
",",O
and,O
thereby,O
inactivated,O
the,O
other,O
BRCA1,B
allele,O
.,O
For,O
example,O
dendritic,B
cells,I
(,O
DC,B
),O
can,O
be,O
found,O
in,O
colonies,O
of,O
GM,B
-,I
CSF,I
-,I
responsive,I
bone,O
marrow,O
cells,O
",",O
and,O
under,O
experimental,O
conditions,O
are,O
routinely,O
expanded,O
as,O
a,O
population,O
in,O
vitro,O
from,O
GM,B
-,I
CSF,I
-,I
responsive,I
progenitor,O
cells,O
.,O
We,O
have,O
used,O
this,O
MTHC,O
system,O
to,O
analyze,O
differences,O
in,O
gene,O
expression,O
as,O
the,O
cells,O
mature,O
along,O
the,O
DC,B
and,O
macrophage,B
pathways,O
.,O
We,O
have,O
investigated,O
mechanisms,O
and,O
consequences,O
of,O
STAT5,B
activation,O
through,O
the,O
human,O
IL,B
-,I
4,I
receptor,I
(,O
IL,B
-,I
4R,I
),O
. By,O
functionally,O
expressing,O
receptor,O
mutants,O
in,O
the,O
murine,O
pro,O
-,O
B,O
cell,O
line,O
Ba,O
/,O
F3,O
",",O
we,O
could,O
show,O
that,O
phosphorylated,O
tyrosine,O
residues,O
within,O
the,O
IL,B
-,I
4R,I
alpha,I
chain,I
are,O
dispensable,O
for,O
IL,B
-,I
4,I
-,I
induced,O
STAT5,B
activity,O
.,O
An,O
inhibitory,O
",",O
`,O
`,O
dominant,O
-,O
negative,O
",",O
',O
',O
form,O
of,O
the,O
calcineurin,O
catalytic,O
(,O
A,B
),O
subunit,O
was,O
prepared,O
",",O
which,O
lacks,O
the,O
calmodulin,O
-,O
binding,O
domain,O
",",O
autoinhibitory,O
domain,O
and,O
most,O
of,O
its,O
catalytic,O
core,O
but,O
possesses,O
the,O
regulatory,O
(,O
B,B
),O
subunit,O
binding,O
domain,O
.,O
Immunoprecipitation,O
of,O
epitope,O
-,O
labeled,O
BKO,O
demonstrated,O
for,O
the,O
formation,O
of,O
a,O
tight,O
complex,O
with,O
endogenous,O
B,O
subunit,O
in,O
Jurkat,O
cells,O
",",O
consistent,O
with,O
an,O
inhibitory,O
mechanism,O
that,O
involves,O
the,O
sequestration,O
of,O
the,O
B,O
subunit,O
.,O
Monoclonal,B
anti,I
-,I
D,I
antibodies,I
submitted,O
to,O
the,O
Third,O
Monoclonal,O
International,O
Workshop,O
were,O
evaluated,O
against,O
a,O
number,O
of,O
D,B
variant,I
cells,I
using,O
standard,O
serological,O
techniques,O
.,O
Cells,O
within,O
each,O
category,O
did,O
not,O
give,O
any,O
aberrant,O
results,O
.,O
B,B
cells,I
were,O
purified,O
from,O
buffy,O
coat,O
preparations,O
of,O
healthy,O
blood,O
donors,O
by,O
positive,O
selection,O
using,O
an,O
anti,B
CD20,I
monoclonal,I
antibody,I
and,O
a,O
MiniMACS,B
separation,I
unit,I
.,O
RNA,B
was,O
extracted,O
by,O
phenol,O
/,O
chloroform,O
and,O
c,O
-,O
fos,B
expression,O
was,O
analyzed,O
by,O
PCR,O
assisted,O
mRNA,B
assay,O
.,O
A,O
significant,O
2,O
-,O
4,O
fold,O
increase,O
of,O
c,O
-,O
fos,B
expression,O
was,O
observed,O
within,O
30,O
min,O
of,O
stimulation,O
with,O
IL,B
-,I
10,I
(,O
p,O
<,O
0,O
.,O
1,O
),O
.,O
Since,O
this,O
is,O
the,O
first,O
report,O
on,O
IL,B
-,I
10,I
induced,O
signal,O
transduction,O
.,O
these,O
data,O
may,O
help,O
to,O
identify,O
the,O
intracellular,O
mechanisms,O
by,O
which,O
IL,B
-,I
10,I
stimulates,O
human,B
B,I
-,I
cells,I
.,O
MNDA,B
was,O
not,O
detected,O
in,O
normal,O
tissue,O
histiocytes,O
but,O
was,O
found,O
in,O
activated,O
macrophages,O
and,O
foreign,O
body,O
giant,O
cells,O
associated,O
with,O
inflammation,O
.,O
Flow,O
cytometric,O
cell,O
sorting,O
of,O
normal,O
bone,O
marrow,O
established,O
that,O
MNDA,B
is,O
initially,O
expressed,O
in,O
myeloid,O
blast,O
cells,O
.,O
Peroxisome,B
proliferator,I
-,I
activated,O
receptors,O
(,O
PPARs,B
),O
",",O
members,O
of,O
the,O
nuclear,O
receptor,O
superfamily,O
of,O
transcription,O
factors,O
",",O
are,O
activated,O
by,O
fatty,O
acid,O
metabolites,O
",",O
peroxisome,B
proliferators,I
",",O
and,O
thiazolidinediones,O
and,O
are,O
now,O
recognized,O
as,O
important,O
mediators,O
in,O
the,O
inflammatory,O
response,O
.,O
Expression,O
of,O
wild,O
-,O
type,O
SHP1.00,B
had,O
a,O
very,O
small,O
effect,O
on,O
the,O
TCR,O
-,O
induced,O
tyrosine,O
phosphorylation,O
of,O
ZAP,B
-,I
70,I
and,O
Syk,B
",",O
even,O
when,O
SHP1.00,B
was,O
overexpressed,O
20,O
-,O
100,O
-,O
fold,O
over,O
endogenous,O
SHP1.00,B
.,O
However,O
",",O
the,O
two,O
SH2,B
domains,I
of,I
SHP1.00,B
did,O
not,O
facilitate,O
its,O
recognition,O
of,O
ZAP,B
-,I
70,I
and,O
Syk,B
as,O
substrates,O
in,O
intact,O
cells,O
.,O
Eosinophil,B
granule,I
major,I
basic,I
protein,I
(,O
MBP,B
),O
is,O
expressed,O
exclusively,O
in,O
eosinophils,B
and,O
basophils,B
in,O
hematopoietic,O
cells,O
.,O
In,O
the,O
cell,O
line,O
HT93A,B
",",O
which,O
is,O
capable,O
of,O
differentiating,O
towards,O
both,O
the,O
eosinophil,B
and,O
neutrophil,B
lineages,O
in,O
response,O
to,O
retinoic,O
acid,O
(,O
RA,B
),O
",",O
C,O
/,O
CEBPalpha,B
mRNA,I
expression,O
decreased,O
significantly,O
concomitant,O
with,O
eosinophilic,B
and,O
neutrophilic,B
differentiation,O
",",O
whereas,O
C,O
/,O
CEBPbeta,B
expression,O
was,O
markedly,O
increased,O
.,O
Furthermore,O
",",O
we,O
have,O
demonstrated,O
that,O
both,O
C,B
/,I
EBPbeta,I
and,O
GATA,B
-,I
1,I
can,O
bind,O
simultaneously,O
to,O
the,O
C,B
/,I
EBP,I
-,I
and,O
GATA,B
-,I
binding,I
sites,I
in,O
the,O
MBP,B
promoter,I
.,O
Role,O
of,O
the,O
camp,B
response,I
element,I
site,I
in,O
mediating,O
repression,O
by,O
the,O
upstream,O
regulatory,O
region,O
.,O
DNase,B
I,I
footprinting,I
identified,O
several,O
protected,O
areas,O
including,O
Sp1,B
",",O
Sp1,B
/,I
AP,I
-,I
2,I
",",O
and,O
cAMP,B
response,I
element,I
(,I
CRE,I
),I
binding,I
sites,I
within,O
the,O
201,O
-,O
bp,O
core,O
promoter,O
region,O
and,O
Sp1,B
",",O
NRE,B
-,I
2a,I
",",O
TCF,B
-,I
1,I
/,I
LEF,I
-,I
1,I
",",O
and,O
Sp1,B
/,I
NF,I
-,I
AT,I
binding,I
sites,I
in,O
the,O
upstream,O
regulatory,O
region,O
.,O
Electrophoretic,O
mobility,O
shift,O
assay,O
analysis,O
of,O
proteins,B
binding,O
to,O
the,O
CRE,B
site,I
identified,O
both,O
ATF,B
-,I
1,I
and,O
ATF,B
-,I
2,I
in,O
Jurkat,B
cells,I
.,O
In,O
summary,O
",",O
we,O
have,O
identified,O
a,O
tissue,B
-,I
specific,I
regulatory,I
region,I
5,O
',O
of,O
the,O
ecto,B
-,I
5,I
',I
-,I
NT,I
core,I
promoter,I
that,O
requires,O
the,O
presence,O
of,O
a,O
functional,B
CRE,I
site,I
within,O
the,O
basal,B
promoter,I
for,O
its,O
suppressive,O
activity,O
.,O
Extracellular,O
signal,O
-,O
regulated,O
protein,B
kinase,I
(,O
ERK,B
),O
-,O
dependent,O
and,O
ERK,B
-,O
independent,O
pathways,O
target,O
STAT3,B
on,O
serine,O
-,O
727,O
in,O
human,O
neutrophils,O
stimulated,O
by,O
chemotactic,O
factors,O
and,O
cytokines,O
.,O
(,O
2,O
-,O
Amino,O
-,O
3,O
',O
-,O
methoxyphenyl,O
),O
oxanaphthalen,O
-,O
4,O
-,O
one,O
(,O
PD,O
98059,O
),O
",",O
an,O
inhibitor,O
of,O
extracellular,O
signal,O
-,O
regulated,O
protein,B
kinase,I
(,O
ERK,B
),O
activation,O
",",O
blocked,O
the,O
serine,O
phosphorylation,O
of,O
STAT3,B
induced,O
by,O
chemotactic,O
factors,O
or,O
PMA,O
.,O
These,O
foci,O
",",O
which,O
were,O
preferentially,O
found,O
adjacent,O
to,O
nucleoli,O
or,O
at,O
the,O
nuclear,O
periphery,O
",",O
did,O
not,O
represent,O
sites,O
of,O
active,O
transcription,O
or,O
binding,O
of,O
GATA,B
-,I
1,I
to,O
consensus,O
sites,O
in,O
the,O
beta,B
-,I
globin,I
loci,I
.,O
After,O
exercise,O
following,O
placebo,O
administration,O
we,O
observed,O
increases,O
in,O
concentrations,O
of,O
blood,O
substrates,O
",",O
plasma,O
adrenocorticotropin,B
(,I
ACTH,I
),I
",",O
growth,O
hormone,O
and,O
cortisol,O
and,O
in,O
the,O
number,O
of,O
glucocorticoid,B
receptors,I
in,O
lymphocytes,O
without,O
changes,O
in,O
the,O
dissociation,O
constant,O
.,O
Intravenous,O
PCr,B
injection,I
led,O
to,O
smaller,O
changes,O
in,O
ACTH,B
and,O
cortisol,B
concentrations,O
as,O
well,O
as,O
to,O
a,O
lower,O
activation,O
of,O
glucocorticoid,B
binding,I
in,O
lymphocytes,O
.,O
Putative,O
steroid,B
binding,I
domain,I
of,I
the,I
human,I
mineralocorticoid,I
receptor,I
",",O
expressed,O
in,O
E,O
.,O
coli,O
in,O
the,O
presence,O
of,O
heat,O
shock,O
proteins,O
shows,O
typical,O
native,O
receptor,O
characteristics,O
.,O
These,O
bacterially,O
-,O
produced,O
MR,B
constructs,I
had,O
no,O
steroid,O
binding,O
activity,O
per,O
se,O
.,O
The,O
Kd,O
value,O
for,O
aldosterone,B
was,O
0,O
.,O
3,O
nM,O
and,O
the,O
Bmax,B
=,O
32,O
pmol,O
/,O
mg,O
.,O
Renal,O
cell,O
carcinoma,O
-,O
derived,O
gangliosides,B
suppress,O
nuclear,O
factor,O
-,O
kappaB,O
activation,O
in,O
T,O
cells,O
.,O
Indeed,O
",",O
we,O
detected,O
gangliosides,B
in,O
supernatants,O
from,O
RCC,O
explants,O
and,O
not,O
from,O
adjacent,O
normal,O
kidney,O
tissue,O
.,O
In,O
this,O
study,O
",",O
we,O
investigate,O
the,O
role,O
of,O
TNFalpha,B
-,I
inducible,I
reactive,I
oxygen,I
species,I
(,O
ROS,B
),O
in,O
IL,B
-,I
8,I
expression,O
by,O
`,O
`,O
monocyte,B
-,I
like,I
',I
',I
U937,B
histiocytic,I
lymphoma,I
cells,I
.,O
These,O
data,O
indicate,O
that,O
TNFalpha,B
induces,O
a,O
delayed,O
ROS,B
-,I
dependent,I
signalling,I
pathway,I
that,O
is,O
required,O
for,O
NF,B
-,I
kappaB,I
transcriptional,I
activation,I
and,O
is,O
separable,O
from,O
that,O
required,O
for,O
its,O
nuclear,O
translocation,O
.,O
Estrogen,B
receptors,I
influence,O
non,O
-,O
genomic,O
events,O
",",O
which,O
are,O
rapid,O
in,O
onset,O
and,O
genomic,O
events,O
",",O
which,O
are,O
longer,O
acting,O
responses,O
.,O
Estrogens,B
also,O
influence,O
production,O
of,O
mitogens,B
which,O
",",O
when,O
released,O
at,O
sites,O
of,O
vascular,B
injury,I
",",O
affect,O
vascular,B
remodeling,I
.,O
Protein,B
kinase,I
C,I
and,O
calcineurin,B
synergize,O
to,O
activate,O
IkappaB,B
kinase,I
and,O
NF,B
-,I
kappaB,I
in,O
T,B
lymphocytes,I
.,O
We,O
also,O
demonstrate,O
that,O
the,O
IKK,B
complex,I
",",O
but,O
not,O
p90,O
(,O
rsk,O
),O
",",O
is,O
responsible,O
for,O
the,O
in,O
vivo,O
phosphorylation,O
of,O
IkappaBalpha,B
mediated,O
by,O
the,O
co,O
-,O
activation,O
of,O
PKC,B
and,O
calcineurin,B
.,O
The,O
p53,B
paradox,O
in,O
the,O
pathogenesis,O
of,O
tumor,O
progression,O
.,O
Additional,O
upstream,O
gene,O
segments,O
dramatically,O
affected,O
B29,B
minimal,I
promoter,I
activity,O
.,O
These,O
findings,O
indicate,O
that,O
B29,B
gene,I
expression,O
is,O
controlled,O
by,O
the,O
complex,O
interplay,O
of,O
positive,O
and,O
negative,O
regulatory,O
elements,O
.,O
A,O
novel,O
immunosuppressive,O
factor,O
in,O
bovine,B
colostrum,I
blocks,O
activation,O
of,O
the,O
interleukin,B
2,I
gene,I
enhancer,O
at,O
the,O
NFAT,B
site,O
.,O
A,O
factor,O
in,O
bovine,B
colostrum,I
(,O
colostrum,I
inhibitory,I
factor,I
",",O
CIF,O
),O
inhibits,O
interleukin,B
2,I
(,O
IL2,O
),O
production,O
in,O
activated,O
T,O
helper,O
cells,O
by,O
blocking,O
the,O
accumulation,O
of,O
IL2,O
mRNA,O
.,O
To,O
determine,O
whether,O
CIF,O
blocks,O
at,O
the,O
level,O
of,O
IL2,B
transcription,O
",",O
we,O
introduced,O
reporter,O
plasmids,O
into,O
the,O
human,O
T,B
leukemia,I
cell,I
line,I
Jurkat,I
by,O
transient,O
transfection,O
.,O
The,O
NFAT,B
-,I
controlled,I
luciferase,I
gene,I
system,I
distinguishes,O
CIF,O
from,O
other,O
T,B
cell,I
inhibitory,I
activities,I
present,O
in,O
colostrum,O
",",O
in,O
particular,O
",",O
TGF,B
beta,I
1,I
and,O
TGF,B
beta,I
2,I
and,O
the,O
glucocorticoids,O
.,O
The,O
NFAT,B
-,I
luc,I
assay,I
is,O
a,O
useful,O
technique,O
for,O
the,O
rapid,O
",",O
sensitive,O
measurement,O
of,O
CIF,B
or,O
other,O
immunosuppressants,O
with,O
a,O
similar,O
mode,O
of,O
action,O
.,O
To,O
propel,O
itself,O
in,O
infected,O
cells,O
",",O
the,O
pathogen,O
Shigella,B
flexneri,I
subverts,O
the,O
Cdc42,B
-,I
controlled,I
machinery,I
responsible,O
for,O
actin,B
assembly,I
during,O
filopodia,O
formation,O
.,O
Using,O
a,O
combination,O
of,O
bacterial,B
motility,I
assays,I
in,O
platelet,O
extracts,O
with,O
Escherichia,O
coli,O
expressing,O
the,O
Shigella,O
IcsA,B
protein,I
and,O
in,O
vitro,O
analysis,O
of,O
reconstituted,O
systems,O
from,O
purified,O
proteins,O
",",O
we,O
show,O
here,O
that,O
the,O
bacterial,B
protein,I
IcsA,B
binds,O
N,O
-,O
WASP,B
and,O
activates,O
it,O
in,O
a,O
Cdc42,B
-,I
like,I
fashion,I
.,O
VASP,B
is,O
not,O
involved,O
in,O
Shigella,B
movement,O
",",O
and,O
the,O
function,O
of,O
profilin,B
does,O
not,O
require,O
its,O
binding,O
to,O
proline,B
-,I
rich,I
regions,I
.,O
c,O
-,O
Maf,B
induces,O
monocytic,B
differentiation,I
and,O
apoptosis,B
in,O
bipotent,B
myeloid,I
progenitors,I
.,O
We,O
have,O
shown,O
that,O
the,O
c,O
-,O
Maf,B
and,O
c,O
-,O
Myb,B
transcription,O
factors,O
physically,O
interact,O
in,O
myeloid,B
cells,I
to,O
form,O
inhibitory,O
complexes,O
that,O
hinder,O
transactivation,O
of,O
c,O
-,O
Myb,B
target,I
genes,I
through,O
direct,O
binding,O
to,O
Myb,B
consensus,I
sites,I
.,O
Elevated,O
levels,O
of,O
c,B
-,I
Maf,I
protein,I
led,O
to,O
marked,O
increases,O
in,O
Myb,B
:,O
Maf,B
complexes,I
and,O
the,O
accumulation,O
of,O
monocyte,B
/,I
macrophage,I
cells,I
",",O
followed,O
by,O
eventual,O
programmed,O
cell,B
death,I
.,O
Analysis,O
of,O
targets,O
that,O
could,O
mediate,O
these,O
phenotypic,O
changes,O
indicated,O
that,O
c,B
-,I
Maf,I
likely,O
plays,O
a,O
key,O
role,O
in,O
myeloid,B
cell,I
development,I
through,O
dual,O
mechanisms,O
;,O
inhibition,O
of,O
a,O
select,O
set,O
of,O
c,B
-,I
Myb,I
regulated,I
targets,I
",",O
such,O
as,O
Bcl,B
-,I
2,I
and,O
CD13,B
/,I
APN,I
",",O
coupled,O
with,O
the,O
activation,O
of,O
as,O
yet,O
undefined,O
differentiation,O
-,O
promoting,O
genes,O
.,O
We,O
have,O
examined,O
the,O
effect,O
of,O
Rb,B
expression,O
on,O
the,O
activation,O
of,O
the,O
promoter,O
for,O
HLA,B
-,I
DRA,I
",",O
the,O
prototype,O
class,O
II,O
gene,O
. Different,O
glucocorticoid,B
hormones,I
(,O
GCH,B
),O
show,O
differences,O
in,O
the,O
intensity,O
and,O
in,O
the,O
kinetics,O
of,O
their,O
immunomodulating,O
activity,O
. The,O
mechanism,O
(,O
s,O
),O
of,O
action,O
of,O
GCH,B
is,O
under,O
investigation,O
",",O
but,O
is,O
has,O
been,O
noted,O
that,O
they,O
exert,O
immune,O
activity,O
via,O
the,O
genomic,O
pathway,O
.,O
These,O
findings,O
suggest,O
that,O
BCL,B
-,I
6,I
may,O
play,O
a,O
role,O
in,O
regulating,O
differentiation,O
of,O
normal,O
germinal,O
center,O
B,B
cells,I
and,O
that,O
its,O
deregulated,O
expression,O
caused,O
by,O
rearrangements,O
may,O
contribute,O
to,O
lymphomagenesis,O
.,O
Activation,O
of,O
NF,B
-,I
kappa,I
B,I
is,O
induced,O
by,O
prooxidants,O
and,O
several,O
stimuli,O
eliciting,O
oxidative,O
stress,O
",",O
such,O
as,O
cytokines,O
",",O
lipopolysaccharide,O
",",O
UV,O
irradiation,O
and,O
other,O
mediators,O
.,O
To,O
better,O
understand,O
the,O
assembly,O
mechanism,O
for,O
the,O
progesterone,B
receptor,I
(,O
PR,B
),O
",",O
we,O
have,O
developed,O
cell,B
-,I
free,I
systems,I
for,O
studying,O
interactions,O
of,O
PR,B
",",O
hsp90,B
",",O
and,O
other,O
associated,O
proteins,O
.,O
These,O
interactions,O
require,O
ATP,B
/,O
Mg2,B
+,I
and,O
when,O
ATP,B
is,O
limiting,O
the,O
PR,B
complex,I
is,O
altered,O
to,O
one,O
containing,O
the,O
proteins,O
p60,B
and,O
p48,B
",",O
but,O
lacking,O
immunophilins,B
and,O
p23,B
.,O
One,O
contains,O
hsp90,B
bound,O
to,O
hsp70,B
and,O
p60,B
and,O
this,O
complex,O
forms,O
spontaneously,O
in,O
the,O
absence,O
of,O
ATP,B
.,O
This,O
explains,O
",",O
in,O
part,O
",",O
the,O
known,O
effects,O
of,O
ATP,B
and,O
molybdate,O
on,O
assembly,O
of,O
PR,O
complexes,O
.,O
We,O
have,O
recently,O
demonstrated,O
that,O
hydrocortisone,O
and,O
other,O
glucocorticoids,O
inhibit,O
reactive,O
oxygen,O
species,O
(,O
ROS,B
),O
generation,O
by,O
mononuclear,B
(,O
MNC,B
),O
and,O
polymorphonuclear,B
leucocytes,I
(,O
PMNL,B
),O
.,O
Since,O
NF,B
-,I
kappaB,I
/,I
IkappaB,B
system,O
regulates,O
the,O
transcription,O
of,O
proinflammatory,O
genes,O
",",O
including,O
those,O
responsible,O
for,O
ROS,O
generation,O
",",O
we,O
tested,O
the,O
hypothesis,O
that,O
hydrocortisone,O
may,O
stimulate,O
IkappaB,B
production,O
thus,O
inhibiting,O
NF,B
-,I
kappaB,I
translocation,O
from,O
the,O
cytosol,O
into,O
the,O
nucleus,O
in,O
MNC,B
",",O
in,O
vivo,O
.,O
Blood,B
samples,I
were,O
obtained,O
prior,O
to,O
the,O
injection,O
and,O
at,O
1,O
",",O
2,O
",",O
4,O
",",O
8,O
and,O
24,O
hr,O
after,O
the,O
injection,O
.,O
The,O
total,O
protein,B
content,I
of,O
NF,B
-,I
kappaB,I
subunit,I
(,O
P65,B
),O
in,O
MNC,B
lysates,I
also,O
showed,O
a,O
decrease,O
following,O
hydrocortisone,O
injection,O
.,O
This,O
decrease,O
was,O
observed,O
at,O
2,O
hr,O
",",O
reached,O
a,O
nadir,O
at,O
4,O
hr,O
",",O
and,O
returned,O
to,O
baseline,O
levels,O
at,O
24,O
hr,O
.,O
Our,O
data,O
demonstrate,O
that,O
hydrocortisone,O
induces,O
IkappaB,B
and,O
suppresses,O
NF,B
-,I
kappaB,I
expression,O
in,O
MNC,O
in,O
parallel,O
.,O
However,O
",",O
the,O
exact,O
cellular,O
mechanisms,O
underlying,O
this,O
anti,O
-,O
inflammatory,O
capacity,O
are,O
still,O
unknown,O
.,O
In,O
our,O
study,O
",",O
we,O
determined,O
the,O
induction,O
of,O
apoptosis,O
by,O
GC,O
in,O
human,O
monocytes,O
.,O
Monocyte,B
apoptosis,O
was,O
determined,O
by,O
four,O
independent,O
methods,O
",",O
including,O
annexin,B
-,I
V,I
staining,O
",",O
TUNEL,B
",",O
DNA,B
-,I
laddering,I
",",O
and,O
typical,O
morphology,O
by,O
means,O
of,O
transmission,O
electron,O
microscopy,O
.,O
Necrosis,B
was,O
excluded,O
by,O
propidium,B
iodide,I
staining,O
.,O
Proinflammatory,O
cytokines,O
such,O
as,O
IL,B
-,I
1beta,I
and,O
TNF,B
-,I
alpha,I
were,O
down,O
-,O
regulated,O
by,O
GC,B
treatment,O
.,O
Continuous,O
treatment,O
of,O
monocytes,B
with,O
IL,B
-,I
1beta,I
",",O
but,O
not,O
with,O
TNF,B
-,I
alpha,I
",",O
could,O
almost,O
completely,O
prevent,O
GC,B
-,I
induced,I
cell,I
death,I
.,O
The,O
addition,O
of,O
mifepristone,B
or,O
caspase,B
-,I
3,I
inhibitor,I
could,O
partially,O
abrogate,O
GC,B
-,I
induced,I
apoptosis,I
as,O
well,O
as,O
GC,B
-,I
induced,I
inhibition,I
of,I
IL,B
-,I
1beta,I
.,O
The,O
inflammatory,O
mediators,O
lipopolysaccharide,B
(,I
LPS,I
),I
and,O
tumor,O
necrosis,O
factor,O
(,O
TNF,B
),I
are,O
potent,O
activators,O
of,O
NF,B
-,I
kappaB,I
.,O
Kinase,O
assays,O
showed,O
that,O
TNF,O
elicited,O
a,O
rapid,O
but,O
short,O
-,O
lived,O
induction,O
of,O
IKK,B
activity,O
with,O
a,O
3,O
-,O
fold,O
greater,O
effect,O
on,O
IKK,B
-,I
alpha,I
than,O
on,O
IKK,B
-,I
beta,I
",",O
peaking,O
at,O
5,O
min,O
.,O
Furthermore,O
",",O
our,O
studies,O
showed,O
association,O
of,O
the,O
IKK,B
-,I
alpha,I
/,O
beta,O
heterodimer,O
with,O
NIK,O
",",O
IkappaB,O
-,O
alpha,O
and,O
-,O
epsilon,O
in,O
unstimulated,O
cells,O
.,O
The,O
understanding,O
of,O
LPS,B
-,I
and,O
TNF,B
-,I
induced,O
signaling,O
may,O
allow,O
the,O
development,O
of,O
specific,O
strategies,O
to,O
treat,O
sepsis,O
-,O
associated,O
disease,O
.,O
The,O
aim,O
of,O
this,O
study,O
was,O
to,O
examine,O
the,O
ability,O
of,O
tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNFalpha,B
",",O
a,O
proinflammatory,O
cytokine,O
),O
and,O
interleukin,B
(,O
IL,B
),O
-,O
10,O
(,O
an,O
anti,O
-,O
inflammatory,O
cytokine,O
),O
to,O
differentially,O
regulate,O
the,O
sensitivity,O
of,O
human,O
monocytes,O
/,O
macrophages,O
to,O
glucocorticoids,O
.,O
Finally,O
",",O
we,O
investigated,O
whether,O
the,O
modulation,O
of,O
corticosensitivity,O
in,O
TNFalpha,O
-,O
and,O
IL,O
-,O
10,O
-,O
pretreated,O
U937,B
cells,I
was,O
related,O
to,O
a,O
change,O
of,O
the,O
glucocorticoid,B
receptor,I
concentration,O
and,O
affinity,O
.,O
TNFalpha,O
decreased,O
(,O
P,O
<,O
0,O
.,O
1,O
),O
",",O
while,O
IL,O
-,O
10,O
increased,O
(,O
P,O
<,O
0,O
.,O
1,O
),O
",",O
the,O
concentration,O
of,O
dexamethasone,B
binding,I
sites,I
in,O
these,O
cells,O
",",O
with,O
no,O
discernible,O
effect,O
on,O
their,O
binding,O
affinity,O
.,O
We,O
conclude,O
that,O
glucocorticoids,B
differentially,O
modulate,O
TNFalpha,B
and,O
IL,B
-,I
10,I
secretion,O
by,O
human,O
monocytes,O
in,O
a,O
LPS,O
dose,O
-,O
dependent,O
fashion,O
and,O
that,O
the,O
sensitivity,O
of,O
these,O
cells,O
to,O
glucocorticoids,B
is,O
altered,O
by,O
TNFalpha,B
or,O
IL,B
-,I
10,I
pretreatment,O
;,O
TNFalpha,B
blocks,O
their,O
effects,O
",",O
whereas,O
IL,B
-,I
10,I
acts,O
synergistically,O
with,O
glucocorticoids,B
.,O
Because,O
NF,B
-,I
kappa,I
B,I
contributes,O
to,O
the,O
transcription,O
of,O
numerous,O
inflammatory,O
genes,O
and,O
has,O
been,O
shown,O
to,O
be,O
a,O
molecular,O
target,O
of,O
antiinflammatory,O
drugs,O
",",O
we,O
sought,O
to,O
characterize,O
the,O
functional,B
role,I
of,O
the,O
NF,B
-,I
kappa,I
B,I
protein,I
complex,I
in,O
lupus,B
T,I
cells,I
.,O
Also,O
",",O
NF,B
-,I
kappa,I
B,I
activity,O
remained,O
absent,O
in,O
follow,O
-,O
up,O
studies,O
.,O
As,O
p65,B
complexes,I
are,O
transcriptionally,O
active,O
in,O
comparison,O
to,O
the,O
p50,B
homodimer,I
",",O
this,O
novel,O
finding,O
may,O
provide,O
insight,O
on,O
the,O
origin,O
of,O
abnormal,O
cytokine,O
or,O
other,O
gene,O
transcription,O
in,O
SLE,O
patients,O
.,O
Here,O
",",O
we,O
investigate,O
further,O
the,O
events,O
triggered,O
by,O
TLR2,B
in,O
response,O
to,O
LPS,B
.,O
Intracellular,O
deletion,O
variants,O
of,O
TLR2,B
lacking,O
C,O
-,O
terminal,O
13,O
or,O
141,O
aa,O
fail,O
to,O
recruit,O
IRAK,B
",",O
which,O
is,O
consistent,O
with,O
the,O
inability,O
of,O
these,O
mutants,O
to,O
transmit,O
LPS,B
cellular,I
signaling,I
.,O
Here,O
we,O
provide,O
novel,O
evidence,O
that,O
AG,B
-,I
490,I
potently,O
inhibits,O
the,O
autokinase,O
activity,O
of,O
JAK3,B
and,O
tyrosine,O
phosphorylation,O
and,O
DNA,B
binding,O
of,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
5a,B
and,O
5b,B
(,O
STAT5a,B
/,I
b,I
),O
.,O
AG,B
-,I
490,I
also,O
inhibited,O
IL,B
-,I
2,I
-,I
mediated,O
proliferative,O
growth,O
in,O
human,O
T,B
cells,I
with,O
an,O
IC50,O
),O
=,O
25,O
microM,O
that,O
was,O
partially,O
recoverable,O
.,O
Taken,O
together,O
",",O
these,O
findings,O
suggest,O
that,O
AG,B
-,I
490,I
inhibits,O
the,O
JAK3,B
-,I
mediated,I
Type,I
II,I
signaling,I
pathway,I
but,O
not,O
the,O
T,B
cell,I
receptor,I
-,I
derived,I
Type,I
I,I
pathway,I
and,O
possesses,O
therapeutic,O
potential,O
for,O
T,B
cell,I
-,I
derived,I
pathologies,I
such,O
as,O
graft,O
-,O
versus,O
-,O
host,O
disease,O
",",O
allergy,O
",",O
and,O
autoimmune,O
disorders,O
.,O
Two,O
-,O
color,O
immunohistochemistry,O
demonstrated,O
that,O
both,O
macrophages,O
and,O
fibroblast,O
-,O
like,O
synoviocytes,O
were,O
positive,O
for,O
nuclear,O
C,B
/,I
EBP,I
beta,I
.,O
PU,O
.,O
1,O
is,O
a,O
hematopoietic,O
-,O
specific,O
Ets,O
family,O
transcription,O
factor,O
that,O
is,O
required,O
for,O
development,O
of,O
some,O
lymphoid,O
and,O
myeloid,O
lineages,O
.,O
We,O
find,O
that,O
PU,B
.,O
1,O
interacts,O
directly,O
with,O
GATA,O
-,O
1,O
",",O
a,O
zinc,O
finger,O
transcription,O
factor,O
required,O
for,O
erythroid,O
differentiation,O
.,O
Both,O
the,O
DNA,B
binding,I
and,O
transactivation,O
domains,O
of,O
PU,O
.,O
1,O
are,O
required,O
for,O
repression,O
and,O
both,O
domains,O
are,O
also,O
needed,O
to,O
block,O
terminal,O
differentiation,O
in,O
MEL,B
cells,I
.,O
To,O
better,O
clarify,O
the,O
molecular,O
basis,O
of,O
IL,B
-,I
12,I
action,O
",",O
we,O
set,O
out,O
to,O
characterize,O
genes,O
up,O
-,O
regulated,O
by,O
IL,B
-,I
12,I
",",O
first,O
by,O
contrasting,O
IL,B
-,I
12,I
-,I
and,O
IFN,B
-,I
alpha,I
-,I
inducible,O
genes,O
.,O
We,O
identified,O
several,O
genes,O
up,O
-,O
regulated,O
by,O
IL,B
-,I
12,I
",",O
namely,O
",",O
MIP,B
-,I
1alpha,I
",",O
MIP,B
-,I
1beta,I
",",O
IL,B
-,I
1RA,I
",",O
and,O
IFN,B
regulatory,I
factor,I
-,I
1,I
(,O
IRF,B
-,I
1,I
),O
.,O
Therefore,O
",",O
IRF,B
-,I
1,I
may,O
be,O
an,O
important,O
contributor,O
to,O
IL,B
-,I
12,I
signaling,O
",",O
and,O
we,O
speculate,O
that,O
the,O
defective,O
IL,B
-,I
12,I
responses,O
seen,O
in,O
IRF,B
-,I
1,I
-,I
/,I
-,I
mice,O
might,O
be,O
attributable,O
",",O
in,O
part,O
",",O
to,O
the,O
absence,O
of,O
this,O
transcription,O
factor,O
.,O
To,O
determine,O
whether,O
it,O
is,O
possible,O
to,O
artificially,O
enhance,O
the,O
opening,O
of,O
the,O
chromatin,O
structure,O
of,O
a,O
minimal,O
beta,B
-,I
globin,I
promoter,I
",",O
we,O
placed,O
a,O
101bp,O
",",O
erythroid,B
-,I
specific,I
DNase,I
1,I
hypersensitive,I
site,I
-,I
forming,I
element,I
(,O
HSFE,O
),O
immediately,O
upstream,O
of,O
the,O
beta,B
-,I
globin,I
promoter,I
and,O
gene,O
.,O
This,O
remodeling,O
of,O
promoter,O
chromatin,O
structure,O
resulted,O
in,O
3,O
-,O
fold,O
increases,O
in,O
beta,B
-,I
globin,I
gene,I
transcription,I
and,O
induction,O
",",O
and,O
inhibited,O
long,O
-,O
term,O
beta,B
-,I
globin,I
gene,I
silencing,I
.,O
Regulation,O
of,O
low,O
shear,O
flow,O
-,O
induced,O
HAEC,B
VCAM,B
-,I
1,I
expression,O
and,O
monocyte,O
adhesion,O
.,O
Here,O
we,O
investigate,O
the,O
hypothesis,O
that,O
low,O
shear,O
-,O
induced,O
activation,O
of,O
NF,B
-,I
kappaB,I
is,O
responsible,O
for,O
enhanced,O
expression,O
of,O
vascular,O
cell,O
adhesion,O
molecule,O
(,O
VCAM,B
-,I
1,I
),O
resulting,O
in,O
augmented,O
endothelial,O
cell,O
-,O
monocyte,O
(,O
EC,B
-,I
Mn,I
),O
adhesion,O
and,O
that,O
this,O
activation,O
is,O
dependent,O
on,O
intracellular,O
oxidant,O
activity,O
.,O
These,O
data,O
suggest,O
that,O
NF,B
-,I
kappaB,I
plays,O
a,O
key,O
role,O
in,O
low,O
shear,O
-,O
induced,O
VCAM,B
-,I
1,I
expression,O
and,O
that,O
pathways,O
mediating,O
low,O
shear,O
-,O
and,O
cytokine,O
-,O
induced,O
EC,B
-,I
Mn,I
adhesion,O
may,O
be,O
differentially,O
regulated,O
.,O
Nuclear,B
factor,I
-,I
90,I
of,I
activated,I
T,I
-,I
cells,I
:,O
A,O
double,O
-,O
stranded,O
RNA,B
-,I
binding,I
protein,I
and,O
substrate,O
for,O
the,O
double,O
-,O
stranded,O
RNA,B
-,I
dependent,I
protein,I
kinase,I
",",O
PKR,B
.,O
Using,O
in,O
vitro,O
translated,O
polypeptides,O
",",O
we,O
have,O
demonstrated,O
that,O
NF90,B
specifically,O
binds,O
to,O
double,O
-,O
stranded,O
RNA,B
.,O
C5a,O
-,O
induced,O
reporter,O
gene,O
expression,O
was,O
abolished,O
by,O
introducing,O
mutations,O
into,O
the,O
kappaB,B
sites,I
and,O
by,O
coexpression,O
of,O
a,O
dominant,O
negative,O
IkappaBalpha,B
construct,I
resistant,O
to,O
agonist,O
-,O
induced,O
phosphorylation,O
.,O
Pertussis,O
toxin,O
",",O
which,O
ADP,B
-,I
ribosylates,O
the,O
Gi,B
proteins,I
known,O
to,O
couple,O
to,O
the,O
C5a,B
receptor,I
",",O
produced,O
minimal,O
inhibition,O
of,O
C5a,B
-,I
induced,I
IL,O
-,O
8,O
expression,O
and,O
had,O
little,O
effect,O
on,O
C5a,B
-,I
induced,I
calcium,O
mobilization,O
in,O
RAW264,B
0.7,I
cells,I
.,O
Patients,O
with,O
GC,B
-,I
insensitive,I
asthma,I
expressed,O
a,O
significantly,O
higher,O
number,O
of,O
GCRbeta,B
-,I
immunoreactive,I
cells,I
in,O
their,O
BAL,B
and,O
peripheral,O
blood,O
than,O
GC,B
-,I
sensitive,I
asthmatics,I
or,O
normal,O
control,O
subjects,O
.,O
CD40,B
/,I
CD40,I
ligand,I
interactions,O
play,O
a,O
key,O
role,O
in,O
the,O
immune,O
responses,O
of,O
B,B
lymphocytes,I
",",O
monocytes,B
",",O
and,O
dendritic,B
cells,I
.,O
However,O
",",O
the,O
components,O
of,O
the,O
NF,B
-,I
kappaB,I
complexes,I
were,O
different,O
in,O
monocytes,B
and,O
B,B
cells,I
",",O
because,O
p50,B
is,O
part,O
of,O
the,O
NF,B
-,I
kappaB,I
complex,I
induced,O
by,O
CD40,B
triggering,O
in,O
both,O
monocytes,B
and,O
B,B
cells,I
",",O
whereas,O
p65,B
was,O
only,O
induced,O
in,O
B,B
cells,I
.,O
In,O
contrast,O
",",O
although,O
the,O
Janus,B
kinase,I
3,I
tyrosine,I
kinase,I
was,O
associated,O
with,O
CD40,B
molecules,I
in,O
both,O
monocytes,B
and,O
resting,O
B,B
cells,I
",",O
Janus,B
kinase,I
3,I
phosphorylation,O
induction,O
was,O
observed,O
only,O
in,O
CD40,B
-,I
activated,I
monocytes,I
",",O
with,O
subsequent,O
induction,O
of,O
STAT5a,B
DNA,I
binding,I
activity,I
in,O
the,O
nucleus,O
.,O
Interestingly,O
",",O
when,O
we,O
fused,O
HT,B
-,I
2,I
cells,I
expressing,O
the,O
EPOR,B
with,O
Ba,B
/,I
F3,I
cells,I
in,O
a,O
complementation,O
assay,O
",",O
the,O
resulting,O
hybridomas,O
proliferated,O
and,O
potently,O
activated,O
STAT,B
-,I
5,I
and,O
MAPK,B
in,O
response,O
to,O
EPO,B
.,O
Moreover,O
",",O
Ba,B
/,I
F3,I
cells,O
apparently,O
express,O
this,O
factor,O
(,O
s,O
),O
and,O
somatic,O
fusions,O
can,O
",",O
therefore,O
",",O
confer,O
EPO,B
-,I
responsiveness,O
to,O
HT,B
-,I
2,I
cells,O
that,O
lack,O
this,O
factor,O
.,O
When,O
a,O
drug,O
appears,O
to,O
be,O
less,O
effective,O
than,O
preclinical,O
models,O
suggest,O
",",O
can,O
failures,O
in,O
effectiveness,O
from,O
delivery,O
or,O
dosing,O
be,O
differentiated,O
?,O
The,O
disappointing,O
results,O
of,O
clinical,O
trials,O
with,O
IL,B
-,I
10,I
-,I
-,I
so,O
at,O
odds,O
with,O
the,O
prediction,O
of,O
benefit,O
from,O
animal,O
models,O
-,O
-,O
bring,O
into,O
question,O
the,O
validity,O
of,O
those,O
models,O
as,O
well,O
as,O
the,O
soundness,O
of,O
design,O
of,O
the,O
clinical,O
trials,O
on,O
which,O
efficacy,O
of,O
IL,B
-,I
10,I
is,O
judged,O
.,O
The,O
variability,O
of,O
response,O
even,O
to,O
the,O
most,O
narrowly,O
targeted,O
agents,O
suggests,O
that,O
these,O
diseases,O
are,O
far,O
more,O
heterogeneous,O
in,O
humans,O
than,O
in,O
their,O
murine,O
counterparts,O
.,O
Potent,O
and,O
stable,O
attenuation,O
of,O
live,O
-,O
HIV,B
-,I
1,I
by,O
gain,O
of,O
a,O
proteolysis,O
-,O
resistant,O
inhibitor,O
of,O
NF,B
-,I
kappaB,I
(,O
IkappaB,B
-,I
alphaS32,I
/,I
36A,I
),O
and,O
the,O
implications,O
for,O
vaccine,O
development,O
.,O
These,O
findings,O
illustrate,O
gain,O
-,O
of,O
-,O
function,O
as,O
a,O
feasible,O
strategy,O
for,O
developing,O
safer,O
live,O
-,O
attenuated,O
HIVs,B
to,O
be,O
tested,O
as,O
candidates,O
for,O
AIDS,O
vaccine,O
.,O
Multiple,O
NF,B
-,I
ATc,I
isoforms,O
with,O
individual,O
transcriptional,O
properties,O
are,O
synthesized,O
in,O
T,B
lymphocytes,I
.,O
The,O
transcription,O
factor,O
NF,B
-,I
ATc,I
that,O
controls,O
gene,O
expression,O
in,O
T,B
lymphocytes,I
and,O
embryonic,O
cardiac,O
cells,O
is,O
expressed,O
in,O
three,O
prominent,O
isoforms,O
.,O
Various,O
stimuli,O
of,O
T,B
cells,I
that,O
induce,O
the,O
activity,O
of,O
TAD,B
-,I
A,I
also,O
enhance,O
the,O
activity,O
of,O
TAD,B
-,I
B,I
",",O
but,O
",",O
unlike,O
TAD,B
-,I
A,I
",",O
TAD,B
-,I
B,I
remains,O
unphosphorylated,O
by,O
protein,B
from,O
12,O
-,O
O,O
-,O
tetradecanoyl,O
12,O
-,O
phorbol,O
13,O
-,O
acetate,O
-,O
stimulated,O
T,B
cells,I
.,O
Selection,O
and,O
long,O
-,O
term,O
persistence,O
of,O
reactive,O
CTL,B
clones,I
during,O
an,O
EBV,B
chronic,I
response,I
are,O
determined,O
by,O
avidity,O
",",O
CD8,B
variable,I
contribution,I
compensating,O
for,O
differences,O
in,O
TCR,B
affinities,I
.,O
We,O
found,O
a,O
wide,O
range,O
of,O
TCR,B
affinities,O
among,O
the,O
different,O
clonotypes,O
that,O
segregated,O
with,O
Vbeta,B
usage,O
.,O
Nuclear,O
localization,O
and,O
formation,O
of,O
beta,B
-,I
catenin,I
-,I
lymphoid,I
enhancer,I
factor,I
1,I
complexes,I
are,O
not,O
sufficient,O
for,O
activation,O
of,O
gene,O
expression,O
.,O
Lymphoid,B
cell,I
differentiation,I
relies,O
on,O
precisely,O
orchestrated,O
gene,O
activation,O
and,O
repression,O
events,O
.,O
Packaging,O
of,O
viral,B
particles,I
",",O
integration,O
into,O
the,O
target,O
genome,O
",",O
and,O
stability,O
of,O
the,O
integrated,O
provirus,O
are,O
not,O
affected,O
by,O
the,O
LTR,B
modification,I
.,O
Enhancer,O
replacement,O
is,O
therefore,O
an,O
effective,O
strategy,O
to,O
target,O
expression,O
of,O
a,O
retroviral,B
transgene,I
to,O
a,O
specific,O
progeny,O
of,O
transduced,O
hematopoietic,B
stem,I
cells,I
.,O
Regulation,O
of,O
Fas,B
ligand,I
expression,O
and,O
cell,O
death,O
by,O
apoptosis,O
-,O
linked,O
gene,O
4,O
.,O
These,O
results,O
indicate,O
that,O
ALG,O
-,O
4,O
is,O
necessary,O
and,O
sufficient,O
for,O
FasL,B
expression,O
.,O
We,O
now,O
find,O
that,O
LMP1,O
signaling,O
through,O
TRADD,O
differs,O
from,O
TNFR1,O
signaling,O
through,O
TRADD,O
.,O
Inhibition,O
of,O
NF,B
-,I
kappa,I
B,I
resulted,O
in,O
the,O
externalization,O
of,O
phosphatidylserine,O
",",O
induction,O
of,O
DNA,B
breaks,O
",",O
and,O
morphological,O
changes,O
consistent,O
with,O
apoptosis,O
.,O
Among,O
upstream,O
signaling,O
molecules,O
of,O
ERK,B
",",O
Shc,B
was,O
constitutively,O
associated,O
with,O
Grb2,B
and,O
was,O
not,O
tyrosine,O
-,O
phosphorylated,O
by,O
GM,O
-,O
CSF,O
and,O
FMLP,O
",",O
and,O
Sos1,B
and,O
c,B
-,I
Raf,I
-,I
1,I
were,O
not,O
phosphorylated,O
by,O
GM,O
-,O
CSF,O
",",O
IL,O
-,O
3,O
",",O
TNF,O
",",O
and,O
FMLP,O
in,O
monocytes,O
",",O
whereas,O
all,O
these,O
signaling,O
molecules,O
were,O
affected,O
and,O
/,O
or,O
utilized,O
by,O
GM,O
-,O
CSF,O
in,O
MO7e,B
cells,I
.,O
In,O
contrast,O
to,O
neutrophils,O
",",O
p38,B
was,O
constitutively,O
phosphorylated,O
and,O
agonist,O
-,O
dependent,O
phosphorylation,O
and,O
activation,O
was,O
not,O
detected,O
in,O
human,O
monocytes,O
.,O
Functional,O
analysis,O
indicates,O
that,O
the,O
BRs,B
are,O
involved,O
in,O
control,O
of,O
hIL,O
-,O
5,O
promoter,O
activity,O
.,O
PNU156804,O
action,O
is,O
restricted,O
to,O
some,O
signaling,O
pathways,O
;,O
it,O
does,O
not,O
affect,O
NF,B
-,I
kappa,I
B,I
activation,O
by,O
PMA,O
in,O
T,O
cells,O
but,O
blocks,O
that,O
induced,O
by,O
CD40,O
cross,O
-,O
linking,O
in,O
B,O
lymphocytes,O
.,O
The,O
expression,O
of,O
STAT1,B
and,O
STAT5,B
in,O
a,O
human,B
T,I
-,I
cell,I
line,I
was,O
induced,O
by,O
Tax,O
.,O
Transcriptional,O
control,O
of,O
the,O
IL,B
-,I
5,I
gene,I
by,O
human,B
helper,I
T,I
cells,I
:,O
IL,B
-,I
5,I
synthesis,I
is,O
regulated,O
independently,O
from,O
IL,B
-,I
2,I
or,O
IL,B
-,I
4,I
synthesis,I
.,O
METHODS,O
:,O
Allergen,O
-,O
specific,O
T,B
-,I
cell,I
clones,I
and,O
T,B
-,I
cell,I
hybridomas,I
were,O
established,O
from,O
the,O
peripheral,O
blood,O
lymphocytes,O
of,O
patients,O
with,O
asthma,O
",",O
and,O
the,O
transcriptional,O
regulation,O
of,O
the,O
IL,B
-,I
5,I
gene,I
was,O
investigated,O
with,O
transient,O
transfection,O
and,O
electrophoretic,O
mobility,O
shift,O
analysis,O
.,O
RESULTS,O
:,O
A,O
human,O
IL,B
-,I
5,I
promoter,I
/,O
enhancer,O
-,O
luciferase,O
gene,O
construct,O
",",O
pIL,O
-,O
5,O
(,O
-,O
511,O
),O
Luc,O
",",O
was,O
transcribed,O
on,O
activation,O
of,O
IL,B
-,I
5,I
-,I
producing,I
T,I
-,I
cell,I
clones,I
",",O
but,O
not,O
IL,B
-,I
5,I
-,I
nonproducing,I
clones,I
.,O
pIL,O
-,O
5,O
(,O
-,O
511,O
),O
Luc,O
was,O
transcribed,O
by,O
T,O
-,O
cell,O
hybridomas,O
derived,O
from,O
fusion,O
between,O
IL,B
-,I
5,I
-,I
producing,I
T,I
-,I
cell,I
clones,I
and,O
an,O
IL,B
-,I
5,I
gene,I
-,I
nonexpressing,I
T,I
-,I
cell,I
line,I
",",O
but,O
not,O
by,O
hybridomas,O
derived,O
from,O
IL,B
-,I
5,I
-,I
nonproducing,I
T,I
-,I
cell,I
clones,I
.,O
CONCLUSION,O
:,O
IL,B
-,I
5,I
synthesis,O
by,O
human,O
helper,O
T,O
cells,O
is,O
regulated,O
at,O
the,O
transcriptional,O
level,O
.,O
We,O
used,O
an,O
adenoviral,O
technique,O
of,O
blocking,O
NF,B
-,I
kappaB,I
through,O
overexpression,O
of,O
the,O
inhibitory,O
subunit,O
IkappaBalpha,O
",",O
which,O
has,O
the,O
advantage,O
that,O
it,O
can,O
be,O
used,O
in,O
the,O
diseased,O
tissue,O
itself,O
",",O
with,O
>,O
90,O
%,O
of,O
the,O
synovial,O
macrophages,O
",",O
fibroblasts,O
",",O
and,O
T,B
cells,I
infected,O
.,O
Of,O
even,O
more,O
interest,O
",",O
IkappaBalpha,B
overexpression,O
inhibited,O
the,O
production,O
of,O
matrix,B
metalloproteinases,I
1,O
and,O
3,O
while,O
not,O
affecting,O
their,O
tissue,O
inhibitor,O
.,O
This,O
finding,O
may,O
provide,O
a,O
tool,O
to,O
improve,O
current,O
protocols,O
of,O
immunotherapy,O
and,O
insights,O
to,O
how,O
tumor,O
cells,O
are,O
or,O
are,O
not,O
killed,O
by,O
LAK,O
cells,O
.,O
Clonality,O
analysis,O
utilizing,O
X,B
-,I
chromosome,I
inactivation,I
has,O
been,O
used,O
in,O
the,O
study,O
of,O
various,O
diseases,O
",",O
including,O
hematological,O
malignancies,O
.,O
One,O
problem,O
in,O
using,O
these,O
clonality,O
analysis,O
methods,O
",",O
however,O
",",O
is,O
that,O
there,O
may,O
be,O
significant,O
variation,O
in,O
Lyonization,O
in,O
blood,O
cells,O
in,O
normal,O
individuals,O
.,O
We,O
also,O
found,O
that,O
the,O
deviation,O
of,O
methylation,O
in,O
granulocytes,O
and,O
T,B
cells,I
was,O
well,O
correlated,O
.,O
Thus,O
",",O
we,O
conclude,O
that,O
appropriate,O
controls,O
from,O
the,O
same,O
individuals,O
",",O
such,O
as,O
T,B
cells,I
in,O
the,O
case,O
of,O
stem,O
cell,O
disorders,O
",",O
should,O
always,O
be,O
employed,O
to,O
conclusively,O
determine,O
whether,O
certain,O
cells,O
of,O
hematopoietic,O
origin,O
are,O
clonal,O
.,O
A,O
high,O
expression,O
of,O
WT1,B
has,O
been,O
detected,O
in,O
a,O
range,O
of,O
acute,O
leukemias,O
",",O
and,O
WT1,B
is,O
downregulated,O
during,O
induced,O
differentiation,O
of,O
some,O
leukemic,O
cell,O
lines,O
. K562,O
cells,O
express,O
endogenous,O
WT1,B
",",O
which,O
is,O
downregulated,O
as,O
a,O
response,O
to,O
induced,O
differentiation,O
along,O
the,O
erythroid,O
and,O
megakaryocytic,O
pathways,O
.,O
However,O
",",O
activation,O
of,O
STAT6,B
",",O
CD23,B
expression,O
",",O
and,O
IgE,B
synthesis,O
induced,O
by,O
IL,O
-,O
4,O
were,O
not,O
affected,O
in,O
p47phox,O
-,O
deficient,O
patients,O
",",O
which,O
raises,O
the,O
possibility,O
that,O
p47phox,O
may,O
be,O
important,O
in,O
other,O
signaling,O
activities,O
as,O
well,O
in,O
B,O
cells,O
.,O
METHODS,O
:,O
Protein,B
production,O
in,O
supernatants,O
was,O
assessed,O
by,O
ELISA,O
",",O
and,O
mRNA,B
expression,O
was,O
evaluated,O
by,O
semiquantitative,O
RT,B
-,I
PCR,I
.,O
On,O
the,O
contrary,O
",",O
the,O
release,O
of,O
MCP,B
-,I
1,I
was,O
significantly,O
inhibited,O
",",O
also,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
.,O
Messenger,O
RNA,B
production,O
coding,O
for,O
IL,B
-,I
8,I
",",O
RANTES,B
",",O
and,O
MCP,B
-,I
1,I
showed,O
parallel,O
variations,O
to,O
the,O
production,O
of,O
the,O
correspondent,O
proteins,O
.,O
Furthermore,O
",",O
SLP,B
-,I
76,I
and,O
Vav,B
have,O
a,O
synergistic,O
effect,O
on,O
interleukin,B
(,O
IL,B
),O
-,O
2,I
promoter,O
activity,O
in,O
T,O
cells,O
.,O
Surprisingly,O
",",O
we,O
find,O
also,O
that,O
the,O
interaction,O
between,O
SLP,B
-,I
76,I
and,O
Vav,B
is,O
not,O
required,O
for,O
their,O
cooperation,O
in,O
augmenting,O
IL,B
-,I
2,I
promoter,I
activity,O
",",O
as,O
the,O
two,O
molecules,O
appear,O
to,O
function,O
in,O
different,O
signaling,O
pathways,O
upstream,O
of,O
IL,B
-,I
2,I
gene,I
expression,O
. In,O
contrast,O
",",O
overexpression,O
of,O
Vav,B
leads,O
to,O
enhanced,O
nuclear,O
factor,O
of,O
activated,O
T,O
cells,O
activity,O
without,O
affecting,O
AP,B
-,I
1,I
.,O
Additionally,O
",",O
overexpression,O
of,O
Vav,B
",",O
but,O
not,O
SLP,B
-,I
76,I
",",O
augments,O
CD28,B
-,I
induced,I
IL,B
-,I
2,I
promoter,I
activity,I
.,O
Here,O
",",O
we,O
show,O
that,O
Jagged1,B
is,O
a,O
Rel,B
/,I
NF,I
-,I
kappaB,I
-,I
responsive,I
gene,I
.,O
This,O
correlated,O
with,O
the,O
initiation,O
of,O
signaling,O
downstream,O
of,O
Notch,B
",",O
as,O
evidenced,O
by,O
increased,O
levels,O
of,O
HES,B
-,I
1,I
transcripts,I
in,O
co,O
-,O
cultivated,O
T,B
cells,I
and,O
of,O
CD23,B
transcripts,I
in,O
co,O
-,O
cultivated,O
B,B
cells,I
.,O
Our,O
results,O
demonstrated,O
that,O
:,O
(,O
i,O
),O
PGN,O
induced,O
phosphorylation,O
of,O
the,O
transcription,O
factors,O
ATF,B
-,I
1,I
and,O
CREB,B
;,O
(,O
ii,O
),O
ATF,B
-,I
1,I
and,O
CREB,B
bound,O
DNA,B
as,O
a,O
dimer,O
and,O
induced,O
transcriptional,O
activation,O
of,O
a,O
CRE,O
reporter,O
plasmid,O
",",O
which,O
was,O
inhibited,O
by,O
dominant,O
negative,O
CREB,B
and,O
ATF,B
-,I
1,I
;,O
(,O
iii,O
),O
PGN,O
induced,O
phosphorylation,O
of,O
c,O
-,O
Jun,B
",",O
protein,O
synthesis,O
of,O
JunB,B
and,O
c,O
-,O
Fos,B
",",O
and,O
transcriptional,O
activation,O
of,O
the,O
AP,O
-,O
1,O
reporter,O
plasmid,O
",",O
which,O
was,O
inhibited,O
by,O
dominant,O
negative,O
c,O
-,O
Fos,B
;,O
and,O
(,O
iv,O
),O
PGN,O
-,O
induced,O
activation,O
of,O
CREB,B
/,O
ATF,B
and,O
AP,O
-,O
1,O
was,O
mediated,O
through,O
CD14,O
.,O
In,O
contrast,O
to,O
these,O
findings,O
",",O
mucosal,O
hGR,B
levels,O
were,O
significantly,O
decreased,O
in,O
both,O
steroid,B
-,I
treated,I
(,O
18,O
0.0,O
+,O
/,O
-,O
15,O
0.5,O
),O
and,O
not,O
steroid,B
-,I
treated,I
(,O
37,O
0.8,O
+,O
/,O
-,O
30,O
0.5,O
),O
patients,O
compared,O
with,O
control,O
subjects,O
(,O
125,O
0.6,O
+,O
/,O
-,O
97,O
0.1,O
;,O
P,O
=,O
0,O
0.00009,O
and,O
P,O
=,O
0,O
0.0008,O
respectively,O
),O
.,O
In,O
this,O
study,O
",",O
we,O
created,O
transgenic,O
mice,O
overexpressing,O
ICSAT,B
in,O
lymphocytes,O
.,O
Altered,O
memory,B
T,I
cell,I
differentiation,O
in,O
patients,O
with,O
early,O
rheumatoid,O
arthritis,O
.,O
A,O
cell,B
culture,I
system,I
was,O
then,O
employed,O
that,O
permitted,O
the,O
differentiation,O
of,O
Th,B
effectors,I
from,O
resting,O
memory,B
T,I
cells,I
by,O
short,O
term,O
priming,O
.,O
Our,O
findings,O
offer,O
important,O
insights,O
into,O
parasite,B
survival,I
strategies,I
and,O
demonstrate,O
that,O
parasite,B
-,I
induced,I
constitutive,I
NF,B
-,I
kappaB,I
activation,I
is,O
an,O
essential,O
step,O
in,O
maintaining,O
the,O
transformed,O
phenotype,O
of,O
the,O
infected,O
cells,O
.,O
A,O
polymorphism,O
that,O
affects,O
OCT,B
-,I
1,I
binding,O
to,O
the,O
TNF,B
promoter,I
region,I
is,O
associated,O
with,O
severe,O
malaria,O
[,O
see,O
comments,O
],O
The,O
results,O
show,O
that,O
the,O
CYP1A1,B
mRNA,I
level,I
induced,O
by,O
UV,O
in,O
the,O
presence,O
of,O
tryptophan,O
was,O
higher,O
than,O
that,O
induced,O
by,O
UV,O
alone,O
in,O
both,O
HaCaT,B
cells,I
and,O
lymphocytes,B
after,O
3,O
h,O
of,O
incubation,O
post,O
-,O
UV,O
irradiation,O
.,O
Wild,O
-,O
type,O
(,O
wt,B
),O
cells,O
were,O
inducible,O
either,O
by,O
the,O
tryptophan,O
photoproduct,O
6,O
-,O
formylindolo,O
[,O
3,O
",",O
2,O
-,O
b,O
],O
carbazole,O
(,O
FICZ,B
),O
or,O
by,O
UV,B
-,I
irradiation,I
but,O
very,O
low,O
or,O
undetectable,O
levels,O
were,O
observed,O
in,O
the,O
c12,B
cells,I
.,O
This,O
shows,O
that,O
the,O
induction,O
of,O
gene,O
expression,O
by,O
FICZ,B
and,O
UV,B
is,O
Ah,O
receptor,O
dependent,O
.,O
Thus,O
",",O
the,O
photoproducts,O
of,O
tryptophan,B
are,O
suggested,O
to,O
be,O
mediators,O
of,O
light,O
via,O
binding,O
to,O
the,O
Ah,B
receptor,I
and,O
as,O
such,O
also,O
could,O
have,O
a,O
role,O
in,O
light,O
-,O
regulated,O
biological,O
rhythms,O
.,O
Repression,O
by,O
Ikaros,B
and,O
Aiolos,B
is,O
mediated,O
through,O
histone,B
deacetylase,I
complexes,I
.,O
To,O
better,O
understand,O
signals,O
controlling,O
proliferation,O
and,O
viability,O
",",O
erythroid,B
cells,I
that,O
resist,O
apoptosis,O
in,O
the,O
absence,O
of,O
EPO,B
were,O
subcloned,O
and,O
characterized,O
(,O
HCD57,B
-,I
SREI,I
cells,I
),O
.,O
Enforced,O
expression,O
of,O
Id3,B
",",O
which,O
has,O
the,O
capacity,O
to,O
inhibit,O
many,O
basic,O
helix,B
-,I
loop,I
-,I
helix,I
(,O
bHLH,B
),O
transcription,O
factors,O
",",O
in,O
human,O
CD34,B
(,O
+,O
),O
hematopoietic,B
progenitor,I
cells,I
that,O
have,O
not,O
undergone,O
T,B
cell,I
receptor,I
(,O
TCR,B
),O
gene,I
rearrangements,I
inhibits,O
development,O
of,O
the,O
transduced,O
cells,O
into,O
TCRalpha,B
beta,I
and,O
gamma,B
delta,I
cells,I
in,O
a,O
fetal,O
thymic,B
organ,I
culture,I
(,O
FTOC,B
),O
.,O
These,O
cells,O
had,O
properties,O
of,O
both,O
natural,B
killer,I
(,O
NK,B
),O
and,O
pre,B
-,I
T,I
cells,I
.,O
HIV,B
-,I
1,I
reactivation,O
in,O
resting,O
peripheral,B
blood,I
mononuclear,I
cells,I
of,O
infected,O
adults,O
upon,O
in,O
vitro,O
CD4,B
cross,I
-,I
linking,I
by,O
ligands,O
of,O
the,O
CDR2,B
-,I
loop,I
in,O
extracellular,B
domain,I
1,I
.,O
Additionally,O
",",O
virus,B
reactivation,O
in,O
resting,O
PBMCs,B
infected,O
in,O
vitro,O
with,O
HIV,B
-,I
1,I
was,O
found,O
to,O
be,O
specifically,O
induced,O
by,O
ligands,O
of,O
the,O
CDR2,B
-,I
loop,I
in,O
domain,I
1,I
(,O
D1,B
),O
of,O
CD4,B
(,O
virus,B
envelope,I
and,O
anti,B
-,I
CD4,I
monoclonal,I
antibodies,I
),O
.,O
In,O
contrast,O
",",O
virus,O
reactivation,O
was,O
not,O
observed,O
following,O
CD4,B
oligomerization,O
by,O
antibodies,O
that,O
bind,O
other,O
epitopes,O
in,O
D1,B
",",O
including,O
the,O
D1,B
/,I
CDR3,I
-,I
loop,I
.,O
Our,O
results,O
indicate,O
that,O
the,O
signaling,O
events,O
initiated,O
in,O
PBMCs,O
by,O
oligomerization,O
of,O
CD4,B
at,O
the,O
D1,B
/,I
CDR2,I
-,I
loop,I
can,O
trigger,O
HIV,B
-,I
1,I
upregulation,O
in,O
infected,O
individuals,O
.,O
Signaling,O
through,O
the,O
lymphotoxin,B
-,I
beta,I
receptor,I
stimulates,O
HIV,B
-,I
1,I
replication,I
alone,O
and,O
in,O
cooperation,O
with,O
soluble,O
or,O
membrane,B
-,I
bound,I
TNF,B
-,I
alpha,I
.,O
The,O
level,O
of,O
ongoing,O
HIV,B
-,I
1,I
replication,I
within,O
an,O
individual,O
is,O
critical,O
to,O
HIV,B
-,I
1,I
pathogenesis,I
.,O
Given,O
the,O
critical,O
role,O
that,O
LT,B
-,I
alpha1beta2,I
plays,O
in,O
lymphoid,B
architecture,I
",",O
we,O
speculate,O
that,O
LT,B
-,I
alpha1beta2,I
may,O
be,O
involved,O
in,O
HIV,B
-,I
associated,I
abnormalities,I
of,O
the,O
lymphoid,B
organs,I
.,O
The,O
secretion,O
levels,O
of,O
interleukin,B
-,I
6,I
(,O
IL,B
-,I
6,I
),O
and,O
von,O
Willebrand,B
factor,I
(,O
vWF,B
),O
were,O
determined,O
",",O
to,O
serve,O
as,O
markers,O
for,O
EC,B
activation,O
.,O
In,O
addition,O
",",O
nuclear,B
extracts,I
of,O
the,O
mAECA,O
-,O
treated,O
EC,B
were,O
analyzed,O
for,O
the,O
induction,O
of,O
translocation,O
of,O
nuclear,B
factor,I
kappaB,I
(,O
NF,B
-,I
kappaB,I
),O
",",O
using,O
a,O
specific,O
NF,B
-,I
kappaB,I
oligoprobe,I
in,O
an,O
electrophoretic,O
mobility,O
shift,O
assay,O
.,O
The,O
mAECA,B
",",O
but,O
not,O
normal,O
human,O
IgG,B
",",O
had,O
anti,O
-,O
human,O
aortic,B
EC,I
activity,O
. Four,O
of,O
the,O
6,O
mAECA,B
activated,O
EC,B
",",O
manifested,O
by,O
increased,O
IL,B
-,I
6,I
and,O
vWF,B
secretion,O
. However,O
NF,B
-,I
ATs,I
appear,O
in,O
the,O
nuclei,O
of,O
IL,B
-,I
4,I
-,I
",",O
IL,B
-,I
5,I
-,I
",",O
or,O
ionomycin,O
-,O
stimulated,O
eosinophils,B
. Both,O
PPARalpha,B
activators,O
decreased,O
cytokine,O
-,O
induced,O
VCAM,B
-,I
1,I
mRNA,I
expression,O
without,O
altering,O
its,O
mRNA,O
half,O
-,O
life,O
.,O
Such,O
findings,O
also,O
have,O
implications,O
regarding,O
the,O
clinical,O
use,O
of,O
lipid,O
-,O
lowering,O
agents,O
",",O
like,O
fibric,O
acids,O
",",O
which,O
can,O
activate,O
PPARalpha,B
.,O
CBP,O
/,O
p300,O
integrates,O
Raf,O
/,O
Rac,O
-,O
signaling,O
pathways,O
in,O
the,O
transcriptional,O
induction,O
of,O
NF,B
-,I
ATc,I
during,O
T,O
cell,O
activation,O
.,O
We,O
have,O
carried,O
out,O
a,O
detailed,O
analysis,O
of,O
the,O
cellular,O
immune,O
functions,O
of,O
breast,B
cancer,I
patients,I
in,O
comparison,O
with,O
healthy,O
controls,O
.,O
Inhibition,O
of,O
NF,B
-,I
kappaB,I
has,O
been,O
achieved,O
by,O
pharmacological,O
and,O
genetic,O
approaches,O
;,O
however,O
",",O
monocyte,O
interactions,O
with,O
activated,O
endothelium,O
in,O
shear,O
flow,O
following,O
gene,O
transfer,O
of,O
the,O
NF,B
-,I
kappaB,I
inhibitor,O
IkappaB,O
-,O
alpha,O
have,O
not,O
been,O
studied,O
0.40,O
This,O
was,O
associated,O
with,O
a,O
reduction,O
in,O
endothelial,O
MCP,B
-,I
1,I
secretion,O
and,O
GRO,B
-,I
alpha,I
immobilization,O
0.58,O
Adhesion,O
assays,O
under,O
physiological,O
shear,O
flow,O
conditions,O
showed,O
that,O
firm,O
arrest,O
",",O
spreading,O
",",O
and,O
transmigration,O
of,O
monocytes,O
on,O
TNF,O
-,O
alpha,O
-,O
activated,O
endothelium,O
was,O
markedly,O
inhibited,O
by,O
IkappaB,O
-,O
alpha,O
overexpression,O
.,O
In,O
contrast,O
",",O
rolling,O
of,O
monocytes,O
was,O
increased,O
by,O
IkappaB,O
-,O
alpha,O
transfer,O
and,O
was,O
partly,O
mediated,O
by,O
P,O
-,O
selectin,O
;,O
however,O
",",O
it,O
appeared,O
to,O
be,O
unaffected,O
by,O
the,O
inhibition,O
of,O
E,O
-,O
selectin,O
induction,O
.,O
Copyright,O
1999,O
Academic,O
Press,O
.,O
The,O
effect,O
of,O
oestrogens,O
on,O
oestrogen,O
-,O
receptive,O
organs,O
and,O
cells,O
is,O
mediated,O
via,O
intracellular,O
receptors,O
(,O
ERalpha,B
and,O
ERbeta,B
),O
.,O
All,O
tissues,O
and,O
cells,O
studied,O
were,O
homozygous,O
for,O
the,O
wild,O
-,O
type,O
gene,O
",",O
and,O
were,O
heterozygous,O
as,O
well,O
as,O
homozygous,O
for,O
the,O
codon,O
-,O
10,O
-,O
variant,O
type,O
.,O
These,O
results,O
indicate,O
that,O
the,O
presence,O
of,O
the,O
codon,O
-,O
10,O
-,O
variant,O
type,O
is,O
not,O
a,O
characteristic,O
of,O
breast,O
cancer,O
.,O
USF,O
/,O
c,O
-,O
Myc,O
enhances,O
",",O
while,O
Yin,O
-,O
Yang,O
1,O
suppresses,O
",",O
the,O
promoter,O
activity,O
of,O
CXCR4,B
",",O
a,O
coreceptor,O
for,O
HIV,O
-,O
1,O
entry,O
.,O
We,O
have,O
identified,O
an,O
E,O
box,O
around,O
-,O
260,O
and,O
a,O
YY1,B
binding,O
site,O
around,O
-,O
300,O
relative,O
to,O
the,O
transcription,O
start,O
site,O
.,O
RCC,O
-,O
S,O
did,O
not,O
alter,O
the,O
cytoplasmic,O
levels,O
of,O
RelA,B
and,O
NF,B
-,I
kappaB1,I
but,O
did,O
suppress,O
their,O
nuclear,O
localization,O
and,O
inhibited,O
the,O
activation,O
of,O
RelA,B
/,O
NF,B
-,I
kappaB1,I
binding,O
complexes,O
.,O
These,O
results,O
show,O
that,O
RCC,O
-,O
S,O
can,O
induce,O
in,O
normal,O
T,O
cells,O
the,O
same,O
phenotype,O
of,O
impaired,O
NF,B
-,I
kappaB,I
activation,O
that,O
is,O
detected,O
in,O
T,O
cells,O
of,O
RCC,O
patient,O
.,O
Human,O
monocytes,B
isolated,O
from,O
peripheral,O
blood,O
of,O
healthy,O
donors,O
show,O
a,O
time,O
-,O
dependent,O
differentiation,O
into,O
macrophages,B
upon,O
in,O
vitro,O
cultivation,O
",",O
closely,O
mimicking,O
their,O
in,O
vivo,O
migration,O
and,O
maturation,O
into,O
extravascular,O
tissues,O
.,O
The,O
mediator,O
(,O
s,O
),O
of,O
this,O
maturation,O
process,O
has,O
not,O
been,O
yet,O
defined,O
.,O
We,O
investigated,O
the,O
involvement,O
of,O
signal,O
transducers,O
and,O
activators,O
of,O
stat,B
),O
factors,O
in,O
this,O
phenomenon,O
and,O
reported,O
the,O
specific,O
",",O
time,O
-,O
dependent,O
",",O
activation,O
of,O
stat1,B
protein,I
starting,O
at,O
day,O
0,O
/,O
1,O
of,O
cultivation,O
and,O
maximally,O
expressed,O
at,O
day,O
5,O
.STAT1,B
activity,O
was,O
evident,O
on,O
the,O
stat,B
binding,I
sequences,I
(,O
sbe,B
),O
present,O
in,O
the,O
promoters,O
of,O
genes,O
which,O
are,O
up,O
-,O
regulated,O
during,O
monocyte,B
to,O
macrophage,B
maturation,O
such,O
as,O
fcgammaRI,B
and,O
icam,B
-,I
1,I
",",O
and,O
in,O
the,O
promoter,O
of,O
the,O
transcription,O
factor,O
ifn,B
regulatory,I
factor,I
-,I
1,I
0.89,O
Compared,O
with,O
monocytes,B
adherent,O
on,O
plastic,O
surfaces,O
",",O
freshly,O
isolated,O
cells,O
allowed,O
to,O
adhere,O
either,O
to,O
fibronectin,B
-,I
or,O
laminin,B
-,I
coated,I
flasks,I
exhibited,O
an,O
increased,O
STAT1,B
binding,I
activity,I
both,O
in,O
control,O
and,O
in,O
IFN,B
-,I
gamma,I
-,I
treated,I
cells,O
.,O
Thereafter,O
",",O
PML,B
is,O
downmodulated,O
in,O
late,O
granulocytic,B
maturation,I
",",O
whereas,O
it,O
is,O
sustainably,O
expressed,O
through,O
the,O
erythroid,B
pathway,I
.,O
Furthermore,O
",",O
PML,B
and,O
pRb,B
105,I
were,O
co,O
-,O
immunoprecipitated,O
in,O
cellular,O
lysates,O
derived,O
from,O
erythroid,B
precursors,I
indicating,O
that,O
this,O
functional,B
interaction,I
may,O
have,O
a,O
biochemical,B
basis,I
.,O
Endogenous,O
and,O
therapeutic,O
steroid,B
hormones,I
affect,O
the,O
immune,B
system,I
",",O
and,O
inflammatory,B
diseases,I
are,O
associated,O
with,O
activation,O
of,O
the,O
hypothalamic,B
-,I
pituitary,I
-,I
adrenal,I
axis,I
",",O
providing,O
evidence,O
of,O
an,O
immune,B
-,I
endocrine,I
interplay,I
.,O
No,O
effect,O
of,O
age,O
",",O
sex,O
",",O
course,O
",",O
duration,O
or,O
severity,O
of,O
disease,O
",",O
or,O
prior,O
steroid,O
treatments,O
was,O
detected,O
.,O
These,O
data,O
suggest,O
that,O
the,O
physiological,O
relationship,O
between,O
binding,O
and,O
function,O
of,O
the,O
glucocorticoid,B
receptor,I
is,O
disturbed,O
in,O
MS,O
.,O
Treatment,O
of,O
cells,O
with,O
PD98059,O
",",O
a,O
specific,O
inhibitor,O
of,O
mitogen,B
-,I
activated,I
protein,I
kinase,I
kinase,I
(,O
MEK,O
),O
",",O
inhibited,O
TPA,O
-,O
induced,O
ERK2,O
activity,O
.,O
METHODS,O
:,O
Twenty,O
-,O
two,O
patients,O
with,O
severe,O
restrictive,O
anorexia,O
nervosa,O
",",O
10,O
patients,O
with,O
active,O
Cushing,O
',O
s,O
disease,O
",",O
and,O
24,O
healthy,O
volunteers,O
without,O
psychiatric,O
disorders,O
or,O
mood,O
alterations,O
were,O
investigated,O
.,O
RESULTS,O
:,O
The,O
number,O
of,O
glucocorticoid,B
receptors,I
on,O
mononuclear,O
leukocytes,O
(,O
MNL,B
),O
was,O
comparable,O
in,O
patients,O
with,O
anorexia,O
nervosa,O
",",O
patients,O
with,O
active,O
Cushing,O
',O
s,O
disease,O
",",O
and,O
normal,O
subjects,O
(,O
binding,O
capacity,O
3,O
.,O
3,O
+,O
/,O
-,O
0,O
.,O
23,O
vs,O
.,O
3,O
.,O
7,O
+,O
/,O
-,O
0,O
.,O
30,O
and,O
3,O
.,O
5,O
+,O
/,O
-,O
0,O
.,O
20,O
fmol,O
/,O
10,O
(,O
6,O
),O
cells,O
.,O
In,O
patients,O
with,O
anorexia,O
nervosa,O
",",O
the,O
incorporation,O
of,O
[,O
3H,O
],O
thymidine,O
into,O
the,O
MNL,O
was,O
inversely,O
correlated,O
with,O
urinary,O
free,O
cortisol,O
levels,O
.,O
Different,O
sequence,O
requirements,O
for,O
expression,O
in,O
erythroid,O
and,O
megakaryocytic,O
cells,O
within,O
a,O
regulatory,O
element,O
upstream,O
of,O
the,O
GATA,B
-,I
1,I
gene,I
.,O
We,O
have,O
localized,O
a,O
317,O
base,O
pair,O
cis,O
-,O
acting,O
regulatory,O
element,O
",",O
HS,B
I,I
",",O
associated,O
with,O
a,O
hematopoietic,B
-,I
specific,I
DNase,B
I,I
hypersensitive,I
site,I
",",O
which,O
lies,O
approx,O
.,O
This,O
core,O
contains,O
a,O
GATA,B
site,I
separated,O
by,O
10,O
base,O
pairs,O
from,O
an,O
E,B
-,I
box,I
motif,I
.,O
In,O
addition,O
",",O
sodium,O
salicylate,O
and,O
additional,O
NSAIDs,O
used,O
at,O
concentrations,O
that,O
activate,O
HSF1,B
also,O
inhibited,O
the,O
expression,O
of,O
other,O
monocytic,B
genes,I
(,O
TNF,B
-,I
alpha,I
",",O
IL,B
-,I
1beta,I
",",O
IL,B
-,I
6,I
",",O
IL,B
-,I
8,I
",",O
IL,B
-,I
10,I
",",O
ICAM,B
-,I
1,I
),O
activated,O
by,O
exposure,O
to,O
a,O
pro,O
-,O
inflammatory,O
stimulus,O
(,O
lipopolysaccharide,O
",",O
LPS,O
),O
.,O
Copyright,O
1999,O
Academic,O
Press,O
.,O
Fibroblast,B
growth,I
factors,I
(,O
FGFs,B
),O
are,O
heparin,O
-,O
binding,O
proteins,O
crucial,O
to,O
embryogenesis,O
",",O
angiogenesis,O
",",O
and,O
wound,O
healing,O
.,O
FGF,B
-,I
1,I
is,O
abundantly,O
expressed,O
in,O
the,O
synovium,O
in,O
rheumatoid,O
arthritis,O
and,O
in,O
rejecting,O
allografts,O
",",O
sites,O
of,O
chronic,O
immune,O
-,O
mediated,O
inflammation,O
.,O
In,O
this,O
paper,O
",",O
we,O
show,O
that,O
HCMV,O
down,O
regulates,O
gamma,B
interferon,I
(,O
IFN,B
-,I
gamma,I
),O
-,O
induced,O
HLA,B
-,I
DR,I
expression,O
in,O
U373,O
MG,O
astrocytoma,O
cells,O
due,O
to,O
a,O
defect,O
downstream,O
of,O
STAT1,O
phosphorylation,O
and,O
nuclear,O
translocation,O
.,O
Inhibition,O
of,O
NF,B
-,I
kappaB,I
transcriptional,I
activity,O
and,O
promotion,O
of,O
IkappaBalpha,O
degradation,O
.,O
DZA,O
inhibits,O
the,O
transcriptional,O
activity,O
of,O
NF,B
-,I
kappaB,I
through,O
the,O
hindrance,O
of,O
p65,B
(,O
Rel,B
-,I
A,I
),O
phosphorylation,O
without,O
reduction,O
of,O
its,O
nuclear,O
translocation,O
and,O
DNA,B
binding,I
activity,I
.,O
The,O
inhibitory,O
effect,O
of,O
DZA,O
on,O
NF,B
-,I
kappaB,I
transcriptional,O
activity,O
is,O
potentiated,O
by,O
the,O
addition,O
of,O
homocysteine,O
.,O
Decidual,O
gammadelta,B
T,I
cells,I
",",O
which,O
significantly,O
increase,O
in,O
number,O
during,O
pregnancy,O
",",O
might,O
play,O
a,O
role,O
in,O
recognition,O
of,O
fetal,O
antigens,O
and,O
also,O
in,O
determining,O
the,O
quality,O
of,O
the,O
response,O
to,O
these,O
antigens,O
.,O
Here,O
",",O
we,O
investigate,O
the,O
role,O
of,O
Rho,B
in,O
regulating,O
the,O
distribution,O
of,O
the,O
monocyte,B
-,I
binding,I
receptors,I
E,B
-,I
selectin,I
",",O
ICAM,B
-,I
1,I
",",O
and,O
VCAM,B
-,I
1,I
in,O
human,B
endothelial,I
cells,I
.,O
C3,B
transferase,I
and,O
cytochalasin,B
D,I
did,O
not,O
alter,O
the,O
expression,O
levels,O
of,O
monocyte,B
-,I
binding,I
receptors,I
on,O
endothelial,B
cells,I
",",O
but,O
did,O
inhibit,O
clustering,O
of,O
E,B
-,I
selectin,I
",",O
ICAM,B
-,I
1,I
",",O
and,O
VCAM,B
-,I
1,I
on,O
the,O
cell,B
surface,I
induced,O
by,O
monocyte,B
adhesion,I
or,O
cross,O
-,O
linking,O
antibodies,I
.,O
Similarly,O
",",O
N19RhoA,B
inhibited,O
receptor,B
clustering,I
.,O
Finally,O
",",O
receptor,B
clusters,I
colocalized,O
with,O
ezrin,B
/,I
moesin,B
/,I
radixin,B
proteins,I
.,O
Although,O
recognized,O
as,O
fundamental,O
aspects,O
of,O
T,B
lymphocyte,I
development,I
",",O
only,O
recently,O
have,O
the,O
mechanisms,O
governing,O
positive,O
and,O
negative,O
selection,O
been,O
examined,O
at,O
a,O
molecular,O
level,O
.,O
Negative,O
selection,O
refers,O
to,O
the,O
deletion,O
or,O
inactivation,O
of,O
potentially,O
autoreactive,O
thymocytes,O
.,O
CD28,B
costimulation,O
augments,O
IL,B
-,I
2,I
secretion,O
of,O
activated,O
lamina,O
propria,O
T,B
cells,I
by,O
increasing,O
mRNA,B
stability,O
without,O
enhancing,O
IL,B
-,I
2,I
gene,I
transactivation,O
.,O
Previous,O
studies,O
have,O
characterized,O
the,O
CD28,B
augmentation,O
of,O
TCR,B
-,I
mediated,I
signaling,O
in,O
peripheral,O
blood,O
T,B
cells,I
through,O
transcriptional,O
activation,O
of,O
an,O
IL,B
-,I
2,I
promoter,I
CD28,B
response,I
element,I
(,O
CD28RE,O
),O
",",O
along,O
with,O
enhanced,O
mRNA,B
stability,O
.,O
LPMC,B
exhibited,O
increased,O
IL,B
-,I
2,I
production,O
in,O
response,O
to,O
CD28,B
costimulation,O
",",O
compared,O
with,O
cells,O
activated,O
through,O
CD2,B
alone,O
.,O
In,O
conclusion,O
",",O
production,O
of,O
a,O
Th1,B
cytokine,O
",",O
IFN,B
-,I
gamma,I
",",O
by,O
HBsAg,B
-,I
reactive,I
cells,I
was,O
associated,O
with,O
hepatocyte,O
damage,O
in,O
chronic,O
hepatitis,O
B,I
",",O
while,O
no,O
counteracting,O
effect,O
of,O
Th2,B
cytokines,O
produced,O
by,O
those,O
cells,O
was,O
observed,O
.,O
BACKGROUND,O
:,O
Arsenic,B
trioxide,I
(,O
As2O3,B
),O
can,O
induce,O
clinical,O
remission,O
in,O
patients,O
with,O
acute,O
promyelocytic,O
leukemia,O
via,O
induction,O
of,O
differentiation,O
and,O
programmed,O
cell,O
death,O
(,O
apoptosis,O
),O
.,O
We,O
investigated,O
the,O
effects,O
of,O
As2O3,B
on,O
a,O
panel,O
of,O
malignant,O
lymphocytes,O
to,O
determine,O
whether,O
growth,O
-,O
inhibitory,O
and,O
apoptotic,O
effects,O
of,O
As2O3,B
can,O
be,O
observed,O
in,O
these,O
cells,O
at,O
clinically,O
achievable,O
concentrations,O
.,O
Caspase,B
-,I
3,I
activation,O
",",O
usually,O
resulting,O
from,O
delta,O
psi,O
(,O
m,O
),O
collapse,O
",",O
was,O
not,O
always,O
associated,O
with,O
As2O3,O
-,O
induced,O
apoptosis,O
.,O
As2O3,O
induced,O
PML,B
(,O
promyelocytic,I
leukemia,I
),O
protein,O
degradation,O
but,O
did,O
not,O
modulate,O
expression,O
of,O
cell,B
cycle,I
-,I
related,I
proteins,I
",",O
including,O
c,B
-,I
myc,I
",",O
retinoblastoma,B
protein,I
",",O
cyclin,B
-,I
dependent,I
kinase,I
4,I
",",O
cyclin,B
D1,I
",",O
and,O
p53,B
",",O
or,O
expression,O
of,O
differentiation,O
-,O
related,O
antigens,O
.,O
A20,B
can,O
be,O
regulated,O
by,O
the,O
NF,B
-,I
kappaB,I
transcription,I
factor,I
",",O
which,O
is,O
known,O
to,O
be,O
activated,O
by,O
the,O
EBV,O
LMP,O
-,O
1,O
protein,O
.,O
CTLA,O
-,O
4,O
ligation,O
inhibited,O
CD3,O
/,O
CD28,O
-,O
induced,O
IL,B
-,I
2,I
mRNA,I
accumulation,I
by,O
inhibiting,O
IL,B
-,I
2,I
transcription,I
",",O
which,O
appears,O
to,O
be,O
mediated,O
in,O
part,O
through,O
decreasing,O
NF,B
-,I
AT,I
accumulation,I
in,O
the,O
nuclei,O
.,O
Further,O
",",O
CTLA,B
-,I
4,I
engagement,O
inhibited,O
progression,O
through,O
the,O
cell,B
cycle,I
by,O
inhibiting,O
the,O
production,O
of,O
cyclin,B
D3,I
",",O
cyclin,B
-,I
dependent,I
kinase,I
(,O
cdk,B
),O
4,I
",",O
and,O
cdk6,B
when,O
the,O
T,B
cells,I
were,O
stimulated,O
with,O
anti,O
-,O
CD3,B
/,I
CD28,I
and,O
with,O
anti,O
-,O
CD3,B
alone,O
.,O
Dexamethasone,B
(,O
Dex,B
),O
",",O
a,O
synthetic,O
glucocorticoid,O
hormone,O
",",O
cooperated,O
with,O
Epo,B
and,O
stem,O
cell,B
factor,I
to,O
induce,O
erythroid,B
progenitors,I
to,O
undergo,O
15,O
to,O
22,O
cell,B
divisions,I
",",O
corresponding,O
to,O
a,O
10,O
(,O
5,O
),O
-,O
to,O
10,O
(,O
6,O
),O
-,O
fold,O
amplification,O
of,O
erythroid,B
cells,I
.,O
Sustained,O
proliferation,O
of,O
erythroid,B
progenitors,I
could,O
be,O
induced,O
equally,O
well,O
from,O
purified,O
erythroid,B
burst,I
-,I
forming,I
units,I
(,O
BFU,B
-,I
E,I
),O
",",O
from,O
CD34,B
(,O
+,O
),O
blast,B
cells,I
",",O
and,O
from,O
bone,B
marrow,I
depleted,O
from,O
CD34,B
(,O
+,O
),O
cells,I
.,O
We,O
conclude,O
that,O
NF,B
-,I
kappaB,I
is,O
a,O
context,O
-,O
dependent,O
apoptosis,O
regulator,O
.,O
SOCS,B
-,I
3,I
protein,I
was,O
detectable,O
as,O
early,O
as,O
30,O
min,O
following,O
IL,B
-,I
2,I
stimulation,I
",",O
while,O
CIS,B
was,O
seen,O
only,O
at,O
low,O
levels,O
after,O
2,O
h,O
.,O
Tyrosine,B
phosphorylation,I
of,I
SOCS,B
-,I
3,I
was,O
observed,O
upon,O
coexpression,O
with,O
Jak1,B
and,O
Jak2,B
but,O
only,O
weakly,O
with,O
Jak3,B
.,O
Finally,O
",",O
proliferation,O
induced,O
by,O
both,O
IL,B
-,I
2,I
-,I
and,I
IL,B
-,I
3,I
was,O
significantly,O
inhibited,O
in,O
the,O
presence,O
of,O
SOCS,B
-,I
3,I
.,O
There,O
was,O
",",O
however,O
",",O
a,O
significant,O
difference,O
in,O
the,O
amounts,O
of,O
the,O
nuclear,B
protein,I
",",O
REF,B
-,I
1,I
(,O
which,O
regulates,O
AP,B
-,I
1,I
DNA,B
binding,I
by,O
altering,O
the,O
redox,B
status,I
of,I
FOS,B
and,O
JUN,B
proteins,I
),O
",",O
in,O
alveolar,B
macrophages,I
compared,O
with,O
monocytes,B
.,O
Finally,O
",",O
addition,O
of,O
REF,B
-,I
1,I
from,O
activated,O
monocytes,O
to,O
alveolar,O
macrophage,O
nuclear,O
proteins,O
resulted,O
in,O
a,O
marked,O
increase,O
in,O
AP,B
-,I
1,I
DNA,B
binding,O
.,O
Studies,O
over,O
the,O
past,O
few,O
years,O
have,O
identified,O
lymphotoxin,B
as,O
a,O
critical,O
signaling,O
molecule,O
not,O
only,O
for,O
the,O
organogenesis,O
of,O
secondary,O
lymphoid,O
tissues,O
but,O
for,O
the,O
maintenance,O
of,O
aspects,O
of,O
their,O
microarchitecture,O
as,O
well,O
.,O
This,O
review,O
focuses,O
on,O
studies,O
defining,O
recently,O
identified,O
crucial,O
signals,O
for,O
the,O
biogenesis,O
of,O
secondary,O
lymphoid,O
organs,O
and,O
for,O
the,O
maintenance,O
of,O
their,O
proper,O
microarchitecture,O
.,O
The,O
costimulatory,O
molecule,O
CD28,B
has,O
a,O
restricted,O
tissue,O
distribution,O
and,O
is,O
expressed,O
on,O
T,B
cells,I
and,O
some,O
plasmacytoma,B
cells,I
.,O
In,O
vivo,O
",",O
CD8,B
+,I
T,I
cells,I
and,O
",",O
less,O
frequently,O
",",O
CD4,B
+,I
T,I
cells,I
may,O
completely,O
lose,O
CD28,B
surface,I
expression,I
during,O
chronic,O
infections,O
and,O
with,O
aging,O
.,O
Both,O
alpha,B
-,I
and,I
beta,I
-,I
bound,I
complexes,I
are,O
found,O
only,O
in,O
lymphoid,O
tissues,O
",",O
in,O
CD28,B
+,I
T,I
cells,I
",",O
and,O
in,O
some,O
transformed,O
B,B
cells,I
.,O
A,O
role,O
for,O
RanBP1,O
in,O
the,O
release,O
of,O
CRM1,O
from,O
the,O
nuclear,O
pore,O
complex,O
in,O
a,O
terminal,O
step,O
of,O
nuclear,O
export,O
.,O
It,O
also,O
stimulates,O
nuclear,O
export,O
in,O
cells,O
that,O
have,O
not,O
been,O
preincubated,O
with,O
RanQ69L,O
.,O
In,O
a,O
model,O
where,O
foreign,O
cells,O
(,O
rat,O
fibroblasts,O
),O
were,O
cocultured,O
with,O
human,O
IL,B
-,I
2,I
activated,O
NK,B
cells,I
",",O
we,O
observed,O
that,O
NK,B
cells,I
were,O
capable,O
of,O
efficiently,O
killing,O
their,O
targets,O
only,O
if,O
the,O
cells,O
overexpressed,O
the,O
oncogene,O
c,B
-,I
Myc,I
or,O
E1A,B
.,O
These,O
results,O
provided,O
evidence,O
that,O
c,O
-,O
Myc,B
and,O
E1A,B
activated,O
the,O
NK,B
cell,I
induced,O
cytolysis,O
at,O
a,O
post,O
-,O
triggering,O
stage,O
of,O
NK,B
cell,I
-,I
target,I
cell,I
interaction,O
.,O
Unicellular,O
-,O
unilineage,O
erythropoietic,B
cultures,O
:,O
molecular,O
analysis,O
of,O
regulatory,O
gene,O
expression,O
at,O
sibling,O
cell,O
level,O
.,O
In,O
the,O
culture,O
system,O
reported,O
here,O
",",O
(,O
1,O
),O
the,O
growth,O
factor,O
(,O
GF,B
),O
stimulus,O
induces,O
cord,O
blood,O
(,O
CB,B
),O
progenitor,O
cells,O
to,O
proliferate,O
and,O
differentiate,O
/,O
mature,O
exclusively,O
along,O
the,O
erythroid,B
lineage,I
;,O
(,O
2,O
),O
this,O
erythropoietic,B
wave,O
is,O
characterized,O
by,O
less,O
than,O
4,O
%,O
apoptotic,O
cells,O
;,O
(,O
3,O
),O
asymmetric,O
divisions,O
are,O
virtually,O
absent,O
",",O
ie,O
",",O
nonresponsive,O
hematopoietic,O
progenitors,O
with,O
no,O
erythropoietic,B
potential,O
are,O
forced,O
into,O
apoptosis,O
;,O
(,O
4,O
),O
the,O
system,O
is,O
cell,O
division,O
controlled,O
(,O
cdc,B
),O
",",O
ie,O
",",O
the,O
number,O
of,O
divisions,O
performed,O
by,O
each,O
cell,O
is,O
monitored,O
.,O
Single,O
-,O
cell,O
reverse,O
transcriptase,O
-,O
polymerase,O
chain,O
reaction,O
(,O
RT,O
-,O
PCR,O
),O
analysis,O
was,O
applied,O
to,O
this,O
culture,O
system,O
to,O
investigate,O
gene,O
expression,O
of,O
diverse,O
receptors,O
",",O
markers,O
of,O
differentiation,O
",",O
and,O
transcription,O
factors,O
(,O
EKLF,B
",",O
GATA,B
-,I
1,I
",",O
GATA,B
-,I
2,I
",",O
p45,O
NF,B
-,I
E2,I
",",O
PU,B
0.1,I
",",O
and,O
SCL,B
/,I
Tal1,I
),O
at,O
discrete,O
stages,O
of,O
erythropoietic,O
development,O
.,O
However,O
",",O
stimulation,O
with,O
IL,B
-,I
2,I
resulted,O
in,O
Jak3,B
and,O
STAT5,B
phosphorylation,O
in,O
both,O
leukemic,B
ATLL,I
cells,I
and,O
IL,B
-,I
2,I
-,I
dependent,I
lines,I
.,O
A,O
skewed,O
XCI,B
pattern,I
with,O
greater,O
than,O
75,O
%,O
amplification,O
of,O
1,O
allele,O
(,O
allele,O
ratio,O
>,O
3,O
:,O
1,O
),O
was,O
found,O
in,O
22,O
(,O
9,O
.,O
1,O
%,O
),O
of,O
242,O
control,O
subjects,O
.,O
Although,O
statistical,O
evaluation,O
of,O
the,O
data,O
showed,O
a,O
significant,O
difference,O
between,O
patients,O
with,O
a,O
chronic,O
MPD,B
and,O
control,O
subjects,O
",",O
proof,O
of,O
clonality,O
in,O
individual,O
",",O
especially,O
elderly,O
",",O
patients,O
is,O
difficult,O
.,O
Here,O
we,O
report,O
that,O
in,O
erythroid,B
cells,I
",",O
GATA,B
-,I
1,I
strongly,O
induces,O
the,O
expression,O
of,O
the,O
anti,O
-,O
apoptotic,O
protein,B
bcl,I
-,I
xL,I
",",O
but,O
not,O
the,O
related,O
proteins,O
bcl,B
-,I
2,I
and,O
mcl,B
-,I
1,I
.,O
In,O
T,B
lymphocytes,I
",",O
the,O
hematopoietic,O
cytokine,O
interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
uses,O
phosphatidylinositol,B
3,I
-,I
kinase,I
(,O
PI,B
3,I
-,I
kinase,I
),O
-,O
induced,O
signaling,O
pathways,O
to,O
regulate,O
E2F,B
transcriptional,I
activity,I
",",O
a,O
critical,O
cell,O
cycle,O
checkpoint,O
.,O
PI,B
3,I
-,I
kinase,I
also,O
regulates,O
the,O
activity,O
of,O
p70,B
(,O
s6k,I
),O
",",O
the,O
40S,B
ribosomal,I
protein,I
S6,I
kinase,I
",",O
a,O
response,O
that,O
is,O
abrogated,O
by,O
the,O
macrolide,O
rapamycin,O
.,O
Moreover,O
",",O
the,O
effects,O
of,O
rapamycin,O
on,O
",",O
and,O
the,O
role,O
of,O
p70,B
(,O
s6k,I
),O
in,O
",",O
IL,O
-,O
2,O
and,O
PI,B
3,I
-,I
kinase,I
activation,O
of,O
E2Fs,O
have,O
not,O
been,O
characterized,O
.,O
Our,O
present,O
results,O
show,O
that,O
IL,B
-,I
2,I
-,I
and,O
PI,B
3,I
-,I
kinase,I
-,I
induced,O
pathways,O
for,O
the,O
regulation,O
of,O
E2F,B
transcriptional,I
activity,I
include,O
both,O
rapamycin,B
-,I
resistant,I
and,O
rapamycin,B
-,I
sensitive,I
components,I
.,O
Thus,O
",",O
the,O
rapamycin,B
-,I
controlled,I
processes,I
involved,O
in,O
E2F,B
regulation,I
appear,O
to,O
be,O
mediated,O
by,O
p70,B
(,O
s6k,I
),O
.,O
Since,O
1988,O
",",O
several,O
families,O
of,O
functionally,O
important,O
T,B
cell,I
transcription,I
factors,I
have,O
been,O
identified,O
.,O
These,O
include,O
the,O
Ikaros,B
",",O
LKLF,B
",",O
and,O
GATA3,B
zinc,I
-,I
finger,I
proteins,I
;,O
the,O
Ets,B
",",O
CREB,B
/,I
ATF,I
",",O
and,O
NF,B
-,I
kappa,I
B,I
/,I
Rel,I
/,I
NFAT,I
transcription,I
factors,I
;,O
the,O
Stat,B
proteins,I
;,O
and,O
HMG,B
box,I
transcription,I
factors,I
such,O
as,O
LEF1,B
",",O
TCF1,B
",",O
and,O
Sox4,B
.,O
The,O
proliferative,O
deficiency,O
of,O
the,O
transgenic,O
T,B
cells,I
was,O
associated,O
with,O
an,O
increased,O
apoptosis,O
.,O
Paradoxical,O
priming,O
effects,O
of,O
IL,B
-,I
10,I
on,O
cytokine,B
production,I
.,O
Interestingly,O
",",O
an,O
enhanced,O
frequency,O
of,O
CD16,B
and,O
CD68,B
(,O
+,O
),O
cells,O
among,O
the,O
CD14,B
(,O
+,O
),O
cells,O
was,O
observed,O
in,O
the,O
presence,O
of,O
IL,B
-,I
10,I
",",O
independently,O
of,O
the,O
pre,O
-,O
culture,O
conditions,O
of,O
the,O
PBMC,O
.,O
Transcription,O
factors,O
Sp1,B
and,O
AP,B
-,I
2,I
mediate,O
induction,O
of,O
acid,O
sphingomyelinase,O
during,O
monocytic,B
differentiation,I
.,O
Cells,O
from,O
the,O
human,O
monocytic,B
leukemia,I
cell,I
line,I
THP,B
-,I
1,I
differentiate,O
towards,O
a,O
macrophage,B
-,I
like,I
phenotype,I
when,O
stimulated,O
with,O
phorbol,O
12,O
-,O
myristate,O
-,O
13,O
-,O
acetate,O
(,O
PMA,B
),O
",",O
1,O
",",O
25,O
-,O
dihydroxy,O
-,O
vitamin,O
D3,B
",",O
and,O
various,O
other,O
agents,O
.,O
A,O
PMA,B
responsive,I
element,I
was,O
localized,O
to,O
a,O
region,O
between,O
-,O
319,O
and,O
-,O
219,O
bp,O
upstream,O
of,O
the,O
initiation,O
codon,O
and,O
co,O
-,O
transfections,O
with,O
transcription,O
factor,O
expression,O
plasmids,O
for,O
AP,O
-,O
2,O
and,O
Sp1,O
resulted,O
in,O
augmented,O
ASM,O
promoter,O
activity,O
",",O
which,O
was,O
abolished,O
when,O
the,O
binding,O
sites,O
for,O
these,O
two,O
factors,O
were,O
deleted,O
.,O
However,O
",",O
the,O
intensity,O
of,O
the,O
complex,O
formed,O
appeared,O
to,O
increase,O
when,O
nuclear,O
extracts,O
from,O
PMA,O
-,O
treated,O
cells,O
were,O
used,O
.,O
NF,B
-,I
kappaB,I
DNA,I
binding,I
was,O
evaluated,O
by,O
electrophoretic,O
mobility,O
shift,O
assay,O
.,O
Direct,O
activation,O
of,O
PKC,O
with,O
PMA,O
induced,O
both,O
NF,B
-,I
kappaB,I
activation,I
and,O
TNF,B
-,I
alpha,I
production,I
by,O
human,O
monocytes,O
.,O
Furthermore,O
",",O
our,O
results,O
provide,O
evidence,O
that,O
PTK,B
plays,O
a,O
role,O
in,O
LPS,O
-,O
induced,O
NF,B
-,I
kappaB,I
activation,O
and,O
TNF,B
-,I
alpha,I
release,O
in,O
human,O
monocytes,O
and,O
thus,O
could,O
be,O
a,O
potential,O
therapeutic,O
target,O
in,O
inflammatory,O
states,O
.,O
The,O
effects,O
of,O
GDSP,O
on,O
pancreatic,O
weight,O
",",O
serum,O
amylase,O
and,O
lipase,O
",",O
morphologic,O
changes,O
in,O
the,O
pancreas,O
",",O
neutrophil,O
infiltration,O
",",O
and,O
nuclear,O
factor,O
KB,B
(,I
NF,B
-,I
KB,I
),I
activation,O
were,O
measured,O
in,O
rats,O
infused,O
with,O
supramaximal,O
dose,O
of,O
cerulein,O
(,O
5,O
(,O
g,O
/,O
kg,O
/,O
h,O
),O
for,O
6,O
h,O
.,O
Elastatinal,O
had,O
some,O
of,O
the,O
same,O
effects,O
as,O
GDSP,O
but,O
was,O
less,O
potent,O
and,O
effective,O
.,O
The,O
nature,O
of,O
the,O
nuclear,O
factor,O
(,O
s,O
),O
that,O
control,O
TNF,B
-,I
alpha,I
gene,I
transcription,O
in,O
humans,O
remains,O
obscure,O
",",O
although,O
NF,B
-,I
kappaB,I
has,O
been,O
suggested,O
.,O
Our,O
previous,O
studies,O
pertaining,O
to,O
macrophage,O
response,O
to,O
LPS,O
identified,O
a,O
novel,O
DNA,B
-,I
binding,I
domain,I
located,O
from,O
-,O
550,O
to,O
-,O
487,O
in,O
the,O
human,O
TNF,B
-,I
alpha,I
promoter,I
that,O
contains,O
transcriptional,O
activity,O
",",O
but,O
lacks,O
any,O
known,O
NF,B
-,I
kappaB,I
-,I
binding,I
sites,I
.,O
Inhibition,O
of,O
LITAF,B
mRNA,I
expression,O
in,O
THP,B
-,I
1,I
cells,O
resulted,O
in,O
a,O
reduction,O
of,O
TNF,B
-,I
alpha,I
transcripts,O
.,O
In,O
addition,O
",",O
high,O
level,O
of,O
expression,O
of,O
LITAF,B
mRNA,I
was,O
observed,O
predominantly,O
in,O
the,O
placenta,O
",",O
peripheral,O
blood,O
leukocytes,O
",",O
lymph,O
nodes,O
",",O
and,O
the,O
spleen,O
.,O
A,O
human,O
IFNGR1,B
small,I
deletion,I
hotspot,I
associated,O
with,O
dominant,O
susceptibility,O
to,O
mycobacterial,O
infection,O
[,O
see,O
comments,O
],O
Characterization,O
of,O
expression,O
of,O
the,O
gene,O
for,O
human,O
pterin,O
carbinolamine,O
dehydratase,O
/,O
dimerization,O
cofactor,O
of,O
HNF1,O
.,O
In,O
the,O
nucleus,O
",",O
it,O
functions,O
as,O
a,O
dimerization,O
cofactor,O
of,O
HNF1,B
and,O
increases,O
the,O
transcriptional,O
activity,O
of,O
HNF1,B
. Transfection,O
of,O
Jurkat,B
cells,I
with,O
the,O
NF,B
-,I
kappaB,I
subunits,I
p50,I
and,O
p65,B
confers,O
resistance,O
against,O
Fas,B
-,I
mediated,I
apoptosis,I
. Capacitance,O
would,O
simply,O
involve,O
expression,O
of,O
IL,B
-,I
12R,I
beta,I
1,I
and,O
beta,B
2,I
subunits,I
",",O
regulated,O
by,O
TCR,B
",",O
IL,B
-,I
4,I
and,O
IFNs,B
.,O
The,O
activation,O
of,O
STAT3,B
was,O
not,O
found,O
in,O
human,O
eosinophils,O
",",O
monocytes,O
",",O
and,O
HL,B
-,I
60,I
cells,I
",",O
although,O
the,O
STAT3,B
protein,I
was,O
expressed,O
in,O
these,O
cells,O
.,O
The,O
transcription,O
factor,O
NF,B
-,I
ATc,I
is,O
synthesized,O
in,O
three,O
prominent,O
isoforms,O
.,O
These,O
differ,O
in,O
the,O
length,O
of,O
their,O
C,O
terminal,O
peptides,O
and,O
mode,O
of,O
synthesis,O
.,O
Together,O
",",O
these,O
results,O
demonstrate,O
that,O
ER,B
and,O
PR,B
can,O
be,O
activated,O
by,O
endogenous,O
or,O
exogenous,O
ligands,O
to,O
induce,O
a,O
genetic,O
response,O
that,O
impairs,O
TNF,B
-,I
alpha,I
-,I
induced,O
apoptosis,O
in,O
U937,B
cells,I
.,O
Retinoidal,O
antagonists,O
and,O
potential,O
agonists,O
.,O
Inhibition,O
of,O
T,B
cell,I
signaling,I
by,O
mitogen,O
-,O
activated,O
protein,B
kinase,I
-,I
targeted,I
hematopoietic,I
tyrosine,I
phosphatase,I
(,O
HePTP,B
),O
.,O
Activation,O
of,O
T,B
lymphocytes,I
to,O
produce,O
cytokines,O
is,O
regulated,O
by,O
the,O
counterbalance,O
of,O
protein,B
-,I
tyrosine,I
kinases,I
and,O
protein,B
-,I
tyrosine,I
phosphatases,I
",",O
many,O
of,O
which,O
have,O
a,O
high,O
degree,O
of,O
substrate,O
specificity,O
because,O
of,O
physical,O
association,O
with,O
their,O
targets,O
.,O
In,O
contrast,O
",",O
HePTP,O
had,O
no,O
effects,O
on,O
N,B
-,I
terminal,I
c,I
-,I
Jun,I
kinase,I
or,O
on,O
events,O
upstream,O
of,O
the,O
MAP,O
kinases,O
.,O
However,O
",",O
p38,B
MAPK,I
is,O
activated,O
strongly,O
and,O
synergistically,O
by,O
either,O
CD3,B
/,I
CD28,I
coligation,I
or,O
PMA,B
/,I
Ca2,I
+,I
ionophore,I
stimulation,O
",",O
which,O
mimics,O
TCR,B
-,I
CD3,I
/,I
CD28,I
-,I
mediated,I
signaling,O
.,O
We,O
have,O
compared,O
the,O
effects,O
of,O
Epo,B
and,O
the,O
chemical,O
inducers,O
",",O
delta,B
-,I
aminolaevulinic,I
acid,I
(,I
delta,I
-,I
ALA,I
),I
and,O
haemin,B
on,O
the,O
differentiation,O
capacity,O
of,O
UT,B
-,I
7,I
cells,O
.,O
Epo,B
alone,O
promoted,O
relatively,O
early,O
events,O
in,O
erythroid,B
maturation,O
",",O
without,O
significant,O
changes,O
in,O
haemoglobin,B
production,O
or,O
morphology,O
.,O
Epo,B
caused,O
an,O
increase,O
in,O
the,O
proportion,O
of,O
cells,O
expressing,O
cell,B
surface,I
glycophorin,I
A,I
(,O
GPA,B
),O
and,O
up,O
-,O
regulated,O
beta,B
-,I
and,I
gamma,I
-,I
globin,I
by,O
several,O
fold,O
.,O
There,O
is,O
little,O
direct,O
evidence,O
regarding,O
the,O
role,O
of,O
alveolar,B
macrophages,I
in,O
these,O
activation,O
events,O
.,O
These,O
data,O
suggest,O
that,O
",",O
in,O
this,O
inflammatory,O
model,O
",",O
initial,O
activation,O
of,O
NF,B
-,I
kappaB,I
occurs,O
in,O
alveolar,O
macrophages,O
and,O
the,O
ensuing,O
production,O
of,O
TNF,B
-,I
alpha,I
may,O
propagate,O
NF,B
-,I
kappaB,I
activation,O
to,O
other,O
cell,O
types,O
in,O
the,O
lung,O
.,O
Interferon,B
-,I
beta,I
mediates,O
stromal,O
cell,O
rescue,O
of,O
T,O
cells,O
from,O
apoptosis,O
.,O
Interferon,O
-,O
alpha,B
and,O
-,O
beta,B
promote,O
the,O
reversion,O
of,O
blast,O
Tcells,B
to,O
a,O
resting,O
G0,O
/,O
G1,O
configuration,O
with,O
all,O
the,O
characteristic,O
features,O
of,O
stromal,O
cell,O
rescue,O
;,O
such,O
as,O
high,O
Bcl,B
-,I
XL,I
expression,O
and,O
low,O
Bcl,B
-,I
2,I
.,O
We,O
also,O
show,O
that,O
DFX,O
treatment,O
limits,O
the,O
in,O
vivo,O
activation,O
of,O
NF,B
-,I
kappaB,I
",",O
a,O
transcription,O
factor,O
involved,O
in,O
both,O
TNF,B
-,I
alpha,I
gene,I
transcription,O
and,O
TNF,B
-,I
alpha,I
signalling,O
(,O
P,O
<,O
0,O
0.78,O
5,O
),O
.,O
In,O
this,O
study,O
",",O
the,O
influence,O
of,O
the,O
sequences,O
located,O
between,O
-,O
3134,O
and,O
-,O
2987,O
on,O
the,O
transcriptional,O
activity,O
of,O
the,O
proIL,B
-,I
1beta,I
gene,I
in,O
LPS,B
-,I
stimulated,I
Raw,B
264,I
0.7,I
cells,I
was,O
examined,O
in,O
detail,O
.,O
These,O
specific,O
bindings,O
were,O
time,O
and,O
LPS,B
dose,I
dependent,I
.,O
These,O
data,O
indicated,O
that,O
two,O
NF,B
-,I
kappaB,I
-,I
binding,I
sites,I
",",O
which,O
are,O
located,O
between,O
-,O
3134,O
and,O
-,O
3059,O
",",O
are,O
critical,O
for,O
the,O
activation,O
of,O
proIL,B
-,I
1beta,I
gene,I
transcription,I
.,O
N,O
-,O
acetyl,O
-,O
L,O
-,O
cysteine,O
inhibits,O
primary,O
human,O
T,B
cell,I
responses,O
at,O
the,O
dendritic,O
cell,O
level,O
:,O
association,O
with,O
NF,B
-,I
kappaB,I
inhibition,O
.,O
Altogether,O
",",O
our,O
results,O
suggest,O
that,O
NAC,O
might,O
impair,O
the,O
generation,O
of,O
primary,O
immune,O
responses,O
in,O
humans,O
through,O
its,O
inhibitory,O
action,O
on,O
DC,B
.,O
Gel,O
supershift,O
assays,O
demonstrated,O
that,O
thrombin,O
induced,O
binding,O
of,O
NF,B
-,I
kappa,I
Bp65,I
(,O
Rel,O
A,O
),O
to,O
downstream,O
NF,B
-,I
kappa,I
B,I
site,O
of,O
the,O
ICAM,B
-,I
1,I
promoter,I
.,O
Thrombin,B
receptor,I
activation,I
peptide,I
",",O
a,O
14,O
-,O
amino,O
-,O
-,O
acid,O
peptide,O
representing,O
the,O
new,O
NH2,O
terminus,O
of,O
proteolytically,O
activated,O
receptor,O
-,O
1,O
",",O
mimicked,O
thrombin,B
',O
s,O
action,O
in,O
inducing,O
ICAM,B
-,I
1,I
expression,I
.,O
These,O
data,O
indicate,O
that,O
thrombin,B
activates,O
endothelial,O
ICAM,B
-,I
1,I
expression,I
and,O
polymorphonuclear,O
leukocyte,O
adhesion,O
by,O
NF,B
-,I
kappa,I
Bp65,I
binding,I
to,O
the,O
downstream,O
NF,B
-,I
kappa,I
B,I
site,I
of,O
ICAM,B
-,I
1,I
promoter,I
after,O
proteolytically,O
activated,O
receptor,O
-,O
1,O
activation,O
.,O
Here,O
we,O
demonstrate,O
that,O
both,O
Smad6,B
and,O
Smad7,B
are,O
human,O
bone,O
morphogenetic,O
protein,B
-,I
2,I
(,O
hBMP,B
-,I
2,I
),O
-,O
inducible,O
antagonists,O
of,O
hBMP,B
-,I
2,I
-,I
induced,O
growth,O
arrest,O
and,O
apoptosis,O
in,O
mouse,O
B,B
cell,I
hybridoma,I
HS,B
-,I
72,I
cells,I
.,O
The,O
effect,O
was,O
dose,O
dependent,O
and,O
appeared,O
relatively,O
late,O
.,O
Significant,O
differences,O
were,O
observed,O
from,O
day,O
4,O
onward,O
.,O
RA,B
previously,O
was,O
found,O
to,O
inhibit,O
granulocyte,B
colony,I
-,I
stimulating,I
factor,I
-,I
-,I
and,O
not,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
-,I
-,I
stimulated,O
proliferation,O
of,O
CD34,B
+,I
cells,I
.,O
Interestingly,O
",",O
CyA,O
and,O
indomethacin,O
did,O
not,O
suppress,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
(,O
TNF,B
-,I
alpha,I
),O
-,O
induced,O
adhesion,O
molecule,O
expression,O
on,O
HUVECs,O
",",O
whereas,O
aspirin,O
had,O
an,O
inhibitory,O
effect,O
.,O
CONCLUSION,O
:,O
Our,O
results,O
show,O
that,O
the,O
tested,O
agents,O
(,O
except,O
indomethacin,O
),O
are,O
inhibitors,O
of,O
the,O
T,B
cell,I
-,I
mediated,I
immune,I
response,I
",",O
as,O
expected,O
",",O
that,O
aspirin,O
is,O
an,O
effective,O
suppressor,O
of,O
adhesion,O
molecule,O
expression,O
",",O
and,O
that,O
all,O
three,O
agents,O
can,O
induce,O
Hsp60,B
in,O
HUVECs,O
.,O
METHODS,O
:,O
Ten,O
atopic,O
asthmatic,O
subjects,O
were,O
treated,O
with,O
FP,O
250,O
microg,O
twice,O
daily,O
for,O
4,O
weeks,O
.,O
In,O
addition,O
",",O
a,O
24,O
-,O
hour,O
urinary,O
cortisol,B
excretion,I
and,O
an,O
adrenocorticotropic,O
hormone,O
test,O
before,O
and,O
after,O
treatment,O
with,O
FP,O
were,O
performed,O
. However,O
",",O
we,O
detected,O
a,O
significant,O
reduction,O
of,O
the,O
GR,B
mRNA,I
levels,I
in,O
the,O
endobronchial,O
biopsy,O
specimens,O
after,O
FP,O
treatment,O
(,O
36,O
. 6,O
+,O
/,O
-,O
23,O
. 1,O
and,O
25,O
. 0,O
+,O
/,O
-,O
10,O
. 0,O
9,O
amol,O
GR,B
mRNA,I
/,O
microg,O
RNA,B
",",O
respectively,O
;,O
P,O
<,O
.,O
1,O
),O
.,O
In,O
the,O
peripheral,O
blood,O
lymphocytes,O
an,O
even,O
more,O
striking,O
downregulation,O
of,O
the,O
GR,B
by,O
its,O
cognate,O
ligand,O
was,O
documented,O
(,O
30,O
.,O
3,O
+,O
/,O
-,O
26,O
.,O
5,O
and,O
8,O
.,O
+,O
/,O
-,O
5,O
amol,O
GR,B
mRNA,I
/,O
microg,O
RNA,B
",",O
respectively,O
;,O
P,O
<,O
.,O
1,O
),O
",",O
possibly,O
reflecting,O
differences,O
in,O
glucocorticoid,O
sensitivity,O
between,O
tissues,O
.,O
Inflammation,O
is,O
constantly,O
observed,O
in,O
allergic,O
reactions,O
.,O
The,O
action,O
of,O
glucocorticosteroids,O
is,O
mediated,O
through,O
glucocorticoid,B
receptors,I
present,O
in,O
the,O
cellular,O
cytoplasm,O
.,O
Interaction,O
to,O
DNA,B
induces,O
changes,O
in,O
the,O
transcription,O
rate,O
",",O
leading,O
to,O
either,O
gene,O
induction,O
or,O
gene,O
repression,O
.,O
RESULTS,O
:,O
Phorbol,O
-,O
myristate,O
-,O
acetate,O
and,O
ionomycine,O
strongly,O
increase,O
the,O
percent,O
-,O
age,O
of,O
IL,B
-,I
2,I
+,I
cells,I
;,O
an,O
additional,O
50,O
%,O
HCSs,O
significantly,O
suppresses,O
the,O
percentage,O
to,O
",",O
or,O
below,O
the,O
level,O
of,O
unstimulated,O
cells,O
.,O
50,O
%,O
HCS,B
downregulates,O
the,O
alpha,B
-,I
chain,I
and,O
slightly,O
upregulates,O
the,O
beta,B
-,I
chain,I
.,O
Inhibition,O
of,O
IL,B
-,I
4,I
-,I
inducible,I
gene,I
expression,I
in,O
human,B
monocytes,I
by,O
type,O
I,B
and,O
type,O
II,B
interferons,I
.,O
However,O
",",O
the,O
mechanism,O
by,O
which,O
IFNs,B
mediate,O
this,O
inhibition,O
has,O
not,O
been,O
defined,O
.,O
Because,O
STAT6,B
activation,I
plays,O
an,O
essential,O
role,O
in,O
IL,B
-,I
4,I
/,I
IL,B
-,I
13,I
-,I
induced,I
gene,I
expression,I
",",O
the,O
ability,O
of,O
IFN,B
-,I
beta,I
and,O
IFN,B
-,I
gamma,I
to,O
inhibit,O
STAT6,B
activity,I
provides,O
an,O
explanation,O
for,O
how,O
IFNs,B
can,O
suppress,O
IL,B
-,I
4,I
/,I
IL,B
-,I
13,I
-,I
inducible,I
gene,I
expression,I
.,O
HLA,B
class,I
I,I
Ags,I
have,O
been,O
implicated,O
to,O
play,O
a,O
major,O
role,O
in,O
this,O
process,O
",",O
since,O
signaling,O
via,O
HLA,B
class,I
I,I
molecules,I
can,O
induce,O
the,O
proliferation,O
of,O
aortic,O
endothelial,B
as,O
well,O
as,O
smooth,B
muscle,I
cells,I
.,O
A,O
cdk2,B
inhibitor,I
",",O
Olomoucine,O
",",O
as,O
well,O
as,O
a,O
dominant,B
-,I
negative,I
cdk2,I
construct,I
prevented,O
HLA,B
class,I
I,I
-,I
mediated,I
inactivation,I
of,I
Rb,I
;,O
in,O
contrast,O
",",O
dominant,B
-,I
negative,I
cdk4,I
and,O
cdk6,B
constructs,I
had,O
no,O
effect,O
.,O
PG490,O
inhibits,O
interleukin,O
expression,O
by,O
normal,O
human,O
peripheral,O
blood,O
lymphocytes,O
stimulated,O
with,O
phorbol,O
12,O
-,O
myristate,O
13,O
-,O
acetate,O
(,O
PMA,B
),O
and,O
antibody,O
to,O
CD3,B
(,O
IC50,O
of,O
10,O
ng,O
/,O
ml,O
),O
",",O
and,O
with,O
PMA,B
and,O
ionomycin,B
(,O
Iono,B
",",O
IC50,O
of,O
40,O
ng,O
/,O
ml,O
),O
.,O
In,O
Jurkat,O
T,O
-,O
cells,O
",",O
PG490,O
inhibits,O
PMA,B
/,O
Iono,B
-,O
stimulated,O
IL,O
-,O
2,O
transcription,O
.,O
PG490,O
can,O
completely,O
inhibit,O
transcriptional,O
activation,O
at,O
the,O
purine,B
-,I
box,I
/,I
ARRE,I
/,I
NF,I
-,I
AT,I
and,I
NF,I
-,I
kappaB,I
target,I
DNA,I
sequences,I
triggered,O
by,O
all,O
stimuli,O
examined,O
(,O
PMA,O
",",O
PMA,O
/,O
Iono,O
",",O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
),O
.,O
PG490,O
also,O
inhibits,O
PMA,O
-,O
stimulated,O
activation,O
of,O
a,O
chimeric,O
transcription,O
factor,O
in,O
which,O
the,O
C,O
-,O
terminal,O
TA1,O
transactivation,O
domain,O
of,O
NF,O
-,O
kappaB,O
p65,O
is,O
fused,O
to,O
the,O
DNA,B
binding,I
domain,I
of,I
GAL4,I
.,O
Unexpected,O
and,O
coordinated,O
expression,O
of,O
Spi,B
-,I
1,I
",",O
Fli,B
-,I
1,I
",",O
and,O
megakaryocytic,B
genes,I
in,O
four,O
Epo,B
-,I
dependent,I
cell,I
lines,I
established,O
from,O
transgenic,O
mice,O
displaying,O
erythroid,B
-,I
specific,I
expression,I
of,O
a,O
thermosensitive,O
SV40,B
T,I
antigen,I
.,O
Most,O
erythroleukemic,B
cell,I
lines,I
established,O
in,O
vitro,O
coexpress,O
erythrocytic,B
and,O
megakaryocytic,B
markers,I
that,O
often,O
are,O
associated,O
with,O
expression,O
of,O
Spi,B
-,I
1,I
and,O
/,O
or,O
Fli,B
-,I
1,I
transcription,O
factors,O
known,O
as,O
transactivators,O
of,O
megakaryocyte,B
-,I
specific,I
promoters,I
.,O
In,O
the,O
present,O
study,O
",",O
we,O
examined,O
the,O
possibility,O
of,O
establishing,O
new,O
cell,O
lines,O
keeping,O
strictly,O
erythroid,B
-,I
specific,I
properties,O
in,O
vitro,O
through,O
the,O
targeted,O
and,O
conditional,O
immortalization,O
of,O
erythrocytic,B
progenitors,O
.,O
However,O
",",O
like,O
normal,O
Ter,B
119,I
erythroid,I
cells,O
",",O
these,O
Ter,B
119,I
positive,I
cells,O
from,O
transgenic,O
mice,O
still,O
expressed,O
high,O
levels,O
of,O
beta,B
-,I
globin,I
and,O
very,O
low,O
or,O
undetectable,O
glycoprotein,B
IIb,I
and,O
platelet,B
factor,I
4,I
megakaryocytic,I
transcripts,O
.,O
Taken,O
together,O
",",O
these,O
data,O
indicate,O
that,O
the,O
unexpected,O
expression,O
of,O
megakaryocytic,B
genes,I
is,O
a,O
specific,O
property,O
of,O
immortalized,O
cells,O
that,O
can,O
not,O
be,O
explained,O
only,O
by,O
enhanced,O
expression,O
of,O
Spi,B
-,I
1,I
and,O
/,O
or,O
Fli,B
-,I
1,I
genes,I
.,O
Fludarabine,O
-,O
induced,O
immunosuppression,O
is,O
associated,O
with,O
inhibition,O
of,O
STAT1,B
signaling,O
.,O
Fludarabine,O
is,O
a,O
nucleoside,B
analog,I
used,O
in,O
the,O
treatment,O
of,O
hematologic,O
malignancies,O
that,O
can,O
induce,O
severe,O
and,O
prolonged,O
immunosuppression,O
.,O
STAT1,B
",",O
which,O
is,O
activated,O
in,O
response,O
to,O
many,O
lymphocyte,B
-,I
activating,I
cytokines,I
including,O
the,O
interferons,B
",",O
is,O
essential,O
for,O
cell,B
-,I
mediated,I
immunity,I
",",O
as,O
the,O
absence,O
of,O
this,O
protein,B
is,O
associated,O
with,O
prominent,O
defects,O
in,O
the,O
ability,O
to,O
control,O
viral,O
infections,O
.,O
Here,O
we,O
show,O
that,O
fludarabine,B
",",O
but,O
not,O
the,O
immunosuppressant,O
cyclosporine,O
A,O
",",O
inhibits,O
the,O
cytokine,O
-,O
induced,O
activation,O
of,O
STAT1,B
and,O
STAT1,B
-,I
dependent,I
gene,I
transcription,I
in,O
normal,O
resting,O
or,O
activated,O
lymphocytes,O
.,O
Fludarabine,B
caused,O
a,O
specific,O
depletion,O
of,O
STAT1,B
protein,I
(,O
and,O
mRNA,O
),O
but,O
not,O
of,O
other,O
STATs,B
.,O
This,O
loss,O
of,O
STAT1,B
was,O
also,O
seen,O
in,O
cells,O
from,O
patients,O
treated,O
with,O
fludarabine,O
in,O
vivo,O
.,O
Thus,O
",",O
STAT1,B
may,O
be,O
a,O
useful,O
target,O
in,O
the,O
development,O
of,O
new,O
immunosuppressive,O
and,O
antineoplastic,O
agents,O
.,O
Furthermore,O
",",O
it,O
demonstrates,O
that,O
aging,O
does,O
not,O
influence,O
the,O
sensitivity,O
of,O
this,O
phosphatase,O
.,O
Spi,O
-,O
C,O
",",O
a,O
novel,O
Ets,B
protein,I
that,O
is,O
temporally,O
regulated,O
during,O
B,B
lymphocyte,I
development,I
.,O
Spi,O
-,O
C,O
interacted,O
with,O
DNA,B
similarly,O
to,O
PU,B
.,O
1,O
as,O
judged,O
by,O
methylation,O
interference,O
",",O
band,O
-,O
shift,O
and,O
site,O
selection,O
analysis,O
",",O
and,O
activated,O
transcription,O
of,O
a,O
kappaY,O
element,O
reporter,O
gene,O
upon,O
co,O
-,O
transfection,O
of,O
HeLa,B
cells,I
.,O
Spi,B
-,I
C,I
RNA,B
was,O
expressed,O
in,O
mature,O
B,B
lymphocytes,I
and,O
at,O
lower,O
levels,O
in,O
macrophages,O
.,O
Under,O
these,O
conditions,O
",",O
dexamethasone,O
had,O
a,O
minimal,O
effect,O
on,O
cell,O
growth,O
",",O
elicited,O
little,O
internucleosomal,B
DNA,I
fragmentation,I
",",O
and,O
induced,O
no,O
cell,O
cycle,O
perturbation,O
.,O
Human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
(,O
HTLV,B
-,I
I,I
),O
is,O
an,O
etiologic,O
agent,O
of,O
adult,O
T,B
-,I
cell,I
leukemia,I
(,O
ATL,B
),O
.,O
The,O
viral,O
protein,O
Tax,B
induces,O
the,O
activation,O
and,O
nuclear,O
translocalization,O
of,O
transcription,O
factor,O
NF,B
-,I
kappaB,I
",",O
which,O
is,O
proposed,O
to,O
play,O
a,O
crucial,O
role,O
in,O
the,O
transformation,O
of,O
T,B
cells,I
by,O
HTLV,B
-,I
I,I
.,O
However,O
",",O
the,O
HTLV,B
-,I
I,I
genes,I
including,O
Tax,O
are,O
not,O
expressed,O
significantly,O
in,O
primary,O
leukemic,O
cells,O
from,O
ATL,O
patients,O
.,O
We,O
found,O
that,O
leukemic,O
cells,O
from,O
ATL,O
patients,O
",",O
like,O
HTLV,B
-,I
I,I
-,I
infected,O
T,O
-,O
cell,O
lines,O
",",O
display,O
constitutive,O
NF,B
-,I
kappaB,I
DNA,I
binding,I
activity,I
and,O
increased,O
degradation,O
of,O
IkappaBalpha,O
(,O
an,O
inhibitor,O
of,O
NF,B
-,I
kappaB,I
),O
.,O
One,O
T,O
-,O
cell,B
line,I
derived,O
from,O
ATL,O
leukemic,O
cells,O
",",O
TL,B
-,I
Om1,I
",",O
displayed,O
constitutive,O
NF,B
-,I
kappaB,I
activity,I
",",O
as,O
well,O
as,O
enhanced,O
degradation,O
of,O
IkappaBalpha,O
",",O
despite,O
the,O
lack,O
of,O
detectable,O
Tax,O
expression,O
.,O
Interestingly,O
",",O
the,O
NF,B
-,I
kappaB,I
in,O
TL,B
-,I
Om1,I
consists,O
of,O
p50,B
/,I
p50,I
and,O
p50,B
/,I
p65,I
like,O
that,O
in,O
fresh,O
primary,O
leukemic,O
cells,O
.,O
The,O
most,O
characterized,O
pathway,O
is,O
via,O
JAK,B
-,I
STAT,I
signaling,I
.,O
Therefore,O
",",O
this,O
study,O
was,O
designed,O
to,O
analyze,O
the,O
role,O
of,O
Lck,B
in,O
IFN,B
-,I
alpha,I
signaling,I
by,O
using,O
the,O
Jurkat,B
",",O
JCam,B
(,O
an,O
Lck,B
-,I
defective,I
cell,I
line,I
derived,O
from,O
Jurkat,B
),O
",",O
and,O
JCam,B
/,I
Lck,B
(,O
JCam,B
cells,I
with,O
Lck,B
restored,O
),O
.,O
Finally,O
",",O
the,O
results,O
demonstrate,O
that,O
IFN,B
-,I
alpha,I
exerts,O
an,O
antiproliferative,O
effect,O
in,O
all,O
three,O
cell,O
lines,O
.,O
We,O
investigated,O
the,O
MAPk,B
kinase,I
(,O
MKK,B
),O
that,O
activates,O
p38,B
MAPk,I
in,O
response,O
to,O
LPS,O
",",O
the,O
p38,B
MAPk,I
isoforms,O
that,O
are,O
activated,O
as,O
part,O
of,O
this,O
pathway,O
",",O
and,O
the,O
functional,B
responses,I
affected,I
by,O
p38,B
MAPk,I
activation,I
. Although,O
MKK3,B
",",O
MKK4,B
",",O
and,O
MKK6,B
all,O
activated,O
p38,B
MAPk,I
in,O
experimental,O
models,O
",",O
only,O
MKK3,B
was,O
found,O
to,O
activate,O
recombinant,O
p38,B
MAPk,I
in,O
LPS,O
-,O
treated,O
neutrophils,O
.,O
The,O
I,O
gamma,B
3,I
ECS,I
lies,O
upstream,O
of,O
the,O
major,O
I,O
gamma,B
3,I
transcription,O
initiation,O
site,O
and,O
displays,O
more,O
than,O
90,O
%,O
identity,O
with,O
the,O
corresponding,O
human,O
I,O
gamma,B
1,I
",",O
I,O
gamma,B
2,I
",",O
and,O
I,O
gamma,B
4,I
regions,O
.,O
In,O
these,O
transfected,O
CL,B
-,I
1,I
cells,I
",",O
CD40,B
:,I
CD40L,I
engagement,O
and,O
exposure,O
to,O
IL,B
-,I
4,I
synergistically,O
induced,O
gamma,B
3,I
ECS,I
-,I
dependent,I
luciferase,I
reporter,I
gene,I
activation,O
.,O
Electrophoretic,O
mobility,O
shift,O
assays,O
showed,O
that,O
p50,B
/,I
p65,I
/,I
c,I
-,I
Rel,I
and,O
STAT,B
-,I
6,I
are,O
effectively,O
induced,O
by,O
CD40L,O
and,O
IL,B
-,I
4,I
",",O
respectively,O
",",O
and,O
bind,O
to,O
specific,O
DNA,B
motifs,I
within,O
the,O
ECS,O
.,O
CIITA,O
-,O
induced,O
occupation,O
of,O
MHC,B
class,I
II,I
promoters,I
is,O
independent,O
of,O
the,O
cooperative,O
stabilization,O
of,O
the,O
promoter,O
-,O
bound,O
multi,O
-,O
protein,B
complexes,I
.,O
Activation,O
of,O
MHC,B
class,I
II,I
promoters,I
requires,O
binding,O
of,O
at,O
least,O
three,O
distinct,O
multi,O
-,O
protein,B
complexes,I
(,O
RFX,B
",",O
X2BP,B
and,O
NF,B
-,I
Y,I
),O
.,O
We,O
show,O
",",O
however,O
",",O
that,O
the,O
presence,O
of,O
CIITA,B
does,O
not,O
affect,O
the,O
stability,O
of,O
the,O
higher,O
-,O
order,O
protein,B
complex,I
formed,O
on,O
DNA,B
by,O
RFX,B
",",O
X2BP,B
and,O
NF,B
-,I
Y,I
.,O
Finally,O
",",O
we,O
conclude,O
that,O
this,O
effect,O
of,O
CIITA,B
is,O
cell,B
-,I
type,I
specific,O
",",O
since,O
expression,O
of,O
CIITA,B
is,O
not,O
required,O
for,O
normal,O
occupation,O
of,O
MHC,B
class,I
II,I
promoters,I
in,O
B,B
lymphocytes,I
.,O
SH2,B
domain,I
-,I
containing,I
protein,I
76,I
(,O
SLP,B
-,I
76,I
),O
interacts,O
with,O
the,O
guanine,O
nucleotide,O
exchange,O
factor,O
Vav,O
to,O
activate,O
the,O
nuclear,O
factor,O
of,O
activated,O
cells,O
(,O
NF,B
-,I
AT,I
),O
",",O
and,O
its,O
expression,O
is,O
required,O
for,O
normal,O
T,B
cell,I
development,I
.,O
In,O
contrast,O
",",O
another,O
inducible,O
gene,O
expression,O
of,O
monocyte,B
chemotactic,I
protein,I
-,I
1,I
(,I
a,I
CC,I
chemokine,I
),I
and,O
the,O
activation,O
of,O
the,O
transcriptional,O
factor,O
(,O
FcRFgamma,B
),O
bound,O
to,O
the,O
gamma,O
response,O
region,O
were,O
similarly,O
or,O
less,O
abundantly,O
induced,O
by,O
IFNgamma,O
treatment,O
in,O
PMA,B
-,I
or,I
RA,I
-,I
differentiated,I
U937,I
cells,I
",",O
indicating,O
that,O
increased,O
IP,B
-,I
10,I
mRNA,I
induction,I
was,O
not,O
due,O
to,O
the,O
augmented,O
ability,O
of,O
the,O
cells,O
to,O
respond,O
to,O
the,O
presence,O
of,O
IFNgamma,O
.,O
Role,O
of,O
cellular,B
tumor,I
necrosis,I
factor,I
receptor,I
-,I
associated,I
factors,I
in,O
NF,B
-,I
kappaB,I
activation,O
and,O
lymphocyte,B
transformation,I
by,O
herpesvirus,O
Saimiri,O
STP,O
.,O
In,O
addition,O
",",O
a,O
somewhat,O
divergent,O
region,O
of,O
STP,O
-,O
C488,O
is,O
critical,O
for,O
TRAF,O
association,O
.,O
In,O
contrast,O
",",O
caspase,B
1,I
(,I
ICE,I
),I
did,O
not,O
cleave,O
SP1,O
in,O
vitro,O
.,O
Comparison,O
of,O
tumor,B
specimen,I
from,O
MM,O
precursor,O
lesions,O
",",O
primary,O
tumors,B
",",O
and,O
metastases,B
revealed,O
that,O
CD40,B
surface,I
expression,I
is,O
down,O
-,O
regulated,O
during,O
tumor,B
progression,I
.,O
CD40,B
expression,I
was,O
confirmed,O
in,O
7,O
human,O
MM,O
cell,B
lines,I
established,O
from,O
immunogenic,O
primary,O
tumors,B
or,O
metastases,B
",",O
whereas,O
11,O
cell,B
lines,I
established,O
from,O
advanced,O
stages,O
were,O
CD40,B
negative,I
.,O
Furthermore,O
",",O
CD40,B
ligation,O
of,O
a,O
HLA,B
-,I
A2,I
+,I
",",O
MelanA,B
/,I
MART1,I
+,I
MM,I
cell,I
line,I
enhanced,O
its,O
susceptibility,O
to,O
specific,O
lysis,O
by,O
a,O
HLA,B
-,I
A2,I
-,I
restricted,I
",",O
MelanA,B
/,I
MART,I
-,I
1,I
-,I
specific,I
CTL,I
clone,I
. Human,O
immunodeficiency,O
virus,O
-,O
associated,O
Hodgkin,O
',O
s,O
disease,O
derives,O
from,O
post,O
-,O
germinal,O
center,O
B,O
cells,O
. Human,O
immunodeficiency,O
virus,O
-,O
associated,O
Hodgkin,O
',O
s,O
disease,O
(,O
HIV,B
-,I
HD,I
),O
displays,O
several,O
peculiarities,O
when,O
compared,O
with,O
HD,O
of,O
the,O
general,O
population,O
.,O
MDS1,B
/,I
EVI1,I
is,O
inappropriately,O
activated,O
in,O
myeloid,O
leukemias,O
following,O
chromosomal,O
rearrangements,O
involving,O
band,O
3q26,O
.,O
This,O
fusion,O
protein,B
contains,O
the,O
DNA,B
-,I
binding,I
domain,I
of,O
the,O
transcription,O
factor,O
AML1,B
fused,O
in,O
-,O
frame,O
to,O
the,O
entire,O
MDS1,B
/,I
EVI1,I
with,O
the,O
exclusion,O
of,O
its,O
first,O
12,O
amino,O
acids,O
.,O
In,O
this,O
report,O
",",O
we,O
have,O
analyzed,O
the,O
response,O
of,O
the,O
hematopoietic,O
precursor,O
cell,O
line,O
32Dcl3,B
",",O
expressing,O
either,O
the,O
normal,O
protein,B
MDS1,I
/,I
EVI1,I
or,O
the,O
fusion,O
protein,B
AML1,I
/,I
MDS1,I
/,I
EVI1,I
",",O
to,O
factors,O
that,O
control,O
cell,O
differentiation,O
or,O
cell,O
replication,O
.,O
This,O
effect,O
is,O
similar,O
to,O
that,O
previously,O
described,O
by,O
others,O
for,O
32Dcl3,B
cells,I
that,O
express,O
transgenic,O
Evil,B
.,O
By,O
using,O
the,O
yeast,O
two,O
-,O
hybrid,O
system,O
",",O
we,O
also,O
show,O
that,O
EVI1,B
(,O
contained,O
in,O
its,O
entirety,O
in,O
MDS1,B
/,I
EVI1,I
and,O
AML1,B
/,I
MDS1,I
/,I
EVI1,I
),O
physically,O
interacts,O
with,O
SMAD3,B
",",O
which,O
is,O
an,O
intracellular,O
mediator,O
of,O
TGF,O
-,O
beta1,O
signaling,O
.,O
The,O
levels,O
of,O
cAMP,B
-,I
dependent,I
protein,I
kinase,I
and,O
Rap1,B
were,O
assessed,O
by,O
Western,O
blot,O
analysis,O
",",O
immunostaining,O
",",O
and,O
computer,O
-,O
assisted,O
imaging,O
.,O
In,O
many,O
pathological,O
situations,O
",",O
the,O
balance,O
between,O
Th1,B
and,O
Th2,B
immune,I
responses,I
determines,O
the,O
outcome,O
of,O
diverse,O
immunologically,O
mediated,O
clinical,O
syndromes,O
including,O
infectious,O
",",O
autoimmune,O
",",O
and,O
allergic,O
diseases,O
.,O
Tcf,O
-,O
1,O
-,O
mediated,O
transcription,O
in,O
T,B
lymphocytes,I
:,O
differential,O
role,O
for,O
glycogen,B
synthase,I
kinase,I
-,I
3,I
in,O
fibroblasts,O
and,O
T,B
cells,I
.,O
Beta,B
-,I
catenin,I
is,O
the,O
vertebrate,O
homolog,O
of,O
the,O
Drosophila,B
segment,I
polarity,I
gene,I
Armadillo,I
and,O
plays,O
roles,O
in,O
both,O
cell,B
-,I
cell,I
adhesion,I
and,O
transduction,O
of,O
the,O
Wnt,B
signaling,I
cascade,I
.,O
Recently,O
",",O
members,O
of,O
the,O
Lef,O
/,O
Tcf,O
transcription,O
factor,O
family,O
have,O
been,O
identified,O
as,O
protein,B
partners,O
of,O
beta,O
-,O
catenin,O
",",O
explaining,O
how,O
beta,O
-,O
catenin,O
alters,O
gene,O
expression,O
.,O
In,O
contrast,O
",",O
in,O
C57MG,O
fibroblast,O
cells,O
",",O
lithium,O
inactivates,O
GSK,O
-,O
3beta,O
and,O
induces,O
Tcf,O
-,O
controlled,O
transcription,O
.,O
Overexpression,O
of,O
SIT,O
in,O
Jurkat,O
cells,O
downmodulates,O
T,B
cell,I
receptor,I
-,I
and,I
phytohemagglutinin,I
-,I
mediated,I
activation,I
of,I
the,I
nuclear,I
factor,I
of,I
activated,I
T,I
cells,I
(,O
NF,B
-,I
AT,I
),O
by,O
interfering,O
with,O
signaling,O
processes,O
that,O
are,O
probably,O
located,O
upstream,O
of,O
activation,O
of,O
phospholipase,O
C,O
.,O
However,O
",",O
binding,O
of,O
SHP2.00,B
to,O
SIT,B
is,O
not,O
required,O
for,O
inhibition,O
of,O
NF,B
-,I
AT,I
induction,O
",",O
suggesting,O
that,O
SIT,B
not,O
only,O
regulates,O
NF,B
-,I
AT,I
activity,O
but,O
also,O
controls,O
NF,B
-,I
AT,I
unrelated,O
pathways,O
of,O
T,O
cell,O
activation,O
involving,O
SHP2.00,B
.,O
We,O
investigated,O
the,O
function,O
of,O
conditionally,O
expressed,O
EBNA2,B
in,O
the,O
context,O
of,O
the,O
IFN,B
response,O
in,O
Burkitt,B
',O
s,O
lymphoma,B
cell,I
lines,I
.,O
Expression,O
of,O
EBNA2,B
led,O
to,O
the,O
transcriptional,O
activation,O
of,O
both,O
endogenous,O
or,O
transfected,O
IFN,B
-,I
stimulated,I
genes,I
(,O
ISGs,B
),O
",",O
genes,O
which,O
contain,O
within,O
their,O
promoters,O
either,O
the,O
interferon,B
-,I
stimulated,I
response,I
element,I
(,O
ISRE,B
),O
or,O
the,O
gamma,B
interferon,I
activation,I
site,I
(,O
GAS,B
),O
.,O
PGG,O
-,O
Glucan,O
",",O
a,O
soluble,O
beta,B
-,I
(,I
1,I
",",I
6,I
),I
-,I
branched,I
beta,I
-,I
(,I
1,I
",",I
3,I
),I
-,I
linked,I
glucose,I
homopolymer,I
derived,I
from,I
the,I
cell,I
wall,I
of,I
the,I
yeast,I
Saccharomyces,I
cerevisiae,I
",",O
is,O
an,O
immunomodulator,O
which,O
enhances,O
leukocyte,O
anti,O
-,O
infective,O
activity,O
and,O
enhances,O
myeloid,O
and,O
megakaryocyte,O
progenitor,O
proliferation,O
.,O
The,O
binding,O
of,O
3H,O
-,O
PGG,O
-,O
Glucan,O
to,O
human,O
leukocyte,B
membranes,I
was,O
specific,O
",",O
concentration,O
-,O
dependent,O
",",O
saturable,O
",",O
and,O
high,O
affinity,O
(,O
Kd,O
approximately,O
6,O
nM,O
),O
.,O
We,O
conclude,O
that,O
potentiation,O
of,O
nonphlogistic,O
clearance,O
of,O
apoptotic,O
leukocytes,B
by,O
phagocytes,O
is,O
a,O
hitherto,O
unrecognized,O
property,O
of,O
glucocorticoids,O
that,O
has,O
potential,O
implications,O
for,O
therapies,O
aimed,O
at,O
promoting,O
the,O
resolution,O
of,O
inflammatory,O
diseases,O
.,O
However,O
",",O
the,O
mechanisms,O
and,O
strategies,O
to,O
overcome,O
RA,B
resistance,O
by,O
APL,B
cells,O
are,O
still,O
unclear,O
.,O
Also,O
",",O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
(,O
10,O
(,O
-,O
10,O
),O
to,O
10,O
(,O
-,O
7,O
),O
mol,O
/,O
L,O
),O
in,O
combination,O
with,O
RA,B
markedly,O
inhibits,O
cellular,O
proliferation,O
in,O
a,O
dose,O
-,O
and,O
time,O
-,O
dependent,O
manner,O
.,O
Interestingly,O
",",O
the,O
combination,O
of,O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
and,O
RA,B
markedly,O
enhanced,O
the,O
levels,O
of,O
p27,B
(,O
KIP1,I
),O
transcript,O
and,O
protein,O
as,O
compared,O
with,O
levels,O
induced,O
by,O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
alone,O
.,O
Molecular,O
mechanisms,O
of,O
neutrophil,B
-,I
endothelial,B
cell,I
adhesion,I
induced,O
by,O
redox,O
imbalance,O
.,O
Previous,O
studies,O
have,O
implicated,O
a,O
role,O
for,O
intracellular,O
thiols,O
in,O
the,O
activation,O
of,O
nuclear,O
factor,O
-,O
kappaB,O
and,O
transcriptional,O
regulation,O
of,O
endothelial,B
cell,I
adhesion,I
molecules,I
.,O
This,O
study,O
was,O
designed,O
to,O
determine,O
whether,O
changes,O
in,O
endothelial,B
cell,I
glutathione,I
(,O
GSH,B
),O
or,O
oxidized,O
glutathione,I
(,O
GSSG,B
),O
can,O
alter,O
neutrophil,B
adhesivity,I
and,O
to,O
define,O
the,O
molecular,O
mechanism,O
that,O
underlies,O
this,O
GSSG,B
/,O
GSH,B
-,O
induced,O
adhesion,I
response,I
.,O
Diamide,O
plus,O
BSO,O
-,O
induced,O
thiol,O
/,O
disulfide,O
imbalance,O
was,O
associated,O
with,O
a,O
biphasic,O
increase,O
in,O
neutrophil,O
adhesion,O
to,O
HUVECs,O
with,O
peak,O
responses,O
observed,O
at,O
15,O
minutes,O
(,O
phase,O
1,O
),O
and,O
240,O
minutes,O
(,O
phase,O
2,O
),O
.,O
This,O
study,O
demonstrates,O
that,O
changes,O
in,O
endothelial,O
cell,O
GSSG,B
/,I
GSH,I
cause,O
transcription,O
-,O
independent,O
and,O
transcription,O
-,O
dependent,O
surface,O
expression,O
of,O
different,O
endothelial,O
cell,O
adhesion,O
molecules,O
",",O
which,O
leads,O
to,O
a,O
2,O
-,O
phase,O
neutrophil,O
-,O
endothelial,O
adhesion,O
response,O
.,O
In,O
-,O
situ,O
detection,O
of,O
fragmented,O
DNA,B
was,O
performed,O
to,O
identify,O
apoptotic,O
cells,O
.,O
Angiotensin,O
II,O
activates,O
the,O
proinflammatory,B
transcription,I
factor,I
nuclear,I
factor,I
-,I
kappaB,I
in,O
human,O
monocytes,O
.,O
ANG,O
II,O
",",O
like,O
TNFalpha,O
",",O
caused,O
rapid,O
activation,O
of,O
NF,B
-,I
kappaB,I
in,O
human,O
mononuclear,O
cells,O
isolated,O
from,O
peripheral,O
blood,O
by,O
Ficoll,O
density,O
gradient,O
.,O
Recently,O
",",O
its,O
presence,O
has,O
been,O
demonstrated,O
in,O
atherosclerotic,O
lesions,O
.,O
Increased,O
mRNA,B
and,O
surface,O
expression,O
of,O
E,B
-,I
selectin,I
",",O
ICAM,B
-,I
1,I
",",O
and,O
VCAM,B
-,I
1,I
were,O
noted,O
within,O
hours,O
.,O
Transient,O
pseudo,O
-,O
hypoaldosteronism,O
following,O
resection,O
of,O
the,O
ileum,O
:,O
normal,O
level,O
of,O
lymphocytic,O
aldosterone,O
receptors,O
outside,O
the,O
acute,O
phase,O
.,O
A,O
urinary,O
steroidogram,O
resulted,O
in,O
highly,O
elevated,O
tetrahydrocortisol,B
(,O
THF,B
:,O
13,O
.,O
3,O
mg,O
/,O
24h,O
;,O
N,O
:,O
1,O
0.4,O
+,O
/,O
-,O
0,O
),O
with,O
no,O
increase,O
in,O
tetrahydrocortisone,B
(,O
THE,B
:,O
3,O
0.16,O
mg,O
/,O
24h,O
;,O
N,O
:,O
2,O
0.7,O
+,O
/,O
-,O
2,O
0.0,O
),O
excretion,O
",",O
and,O
with,O
low,O
THE,B
/,O
THF,B
(,O
0,O
0.24,O
;,O
N,O
:,O
1,O
0.87,O
+,O
/,O
-,O
0,O
0.36,O
),O
and,O
alpha,O
THF,B
/,O
THF,B
(,O
0,O
0.35,O
;,O
N,O
:,O
0,O
0.85,O
92,O
+,O
/,O
-,O
0,O
.,O
42,O
 ),O
ratios,O
.,O
Small,O
-,O
bowel,O
resection,O
in,O
ileostomized,O
patients,O
causes,O
excessive,O
fecal,O
sodium,B
losses,O
and,O
results,O
in,O
chronic,O
sodium,B
depletion,O
with,O
contraction,O
of,O
the,O
plasma,O
volume,O
and,O
severe,O
secondary,O
hyperaldosteronism,O
.,O
A,O
decrease,O
in,O
the,O
translation,O
rate,O
is,O
observed,O
when,O
the,O
cells,O
are,O
induced,O
to,O
differentiate,O
along,O
the,O
monocytic,O
/,O
macrophage,O
pathway,O
or,O
along,O
the,O
granulocytic,O
pathway,O
.,O
In,O
contrast,O
",",O
treatment,O
of,O
HL,B
-,I
60,I
cells,I
with,O
retinoic,O
acid,O
or,O
DMSO,O
",",O
which,O
results,O
in,O
a,O
granulocytic,O
differentiation,O
of,O
these,O
cells,O
",",O
decreases,O
4E,B
-,I
BP1,I
amount,O
without,O
affecting,O
its,O
phosphorylation,O
and,O
strongly,O
increases,O
4E,B
-,I
BP2,I
amount,O
.,O
We,O
found,O
frequent,O
hypermutation,O
in,O
follicular,B
lymphoma,I
(,O
25,O
of,O
59,O
=,O
42,O
%,O
),O
(,O
germinal,B
center,I
cell,I
origin,I
),O
and,O
mucosa,B
-,I
associated,I
lymphoid,I
tissue,I
(,O
MALT,B
),O
lymphoma,I
(,O
postgerminal,B
center,I
),O
",",O
but,O
only,O
occasionally,O
in,O
mantle,B
cell,I
lymphoma,I
(,O
1,O
of,O
21,O
=,O
4,O
.,O
8,O
%,O
),O
(,O
(,O
pregerminal,O
center,O
),O
.,O
Most,O
mutations,O
were,O
outside,O
the,O
motifs,O
potentially,O
important,O
for,O
transcription,O
",",O
suggesting,O
they,O
were,O
not,O
important,O
in,O
lymphomagenesis,O
but,O
may,O
",",O
like,O
Ig,B
mutation,I
",",O
represent,O
an,O
inherent,O
feature,O
of,O
the,O
lymphoma,O
precursor,O
cells,O
.,O
Markedly,O
impaired,O
binding,O
was,O
observed,O
",",O
consistent,O
with,O
both,O
the,O
use,O
of,O
different,O
anchor,O
residues,O
and,O
with,O
changes,O
in,O
levels,O
of,O
DQ,B
cis,I
-,I
dimer,I
availability,I
for,O
peptide,O
binding,O
interactions,O
.,O
Detection,O
of,O
intracellular,O
phosphorylated,O
STAT,B
-,I
1,I
by,O
flow,O
cytometry,O
.,O
In,O
addition,O
",",O
this,O
technique,O
should,O
permit,O
dissection,O
of,O
a,O
full,O
range,O
of,O
cellular,O
signaling,O
pathways,O
at,O
the,O
protein,B
level,I
.,O
Consequently,O
",",O
cytosolic,O
activation,O
",",O
nuclear,O
translocation,O
and,O
DNA,B
-,I
binding,I
of,O
nuclear,O
factor,O
-,O
kappaB,O
were,O
decreased,O
.,O
5,O
.,O
Neutrophil,B
apoptosis,O
and,O
inhibition,O
of,O
neutrophil,O
function,O
were,O
induced,O
at,O
lower,O
concentrations,O
of,O
SMX,O
-,O
NHOH,O
and,O
SMX,O
-,O
NO,O
than,O
those,O
inducing,O
loss,O
of,O
membrane,O
viability,O
",",O
with,O
SMX,O
having,O
no,O
effect,O
.,O
7,O
.,O
Our,O
results,O
suggest,O
that,O
the,O
balance,O
between,O
oxidation,O
of,O
SMX,O
to,O
its,O
toxic,O
metabolites,O
and,O
their,O
reduction,O
is,O
an,O
important,O
protective,O
cellular,O
mechanism,O
.,O
Recently,O
",",O
we,O
reported,O
cases,O
of,O
angioimmunoblastic,B
T,I
-,I
cell,I
lymphoma,I
(,O
AITL,B
),O
with,O
hyperplastic,O
GCs,B
(,O
AITL,B
/,I
GC,I
),O
",",O
and,O
observed,O
that,O
borders,O
of,O
enlarged,O
GCs,B
were,O
ill,O
defined,O
",",O
with,O
features,O
suggestive,O
of,O
an,O
outward,O
migration,O
of,O
GC,B
cells,I
to,O
surrounding,O
interfollicular,O
zones,O
.,O
In,O
FL,O
",",O
follicles,O
were,O
densely,O
populated,O
",",O
and,O
their,O
borders,O
were,O
irregular,O
",",O
with,O
some,O
Bcl,B
-,I
6,I
+,I
cells,I
in,O
the,O
interfollicular,O
zones,O
.,O
Double,O
staining,O
revealed,O
that,O
these,O
interfollicular,O
Bcl,B
+,I
cells,O
in,O
AITL,O
/,O
GC,O
were,O
Bcl6,B
+,I
/,O
CD3,B
+,I
/,O
CD20,B
-,I
/,O
CD57,B
-,I
T,O
cells,O
.,O
In,O
typical,O
AITL,O
",",O
some,O
neoplastic,O
cells,O
were,O
positive,O
for,O
Bcl,B
-,I
6,I
",",O
showing,O
variable,O
degrees,O
of,O
staining,O
.,O
(,O
2,O
),O
Intrafollicular,O
CD3,B
+,I
T,O
cells,O
",",O
many,O
of,O
which,O
were,O
also,O
positive,O
for,O
Bcl,B
-,I
6,I
",",O
were,O
markedly,O
depleted,O
in,O
AITL,O
/,O
GC,O
",",O
with,O
increased,O
interfollicular,O
Bcl,B
-,I
6,I
+,I
/,O
CD3,B
+,I
cells,O
",",O
suggesting,O
an,O
outward,O
migration,O
of,O
intrafollicular,O
T,O
cells,O
in,O
this,O
condition,O
.,O
(,O
5,O
),O
Some,O
neoplastic,O
cells,O
in,O
AITL,O
stained,O
for,O
Bcl,B
-,I
6,I
",",O
suggesting,O
up,O
-,O
regulation,O
of,O
Bcl,B
-,I
6,I
expression,O
in,O
this,O
tumor,O
.,O
To,O
continue,O
our,O
investigation,O
of,O
the,O
cellular,O
events,O
that,O
occur,O
following,O
human,O
CMV,O
(,O
HCMV,O
),O
infection,O
",",O
we,O
focused,O
on,O
the,O
regulation,O
of,O
cellular,O
activation,O
following,O
viral,O
binding,O
to,O
human,O
monocytes,O
.,O
Because,O
these,O
induced,O
gene,O
products,O
have,O
NF,B
-,I
kappaB,I
sites,O
in,O
their,O
promoter,O
regions,O
",",O
we,O
next,O
examined,O
whether,O
there,O
was,O
an,O
up,O
-,O
regulation,O
of,O
nuclear,O
NF,B
-,I
kappaB,I
levels,O
.,O
These,O
results,O
support,O
our,O
hypothesis,O
that,O
HCMV,O
initiates,O
a,O
signal,O
transduction,O
pathway,O
that,O
leads,O
to,O
monocyte,O
activation,O
and,O
pinpoints,O
a,O
potential,O
mechanism,O
whereby,O
HCMV,O
infection,O
of,O
monocytes,O
can,O
result,O
in,O
profound,O
pathogenesis,O
",",O
especially,O
in,O
chronic,O
inflammatory,O
-,O
type,O
conditions,O
.,O
Glycoprotein,B
(,O
GP,B
),O
IX,B
is,O
a,O
subunit,O
of,O
the,O
von,O
Willebrand,O
receptor,O
",",O
GPIb,B
-,I
V,I
-,I
IX,I
",",O
which,O
mediates,O
adhesion,O
of,O
platelets,O
to,O
the,O
subendothelium,O
of,O
damaged,O
blood,O
vessels,O
.,O
Previous,O
characterization,O
of,O
the,O
GPIX,B
promoter,I
identified,O
a,O
functional,B
Ets,I
site,I
that,O
",",O
when,O
disrupted,O
",",O
reduced,O
promoter,I
activity,I
.,O
These,O
results,O
suggest,O
that,O
Fli,B
-,I
1,I
is,O
likely,O
to,O
regulate,O
lineage,O
-,O
specific,O
genes,O
during,O
megakaryocytopoiesis,O
.,O
However,O
",",O
I,B
(,O
kappa,I
),O
B,B
(,O
alpha,I
),O
has,O
also,O
been,O
detected,O
in,O
the,O
nucleus,O
of,O
cell,B
lines,I
and,O
when,O
overexpressed,O
by,O
transient,O
transfection,O
.,O
Immunoprecipitation,O
experiments,O
failed,O
to,O
demonstrate,O
an,O
association,O
between,O
nuclear,O
I,B
(,O
kappa,I
),O
B,B
(,O
alpha,I
),O
and,O
NF,B
-,I
kappaB,I
proteins,I
.,O
SERCA,B
activity,O
was,O
measured,O
as,O
the,O
thapsigargin,O
sensitive,O
",",O
Ca2,B
+,I
dependent,O
and,O
ouabain,B
resistant,O
",",O
ATP,B
hydrolyses,O
in,O
platelet,B
membranes,I
.,O
Cobalt,B
chloride,I
-,I
induced,O
signaling,O
in,O
endothelium,B
leading,O
to,O
the,O
augmented,O
adherence,O
of,O
sickle,B
red,I
blood,I
cells,I
and,O
transendothelial,B
migration,O
of,O
monocyte,B
-,I
like,I
HL,I
-,I
60,I
cells,I
is,O
blocked,O
by,O
PAF,B
-,I
receptor,I
antagonist,I
.,O
In,O
response,O
to,O
hypoxia,O
",",O
sickle,B
red,I
blood,I
cells,I
(,O
SS,B
RBC,I
),O
and,O
leukocytes,B
exhibit,O
increased,O
adherence,O
to,O
the,O
vascular,B
endothelium,I
",",O
while,O
diapedesis,O
of,O
leukocytes,B
through,O
the,O
blood,B
vessel,I
increases,O
.,O
We,O
utilized,O
CoCl2,O
as,O
a,O
mimetic,O
molecule,O
for,O
hypoxia,O
to,O
study,O
cellular,B
signaling,I
pathways,I
. Additionally,O
",",O
CoCl2,O
caused,O
a,O
two,O
-,O
to,O
threefold,O
increase,O
in,O
the,O
rate,O
of,O
transendothelial,O
migration,O
of,O
monocyte,B
-,I
like,I
HL,I
-,I
60,I
cells,I
and,O
a,O
twentyfold,O
increase,O
in,O
phosphorylation,O
of,O
platelet,B
endothelial,I
cell,I
adhesion,I
molecules,I
(,O
PECAM,B
-,I
1,I
),O
.,O
Activation,O
of,O
NF,B
-,I
kappaB,I
is,O
thought,O
to,O
be,O
required,O
for,O
cytokine,O
release,O
from,O
LPS,B
-,I
responsive,I
cells,I
",",O
a,O
critical,O
step,O
for,O
endotoxic,O
effects,O
.,O
LPS,B
-,I
induced,I
NF,B
-,I
kappaB,I
activation,I
was,O
not,O
inhibited,O
by,O
a,O
dominant,O
negative,O
mutant,O
of,O
TRAF2,B
that,O
is,O
involved,O
in,O
TNF,B
signaling,I
.,O
Tyrosine,O
phosphorylation,O
of,O
IFN,B
-,I
gammaR,I
",",O
Jak1,B
",",O
Jak2,B
",",O
and,O
Stat1alpha,B
was,O
examined,O
by,O
immunoblotting,O
.,O
In,O
addition,O
",",O
IFN,O
-,O
gamma,O
enhanced,O
the,O
DNA,B
-,I
binding,I
activity,I
of,O
Stat1alpha,O
.,O
Moreover,O
",",O
several,O
transgenic,O
mice,O
developed,O
acute,O
leukemia,O
",",O
classified,O
as,O
T,O
-,O
ALL,O
based,O
on,O
the,O
surface,O
marker,O
analysis,O
and,O
DNA,B
rearrangements,I
",",O
suggesting,O
that,O
an,O
additional,O
event,O
is,O
required,O
for,O
malignant,O
transformation,O
of,O
lymphoid,O
cells,O
expressing,O
E2A,O
-,O
HLF,O
.,O
Our,O
findings,O
provide,O
insight,O
into,O
the,O
biological,O
function,O
of,O
E2A,B
-,I
HLF,I
in,O
lymphoid,B
development,I
and,O
also,O
its,O
role,O
in,O
leukemogenesis,O
.,O
This,O
RXR,B
agonist,I
activity,I
is,O
blocked,O
by,O
RAR,B
-,I
specific,I
antagonists,I
",",O
suggesting,O
extensive,O
cross,O
-,O
talk,O
between,O
the,O
partners,O
of,O
the,O
RXR,B
-,I
RARalpha403,I
heterodimer,I
.,O
We,O
found,O
IL,B
-,I
2Ralpha,I
expression,O
to,O
be,O
increased,O
in,O
BAL,B
cells,I
from,O
involved,O
sites,O
of,O
active,O
pulmonary,B
tuberculosis,I
.,O
Expression,O
of,O
the,O
alpha,B
-,I
chain,I
of,I
IL,B
-,I
2Ralpha,I
on,O
peripheral,O
blood,O
monocytes,O
(,O
PBM,O
),O
was,O
induced,O
by,O
M,O
.,O
tuberculosis,O
by,O
flow,O
cytometry,O
evaluation,O
.,O
Furthermore,O
",",O
the,O
two,O
VDR,O
3,O
',O
-,O
UTR,O
haplotypes,O
conferred,O
an,O
identical,O
half,O
-,O
life,O
on,O
a,O
heterologous,O
beta,B
-,I
globin,I
reporter,I
gene,I
",",O
in,O
an,O
in,O
vitro,O
assay,O
.,O
The,O
IL,B
-,I
2,I
growth,I
hormone,I
is,O
the,O
major,O
growth,O
factor,O
of,O
activated,O
T,B
lymphocytes,I
during,O
a,O
developing,O
immune,O
response,O
.,O
In,O
several,O
cell,B
types,I
",",O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
and,O
/,O
or,O
activating,O
protein,B
-,I
1,I
(,O
AP,B
-,I
1,I
),O
has,O
been,O
demonstrated,O
to,O
be,O
extremely,O
important,O
in,O
blocking,O
apoptosis,O
.,O
Similarly,O
",",O
IL,B
-,I
2,I
neither,O
activates,O
JNK,B
nor,O
increases,O
AP,B
-,I
1,I
binding,O
activity,O
to,O
a,O
consensus,O
o,O
-,O
tetradecanoylphorbol,O
13,O
-,O
acetate,O
(,O
TPA,O
),O
response,O
element,O
.,O
In,O
particular,O
",",O
our,O
findings,O
suggest,O
that,O
local,O
metabolism,O
of,O
steroids,B
by,O
normal,O
as,O
well,O
as,O
leukemic,O
myeloid,O
cells,O
influences,O
their,O
responsiveness,O
to,O
D3,B
and,O
retinoids,B
.,O
The,O
phosphorylation,O
appears,O
to,O
be,O
related,O
to,O
the,O
signaling,O
events,O
that,O
are,O
activated,O
by,O
TRAF2,O
under,O
these,O
circumstances,O
",",O
since,O
two,O
nonfunctional,O
mutants,O
were,O
found,O
to,O
be,O
phosphorylated,O
significantly,O
less,O
than,O
the,O
wild,O
-,O
type,O
protein,B
.,O
We,O
conclude,O
from,O
these,O
studies,O
that,O
the,O
phosphorylation,O
of,O
TRAF2,B
is,O
likely,O
to,O
play,O
an,O
important,O
role,O
in,O
regulating,O
signaling,O
by,O
virtue,O
of,O
its,O
ability,O
to,O
influence,O
the,O
CD40,B
-,I
TRAF2,I
interaction,O
0.32,O
Unlike,O
the,O
proposed,O
role,O
of,O
Cbl,B
as,O
a,O
negative,O
regulator,O
",43",O
our,O
results,O
suggest,O
that,O
the,O
Cbl,B
homologue,O
Cbl,B
-,I
b,I
has,O
a,O
positive,O
role,O
in,O
T,B
-,I
cell,I
signaling,O
",63",O
most,O
likely,O
via,O
a,O
direct,O
interaction,O
with,O
the,O
upstream,O
kinase,O
Zap,B
-,I
70,I
0.77,O
Grf40,O
",",O
A,O
novel,O
Grb2,B
family,I
member,I
",",O
is,O
involved,O
in,O
T,B
cell,I
signaling,I
through,O
interaction,O
with,O
SLP,B
-,I
76,I
and,O
LAT,B
.,O
As,O
a,O
result,O
of,O
its,O
transforming,O
abilities,O
",",O
activated,O
Ras,B
is,O
expressed,O
in,O
a,O
great,O
number,O
of,O
cancers,O
.,O
This,O
review,O
will,O
discuss,O
the,O
mechanisms,O
by,O
which,O
Ras,B
expressing,O
tumors,O
are,O
able,O
to,O
evade,O
destruction,O
by,O
the,O
immune,B
system,I
and,O
enhance,O
their,O
growth,O
and,O
metastatic,O
potential,O
.,O
Though,O
the,O
levels,O
of,O
DP1,B
and,O
-,O
2,O
increase,O
when,O
cells,O
progress,O
from,O
G0,O
to,O
S,O
",",O
the,O
proportion,O
of,O
DP1,B
to,O
DP2,B
remains,O
relatively,O
constant,O
during,O
the,O
cell,O
cycle,O
.,O
We,O
also,O
observed,O
an,O
increase,O
in,O
electrophoretic,O
mobility,O
of,O
the,O
predominant,O
E2F,B
components,I
",",O
DP1,B
and,O
E2F4,B
",",O
as,O
B,O
-,O
lymphocytes,O
progressed,O
from,O
G0,O
into,O
early,O
G1,O
.,O
In,O
addition,O
",",O
DNA,B
-,I
binding,I
activities,I
of,O
Jun,O
-,O
Fos,O
heterodimers,O
were,O
observed,O
by,O
electrophoretic,O
mobility,O
shift,O
assays,O
during,O
the,O
course,O
of,O
natural,O
cytotoxicity,O
.,O
The,O
therapeutic,O
potential,O
of,O
drugs,O
that,O
block,O
the,O
induction,O
of,O
cyclooxygenase,O
-,O
2,O
has,O
been,O
emphasized,O
.,O
When,O
two,O
4,O
-,O
trifluoromethyl,O
salicylate,O
derivatives,O
[,O
2,O
-,O
acetoxy,O
-,O
4,O
-,O
trifluoromethyl,O
-,O
benzoic,O
acid,O
(,O
triflusal,O
),O
and,O
its,O
deacetylated,O
metabolite,O
2,O
-,O
hydroxy,O
-,O
4,O
-,O
trifluoromethylbenzo,O
acid,O
(,O
HTB,O
),O
],O
were,O
compared,O
with,O
aspirin,O
and,O
sodium,O
salicylate,O
as,O
cyclooxygenase,O
-,O
2,O
(,O
COX,O
-,O
2,O
),O
inhibitors,O
",",O
we,O
observed,O
that,O
in,O
bacterial,O
lipopolysaccharide,O
-,O
activated,O
human,O
blood,O
",",O
triflusal,O
",",O
aspirin,O
",",O
and,O
HTB,O
",",O
but,O
not,O
sodium,O
salicylate,O
",",O
inhibited,O
COX,O
-,O
2,O
-,O
mediated,O
prostaglandin,O
E2,O
(,O
PGE2,O
),O
production,O
(,O
IC50,O
=,O
0,O
.,O
16,O
",",O
0,O
.,O
18,O
",",O
0,O
.,O
39,O
",",O
and,O
>,O
10,O
mM,O
",",O
respectively,O
.,O
),O
.,O
Intracellular,O
signals,O
that,O
mediate,O
differentiation,O
of,O
pluripotent,O
hemopoietic,O
progenitors,O
to,O
dendritic,O
cells,O
(,O
DC,B
),O
are,O
largely,O
undefined,O
.,O
The,O
CD34,B
+,I
myelomonocytic,I
cell,I
line,I
KG1,B
differentiates,O
into,O
dendritic,O
-,O
like,O
cells,O
in,O
response,O
to,O
granulocyte,O
-,O
macrophage,O
CSF,B
plus,O
TNF,B
-,I
alpha,I
",",O
or,O
PMA,B
(,O
with,O
or,O
without,O
the,O
calcium,B
ionophore,I
ionomycin,I
",",O
or,O
TNF,B
-,I
alpha,I
",",O
with,O
different,O
stimuli,O
mediating,O
different,O
aspects,O
of,O
the,O
process,O
.,O
In,O
this,O
study,O
",",O
we,O
examined,O
whether,O
gp41,B
-,I
induced,O
IL,O
-,O
up,O
-,O
regulation,O
is,O
mediated,O
by,O
the,O
previously,O
described,O
synergistic,O
activation,O
of,O
cAMP,B
and,O
NF,B
-,I
kappaB,I
pathways,O
.,O
Analysis,O
of,O
the,O
modulation,O
of,O
transcriptional,O
activity,O
in,O
myelopoiesis,O
and,O
leukemogenesis,O
.,O
The,O
transcription,O
factors,O
PU,B
0.47,I
1,I
and,O
C,B
/,I
EBPalpha,I
are,O
responsible,O
for,O
normal,O
myeloid,O
differentiation,O
from,O
stem,O
cells,O
to,O
monocytes,O
or,O
granulocytes,O
.,O
However,O
",",O
the,O
phenotypic,O
analysis,O
of,O
NF,B
-,I
AT,I
-,I
deficient,I
mice,O
supports,O
the,O
idea,O
that,O
there,O
are,O
tissue,O
-,O
and,O
gene,O
-,O
specific,O
functions,O
as,O
well,O
.,O
Despite,O
minimal,O
discrepancies,O
in,O
the,O
coding,O
region,O
",",O
there,O
are,O
striking,O
tissue,O
-,O
and,O
cell,B
type,I
-,I
specific,I
differences,O
in,O
isoform,O
expression,O
patterns,O
.,O
Thus,O
CTL,O
clones,O
that,O
recognized,O
the,O
viral,O
",",O
self,O
",",O
and,O
bacterial,O
peptides,O
expressed,O
a,O
highly,O
restricted,O
alphabeta,O
TCR,O
phenotype,O
.,O
RFLAT,B
-,I
1,I
:,O
a,O
new,O
zinc,O
finger,O
transcription,O
factor,O
that,O
activates,O
RANTES,B
gene,I
expression,I
in,O
T,B
lymphocytes,I
.,O
Furthermore,O
",",O
these,O
oxidative,O
stresses,O
inhibited,O
activity,O
of,O
calcineurin,B
",",O
a,O
serine,O
/,O
threonine,O
phosphatase,O
that,O
regulates,O
NFAT,B
activation,I
.,O
Several,O
intracellular,O
signaling,O
proteins,O
",",O
such,O
as,O
CBL,B
and,O
VAV,B
",",O
were,O
phosphorylated,O
on,O
tyrosine,O
in,O
response,O
to,O
CD80,B
",",O
CD86,B
",",O
and,O
anti,O
-,O
CD28,B
mAb,I
.,O
In,O
addition,O
",",O
the,O
association,O
of,O
phosphoinositide,B
3,I
-,I
kinase,I
with,O
CD28,B
and,O
enhanced,O
tyrosine,O
phosphorylation,O
of,O
phospholipase,B
Cgamma,I
were,O
seen,O
after,O
anti,O
-,O
CD28,B
mAb,I
and,O
CHO,B
-,I
CD80,I
stimulation,O
but,O
to,O
a,O
much,O
lesser,O
extent,O
after,O
CHO,B
-,I
CD86,I
stimulation,O
.,O
However,O
",",O
CD80,B
and,O
CD86,B
also,O
induce,O
distinct,O
signal,O
transduction,O
pathways,O
including,O
the,O
tyrosine,O
phosphorylation,O
of,O
CD28,B
and,O
phospholipase,B
Cgamma1,I
and,O
the,O
SH2,B
-,I
dependent,I
association,O
of,O
phosphoinositide,B
3,I
-,I
kinase,I
with,O
CD28,B
.,O
Binding,O
of,O
HMG,B
-,I
I,I
(,O
Y,O
),O
elicits,O
structural,O
changes,O
in,O
a,O
silencer,O
of,O
the,O
human,O
beta,B
-,I
-,I
globin,I
gene,I
.,O
If,O
there,O
is,O
a,O
reciprocal,O
elevation,O
of,O
gamma,B
-,I
-,I
globin,I
expression,I
upon,O
repression,O
",",O
this,O
approach,O
could,O
be,O
useful,O
in,O
additional,O
hemoglobinopathies,O
.,O
We,O
demonstrate,O
that,O
binding,O
of,O
HMG,B
-,I
I,I
(,O
Y,O
),O
to,O
this,O
oligonucleotide,O
causes,O
bending,O
/,O
flexure,O
of,O
the,O
DNA,B
.,O
The,O
master,O
switch,O
for,O
the,O
expression,O
of,O
these,O
genes,O
is,O
the,O
class,O
II,O
transactivator,O
(,O
CIITA,B
),O
.,O
In,O
contrast,O
",",O
overexpression,O
of,O
CREB,B
inhibited,O
GAL4,O
-,O
p65,O
(,O
286,O
-,O
551,O
),O
-,O
mediated,O
transcription,O
.,O
Glucocorticoid,B
receptors,I
in,O
cord,O
blood,O
lymphocytes,O
of,O
healthy,O
neonates,O
and,O
of,O
preterms,O
suffering,O
from,O
respiratory,O
distress,O
syndrome,O
.,O
We,O
measured,O
the,O
number,O
of,O
glucocorticoid,B
receptors,I
(,O
GR,B
),O
in,O
cord,O
blood,O
lymphocytes,O
and,O
the,O
binding,O
affinity,O
(,O
Kd,B
),O
in,O
15,O
term,O
and,O
in,O
20,O
preterm,O
babies,O
.,O
Thirteen,O
preterms,O
of,O
the,O
latter,O
group,O
received,O
prenatal,O
steroid,O
treatment,O
.,O
The,O
number,O
of,O
GR,B
and,O
the,O
Kd,B
were,O
similar,O
in,O
the,O
term,O
and,O
preterm,O
(,O
with,O
and,O
without,O
NRDS,O
),O
babies,O
.,O
In,O
order,O
to,O
elucidate,O
the,O
role,O
of,O
NF,B
-,I
ATp,I
",",O
one,O
of,O
the,O
most,O
prominent,O
members,O
of,O
family,O
of,O
NF,B
-,I
AT,I
transcription,I
factors,I
in,O
peripheral,O
T,B
lymphocytes,I
",",O
in,O
T,B
cell,I
activation,I
and,O
differentiation,O
we,O
created,O
NF,B
-,I
ATp,I
-,I
deficient,O
mice,O
by,O
gene,O
targeting,O
.,O
Apart,O
from,O
clear,O
-,O
cut,O
defects,O
in,O
the,O
synthesis,O
of,O
mRNAs,O
for,O
Th2,B
-,I
type,I
lymphokines,I
",",O
such,O
as,O
IL,B
-,I
4,I
",",O
IL,B
-,I
5,I
",",O
IL,B
-,I
10,I
and,O
IL,B
-,I
13,I
",",O
in,O
primary,O
and,O
secondary,O
stimulations,O
of,O
spleen,O
cells,O
in,O
vitro,O
",",O
of,O
a,O
distinct,O
impaired,O
deletion,O
of,O
V,B
beta,I
11,I
+,I
/,I
CD4,B
+,I
T,B
lymphocytes,I
from,O
these,O
mice,O
was,O
detected,O
after,O
superantigen,O
injection,O
.,O
Moreover,O
",",O
NF,B
-,I
ATp,I
-,I
-,I
mice,O
older,O
than,O
6,O
weeks,O
show,O
an,O
2,O
-,O
5,O
fold,O
increase,O
in,O
number,O
of,O
lymphocytes,O
.,O
Our,O
data,O
constitute,O
a,O
starting,O
point,O
for,O
studies,O
to,O
elucidate,O
the,O
molecular,O
mechanism,O
by,O
which,O
TGF,B
-,I
beta,I
regulates,O
IgA,B
production,O
.,O
Daidzein,O
and,O
genistein,O
glucuronides,O
in,O
vitro,O
are,O
weakly,O
estrogenic,O
and,O
activate,O
human,O
natural,O
killer,O
cells,O
at,O
nutritionally,O
relevant,O
concentrations,O
.,O
Daidzein,B
and,O
genistein,B
glucuronides,I
(,O
DG,B
and,O
GG,B
),O
",",O
major,O
isoflavone,O
metabolites,O
",",O
may,O
be,O
partly,O
responsible,O
for,O
biological,O
effects,O
of,O
isoflavones,O
",",O
such,O
as,O
estrogen,B
receptor,I
binding,I
and,O
natural,O
killer,O
cell,B
(,O
NK,B
),O
activation,O
or,O
inhibition,O
.,O
DG,B
and,O
GG,B
were,O
synthesized,O
using,O
3,O
-,O
methylcholanthrene,O
-,O
induced,O
rat,O
liver,O
microsomes,O
.,O
DG,B
and,O
GG,B
were,O
further,O
purified,O
by,O
a,O
Sephadex,O
LH,O
-,O
20,O
column,O
.,O
In,O
this,O
study,O
",",O
we,O
propose,O
a,O
novel,O
function,O
for,O
CD44,B
.,O
Using,O
synovial,B
cells,I
from,O
rheumatoid,B
arthritis,I
(,O
RA,B
),O
patients,O
",",O
we,O
demonstrated,O
that,O
CD44,B
cross,O
-,O
linking,O
and,O
binding,O
to,O
hyaluronan,B
augmented,O
VCAM,B
-,I
1,I
expression,O
and,O
subsequently,O
VCAM,B
-,I
1,I
-,I
mediated,I
cell,I
adhesion,O
.,O
In,O
neutrophils,B
",",O
TNF,B
-,I
alpha,I
caused,O
a,O
gliotoxin,O
-,O
inhibitable,O
activation,O
of,O
an,O
inducible,O
form,O
of,O
NF,B
-,I
kappaB,I
",",O
a,O
response,O
that,O
may,O
underlie,O
the,O
ability,O
of,O
TNF,B
-,I
alpha,I
to,O
delay,O
apoptosis,O
at,O
later,O
times,O
(,O
12,O
-,O
24,O
h,O
),O
and,O
limit,O
its,O
early,O
killing,O
effect,O
.,O
We,O
previously,O
identified,O
a,O
Fas,B
ligand,I
regulatory,I
element,I
(,O
FLRE,O
),O
in,O
the,O
Fas,B
ligand,I
(,O
fasL,B
),O
promoter,O
that,O
binds,O
Egr,B
family,I
proteins,I
and,O
demonstrated,O
that,O
Egr,B
-,I
3,I
(,O
PILOT,O
),O
but,O
not,O
Egr,B
-,I
1,I
(,O
NGFI,B
-,I
A,I
",",I
Krox,I
-,I
24,I
",",I
Tis,I
-,I
8,I
",",I
and,I
Zif,I
-,I
268,I
),O
induces,O
transcription,O
of,O
fasL,B
.,O
The,O
aberrant,O
CD4,B
(,O
-,O
),O
CD8,B
(,O
-,O
),O
T,B
cells,I
from,O
lpr,O
/,O
lpr,O
and,O
gld,O
/,O
gld,O
mice,O
",",O
which,O
have,O
mutations,O
in,O
the,O
genes,O
encoding,O
Fas,B
and,O
FasL,B
",",O
respectively,O
",",O
have,O
an,O
activated,O
phenotype,O
and,O
constitutively,O
express,O
high,O
levels,O
of,O
fasL,B
mRNA,I
",",O
prompting,O
us,O
to,O
ask,O
what,O
role,O
if,O
any,O
the,O
FLRE,B
and,O
Egr,B
family,I
proteins,I
have,O
in,O
this,O
aberrant,O
expression,O
of,O
fasL,B
.,O
Although,O
overexpressed,O
Egr,B
-,I
1,I
was,O
ineffective,O
",",O
overexpressed,O
Egr,B
-,I
2,I
was,O
as,O
potent,O
as,O
Egr,B
-,I
3,I
in,O
inducing,O
fasL,B
promoter,I
-,I
dependent,I
reporter,I
constructs,I
in,O
T,B
cell,I
hybridomas,I
and,O
HeLa,B
cells,I
",",O
and,O
both,O
up,O
-,O
regulated,O
endogenous,O
fasL,B
mRNA,I
in,O
HeLa,B
cells,I
.,O
FasL,B
-,I
dependent,I
reporter,I
constructs,I
in,O
MRL,B
-,I
lpr,I
/,I
lpr,I
and,O
C3H,B
-,I
gld,I
/,I
gld,I
CD4,B
(,I
-,I
),I
CD8,I
(,I
-,I
),I
T,B
cells,I
were,O
constitutively,O
active,O
",",O
and,O
this,O
activity,O
was,O
largely,O
prevented,O
by,O
mutation,O
of,O
the,O
critical,O
Egr,B
family,I
binding,I
element,I
.,O
The,O
activity,O
of,O
the,O
CCAAT,B
-,I
box,I
binding,I
factor,I
NF,I
-,I
Y,I
is,O
modulated,O
through,O
the,O
regulated,O
expression,O
of,O
its,O
A,O
subunit,O
during,O
monocyte,O
to,O
macrophage,O
differentiation,O
:,O
regulation,O
of,O
tissue,O
-,O
specific,O
genes,O
through,O
a,O
ubiquitous,O
transcription,O
factor,O
.,O
Recent,O
studies,O
have,O
suggested,O
that,O
Y319,O
also,O
positively,O
regulate,O
ZAP,O
-,O
70,O
function,O
.,O
Deletion,O
of,O
interdomain,O
B,B
did,O
not,O
affect,O
the,O
ability,O
of,O
ZAP,B
-,I
70,I
to,O
bind,O
to,O
the,O
receptor,O
.,O
Differential,O
induction,O
of,O
DNA,B
-,I
binding,I
activities,I
following,O
CD19,B
cross,I
-,I
linking,I
in,O
human,O
B,B
lineage,I
cells,I
.,O
The,O
B,B
cell,I
-,I
specific,I
cell,I
surface,I
molecule,I
CD19,B
is,O
expressed,O
at,O
all,O
stages,O
of,O
B,B
cell,I
development,I
",",O
including,O
normal,O
plasma,O
cells,I
",",O
and,O
mediates,O
signal,O
transduction,O
via,O
interaction,O
with,O
cytoplasmic,O
effector,O
proteins,O
.,O
Oxidants,O
",",O
transcription,O
factors,O
",",O
and,O
intestinal,O
inflammation,O
.,O
It,O
is,O
now,O
well,O
appreciated,O
that,O
chronic,O
gut,O
inflammation,O
is,O
characterized,O
by,O
enhanced,O
production,O
of,O
reactive,O
metabolites,O
of,O
oxygen,O
and,O
nitrogen,O
.,O
Finally,O
",",O
oxidants,O
are,O
believed,O
to,O
promote,O
intestinal,O
epithelial,O
cell,O
apoptosis,O
",",O
and,O
the,O
B,B
-,I
cell,I
lymphoma,I
/,I
leukemia,I
-,I
2,I
gene,I
product,I
is,O
believed,O
to,O
inhibit,O
this,O
phenomenon,O
in,O
an,O
antioxidant,O
-,O
dependent,O
manner,O
.,O
The,O
regulatory,O
regions,O
of,O
several,O
genes,O
specifically,O
expressed,O
in,O
B,B
cells,I
contain,O
functional,B
binding,I
sites,I
for,O
Oct2,O
.,O
These,O
target,O
genes,O
show,O
quite,O
distinct,O
expression,O
patterns,O
demonstrating,O
that,O
transcription,O
factors,O
in,O
addition,O
to,O
Oct2,O
are,O
involved,O
in,O
their,O
regulation,O
.,O
The,O
protein,B
has,O
no,O
known,O
DNA,B
-,I
binding,I
domain,I
but,O
does,O
contain,O
three,O
ankyrin,B
repeats,I
that,O
are,O
likely,O
to,O
be,O
important,O
in,O
protein,O
-,O
protein,O
interactions,O
.,O
Binding,O
of,O
c,O
-,O
Rel,B
to,O
STAT5,B
target,I
sequences,I
in,O
HTLV,B
-,I
I,I
-,I
transformed,I
T,I
cells,I
.,O
Fas,B
(,O
CD95,I
),O
and,O
Fas,B
ligand,I
(,O
CD95L,I
),O
are,O
an,O
interacting,O
receptor,O
-,O
ligand,O
pair,O
required,O
for,O
immune,O
homeostasis,O
.,O
Although,O
resting,O
Jurkat,B
cells,I
express,O
Fas,B
",",O
Fas,B
mRNA,I
was,O
induced,O
approximately,O
10,O
-,O
fold,O
in,O
2,O
h,O
upon,O
P,O
/,O
I,O
stimulation,O
.,O
The,O
functional,B
contribution,I
of,O
the,O
kappaB,B
-,I
Sp1,I
composite,I
site,I
in,O
P,O
/,O
I,O
-,O
inducible,O
fas,B
promoter,I
activation,I
was,O
verified,O
by,O
using,O
kappaB,B
-,I
Sp1,I
concatamers,I
(-,O
295,O
to,O
-,O
286,O
),O
in,O
a,O
thymidine,B
kinase,I
promoter,I
-,I
driven,I
reporter,I
construct,I
and,O
native,B
promoter,I
constructs,I
in,O
Jurkat,B
cells,I
overexpressing,O
IkappaB,B
-,I
alpha,I
.,O
The,O
induction,O
of,O
clonal,O
anergy,O
in,O
a,O
T,B
cell,I
inhibits,O
IL,B
-,I
2,I
secretion,O
because,O
of,O
the,O
development,O
of,O
a,O
proximal,O
signal,O
transduction,O
defect,O
.,O
Members,O
of,O
the,O
cyclic,O
adenosine,O
monophosphate,O
(,O
cAMP,B
),O
response,O
element,O
binding,O
(,O
CREB,B
),O
/,O
activating,O
transcription,O
factor,O
1,O
(,O
ATF,B
-,I
1,I
),O
family,O
of,O
transcription,O
factors,O
bind,O
three,O
21,O
-,O
bp,O
repeats,O
(,O
Tax,B
-,I
responsive,I
element,I
-,I
1,I
",",O
or,O
TRE,B
-,I
1,I
),O
within,O
the,O
viral,O
promoter,O
and,O
are,O
important,O
for,O
basal,O
and,O
Tax,B
-,I
mediated,I
transcription,O
.,O
Exposing,O
human,B
umbilical,I
vein,I
endothelial,I
cells,I
(,O
HUVECs,B
),O
to,O
anoxia,O
/,O
reoxygenation,O
(,O
A,B
/,O
R,I
),O
results,O
in,O
an,O
increase,O
in,O
polymorphonuclear,B
leukocyte,I
(,O
PMN,B
),O
adhesion,O
to,O
HUVECs,B
.,O
NO,B
production,O
by,O
HUVECs,B
is,O
increased,O
after,O
the,O
second,O
A,B
/,O
R,I
challenge,O
",",O
but,O
not,O
after,O
the,O
first,O
A,B
/,O
R,I
challenge,O
.,O
However,O
",",O
while,O
HUVECs,B
contained,O
endothelial,B
NOS,I
protein,I
",",O
no,O
inducible,O
NOS,B
was,O
detected,O
in,O
either,O
tolerant,O
or,O
nontolerant,O
cells,I
.,O
The,O
inhibition,O
of,O
IL,B
-,I
2,I
production,O
was,O
observed,O
in,O
the,O
CD3,B
(,O
+,O
),O
T,B
-,I
lymphocyte,I
cytoplasm,O
as,O
early,O
as,O
4,O
h,O
after,O
activation,O
by,O
PMA,O
+,O
ionomycin,O
.,O
Delta,B
-,I
opioid,I
receptors,O
expressed,O
by,O
Jurkat,B
T,I
cells,I
enhance,O
IL,B
-,I
2,I
secretion,O
by,O
increasing,O
AP,B
-,I
1,I
complexes,O
and,O
activity,O
of,O
the,O
NF,B
-,I
AT,I
/,I
AP,I
-,I
1,I
-,I
binding,O
promoter,O
element,O
.,O
Reporter,O
gene,O
constructs,O
were,O
used,O
to,O
map,O
this,O
effect,O
of,O
deltorphin,O
to,O
the,O
AP,B
-,I
1,I
-,I
and,O
NF,B
-,I
AT,I
/,I
AP,I
-,I
1,I
-,I
binding,I
sites,I
of,O
the,O
IL,B
-,I
2,I
promoter,I
.,O
These,O
cells,O
",",O
stimulated,O
by,O
an,O
agonistic,O
monoclonal,O
antibody,O
against,O
CD40,B
or,O
by,O
transfection,O
with,O
a,O
CD40L,B
expression,O
vector,O
",",O
secreted,O
p40,B
and,O
showed,O
enhanced,O
p40,B
mRNA,I
expression,O
.,O
No,O
mutation,O
was,O
identified,O
in,O
either,O
of,O
the,O
genes,I
in,O
the,O
gynecomastias,O
.,O
We,O
have,O
mapped,O
the,O
DNase,B
-,I
I,I
-,I
hypersensitive,I
(,O
HS,B
),O
regions,O
of,O
the,O
human,O
GATA,B
-,I
3,I
gene,I
in,O
T,B
-,I
cells,I
and,O
non,B
-,I
T,I
-,I
cells,I
and,O
studied,O
their,O
transcriptional,O
activities,O
.,O
HS,B
I,I
-,I
III,I
",",O
located,O
5,O
',O
from,O
the,O
transcriptional,O
initiation,O
site,O
",",O
were,O
found,O
in,O
hematopoietic,B
and,O
non,B
-,I
hematopoietic,I
cells,I
",",O
whereas,O
HS,B
IV,I
-,I
VII,I
",",O
located,O
3,O
',O
from,O
the,O
transcriptional,O
start,O
site,O
",",O
were,O
exclusively,O
observed,O
in,O
T,B
-,I
cells,I
.,O
Among,O
these,O
hypersensitive,O
sites,O
",",O
two,O
transcriptional,O
control,O
elements,O
were,O
found,O
",",O
one,O
in,O
the,O
first,O
intron,O
of,O
the,O
GATA,B
-,I
3,I
gene,I
and,O
the,O
other,O
between,O
8,O
. 28,O
3,O
and,O
5,O
. 32,O
9,O
kilobases,O
5,O
',O
from,O
the,O
GATA,B
-,I
3,I
transcriptional,I
initiation,I
site,I
. 45,O
Two,O
CAGGTG,B
E,I
-,I
boxes,I
",",O
located,O
at,O
the,O
5,O
',O
-,O
and,O
3,O
',O
-,O
ends,O
of,O
the,O
silencer,O
",",O
were,O
necessary,O
for,O
this,O
silencer,O
activity,O
. 73,O
The,O
3,O
',O
-,O
CAGGTG,B
E,I
-,I
box,I
could,O
bind,O
USF,B
proteins,O
",",O
the,O
ubiquitous,O
repressor,O
ZEB,B
",",O
or,O
the,O
basic,O
helix,B
-,I
loop,I
-,I
helix,I
proteins,O
E2A,B
and,O
HEB,B
",",O
and,O
we,O
showed,O
that,O
a,O
competition,O
between,O
ZEB,B
and,O
E2A,B
/,I
HEB,B
proteins,O
is,O
involved,O
in,O
the,O
silencer,O
activity,O
.,O
Reactive,O
oxygen,B
intermediate,I
-,I
dependent,I
NF,B
-,I
kappaB,I
activation,O
by,O
interleukin,B
-,I
1beta,I
requires,O
5,O
-,O
lipoxygenase,B
or,O
NADPH,B
oxidase,I
activity,O
.,O
However,O
",",O
the,O
sources,O
for,O
ROIs,O
in,O
various,O
cell,B
types,I
are,O
yet,O
to,O
be,O
determined,O
and,O
might,O
include,O
5,O
-,O
lipoxygenase,B
(,O
5,O
-,O
LOX,B
),O
and,O
NADPH,B
oxidase,I
.,O
Stimulation,O
of,O
lymphoid,B
cells,I
with,O
interleukin,B
-,I
1beta,I
(,O
IL,B
-,I
1beta,I
),O
led,O
to,O
ROI,O
production,O
and,O
NF,B
-,I
kappaB,I
activation,I
",",O
which,O
could,O
both,O
be,O
blocked,O
by,O
antioxidants,B
or,O
FLAP,B
inhibitors,I
",",O
confirming,O
that,O
5,O
-,O
LOX,B
was,O
the,O
source,O
of,O
ROIs,O
and,O
was,O
required,O
for,O
NF,B
-,I
kappaB,I
activation,I
in,O
these,O
cells,O
.,O
Cutting,O
edge,O
:,O
dominant,O
effect,O
of,O
Ile50Val,O
variant,O
of,O
the,O
human,O
IL,B
-,I
4,I
receptor,I
alpha,I
-,I
chain,I
in,O
IgE,O
synthesis,O
.,O
Constitutive,O
expression,O
of,O
human,O
colony,B
-,I
stimulating,I
factor,I
-,I
1,I
receptor,I
(,O
CSF,B
-,I
1R,I
),O
confers,O
long,O
-,O
lasting,O
CSF,B
-,I
1,I
-,I
dependent,I
proliferation,O
to,O
mouse,O
myeloid,O
cell,O
lines,O
.,O
Morphologic,O
and,O
cytofluorometry,O
analysis,O
established,O
that,O
most,O
47,O
.,O
10,O
cells,O
are,O
immature,O
myelomonocytic,B
cells,O
.,O
In,O
agar,O
cultures,O
",",O
47,O
.,O
10,O
cells,O
form,O
7,O
-,O
and,O
14,O
-,O
day,O
colonies,O
in,O
response,O
to,O
a,O
cocktail,O
of,O
granulocyte,B
/,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
(,O
2,O
.,O
5,O
ng,O
/,O
mL,O
),O
",",O
interleukin,B
-,I
3,I
(,O
1,O
ng,O
/,O
mL,O
),O
",",O
and,O
mouse,O
CSF,B
-,I
1,I
(,O
10,O
ng,O
/,O
mL,O
),O
.,O
In,O
conclusion,O
",",O
we,O
have,O
characterized,O
a,O
novel,O
continuous,O
myeloid,B
cell,I
line,I
presenting,O
a,O
hierarchical,O
structure,O
similar,O
to,O
that,O
of,O
the,O
bone,O
marrow,O
progenitor,O
cell,O
compartment,O
.,O
Regulation,O
of,O
IL,B
-,I
4,I
expression,O
by,O
the,O
transcription,O
factor,O
JunB,B
during,O
T,B
helper,I
cell,I
differentiation,O
.,O
Here,O
we,O
show,O
that,O
JunB,B
",",O
but,O
not,O
the,O
other,O
Jun,B
family,I
members,I
",",O
was,O
selectively,O
induced,O
in,O
Th2,B
cells,I
and,O
not,O
in,O
Th1,B
cells,I
during,O
differentiation,O
.,O
The,O
finding,O
of,O
Tax,O
mutants,O
segregating,O
these,O
two,O
pathways,O
suggested,O
that,O
the,O
NF,B
-,I
kappaB,I
pathway,I
was,O
essential,O
for,O
IL,B
-,I
2,I
-,I
independent,I
growth,O
of,O
CTLL,B
-,I
2,I
cells,I
while,O
the,O
CRE,B
pathway,I
was,O
unnecessary,O
.,O
However,O
",",O
both,O
pathways,O
were,O
necessary,O
for,O
another,O
transformation,O
-,O
related,O
activity,O
(,O
colony,O
formation,O
in,O
soft,O
agar,O
),O
of,O
CTLL,B
-,I
2,I
/,I
Tax,B
.,O
Our,O
results,O
show,O
that,O
Tax,B
has,O
at,O
least,O
two,O
distinct,O
activities,O
on,O
T,B
cells,I
",",O
and,O
suggest,O
that,O
Tax,B
plays,O
a,O
crucial,O
role,O
in,O
IL,B
-,I
2,I
-,I
independent,I
T,B
-,I
cell,I
transformation,I
induced,O
by,O
HTLV,B
-,I
1,I
",",O
in,O
addition,O
to,O
its,O
well,O
-,O
known,O
IL,B
-,I
2,I
-,I
dependent,I
cell,I
transformation,I
.,O
First,O
",",O
it,O
gives,O
no,O
information,O
on,O
memory,O
to,O
lytic,O
cycle,O
antigens,O
;,O
second,O
",",O
it,O
preferentially,O
amplifies,O
the,O
dominant,O
components,O
of,O
latent,O
antigen,O
-,O
specific,O
memory,O
at,O
the,O
expense,O
of,O
key,O
subdominant,O
reactivities,O
.,O
Here,O
we,O
describe,O
an,O
alternative,O
approach,O
",",O
based,O
on,O
in,O
vitro,O
stimulation,O
with,O
epitope,O
peptide,O
-,O
loaded,O
dendritic,B
cells,I
(,O
DCs,B
),O
",",O
which,O
allows,O
one,O
to,O
probe,O
the,O
CTL,B
repertoire,I
for,O
any,O
individual,O
reactivity,O
of,O
choice,O
;,O
this,O
method,O
proved,O
significantly,O
more,O
efficient,O
than,O
stimulation,O
with,O
peptide,O
alone,O
.,O
The,O
present,O
study,O
was,O
designed,O
to,O
analyze,O
the,O
roles,O
of,O
the,O
two,O
GR,B
isoforms,I
on,O
glucocorticoid,O
-,O
mediated,O
transrepression,O
of,O
the,O
IL,B
-,I
2,I
gene,I
.,O
Furthermore,O
",",O
GRbeta,B
did,O
not,O
antagonize,O
the,O
repressive,O
effects,O
of,O
GRalpha,B
on,O
IL,B
-,I
2,I
promoter,I
activity,I
.,O
Surprisingly,O
",",O
overexpression,O
of,O
GRbeta,B
in,O
Jurkat,B
cells,I
did,O
not,O
cause,O
significant,O
inhibition,O
of,O
GRalpha,B
-,O
induced,O
transactivation,O
of,O
a,O
GRE,B
-,I
dependent,I
luciferase,I
reporter,I
gene,I
either,O
.,O
Extinction,O
of,O
immunoglobulin,B
gene,I
expression,I
in,O
B,B
cells,I
upon,O
fusion,O
with,O
HeLa,B
cells,I
is,O
preceded,O
by,O
rapid,O
nuclear,O
depletion,O
of,O
essential,O
transcription,B
factors,I
and,O
is,O
accompanied,O
by,O
widespread,O
inactivation,O
of,O
genes,O
expressed,O
in,O
a,O
B,B
cell,I
-,I
specific,I
manner,O
.,O
Evidence,O
for,O
suppressed,O
activity,O
of,O
the,O
transcription,B
factor,I
NFAT1,B
at,O
its,O
proximal,O
binding,O
element,O
P0,O
in,O
the,O
IL,B
-,I
4,I
promoter,I
associated,O
with,O
enhanced,O
IL,B
-,I
4,I
gene,I
transcription,O
in,O
T,B
cells,I
of,O
atopic,O
patients,O
.,O
In,O
a,O
series,O
of,O
electrophoretic,O
mobility,O
shift,O
assays,O
with,O
protein,B
extracts,I
of,O
highly,O
polarized,O
Th2,B
clones,I
from,O
atopics,O
and,O
Th1,B
clones,I
from,O
controls,O
we,O
compared,O
DNA,B
-,I
binding,I
activities,O
at,O
the,O
two,O
NFAT,B
-,I
binding,I
elements,I
P0,O
and,O
P1,O
of,O
the,O
crucial,O
proximal,O
human,O
IL,B
-,I
4,I
promoter,I
.,O
At,O
the,O
most,O
proximal,O
P0,O
site,O
",",O
NFAT,B
-,I
containing,I
complexes,I
devoid,O
of,O
NFAT2,B
were,O
readily,O
inducible,O
in,O
the,O
Th1,B
clones,I
",",O
but,O
hardly,O
or,O
not,O
in,O
the,O
Th2,B
clones,I
.,O
These,O
findings,O
suggest,O
that,O
high,O
-,O
level,O
IL,B
-,I
4,I
production,O
in,O
atopic,O
Th2,B
cells,I
is,O
associated,O
with,O
selective,O
reduction,O
of,O
suppressive,O
NFAT1,B
activity,O
at,O
the,O
IL,B
-,I
4,I
P0,I
element,I
and,O
that,O
some,O
patients,O
with,O
this,O
multifactorial,O
disease,O
may,O
have,O
a,O
putative,O
systemic,O
disorder,O
at,O
this,O
level,O
.,O
Rather,O
",",O
squirrel,B
monkeys,I
express,O
a,O
soluble,O
factor,O
that,O
",",O
in,O
mixing,O
studies,O
of,O
cytosol,O
from,O
squirrel,B
monkey,I
lymphocytes,I
(,O
SML,B
),O
and,O
mouse,B
L929,I
cells,I
",",O
reduced,O
GR,B
binding,I
affinity,I
by,O
11,O
-,O
fold,O
.,O
A,O
role,O
for,O
changes,O
in,O
immunophilins,B
",",O
causing,O
glucocorticoid,B
resistance,I
in,O
neotropical,O
primates,O
",",O
is,O
supported,O
by,O
the,O
following,O
:,O
the,O
changes,O
in,O
FKBP51,B
and,O
FKBP52,B
were,O
observed,O
in,O
cells,O
from,O
other,O
neotropical,O
primates,O
with,O
glucocorticoid,B
resistance,I
;,O
the,O
elevated,O
level,O
of,O
FKBP51,B
was,O
reflected,O
in,O
an,O
abundance,O
of,O
FKBP51,B
in,O
heat,O
shock,O
protein,O
90,O
complexes,O
in,O
SML,B
;,O
when,O
cytosols,O
of,O
SML,B
and,O
L929,B
cells,O
were,O
mixed,O
",",O
the,O
decrease,O
in,O
GR,B
binding,I
was,O
associated,O
with,O
incorporation,O
of,O
FKBP51,B
into,O
GR,B
heterocomplexes,I
;,O
the,O
effect,O
of,O
SML,B
cytosol,O
on,O
GR,B
binding,I
was,O
reproduced,O
with,O
cytosol,O
from,O
COS,B
cells,O
expressing,O
squirrel,O
monkey,O
FKBP51,B
;,O
and,O
both,O
the,O
effect,O
of,O
SML,B
cytosol,O
on,O
GR,B
binding,I
and,O
the,O
incorporation,O
of,O
FKBP51,B
into,O
GR,B
heterocomplexes,I
were,O
blocked,O
by,O
FK506,B
.,O
The,O
prevalent,O
complex,O
is,O
the,O
heterodimer,B
p50,I
-,I
p65,I
.,O
NF,B
-,I
kappaB,I
activity,O
is,O
tightly,O
correlated,O
with,O
the,O
transcriptional,O
activity,O
of,O
a,O
long,O
terminal,O
repeat,O
(,O
LTR,O
),O
of,O
HIV,B
-,I
1,I
transfected,O
in,O
thymocytes,O
.,O
GCs,B
induce,O
apoptosis,O
in,O
neoplastic,O
lymphoid,B
cells,I
;,O
and,O
",",O
defective,O
apoptosis,O
is,O
implicated,O
in,O
the,O
genesis,O
of,O
chronic,O
lymphocytic,B
leukemia,I
(,O
CLL,O
),O
.,O
These,O
findings,O
indicate,O
that,O
imbalanced,O
expression,O
of,O
the,O
GR,B
isoforms,I
may,O
be,O
a,O
mechanism,O
of,O
GC,O
resistance,O
",",O
and,O
may,O
have,O
implications,O
for,O
tumorigenesis,O
by,O
enhancing,O
cell,B
survival,O
.,O
A,O
second,O
hypersensitive,O
site,O
(,O
HS,B
2,I
),O
was,O
identified,O
within,O
the,O
first,O
intron,O
in,O
pre,O
-,O
monocytic,B
cells,I
",",O
which,O
express,O
Elk,B
-,I
1,I
only,O
when,O
differentiating,O
to,O
monocytes,B
.,O
Twenty,O
-,O
seven,O
patients,O
with,O
tumors,O
of,O
the,O
oral,O
cavity,O
",",O
oropharynx,O
",",O
and,O
maxillary,O
sinus,O
were,O
examined,O
",",O
all,O
of,O
which,O
were,O
confirmed,O
as,O
squamous,B
cell,I
carcinomas,I
.,O
Serial,O
sectioning,O
of,O
6,O
micrometer,O
was,O
performed,O
using,O
a,O
cryostat,O
",",O
and,O
samples,O
were,O
immunohistochemicall,O
stained,O
using,O
the,O
streptoavidin,O
-,O
biotin,O
peroxidase,O
method,O
and,O
a,O
monoclonal,O
antibody,O
against,O
c,B
-,I
fos,I
.,O
Three,O
of,O
the,O
27,O
patients,O
with,O
squamous,B
cell,I
carcinoma,I
showed,O
slight,O
expression,O
of,O
c,B
-,I
fos,I
in,O
their,O
tumor,O
cells,O
before,O
and,O
/,O
or,O
at,O
4,O
or,O
10,O
Gy,O
of,O
radiotherapy,O
.,O
In,O
patients,O
whose,O
infiltration,O
of,O
c,B
-,I
fos,I
-,I
positive,I
lymphocytes,O
into,O
tumor,O
tissues,O
were,O
moderate,O
or,O
remarkable,O
at,O
4,O
Gy,O
of,O
radiotherapy,O
",",O
the,O
tumors,O
responded,O
significantly,O
well,O
to,O
radiation,O
therapy,O
(,O
P,O
<,O
0,O
.,O
25,O
",",O
chi2,O
test,O
),O
",",O
and,O
the,O
patients,O
took,O
a,O
significantly,O
favorable,O
clinical,O
course,O
(,O
P,O
<,O
0,O
.,O
5,O
",",O
chi2,O
test,O
),O
.,O
The,O
allele,O
-,O
specific,O
expression,O
profiles,O
of,O
other,O
imprinted,O
genes,O
",",O
IGF2,B
and,O
H19,B
",",O
on,O
human,O
chromosome,O
11,O
were,O
constant,O
and,O
consistent,O
with,O
those,O
in,O
other,O
tissues,O
.,O
Our,O
unexpected,O
observations,O
of,O
paternal,O
or,O
biallelic,O
expression,O
of,O
WT1,B
in,O
fibroblasts,O
and,O
lymphocytes,O
",",O
together,O
with,O
the,O
previous,O
findings,O
of,O
maternal,O
or,O
biallelic,O
expression,O
in,O
placentae,O
and,O
brains,O
",",O
suggest,O
that,O
the,O
allele,O
-,O
specific,O
regulatory,O
system,O
of,O
WT1,B
is,O
unique,O
and,O
may,O
be,O
controlled,O
by,O
a,O
putative,O
tissue,O
-,O
and,O
individual,O
-,O
specific,O
modifier,O
.,O
T,O
cell,B
responses,O
to,O
some,O
nuclear,B
antigens,I
",",O
particularly,O
U1RNP,B
",",O
have,O
been,O
detected,O
in,O
patients,O
with,O
systemic,O
lupus,O
erythematosus,O
(,O
SLE,O
),O
and,O
in,O
healthy,O
subjects,O
.,O
METHODS,O
.,O
HLA,B
-,I
DR,I
typing,O
was,O
by,O
polymerase,O
chain,O
reaction,O
and,O
sequence,O
specific,O
oligonucleotide,O
typing,O
.,O
RESULTS,O
.,O
Six,O
of,O
20,O
patients,O
with,O
SS,O
and,O
10,O
/,O
19,O
controls,O
proliferated,O
to,O
La,B
(,O
rSSB,I
),O
.,O
Tumor,O
necrosis,O
factor,O
(,O
TNF,B
),O
-,O
alpha,O
-,O
induced,O
HIV,B
-,I
1,I
replication,O
in,O
OM10,B
0.16,I
1,I
or,O
Ach2,B
cells,I
was,O
significantly,O
inhibited,O
by,O
non,O
-,O
cytotoxic,O
doses,O
of,O
AuTG,O
(,O
>,O
10,O
microM,O
in,O
OM10,B
0.37,I
1,I
cells,I
and,O
>,O
25,O
F,O
.,O
M,O
in,O
Ach2,B
cells,I
),O
",",O
while,O
25,O
microM,O
of,O
the,O
counter,O
-,O
anion,O
thioglucose,O
(,O
TG,B
),O
or,O
gold,O
compound,O
containing,O
divalent,O
gold,O
ion,O
",",O
HAuCl3,O
",",O
had,O
no,O
effect,O
.,O
Specific,O
staining,O
as,O
well,O
as,O
electron,O
microscopic,O
examinations,O
revealed,O
the,O
accumulation,O
of,O
metal,O
gold,B
in,O
the,O
cells,O
",",O
supporting,O
our,O
previous,O
hypothesis,O
that,O
gold,B
ions,O
could,O
block,O
NF,B
-,I
kappaB,I
-,I
DNA,I
binding,O
by,O
a,O
redox,O
mechanism,O
.,O
In,O
the,O
absence,O
of,O
karyotypic,O
abnormalities,O
",",O
there,O
is,O
no,O
specific,O
test,O
to,O
detect,O
clonal,O
eosinophilia,O
in,O
IHES,O
.,O
Peripheral,O
blood,O
eosinophils,B
were,O
isolated,O
by,O
their,O
autofluoresence,O
using,O
flow,O
cytometric,O
sorting,O
.,O
After,O
corticosteroid,O
suppression,O
of,O
her,O
blood,O
eosinophilia,B
",",O
a,O
clonal,O
population,O
of,O
eosinophils,B
could,O
no,O
longer,O
be,O
detected,O
in,O
purified,O
eosinophils,B
.,O
This,O
pro,O
-,O
IL,B
-,I
-,I
16,I
is,O
subsequently,O
processed,O
to,O
the,O
mature,O
cytokine,O
of,O
13,O
kDa,O
.,O
The,O
5,O
',O
sequences,O
up,O
to,O
nucleotide,O
-,O
120,O
of,O
the,O
human,O
and,O
murine,O
IL,B
-,I
16,I
genes,I
share,O
>,O
84,O
%,O
sequence,O
homology,O
and,O
harbor,O
promoter,B
elements,I
for,O
constitutive,O
and,O
inducible,O
transcription,O
in,O
T,O
cells,O
.,O
Therefore,O
",",O
this,O
genetic,O
variant,O
",",O
which,O
predisposes,O
to,O
low,O
bone,O
mineral,O
density,O
in,O
many,O
populations,O
",",O
may,O
confer,O
resistance,O
to,O
certain,O
infectious,O
diseases,O
.,O
Indeed,O
",",O
the,O
availability,O
of,O
selective,O
and,O
orally,O
active,O
proteasome,B
inhibitors,I
should,O
prove,O
useful,O
in,O
delineating,O
the,O
roles,O
of,O
the,O
proteasome,B
and,O
NF,B
-,I
kappa,I
B,I
in,O
other,O
pathophysiological,O
conditions,O
such,O
as,O
cancer,O
and,O
heart,O
disease,O
.,O
Lysophosphatidyletha,O
(,O
lysoPE,B
),O
and,O
other,O
lysophospholipids,O
did,O
not,O
affect,O
LPS,O
-,O
induced,O
TF,O
activity,O
of,O
human,O
monocytes,O
.,O
TF,B
antigen,I
expression,O
as,O
elicited,O
by,O
LPS,O
was,O
also,O
lowered,O
by,O
lysoPC,O
.,O
LysoPC,O
inhibited,O
the,O
TF,B
activity,O
of,O
Mono,B
Mac,I
-,I
6,I
cells,I
to,O
a,O
similar,O
extent,O
as,O
in,O
the,O
monocytes,O
.,O
A,O
Taq,O
I,O
polymorphism,O
was,O
identified,O
which,O
enabled,O
chicken,O
IL2,B
to,O
be,O
mapped,O
to,O
chromosome,O
4,O
",",O
linked,O
to,O
ANX5,O
",",O
with,O
synteny,O
with,O
mouse,B
chromosome,I
3,I
and,O
human,B
chromosome,I
4,I
.,O
There,O
is,O
increasing,O
evidence,O
that,O
IFN,B
-,I
alpha,I
has,O
an,O
important,O
role,O
in,O
T,B
-,I
cell,I
biology,O
.,O
The,O
induction,O
of,O
these,O
genes,O
is,O
associated,O
with,O
interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
-,O
induced,O
T,B
-,I
cell,I
proliferation,O
.,O
Taken,O
together,O
",",O
our,O
results,O
suggest,O
that,O
IFN,B
-,I
alpha,I
",",O
IL,B
-,I
2,I
",",O
IL,B
-,I
12,I
",",O
and,O
IL,B
-,I
15,I
have,O
overlapping,O
activities,O
on,O
human,O
T,B
cells,I
.,O
The,O
Megakaryocyte,B
/,I
Platelet,I
-,I
specific,I
enhancer,I
of,I
the,I
alpha2beta1,I
integrin,I
gene,I
:,O
two,O
tandem,O
AP1,O
sites,O
and,O
the,O
mitogen,O
-,O
activated,O
protein,O
kinase,O
signaling,O
cascade,O
. Transcriptional,O
regulation,O
of,O
the,O
alpha2,B
integrin,I
gene,I
in,O
cells,O
undergoing,O
megakaryocytic,B
differentiation,I
requires,O
a,O
core,O
promoter,O
between,O
bp,O
-,O
30,O
and,O
-,O
92,O
",",O
a,O
silencer,O
between,O
bp,O
-,O
92,O
and,O
-,O
351,O
",",O
and,O
megakaryocytic,B
enhancers,I
in,O
the,O
distal,O
5,O
',O
flank,O
.,O
Therefore,O
",",O
our,O
data,O
not,O
only,O
reveal,O
that,O
Nmi,B
can,O
potentiate,O
STAT,B
-,I
dependent,I
transcription,I
",",O
but,O
also,O
suggest,O
that,O
it,O
can,O
augment,O
coactivator,B
protein,I
recruitment,O
to,O
at,O
least,O
some,O
members,O
of,O
a,O
group,O
of,O
sequence,O
-,O
specific,O
transcription,O
factors,O
.,O
In,O
contrast,O
",",O
activation,O
in,O
THP,B
-,I
1,I
cells,O
occurred,O
in,O
the,O
absence,O
of,O
vanadate,O
and,O
was,O
unaffected,O
by,O
catalase,O
.,O
These,O
findings,O
suggest,O
the,O
presence,O
in,O
vaginal,B
fluid,I
of,O
agent,O
(,O
s,O
),O
derived,O
from,O
indigenous,O
bacteria,O
that,O
can,O
activate,O
the,O
HIV,B
-,I
1,I
LTR,I
",",O
cytokine,O
production,O
",",O
and,O
NF,B
-,I
kappaB,I
in,O
cells,O
of,O
macrophage,B
lineage,I
",",O
with,O
possible,O
influence,O
on,O
vaginal,O
physiology,O
and,O
host,O
defense,O
.,O
Activated,O
primed,O
CD4,B
T,I
cells,I
contain,O
more,O
NFAT1,B
and,O
support,O
greater,O
NFAT,B
-,I
directed,I
transcription,I
than,O
unprimed,O
CD4,B
T,I
cells,I
",",O
while,O
activator,O
protein,O
1,O
binding,O
and,O
activator,O
protein,O
1,O
-,O
mediated,O
transcription,O
by,O
both,O
cell,O
types,O
is,O
similar,O
.,O
These,O
agents,O
also,O
significantly,O
decreased,O
TNF,B
-,I
and,O
LPS,B
-,I
stimulated,O
increases,O
in,O
HUVEC,B
surface,I
VCAM,I
-,I
1,I
.,O
TNF,B
stimulated,O
expression,O
of,O
both,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
and,O
E,B
-,I
selectin,I
in,O
HUVECs,B
",",O
but,O
in,O
HUAECs,B
",",O
only,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
was,O
increased,O
.,O
Functional,O
testosterone,B
receptors,I
in,O
plasma,B
membranes,I
of,O
T,B
cells,I
.,O
AR,B
can,O
be,O
visualized,O
with,O
the,O
anti,O
-,O
AR,B
antibodies,I
in,O
the,O
cytoplasm,O
of,O
permeabilized,O
T,B
cells,I
by,O
using,O
CLSM,O
",",O
though,O
AR,B
are,O
not,O
detectable,O
in,O
cytosol,O
fractions,O
when,O
using,O
the,O
charcoal,O
binding,O
assay,O
with,O
3H,O
-,O
R1881,O
as,O
ligand,O
.,O
Cytoplasmic,O
AR,B
do,O
not,O
translocate,O
to,O
the,O
nucleus,O
of,O
T,B
cells,I
in,O
the,O
presence,O
of,O
testosterone,O
",",O
in,O
contrast,O
to,O
cytoplasmic,O
AR,B
in,O
human,O
cancer,O
LNCaP,B
cells,I
.,O
By,O
contrast,O
",",O
the,O
cell,B
surface,I
receptors,I
for,O
testosterone,B
are,O
in,O
a,O
functionally,O
active,O
state,O
",",O
enabling,O
T,B
cells,I
a,O
nongenomic,O
response,O
to,O
testosterone,B
.,O
Limited,O
proteolysis,B
for,O
assaying,O
ligand,B
binding,I
affinities,I
of,O
nuclear,B
receptors,I
.,O
Using,O
the,O
wild,O
-,O
type,O
or,O
mutated,O
human,B
retinoic,I
acid,I
receptor,I
alpha,I
as,O
a,O
model,O
",",O
kDa,O
values,O
determined,O
by,O
classical,O
competition,O
binding,I
assays,I
using,O
tritiated,O
ligands,B
are,O
in,O
agreement,O
with,O
those,O
measured,O
by,O
the,O
proteolytic,B
assay,I
.,O
B,B
lymphocytes,O
from,O
patients,O
with,O
chronic,O
lymphocytic,O
leukemia,O
contain,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
(,O
STAT,B
),O
1,O
and,O
STAT3,B
constitutively,O
phosphorylated,O
on,O
serine,B
residues,I
.,O
In,O
summary,O
",",O
the,O
constitutive,O
serine,B
phosphorylation,I
of,O
STAT1,B
and,O
STAT3,B
is,O
present,O
in,O
all,O
CLL,O
samples,O
tested,O
to,O
date,O
",",O
although,O
the,O
physiologic,O
significance,O
of,O
this,O
modification,O
remains,O
to,O
be,O
determined,O
.,O
G,O
.,O
vaginalis,O
lysates,O
also,O
activated,O
HIV,B
expression,O
in,O
certain,O
T,B
cell,I
lines,I
.,O
Highly,O
purified,O
monocytes,O
were,O
incubated,O
with,O
IL,B
-,I
10,I
for,O
60,O
to,O
90,O
minutes,O
before,O
the,O
addition,O
of,O
IFNgamma,B
or,O
IFNalpha,B
.,O
IL,B
-,I
10,I
preincubation,O
resulted,O
in,O
the,O
inhibition,O
of,O
gene,O
expression,O
for,O
several,O
IFN,B
-,I
induced,I
genes,I
",",O
such,O
as,O
IP,B
-,I
10,I
",",O
ISG54,B
",",O
and,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
.,O
The,O
development,O
of,O
ringed,O
sideroblasts,O
in,O
erythroid,O
colonies,O
by,O
iron,B
staining,O
and,O
their,O
X,O
-,O
inactivation,O
pattern,O
were,O
also,O
examined,O
.,O
Granulosa,O
cell,O
tumor,O
of,O
the,O
ovary,O
.,O
All,O
of,O
the,O
tumors,O
exhibited,O
typical,O
morphology,O
",",O
were,O
limited,O
to,O
the,O
ovary,O
(,O
stage,O
I,O
),O
",",O
and,O
7,O
cases,O
followed,O
a,O
benign,O
clinical,O
course,O
.,O
Comparison,O
of,O
primary,O
sensitization,O
of,O
naive,O
human,B
T,I
cells,I
to,O
varicella,O
-,O
zoster,O
virus,O
peptides,O
by,O
dendritic,B
cells,I
in,O
vitro,O
with,O
responses,O
elicited,O
in,O
vivo,O
by,O
varicella,O
vaccination,O
.,O
Dendritic,B
cells,I
(,O
DC,B
),O
are,O
potent,O
APC,O
during,O
primary,O
and,O
secondary,O
immune,O
responses,O
.,O
Monocytes,B
were,O
effective,O
APC,O
for,O
VZV,O
peptides,O
only,O
after,O
immunization,O
.,O
IL,B
-,I
10,I
treatment,O
prevented,O
the,O
downregulation,O
of,O
p27,B
(,O
Kip1,B
),O
",",O
an,O
inhibitory,O
protein,O
that,O
controls,O
progression,O
out,O
of,O
the,O
G0,O
phase,O
of,O
the,O
cell,B
cycle,I
.,O
Associated,O
with,O
the,O
inhibition,O
of,O
the,O
cell,B
cycle,I
",",O
IL,B
-,I
10,I
suppressed,O
SEB,O
induction,O
of,O
interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
.,O
Although,O
this,O
reversal,O
by,O
IL,B
-,I
2,I
was,O
pronounced,O
",",O
it,O
was,O
not,O
complete,O
",",O
suggesting,O
that,O
IL,B
-,I
10,I
may,O
have,O
some,O
effects,O
not,O
directly,O
related,O
to,O
the,O
suppression,O
of,O
IL,B
-,I
2,I
production,O
.,O
IL,B
-,I
4,I
and,O
IL,B
-,I
13,I
induced,O
dose,O
-,O
and,O
time,O
-,O
dependent,O
increases,O
in,O
IL,B
-,I
1RI,I
and,O
IL,B
-,I
1RII,I
mRNA,O
levels,O
.,O
IFN,B
-,I
gamma,I
decreased,O
basal,O
expression,O
as,O
well,O
as,O
the,O
induction,O
of,O
these,O
genes,O
by,O
IL,B
-,I
4,I
and,O
IL,B
-,I
13,I
.,O
Inhibition,O
of,O
IL,B
-,I
1RI,I
and,O
IL,B
-,I
1RII,I
mRNA,O
levels,O
by,O
IFN,B
-,I
gamma,I
was,O
transcriptionally,O
mediated,O
",",O
and,O
correlated,O
directly,O
with,O
decreased,O
production,O
of,O
soluble,O
IL,B
-,I
1RII,I
.,O
In,O
both,O
cell,B
types,I
",",O
the,O
cytokine,O
that,O
inhibits,O
the,O
induction,O
of,O
IkappaBalpha,B
by,O
DEX,B
",",O
also,O
rescues,O
these,O
cells,O
from,O
DEX,B
-,I
induced,I
apoptosis,I
",",O
although,O
the,O
rescue,O
cytokine,O
is,O
different,O
in,O
Th1,B
and,O
Th2,B
cells,I
.,O
Infection,O
of,O
human,O
monocytes,B
with,O
influenza,O
A,O
virus,O
induces,O
a,O
broad,O
range,O
of,O
proinflammatory,B
cytokines,I
and,O
mononuclear,B
cell,I
attracting,I
chemokines,I
before,O
the,O
infected,O
cells,O
undergo,O
apoptosis,O
.,O
In,O
conclusion,O
",",O
the,O
long,O
-,O
term,O
regulation,O
of,O
transcription,O
factor,B
gene,I
expression,I
in,O
non,O
-,O
proliferating,O
cells,O
seems,O
to,O
be,O
of,O
minor,O
importance,O
after,O
influenza,O
infection,O
since,O
in,O
apoptosisprone,O
cells,O
an,O
immediate,O
availability,O
of,O
transcription,O
factor,B
proteins,I
is,O
required,O
. Patients,O
with,O
diabetic,B
nephropathy,I
showed,O
higher,O
NF,B
-,I
kappaB,I
binding,I
activity,I
in,O
Electrophoretic,O
Mobility,O
Shift,O
Assays,O
and,O
stronger,O
immunohistological,O
staining,O
for,O
activated,O
NF,B
-,I
kappaBp65,I
than,O
patients,O
without,O
renal,O
complications,O
.,O
Resorption,O
lacunae,O
can,O
be,O
observed,O
by,O
day,O
22,O
.,O
We,O
incubated,O
sodium,B
oleate,I
with,O
human,B
umbilical,I
vein,I
endothelial,I
cells,I
for,O
0,O
to,O
72,O
hours,O
",",O
followed,O
by,O
coincubation,O
of,O
oleate,B
with,O
human,B
recombinant,I
tumor,I
necrosis,I
factor,I
",",O
interleukin,B
(,O
IL,B
),O
-,O
1alpha,O
",",O
IL,B
-,O
1beta,O
",",O
IL,B
-,O
-,O
4,O
",",O
Escherichia,B
coli,I
lipopolysaccharide,I
(,O
LPS,B
),O
",",O
or,O
phorbol,B
12,I
-,I
myristate,I
13,I
-,I
acetate,I
for,O
a,O
further,O
6,O
to,O
24,O
hours,O
.,O
The,O
endothelial,B
expression,O
of,O
vascular,B
cell,I
adhesion,I
molecule,I
-,I
1,I
(,O
VCAM,B
-,I
1,I
),O
",",O
E,B
-,I
selectin,I
",",O
and,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
was,O
monitored,O
by,O
cell,B
surface,I
enzyme,I
immunoassays,I
or,O
flow,B
cytometry,I
",",O
and,O
steady,O
-,O
state,O
levels,O
of,O
VCAM,B
-,I
1,I
mRNA,I
were,O
assessed,O
by,O
Northern,B
blot,I
analysis,I
.,O
Incubation,O
of,O
endothelial,B
cells,I
with,O
oleate,O
for,O
72,O
hours,O
decreased,O
the,O
relative,O
proportions,O
of,O
saturated,B
(,O
palmitic,I
and,O
stearic,I
),O
acids,I
in,O
total,B
cell,I
lipids,I
and,O
increased,O
the,O
proportions,O
of,O
oleate,O
in,O
total,B
cell,I
lipids,I
without,O
significantly,O
changing,O
the,O
relative,O
proportions,O
of,O
polyunsaturated,B
fatty,I
acids,I
.,O
The,O
importance,O
of,O
BCL2,B
and,O
Stat3,B
on,O
IL,O
-,O
6,O
-,O
induced,O
macrophage,B
-,I
differentiation,I
and,O
apoptosis,O
was,O
studied,O
with,O
1A9,O
-,O
M,O
cells,O
expressing,O
human,O
BCL2,B
or,O
a,O
dominant,O
-,O
negative,O
form,O
of,O
Stat3,B
",",O
respectively,O
.,O
IL,O
-,O
6,O
-,O
induced,O
apoptosis,O
",",O
but,O
not,O
macrophage,B
-,I
differentiation,I
",",O
was,O
blocked,O
by,O
continuously,O
expressed,O
BCL2,B
.,O
Interleukin,B
-,I
8,I
(,O
IL,B
-,I
8,I
),O
is,O
a,O
chemokine,O
that,O
belongs,O
to,O
the,O
alpha,O
-,O
chemokine,O
or,O
CXC,O
subfamily,O
and,O
is,O
produced,O
by,O
a,O
wide,O
variety,O
of,O
human,O
cells,O
",",O
including,O
monocytes,O
and,O
polymorphonuclear,O
cells,O
(,O
PMN,O
),O
.,O
IL,B
-,I
8,I
is,O
secreted,O
in,O
response,O
to,O
inflammatory,O
stimuli,O
",",O
notably,O
bacterial,O
products,O
such,O
as,O
lipopolysaccharide,O
(,O
LPS,O
),O
",",O
but,O
little,O
is,O
known,O
about,O
the,O
mechanisms,O
by,O
which,O
these,O
agents,O
mediate,O
IL,B
-,I
8,I
induction,O
.,O
In,O
this,O
report,O
",",O
we,O
show,O
that,O
Mycoplasma,B
fermentans,I
lipid,I
-,I
associated,I
membrane,I
proteins,I
(,O
LAMPf,B
),O
induce,O
the,O
production,O
of,O
high,O
levels,O
of,O
IL,B
-,I
8,I
by,O
THP,B
-,I
1,I
(,O
human,B
monocyte,I
),O
cells,O
and,O
PMN,B
at,O
the,O
same,O
extent,O
as,O
LPS,B
.,O
In,O
this,O
study,O
we,O
investigated,O
the,O
effects,O
of,O
C3a,B
and,O
C3a,B
(,O
desArg,I
),O
on,O
gene,O
expression,O
and,O
protein,B
secretion,I
of,O
IL,B
-,I
6,I
in,O
human,B
PBMCs,I
",",O
either,O
alone,O
or,O
in,O
combination,O
with,O
LPS,B
or,O
IL,B
-,I
1beta,I
.,O
Furthermore,O
",",O
we,O
investigated,O
the,O
effects,O
of,O
C3a,B
and,O
C3a,B
(,O
desArg,O
),O
on,O
induction,O
of,O
NF,B
-,I
kappaB,I
and,O
activating,O
protein,O
-,O
1,O
binding,O
.,O
These,O
results,O
demonstrate,O
the,O
capacity,O
of,O
intact,O
C3a,B
and,O
its,O
circulating,O
des,O
-,O
Arg,O
form,O
to,O
exert,O
immunmodulatory,O
effects,O
in,O
vitro,O
.,O
Phenylarsine,O
oxide,O
inhibits,O
ex,O
vivo,O
HIV,B
-,I
1,I
expression,O
.,O
Pharmacological,O
control,O
of,O
antigen,O
responsiveness,O
in,O
genetically,O
modified,O
T,B
lymphocytes,I
.,O
Recently,O
",",O
fibromyalgia,O
(,O
FMS,B
),O
was,O
shown,O
to,O
be,O
a,O
disorder,O
associated,O
with,O
an,O
altered,O
functioning,O
of,O
the,O
stress,O
response,O
system,O
.,O
FMS,B
patients,O
display,O
a,O
hyperreactive,O
pituitary,O
adrenocorticotropic,O
hormone,O
(,O
ACTH,B
),O
release,O
in,O
response,O
to,O
corticotropin,O
-,O
releasing,O
hormone,O
(,O
CRH,B
),O
and,O
to,O
insulin,O
-,O
induced,O
hypoglycemia,O
.,O
Therefore,O
we,O
investigated,O
the,O
properties,O
and,O
function,O
of,O
the,O
glucocorticoid,B
receptors,I
(,O
GR,B
),O
in,O
FMS,O
patients,O
and,O
compared,O
the,O
results,O
with,O
those,O
of,O
healthy,O
persons,O
and,O
patients,O
with,O
chronic,O
low,O
back,O
pain,O
(,O
LBP,O
a,O
localized,O
pain,O
condition,O
),O
.,O
Forty,O
primary,O
FMS,O
patients,O
(,O
F,O
:,O
M,O
=,O
36,O
:,O
4,O
),O
",",O
28,O
LBP,O
patients,O
(,O
25,O
:,O
3,O
),O
and,O
14,O
(,O
12,O
:,O
2,O
),O
healthy,O
",",O
sedentary,O
control,O
persons,O
were,O
recruited,O
for,O
the,O
study,O
.,O
Urinary,O
free,O
cortisol,B
excretion,O
in,O
FMS,O
and,O
LBP,O
patients,O
was,O
lower,O
compared,O
to,O
controls,O
.,O
We,O
conclude,O
that,O
FMS,O
patients,O
have,O
a,O
mild,O
hypocortisolemia,O
",",O
increased,O
cortisol,B
feedback,O
resistance,O
in,O
combination,O
probably,O
with,O
a,O
reduced,O
CRH,O
synthesis,O
or,O
release,O
in,O
the,O
hypothalamus,O
.,O
The,O
suggested,O
roles,O
of,O
the,O
downstream,O
3,O
',O
regions,O
acting,O
as,O
a,O
Locus,O
Control,O
Region,O
(,O
LCR,O
),O
",",O
have,O
allowed,O
comparisons,O
to,O
be,O
made,O
between,O
the,O
regulation,O
of,O
the,O
IgH,O
locus,O
with,O
other,O
model,O
systems,O
whose,O
gene,O
expression,O
is,O
governed,O
by,O
LCR,O
activity,O
.,O
T,O
lymphocytes,O
recognize,O
antigens,O
in,O
the,O
form,O
of,O
peptides,O
bound,O
to,O
HLA,B
-,I
molecules,I
.,O
MATERIALS,O
AND,O
METHODS,O
:,O
Peptides,O
derived,O
from,O
oncogenic,B
proteins,I
were,O
screened,O
for,O
the,O
presence,O
of,O
HLA,B
binding,O
motifs,O
;,O
actual,O
binding,O
were,O
evaluated,O
by,O
HLA,B
stabilization,O
experiments,O
using,O
transfectants,O
and,O
specific,O
anti,O
-,O
HLA,B
antibodies,I
.,O
Specific,O
lymphocytes,O
were,O
induced,O
by,O
in,O
vitro,O
peptide,O
sensitization,O
and,O
screened,O
by,O
thymidine,O
uptake,O
or,O
cellular,O
cytotoxic,O
assays,O
.,O
RESULTS,O
:,O
We,O
identified,O
peptides,O
derived,O
from,O
EWS,B
/,I
FLI,I
-,I
1,I
fusion,I
protein,I
and,O
from,O
mutated,O
K,B
-,I
RAS,I
protein,I
(,O
encompassing,O
respectively,O
the,O
fusion,O
point,O
and,O
the,O
mutation,O
at,O
position,O
12,O
),O
that,O
showed,O
binding,O
motif,O
for,O
HLA,B
-,I
Cw,I
*,I
702,I
and,O
HLA,B
-,I
A3,I
respectively,O
.,O
OCA,O
-,O
B,O
is,O
a,O
functional,B
analog,I
of,O
VP16,O
but,O
targets,O
a,O
separate,O
surface,O
of,O
the,O
Oct,O
-,O
1,O
POU,O
domain,O
[,O
published,O
erratum,O
appears,O
in,O
Mol,O
Cell,O
Biol,O
1998,O
Apr,O
;,O
18,O
(,O
4,O
),O
:,O
2430,O
].,O
Here,O
",",O
we,O
show,O
that,O
OCA,O
-,O
B,O
alters,O
the,O
activity,O
of,O
Oct,O
-,O
1,O
in,O
two,O
ways,O
.,O
These,O
results,O
emphasize,O
the,O
structural,O
versatility,O
of,O
the,O
Oct,O
-,O
1,O
POU,O
domain,O
in,O
its,O
interaction,O
with,O
coregulators,O
.,O
Phosphatidylinositol,B
3,I
-,I
kinase,I
couples,O
the,O
interleukin,O
-,O
2,O
receptor,O
to,O
the,O
cell,B
cycle,I
regulator,I
E2F,I
.,O
We,O
eliminate,O
both,O
Stat5,B
and,O
Raf,B
/,I
MEK,I
pathways,I
from,O
E2F,I
regulation,I
.,O
TRADD,B
was,O
the,O
only,O
protein,B
that,O
interacted,O
with,O
wild,O
-,O
type,O
TES2,B
and,O
not,O
with,O
isoleucine,O
-,O
mutated,O
TES2,B
.,O
In,O
transfection,O
assays,O
",",O
TRADD,B
and,O
TES2,B
synergistically,O
mediated,O
high,O
-,O
level,O
NF,B
-,I
kappaB,I
activation,I
.,O
Bipotential,O
T,O
/,O
natural,O
killer,O
(,O
NK,B
),O
progenitor,O
cells,O
are,O
present,O
in,O
the,O
human,O
thymus,O
.,O
Although,O
experimental,O
evidence,O
is,O
lacking,O
",",O
lytic,O
viral,B
DNA,I
replication,O
is,O
believed,O
to,O
remove,O
modifications,O
or,O
binding,O
factors,O
from,O
the,O
genome,O
which,O
serve,O
to,O
repress,O
late,O
gene,O
expression,O
during,O
latency,O
or,O
the,O
early,O
lytic,O
cycle,O
.,O
Thus,O
",",O
replication,O
of,O
the,O
transcriptional,O
template,O
is,O
not,O
a,O
prerequisite,O
for,O
expression,O
with,O
late,O
kinetics,O
",",O
a,O
finding,O
inconsistent,O
with,O
the,O
current,O
models,O
which,O
posit,O
a,O
cis,O
-,O
active,O
relationship,O
between,O
lytic,O
EBV,B
DNA,I
replication,I
and,O
late,O
gene,O
expression,O
.,O
This,O
induction,O
of,O
C,O
/,O
EBP,B
epsilon,I
mRNA,I
expression,O
is,O
transcriptionally,O
mediated,O
and,O
occurs,O
in,O
the,O
absence,O
of,O
synthesis,O
of,O
additional,O
protein,B
factors,I
.,O
We,O
suspect,O
that,O
the,O
C,B
/,I
EBP,I
epsilon,I
promoter,I
/,I
enhancer,I
contains,O
a,O
retinoic,O
acid,O
-,O
response,O
element,O
that,O
is,O
directly,O
stimulated,O
by,O
retinoids,O
.,O
Core,O
-,O
specific,O
mAb,O
inhibited,O
mCD14,B
-,I
mediated,I
uptake,I
of,O
homologous,O
and,O
heterologous,O
LPS,O
",",O
while,O
producing,O
less,O
concurrent,O
enhancement,O
of,O
non,O
-,O
mCD14,B
-,I
mediated,I
LPS,I
uptake,I
.,O
Transfection,O
of,O
EL,B
-,I
4,I
cells,O
with,O
the,O
IL,B
-,I
4,I
promoter,I
-,I
reporter,I
constructs,O
carrying,O
mutated,O
P,B
-,I
like,I
elements,I
showed,O
that,O
four,O
P,B
-,I
like,I
elements,I
",",O
CLE0.00,O
",",O
P,B
",",O
P2,B
and,O
P4,B
",",O
but,O
not,O
P3,B
",",O
were,O
required,O
for,O
optimal,O
activation,O
of,O
the,O
IL,B
-,I
4,I
promoter,I
.,O
The,O
initiating,O
event,O
is,O
still,O
uncertain,O
",",O
but,O
activation,O
of,O
a,O
recently,O
described,O
receptor,O
-,O
associated,O
protein,B
kinase,I
is,O
one,O
of,O
the,O
earliest,O
events,O
detectable,O
(,O
Martin,O
et,O
al,O
.,O
",",O
Eur,O
.,O
J,O
.,O
Immunol,O
.,O
1994,O
.,O
24,O
:,O
1566,O
),O
.,O
From,O
these,O
observations,O
we,O
conclude,O
that,O
free,O
thiols,O
in,O
the,O
IL,B
-,I
1RI,I
complex,I
are,O
essential,O
for,O
the,O
activation,O
of,O
the,O
IL,B
-,I
1RI,I
-,I
associated,I
protein,I
kinase,I
and,O
that,O
this,O
process,O
is,O
mandatory,O
for,O
IL,B
-,I
1,I
signaling,I
leading,O
to,O
NF,B
-,I
kappa,I
B,I
activation,O
.,O
Strikingly,O
",",O
Western,O
blotting,O
and,O
immunocytochemical,O
experiments,O
indicated,O
that,O
PDTC,O
promoted,O
a,O
transient,O
and,O
rapid,O
shuttling,O
of,O
NFATp,B
and,O
NFATc,B
",",O
leading,O
to,O
their,O
accelerated,O
export,O
from,O
the,O
nucleus,O
of,O
activated,O
T,O
cells,O
.,O
The,O
A,O
-,O
myb,B
transcription,I
factor,I
in,O
neoplastic,O
and,O
normal,O
B,B
cells,I
.,O
Its,O
normal,O
cellular,O
equivalent,O
c,B
-,I
myb,I
",",O
has,O
been,O
shown,O
to,O
promote,O
the,O
proliferation,O
and,O
block,O
the,O
differentiation,O
of,O
haematopoietic,O
cells,O
in,O
several,O
experimental,O
models,O
and,O
is,O
required,O
for,O
fetal,O
haematopoiesis,O
.,O
Both,O
have,O
been,O
shown,O
to,O
be,O
transcription,O
factors,O
.,O
These,O
studies,O
indicate,O
that,O
A,O
-,O
myb,B
plays,O
a,O
role,O
during,O
a,O
narrow,O
window,O
of,O
normal,O
B,B
cell,I
differentiation,I
.,O
Expression,O
of,O
bcl,B
-,I
6,I
protein,I
in,O
normal,O
skin,B
and,O
epidermal,B
neoplasms,I
.,O
It,O
was,O
recently,O
shown,O
by,O
us,O
that,O
the,O
protein,B
is,O
located,O
in,O
germinal,B
center,I
B,I
cells,I
and,O
their,O
neoplastic,B
counterparts,I
.,O
Squamous,B
cell,I
carcinomas,I
showed,O
a,O
variety,O
of,O
expression,O
levels,O
",",O
while,O
two,O
undifferentiated,B
spindle,I
-,I
shaped,I
carcinomas,I
and,O
one,O
undifferentiated,B
SCC,I
cell,I
line,I
remained,O
unstained,O
.,O
We,O
recently,O
identified,O
the,O
winged,O
-,O
helix,O
transcription,O
factor,O
Trident,O
and,O
described,O
its,O
expression,O
pattern,O
in,O
synchronized,O
fibroblasts,O
.,O
During,O
T,O
cell,O
differentiation,O
",",O
expression,O
peaked,O
in,O
the,O
actively,O
dividing,O
immature,O
single,O
positive,O
cells,O
.,O
The,O
estrogen,O
receptor,O
(,O
ER,B
),O
repressed,O
erythroid,B
differentiation,I
and,O
erythroid,B
-,I
specific,I
gene,I
expression,I
.,O
These,O
bHLH,B
antagonists,O
are,O
induced,O
during,O
a,O
mitogenic,O
signalling,O
response,O
",",O
and,O
they,O
function,O
by,O
sequestering,O
their,O
bHLH,B
targets,O
in,O
inactive,O
heterodimers,O
that,O
are,O
unable,O
to,O
bind,O
to,O
specific,O
gene,O
regulatory,O
(,O
E,B
box,I
),O
sequences,O
.,O
Recently,O
",",O
cyclin,B
E,I
-,I
Cdk2,I
-,I
and,O
cyclin,B
A,I
-,I
Cdk2,I
-,I
dependent,O
phosphorylation,O
of,O
a,O
single,O
conserved,B
serine,I
residue,I
(,O
Ser5,O
),O
in,O
Id2,O
has,O
been,O
shown,O
to,O
occur,O
during,O
late,O
G1,O
-,O
to,O
-,O
S,O
phase,O
transition,O
of,O
the,O
cell,B
cycle,I
",",O
and,O
this,O
neutralizes,O
the,O
function,O
of,O
Id2,O
in,O
abrogating,O
E,B
-,I
box,I
-,I
dependent,O
bHLH,B
homo,I
-,I
or,O
heterodimer,O
complex,O
formation,O
in,O
vitro,O
(,O
E,B
.,O
Hara,O
",",O
M,O
.,O
Hall,O
",",O
and,O
G,O
.,O
Peters,O
",",O
EMBO,O
J,O
.,O
16,O
:,O
332,O
-,O
342,O
",",O
1997,O
.,O
),O
.,O
Furthermore,O
",",O
compared,O
with,O
wild,O
-,O
type,O
Id3,B
",",O
an,O
Id3,B
Asp5,O
mutant,O
(,O
mimicking,O
phosphorylation,O
),O
is,O
unable,O
to,O
promote,O
cell,O
cycle,O
S,O
phase,O
entry,O
in,O
transfected,O
fibroblasts,O
",",O
whereas,O
an,O
Id3,B
Ala5,O
mutant,O
(,O
ablating,O
phosphorylation,O
),O
displays,O
an,O
activity,O
significantly,O
greater,O
than,O
that,O
of,O
wild,O
-,O
type,O
Id3,B
protein,O
.,O
Here,O
we,O
describe,O
cloning,O
and,O
characterization,O
of,O
full,O
-,O
length,O
cDNA,B
encoding,O
murine,O
(,O
m,B
),O
NFATc,B
which,O
predicts,O
that,O
the,O
protein,B
has,O
all,O
the,O
conserved,O
structural,O
motifs,O
of,O
NFAT,B
family,I
members,I
",",O
including,O
the,O
rel,B
homology,I
domain,I
",",O
the,O
NFAT,B
homology,I
domain,I
and,O
the,O
nuclear,O
translocation,O
signals,O
.,O
In,O
the,O
mouse,O
embryo,O
",",O
mNFATc,B
transcript,O
was,O
strongly,O
expressed,O
in,O
thymus,O
",",O
lung,O
and,O
submandibular,O
gland,O
and,O
weakly,O
in,O
skeletal,O
muscle,O
and,O
heart,O
suggesting,O
that,O
mNFATc,B
may,O
have,O
a,O
role,O
both,O
in,O
embryogenesis,O
and,O
in,O
mature,O
T,B
cells,I
.,O
These,O
data,O
indicate,O
that,O
the,O
TRE,B
-,I
like,I
cAMP,B
-,I
responsive,I
DSE,O
sites,O
within,O
the,O
5,O
',O
-,O
untranslated,O
leader,O
can,O
mediate,O
the,O
transcriptional,O
cooperativity,O
between,O
TNFalpha,O
and,O
the,O
cAMP,B
/,I
PKA,I
pathway,O
.,O
Copyright,O
1997,O
Academic,O
Press,O
.,O
In,O
many,O
chronic,O
inflammatory,O
disorders,O
",",O
glucocorticoid,B
(,O
GC,B
),O
insensitivity,O
is,O
a,O
challenging,O
clinical,O
problem,O
associated,O
with,O
life,O
-,O
threatening,O
disease,O
progression,O
.,O
Furthermore,O
",",O
we,O
show,O
that,O
patients,O
with,O
GC,B
-,I
insensitive,I
asthma,I
have,O
cytokine,O
-,O
induced,O
abnormalities,O
in,O
the,O
DNA,B
binding,I
capability,I
of,O
the,O
GCR,B
.,O
Mutation,O
of,O
the,O
CBF1,B
/,I
RBP,I
-,I
Jkappa,I
binding,I
site,I
in,O
EBNA3C,B
abrogated,O
repression,O
",",O
strongly,O
suggesting,O
that,O
CBF1,B
/,I
RBP,I
-,I
Jkappa,I
is,O
necessary,O
for,O
targeting,O
the,O
viral,O
protein,O
to,O
Cp,B
.,O
PURPOSE,O
:,O
To,O
clarify,O
the,O
relationship,O
between,O
the,O
glucocorticoid,B
receptor,I
and,O
the,O
effectiveness,O
of,O
glucocorticoid,B
therapy,I
in,O
patients,O
with,O
ulcerative,O
colitis,O
",",O
we,O
investigated,O
the,O
number,O
and,O
apparent,O
dissociation,O
constant,O
of,O
glucocorticoid,B
receptor,I
in,O
peripheral,O
blood,O
mononuclear,O
leukocytes,O
of,O
patients,O
with,O
ulcerative,O
colitis,O
.,O
The,O
apparent,O
dissociation,O
constant,O
of,O
the,O
glucocorticoid,B
receptors,I
from,O
the,O
nonresponders,O
",",O
responders,O
",",O
and,O
healthy,O
controls,O
were,O
7,O
. 19,O
3,O
(,O
range,O
",",O
5,O
. 25,O
66,O
-,O
10,O
),O
",",O
4,O
. 32,O
27,O
(,O
range,O
",",O
4,O
-,O
5,O
. 40,O
13,O
),O
",",O
and,O
6,O
. 46,O
18,O
(,O
range,O
",",O
5,O
. 52,O
86,O
-,O
6,O
. 56,O
74,O
),O
nM,O
",",O
respectively,O
. 62,O
Nonresponders,O
had,O
a,O
significant,O
increase,O
both,O
in,O
the,O
number,O
of,O
binding,O
sites,O
and,O
in,O
the,O
apparent,O
dissociation,O
constant,O
compared,O
with,O
responders,O
(,O
P,O
=,O
0,O
. 88,O
45,O
;,O
P,O
=,O
0,O
.,O
29,O
),O
.,O
Cooperation,O
of,O
binding,O
sites,O
for,O
STAT6,O
and,O
NF,O
kappa,O
B,O
/,O
rel,O
in,O
the,O
IL,O
-,O
4,O
-,O
induced,O
up,O
-,O
regulation,O
of,O
the,O
human,O
IgE,B
germline,I
promoter,I
.,O
In,O
contrast,O
",",O
lipopolysaccharide,O
stimulation,O
primarily,O
induced,O
the,O
p65,O
/,O
p50,O
heterodimer,O
that,O
has,O
been,O
shown,O
to,O
result,O
in,O
gene,O
activation,O
.,O
Cyclosporin,O
A,O
inhibits,O
early,O
mRNA,O
expression,O
of,O
G0,O
/,O
G1,O
switch,O
gene,O
2,O
(,O
G0S2,B
),O
in,O
cultured,O
human,O
blood,O
mononuclear,O
cells,O
.,O
In,O
cells,O
that,O
have,O
been,O
preincubated,O
to,O
lower,O
mRNA,B
levels,I
",",O
there,O
is,O
a,O
transient,O
increase,O
in,O
G0S2,B
mRNA,I
",",O
peaking,O
between,O
1,O
-,O
2,O
h,O
",",O
in,O
response,O
to,O
Concanavalin,O
-,O
A,O
(,O
ConA,O
),O
",",O
or,O
to,O
the,O
combination,O
of,O
phorbol,O
ester,O
(,O
TPA,O
),O
",",O
and,O
the,O
calcium,O
ionophore,O
",",O
ionomycin,O
. ,O
YY1,O
",",O
a,O
widely,O
distributed,O
human,O
transcription,O
factor,O
",",O
is,O
known,O
to,O
inhibit,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,I
LTR,I
),I
transcription,O
and,O
virus,O
production,O
. ,O
LSF,B
(,O
also,O
known,O
as,O
LBP,B
-,I
1,I
",",O
UBP,B
",",O
and,O
CP,B
-,I
2,I
),O
has,O
been,O
shown,O
to,O
repress,O
LTR,B
transcription,I
in,O
vitro,O
",",O
but,O
transient,O
expression,O
of,O
LSF,B
has,O
no,O
effect,O
on,O
LTR,B
activity,I
in,O
vivo,O
.,O
Relative,O
affinities,O
of,O
transcriptional,O
regulatory,O
elements,O
for,O
their,O
respective,O
factor,O
have,O
been,O
essentially,O
studied,O
by,O
bandshift,O
analysis,O
.,O
Here,O
we,O
report,O
a,O
real,O
-,O
time,O
study,O
of,O
factor,O
/,O
DNA,B
interactions,O
using,O
a,O
surface,O
plasmon,O
resonance,O
approach,O
and,O
further,O
characterization,O
of,O
recovered,O
proteins,B
involved,O
in,O
this,O
interaction,O
.,O
This,O
result,O
",",O
confirmed,O
by,O
competitions,O
with,O
each,O
GATA,O
site,O
",",O
demonstrated,O
the,O
higher,O
relative,O
affinity,O
(,O
at,O
least,O
sevenfold,O
),O
of,O
site,O
3,O
.,O
Stable,O
transfection,O
of,O
U937,B
cells,I
with,O
sense,O
or,O
antisense,O
RXR,B
-,I
alpha,I
cDNA,I
suggests,O
a,O
role,O
for,O
RXR,B
-,I
alpha,I
in,O
the,O
control,O
of,O
monoblastic,O
differentiation,O
induced,O
by,O
retinoic,O
acid,O
and,O
vitamin,O
D,O
.,O
The,O
role,O
of,O
the,O
viral,O
trans,O
-,O
activator,O
Tax,B
protein,I
in,O
the,O
induction,O
of,O
VCAM,B
-,I
1,I
was,O
first,O
indicated,O
by,O
the,O
detection,O
of,O
this,O
adhesion,O
molecule,O
on,O
Jurkat,B
T,I
-,I
cell,I
clones,I
stably,O
expressing,O
the,O
tax,O
gene,O
.,O
The,O
effect,O
of,O
Tax,B
on,O
VCAM,B
-,I
1,I
gene,I
transcription,O
was,O
next,O
confirmed,O
in,O
JPX,B
-,I
9,I
cells,O
",",O
a,O
subclone,O
of,O
Jurkat,B
cells,O
",",O
carrying,O
the,O
tax,O
sequences,O
under,O
the,O
control,O
of,O
an,O
inducible,O
promoter,O
.,O
Furthermore,O
",",O
deletion,O
and,O
mutation,O
analyses,O
of,O
the,O
VCAM,B
-,I
1,I
promoter,I
performed,O
with,O
chloramphenicol,O
acetyltransferase,O
constructs,O
revealed,O
that,O
Tax,B
was,O
trans,O
activating,O
the,O
VCAM,B
-,I
1,I
promoter,I
via,O
two,O
NF,B
-,I
kappaB,I
sites,O
present,O
at,O
bp,O
-,O
72,O
and,O
-,O
57,O
in,O
the,O
VCAM,B
-,I
1,I
gene,I
promoter,I
",",O
with,O
both,O
of,O
them,O
being,O
required,O
for,O
the,O
Tax,B
-,I
induced,I
expression,O
of,O
this,O
adhesion,O
molecule,O
.,O
We,O
have,O
investigated,O
the,O
effects,O
of,O
Vpr,B
on,O
host,O
cell,B
activation,O
and,O
confirm,O
that,O
it,O
influences,O
cellular,B
proliferation,O
.,O
In,O
the,O
absence,O
of,O
TCR,B
-,I
mediated,I
activation,I
",",O
Vpr,B
induces,O
apoptosis,O
whereas,O
in,O
its,O
presence,O
",",O
Vpr,B
interrupts,O
the,O
expected,O
induction,O
of,O
apoptosis,O
.,O
Our,O
finding,O
that,O
Vpr,B
can,O
regulate,O
NF,B
-,I
kappa,I
B,I
supports,O
the,O
hypothesis,O
that,O
some,O
aspects,O
of,O
viral,O
pathogenesis,O
are,O
the,O
consequence,O
of,O
cell,B
dysregulation,O
by,O
Vpr,B
.,O
In,O
fact,O
",",O
by,O
employing,O
a,O
novel,O
haptenized,O
lysis,O
synthetic,O
substrate,O
which,O
allows,O
the,O
isolation,O
of,O
glutaminyl,B
-,I
tTG,I
substrates,O
in,O
vivo,O
",",O
we,O
identified,O
pRB,B
as,O
a,O
potential,O
tTG,B
substrate,O
in,O
U937,B
cells,O
undergoing,O
apoptosis,O
.,O
Interleukin,B
2,I
(,O
IL,B
-,I
2,I
),O
induces,O
tyrosine,O
phosphorylation,O
of,O
STATs,B
3,I
and,O
5,I
(,O
signal,B
transducer,I
and,I
activator,I
of,I
transcription,I
),O
.,O
IL,O
-,O
2,O
and,O
T,B
cell,I
antigen,I
receptor,I
complex,I
induction,O
of,O
STAT3alpha,B
serine,I
727,I
phosphorylation,I
is,O
dependent,O
on,O
the,O
activity,O
of,O
the,O
MEK,B
/,I
ERK,I
pathway,I
.,O
These,O
results,O
thus,O
show,O
that,O
STAT3,B
proteins,I
are,O
targets,O
for,O
multiple,O
kinase,O
pathways,O
in,O
T,B
cells,I
and,O
can,O
integrate,O
signals,O
from,O
both,O
cytokine,O
receptors,O
and,O
antigen,O
receptors,O
.,O
In,O
addition,O
",",O
both,O
RelA,B
and,O
c,O
-,O
Rel,O
",",O
but,O
not,O
NF,B
-,I
kappa,I
B1,I
",",O
were,O
shown,O
to,O
transactivate,O
an,O
ICAM,O
-,O
1,O
kappa,O
B,O
-,O
reporter,O
construct,O
.,O
Competent,O
transcription,O
initiation,O
by,O
RNA,B
polymerase,I
II,I
in,O
cell,B
-,I
free,I
extracts,I
from,O
xeroderma,B
pigmentosum,I
groups,I
B,I
and,O
D,O
in,O
an,O
optimized,O
RNA,B
transcription,I
assay,I
.,O
We,O
have,O
employed,O
an,O
optimized,O
cell,B
-,I
free,I
RNA,B
transcription,I
assay,I
to,O
analyze,O
transcription,O
activity,O
of,O
XP,O
-,O
B,O
and,O
XP,O
-,O
D,O
.,O
Binding,O
capacity,O
(,O
4978,O
+,O
/,O
-,O
391,O
versus,O
4131,O
+,O
/,O
-,O
321,O
sites,O
/,O
cell,O
),O
",",O
Kd,O
values,O
for,O
dexamethasone,O
(,O
6,O
.,O
7,O
+,O
/,O
-,O
0,O
.,O
5,O
versus,O
5,O
.,O
7,O
+,O
/,O
-,O
0,O
.,O
3,O
nmol,O
/,O
L,O
),O
",",O
and,O
IC50,O
values,O
for,O
dexamethasone,O
(,O
3,O
.,O
4,O
+,O
/,O
-,O
0,O
.,O
3,O
versus,O
3,O
.,O
1,O
+,O
/,O
-,O
0,O
.,O
2,O
nmol,O
/,O
L,O
),O
and,O
cortisol,O
(,O
12,O
.,O
2,O
+,O
/,O
-,O
1,O
.,O
6,O
versus,O
9,O
.,O
5,O
+,O
/,O
-,O
0,O
.,O
3,O
nmol,O
/,O
L,O
),O
were,O
not,O
significantly,O
different,O
.,O
Patients,O
with,O
renin,B
values,O
less,O
than,O
0,O
.,O
13,O
ng,O
angiotensin,O
I,O
/,O
L,O
per,O
second,O
were,O
markedly,O
less,O
sensitive,O
to,O
cortisol,O
than,O
those,O
with,O
higher,O
values,O
.,O
The,O
composite,O
PU,O
.,O
1,O
and,O
Pip,O
site,O
likely,O
accounts,O
for,O
both,O
lineage,O
and,O
stage,O
-,O
specific,O
expression,O
of,O
CD20,B
whereas,O
the,O
CD20,B
E,I
box,I
binding,I
proteins,I
enhance,O
overall,O
promoter,O
activity,O
and,O
may,O
link,O
the,O
promoter,O
to,O
a,O
distant,O
enhancer,O
.,O
HIV,B
infection,I
is,O
also,O
associated,O
with,O
activation,O
of,O
the,O
hypothalamo,O
-,O
pituitary,O
-,O
adrenal,O
axis,O
function,O
and,O
increased,O
plasma,O
and,O
urinary,O
cortisol,B
concentrations,I
.,O
After,O
DMSO,O
treatment,O
",",O
HL,B
-,I
60,I
cells,O
eventually,O
died,O
via,O
apoptosis,O
",",O
whereas,O
the,O
viability,O
of,O
PDBu,O
-,O
treated,O
cells,O
was,O
not,O
affected,O
during,O
the,O
same,O
interval,O
.,O
The,O
generality,O
of,O
this,O
finding,O
was,O
confirmed,O
by,O
the,O
induction,O
of,O
Bcl,B
-,I
xL,I
in,O
human,B
myeloid,I
U,I
-,I
937,I
cells,I
",",O
human,B
peripheral,I
blood,I
monocytes,I
exposed,O
to,O
phorbol,O
ester,O
",",O
and,O
mouse,B
thioglycollate,I
-,I
activated,I
and,I
resident,I
peritoneal,I
macrophages,I
.,O
Monochloramine,O
derivatives,O
are,O
long,O
lived,O
physiological,O
oxidants,O
produced,O
by,O
neutrophils,I
during,O
the,O
respiratory,O
burst,O
.,O
Cyclosporine,B
(,O
CsA,B
),O
is,O
both,O
a,O
clinical,O
immunosuppressive,O
drug,O
and,O
a,O
probe,O
to,O
dissect,O
intracellular,O
signaling,O
pathways,O
.,O
Furthermore,O
",",O
the,O
degree,O
of,O
CN,B
inhibition,O
was,O
reflected,O
by,O
a,O
similar,O
degree,O
of,O
reduction,O
in,O
lymphocyte,B
proliferation,O
and,O
IFN,B
-,I
gamma,I
production,O
in,O
the,O
allogeneic,O
mixed,O
lymphocyte,B
cultures,O
.,O
Thus,O
",",O
the,O
reduction,O
of,O
CN,B
activity,O
observed,O
in,O
CsA,O
-,O
treated,O
patients,O
is,O
accompanied,O
by,O
a,O
similar,O
degree,O
of,O
reduction,O
in,O
lymphocyte,O
gene,O
activation,O
",",O
and,O
accounts,O
for,O
the,O
immunosuppression,O
observed,O
.,O
Control,O
of,O
NF,B
-,I
kappa,I
B,I
activity,O
by,O
the,O
I,B
kappa,I
B,I
beta,I
inhibitor,I
.,O
The,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
is,O
maintained,O
in,O
an,O
inactive,O
cytoplasmic,O
state,O
by,O
I,B
kappa,I
B,I
inhibitors,I
.,O
G28,O
-,O
5,O
sFv,B
was,O
a,O
more,O
potent,O
agonist,O
than,O
G28,O
-,O
5,O
IgG,B
and,O
was,O
able,O
to,O
stimulate,O
CD40,B
responses,I
by,O
B,B
cells,I
and,O
monocytes,B
.,O
Increased,O
CRH,B
promoter,I
activity,I
following,O
phorbol,O
ester,O
treatment,O
was,O
inhibited,O
by,O
a,O
dominant,O
negative,O
NF,B
-,I
IL6,I
mutant,I
",",O
showing,O
that,O
the,O
effects,O
of,O
phorbol,O
ester,O
were,O
principally,O
mediated,O
by,O
C,B
/,I
EBP,I
.,O
We,O
screened,O
TSG101,B
for,O
somatic,O
mutations,O
in,O
DNA,B
and,O
RNA,B
samples,O
isolated,O
from,O
a,O
variety,O
of,O
common,O
human,O
malignancies,O
",",O
EBV,O
-,O
immortalised,O
B,O
-,O
cells,O
",",O
and,O
normal,O
lung,O
parenchyma,O
.,O
Intragenic,O
TSG101,B
deletions,O
in,O
RNA,B
transcripts,O
were,O
frequently,O
found,O
in,O
all,O
types,O
of,O
samples,O
.,O
A,O
similar,O
spectrum,O
of,O
transcript,O
deletions,O
has,O
previously,O
been,O
described,O
in,O
the,O
putative,O
tumour,O
suppressor,O
gene,O
FHIT,B
.,O
Interleukin,B
-,I
7,I
upregulates,O
the,O
interleukin,B
-,I
2,I
-,I
gene,I
expression,O
in,O
activated,O
human,O
T,B
lymphocytes,I
at,O
the,O
transcriptional,O
level,O
by,O
enhancing,O
the,O
DNA,B
binding,I
activities,O
of,O
both,O
nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
and,O
activator,O
protein,O
-,O
1,O
.,O
Production,O
of,O
IL,B
-,I
2,I
requires,O
the,O
formation,O
of,O
transcription,O
factors,O
involved,O
in,O
the,O
IL,B
-,I
2,I
-,I
gene,I
regulation,O
.,O
The,O
three,O
-,O
dimensional,O
positioning,O
of,O
immunoglobulin,B
(,O
Ig,B
),O
genes,O
within,O
the,O
nucleus,O
of,O
human,O
cells,O
was,O
investigated,O
using,O
in,O
situ,O
hybridization,O
and,O
confocal,O
microscopy,O
.,O
The,O
visualization,O
of,O
heavy,B
and,O
light,B
chain,I
genes,I
in,O
B,O
-,O
lymphoid,O
cells,O
showed,O
that,O
the,O
three,O
Ig,B
genes,I
are,O
differentially,O
and,O
nonrandomly,O
distributed,O
in,O
different,O
nuclear,O
subvolumes,O
:,O
the,O
kappa,B
genes,I
were,O
found,O
to,O
be,O
preferentially,O
confined,O
to,O
an,O
outer,O
nuclear,O
volume,O
",",O
whereas,O
the,O
gamma,B
and,O
lambda,B
genes,I
consistently,O
occupied,O
more,O
central,O
positions,O
within,O
the,O
nucleus,O
",",O
the,O
lambda,B
genes,I
being,O
more,O
interior,O
when,O
compared,O
with,O
the,O
gamma,B
genes,I
.,O
These,O
findings,O
show,O
that,O
healthy,O
virus,O
carriers,O
maintain,O
a,O
high,O
frequency,O
of,O
BZLF1,B
-,I
specific,I
memory,I
T,I
cells,I
",",O
potentially,O
to,O
control,O
virus,O
spread,O
from,O
lytically,O
infected,O
cells,O
.,O
We,O
have,O
therefore,O
investigated,O
the,O
transcriptional,O
activity,O
of,O
A,O
-,O
MYB,O
and,O
its,O
regulation,O
in,O
several,O
human,O
lymphoid,O
cell,O
lines,O
using,O
co,O
-,O
transfection,O
assays,O
and,O
show,O
that,O
A,O
-,O
MYB,O
is,O
transcriptionally,O
active,O
in,O
all,O
the,O
B,B
cell,I
lines,I
studied,O
",",O
but,O
not,O
in,O
T,B
cells,I
.,O
Transcription,O
factor,O
Egr,B
-,I
1,I
activity,O
down,O
-,O
regulates,O
Fas,B
and,O
CD23,B
expression,O
in,O
B,B
cells,I
.,O
Transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
must,O
be,O
released,O
from,O
cytoplasmic,O
inhibitory,O
molecules,O
(,O
I,B
kappa,I
Bs,I
),O
in,O
order,O
to,O
move,O
to,O
the,O
nucleus,O
and,O
to,O
activate,O
its,O
target,O
genes,O
.,O
The,O
half,O
-,O
life,O
of,O
both,O
inhibitors,O
is,O
increased,O
in,O
HeLa,B
cells,I
.,O
PCR,O
analysis,O
of,O
spontaneous,O
EBV,B
-,I
transformed,I
lymphoblastoid,I
cell,I
lines,I
(,O
LCL,B
),O
from,O
three,O
individuals,O
with,O
primary,O
infection,O
showed,O
that,O
two,O
were,O
infected,O
with,O
type,O
A,O
and,O
one,O
with,O
type,O
B,O
EBV,B
.,O
TCR,B
beta,I
analysis,I
showed,O
that,O
while,O
there,O
was,O
loop,O
length,O
restriction,O
in,O
the,O
putative,O
peptide,O
contact,O
site,O
of,O
all,O
responding,O
beta,O
chains,O
",",O
diverse,O
and,O
unique,O
(,O
non,O
-,O
recurrent,O
),O
TCR,B
beta,I
clonotypes,I
were,O
selected,O
in,O
individuals,O
during,O
primary,O
infection,O
and,O
continued,O
to,O
emerge,O
after,O
long,O
-,O
term,O
virus,O
exposure,O
.,O
CD40,B
ligation,O
leads,O
to,O
B,B
cell,I
activation,I
events,O
such,O
as,O
proliferation,O
",",O
Ig,B
secretion,I
",",O
isotype,O
switching,O
",",O
and,O
up,O
-,O
regulation,O
of,O
cell,B
surface,I
molecules,I
",",O
as,O
well,O
as,O
the,O
generation,O
of,O
memory,O
B,B
cells,I
.,O
Many,O
of,O
these,O
events,O
are,O
dependent,O
upon,O
the,O
ability,O
of,O
CD40,B
to,O
activate,O
the,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),O
.,O
To,O
define,O
the,O
CD40,B
signaling,I
components,I
upstream,I
of,I
NF,B
-,I
kappa,I
B,I
activation,I
and,O
the,O
functional,O
consequences,O
downstream,O
of,O
NF,B
-,I
kappa,I
B,I
activation,I
",",O
we,O
examined,O
mouse,O
B,B
cell,I
transfectants,I
expressing,O
wild,O
-,O
type,O
or,O
mutant,O
human,O
CD40,B
.,O
A,O
threonine,O
residue,O
at,O
position,O
234,O
",",O
previously,O
shown,O
to,O
be,O
important,O
for,O
CD40,B
association,O
with,O
TNF,B
receptor,I
-,I
associated,I
factor,I
2,I
(,O
TRAF2,B
),O
",",O
TRAF3,B
",",O
and,O
TRAF5,B
",",O
was,O
not,O
required,O
for,O
NF,B
-,I
kappa,I
B,I
activation,I
.,O
NF,O
-,O
kappa,B
B,I
activation,O
was,O
independent,O
of,O
the,O
transmembrane,O
domain,O
of,O
CD40,B
",",O
suggesting,O
that,O
it,O
is,O
independent,O
of,O
p23,O
",",O
a,O
molecule,O
that,O
associates,O
with,O
CD40,B
in,O
a,O
region,O
other,O
than,O
the,O
cytoplasmic,O
domain,O
.,O
CD40,B
-,O
or,O
pervanadate,O
-,O
mediated,O
I,B
kappa,I
B,I
tyrosine,O
phosphorylation,O
was,O
not,O
detected,O
.,O
NF,B
-,O
kappa,I
B,I
activation,O
correlated,O
with,O
the,O
ability,O
of,O
CD40,B
to,O
induce,O
Ab,O
secretion,O
and,O
the,O
up,O
-,O
regulation,O
of,O
ICAM,B
-,I
1,I
and,O
LFA,B
-,I
1,I
.,O
The,O
M,B
-,I
CSF,I
receptor,I
was,O
first,O
detectable,O
in,O
the,O
myeloid,B
-,I
committed,I
CD34,B
+,I
Thy,B
-,I
l,I
-,I
CD45RA,B
+,I
subset,I
.,O
All,O
other,O
molecules,O
studied,O
were,O
found,O
to,O
be,O
expressed,O
at,O
this,O
stage,O
of,O
differentiation,O
.,O
Addition,O
of,O
GM,B
-,I
CSF,I
to,O
this,O
basic,O
cocktail,O
consistently,O
increased,O
the,O
clonogenic,O
capacity,O
of,O
single,O
CD34,B
+,I
Thy,B
-,I
1,I
+,I
cells,I
",",O
and,O
this,O
effect,O
was,O
further,O
enhanced,O
(,O
up,O
to,O
72,O
0.72,O
3,O
+,O
/,O
-,O
4,O
.,O
3,O
%,O
on,O
day,O
7,O
),O
by,O
the,O
inclusion,O
of,O
TNF,B
-,I
alpha,I
.,O
Induction,O
of,O
endothelial,B
cell,I
surface,I
adhesion,I
molecules,I
by,O
tumor,O
necrosis,O
factor,O
is,O
blocked,O
by,O
protein,B
tyrosine,I
phosphatase,I
inhibitors,I
:,O
role,O
of,O
the,O
nuclear,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
.,O
The,O
induction,O
of,O
ICAM,B
-,I
1,I
",",O
VCAM,B
-,I
1,I
",",O
and,O
ELAM,B
-,I
1,I
by,O
TNF,B
in,O
MVEC,O
occurred,O
within,O
6,O
h,O
and,O
was,O
also,O
completely,O
down,O
-,O
regulated,O
by,O
PAO,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
.,O
Further,O
",",O
monocytes,B
from,O
patients,O
demonstrate,O
an,O
augmented,O
susceptibility,O
to,O
a,O
productive,O
infection,O
with,O
HIV,B
-,I
1,I
in,O
vitro,O
.,O
In,O
contrast,O
",",O
I,O
kappa,B
B,I
-,I
alpha,I
levels,O
in,O
PBMC,B
and,O
monocytes,B
from,O
healthy,O
subjects,O
or,O
from,O
patients,O
with,O
nontuberculous,O
pulmonary,O
conditions,O
were,O
intact,O
.,O
Further,O
",",O
M,O
.,O
tuberculosis,B
and,O
its,O
tuberculin,O
",",O
purified,O
protein,B
derivative,I
",",O
induced,O
the,O
degradation,O
of,O
I,O
kappa,B
B,I
-,I
alpha,I
and,O
the,O
expression,O
of,O
I,O
kappa,B
B,I
-,I
alpha,I
mRNA,O
",",O
and,O
purified,O
protein,B
derivative,I
induced,O
the,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
monocytes,B
.,O
Spi,B
-,I
1,I
/,I
PU,I
.,O
1,O
is,O
a,O
myeloid,B
-,I
and,I
B,I
-,I
cell,I
specific,I
transcription,I
factor,I
which,O
is,O
also,O
involved,O
in,O
Friend,O
virus,O
-,O
induced,O
murine,B
erythroleukemia,I
.,O
We,O
developed,O
a,O
heterologous,O
system,O
to,O
analyze,O
the,O
contribution,O
of,O
these,O
alterations,O
to,O
the,O
induction,O
of,O
primary,O
erythroblast,B
transformation,I
.,O
These,O
results,O
show,O
that,O
Spi,B
-,I
1,I
/,I
PU,I
.,O
1,O
requires,O
signals,O
emanating,O
from,O
specific,O
cytokine,B
and,O
growth,B
factor,I
receptors,I
to,O
affect,O
the,O
survival,O
",",O
proliferation,O
and,O
differentiation,O
control,O
of,O
primary,B
erythroblasts,I
.,O
They,O
also,O
suggest,O
that,O
the,O
function,O
of,O
Spi,B
-,I
1,I
/,I
PU,I
.,I
1,I
in,O
the,O
late,O
phase,O
of,O
Friend,B
leukemia,I
requires,O
specific,O
signaling,O
from,O
the,O
gp55,B
-,I
modified,I
EpoR,I
generated,O
during,O
the,O
early,O
phase,O
of,O
the,O
disease,O
.,O
METHODS,O
:,O
Allergen,O
-,O
specific,O
T,B
cell,I
clones,I
and,O
T,B
cell,I
hybridomas,I
were,O
established,O
from,O
the,O
peripheral,O
blood,O
lymphocytes,O
of,O
patients,O
with,O
asthma,O
",",O
and,O
the,O
responses,O
to,O
various,O
stimuli,O
were,O
determined,O
.,O
BACKGROUND,O
:,O
Fibrin,B
deposition,I
and,O
thrombosis,O
have,O
been,O
implicated,O
in,O
both,O
allograft,O
rejection,O
and,O
vasculopathy,O
after,O
cardiac,O
transplantation,O
.,O
Inhibition,O
of,O
TF,B
induction,O
in,O
the,O
presence,O
of,O
high,O
CsA,O
blood,O
concentrations,O
was,O
also,O
observed,O
when,O
stimulation,O
of,O
cells,O
was,O
performed,O
with,O
interferon,O
-,O
gamma,O
or,O
interleukin,O
-,O
1beta,O
.,O
As,O
shown,O
by,O
reverse,O
transcription,O
-,O
polymerase,O
chain,O
reaction,O
and,O
electrophoretic,O
mobility,O
shift,O
assay,O
",",O
respectively,O
",",O
treatment,O
with,O
CsA,O
leads,O
to,O
decreased,O
TF,B
mRNA,I
expression,O
and,O
reduced,O
activation,O
of,O
the,O
NF,B
-,I
kappaB,I
transcription,I
factor,I
",",O
which,O
is,O
known,O
to,O
contribute,O
to,O
the,O
induction,O
of,O
the,O
TF,B
promotor,O
in,O
human,O
monocytes,O
.,O
Inhibition,O
of,O
monocyte,B
TF,I
induction,O
by,O
CsA,O
may,O
contribute,O
to,O
its,O
successful,O
use,O
in,O
cardiac,O
transplant,O
medicine,O
and,O
might,O
be,O
useful,O
in,O
managing,O
further,O
settings,O
of,O
vascular,O
pathology,O
also,O
known,O
to,O
involve,O
TF,B
expression,O
and,O
NF,B
-,I
kappaB,I
activation,I
.,O
Both,O
cytokines,O
induced,O
assembly,O
of,O
STAT5A,B
and,O
STAT5B,B
containing,O
complexes,O
capable,O
of,O
binding,O
to,O
the,O
interferon,B
-,I
gamma,I
activation,I
sequence,I
(,O
GAS,O
),O
",",O
and,O
these,O
complexes,O
rapidly,O
translocated,O
(,O
within,O
1,O
min,O
),O
into,O
the,O
nucleus,O
of,O
IL,B
-,I
2,I
-,I
or,O
IL,B
-,I
7,I
-,I
treated,O
cells,O
.,O
IL,B
-,I
2,I
and,O
IL,B
-,I
7,I
were,O
equivalent,O
in,O
their,O
ability,O
to,O
induce,O
tyrosine,O
phosphorylation,O
of,O
STAT5A,B
and,O
STAT5B,B
and,O
to,O
facilitate,O
binding,O
of,O
these,O
STATs,B
to,O
an,O
immobilized,O
GAS,B
element,I
.,O
These,O
data,O
suggest,O
that,O
IL,B
-,I
2,I
and,O
IL,B
-,I
7,I
induce,O
assembly,O
of,O
STAT,B
heterodimers,I
in,O
a,O
similar,O
manner,O
and,O
that,O
subsequent,O
cellular,O
responses,O
may,O
be,O
driven,O
by,O
induction,O
of,O
similar,O
sets,O
of,O
genes,O
.,O
The,O
POU,B
transcription,I
factors,I
Oct,B
-,I
1,I
and,O
Oct,B
-,I
2,I
regulate,O
the,O
activity,O
of,O
octamer,B
-,I
dependent,I
promoters,I
",",O
including,O
those,O
that,O
direct,O
transcription,O
from,O
rearranged,O
immunoglobulin,B
genes,I
.,O
The,O
class,O
II,O
trans,O
-,O
activator,O
(,O
CIITA,B
),O
is,O
a,O
bi,B
-,I
or,I
multi,I
-,I
functional,I
domain,I
protein,I
which,O
plays,O
a,O
critical,O
role,O
in,O
the,O
expression,O
of,O
MHC,B
class,I
II,I
genes,I
.,O
Transient,O
transfection,O
of,O
a,O
B,B
lymphoma,I
line,I
resulted,O
in,O
up,O
to,O
89,O
%,O
reduction,O
of,O
constitutive,O
MHC,B
class,I
II,I
expression,O
within,O
5,O
days,O
and,O
suppression,O
of,O
HLA,B
-,I
DRA,I
mRNA,I
synthesis,O
.,O
The,O
active,O
ingredients,O
mediating,O
the,O
pharmacological,O
effect,O
are,O
mainly,O
sesquiterpene,B
lactones,I
",",O
such,O
as,O
helenalin,B
",",O
11alpha,B
",",O
13,B
-,I
dihydrohelenalin,I
",",O
chamissonolid,B
and,O
their,O
ester,B
derivatives,I
.,O
We,O
show,O
here,O
that,O
helenalin,B
",",O
and,O
",",O
to,O
a,O
much,O
lesser,O
degree,O
",",O
11alpha,B
",",O
13,O
-,O
dihydrohelenalin,B
and,O
chamissonolid,B
",",O
inhibit,O
activation,O
of,O
transcription,O
factor,O
NF,B
-,I
kappaB,I
.,O
Rather,O
",",O
helenalin,B
modifies,O
the,O
NF,B
-,I
kappaB,I
/,I
IkappaB,I
complex,I
",",O
preventing,O
the,O
release,O
of,O
IkappaB,B
.,O
The,O
tax,O
protein,O
of,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
1,I
mediates,O
the,O
transactivation,O
of,O
the,O
c,B
-,I
sis,I
/,I
platelet,I
-,I
derived,I
growth,I
factor,I
-,I
B,I
promoter,I
through,O
interactions,O
with,O
the,O
zinc,B
finger,I
transcription,I
factors,I
Sp1,B
and,O
NGFI,B
-,I
A,I
/,I
Egr,I
-,I
1,I
.,O
In,O
the,O
present,O
work,O
",",O
we,O
have,O
investigated,O
the,O
mechanism,O
(,O
s,O
),O
whereby,O
Tax,B
transactivates,O
the,O
c,O
-,O
sis,O
/,O
PDGF,B
-,I
B,I
proto,I
-,I
oncogene,I
.,O
Interestingly,O
",",O
co,O
-,O
immunoprecipitation,O
analysis,O
also,O
revealed,O
that,O
Tax,B
mutant,O
IEXC29S,O
is,O
unable,O
to,O
interact,O
with,O
NGFI,B
-,I
A,I
/,I
Egr,I
-,I
1,I
",",O
whereas,O
Tax,B
mutant,O
IEXL320G,O
is,O
able,O
to,O
interact,O
with,O
NGFI,B
-,I
A,I
/,I
Egr,I
-,I
1,I
.,O
Dendritic,B
cells,I
(,O
DC,B
),O
are,O
potent,O
APCs,O
that,O
enter,O
resting,O
tissues,O
as,O
precursors,O
and,O
",",O
after,O
Ag,O
exposure,O
",",O
differentiate,O
and,O
migrate,O
to,O
draining,O
lymph,O
nodes,O
.,O
Immunohistochemical,O
staining,O
demonstrated,O
RelB,O
within,O
the,O
differentiated,O
lymph,O
node,O
interdigitating,O
DC,B
and,O
follicular,O
DC,B
",",O
but,O
not,O
undifferentiated,O
DC,B
in,O
normal,O
skin,O
.,O
NF,B
-,I
AT,I
activation,O
induced,O
by,O
a,O
CAML,B
-,I
interacting,I
member,I
of,I
the,I
tumor,I
necrosis,I
factor,I
receptor,I
superfamily,I
.,O
The,O
CAML,B
(,O
calcium,I
-,I
modulator,I
and,I
cyclophilin,I
ligand,I
),O
protein,O
is,O
a,O
coinducer,O
of,O
NF,B
-,I
AT,I
activation,O
when,O
overexpressed,O
in,O
Jurkat,B
T,I
cells,I
.,O
In,O
most,O
cells,I
",",O
Rel,B
/,I
NF,I
-,I
kappa,I
B,I
transcription,I
factors,I
appear,O
to,O
mediate,O
survival,O
signals,O
that,O
protect,O
cells,I
from,O
apoptosis,O
;,O
however,O
",",O
under,O
some,O
circumstances,O
",",O
activation,O
of,O
these,O
factors,I
may,O
also,O
promote,O
apoptosis,O
.,O
These,O
results,O
suggest,O
that,O
coordination,O
of,O
NF,B
-,I
kappaB,I
and,O
STAT6,B
may,O
be,O
required,O
for,O
induction,O
of,O
germline,O
Cepsilon,B
transcription,O
by,O
IL,O
-,O
4,O
",",O
and,O
that,O
CD40,O
-,O
mediated,O
NF,B
-,I
kappaB,I
activation,O
may,O
be,O
important,O
in,O
regulating,O
both,O
enhancement,O
of,O
germline,O
Cepsilon,B
transcription,O
and,O
class,O
switching,O
to,O
IgE,B
.,O
There,O
are,O
many,O
hypotheses,O
concerning,O
the,O
pathogenesis,O
of,O
endometriosis,O
",",O
though,O
no,O
single,O
theory,O
can,O
explain,O
all,O
cases,O
.,O
This,O
review,O
considers,O
the,O
evidence,O
for,O
different,O
theories,O
of,O
the,O
histogenesis,O
of,O
endometriosis,O
and,O
discusses,O
possible,O
immune,O
factors,O
that,O
may,O
be,O
involved,O
in,O
the,O
pathophysiology,O
of,O
the,O
disease,O
.,O
Proteins,B
of,I
the,I
ATF,B
/,I
CREB,I
class,I
of,I
transcription,I
factors,I
stimulate,O
gene,O
expression,O
of,O
several,O
cell,B
growth,I
-,I
related,I
genes,I
through,O
protein,B
kinase,I
A,I
-,I
related,I
cAMP,I
response,I
elements,I
.,O
One,O
ATF,B
/,I
CRE,I
motif,I
is,O
located,O
in,O
the,O
distal,O
promoter,O
at,O
the,O
nuclear,B
matrix,I
-,I
associated,I
Site,I
IV,I
",",O
and,O
the,O
second,O
motif,O
is,O
present,O
in,O
the,O
proximal,O
promoter,O
at,O
Site,O
I,O
.,O
Site,O
-,O
directed,O
mutational,O
studies,O
demonstrate,O
that,O
Site,B
I,I
and,O
Site,B
IV,I
together,O
support,O
ATF1,O
-,O
and,O
CREB,O
-,O
induced,O
trans,O
-,O
activation,O
of,O
the,O
H4,B
promoter,I
.,O
Thus,O
",",O
our,O
data,O
establish,O
that,O
ATF,O
/,O
CREB,O
factors,O
functionally,O
modulate,O
histone,O
H4,B
gene,I
transcription,I
at,O
distal,O
and,O
proximal,O
promoter,O
elements,O
.,O
Abnormal,O
apoptosis,O
and,O
cell,O
cycle,O
progression,O
in,O
humans,O
exposed,O
to,O
methyl,O
tertiary,O
-,O
butyl,O
ether,O
and,O
benzene,O
contaminating,O
water,O
.,O
Because,O
cell,B
cycle,I
analysis,I
showed,O
that,O
in,O
PBL,O
from,O
chemically,O
-,O
exposed,O
individuals,O
",",O
between,O
20,O
-,O
50,O
%,O
of,O
cells,O
were,O
accumulated,O
at,O
the,O
S,B
-,I
G2,I
/,I
M,I
boundaries,I
.,O
Indeed,O
",",O
addition,O
of,O
inhibitors,O
of,O
NF,B
-,I
kappa,I
B,I
activation,I
pyrrolidine,O
dithiocarbamate,O
(,O
PDTC,O
),O
",",O
to,O
the,O
lymphocytes,O
of,O
the,O
chemically,O
-,O
exposed,O
group,O
was,O
capable,O
of,O
inhibiting,O
programmed,O
cell,B
death,I
by,O
40,O
%,O
.,O
This,O
reversal,O
of,O
apoptosis,O
almost,O
to,O
the,O
control,O
level,O
by,O
inhibitor,O
of,O
NF,B
-,I
kappa,I
B,I
activation,I
may,O
indicate,O
involvement,O
of,O
this,O
signaling,O
molecule,O
in,O
MTBE,O
and,O
benzene,O
induction,O
of,O
programmed,O
cell,O
death,O
.,O
Purification,O
and,O
characterization,O
of,O
the,O
human,O
SR,B
31747A,I
-,I
binding,I
protein,I
.,O
A,O
nuclear,O
membrane,O
protein,O
related,O
to,O
yeast,O
sterol,O
isomerase,O
.,O
SR,O
31747A,O
",",O
defined,O
as,O
a,O
sigma,O
ligand,O
",",O
is,O
a,O
novel,O
immunosuppressive,O
agent,O
that,O
blocks,O
proliferation,O
of,O
human,O
and,O
mouse,O
lymphocytes,O
.,O
Using,O
a,O
radiolabeled,O
chemical,O
probe,O
",",O
we,O
here,O
purified,O
a,O
target,O
of,O
SR,B
31747A,I
and,O
called,O
it,O
SR,B
31747A,I
-,I
binding,I
protein,I
(,O
SR,B
-,I
BP,I
),O
.,O
Purified,O
SR,B
-,I
BP,I
retained,O
its,O
binding,O
properties,O
and,O
migrated,O
on,O
SDS,O
-,O
polyacrylamide,O
gel,O
as,O
a,O
Mr,O
28,B
",",I
0,I
protein,I
.,O
Northern,O
blot,O
analysis,O
of,O
SR,B
-,I
BP,I
gene,I
expression,O
revealed,O
a,O
single,O
transcript,O
of,O
2,O
kilobases,O
which,O
was,O
widely,O
expressed,O
among,O
organs,O
",",O
with,O
the,O
highest,O
abundance,O
in,O
liver,O
and,O
the,O
lowest,O
abundance,O
in,O
brain,O
.,O
Here,O
we,O
report,O
the,O
induction,O
of,O
the,O
synthesis,O
and,O
of,O
the,O
hydrolytic,O
activity,O
of,O
phospholipase,B
C,I
gamma,I
1,I
(,O
PLC,B
gamma,I
1,I
),O
in,O
human,O
T,B
lymphocytes,I
by,O
IFN,O
-,O
beta,O
.,O
The,O
increased,O
level,O
of,O
PLC,B
gamma,I
1,I
becomes,O
evident,O
after,O
90,O
min,O
of,O
IFN,O
-,O
beta,O
treatment,O
and,O
is,O
still,O
detectable,O
after,O
24,O
h,O
.,O
Neither,O
the,O
PLC,B
gamma,I
1,I
overexpression,O
induced,O
by,O
IFN,O
nor,O
the,O
increased,O
hydrolytic,O
activity,O
of,O
the,O
enzyme,O
appear,O
to,O
be,O
affected,O
by,O
pretreatment,O
of,O
the,O
cells,O
with,O
the,O
protein,B
tyrosine,I
kinase,I
inhibitor,I
genistein,O
",",O
which,O
is,O
known,O
to,O
prevent,O
the,O
association,O
of,O
ISGF3,O
components,O
.,O
These,O
results,O
suggest,O
that,O
in,O
human,O
T,B
lymphocytes,I
IFN,O
-,O
beta,O
can,O
activate,O
other,O
transcription,O
factor,O
(,O
s,O
),O
distinct,O
from,O
ISGF3,O
to,O
regulate,O
PLC,B
gamma,I
1,I
expression,O
.,O
In,O
this,O
study,O
",",O
we,O
used,O
a,O
RT,O
-,O
PCR,O
based,O
approach,O
to,O
compare,O
the,O
stability,O
of,O
the,O
big,O
T,B
and,O
small,O
t,B
allele,O
in,O
normal,O
heterozygous,O
lymphocytes,I
and,O
the,O
heterozygous,O
cell,B
lines,I
NB4,B
(,O
myeloid,O
leukemia,O
),O
and,O
PC,B
-,I
3,I
and,O
DU,B
145,I
(,O
prostate,O
cancers,O
),O
.,O
Interestingly,O
",",O
we,O
consistently,O
observed,O
30,O
%,O
less,O
RT,B
-,I
PCR,I
product,I
derived,I
from,I
the,I
small,I
t,I
allele,I
mRNA,I
in,I
steady,I
state,I
",",O
a,O
finding,O
which,O
also,O
speaks,O
against,O
a,O
higher,O
stability,O
of,O
the,O
small,O
t,O
allele,O
mRNA,O
. Moreover,O
",",O
anti,O
-,O
TNF,B
-,I
alpha,I
inhibited,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,I
LTR,I
),I
-,I
driven,I
transcription,I
of,I
a,I
reporter,I
gene,I
in,I
primary,I
T,I
cells,I
in,I
response,I
to,I
activation,I
",",O
either,O
in,O
the,O
presence,O
or,O
the,O
absence,O
of,O
HIV,B
-,I
1,I
Tat,I
.,O
Our,O
results,O
support,O
an,O
important,O
role,O
for,O
autocrine,O
TNF,B
-,I
alpha,I
secretion,O
in,O
controlling,O
HIV,B
replication,O
in,O
primary,O
T,B
cells,I
because,O
of,O
its,O
ability,O
to,O
maintain,O
NF,B
-,I
kappa,I
B,I
elevated,O
in,O
the,O
nucleus,O
of,O
T,B
cells,I
.,O
Intercellular,O
adhesion,O
molecule,O
1,O
(,O
ICAM,B
-,I
1,I
),O
is,O
an,O
important,O
molecule,O
in,O
promotion,O
of,O
polymorphonuclear,O
neutrophil,O
transendothelial,O
migration,O
during,O
inflammation,O
.,O
The,O
compound,O
induced,O
G1,B
arrest,I
and,O
granulocytic,B
differentiation,I
of,O
HL,B
-,I
60,I
cells,I
",",O
although,O
the,O
differentiation,O
-,O
inducing,O
effect,O
was,O
modest,O
. These,O
results,O
indicate,O
that,O
JAK2,B
/,I
STAT5,I
activation,O
is,O
a,O
common,O
JAK,B
/,I
STAT,I
pathway,I
for,O
hIL,B
-,I
5,I
-,I
mediated,I
signal,I
in,O
these,O
cells,O
. Nuclear,O
factor,O
-,O
kappa,O
B,B
(,I
NF,B
-,I
kappa,I
B,I
),I
/,I
Rel,I
transcription,I
factors,I
may,O
be,O
involved,O
in,O
atherosclerosis,O
",",O
as,O
is,O
suggested,O
by,O
the,O
presence,O
of,O
activated,O
NF,B
-,I
kappa,I
B,I
in,O
human,O
atherosclerotic,O
lesions,O
.,O
Our,O
results,O
demonstrate,O
that,O
short,O
-,O
term,O
incubation,O
of,O
these,O
cells,O
with,O
oxLDL,O
activated,O
p50,B
/,I
p65,I
containing,O
NF,B
-,I
kappa,I
B,I
dimers,O
and,O
induced,O
the,O
expression,O
of,O
the,O
target,O
gene,O
IL,B
-,I
8,I
.,O
This,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
was,O
inhibited,O
by,O
the,O
antioxidant,O
and,O
H2O2,O
scavenger,O
pyrrolidine,O
dithiocarbamate,O
and,O
the,O
proteasome,O
inhibitor,O
PSI,O
.,O
The,O
oxLDL,B
-,I
induced,O
NF,B
-,I
kappa,I
B,I
activation,O
was,O
accompanied,O
by,O
an,O
initial,O
depletion,O
of,O
I,B
kappa,I
B,I
-,I
alpha,I
followed,O
by,O
a,O
slight,O
transient,O
increase,O
in,O
the,O
level,O
of,O
this,O
inhibitor,O
protein,B
.,O
These,O
observations,O
provide,O
additional,O
evidence,O
that,O
oxLDL,B
is,O
a,O
potent,O
modulator,O
of,O
gene,O
expression,O
and,O
suggest,O
that,O
(,O
dys,O
),O
regulation,O
of,O
NF,B
-,I
kappa,I
B,I
/,I
Rel,I
is,O
likely,O
to,O
play,O
an,O
important,O
role,O
in,O
atherogenesis,O
.,O
PURPOSE,O
:,O
To,O
demonstrate,O
that,O
leukocyte,B
adhesion,O
to,O
cultured,O
corneal,B
endothelial,I
cells,I
is,O
mediated,O
by,O
the,O
CD18,B
antigen,O
",",O
and,O
to,O
determine,O
whether,O
dexamethasone,O
directly,O
suppresses,O
adhesion,O
by,O
inhibiting,O
activation,O
of,O
nuclear,B
factor,I
kappa,I
B,I
(,O
NFkappaB,B
),O
.,O
Nonadherent,O
neutrophils,B
were,O
removed,O
by,O
sealing,O
and,O
inverting,O
the,O
culture,O
well,O
.,O
RESULTS,O
:,O
Neutrophil,O
adhesion,O
to,O
cultured,O
corneal,O
endothelial,O
cells,O
increased,O
significantly,O
on,O
exposure,O
to,O
TNFalpha,B
(,O
451,O
.,O
4,O
+,O
/,O
-,O
45,O
.,O
4,O
cells,O
/,O
mm2,O
",",O
n,O
=,O
16,O
),O
compared,O
to,O
control,O
(,O
156,O
.,O
7,O
+,O
/,O
-,O
27,O
.,O
3,O
cells,O
/,O
mm2,O
",",O
n,O
=,O
16,O
",",O
P,O
<,O
0,O
.,O
1,O
).,O
The,O
transcriptional,O
start,O
sites,O
were,O
identified,O
by,O
an,O
RNase,B
protection,I
assay,I
.,O
Since,O
GH,B
stimulates,O
the,O
development,O
and,O
function,O
of,O
granulocytes,B
",",O
we,O
investigated,O
the,O
expression,O
of,O
GH,B
in,O
granulocyte,B
subsets,I
.,O
Restriction,O
analysis,O
revealed,O
that,O
neutrophils,B
express,O
the,O
GH,B
-,I
N,I
gene,I
but,O
not,O
the,O
GH,B
-,I
V,I
gene,I
.,O
In,O
addition,O
",",O
BHRF1,O
protected,O
these,O
cells,O
from,O
monocyte,B
-,I
mediated,I
killing,I
but,O
failed,O
to,O
protect,O
them,O
from,O
killing,O
mediated,O
by,O
lymphokine,B
-,I
activated,I
killer,I
cells,I
.,O
Genomic,O
organization,O
",",O
sequence,O
",",O
and,O
transcriptional,O
regulation,O
of,O
the,O
human,O
eotaxin,B
gene,I
.,O
Eotaxin,B
is,O
an,O
eosinophil,B
specific,I
beta,I
-,I
chemokine,I
assumed,O
to,O
be,O
involved,O
in,O
eosinophilic,B
inflammatory,I
diseases,I
such,O
as,O
atopic,B
dermatitis,I
",",O
allergic,B
rhinitis,I
",",O
asthma,B
and,O
parasitic,B
infections,I
.,O
Here,O
we,O
describe,O
the,O
functional,B
characterization,I
of,O
this,O
promoter,I
and,O
identification,O
of,O
the,O
factors,O
in,O
B,B
and,O
T,B
cells,I
that,O
regulate,O
its,O
activity,O
.,O
The,O
pp52,B
promoter,I
contains,O
an,O
initiator,O
specifying,O
the,O
unique,O
5,O
',O
terminus,O
of,O
pp52,B
mRNA,I
",",O
tandem,O
pairs,O
of,O
Ets,B
and,O
SP1,B
motifs,I
",",O
and,O
a,O
lone,O
C,B
/,I
EBP,I
motif,I
.BACKGROUND,O
:,O
Recent,O
studies,O
have,O
raised,O
the,O
hypothesis,O
that,O
glucocorticoids,O
could,O
diminish,O
the,O
ability,O
of,O
endothelial,B
cells,I
to,O
direct,O
leukocyte,O
traffic,O
into,O
inflamed,O
tissues,O
by,O
inhibiting,O
expression,O
of,O
the,O
adhesion,O
molecules,O
endothelial,B
-,I
leukocyte,I
adhesion,I
molecule,I
-,I
1,I
and,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
.,O
The,O
immediate,O
-,O
early,O
gene,O
product,O
Egr,B
-,I
1,I
regulates,O
the,O
human,O
interleukin,B
-,I
2,I
receptor,I
beta,I
-,I
chain,I
promoter,I
through,O
noncanonical,O
Egr,B
and,O
Sp1,B
binding,O
sites,O
.,O
In,O
Jurkat,B
cells,I
",",O
both,O
sites,O
were,O
required,O
for,O
maximal,O
IL,B
-,I
2Rbeta,I
promoter,I
activity,O
",",O
and,O
in,O
HeLaS3,B
cells,I
",",O
transfection,O
of,O
Egr,B
-,I
1,I
could,O
drive,O
activity,O
of,O
a,O
reporter,O
construct,O
containing,O
both,O
sites,O
.,O
Acquisition,O
of,O
heat,B
shock,I
factor,I
2,I
(,O
HSF2,B
),O
DNA,B
binding,I
activity,I
is,O
accompanied,O
by,O
induced,O
transcription,O
of,O
heat,B
shock,I
genes,I
in,O
hemin,O
-,O
treated,O
K562,B
cells,I
undergoing,O
erythroid,O
differentiation,O
.,O
Sequential,O
development,O
of,O
structural,O
and,O
functional,O
alterations,O
in,O
T,B
cells,I
from,O
tumor,O
-,O
bearing,O
mice,O
.,O
These,O
defects,O
are,O
paralleled,O
by,O
an,O
impaired,O
ability,O
to,O
produce,O
Th1,B
cytokines,I
(,O
IL,B
-,I
2,I
and,O
IFN,B
-,I
gamma,I
),O
.,O
Like,O
the,O
class,B
II,I
genes,I
",",O
the,O
HLA,B
-,I
DM,I
genes,I
contain,O
upstream,O
regulatory,O
sequences,O
similar,O
to,O
the,O
S,O
-,O
X,O
-,O
Y,O
regulatory,O
region,O
as,O
well,O
as,O
additional,O
putative,O
regulatory,O
sites,O
.,O
The,O
class,B
II,I
-,I
specific,I
transcription,O
factors,O
RFX,B
and,O
CIITA,B
are,O
also,O
required,O
for,O
expression,O
",",O
as,O
cell,B
lines,I
deficient,O
in,O
these,O
factors,O
failed,O
to,O
allow,O
transcription,O
from,O
the,O
DM,B
promoters,I
.,O
In,O
addition,O
",",O
in,O
vivo,O
footprint,O
analysis,O
showed,O
the,O
putative,O
X,B
and,O
Y,B
boxes,I
to,O
be,O
occupied,O
by,O
transcription,O
factors,O
in,O
wild,O
-,O
type,O
B,O
cells,O
",",O
but,O
not,O
in,O
RFX,O
-,O
deficient,O
B,O
cells,O
.,O
None,O
of,O
the,O
other,O
putative,O
regulatory,O
sites,O
was,O
occupied,O
in,O
vivo,O
",",O
indicating,O
that,O
they,O
may,O
not,O
be,O
functional,O
.,O
On,O
the,O
other,O
hand,O
",",O
Ad2,O
was,O
internalized,O
by,O
macrophages,O
.,O
Critical,O
cytoplasmic,O
domains,O
of,O
human,O
interleukin,B
-,I
9,I
receptor,I
alpha,I
chain,I
in,O
interleukin,B
-,I
9,I
-,I
mediated,O
cell,O
proliferation,O
and,O
signal,O
transduction,O
.,O
In,O
a,O
previous,O
study,O
",",O
we,O
demonstrated,O
that,O
bufalin,O
",",O
which,O
is,O
an,O
active,O
principle,O
of,O
Chinese,O
medicine,O
",",O
chan,O
',O
su,O
",",O
caused,O
apoptosis,O
in,O
human,O
leukemia,O
U937,B
cells,O
by,O
anomalous,O
activation,O
of,O
mitogen,O
-,O
activated,O
protein,B
kinase,I
(,O
MAPK,B
),O
via,O
the,O
signaling,O
pathway,O
of,O
Ras,B
",",O
Raf,B
-,I
1,I
",",O
and,O
MAPK,B
kinase,I
-,I
1,I
.,O
Here,O
",",O
we,O
report,O
the,O
effect,O
of,O
overexpression,O
of,O
bcl,B
-,I
2,I
in,O
U937,B
cells,I
on,O
the,O
signaling,O
pathway,O
of,O
apoptosis,O
that,O
is,O
induced,O
by,O
bufalin,O
.,O
The,O
genes,O
encoding,O
the,O
functionally,O
related,O
hepatocyte,B
nuclear,I
factors,I
HNF,B
-,I
1alpha,I
and,O
HNF,B
-,I
4alpha,I
play,O
a,O
critical,O
role,O
in,O
normal,O
pancreatic,B
beta,I
-,I
cell,I
function,O
.,O
In,O
this,O
study,O
",",O
we,O
show,O
that,O
HNF,B
-,I
3alpha,I
",",O
-,O
3beta,B
",",O
-,O
3gamma,B
",",O
-,O
4gamma,B
",",O
and,O
-,O
6,B
are,O
expressed,O
in,O
pancreatic,B
beta,I
-,I
cells,I
.,O
We,O
report,O
the,O
identification,O
and,O
characterization,O
of,O
simple,O
tandem,O
repeat,O
DNA,B
polymorphisms,I
in,O
the,O
genes,O
encoding,O
HNF,B
-,I
3alpha,I
",",O
-,O
3beta,B
",",O
-,O
3gamma,B
",",O
-,O
4gamma,B
",",O
and,O
-,O
6,B
and,O
the,O
mapping,O
of,O
HNF,B
-,I
6,I
to,O
chromosome,O
bands,O
15q21,O
.,O
1,O
-,O
21,O
.,O
2,O
by,O
fluorescence,O
in,O
situ,O
hybridization,O
.,O
Anti,O
-,O
E,B
.,O
chaffeensis,I
antibody,O
complexed,O
with,O
E,B
.,O
chaffeensis,I
significantly,O
enhanced,O
mRNA,O
expression,O
of,O
IL,O
-,O
1beta,O
in,O
THP,B
-,I
1,I
cells,O
.,O
Decreased,O
transcriptional,O
activation,O
by,O
N,O
-,O
terminal,O
deletions,O
of,O
CIITA,O
is,O
correlated,O
directly,O
with,O
their,O
reduced,O
binding,O
to,O
TAFII32,O
.,O
Ligand,O
binding,O
and,O
activation,O
of,O
the,O
IL,B
-,I
10,I
receptor,I
expressed,O
on,O
B,B
-,I
CLL,I
cells,I
results,O
in,O
the,O
phosphorylation,O
of,O
signal,B
transducer,I
and,I
activator,I
of,I
transcription,I
1,I
(,O
STAT1,B
),O
and,O
STAT3,B
proteins,I
.,O
When,O
18C7,B
was,O
incubated,O
with,O
MR,B
before,O
aldosterone,B
or,O
progesterone,B
",",O
the,O
antibody,O
inhibited,O
75,O
-,O
80,O
%,O
of,O
the,O
binding,O
.,O
Molecular,O
cloning,O
of,O
SLAP,B
-,I
130,I
",",O
an,O
SLP,B
-,I
76,I
-,I
associated,O
substrate,O
of,O
the,O
T,B
cell,I
antigen,I
receptor,I
-,I
stimulated,O
protein,B
tyrosine,I
kinases,I
.,O
These,O
data,O
suggest,O
that,O
SLP,B
-,I
76,I
recruits,O
a,O
negative,O
regulator,O
",",O
SLAP,B
-,I
130,I
",",O
as,O
well,O
as,O
positive,O
regulators,O
of,O
signal,O
transduction,O
in,O
T,B
cells,I
.,O
This,O
review,O
focuses,O
on,O
the,O
molecular,O
actions,O
of,O
prolactin,B
in,O
the,O
immune,B
system,I
.,O
From,O
analyses,O
of,O
mice,O
deficient,O
in,O
transcription,O
factor,O
genes,O
and,O
from,O
the,O
characterizations,O
of,O
chromosome,O
breakpoints,O
in,O
human,O
leukemias,O
",",O
it,O
has,O
become,O
evident,O
that,O
transcription,O
factors,O
are,O
important,O
regulators,O
of,O
hematopoiesis,O
.,O
Induction,O
of,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
expression,O
in,O
monocytic,O
cells,O
by,O
Cryptococcus,O
neoformans,O
and,O
Candida,O
albicans,O
.,O
Because,O
candidiasis,B
and,O
cryptococcosis,B
are,O
common,O
in,O
human,O
immunodeficiency,O
virus,O
(,O
HIV,B
),O
-,O
infected,O
persons,O
",",O
the,O
effect,O
of,O
Cryptococcus,B
neoformans,I
and,O
Candida,B
albicans,I
on,O
HIV,B
expression,O
in,O
monocytic,B
cells,I
was,O
examined,O
.,O
Stimulation,O
of,O
the,O
latently,O
HIV,B
-,O
infected,O
myelomonocytic,B
cell,I
line,I
OM,B
-,I
10,I
.,O
1,O
with,O
C,O
.,O
neoformans,O
and,O
C,B
.,O
albicans,O
in,O
the,O
presence,O
of,O
pooled,O
human,O
serum,O
caused,O
a,O
ratio,O
-,O
dependent,O
increase,O
in,O
HIV,B
production,O
.,O
In,O
THP,B
-,I
1,I
cells,I
transfected,O
with,O
HIV,B
plasmid,I
constructs,I
",",O
both,O
organisms,O
induced,O
transcription,O
from,O
the,O
HIV,B
long,I
terminal,I
repeat,I
that,O
was,O
dependent,O
on,O
intact,O
NF,B
-,I
kappaB,I
binding,I
sequences,I
.,O
Thus,O
",",O
C,B
.,O
neoformans,O
and,O
C,B
.,O
albicans,O
enhance,O
HIV,B
expression,O
in,O
monocytic,O
cells,O
through,O
a,O
TNF,O
-,O
alpha,O
-,O
and,O
NF,B
-,I
kappaB,I
-,I
dependent,O
mechanism,O
.,O
In,O
this,O
report,O
we,O
present,O
the,O
characterisation,O
of,O
NF,B
-,I
kappaB,I
subunits,O
engaged,O
in,O
complexes,O
binding,O
to,O
the,O
HIV,B
-,I
1,I
NF,B
-,I
kappaB,I
site,O
in,O
human,O
8E+51,O
T,O
-,O
cells,O
",",O
that,O
harbour,O
a,O
defective,O
HIV,B
-,I
1,I
.,O
With,O
the,O
use,O
of,O
specific,O
antibodies,B
we,O
have,O
determined,O
the,O
composition,O
of,O
each,O
complex,O
using,O
electrophoretic,O
mobility,O
shift,O
assays,O
.,O
c,O
-,O
Myb,B
and,O
Ets,B
proteins,O
synergize,O
to,O
overcome,O
transcriptional,O
repression,O
by,O
ZEB,O
.,O
IL,O
-,O
4,O
-,O
dependent,O
activation,O
of,O
Stat6,B
was,O
also,O
observed,O
in,O
HC11,B
mammary,I
epithelial,I
cells,I
.,O
In,O
these,O
cells,O
",",O
Stat6,B
activation,O
led,O
to,O
the,O
induction,O
of,O
the,O
beta,B
-,I
casein,I
gene,I
promoter,I
.,O
In,O
pre,O
-,O
B,O
cells,O
(,O
Ba,O
/,O
F3,O
),O
",",O
the,O
transactivation,O
domain,O
of,O
Stat6,B
was,O
IL,O
-,O
4,O
regulated,O
",",O
independently,O
from,O
its,O
DNA,B
binding,I
function,I
.,O
Activation,O
of,O
helper,O
T,O
cells,O
results,O
in,O
coordinate,O
expression,O
of,O
a,O
number,O
of,O
cytokines,O
involved,O
in,O
differentiation,O
",",O
proliferation,O
and,O
activation,O
of,O
the,O
haematopoietic,O
system,O
.,O
Granulocyte,B
-,I
macrophage,I
colony,I
stimulating,I
factor,I
(,O
GM,B
-,I
CSF,I
),O
is,O
one,O
such,O
cytokine,O
",",O
whose,O
increased,O
expression,O
results,O
mostly,O
from,O
increases,O
in,O
transcription,O
.,O
ETS1,B
is,O
a,O
transcription,O
factor,O
of,O
the,O
ETS,B
family,I
that,O
is,O
expressed,O
in,O
T,B
cells,I
.,O
We,O
have,O
previously,O
shown,O
that,O
ETS1,B
can,O
transactivate,O
GM,B
-,I
CSF,I
in,O
Jurkat,B
T,I
cells,I
",",O
but,O
only,O
after,O
the,O
cells,O
have,O
been,O
stimulated,O
by,O
treatment,O
with,O
PMA,O
and,O
ionomycin,O
",",O
agents,O
that,O
mimic,O
T,B
cell,I
activation,I
.,O
This,O
defect,O
in,O
maturation,O
resulted,O
in,O
a,O
transgene,O
dose,O
-,O
dependent,O
reduction,O
in,O
peripheral,O
T,B
lymphocytes,I
",",O
with,O
the,O
CD8,B
lineage,I
being,O
more,O
severely,O
affected,O
.,O
CD40,B
is,O
an,O
important,O
signaling,O
and,O
activation,O
Ag,O
found,O
on,O
certain,O
bone,B
marrow,I
-,I
derived,I
cells,I
.,O
Recently,O
",",O
CD40,B
also,O
has,O
been,O
shown,O
to,O
be,O
expressed,O
by,O
mesenchymal,B
cells,I
",",O
including,O
human,B
fibroblasts,I
.,O
Little,O
is,O
known,O
about,O
the,O
role,O
of,O
CD40,B
in,O
fibroblasts,O
.,O
The,O
current,O
study,O
investigates,O
the,O
hypothesis,O
that,O
CD40,B
expressed,O
on,O
lung,O
fibroblasts,O
is,O
an,O
activation,O
structure,O
and,O
mechanism,O
for,O
interaction,O
with,O
hemopoietic,O
cells,O
.,O
Signaling,O
through,O
CD40,B
with,O
soluble,O
CD40,B
ligand,I
stimulated,O
fibroblast,O
activation,O
",",O
as,O
evidenced,O
by,O
mobilization,O
of,O
nuclear,O
factor,O
-,O
kappaB,O
and,O
by,O
induction,O
of,O
the,O
proinflammatory,O
and,O
chemoattractant,O
cytokines,O
IL,B
-,I
6,I
and,O
IL,B
-,I
8,I
.,O
In,O
contrast,O
",",O
it,O
was,O
found,O
to,O
be,O
TNF,B
-,I
alpha,I
independent,O
in,O
the,O
early,O
time,O
point,O
.,O
In,O
fact,O
",",O
mAb,O
L243,O
but,O
not,O
the,O
staphylococcal,O
superantigens,O
",",O
staphylococcal,O
exotoxin,O
toxic,O
shock,O
syndrome,O
toxin,O
-,O
I,O
or,O
staphylococcal,O
enterotoxin,O
B,O
",",O
regulate,O
the,O
NF,B
-,I
kappa,I
B,I
binding,I
activity,I
.,O
Regulation,O
of,O
inosine,O
-,O
5,O
',O
-,O
monophosphate,O
dehydrogenase,O
type,O
II,O
gene,O
expression,O
in,O
human,O
T,B
cells,I
.,O
Additional,O
major,O
protein,B
-,I
DNA,I
interactions,O
do,O
not,O
occur,O
within,O
the,O
promoter,O
region,O
after,O
T,O
lymphocyte,B
activation,O
",",O
indicating,O
a,O
requirement,O
for,O
additional,O
protein,B
-,I
protein,I
interactions,O
and,O
/,O
or,O
post,O
-,O
translational,O
modifications,O
of,O
pre,O
-,O
bound,O
transcription,O
factors,O
to,O
account,O
for,O
the,O
observed,O
increase,O
in,O
IMPDH,O
type,O
II,O
gene,O
expression,O
.,O
NAC,O
had,O
no,O
effect,O
on,O
the,O
half,O
-,O
life,O
of,O
E,B
-,I
selectin,I
or,O
VCAM,B
-,I
1,I
mRNA,I
.,O
Fusion,O
proteins,O
involving,O
the,O
retinoic,B
acid,I
receptor,I
alpha,I
(,O
RAR,B
alpha,I
),O
and,O
the,O
PML,B
or,O
PLZF,B
nuclear,I
protein,I
are,O
the,O
genetic,O
markers,O
of,O
acute,O
promyelocytic,O
leukemias,O
(,O
APLs,O
),O
.,O
Cytomegalovirus,B
(,O
CMV,B
),O
infection,O
induced,O
interleukin,B
-,I
8,I
(,O
IL,B
-,I
8,I
),O
gene,O
transcription,O
in,O
a,O
human,O
monocytic,B
cell,I
line,I
",",O
THP,B
-,I
1,I
cells,I
",",O
leading,O
to,O
IL,B
-,I
8,I
secretion,O
.,O
Moreover,O
",",O
electrophoretic,O
mobility,O
shift,O
assays,O
demonstrated,O
that,O
CMV,O
induced,O
the,O
formation,O
of,O
NF,B
-,I
kappaB,I
and,O
AP,B
-,I
1,I
complexes,I
.,O
Interleukin,O
-,O
12,O
(,O
IL,B
-,I
12,I
),O
is,O
a,O
cytokine,O
that,O
exhibits,O
pleiotropic,O
effects,O
on,O
lymphocytes,O
and,O
natural,O
killer,O
cells,O
and,O
has,O
been,O
shown,O
to,O
have,O
promise,O
for,O
the,O
immunotherapy,O
of,O
cancer,O
.,O
This,O
presents,O
several,O
problems,O
in,O
vectors,O
",",O
particularly,O
those,O
in,O
which,O
additional,O
genes,I
",",O
either,O
a,O
co,O
-,O
stimulatory,O
gene,O
or,O
a,O
selectable,O
marker,O
",",O
are,O
inserted,O
.,O
Direct,O
analysis,O
of,O
these,O
modified,O
cells,O
acting,O
as,O
tumor,O
vaccines,O
is,O
underway,O
.,O
Plasma,O
sialyltransferase,B
levels,I
in,O
psychiatric,O
disorders,O
as,O
a,O
possible,O
indicator,O
of,O
HPA,O
axis,O
function,O
.,O
While,O
there,O
was,O
a,O
significant,O
increase,O
in,O
plasma,O
cortisol,B
levels,O
in,O
the,O
depressed,O
group,O
",",O
there,O
were,O
no,O
changes,O
in,O
the,O
lymphocyte,O
GR,B
binding,I
parameters,I
(,O
K,O
(,O
m,O
),O
and,O
Bmax,O
),O
.,O
There,O
was,O
",",O
however,O
",",O
a,O
significant,O
decrease,O
in,O
the,O
plasma,O
sialyltransferase,B
:,O
cortisol,O
ratio,O
in,O
the,O
depressed,O
group,O
suggesting,O
an,O
inability,O
of,O
the,O
raised,O
cortisol,O
levels,O
to,O
induce,O
enzyme,O
expression,O
and,O
this,O
ratio,O
may,O
provide,O
a,O
useful,O
biochemical,O
marker,O
of,O
cortisol,O
receptor,O
function,O
.,O
Therefore,O
",",O
while,O
the,O
total,O
plasma,O
sialyltransferase,B
:,O
cortisol,O
ratio,O
reflects,O
HPA,O
axis,O
function,O
",",O
alterations,O
in,O
specific,O
isozyme,O
activity,O
may,O
also,O
be,O
associated,O
with,O
other,O
CNS,O
disease,O
states,O
.,O
Using,O
a,O
previously,O
described,O
mutant,O
of,O
the,O
Jurkat,B
T,I
cell,I
line,I
",",O
we,O
show,O
that,O
proximal,O
signaling,O
events,O
dependent,O
on,O
the,O
presence,O
of,O
the,O
CD45,B
tyrosine,I
phosphatase,I
are,O
required,O
for,O
TCR,O
-,O
stimulated,O
CD95,B
ligand,I
expression,O
.,O
Together,O
",",O
these,O
studies,O
begin,O
a,O
dissection,O
of,O
the,O
biochemical,O
events,O
that,O
lead,O
to,O
expression,O
of,O
CD95,B
ligand,I
",",O
a,O
required,O
step,O
for,O
TCR,O
-,O
induced,O
apoptosis,O
.,O
This,O
paper,O
aims,O
to,O
review,O
the,O
role,O
of,O
free,O
radical,O
-,O
induced,O
tissue,O
damage,O
and,O
antioxidant,O
defence,O
mechanisms,O
in,O
inflammatory,O
diseases,O
that,O
involve,O
pathogenic,O
processes,O
similar,O
to,O
the,O
periodontal,O
diseases,O
.,O
There,O
is,O
a,O
clearly,O
defined,O
and,O
substantial,O
role,O
for,O
free,O
radicals,O
or,O
reactive,O
oxygen,O
species,O
(,O
ROS,B
),O
in,O
periodontitis,O
",",O
but,O
little,O
research,O
has,O
been,O
performed,O
in,O
this,O
area,O
.,O
Large,O
germline,O
deletions,O
of,O
TSC2,B
occur,O
in,O
<,O
5,O
%,O
of,O
cases,O
",",O
and,O
a,O
number,O
of,O
small,O
intragenic,O
mutations,O
have,O
been,O
described,O
.,O
TCP,B
succinate,I
(,O
200,O
microM,O
",",O
24,O
h,O
),O
reduced,O
TNF,B
-,I
induced,I
VCAM,B
-,I
1,I
and,O
E,B
-,I
selectin,I
expression,O
from,O
a,O
specific,O
mean,O
fluorescence,O
intensity,O
of,O
151,O
+,O
/,O
-,O
28,O
to,O
12,O
+,O
/,O
-,O
4,O
channels,O
and,O
from,O
225,O
+,O
/,O
-,O
38,O
to,O
79,O
+,O
/,O
-,O
21,O
channels,O
",",O
respectively,O
.,O
The,O
Eed,B
-,I
mediated,I
transcriptional,I
effects,I
are,O
likely,O
to,O
reflect,O
the,O
interaction,O
of,O
Eed,B
with,O
multiple,O
molecular,O
partners,O
",",O
including,O
K,B
protein,I
.,O
When,O
macrophages,O
were,O
pretreated,O
with,O
low,O
doses,O
of,O
IFN,B
-,I
gamma,I
and,O
then,O
stimulated,O
with,O
IFN,B
-,I
alpha,I
",",O
clearly,O
enhanced,O
formation,O
of,O
specific,O
transcription,O
factor,O
complexes,O
was,O
detected,O
.,O
Activation,O
and,O
regulation,O
of,O
NF,B
-,I
kappa,I
B,I
are,O
tightly,O
controlled,O
by,O
a,O
group,O
of,O
inhibitory,O
proteins,O
(,O
I,B
kappa,I
B,I
),O
that,O
sequester,O
NF,B
-,I
kappa,I
B,I
in,O
the,O
cytoplasm,O
of,O
immune,O
/,O
inflammatory,O
effector,O
cells,O
.,O
Liberated,O
NF,B
-,I
kappa,I
B,I
migrates,O
to,O
the,O
nucleus,O
",",O
where,O
it,O
binds,O
to,O
specific,O
promoter,O
sites,O
and,O
activates,O
gene,O
transcription,O
.,O
Constitutive,O
expression,O
of,O
E2a,B
-,I
Pbx1,I
did,O
not,O
induce,O
apoptosis,O
or,O
continued,O
cycling,O
of,O
Rat,B
-,I
1,I
fibroblasts,I
in,O
low,O
serum,O
conditions,O
.,O
The,O
human,B
C,I
/,I
E2BPepsilon,I
gene,I
is,O
transcribed,O
by,O
two,O
alternative,O
promoters,O
",",O
Palpha,O
and,O
Pbeta,O
.,O
A,O
combination,O
of,O
differential,O
splicing,O
and,O
alternative,O
use,O
of,O
promoters,O
generates,O
four,O
mRNA,O
isoforms,O
",",O
of,O
2,O
.,O
6,O
kb,O
and,O
1,O
.,O
3,O
-,O
1,O
.,O
5,O
kb,O
in,O
size,O
.,O
C,O
/,O
EBPepsilon,B
mRNA,O
was,O
greatly,O
induced,O
during,O
in,O
vitro,O
granulocytic,O
differentiation,O
of,O
human,O
primary,O
CD34,B
(,O
+,O
),O
cells,O
.,O
Thus,O
",",O
C,O
/,O
EBPepsilon,B
is,O
regulated,O
in,O
a,O
complex,O
fashion,O
and,O
may,O
play,O
a,O
role,O
in,O
the,O
regulation,O
of,O
genes,O
involved,O
in,O
myeloid,O
differentiation,O
.,O
We,O
now,O
report,O
that,O
PO,B
-,I
B,I
DNA,I
-,I
binding,I
in,O
HL,B
-,I
60,I
cells,O
is,O
similarly,O
induced,O
during,O
differentiation,O
to,O
the,O
granulocytic,O
lineage,O
(,O
with,O
either,O
retinoic,O
acid,O
or,O
dimethylsulfoxide,O
),O
.,O
Recent,O
studies,O
have,O
revealed,O
that,O
interactions,O
between,O
transcription,O
factors,O
play,O
an,O
important,O
role,O
in,O
regulation,O
of,O
gene,O
expression,O
in,O
eukaryotic,O
cells,O
.,O
Oct,O
-,O
2,O
expressed,O
in,O
this,O
tester,O
strain,O
represses,O
the,O
expression,O
of,O
the,O
reporter,O
gene,O
and,O
changes,O
the,O
phenotype,O
of,O
the,O
cell,O
from,O
Lac,O
+,O
to,O
Lac,O
-,O
.,O
One,O
of,O
them,O
",",O
hT86,O
",",O
encoding,O
a,O
putative,O
zinc,B
finger,I
protein,I
was,O
found,O
to,O
derepress,O
beta,O
-,O
galactosidase,O
activity,O
in,O
the,O
Oct,O
-,O
2,O
-,O
harboring,O
tester,O
strain,O
at,O
the,O
transcriptional,O
level,O
.,O
Thus,O
",",O
Tap,B
is,O
likely,O
to,O
be,O
an,O
important,O
cellular,O
mediator,O
of,O
Tip,O
function,O
in,O
T,B
cell,I
transformation,O
by,O
herpesvirus,O
saimiri,O
.,O
Triggering,O
of,O
the,O
T,B
-,I
cell,I
receptor,I
-,I
CD3,I
complex,I
activates,O
two,O
major,O
signal,O
cascades,O
in,O
T,B
lymphocytes,I
",",O
(,O
i,O
),O
Ca2,B
+,I
-,I
dependent,I
signal,I
cascades,I
and,O
(,O
ii,O
),O
protein,B
kinase,I
cascades,I
.,O
Both,O
signal,O
cascades,O
contribute,O
to,O
the,O
induction,O
of,O
the,O
interleukin,B
2,I
(,O
IL,B
-,I
2,I
),O
gene,O
during,O
T,B
-,I
cell,I
activation,O
.,O
Functional,O
analysis,O
of,O
monocytic,B
THP,B
-,I
1,I
cells,I
transfected,O
with,O
plasmids,O
containing,O
various,O
lengths,O
of,O
TNF,B
-,I
alpha,I
promoter,I
localized,O
enhancer,B
elements,I
in,O
a,O
region,O
(,O
-,O
182,O
to,O
-,O
37,O
base,O
pairs,O
(,O
bp,O
),O
that,O
were,O
required,O
for,O
optimal,O
transcription,O
of,O
the,O
TNF,B
-,I
alpha,I
gene,I
in,O
response,O
to,O
LPS,O
.,O
In,O
unstimulated,O
THP,B
-,I
1,I
",",O
CRE,B
-,I
binding,I
protein,I
and,O
",",O
to,O
a,O
lesser,O
extent,O
",",O
c,O
-,O
Jun,O
complexes,O
were,O
found,O
to,O
bind,O
to,O
the,O
CRE,B
site,I
.,O
The,O
CRE,B
and,O
kappaB3,O
sites,O
in,O
region,O
II,O
together,O
conferred,O
strong,O
LPS,O
responsiveness,O
to,O
a,O
heterologous,O
promoter,O
",",O
whereas,O
individually,O
they,O
failed,O
to,O
provide,O
transcriptional,O
activation,O
.,O
Furthermore,O
",",O
increasing,O
the,O
spacing,O
between,O
the,O
CRE,B
and,O
the,O
kappaB3,B
sites,I
completely,O
abolished,O
LPS,O
induction,O
",",O
suggesting,O
a,O
cooperative,O
interaction,O
between,O
c,O
-,O
Jun,O
complexes,O
and,O
p50,B
/,I
p65,I
.,O
IFN,O
-,O
alpha,O
/,O
beta,O
specifically,O
induced,O
tyrosine,O
phosphorylation,O
and,O
translocation,O
into,O
nucleus,O
of,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
STAT,B
),O
2,O
protein,B
in,O
the,O
T,O
cell,B
clones,I
.,O
IL,B
-,I
10,I
inhibition,O
of,O
IFN,B
-,I
gamma,I
-,I
induced,O
ICAM,B
-,I
1,I
expression,O
was,O
apparent,O
as,O
early,O
as,O
3,O
hours,O
and,O
was,O
blocked,O
by,O
an,O
anti,O
-,O
IL,B
-,I
10,I
antibody,O
but,O
not,O
by,O
an,O
isotype,O
-,O
matched,O
control,O
antibody,O
.,O
The,O
other,O
",",O
CIITA,O
",",O
encodes,O
a,O
large,O
protein,O
with,O
a,O
defined,O
acidic,O
transcriptional,O
activation,O
domain,O
;,O
this,O
protein,O
does,O
not,O
interact,O
with,O
DNA,B
.,O
However,O
",",O
these,O
plasmids,O
produced,O
transcriptional,O
activity,O
in,O
HeLa,B
cells,I
only,O
in,O
conjunction,O
with,O
interferon,O
gamma,O
stimulation,O
",",O
a,O
condition,O
in,O
which,O
expression,O
of,O
both,O
CIITA,B
and,O
class,B
II,I
major,I
histocompatibility,I
complex,I
surface,I
proteins,I
are,O
induced,O
.,O
Thus,O
",",O
RFX5,B
can,O
activate,O
transcription,O
only,O
in,O
cooperation,O
with,O
CIITA,B
.,O
Phosphatidylinositol,B
3,I
-,I
kinase,I
(,O
PI3,B
-,I
K,I
),O
has,O
been,O
implicated,O
in,O
the,O
regulation,O
of,O
cell,O
proliferation,O
in,O
many,O
cell,O
types,O
.,O
Acute,O
promyelocytic,O
leukemia,O
(,O
APL,O
),O
is,O
associated,O
with,O
reciprocal,O
chromosomal,O
translocations,O
involving,O
the,O
retinoic,O
acid,O
receptor,O
alpha,O
(,O
RARalpha,B
),O
locus,O
on,O
chromosome,O
17,O
.,O
The,O
resulting,O
fusion,O
genes,O
encode,O
the,O
two,O
structurally,O
unique,O
PML,B
/,I
RARalpha,I
and,O
RARalpha,B
/,I
PML,I
fusion,O
proteins,O
as,O
well,O
as,O
aberrant,O
PML,B
gene,I
products,I
",",O
the,O
respective,O
pathogenetic,O
roles,O
of,O
which,O
have,O
not,O
been,O
elucidated,O
.,O
Interferon,B
-,I
gamma,I
(,O
IFN,B
-,I
gamma,I
),O
is,O
a,O
key,O
cytokine,O
of,O
T,B
lymphocytes,I
with,O
major,O
regulatory,O
functions,O
in,O
the,O
immune,B
system,I
.,O
This,O
novel,O
target,O
site,O
",",O
denoted,O
the,O
C,B
-,I
site,I
",",O
was,O
shown,O
by,O
several,O
criteria,O
",",O
including,O
cell,B
distribution,I
studies,I
",",O
stimulation,O
experiments,O
",",O
supershift,O
assays,O
",",O
and,O
cross,O
-,O
competition,O
electrophoretic,O
mobility,O
shift,O
assays,O
to,O
bind,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
.,O
Mutation,O
of,O
the,O
C,B
-,I
site,I
that,O
prevented,O
AP,B
-,I
1,I
binding,O
to,O
this,O
site,O
was,O
sufficient,O
strikingly,O
to,O
reduce,O
inducible,O
promoter,B
activity,I
in,O
primary,O
CD45R0,B
T,I
cells,I
.,O
Latent,O
infection,O
of,O
B,B
lymphocytes,I
by,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
),O
can,O
be,O
disrupted,O
by,O
expression,O
of,O
the,O
EBV,B
ZEBRA,I
protein,I
.,O
The,O
studies,O
described,O
herein,O
demonstrate,O
that,O
the,O
activation,O
domain,O
.,O
The,O
involvement,O
of,O
the,O
CCK,B
(,O
B,I
),O
receptor,O
in,O
such,O
a,O
stimulation,O
was,O
demonstrated,O
by,O
the,O
inhibiting,O
effect,O
of,O
the,O
selective,O
CCK,B
(,O
B,I
),O
receptor,O
antagonist,O
PD,O
-,O
135,O
",",O
158,O
.,O
To,O
better,O
understand,O
the,O
AP,O
-,O
1,O
-,O
dependent,O
luciferase,O
expression,O
in,O
Jurkat,B
T,I
cells,I
",",O
we,O
tested,O
two,O
specific,O
inhibitors,O
of,O
serine,B
/,I
threonine,I
phosphatases,I
-,I
1,I
and,O
-,O
2A,O
:,O
okadaic,O
acid,O
and,O
calyculin,O
A,O
.,O
In,O
Jurkat,B
T,I
cells,I
activated,O
by,O
phorbol,O
-,O
12,O
-,O
myristate,O
-,O
13,O
-,O
acetate,O
and,O
phytohemagglutinin,O
",",O
CCK,B
-,I
8,I
induced,O
IL,B
-,I
2,I
expression,O
.,O
Our,O
results,O
indicate,O
that,O
CCK,B
-,I
8,I
exerts,O
a,O
trophic,O
effect,O
in,O
Jurkat,B
T,I
cells,I
through,O
stimulation,O
of,O
CCK,B
(,O
B,O
),O
receptors,O
by,O
modulation,O
of,O
expression,O
of,O
AP,B
-,I
1,I
-,I
regulated,O
genes,O
.,O
Binding,O
sites,O
at,O
the,O
core,O
region,O
show,O
little,O
conservation,O
with,O
consensus,O
sites,O
.,O
While,O
the,O
activation,O
of,O
JAK2,B
",",O
Shc,B
",",O
Erk,B
",",O
and,O
STAT5,B
proteins,I
correlated,O
with,O
hGM,O
-,O
CSF,O
-,O
mediated,O
cell,O
growth,O
",",O
cellular,O
differentiation,O
occurred,O
in,O
the,O
absence,O
of,O
activation,O
of,O
these,O
signal,O
transduction,O
pathways,O
.,O
We,O
utilized,O
THP,B
-,I
1,I
cells,I
to,O
examine,O
the,O
response,O
to,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
with,O
macrophage,O
activation,O
.,O
Molecular,O
cloning,O
and,O
characterization,O
of,O
a,O
cDNA,B
",",O
CHEMR1,B
",",O
encoding,O
a,O
chemokine,O
receptor,O
with,O
a,O
homology,O
to,O
the,O
human,O
C,B
-,I
C,I
chemokine,I
receptor,I
",",O
CCR,B
-,I
4,I
.,O
Chemokines,O
refer,O
to,O
a,O
rapidly,O
expanding,O
family,O
of,O
small,O
cytokines,O
whose,O
primary,O
function,O
is,O
recruitment,O
of,O
leukocytes,O
to,O
inflammatory,O
sites,O
.,O
These,O
are,O
known,O
to,O
bind,O
to,O
seven,O
-,O
transmembrane,O
-,O
domain,O
containing,O
receptors,O
.,O
Northern,O
blot,O
analysis,O
in,O
mouse,O
cell,B
lines,I
suggests,O
that,O
its,O
expression,O
is,O
found,O
in,O
a,O
variety,O
of,O
cells,O
",",O
including,O
T,B
cells,I
",",O
B,B
cells,I
",",O
and,O
macrophages,O
.,O
This,O
suggests,O
that,O
CHEMR1,O
may,O
be,O
a,O
receptor,O
for,O
unidentified,O
C,B
-,I
C,I
chemokine,I
or,O
a,O
low,O
-,O
affinity,O
receptor,O
for,O
MIP,B
-,I
1alpha,I
.,O
Its,O
N,B
-,I
terminal,I
region,I
is,O
capable,O
of,O
activating,O
transcription,O
from,O
a,O
reporter,O
gene,O
when,O
fused,O
to,O
a,O
DNA,B
binding,I
domain,I
.,O
To,O
understand,O
the,O
mechanisms,O
underlined,O
in,O
this,O
regulation,O
in,O
normal,O
human,O
cells,O
",",O
we,O
have,O
analysed,O
in,O
vivo,O
protein,B
-,I
DNA,I
interactions,O
at,O
the,O
Cyclin,O
A,O
locus,O
in,O
primary,O
T,B
lymphocytes,I
.,O
The,O
third,O
site,O
was,O
occupied,O
in,O
quiescent,O
cells,O
or,O
in,O
cells,O
stimulated,O
by,O
anti,O
CD2,O
or,O
anti,O
CD28,O
alone,O
.,O
We,O
have,O
recently,O
reported,O
a,O
series,O
(,O
A,O
),O
of,O
1,O
",",O
25D3,O
-,O
resistant,O
variants,O
of,O
HL60,O
cells,O
which,O
proliferate,O
in,O
the,O
presence,O
of,O
1,O
",",O
25D3,O
and,O
do,O
not,O
express,O
differentiation,O
markers,O
(,O
Exp,O
.,O
Cell,B
Res,I
.,O
224,O
",",O
312,O
",",O
1996,O
.,O
),O
.,O
Human,O
immunodeficiency,O
virus,O
type,O
1,O
(,O
HIV,B
-,I
1,I
),O
Tat,B
",",O
an,O
early,O
regulatory,O
protein,B
that,O
is,O
critical,O
for,O
viral,O
gene,O
expression,O
and,O
replication,O
",",O
transactivates,O
the,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,O
LTR,B
),O
via,O
its,O
binding,O
to,O
the,O
transactivation,O
response,O
element,O
(,O
TAR,B
),O
and,O
",",O
along,O
with,O
other,O
cellular,B
factors,I
",",O
increases,O
viral,O
transcription,O
initiation,O
and,O
elongation,O
.,O
In,O
this,O
study,O
",",O
a,O
combined,O
pharmacologic,O
and,O
genetic,O
strategy,O
using,O
two,O
PKC,B
(,O
NF,B
-,I
kappa,I
B,I
),O
inhibitors,O
",",O
pentoxifylline,O
(,O
PTX,O
),O
and,O
a,O
stably,O
expressed,O
anti,B
-,I
Tat,I
single,I
-,I
chain,I
intracellular,I
antibody,I
(,O
sFv,O
intrabody,O
),O
was,O
employed,O
to,O
obtain,O
cooperative,O
inhibition,O
of,O
both,O
HIV,B
-,I
1,I
LTR,I
-,I
driven,I
gene,I
expression,I
and,O
HIV,B
-,I
1,I
replication,I
.,O
Treatment,O
of,O
cells,O
with,O
PTX,B
and,O
Go,B
-,I
6976,I
resulted,O
in,O
cooperative,O
inhibition,O
of,O
both,O
HIV,B
-,I
1,I
LTR,I
-,I
driven,I
gene,I
expression,I
and,O
HIV,B
-,I
1,I
replication,I
.,O
The,O
combined,O
treatment,O
resulted,O
in,O
more,O
durable,O
inhibition,O
of,O
HIV,B
-,I
1,I
replication,I
than,O
was,O
seen,O
with,O
the,O
NF,B
-,I
kappa,I
B,I
inhibitors,I
alone,O
or,O
the,O
anti,O
-,O
Tat,O
sFv,O
intrabodies,O
alone,O
.,O
CD28,B
is,O
an,O
important,O
costimulatory,O
molecule,O
in,O
the,O
activation,O
of,O
human,B
T,I
cells,I
.,O
Also,O
in,O
the,O
current,O
study,O
",",O
binding,O
activity,O
to,O
the,O
CD28RE,B
/,I
AP,I
-,I
1,I
sequence,I
of,O
the,O
IL,B
-,I
2,I
promoter,I
is,O
evaluated,O
.,O
These,O
data,O
indicate,O
that,O
functional,B
complexes,I
encompassing,I
both,O
the,O
CD28RE,B
and,O
the,O
AP,B
-,I
1,I
-,I
binding,I
sites,I
influence,O
IL,B
-,I
2,I
promoter,I
activity,O
in,O
CD28,B
-,I
costimulated,I
T,I
cells,I
.,O
Inducible,O
expression,O
and,O
phosphorylation,O
of,O
coactivator,O
BOB,B
.,O
1,I
/,I
OBF,I
.,O
1,I
in,O
T,B
cells,I
[,O
see,O
comments,O
],O
Upon,O
activation,O
of,O
Jurkat,B
T,I
cells,I
and,O
primary,O
murine,O
thymocytes,O
with,O
phorbol,O
esters,O
and,O
ionomycin,O
",",O
BOB,B
.,O
1,I
/,I
OBF,I
.,O
1,I
expression,O
and,O
transactivation,O
function,O
were,O
induced,O
.,O
Mutation,O
of,O
Ser184,O
also,O
diminished,O
transactivation,O
function,O
in,O
B,B
cells,I
",",O
suggesting,O
that,O
the,O
activating,O
phosphorylation,O
that,O
is,O
inducible,O
in,O
T,B
cells,I
is,O
constitutively,O
present,O
in,O
B,B
cells,I
.,O
In,O
fact,O
",",O
the,O
offspring,O
of,O
alcoholics,O
have,O
higher,O
levels,O
of,O
G,B
(,O
S,I
),O
alpha,O
expression,O
in,O
certain,O
tissues,O
compared,O
with,O
the,O
offspring,O
of,O
nonalcoholics,O
.,O
The,O
aim,O
of,O
this,O
research,O
was,O
to,O
test,O
the,O
hypothesis,O
that,O
a,O
causal,O
relationship,O
exists,O
between,O
the,O
level,O
of,O
expression,O
of,O
G,B
(,O
S,I
),O
alpha,O
and,O
induction,O
of,O
the,O
adenylyl,O
cyclase,O
(,O
AC,B
),O
cascade,O
.,O
The,O
methodology,O
employed,O
transient,O
transfection,O
of,O
HEK,B
293,I
cells,I
with,O
a,O
cDNA,B
for,O
the,O
52,O
-,O
kDa,O
form,O
of,O
G,B
(,O
S,B
),O
alpha,O
under,O
regulation,O
by,O
inducible,O
metallothionein,O
promoters,O
.,O
VSMCs,B
derived,O
from,O
human,O
coronary,O
atherosclerotic,O
plaques,O
that,O
apoptose,O
even,O
in,O
serum,O
also,O
generated,O
thrombin,B
(,O
AUC,O
of,O
260,O
+,O
/,O
-,O
2,O
nmol,O
x,O
min,O
/,O
L,O
;,O
PT,O
of,O
128,O
+,O
/,O
-,O
4,O
nmol,O
/,O
L,O
.,O
Patients,O
with,O
one,O
type,O
of,O
major,O
histocompatibility,B
complex,I
class,I
II,I
combined,I
immunodeficiency,I
have,O
mutations,O
in,O
a,O
gene,O
termed,O
class,B
II,I
transactivator,I
(,O
CIITA,B
),O
",",O
which,O
coordinately,O
controls,O
the,O
transcription,O
of,O
the,O
three,O
major,O
human,O
class,B
II,I
genes,I
",",O
HLA,B
-,I
DR,I
",",O
-,O
DQ,B
",",O
and,O
-,O
DP,B
.,O
We,O
report,O
here,O
that,O
ectopic,O
expression,O
of,O
CIITA,B
cDNAs,I
derived,O
by,O
reverse,O
transcriptase,O
polymerase,O
chain,O
reaction,O
from,O
clone,O
13,O
do,O
not,O
restore,O
expression,O
of,O
HLA,B
-,I
DQ,I
in,O
another,O
CIITA,B
-,O
deficient,O
cell,O
line,O
",",O
RJ2,O
.,O
2,O
.,O
5,O
.,O
In,O
contrast,O
",",O
somatic,O
cell,O
fusion,O
between,O
clone,O
13,O
and,O
RJ2,B
.,O
2,O
.,O
5,O
restored,O
expression,O
of,O
the,O
HLA,B
-,I
DQ,I
haplotype,I
encoded,O
by,O
the,O
RJ2,B
.,O
2,O
.,O
5,O
DQB,B
gene,I
.,O
The,O
cytokines,O
interleukin,B
(,O
IL,B
),O
-,O
4,O
and,O
IL,B
-,O
13,O
play,O
a,O
critical,O
role,O
in,O
inducing,O
Cepsilon,B
germline,I
transcripts,I
and,O
IgE,B
isotype,I
switching,I
in,O
human,B
B,I
cells,I
.,O
We,O
show,O
that,O
ligand,O
-,O
induced,O
homodimerization,O
of,O
chimeric,O
surface,O
receptors,O
consisting,O
of,O
the,O
extracellular,O
and,O
transmembrane,O
domains,O
of,O
the,O
erythropoietin,B
receptor,I
and,O
of,O
the,O
intracellular,O
domain,O
of,O
IL,B
-,I
4Ralpha,I
induces,O
Janus,B
kinase,I
1,I
(,O
Jak1,B
),O
activation,O
",",O
STAT6,B
activation,O
",",O
and,O
Cepsilon,B
germline,I
transcripts,I
in,O
human,O
B,B
cell,I
line,I
BJAB,I
.,O
Characterization,O
of,O
peripheral,O
blood,O
T,B
-,I
lymphocytes,I
transduced,O
with,O
HTLV,O
-,O
I,O
Tax,O
mutants,O
with,O
different,O
trans,O
-,O
activating,O
phenotypes,O
.,O
Analysis,O
of,O
these,O
PBLs,O
revealed,O
that,O
activation,O
of,O
the,O
NF,B
-,I
kappaB,I
pathway,I
is,O
sufficient,O
to,O
promote,O
the,O
growth,O
response,O
to,O
IL,B
-,I
2,I
.,O
Some,O
of,O
the,O
most,O
potent,O
antiinflammatory,O
and,O
immunosuppressive,O
agents,O
are,O
synthetic,O
glucocorticoids,O
.,O
The,O
development,O
of,O
improved,O
glucocorticoid,B
-,I
based,I
drugs,I
will,O
require,O
the,O
separation,O
of,O
beneficial,O
from,O
deleterious,O
effects,O
.,O
One,O
possibility,O
toward,O
this,O
goal,O
is,O
to,O
try,O
to,O
dissociate,O
two,O
main,O
activities,O
of,O
glucocorticoids,B
",",O
i,O
.,O
e,O
.,O
transactivation,O
and,O
transrepression,O
.,O
To,O
understand,O
the,O
molecular,O
mechanisms,O
controlling,O
CD19,B
gene,I
expression,I
",",O
we,O
isolated,O
and,O
functionally,O
characterized,O
the,O
CD19,B
promoter,I
using,O
in,O
vivo,O
footprinting,O
",",O
gel,O
shift,O
assays,O
",",O
and,O
transfection,O
studies,O
.,O
EBF,B
and,O
E47,B
collaborate,O
to,O
induce,O
expression,O
of,O
the,O
endogenous,O
immunoglobulin,B
surrogate,I
light,I
chain,I
genes,I
.,O
Taken,O
together,O
",",O
these,O
data,O
suggest,O
that,O
EBF,B
and,O
E47,B
synergize,O
to,O
activate,O
expression,O
of,O
a,O
subset,O
of,O
genes,O
that,O
define,O
an,O
early,O
stage,O
of,O
the,O
B,B
cell,I
lineage,I
.,O
Treatment,O
of,O
cells,O
expressing,O
the,O
chimeric,O
receptor,O
kit,B
/,I
IL,I
-,I
4R,I
alpha,I
with,O
SCF,O
induces,O
activation,O
of,O
the,O
IL,B
-,I
4R,I
alpha,I
-,I
associated,I
kinase,I
JAK,B
-,I
1,I
and,O
the,O
transcription,O
factor,O
STAT6,B
.,O
Dose,O
-,O
dependence,O
studies,O
using,O
histamine,B
and,O
dimaprit,O
showed,O
that,O
the,O
EC50,O
values,O
for,O
cAMP,B
production,O
and,O
c,O
-,O
fos,O
increase,O
were,O
similar,O
",",O
suggesting,O
that,O
cAMP,B
might,O
be,O
involved,O
in,O
c,O
-,O
fos,O
induction,O
via,O
H2,O
receptors,O
.,O
BACKGROUND,O
:,O
Activated,O
platelets,B
tether,O
and,O
activate,O
myeloid,B
leukocytes,I
.,O
Throughout,O
the,O
study,O
period,O
",",O
CD41,B
immunofluorescence,O
of,O
leukocytes,I
(,O
flow,O
cytometry,O
),O
revealed,O
increased,O
leukocyte,B
-,I
platelet,I
adhesion,O
in,O
patients,O
with,O
AMI,O
compared,O
with,O
control,O
patients,O
(,O
mean,O
+,O
/,O
-,O
SE,O
of,O
fluorescence,O
[,O
channels,O
],O
before,O
PTCA,O
:,O
77,O
+,O
/,O
-,O
16,O
versus,O
35,O
+,O
/,O
-,O
9,O
;,O
P,O
=,O
.,O
3,O
),O
.,O
After,O
4,O
hours,O
",",O
IL,B
-,I
1,I
beta,I
and,O
IL,B
-,I
8,I
concentration,O
of,O
the,O
cell,B
-,I
free,I
supernatant,I
had,O
increased,O
by,O
268,O
+,O
/,O
-,O
36,O
%,O
and,O
210,O
+,O
/,O
-,O
7,O
%,O
",",O
respectively,O
",",O
and,O
cellular,O
MCP,B
-,I
1,I
content,O
had,O
increased,O
by,O
170,O
+,O
/,O
-,O
8,O
%,O
.,O
The,O
present,O
work,O
shows,O
that,O
the,O
primary,O
CD8,B
+,I
CTL,I
response,O
to,O
EBV,B
in,O
infectious,O
mononucleosis,O
patients,O
contains,O
multiple,O
lytic,O
antigen,O
-,I
specific,I
reactivities,O
at,O
levels,O
at,O
least,O
as,O
high,O
as,O
those,O
seen,O
against,O
latent,O
antigens,O
;,O
similar,O
reactivities,O
are,O
also,O
detectable,O
in,O
CTL,B
memory,O
.,O
Clonal,O
analysis,O
revealed,O
individual,O
responses,O
to,O
the,O
two,O
immediate,O
early,O
proteins,B
BZLF1,I
and,O
BRLF1,B
",",O
and,O
to,O
three,O
(,O
BMLF1,B
",",O
BMRF1,B
",",O
and,O
BALF2,B
),O
of,O
the,O
six,O
early,O
proteins,B
tested,O
.,O
The,O
unique,O
capacity,O
of,O
gamma,B
-,I
herpesvirus,I
to,O
amplify,O
the,O
viral,B
load,I
in,O
vivo,O
through,O
a,O
latent,O
growth,O
-,O
transforming,O
infection,O
may,O
have,O
rendered,O
these,O
agents,O
less,O
dependent,O
upon,O
viral,B
replication,I
as,O
a,O
means,O
of,O
successfully,O
colonizing,O
their,O
hosts,O
.,O
Triggering,O
of,O
HLA,B
class,I
II,I
antigens,I
by,O
the,O
anti,O
-,O
HLA,B
-,I
DR,I
monoclonal,I
antibody,I
(,O
mAb,O
),O
L243,O
significantly,O
(,O
P,O
<,O
0,O
.,O
5,O
),O
and,O
differentially,O
enhanced,O
the,O
release,O
of,O
tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNF,B
-,I
alpha,I
),O
by,O
the,O
non,O
-,O
Hodgkin,B
',O
s,O
lymphoma,I
cells,I
Ri,O
-,O
I,O
",",O
Ci,O
-,O
I,O
",",O
and,O
Sc,O
-,O
I,O
",",O
which,O
are,O
at,O
a,O
distinct,O
stage,O
of,O
B,B
-,I
cell,I
differentiation,I
",",O
and,O
by,O
the,O
more,O
mature,O
Burkitt,B
lymphoma,I
cell,I
Raji,O
;,O
in,O
contrast,O
",",O
it,O
did,O
not,O
induce,O
TNF,B
-,I
alpha,I
release,O
by,O
the,O
pre,O
-,O
B,B
leukemia,I
cells,I
Nalm,O
-,O
6,O
and,O
BV173,O
.,O
Altogether,O
",",O
our,O
data,O
demonstrate,O
that,O
:,O
(,O
a,O
),O
the,O
ability,O
of,O
B,B
cells,I
to,O
release,O
TNF,B
-,I
alpha,I
after,O
triggering,O
of,O
HLA,B
-,I
DR,I
antigens,I
depends,O
on,O
their,O
stage,O
of,O
differentiation,O
;,O
(,O
b,O
),O
levels,O
of,O
released,O
TNF,B
-,I
alpha,I
seem,O
to,O
correlate,O
with,O
the,O
stage,O
of,O
B,B
-,I
cell,I
maturation,I
but,O
do,O
not,O
correlate,O
with,O
the,O
amounts,O
of,O
cell,O
surface,O
HLA,B
-,I
DR,I
antigens,I
;,O
(,O
c,O
),O
secreted,O
TNF,B
-,I
alpha,I
regulates,O
the,O
levels,O
of,O
expression,O
of,O
NF,B
-,I
kappa,I
B,I
and,O
AP,B
-,I
1,I
by,O
an,O
autocrine,O
loop,O
;,O
and,O
(,O
d,O
),O
intracellular,O
signals,O
mediating,O
TNF,B
-,I
alpha,I
release,O
by,O
B,B
cells,I
are,O
distinct,O
from,O
those,O
regulating,O
homotypic,O
aggregation,O
and,O
proliferation,O
.,O
To,O
identify,O
genes,O
that,O
are,O
expressed,O
in,O
T,B
cells,I
after,O
stimulation,O
",",O
mRNA,B
from,O
T,B
lymphocytes,I
that,O
had,O
been,O
activated,O
by,O
the,O
simultaneous,O
stimulation,O
of,O
the,O
CD3,B
and,O
CD28,B
trigger,I
molecules,I
was,O
transcribed,O
for,O
a,O
differential,O
mRNA,B
display,I
analysis,I
into,O
cDNA,B
and,O
was,O
compared,O
with,O
cDNA,B
from,O
CD28,B
-,I
or,O
CD3,B
-,I
activated,O
or,O
resting,O
lymphocytes,I
.,O
The,O
predictive,O
protein,B
-,I
coding,I
region,I
of,O
RP1,B
had,O
a,O
significant,O
homology,O
to,O
members,O
of,O
the,O
recently,O
found,O
adenomatous,O
polyposis,O
coli,O
(,O
APC,B
),O
protein,O
-,O
binding,O
EB1,O
gene,O
family,O
",",O
which,O
codes,O
for,O
yet,O
unknown,O
protein,O
(,O
s,O
),O
.,O
Bacterially,O
expressed,O
RP1,B
protein,O
revealed,O
specific,O
binding,O
to,O
wild,O
-,O
type,O
but,O
not,O
to,O
mutated,O
APC,B
protein,O
.,O
Cyclosporin,O
A,O
interferes,O
with,O
the,O
inducible,O
degradation,O
of,O
NF,B
-,I
kappa,I
B,I
inhibitors,O
",",O
but,O
not,O
with,O
the,O
processing,O
of,O
p105,B
/,I
NF,B
-,I
kappa,I
B1,I
in,O
T,O
cells,O
.,O
We,O
show,O
for,O
human,O
Jurkat,B
T,I
leukemia,I
cells,I
",",O
as,O
well,O
as,O
human,O
and,O
mouse,O
primary,O
T,O
lymphocytes,O
",",O
that,O
this,O
inhibitory,O
effect,O
is,O
accompanied,O
by,O
an,O
impaired,O
nuclear,O
translocation,O
of,O
the,O
Rel,B
proteins,I
c,I
-,I
Rel,I
",",O
RelA,B
/,I
p65,I
and,O
NF,B
-,I
kappa,I
B1,I
/,I
p50,I
",",O
whereas,O
the,O
nuclear,O
appearance,O
of,O
RelB,B
remains,O
unaffected,O
.,O
Accordingly,O
",",O
immunoblot,O
experiments,O
showed,O
that,O
amongst,O
NF,B
-,I
kappa,I
B,I
/,I
Rel,B
proteins,I
",",O
RelA,B
and,O
p50,B
are,O
mobilized,O
to,O
the,O
nucleus,O
following,O
microglial,B
cell,I
stimulation,O
with,O
A,B
beta,I
(,I
25,I
-,I
35,I
),I
plus,O
IFN,B
gamma,I
.,O
Higher,O
concentrations,O
of,O
A,B
beta,I
(,I
25,I
-,I
35,I
),I
were,O
effective,O
by,O
themselves,O
in,O
inducing,O
NF,B
-,I
kappa,I
B,I
activation,O
",",O
both,O
in,O
the,O
N9,B
microglial,I
cell,I
line,I
and,O
in,O
rat,O
primary,O
microglia,B
",",O
as,O
well,O
as,O
in,O
human,O
monocytes,B
.,O
For,O
purposes,O
of,O
comparison,O
",",O
microglia,B
were,O
also,O
stimulated,O
with,O
bacterial,O
LPS,B
",",O
a,O
known,O
NF,B
-,I
kappa,I
B,I
inducer,O
.,O
As,O
expected,O
",",O
LPS,B
strongly,O
induced,O
the,O
formation,O
of,O
two,O
NF,B
-,I
kappa,I
B,I
DNA,B
-,I
binding,I
activities,I
",",O
one,O
of,O
which,O
was,O
identified,O
as,O
RelA,B
/,I
p50,I
.,O
Collectively,O
",",O
these,O
findings,O
indicate,O
that,O
NF,B
-,I
kappa,I
B,I
activation,O
might,O
constitute,O
one,O
of,O
the,O
mechanisms,O
underlying,O
the,O
inducible,O
expression,O
of,O
kappa,O
B,O
-,O
dependent,O
genes,O
in,O
microglia,O
stimulated,O
by,O
A,O
beta,O
peptides,O
and,O
IFN,O
gamma,O
",",O
or,O
by,O
LPS,B
.,O
The,O
persistence,O
of,O
TGF,B
-,I
beta1,I
-,I
transcribing,O
macrophages,O
",",O
despite,O
paralysis,O
of,O
T,B
cell,I
function,I
",",O
may,O
provide,O
an,O
explanation,O
for,O
the,O
chronicity,O
of,O
the,O
disease,O
",",O
and,O
may,O
identify,O
a,O
novel,O
therapeutic,O
target,O
in,O
this,O
inflammatory,O
vasculopathy,O
.,O
We,O
have,O
generated,O
transgenic,O
mice,O
that,O
express,O
a,O
catalytically,O
inactive,O
form,O
of,O
Ca2,B
+,I
/,I
calmodulin,I
-,I
dependent,I
protein,I
kinase,I
IV,I
(,O
CaMKIV,B
),O
specifically,O
in,O
thymic,O
T,B
cells,I
.,O
We,O
isolated,O
a,O
new,O
mouse,B
gene,I
that,O
is,O
highly,O
expressed,O
in,O
thymocytes,B
",",O
testis,B
",",O
and,O
brain,B
.,O
Rabbit,O
antiserum,O
raised,O
against,O
a,O
COOH,B
-,I
terminal,I
polypeptide,I
of,O
the,O
SRG3.00,B
recognized,O
a,O
protein,B
with,O
an,O
apparent,O
molecular,O
mass,O
of,O
155,O
kD,O
.,O
The,O
serum,O
also,O
detected,O
a,O
170,O
-,O
kD,O
protein,B
that,O
seems,O
to,O
be,O
a,O
mouse,B
homologue,O
of,O
human,O
BAF170,B
.,O
Transcriptional,O
induction,O
of,O
collagenase,B
-,I
1,I
in,O
differentiated,O
monocyte,B
-,I
like,I
(,O
U937,B
),O
cells,O
is,O
regulated,O
by,O
AP,O
-,O
1,O
and,O
an,O
upstream,O
C,B
/,I
EBP,I
-,I
beta,I
site,O
.,O
Chloramphenicol,O
acetyltransferase,O
expression,O
constructs,O
containing,O
regions,O
of,O
the,O
human,O
collagenase,B
-,I
1,I
promoter,I
were,O
stably,O
or,O
transiently,O
transfected,O
into,O
U937,B
cells,O
",",O
and,O
reporter,O
activity,O
was,O
assessed,O
at,O
various,O
times,O
after,O
the,O
onset,O
of,O
phorbol,O
12,O
-,O
myristate,O
13,O
-,O
acetate,O
(,O
PMA,O
),O
-,O
mediated,O
differentiation,O
.,O
In,O
particular,O
",",O
Western,O
",",O
supershift,O
",",O
and,O
promoter,O
deletion,O
analyses,O
suggested,O
a,O
role,O
for,O
CCAAT,O
/,O
enhancer,O
-,O
binding,O
protein,B
-,O
beta,I
(,O
C,B
/,I
EBP,I
-,I
beta,I
),O
binding,O
site,O
between,O
-,O
2010,O
and,O
-,O
1954,O
in,O
regulating,O
transcription,O
of,O
collagenase,O
-,O
1,O
in,O
monocytic,B
cells,I
.,O
It,O
has,O
been,O
recently,O
claimed,O
that,O
polymorphism,O
for,O
the,O
vitamin,B
D,I
receptor,I
(,O
VDR,B
),O
influences,O
several,O
aspects,O
of,O
calcium,B
and,I
bone,I
metabolism,I
.,O
To,O
evaluate,O
the,O
physiologic,O
plausibility,O
of,O
these,O
claims,O
",",O
we,O
compared,O
the,O
abundance,O
of,O
the,O
VDR,B
mRNA,I
in,O
peripheral,O
blood,O
mononuclear,O
cells,O
(,O
PBMCs,B
),O
between,O
different,O
VDR,B
genotypes,O
using,O
a,O
quantitative,O
reverse,O
transcribed,O
polymerase,O
chain,O
reaction,O
-,O
based,O
method,O
.,O
The,O
concentration,O
of,O
the,O
VDR,B
mRNA,I
",",O
corrected,O
for,O
the,O
number,O
of,O
monocytes,O
",",O
was,O
similar,O
among,O
the,O
three,O
genotype,O
groups,O
",",O
as,O
were,O
the,O
other,O
variables,O
examined,O
:,O
serum,O
calcitriol,B
",",O
serum,O
osteocalcin,B
",",O
and,O
vertebral,O
and,O
hip,O
bone,O
density,O
.,O
Both,O
truncated,O
forms,O
also,O
bound,O
to,O
the,O
transcription,O
factor,O
RBP,B
-,I
Jkappa,I
in,O
extracts,O
prepared,O
from,O
human,O
and,O
murine,O
T,B
-,I
ALL,I
cell,I
lines,I
.,O
Unexpectedly,O
",",O
a,O
second,O
",",O
stronger,O
RBP,B
-,I
Jkappa,I
-,I
binding,I
site,I
",",O
which,O
lies,O
within,O
the,O
intracellular,O
domain,O
close,O
to,O
the,O
transmembrane,O
region,O
and,O
significantly,O
augments,O
association,O
with,O
RBP,B
-,I
Jkappa,I
",",O
was,O
not,O
needed,O
for,O
oncogenesis,O
or,O
for,O
transcriptional,O
activation,O
.,O
In,O
support,O
of,O
this,O
interpretation,O
",",O
mutation,O
of,O
putative,O
nuclear,B
localization,I
sequences,I
decreased,O
nuclear,B
localization,I
and,O
increased,O
transcriptional,O
activation,O
by,O
membrane,O
-,O
bound,O
DeltaE,O
.,O
These,O
studies,O
have,O
indicated,O
that,O
the,O
individual,O
repeats,O
are,O
not,O
identical,O
with,O
respect,O
to,O
the,O
cellular,B
factors,I
with,O
which,O
they,O
interact,O
.,O
EMS,O
analyses,O
utilizing,O
a,O
series,O
of,O
mutated,O
pp,O
repeat,O
elements,O
demonstrate,O
that,O
the,O
nucleotide,O
sequence,O
requirements,O
for,O
U1,B
(,O
U1A,B
/,O
U1B,B
),O
and,O
U2,B
formation,O
are,O
separable,O
from,O
those,O
required,O
for,O
C1,B
-,I
C3,I
formation,O
.,O
EMS,O
supershift,O
analyses,O
have,O
demonstrated,O
that,O
Sp1,B
is,O
involved,O
in,O
U1A,B
formation,O
while,O
Sp3,B
is,O
involved,O
in,O
U1B,B
and,O
U2,B
formation,O
.,O
In,O
the,O
adult,O
bone,O
marrow,O
",",O
we,O
found,O
expression,O
of,O
runt,B
polypeptides,I
in,O
differentiating,O
myeloid,B
cells,I
and,O
in,O
B,B
lymphocytes,I
.,O
Signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
-,O
3,O
(,O
STAT3,B
),O
is,O
constitutively,O
activated,O
in,O
normal,O
",",O
self,O
-,O
renewing,O
B,B
-,I
1,I
cells,I
but,O
only,O
inducibly,O
expressed,O
in,O
conventional,O
B,B
lymphocytes,I
[,O
see,O
comments,O
],O
Cytokine,O
and,O
growth,O
factor,O
receptor,O
engagement,O
leads,O
to,O
the,O
rapid,O
phosphorylation,O
and,O
activation,O
of,O
latent,O
",",O
cytosolic,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
STAT,B
),O
proteins,O
",",O
which,O
then,O
translocate,O
to,O
the,O
nucleus,O
where,O
they,O
regulate,O
transcriptional,O
events,O
from,O
specific,O
promoter,O
sequences,O
.,O
B,B
-,O
1,O
lymphocytes,B
are,O
self,O
-,O
renewing,O
",",O
CD5,B
+,O
B,B
cells,O
that,O
display,O
a,O
propensity,O
for,O
malignant,O
transformation,O
and,O
are,O
the,O
normal,O
counterpart,O
to,O
human,O
chronic,O
lymphocytic,O
leukemias,O
.,O
Further,O
",",O
B,B
-,O
1,O
cells,O
are,O
characterized,O
by,O
aberrant,O
intracellular,O
signaling,O
",",O
including,O
hyperresponsiveness,O
to,O
phorbol,O
ester,O
PKC,B
agonists,O
.,O
Induction,O
of,O
STAT3,B
is,O
inhibited,O
by,O
both,O
the,O
serine,B
/,I
threonine,I
protein,I
kinase,I
inhibitor,I
H,O
-,O
7,O
and,O
the,O
immunosuppressive,O
drug,O
rapamycin,O
and,O
requires,O
de,O
novo,O
protein,O
synthesis,O
",",O
demonstrating,O
novel,O
coupling,O
between,O
sIg,O
and,O
STAT,B
proteins,I
that,O
differs,O
from,O
the,O
classical,O
paradigm,O
for,O
STAT,B
induction,O
by,O
cytokine,O
receptors,O
.,O
One,O
of,O
the,O
potential,O
advantages,O
of,O
autologous,O
PBSCT,O
is,O
the,O
possibility,O
that,O
peripheral,O
blood,O
stem,O
cells,O
(,O
PBSC,B
),O
are,O
less,O
likely,O
to,O
be,O
contaminated,O
by,O
leukemic,O
cells,O
than,O
bone,O
marrow,O
grafts,O
.,O
This,O
effect,O
was,O
specifically,O
due,O
to,O
Tat,B
",",O
since,O
Jurkat,B
and,O
U937,B
cells,O
cotransfected,O
either,O
with,O
tat,O
cDNA,B
in,O
antisense,O
orientation,O
(,O
tat,O
/,O
AS,O
),O
",",O
tat,O
carrying,O
a,O
mutation,O
in,O
the,O
aminoacid,O
cys22,B
-,I
gly22,I
(,O
tat,O
22,O
/,O
S,O
),O
or,O
with,O
the,O
backbone,O
vector,O
alone,O
(,O
pRPneo,O
-,O
SL3,O
),O
did,O
not,O
show,O
any,O
significant,O
difference,O
in,O
c,O
-,O
fos,O
promoter,O
activity,O
as,O
compared,O
to,O
cells,O
transfected,O
with,O
FC3,O
plasmid,O
alone,O
.,O
c,O
-,O
Fos,B
protein,I
was,O
shown,O
essential,O
for,O
an,O
optimal,O
transactivation,O
of,O
the,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,O
LTR,B
),O
by,O
Tat,O
:,O
incubation,O
of,O
Jurkat,B
cells,I
with,O
antisense,O
",",O
but,O
not,O
sense,O
",",O
c,O
-,O
fos,O
oligonucleotides,O
significantly,O
reduced,O
either,O
the,O
Tat,O
-,O
enhanced,O
expression,O
of,O
an,O
LTR,B
-,I
CAT,I
reporter,I
construct,I
or,O
the,O
levels,O
of,O
gag,B
p24,I
in,O
the,O
culture,O
supernatants,O
of,O
Jurkat,B
cells,I
and,O
PBMC,B
acutely,O
infected,O
with,O
HIV,B
-,I
1,I
.,O
Regulation,O
of,O
the,O
tissue,O
factor,B
gene,I
in,O
human,O
monocytic,B
cells,I
.,O
Role,O
of,O
AP,B
-,I
1,I
",",O
NF,B
-,I
kappa,I
B,I
/,I
Rel,I
",",O
and,O
Sp1,B
proteins,I
in,O
uninduced,O
and,O
lipopolysaccharide,O
-,O
induced,O
expression,O
.,O
The,O
human,O
TF,B
promoter,I
contains,O
binding,O
sites,O
for,O
the,O
transcription,O
factors,O
AP,B
-,I
1,I
",",O
c,B
-,I
Rel,I
/,I
p65,I
",",O
Egr,B
-,I
1,I
",",O
and,O
Sp1,B
.,O
The,O
two,O
AP,B
-,I
1,I
sites,I
bound,O
c,O
-,O
Fos,B
/,I
c,I
-,I
Jun,I
heterodimers,I
in,O
both,O
unstimulated,O
and,O
LPS,O
-,O
stimulated,O
cells,O
.,O
Inhibitory,O
effect,O
of,O
growth,B
hormone,I
on,O
TNF,B
-,I
alpha,I
secretion,O
and,O
nuclear,B
factor,I
-,I
kappaB,I
translocation,O
in,O
lipopolysaccharide,B
-,I
stimulated,I
human,B
monocytes,I
.,O
The,O
present,O
study,O
demonstrates,O
that,O
human,B
THP,B
-,I
1,I
promonocytic,I
cells,I
",",O
engineered,O
by,O
gene,B
transfer,I
to,O
constitutively,O
produce,O
human,B
growth,I
hormone,I
(,O
hGH,B
),O
",",O
secreted,O
depressed,O
amounts,O
of,O
TNF,B
-,I
alpha,I
in,O
response,O
to,O
challenge,O
by,O
LPS,B
.,O
Previously,O
",",O
we,O
showed,O
that,O
fibroblast,B
conditioned,I
medium,I
(,O
FCM,B
),O
is,O
able,O
to,O
inhibit,O
both,O
TNF,B
mRNA,I
accumulation,I
and,O
protein,B
release,I
in,O
peripheral,B
blood,I
-,I
derived,I
human,I
monocytes,I
(,O
PBM,B
),O
stimulated,O
with,O
lipopolysaccharide,B
(,O
LPS,B
),O
.,O
Furthermore,O
",",O
we,O
show,O
that,O
exogenous,O
PGE2,B
mimics,O
the,O
NF,B
-,I
kappaB,I
inhibitory,I
effect,I
of,O
FCM,B
.,O
Two,O
main,O
pieces,O
of,O
data,O
prompted,O
us,O
to,O
focus,O
on,O
the,O
activation,O
of,O
the,O
platelet,O
fibrinogen,B
receptor,I
",",O
the,O
alphaIIbbeta3,B
integrin,I
.,O
Immunoblot,O
and,O
flow,O
cytometry,O
analysis,O
revealed,O
a,O
limited,O
proteolysis,O
of,O
the,O
carboxyl,O
terminus,O
of,O
the,O
alphaIIb,B
subunit,I
heavy,I
chain,I
(,O
alphaIIbH,B
),O
",",O
as,O
judged,O
by,O
the,O
disappearance,O
of,O
the,O
epitope,O
for,O
the,O
monoclonal,O
antibody,O
PMI,O
-,O
1,O
.,O
Treatment,O
by,O
NE,O
of,O
ATP,B
-,I
depleted,I
platelets,I
or,O
Chinese,B
hamster,I
ovary,I
cells,I
expressing,O
human,O
recombinant,O
alphaIIbbeta3,B
clearly,O
established,O
that,O
activation,O
of,O
the,O
integrin,O
was,O
independent,O
of,O
signal,O
transduction,O
events,O
and,O
was,O
concomitant,O
with,O
the,O
proteolysis,O
of,O
alphaIIbH,B
.,O
In,O
contrast,O
",",O
LAI,O
replicates,O
well,O
in,O
memory,B
CD4,I
T,I
cells,I
stimulated,O
in,O
the,O
same,O
way,O
.,O
These,O
studies,O
were,O
conducted,O
with,O
highly,O
purified,O
(,O
FACS,O
-,O
isolated,O
),O
subsets,O
of,O
CD4,B
T,I
cells,I
identified,O
by,O
expression,O
of,O
both,O
CD45RA,B
and,O
CD62L,B
.,O
The,O
suppression,O
of,O
productive,O
LAI,O
replication,O
in,O
naive,O
T,B
cells,I
is,O
not,O
due,O
to,O
differential,O
expression,O
of,O
viral,O
coreceptors,O
",",O
nor,O
is,O
it,O
due,O
to,O
inhibition,O
of,O
activation,O
of,O
the,O
important,O
HIV,B
transcription,I
factors,I
",",O
nuclear,O
factor,O
-,O
kappaB,B
and,O
activator,O
protein,O
-,O
1,O
.,O
To,O
test,O
the,O
hypothesis,O
that,O
the,O
chimera,O
PMLRAR,B
alpha,I
plays,O
a,O
role,O
in,O
leukemogenesis,O
",",O
we,O
expressed,O
a,O
PMLRAR,B
alpha,I
cDNA,O
in,O
myeloid,B
cells,I
of,O
transgenic,O
mice,O
.,O
Retinoic,O
acid,O
caused,O
the,O
leukemic,B
cells,I
to,O
differentiate,O
in,O
vitro,O
and,O
in,O
vivo,O
",",O
eliciting,O
remissions,O
of,O
both,O
the,O
preleukemic,B
state,I
and,O
APL,B
in,O
mice,O
.,O
Our,O
results,O
demonstrate,O
that,O
PMLRAR,B
alpha,I
impairs,O
neutrophil,B
differentiation,I
and,O
initiates,O
the,O
development,O
of,O
APL,B
.,O
The,O
transgenic,O
mice,O
described,O
here,O
provide,O
an,O
apparently,O
accurate,O
model,O
for,O
human,O
APL,B
that,O
includes,O
clear,O
evidence,O
of,O
tumor,O
progression,O
.,O
Such,O
hypermethylation,O
-,O
associated,O
silencing,O
of,O
gene,O
expression,O
has,O
been,O
shown,O
for,O
several,O
genes,O
regulating,O
the,O
growth,O
and,O
differentiation,O
of,O
hematopoietic,B
cells,I
",",O
including,O
the,O
estrogen,B
receptor,I
(,O
ER,B
),O
gene,O
",",O
P15,B
",",O
P16,B
and,O
others,O
.,O
The,O
high,O
prevalence,O
of,O
promoter,B
methylation,I
suggests,O
that,O
this,O
molecular,O
abnormality,O
can,O
be,O
used,O
to,O
monitor,O
disease,O
activity,O
during,O
therapy,O
.,O
Finally,O
",",O
reactivation,O
of,O
tumor,O
-,O
suppressor,O
gene,O
expression,O
through,O
pharmacologic,O
inhibition,O
of,O
DNA,B
methyltransferase,I
and,O
resultant,O
DNA,B
demethylation,I
appears,O
to,O
be,O
a,O
promising,O
new,O
avenue,O
of,O
therapy,O
in,O
acute,O
leukemia,O
.,O
Redox,O
regulation,O
of,O
the,O
mitogen,O
-,O
activated,O
protein,B
kinase,I
pathway,I
during,O
lymphocyte,O
activation,O
.,O
In,O
earlier,O
studies,O
",",O
we,O
have,O
identified,O
the,O
transcription,O
factors,O
NF,B
-,I
kappa,I
B,I
and,O
AP,B
-,I
1,I
as,O
molecular,O
targets,O
for,O
oxidative,O
signalling,O
processes,O
during,O
cell,B
cycle,I
entry,I
",",O
and,O
have,O
shown,O
that,O
oxidative,O
signalling,O
is,O
involved,O
in,O
the,O
regulation,O
of,O
early,O
changes,O
in,O
gene,B
expression,I
during,O
the,O
G0,O
to,O
G1,O
phase,O
transition,O
.,O
Using,O
the,O
yeast,O
two,O
-,O
hybrid,O
system,O
to,O
screen,O
for,O
proteins,B
which,O
interact,O
with,O
Tax1,B
",",O
we,O
isolated,O
the,O
B,B
subunit,I
of,I
the,I
CCAAT,I
binding,I
protein,I
NF,B
-,I
Y,I
from,O
a,O
HeLa,B
cDNA,I
library,I
.,O
The,O
interaction,O
of,O
Tax1,B
with,O
NF,B
-,I
YB,I
was,O
specific,O
in,O
that,O
NF,B
-,I
YB,I
did,O
not,O
interact,O
with,O
a,O
variety,O
of,O
other,O
transcription,O
factors,O
",",O
including,O
human,B
immunodeficiency,I
virus,I
Tat,I
",",O
human,B
papillomavirus,I
E6,I
",",O
and,O
Bicoid,B
",",O
or,O
with,O
the,O
M7,B
(,I
amino,I
acids,I
29CP,I
-,I
AS,I
),I
Tax1,B
mutant,I
.,O
However,O
",",O
NF,B
-,I
YB,I
did,O
interact,O
with,O
the,O
C,B
-,I
terminal,I
Tax1,I
mutants,O
M22,O
(,O
130TL,O
-,O
AS,O
),O
and,O
M47,O
(,O
319LL,O
-,O
RS,O
),O
.,O
Through,O
activation,O
of,O
this,O
and,O
other,O
NF,B
-,I
Y,I
driven,I
promoters,O
",",O
the,O
Tax1,I
-,I
NF,B
-,I
Y,I
interaction,O
may,O
play,O
a,O
critical,O
role,O
in,O
causing,O
cellular,O
transformation,O
and,O
HTLV,O
-,O
1,O
pathogenesis,O
.,O
In,O
murine,O
Ba,O
/,O
F3,O
cells,O
transfected,O
with,O
the,O
human,O
G,B
-,I
CSFR,I
and,O
NFS,B
-,I
60,I
cells,O
constitutively,O
expressing,O
the,O
murine,O
G,B
-,I
CSF,I
induced,O
tyrosine,O
phosphorylation,O
and,O
activation,O
of,O
Jak1,O
",",O
Jak2,O
",",O
and,O
Tyk2,O
.,O
Using,O
a,O
mitogenically,O
incompetent,O
human,O
G,B
-,I
CSFR,I
mutant,O
in,O
which,O
Pro639,B
and,O
Pro641,B
were,O
substituted,O
by,O
alanine,O
",",O
the,O
box,O
1,O
PDP,O
motif,O
was,O
found,O
to,O
be,O
required,O
for,O
activation,O
of,O
Jak,B
kinases,I
",",O
tyrosine,O
phosphorylation,O
of,O
the,O
G,B
-,I
CSFR,I
",",O
and,O
recruitment,O
of,O
Stat,B
proteins,I
.,O
Activation,O
of,O
the,O
Jak,B
-,I
Stat,I
pathway,I
correlates,O
with,O
proliferative,O
signaling,O
by,O
the,O
G,B
-,I
CSFR,I
and,O
requires,O
the,O
membrane,O
-,O
proximal,O
box,O
1,O
PXP,O
motif,O
",",O
which,O
is,O
conserved,O
in,O
members,O
of,O
the,O
cytokine,B
receptor,I
superfamily,I
.,O
Impaired,O
induction,O
of,O
c,B
-,I
fos,I
/,I
c,I
-,I
jun,I
genes,I
and,O
of,O
transcriptional,O
regulatory,O
proteins,O
binding,O
distinct,O
c,B
-,I
fos,I
/,I
c,I
-,I
jun,I
promoter,I
elements,I
in,O
activated,O
human,O
T,B
cells,I
during,O
aging,O
.,O
In,O
addition,O
",",O
RNase,O
protection,O
assays,O
revealed,O
that,O
anti,O
-,O
CD3,B
/,I
PMA,I
-,I
stimulated,O
T,B
cells,I
from,O
a,O
substantial,O
proportion,O
of,O
elderly,O
subjects,O
exhibited,O
decreased,O
levels,O
of,O
c,B
-,I
fos,I
and,O
/,O
or,O
c,B
-,I
jun,I
mRNA,I
compared,O
to,O
T,B
cells,I
from,O
young,O
subjects,O
.,O
BACKGROUND,O
:,O
Retinoic,B
acid,I
(,O
RA,B
),O
has,O
important,O
immune,O
-,O
modulating,O
effects,O
on,O
both,O
T,B
and,O
B,B
cell,I
function,O
.,O
CONCLUSION,O
:,O
These,O
studies,O
suggest,O
that,O
RA,B
can,O
augment,O
IL,B
-,I
2,I
mRNA,I
production,O
by,O
T,B
cells,I
with,O
a,O
possible,O
paracrine,O
effect,O
on,O
IL,B
-,I
2R,I
-,I
alpha,I
expression,O
.,O
Interleukin,B
-,I
6,I
levels,O
are,O
increased,O
in,O
lung,O
transplant,O
patients,O
clinically,O
diagnosed,O
with,O
CMV,O
pneumonitis,O
.,O
In,O
contrast,O
",",O
the,O
RelA,B
(,O
p65,B
),O
subunit,O
was,O
barely,O
detectable,O
in,O
monocytes,B
",",O
but,O
its,O
level,O
increased,O
markedly,O
in,O
MDMs,B
.,O
In,O
MDMs,B
",",O
an,O
upregulation,O
of,O
I,B
kappa,I
B,I
alpha,I
synthesis,O
as,O
well,O
as,O
the,O
appearance,O
of,O
a,O
novel,O
M,B
(,O
r,I
),O
40,O
",",O
0,O
form,O
of,O
I,B
kappa,I
B,I
alpha,I
were,O
also,O
observed,O
". However , the intensity of p65 labeling was much higher in several thymocytes from the medulla .",O
p65,B
",",O
p50,B
",",O
and,O
c,B
-,I
Rel,I
activities,O
were,O
found,O
in,O
both,O
CD4,B
-,I
and,I
CD8,I
-,I
positive,I
thymocytes,I
.,O
These,O
observations,O
suggest,O
that,O
p65,B
and,O
c,B
-,I
Rel,I
complexes,I
play,O
distinct,O
roles,O
in,O
gene,O
expression,O
and,O
that,O
both,O
forms,O
of,O
NF,B
-,I
kappa,I
B,I
play,O
critical,O
roles,O
during,O
late,O
stages,O
of,O
the,O
intrathymic,O
maturation,O
of,O
T,B
cells,I
.,O
The,O
function,O
of,O
LEF,B
-,I
1,I
is,O
dependent,O
",",O
in,O
part,O
",",O
on,O
the,O
HMG,B
domain,I
that,O
induces,O
a,O
sharp,O
bend,O
in,O
the,O
DNA,B
helix,I
",",O
and,O
on,O
an,O
activation,O
domain,O
that,O
stimulates,O
transcription,O
only,O
in,O
a,O
specific,O
context,O
of,O
other,O
enhancer,O
-,O
binding,O
proteins,O
.,O
Overexpression,O
of,O
ALY,B
stimulates,O
the,O
activity,O
of,O
the,O
TCR,B
alpha,I
enhancer,I
complex,I
reconstituted,O
in,O
transfected,O
nonlymphoid,O
HeLa,B
cells,I
",",O
whereas,O
down,O
-,O
regulation,O
of,O
ALY,B
by,O
anti,O
-,O
sense,O
oligonucleotides,O
virtually,O
eliminates,O
TCR,B
alpha,I
enhancer,I
activity,O
in,O
T,B
cells,I
.,O
AML1,B
may,O
play,O
a,O
role,O
in,O
growth,O
and,O
differentiation,O
of,O
cells,O
along,O
erythroid,B
and,O
/,O
or,O
megakaryocytic,B
lineages,O
",",O
because,O
a,O
significant,O
level,O
of,O
the,O
AML1,B
gene,O
is,O
expressed,O
in,O
these,O
cells,O
.,O
We,O
overexpressed,O
AML1a,B
(,O
without,O
the,O
transcription,O
-,O
activating,O
domain,O
),O
and,O
AML1b,B
(,O
with,O
the,O
domain,O
),O
proteins,O
in,O
K562,B
leukemia,I
cells,I
",",O
which,O
can,O
be,O
induced,O
to,O
differentiate,O
into,O
hemoglobin,B
-,I
producing,I
cells,I
and,O
megakaryocytes,B
.,O
The,O
AML1a,B
-,I
transfected,O
K562,B
cells,I
had,O
a,O
reduced,O
capacity,O
to,O
differentiate,O
in,O
the,O
presence,O
of,O
sodium,O
n,O
-,O
butyrate,O
but,O
not,O
in,O
the,O
presence,O
of,O
other,O
inducers,O
",",O
such,O
as,O
hemin,O
",",O
1,O
-,O
beta,O
-,O
D,O
-,O
arabinofuranosylcyto,O
",",O
and,O
herbimycin,O
A,O
.,O
We,O
have,O
cloned,O
and,O
sequenced,O
a,O
portion,O
of,O
the,O
ER,B
upstream,I
regulatory,I
region,I
from,O
the,O
ER,B
-,I
positive,I
MCF,I
-,I
7,I
and,O
the,O
ER,B
-,I
negative,I
MDA,I
-,I
MB,I
-,I
231,I
breast,I
cancer,I
cell,I
lines,I
to,O
determine,O
if,O
sequence,O
alterations,O
in,O
this,O
region,O
account,O
for,O
the,O
ER,B
-,I
negative,I
phenotype,O
of,O
some,O
tumors,O
.,O
The,O
influence,O
of,O
the,O
anti,O
-,O
allergy,O
agent,O
azelastine,O
hydrochloride,O
(,O
Azeptin,O
),O
on,O
NF,B
-,I
kappa,I
B,I
activation,O
associated,O
with,O
the,O
generation,O
of,O
cytokines,O
and,O
nitric,O
oxide,O
(,O
NO,B
),O
was,O
investigated,O
in,O
various,O
kinds,O
of,O
human,O
and,O
mouse,O
cells,O
.,O
In,O
parallel,O
with,O
the,O
decreased,O
cytokine,O
generation,O
",",O
each,O
cytokine,O
mRNA,O
was,O
less,O
expressed,O
in,O
the,O
presence,O
of,O
10,O
(,O
-,O
5,O
),O
M,O
Azeptin,O
.,O
In,O
addition,O
",",O
both,O
inducible,O
nitric,B
oxide,I
synthase,I
-,I
mRNA,O
level,O
and,O
NO,B
generation,O
in,O
mouse,O
peritoneal,O
macrophages,O
were,O
suppressed,O
by,O
10,O
(,O
-,O
5,O
),O
M,O
Azeptin,O
.,O
Using,O
anti,O
-,O
C,O
/,O
EBPbeta,O
(,O
NF,O
-,O
IL6,O
),O
",",O
anti,O
-,O
C,O
/,O
EBPdelta,O
(,O
NF,O
-,O
IL6beta,O
),O
",",O
anti,O
-,O
NF,O
-,O
ATc,O
",",O
anti,O
-,O
NF,O
-,O
ATp,O
",",O
anti,O
-,O
Fos,O
",",O
and,O
anti,O
-,O
Jun,O
Abs,O
we,O
demonstrate,O
that,O
the,O
previously,O
identified,O
PRE,O
-,O
I,O
binding,O
factor,O
POS,O
-,O
1,O
is,O
composed,O
of,O
different,O
transcription,O
factors,O
in,O
different,O
Th,O
cell,O
subsets,O
.,O
Different,O
cytokines,O
activate,O
transcription,O
at,O
the,O
appropriate,O
germline,O
promoter,O
.,O
Experimental,O
expression,O
in,O
mice,O
and,O
spontaneous,O
expression,O
in,O
human,O
SLE,O
of,O
polyomavirus,B
T,I
-,I
antigen,I
.,O
A,O
molecular,O
basis,O
for,O
induction,O
of,O
antibodies,O
to,O
DNA,B
and,O
eukaryotic,O
transcription,O
factors,O
.,O
We,O
have,O
previously,O
demonstrated,O
that,O
experimental,O
expression,O
of,O
the,O
polyomavirus,B
transcription,O
factor,O
T,I
-,I
antigen,I
has,O
the,O
potential,O
to,O
induce,O
anti,O
-,O
DNA,B
antibodies,O
in,O
mice,O
.,O
Two,O
sets,O
of,O
independent,O
evidences,O
are,O
presented,O
here,O
that,O
demonstrate,O
a,O
biological,O
relevance,O
for,O
this,O
model,O
.,O
Secondly,O
",",O
we,O
investigated,O
whether,O
polyomavirus,B
reactivation,I
occurs,O
in,O
SLE,B
patients,O
",",O
and,O
whether,O
antibodies,O
to,O
T,B
-,I
antigen,I
",",O
DNA,B
",",O
and,O
to,O
TBP,B
and,O
CREB,B
are,O
linked,O
to,O
such,O
events,O
.,O
Both,O
within,O
and,O
among,O
these,O
SLE,B
patients,O
",",O
frequent,O
polyomavirus,B
reactivations,I
were,O
observed,O
that,O
could,O
not,O
be,O
explained,O
by,O
certain,O
rearrangements,O
of,O
the,O
noncoding,O
control,O
regions,O
",",O
nor,O
by,O
corticosteroid,O
treatment,O
.,O
Antibodies,O
recognizing,O
double,O
-,O
stranded,O
DNA,B
were,O
confined,O
to,O
patients,O
with,O
frequent,O
polyomavirus,O
reactivations,O
.,O
The,O
results,O
described,O
here,O
indicate,O
that,O
cognate,O
interaction,O
of,O
B,B
cells,I
recognizing,O
DNA,B
or,O
DNA,B
-,I
associated,I
proteins,I
and,O
T,B
cells,I
recognizing,O
T,B
antigen,I
had,O
taken,O
place,O
as,O
a,O
consequence,O
of,O
complex,O
formation,O
between,O
T,B
ag,I
and,O
DNA,B
in,O
vivo,O
in,O
the,O
context,O
of,O
polyomavirus,O
reactivations,O
.,O
Intimate,O
interactions,O
between,O
multipotential,O
hemopoietic,O
stem,O
cells,O
and,O
their,O
microenvironment,O
work,O
towards,O
redefining,O
the,O
identity,O
and,O
the,O
differentiative,O
fate,O
of,O
these,O
primitive,O
cells,O
.,O
Thus,O
",",O
gammac,B
is,O
not,O
necessary,O
to,O
trigger,O
IL,B
-,I
4,I
-,I
mediated,I
responses,I
in,O
B,B
cells,I
",",O
but,O
its,O
presence,O
is,O
important,O
for,O
optimal,O
IL,B
-,I
4,I
-,I
signaling,I
.,O
Cell,B
-,I
to,I
-,I
cell,I
contact,I
activates,O
the,O
long,O
terminal,O
repeat,O
of,O
human,O
immunodeficiency,O
virus,O
1,O
through,O
its,O
kappaB,O
motif,O
.,O
Cell,B
-,I
to,I
-,I
cell,I
contact,I
between,O
peripheral,O
blood,O
lymphocytes,O
and,O
transfected,O
human,O
colonic,O
carcinoma,O
cell,B
line,I
HT29,I
activates,O
transcription,O
of,O
the,O
long,O
terminal,O
repeats,O
(,O
LTR,O
),O
of,O
human,O
immunodeficiency,O
virus,O
.,O
HIV,B
-,I
1,I
LTR,I
transcription,O
is,O
controlled,O
by,O
a,O
complex,O
array,O
of,O
virus,B
-,I
encoded,I
and,O
cellular,O
proteins,O
.,O
Identification,O
of,O
nucleotide,O
sequences,O
that,O
regulate,O
transcription,O
of,O
the,O
MCF13.00,O
murine,O
leukemia,O
virus,B
long,I
terminal,I
repeat,I
in,O
activated,O
T,B
cells,I
.,O
Differentiation,O
of,O
U,B
-,I
937,I
promonocytic,I
cells,I
by,O
etoposide,O
and,O
ICRF,O
-,O
193,O
",",O
two,O
antitumour,O
DNA,B
topoisomerase,I
II,I
inhibitors,I
with,O
different,O
mechanisms,O
of,O
action,O
.,O
By,O
contrast,O
",",O
these,O
effects,O
were,O
not,O
observed,O
upon,O
pulse,O
-,O
treatment,O
with,O
6,O
microM,O
ICRF,O
-,O
193,O
.,O
By,O
contrast,O
",",O
ICRF,O
-,O
193,O
only,O
provoked,O
a,O
late,O
activation,O
(,O
from,O
hours,O
72,O
to,O
96,O
),O
of,O
the,O
total,O
enzyme,O
.,O
By,O
contrast,O
",",O
the,O
binding,O
activity,O
of,O
the,O
NF,B
-,I
kappa,I
(,I
B,I
),I
and,O
EGR,B
-,I
1,I
transcription,I
factors,I
was,O
little,O
affected,O
.,O
GATA,B
-,I
1,I
DNA,B
binding,I
activity,I
is,O
down,O
-,O
regulated,O
in,O
late,O
S,O
phase,O
in,O
erythroid,B
cells,I
.,O
These,O
results,O
may,O
also,O
relate,O
to,O
recent,O
data,O
implicating,O
GATA,B
-,I
1,I
function,O
in,O
apoptosis,O
and,O
cell,O
cycle,O
progression,O
Activated,O
neutrophils,B
have,O
the,O
ability,O
to,O
upregulate,O
the,O
expression,O
of,O
many,O
genes,O
",",O
in,O
particular,O
those,O
encoding,O
cytokines,B
and,O
chemokines,B
",",O
and,O
to,O
subsequently,O
release,O
the,O
corresponding,O
proteins,O
.,O
Following,O
neutrophil,B
stimulation,O
with,O
proinflammatory,O
agonists,O
(,O
such,O
as,O
lipopolysaccharide,B
[,O
LPS,B
],O
",",O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
[,O
TNF,B
-,I
alpha,I
],O
",",O
and,O
fMet,B
-,I
Leu,I
-,I
Phe,I
),O
that,O
induce,O
the,O
production,O
of,O
cytokines,B
and,O
chemokines,B
in,O
these,O
cells,O
",",O
NF,B
-,I
kappaB,I
/,I
Rel,I
proteins,O
translocated,O
to,O
nuclear,O
fractions,O
",",O
resulting,O
in,O
a,O
transient,O
induction,O
of,O
NF,B
-,I
kappaB,I
DNA,B
binding,I
activity,I
",",O
as,O
determined,O
in,O
gel,O
mobility,O
shift,O
assays,O
.,O
The,O
onset,O
of,O
both,O
processes,O
was,O
found,O
to,O
be,O
closely,O
paralleled,O
by,O
",",O
and,O
dependent,O
on,O
",",O
IkappaB,B
-,I
alpha,I
degradation,I
.,O
Two,O
distinct,O
pathways,O
of,O
interleukin,B
-,I
5,I
synthesis,I
in,O
allergen,O
-,O
specific,O
human,B
T,I
-,I
cell,I
clones,I
are,O
suppressed,O
by,O
glucocorticoids,B
.,O
Glucocorticoids,B
(,O
GC,B
),O
have,O
long,O
been,O
used,O
as,O
the,O
most,O
effective,O
agents,O
for,O
the,O
treatment,O
of,O
allergic,O
diseases,O
accompanied,O
by,O
eosinophilia,O
such,O
as,O
chronic,O
asthma,O
and,O
atopic,O
dermatitis,O
.,O
GC,B
efficiently,O
suppressed,O
IL,B
-,I
5,I
synthesis,O
of,O
T,B
-,I
cell,I
clones,I
activated,O
via,O
either,O
T,B
-,I
cell,I
receptor,I
(,O
TCR,B
),O
or,O
IL,B
-,I
2,I
receptor,I
(,O
IL,B
-,I
2R,I
),O
.,O
Stimulation,O
of,O
CD2,B
or,O
TCR,B
/,I
CD3,I
induced,O
activation,O
of,O
the,O
nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
(,O
NFAT,B
),O
",",O
the,O
binding,O
site,O
of,O
which,O
is,O
included,O
in,O
the,O
IL,B
-,I
2,I
gene,I
promoter,I
.,O
The,O
LAZ3,B
/,I
BCL6,I
transcript,O
was,O
found,O
in,O
a,O
variety,O
of,O
tissues,O
",",O
including,O
skeletal,B
muscle,I
",",O
peripheral,B
blood,I
leukocytes,I
",",O
and,O
weakly,O
in,O
normal,B
lymph,I
nodes,I
.,O
IL,O
-,O
4,O
treatment,O
rapidly,O
induced,O
tyrosine,O
phosphorylation,O
of,O
insulin,B
receptor,I
substrate,I
(,O
IRS,B
),O
-,O
1,O
and,O
IRS,B
-,O
2,O
in,O
1D4,O
but,O
not,O
in,O
E1C3,O
cells,O
.,O
Nuclear,B
transcription,I
factor,I
kB,I
(,O
NF,B
-,I
kappa,I
B,I
),O
is,O
a,O
ubiquitous,O
transcription,O
factor,O
and,O
pleiotropic,O
regulator,O
of,O
numerous,O
genes,O
involved,O
in,O
the,O
immune,B
and,O
inflammatory,B
responses,I
.,O
This,O
transcription,O
factor,O
is,O
activated,O
via,O
the,O
selective,O
phosphorylation,O
",",O
ubiquination,O
and,O
degradation,O
of,O
its,O
inhibitor,O
protein,B
I,I
-,I
kB,I
thereby,O
allowing,O
translocation,O
of,O
NF,B
-,I
kappa,I
B,I
into,O
the,O
nucleus,O
where,O
it,O
upregulates,O
the,O
transcription,O
of,O
a,O
variety,O
of,O
adhesion,O
molecules,O
(,O
e,O
.,O
g,O
.,O
ICAM,B
-,I
1,I
",",O
VCAM,B
-,I
1,I
),O
",",O
cytokines,O
(,O
TNF,B
",",O
IL,B
-,I
1,I
",",O
IL,B
-,I
6,I
),O
and,O
enzymes,O
(,O
iNOS,B
),O
.,O
Based,O
upon,O
work,O
from,O
our,O
laboratory,O
",",O
we,O
propose,O
that,O
inhibition,O
of,O
NF,B
-,I
kappa,I
B,I
activation,O
produces,O
significant,O
anti,O
inflammatory,O
activity,O
which,O
may,O
be,O
mediated,O
by,O
the,O
inhibition,O
of,O
transcription,O
of,O
certain,O
pro,O
-,O
inflammatory,O
mediators,O
and,O
adhesion,O
molecules,O
.,O
Generation,O
of,O
cytotoxic,O
T,B
lymphocytes,I
against,O
immunorecessive,O
epitopes,O
after,O
multiple,O
immunizations,O
with,O
adenovirus,O
vectors,O
is,O
dependent,O
on,O
haplotype,O
.,O
However,O
",",O
the,O
cytotoxic,O
T,B
lymphocyte,I
(,O
CTL,B
),O
response,O
to,O
Ad,O
could,O
limit,O
the,O
effectiveness,O
of,O
such,O
approaches,O
.,O
The,O
immune,O
response,O
to,O
Ad,O
in,O
BALB,O
/,O
c,O
mice,O
was,O
more,O
complex,O
.,O
Understanding,O
the,O
cis,O
-,O
and,O
transacting,O
factors,O
that,O
regulate,O
the,O
tissue,O
-,O
specific,O
expression,O
of,O
PECAM,B
-,I
1,I
should,O
increase,O
our,O
understanding,O
of,O
the,O
mechanisms,O
by,O
which,O
vascular,O
-,O
specific,O
gene,O
expression,O
is,O
achieved,O
.,O
However,O
",",O
little,O
is,O
known,O
about,O
negative,O
regulation,O
of,O
IL,B
-,I
1beta,I
expression,O
at,O
the,O
transcriptional,O
level,O
",",O
which,O
may,O
play,O
an,O
important,O
role,O
in,O
anti,O
-,O
inflammatory,O
and,O
immunosuppressive,O
effects,O
.,O
Interaction,O
of,O
transcription,O
factors,O
RFX1,O
and,O
MIBP1,O
with,O
the,O
gamma,O
motif,O
of,O
the,O
negative,O
regulatory,O
element,O
of,O
the,O
hepatitis,O
B,B
virus,I
core,I
promoter,I
.,O
The,O
negative,O
regulatory,O
element,O
(,O
NRE,B
),O
of,O
the,O
hepatitis,B
B,I
virus,I
(,O
HBV,B
),O
core,I
promoter,I
contains,O
three,O
subregions,O
which,O
act,O
synergistically,O
to,O
suppress,O
core,I
promoter,I
activity,O
.,O
In,O
addition,O
",",O
RFX1,B
can,O
bind,O
simultaneously,O
",",O
most,O
likely,O
as,O
a,O
heterodimer,O
",",O
with,O
the,O
transcription,O
factor,O
MIBP1,B
to,O
NRE,B
gamma,I
.,O
Use,O
of,O
arsenic,B
trioxide,I
(,O
As2O3,B
),O
in,O
the,O
treatment,O
of,O
acute,O
promyelocytic,O
leukemia,O
(,O
APL,O
),O
:,O
II,O
.,O
Pharmacokinetic,O
studies,O
",",O
which,O
were,O
performed,O
in,O
eight,O
patients,O
",",O
showed,O
that,O
after,O
a,O
peak,O
level,O
of,O
5,O
.,O
54,O
micromol,O
/,O
L,O
to,O
7,O
.,O
30,O
micromol,O
/,O
L,O
",",O
plasma,O
arsenic,B
was,O
rapidly,O
eliminated,O
",",O
and,O
the,O
continuous,O
administration,O
of,O
As2O3,B
did,O
not,O
alter,O
its,O
pharmacokinetic,O
behaviors,O
.,O
We,O
conclude,O
that,O
As2O3,B
treatment,O
is,O
an,O
effective,O
and,O
relatively,O
safe,O
drug,O
in,O
APL,O
patients,O
refractory,O
to,O
ATRA,O
and,O
conventional,O
chemotherapy,O
.,O
LR1,O
also,O
binds,O
Ig,B
heavy,I
chain,I
switch,I
region,I
sequences,I
and,O
may,O
function,O
in,O
class,O
switch,O
recombination,O
.,O
Both,O
of,O
these,O
parameters,O
",",O
however,O
",",O
did,O
not,O
change,O
significantly,O
after,O
mitogen,O
stimulation,O
.,O
There,O
was,O
a,O
significant,O
negative,O
correlation,O
between,O
IC50S,B
of,O
prednisolone,O
and,O
increase,O
-,O
ratios,O
(,O
post,O
/,O
pre,O
ratio,O
),O
of,O
Bmax,B
after,O
mitogen,O
stimulation,O
(,O
p,O
<,O
0,O
0.29,O
5,O
),O
0.32,O
The,O
Bmax,B
and,O
Kd,B
were,O
not,O
significantly,O
changed,O
after,O
mitogen,O
stimulation,O
in,O
both,O
subgroups,O
of,O
CRF,O
0.49,O
The,O
ZEBRA,B
protein,O
from,O
Epstein,O
-,O
Barr,O
virus,O
(,O
EBV,B
),O
activates,O
a,O
switch,O
from,O
the,O
latent,O
to,O
the,O
lytic,O
expression,O
program,O
of,O
the,O
virus,O
0.75,O
The,O
additional,O
function,O
that,O
is,O
required,O
for,O
initiation,O
of,O
the,O
lytic,O
viral,O
life,O
cycle,O
is,O
likely,O
to,O
require,O
phosphorylation,O
of,O
serine,B
186,I
of,O
the,O
ZEBRA,B
protein,I
",",O
which,O
may,O
influence,O
either,O
DNA,B
recognition,I
or,O
transcriptional,O
activation,O
of,O
lytic,O
viral,O
promoters,O
in,O
a,O
chromatinized,O
viral,O
episome,O
.,O
Immune,O
hyperactivation,O
of,O
HIV,B
-,I
1,I
-,I
infected,I
T,I
cells,I
mediated,O
by,O
Tat,O
and,O
the,O
CD28,O
pathway,O
.,O
CONCLUSIONS,O
:,O
The,O
reduction,O
of,O
symptoms,O
due,O
to,O
topical,O
fluticasone,O
propionate,O
in,O
patients,O
with,O
rhinitis,O
and,O
allergy,O
to,O
house,O
dust,O
mite,O
is,O
not,O
correlated,O
with,O
the,O
characteristics,O
of,O
the,O
glucocorticoid,B
receptor,I
.,O
Human,O
immunodeficiency,B
virus,I
type,I
1,I
(,O
HIV,B
-,I
1,I
),O
replicates,O
more,O
efficiently,O
in,O
vitro,O
in,O
differentiated,O
macrophages,O
than,O
in,O
freshly,O
isolated,O
monocytes,O
.,O
We,O
demonstrated,O
that,O
constitutive,O
expression,O
of,O
NF,B
-,I
kappaB,I
in,O
primary,O
human,O
monocytes,O
changed,O
significantly,O
with,O
differentiation,O
in,O
vitro,O
to,O
monocyte,O
-,O
derived,O
macrophages,O
(,O
MDMs,O
),O
and,O
differentiation,O
in,O
vivo,O
to,O
alveolar,O
macrophages,O
(,O
AMs,O
),O
.,O
NF,B
-,I
kappa,I
B,I
-,I
independent,O
suppression,O
of,O
HIV,O
expression,O
by,O
ascorbic,O
acid,O
.,O
Pretreatment,O
of,O
ACH,B
-,I
2,I
T,I
cells,I
by,O
NAC,O
followed,O
by,O
stimulation,O
with,O
PMA,O
",",O
TNF,O
-,O
alpha,O
",",O
or,O
hydrogen,O
peroxide,O
(,O
H2O2,B
),O
resulted,O
in,O
strong,O
suppression,O
of,O
NF,B
-,I
kappa,I
B,I
activation,I
.,O
These,O
results,O
suggest,O
that,O
the,O
molecular,O
mechanism,O
of,O
HIV,B
inhibition,O
by,O
ascorbate,O
is,O
not,O
mediated,O
via,O
NF,B
-,I
kappa,I
B,I
inhibition,I
",",O
unlike,O
that,O
seen,O
with,O
other,O
antioxidants,O
.,O
A,O
T,O
cell,B
-,I
specific,I
enhancer,I
in,O
the,O
interleukin,B
-,I
3,I
locus,I
is,O
activated,O
cooperatively,O
by,O
Oct,B
and,O
NFAT,B
elements,I
within,O
a,O
DNase,B
I,I
-,I
hypersensitive,I
site,I
.,O
Interleukin,B
-,I
3,I
(,I
IL,I
-,I
3,I
),I
is,O
a,O
cytokine,O
that,O
is,O
expressed,O
primarily,O
in,O
activated,O
T,B
cells,I
.,O
We,O
suggest,O
that,O
the,O
T,B
cell,I
-,I
specific,I
expression,O
of,O
the,O
IL,B
-,I
3,I
gene,I
is,O
partly,O
controlled,O
through,O
the,O
enhancer,O
by,O
cooperation,O
between,O
Oct,B
and,O
NFAT,B
family,I
proteins,I
.,O
The,O
adenovirus,B
E1B,B
19K,I
gene,I
plays,O
an,O
essential,O
role,O
in,O
transformation,O
of,O
primary,O
rodent,O
cells,O
in,O
cooperation,O
with,O
E1A,B
and,O
in,O
the,O
inhibition,O
of,O
apoptosis,O
during,O
lytic,O
infection,O
.,O
It,O
has,O
been,O
shown,O
that,O
this,O
E1B,B
19K,I
protein,I
is,O
not,O
necessary,O
for,O
viral,O
DNA,B
replication,O
in,O
human,O
cell,B
lines,I
",",O
such,O
as,O
HeLa,B
and,O
KB,B
.,O
Activation,O
of,O
Ras,B
and,O
mitogen,O
-,O
activated,O
protein,B
kinase,I
pathway,I
by,O
terminal,O
complement,O
complexes,O
is,O
G,B
protein,I
dependent,I
.,O
Spontaneous,O
occurrence,O
of,O
early,O
region,O
1A,O
reiteration,O
mutants,O
of,O
type,O
5,O
adenovirus,B
in,O
persistently,O
infected,O
human,B
T,I
-,I
lymphocytes,I
.,O
Mutants,O
of,O
type,O
5,O
adenovirus,B
(,O
Ad5,B
),O
with,O
reiterated,O
DNA,B
sequences,I
in,O
the,O
E1a,B
region,I
appeared,O
in,O
a,O
human,B
T,I
-,I
lymphocyte,I
cell,I
line,I
",",O
Molt,B
-,I
4,I
",",O
persistently,O
infected,O
with,O
H5sub304,O
",",O
a,O
deletion,O
/,O
substitution,O
mutant,O
that,O
has,O
a,O
wild,O
-,O
type,O
phenotype,O
in,O
viral,O
replication,O
.,O
There,O
was,O
not,O
any,O
DNA,B
homology,O
between,O
the,O
breakpoints,O
in,O
the,O
second,O
exon,O
and,O
the,O
inserting,O
sequences,O
(,O
starting,O
at,O
nt,O
532,O
",",O
710,O
",",O
or,O
792,O
),O
.,O
The,O
observed,O
E1a,O
reiterations,O
provide,O
a,O
model,O
to,O
gain,O
insight,O
into,O
understanding,O
the,O
evolutionary,O
events,O
of,O
some,O
",",O
if,O
not,O
all,O
",",O
adenovirus,O
types,O
during,O
many,O
years,O
of,O
symbiotic,O
",",O
persistent,O
relationship,O
in,O
human,O
tonsils,O
and,O
adenoids,O
and,O
possibly,O
other,O
lymphoid,O
organs,O
.,O
Residues,O
432,B
",",O
435,B
",",O
437,B
",",O
438,B
",",O
and,O
440,B
(,O
position,O
P1,O
",",O
P4,O
",",O
P6,O
",",O
P7,O
",",O
and,O
P9,O
),O
contributed,O
to,O
DQ2,B
binding,O
",",O
whereas,O
residues,O
431,B
",",O
433,B
",",O
434,B
",",O
and,O
436,B
(,O
positions,O
P,O
1,O
",",O
P2,O
",",O
P3,O
",",O
and,O
P5,O
),O
contributed,O
to,O
TCR,B
contact,O
.,O
The,O
hypothesis,O
that,O
the,O
nuclear,O
factor,O
of,O
activated,O
T,B
cells,I
(,O
NF,B
-,I
AT,I
),O
may,O
influence,O
HIV,B
-,I
1,I
replication,O
is,O
therefore,O
compelling,O
given,O
the,O
tight,O
correlation,O
of,O
HIV,B
-,I
1,I
transcriptional,O
induction,O
to,O
T,B
cell,I
activation,O
.,O
These,O
results,O
link,O
regulatory,O
factors,O
critical,O
to,O
T,B
cell,I
commitment,O
directly,O
to,O
HIV,B
-,I
1,I
replication,O
.,O
eTh2,B
cells,I
are,O
the,O
major,O
source,O
of,O
IL,B
-,I
4,I
",",O
while,O
gamma,B
interferon,I
is,O
produced,O
by,O
eTh1,B
cells,I
.,O
However,O
",",O
although,O
NFAT,B
DNA,I
binding,I
is,O
similarly,O
induced,O
in,O
both,O
eTh1,B
and,O
eTh2,B
cells,I
upon,O
antigen,O
stimulation,O
",",O
only,O
the,O
NFAT,B
complexes,I
present,O
in,O
eTh2,B
cells,I
are,O
able,O
to,O
mediate,O
high,O
-,O
level,O
transcription,O
",",O
and,O
relatively,O
little,O
NFAT,B
transcriptional,I
activity,I
was,O
induced,O
in,O
eTh1,B
cells,I
.,O
The,O
greater,O
selectivity,O
of,O
PF,B
",",O
compared,O
with,O
FK506,O
",",O
at,O
both,O
the,O
molecular,O
and,O
cellular,O
levels,O
may,O
prove,O
advantageous,O
in,O
manipulating,O
T,B
cell,I
responses,O
in,O
vivo,O
.,O
V3,B
loop,I
of,I
human,I
immunodeficiency,I
virus,I
type,I
1,I
suppresses,O
interleukin,B
2,I
-,I
induced,I
T,B
cell,I
growth,O
[,O
published,O
erratum,O
appears,O
in,O
AIDS,B
Res,I
Hum,I
Retroviruses,I
1997,I
May,I
1,I
;,O
13,I
(,O
7,I
),I
:,O
633,I
].,O
V3,B
-,I
BH10,I
neither,O
blocked,O
radiolabeled,O
IL,B
-,I
2,I
binding,O
to,O
IL,B
-,I
2,I
receptors,O
nor,O
affected,O
tyrosyl,O
phosphorylation,O
of,O
several,O
cellular,O
proteins,O
(,O
p120,B
",",O
p98,B
",",O
p96,B
",",O
p54,B
",",O
and,O
p38,B
),I
",",O
which,O
is,O
immediately,O
induced,O
by,O
IL,B
-,I
2,I
stimulation,O
.,O
However,O
",",O
V3,B
-,I
BH10,I
enhanced,O
IL,O
-,O
2,O
-,O
induced,O
mRNA,O
expression,O
of,O
c,O
-,O
fos,B
but,O
not,O
c,O
-,O
myc,B
or,O
junB,B
.,O
CONCLUSIONS,O
:,O
Our,O
results,O
establish,O
that,O
PI,B
3,I
-,I
kinase,I
can,O
both,O
positively,O
and,O
negatively,O
regulate,O
T,B
-,I
cell,I
function,I
",",O
and,O
uncover,O
a,O
previously,O
unrecognized,O
function,O
for,O
PI,B
3,I
-,I
kinase,I
in,O
T,B
-,I
cells,I
as,O
a,O
selective,O
negative,O
regulator,O
of,O
TCR,B
-,I
signalling,I
events,I
and,O
therefore,O
as,O
a,O
determinant,O
of,O
T,B
-,I
cell,I
homeostasis,I
.,O
Pax,B
-,I
5a,I
was,O
detectable,O
in,O
pro,B
-,I
",",O
pre,B
-,I
",",O
and,O
mature,B
B,I
-,I
cell,I
lines,I
",",O
but,O
not,O
in,O
two,O
plasmacytomas,O
;,O
Pax,B
-,I
5b,I
was,O
shown,O
to,O
be,O
present,O
at,O
low,O
levels,O
in,O
mature,B
B,I
-,I
cell,I
lines,I
and,O
",",O
unexpectedly,O
",",O
in,O
one,O
plasma,B
cell,I
line,I
",",O
but,O
not,O
in,O
pro,B
-,I
B,I
-,I
cell,I
or,O
T,B
-,I
cell,I
lines,I
.,O
The,O
two,O
related,O
protein,B
-,I
tyrosine,I
kinases,I
Syk,B
and,O
Zap,B
are,O
rapidly,O
phosphorylated,O
on,O
tyrosine,O
residues,O
and,O
enzymatically,O
activated,O
upon,O
crosslinking,O
of,O
the,O
T,B
cell,I
antigen,I
receptor,I
.,O
One,O
means,O
of,O
understanding,O
the,O
role,O
of,O
p38,B
in,O
these,O
responses,O
is,O
to,O
identify,O
proteins,B
with,O
functions,O
regulated,O
by,O
p38,B
-,O
catalysed,O
phosphorylation,O
.,O
Altogether,O
",",O
these,O
results,O
support,O
the,O
hypothesis,O
that,O
the,O
activation,O
of,O
NK,O
cells,O
involved,O
transcriptional,O
and,O
post,O
-,O
transcriptional,O
events,O
",",O
and,O
that,O
reactive,O
intermediates,O
may,O
play,O
an,O
important,O
role,O
in,O
the,O
molecular,O
processes,O
related,O
with,O
the,O
generation,O
of,O
a,O
cytotoxic,O
response,O
by,O
NK,O
cells,O
.,O
The,O
predominant,O
E2F,B
complex,I
in,O
human,O
primary,O
haemopoietic,O
cells,O
and,O
in,O
AML,B
blasts,O
contains,O
E2F,B
-,I
4,I
",",O
DP,B
-,I
1,I
and,O
p130,B
.,O
We,O
also,O
studied,O
blasts,O
from,O
18,O
patients,O
with,O
acute,O
myeloid,O
leukaemia,O
(,O
AML,B
),O
.,O
An,O
E2F,B
-,I
4,I
/,O
p130,B
complex,O
was,O
detected,O
in,O
representative,O
samples,O
of,O
all,O
FAB,O
types,O
analysed,O
.,O
Associated,O
with,O
its,O
inhibitor,O
",",O
I,O
kappaB,B
",",O
NF,B
-,I
kappaB,I
resides,O
as,O
an,O
inactive,O
form,O
in,O
the,O
cytoplasm,O
.,O
The,O
transduction,O
pathways,O
that,O
lead,O
to,O
I,B
kappaB,I
inactivation,O
remain,O
poorly,O
understood,O
.,O
In,O
this,O
study,O
",",O
we,O
have,O
characterized,O
a,O
cellular,O
mutant,O
",",O
the,O
70,O
/,O
Z3,O
-,O
derived,O
1,O
.,O
3E+02,O
murine,O
pre,O
-,O
B,B
cell,I
line,I
",",O
that,O
does,O
not,O
activate,O
NF,B
-,I
kappaB,I
in,O
response,O
to,O
several,O
stimuli,O
.,O
Our,O
results,O
demonstrate,O
that,O
1,O
.,O
3E+02,O
is,O
a,O
cellular,B
transduction,I
mutant,O
exhibiting,O
a,O
defect,O
in,O
a,O
step,O
that,O
is,O
required,O
by,O
several,O
different,O
stimuli,O
to,O
activate,O
NF,B
-,I
kappaB,I
.,O
In,O
order,O
to,O
evaluate,O
the,O
conditions,O
for,O
optimal,O
expression,O
and,O
immunogenicity,O
of,O
varicella,B
-,I
zoster,I
virus,I
(,O
VZV,B
),O
proteins,O
in,O
a,O
herpes,B
simplex,I
virus,I
-,I
1,I
(,O
HSV,B
-,I
1,I
),O
vector,O
",",O
we,O
selected,O
the,O
VZV,B
glycoprotein,I
E,I
(,O
gE,B
),O
",",O
encoded,O
by,O
ORF,O
68,O
and,O
the,O
VZV,B
product,O
of,O
ORF,O
62,O
",",O
an,O
immediate,O
-,O
early,O
major,O
tegument,O
protein,O
(,O
IE62,B
),O
.,O
Immunoblot,O
analysis,O
and,O
immunoperoxidase,O
staining,O
of,O
infected,O
cell,O
monolayers,O
demonstrated,O
vector,O
expression,O
of,O
VZV,B
proteins,I
.,O
When,O
tested,O
in,O
cytotoxicity,O
assays,O
using,O
T,O
-,O
lymphocytes,O
from,O
VZV,B
immune,O
human,O
donors,O
",",O
the,O
range,O
of,O
precursor,O
frequencies,O
for,O
T,O
-,O
lymphocytes,O
that,O
recognized,O
VZV,B
gE,I
or,O
VZV,B
IE62,I
was,O
similar,O
whether,O
these,O
proteins,I
were,O
expressed,O
by,O
HSV,B
-,I
1,I
or,O
a,O
vaccinia,O
vector,O
.,O
In,O
this,O
report,O
",",O
we,O
demonstrate,O
that,O
the,O
active,O
form,O
of,O
NF,B
-,I
AT1,I
is,O
also,O
present,O
in,O
the,O
nuclei,O
of,O
HTLV,B
-,I
I,I
-,I
transformed,O
T,B
cells,I
that,O
express,O
the,O
Tax,B
protein,I
.,O
Interestingly,O
",",O
the,O
constitutive,O
activation,O
of,O
NF,B
-,I
AT1,I
in,O
these,O
T,B
cells,I
is,O
associated,O
with,O
its,O
dephosphorylation,O
.,O
Expression,O
of,O
NFAT,B
-,I
family,I
proteins,I
in,O
normal,O
human,O
T,B
cells,I
.,O
Higher,O
-,O
molecular,O
-,O
weight,O
species,O
of,O
NFATc,B
(,O
of,O
110,O
and,O
140,O
kDa,O
),O
were,O
also,O
detected,O
.,O
In,O
contrast,O
to,O
ionomycin,O
treatment,O
",",O
exposure,O
of,O
cells,O
to,O
phorbol,O
myristate,O
acetate,O
(,O
PMA,O
),O
plus,O
anti,O
-,O
CD28,O
did,O
not,O
induce,O
NFATc,B
",",O
indicating,O
that,O
under,O
these,O
conditions,O
",",O
interleukin,O
-,O
2,O
synthesis,O
by,O
these,O
cells,O
is,O
apparently,O
independent,O
of,O
NFATc,B
.,O
Cotransfection,O
experiments,O
revealed,O
that,O
both,O
hGATA,B
-,I
4,I
and,O
PMA,O
/,O
A23187,O
stimulation,O
are,O
necessary,O
for,O
the,O
IL,O
-,O
5,O
promoter,O
activation,O
.,O
The,O
requirement,O
of,O
another,O
regulatory,O
element,O
called,O
CLE0.00,O
",",O
which,O
lies,O
downstream,O
of,O
the,O
-,O
70,O
GATA,O
site,O
",",O
was,O
also,O
demonstrated,O
.,O
The,O
electrophoretic,O
mobility,O
shift,O
assay,O
with,O
extracts,O
of,O
COS,B
cells,I
expressing,O
GATA,B
-,I
binding,I
proteins,I
showed,O
that,O
GATA,B
-,I
4,I
has,O
the,O
highest,O
binding,O
affinity,O
to,O
the,O
-,O
70,O
GATA,O
site,O
among,O
the,O
three,O
GATA,O
-,O
binding,O
proteins,O
.,O
These,O
results,O
demonstrate,O
the,O
selective,O
role,O
of,O
GATA,B
-,I
4,I
in,O
the,O
transcriptional,O
regulation,O
of,O
the,O
IL,B
-,I
5,I
gene,I
in,O
a,O
circumstance,O
where,O
multiple,O
members,O
of,O
the,O
GATA,B
-,I
binding,I
proteins,I
are,O
expressed,O
.,O
We,O
found,O
that,O
NFATx1,B
DNA,I
binding,I
activity,I
and,O
interaction,O
with,O
AP,B
-,I
1,I
polypeptides,I
were,O
dependent,O
on,O
its,O
central,O
Rel,B
similarity,I
region,I
and,O
that,O
transcriptional,O
activation,O
was,O
reduced,O
by,O
deletions,O
of,O
either,O
its,O
N,B
-,I
terminal,I
domain,I
or,O
its,O
C,B
-,I
terminal,I
domain,I
",",O
suggesting,O
the,O
presence,O
of,O
intrinsic,O
transcriptional,O
activation,O
motifs,O
in,O
both,O
regions,O
.,O
NO,B
is,O
produced,O
from,O
at,O
least,O
three,O
different,O
NO,B
synthase,I
(,O
NOS,B
),O
isoforms,O
:,O
neuronal,B
NOS,I
(,O
nNOS,B
),O
",",O
endothelial,B
NOS,I
",",O
and,O
immunologic,B
NOS,I
(,O
iNOS,B
),O
.,O
Pyrrolidine,O
dithiocarbamate,O
(,O
PDTC,B
),O
is,O
an,O
inhibitor,O
of,O
NF,B
kappaB,I
in,O
most,O
cells,O
;,O
however,O
",",O
we,O
show,O
that,O
PDTC,B
is,O
also,O
a,O
potent,O
scavenger,O
of,O
NO,B
through,O
formation,O
of,O
mononitrosyl,O
iron,O
complexes,O
with,O
PDTC,B
.,O
Contrary,O
to,O
the,O
results,O
in,O
Jurkat,O
cells,O
",",O
PDTC,O
did,O
not,O
inhibit,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
-,O
induced,O
NF,B
kappaB,I
activation,I
in,O
astrocytes,O
;,O
instead,O
PDTC,O
itself,O
induces,O
NF,B
kappaB,I
activation,I
in,O
astrocytes,O
",",O
and,O
this,O
may,O
be,O
related,O
to,O
scavenging,O
of,O
endogenously,O
produced,O
NO,B
by,O
the,O
PDTC,O
iron,O
complex,O
.,O
In,O
astrocytes,O
PDTC,O
also,O
dramatically,O
induces,O
the,O
NF,B
kappaB,I
-,I
dependent,I
enzyme,I
",",O
iNOS,B
",",O
supporting,O
the,O
physiologic,O
relevance,O
of,O
endogenous,O
NO,B
regulation,O
of,O
NF,B
kappaB,I
.,O
Involvement,O
of,O
Stat3,B
in,O
interleukin,O
-,O
6,O
-,O
induced,O
IgM,B
production,O
in,O
a,O
human,O
B,O
-,O
cell,O
line,O
.,O
EGF,O
treatment,O
induced,O
IgM,B
production,O
in,O
cells,O
transfected,O
with,O
an,O
intact,O
gp130,O
cytoplasmic,O
tail,O
",",O
but,O
not,O
in,O
untransfected,O
cells,O
or,O
cells,O
transfected,O
with,O
a,O
cytoplasmic,O
tail,O
lacking,O
all,O
four,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
Stat,B
),O
binding,O
sites,O
.,O
Moreover,O
",",O
EGF,B
treatment,O
induced,O
Stat3,B
phosphorylation,O
in,O
cells,O
transfected,O
with,O
the,O
intact,O
chimeric,O
EGF,B
-,I
gp130,I
receptor,I
along,O
with,O
induction,O
of,O
DNA,B
-,I
mobility,I
shift,I
of,O
a,O
classical,O
interferon,O
-,O
gamma,O
-,O
activated,O
site,O
.,O
The,O
in,O
vitro,O
transendothelial,O
migration,O
of,O
circulating,O
filarial,O
antigen,O
-,O
specific,O
T,B
-,I
cells,I
was,O
examined,O
in,O
Wuchereria,O
banerofti,O
infection,O
.,O
This,O
cis,O
element,O
binds,O
a,O
protein,B
complex,I
referred,O
to,O
as,O
HRF,O
(,O
heme,O
-,O
responsive,O
factor,O
),O
",",O
which,O
is,O
greatly,O
enhanced,O
both,O
in,O
heme,O
-,O
treated,O
FLCs,O
and,O
during,O
monocyte,O
-,O
to,O
-,O
macrophage,O
differentiation,O
.,O
One,O
of,O
the,O
latter,O
elements,O
",",O
the,O
IgH,B
3,I
',I
enhancer,I
",",O
is,O
of,O
particular,O
interest,O
:,O
(,O
1,O
),O
it,O
is,O
B,O
cell,O
-,O
specific,O
and,O
active,O
only,O
in,O
late,O
B,O
cell,O
development,O
;,O
(,O
2,O
),O
in,O
rodent,O
plasmacytomas,O
and,O
in,O
some,O
human,O
Burkitt,O
',O
s,O
lymphomas,O
it,O
is,O
part,O
of,O
a,O
locus,O
control,O
region,O
(,O
LCR,O
),O
that,O
is,O
involved,O
in,O
deregulation,O
of,O
the,O
c,O
-,O
myc,O
oncogene,O
as,O
a,O
result,O
of,O
translocation,O
into,O
the,O
IgH,B
locus,I
;,O
and,O
(,O
3,O
),O
it,O
has,O
been,O
implicated,O
in,O
the,O
mechanisms,O
that,O
control,O
Ig,O
gene,O
class,O
switch,O
recombination,O
.,O
Reactive,O
oxygen,B
species,I
(,O
ROS,B
),O
such,O
as,O
hydrogen,B
peroxide,I
serve,O
as,O
second,O
messengers,O
in,O
the,O
induction,O
of,O
the,O
transcription,O
factor,O
NF,B
-,I
kappaB,I
",",O
and,O
hence,O
in,O
the,O
activation,O
and,O
replication,O
of,O
human,B
immunodeficiency,I
virus,I
type,I
1,I
(,O
HIV,B
-,I
1,I
),O
in,O
human,B
cells,I
.,O
NF,B
-,I
kappaB,I
activation,O
was,O
very,O
effective,O
when,O
cells,O
were,O
subjected,O
to,O
hyperthermia,O
before,O
being,O
treated,O
with,O
HOCl,B
.,O
Collectively,O
",",O
these,O
results,O
suggest,O
that,O
HOCl,B
should,O
be,O
considered,O
as,O
an,O
oxidative,O
species,O
capable,O
of,O
inducing,O
NF,B
-,I
kappaB,I
in,O
a,O
T,B
-,I
lymphocytic,I
cell,I
line,I
through,O
a,O
transduction,O
mechanism,O
involving,O
ROS,B
",",O
and,O
having,O
a,O
long,O
-,O
distance,O
effect,O
through,O
subsequent,O
TNF,B
-,I
alpha,I
release,I
.,O
Rap1,B
is,O
a,O
small,O
",",O
Ras,B
-,I
like,I
GTPase,I
whose,O
function,O
and,O
regulation,O
are,O
still,O
largely,O
unknown,O
.,O
Stimulation,O
of,O
blood,O
platelets,O
with,O
alpha,O
-,O
thrombin,O
or,O
other,O
platelet,O
activators,O
caused,O
a,O
rapid,O
and,O
strong,O
induction,O
of,O
Rap1,B
that,O
associated,O
with,O
RBD,O
in,O
vitro,O
.,O
From,O
our,O
results,O
",",O
we,O
conclude,O
that,O
Rap1,B
activation,O
in,O
platelets,O
is,O
an,O
important,O
common,O
event,O
in,O
early,O
agonist,O
-,O
induced,O
signalling,O
",",O
and,O
that,O
this,O
activation,O
is,O
mediated,O
by,O
an,O
increased,O
intracellular,O
Ca2,B
+,I
concentration,I
The,O
transcriptional,O
regulatory,O
elements,O
of,O
many,O
inducible,O
T,B
-,I
cell,I
genes,I
contain,O
adjacent,O
or,O
overlapping,O
binding,O
sites,O
for,O
the,O
Ets,B
and,O
NF,B
-,I
kappaB,I
/,I
NFAT,I
families,I
of,I
transcription,I
factors,I
.,O
From,O
AML1,B
gene,I
",",O
two,O
representative,O
forms,O
of,O
proteins,B
",",O
AML1a,B
and,O
AML1b,B
",",O
are,O
produced,O
by,O
an,O
alternative,O
splicing,O
.,O
These,O
data,O
strongly,O
suggest,O
that,O
a,O
transcriptionally,O
active,O
form,O
of,O
AML1,B
is,O
essential,O
for,O
the,O
myeloid,B
cell,I
differentiation,I
.,O
When,O
introduced,O
into,O
interleukin,B
3,I
(,I
IL,I
-,I
3,I
),I
-,I
dependent,I
mouse,I
pro,I
-,I
B,I
lymphocytes,I
",",O
E2A,B
-,I
HLF,I
prevents,O
apoptosis,O
induced,O
by,O
growth,O
factor,O
deprivation,O
",",O
suggesting,O
that,O
IL,B
-,I
3,I
mediates,O
cell,O
survival,O
through,O
activation,O
of,O
a,O
transcription,O
factor,O
whose,O
activity,O
can,O
be,O
constitutively,O
replaced,O
by,O
the,O
chimeric,O
oncoprotein,O
.,O
The,O
expression,O
and,O
binding,O
activity,O
of,O
the,O
Nfil3,B
protein,I
(,O
also,O
called,O
E4bp4,B
),O
",",O
but,O
not,O
of,O
Hlf,B
",",O
Dbp,B
",",O
or,O
Tef,B
",",O
was,O
found,O
to,O
be,O
regulated,O
by,O
IL,O
-,O
3,O
in,O
mouse,O
pro,O
-,O
B,O
cell,O
lines,O
(,O
Baf,B
-,I
3,I
and,O
FL5,B
.,O
12,O
),O
.,O
Detection,O
of,O
adenovirus,B
DNA,I
in,O
peripheral,O
blood,O
mononuclear,O
cells,O
by,O
polymerase,O
chain,O
reaction,O
assay,O
.,O
The,O
E1A,B
and,O
hexon,B
primers,O
amplified,O
DNA,B
from,O
representative,O
adenoviral,B
serotypes,O
in,O
all,O
six,O
adenoviral,B
groups,O
(,O
A,O
-,O
F,O
),O
.,O
In,O
addition,O
",",O
assay,O
of,O
PBMC,B
by,O
the,O
adenovirus,B
-,I
specific,I
PCR,I
may,O
help,O
detect,O
early,O
invasive,O
disease,O
and,O
warrants,O
further,O
evaluation,O
.,O
Common,O
and,O
distinct,O
intracellular,O
signaling,O
pathways,O
in,O
human,B
neutrophils,I
utilized,O
by,O
platelet,B
activating,I
factor,I
and,O
FMLP,B
.,O
Stimulation,O
of,O
human,O
neutrophils,O
with,O
chemoattractants,O
FMLP,B
or,O
platelet,B
activating,I
factor,I
(,O
PAF,B
),O
results,O
in,O
different,O
but,O
overlapping,O
functional,B
responses,I
.,O
We,O
questioned,O
whether,O
these,O
differences,O
might,O
reflect,O
patterns,O
of,O
intracellular,O
signal,O
transduction,O
.,O
Stimulation,O
with,O
either,O
PAF,B
or,O
FMLP,B
resulted,O
in,O
equivalent,O
phosphorylation,O
and,O
activation,O
of,O
the,O
mitogen,B
-,I
activated,I
protein,I
kinase,I
(,O
MAPk,B
),O
homologue,O
38,O
-,O
kD,O
murine,O
MAP,B
kinase,I
homologous,I
to,O
HOG,O
-,O
1,O
(,O
p38,B
),O
MAPk,B
.,O
A,O
specific,O
p38,B
MAPk,I
inhibitor,I
(,O
SK,B
&,I
F,I
86002,I
),O
blocked,O
superoxide,B
anion,I
production,I
in,O
response,O
to,O
FMLP,O
and,O
reduced,O
adhesion,O
and,O
chemotaxis,O
in,O
response,O
to,O
PAF,O
or,O
FMLP,O
.,O
Chicken,O
NF,B
-,I
M,I
transcription,I
factor,I
",",O
in,O
cooperation,O
with,O
either,O
c,O
-,O
Myb,O
or,O
v,O
-,O
Myb,O
",",O
is,O
active,O
in,O
the,O
combinatorial,O
activation,O
of,O
myeloid,B
-,I
cell,I
-,I
specific,I
genes,I
in,O
heterologous,O
cell,O
types,O
",",O
such,O
as,O
embryonic,O
fibroblasts,O
.,O
In,O
the,O
present,O
report,O
",",O
we,O
show,O
that,O
A6H,B
costimulated,O
cell,O
proliferation,O
and,O
cytokine,O
production,O
in,O
purified,O
CD4,B
+,I
T,I
cells,I
.,O
Co,O
-,O
ligation,O
of,O
the,O
A6H,B
antigen,O
and,O
the,O
CD3,B
complex,I
induced,O
expression,O
of,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
in,O
CD4,B
+,I
T,I
cells,I
",",O
whereas,O
no,O
increase,O
in,O
NF,B
-,I
kappa,I
B,I
and,O
octamer,O
-,O
binding,O
(,O
Oct,B
),O
proteins,O
was,O
seen,O
compared,O
to,O
T,B
cells,I
stimulated,O
with,O
anti,O
-,O
CD3,B
alone,O
.,O
Molecular,O
differences,O
of,O
the,O
A6H,B
molecule,I
or,O
distinct,O
regulation,O
of,O
the,O
A6H,B
transduced,O
AP,B
-,I
1,I
activation,I
pathway,I
may,O
exist,O
in,O
CD4,B
+,I
and,O
CD8,B
+,I
T,I
cell,I
subpopulations,I
.,O
The,O
DNA,B
-,I
binding,I
domain,I
(,O
amino,O
acids,O
421,O
-,O
486,O
),O
is,O
completely,O
conserved,B
among,O
human,O
",",O
squirrel,O
monkey,O
",",O
owl,O
monkey,O
",",O
and,O
cotton,O
-,O
top,O
tamarin,O
receptors,O
.,O
Expressions,O
of,O
human,O
and,O
squirrel,B
monkey,I
glucocorticoid,B
receptors,I
and,O
a,O
squirrel,B
monkey,I
receptor,I
in,O
which,O
Phe774,O
was,O
mutated,O
to,O
Leu,O
(,O
F774L,O
),O
were,O
similar,O
.,O
Shared,O
gamma,B
(,O
c,I
),O
subunit,I
within,O
the,O
human,O
interleukin,B
-,I
7,I
receptor,I
complex,I
.,O
The,O
gamma,B
(,O
c,I
),O
subunit,I
can,O
be,O
employed,O
in,O
receptor,I
complexes,I
for,O
IL,B
-,I
2,I
",",O
-,I
4,I
",",O
-,I
7,I
",",O
-,I
9,I
",",O
and,O
-,I
15,I
",",O
and,O
the,O
multiple,O
signaling,O
defects,O
that,O
would,O
result,O
from,O
a,O
defective,O
gamma,B
(,O
c,I
),O
chain,I
in,O
these,O
receptors,I
are,O
proposed,O
to,O
cause,O
the,O
severe,O
phenotype,O
of,O
X,O
-,O
SCID,O
patients,O
.,O
These,O
observations,O
suggest,O
the,O
functional,B
importance,I
of,O
gamma,B
(,O
c,B
),O
in,O
the,O
IL,O
-,O
7R,O
complex,O
.,O
In,O
this,O
study,O
we,O
determined,O
the,O
effects,O
of,O
SAC,O
on,O
NF,O
-,O
kappa,O
B,O
activation,O
in,O
human,B
T,I
lymphocytes,I
(,O
Jurkat,B
cells,I
),O
induced,O
by,O
tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNF,O
-,O
alpha,O
),O
and,O
H2O2,O
.,O
Elf,O
-,O
2,O
",",O
a,O
rhombotin,O
-,O
2,O
binding,O
ets,O
transcription,O
factor,O
:,O
discovery,O
and,O
potential,O
role,O
in,O
T,B
cell,I
leukemia,I
.,O
By,O
screening,O
a,O
T,B
cell,I
cDNA,I
library,I
",",O
we,O
identified,O
a,O
novel,O
ets,O
transcription,O
factor,O
that,O
binds,O
RBTN,B
-,I
2,I
.,O
Thymocytes,O
expressed,O
four,O
-,O
to,O
10,O
-,O
fold,O
greater,O
amounts,O
of,O
the,O
3,O
.,O
5,O
kb,O
transcript,O
than,O
other,O
tissues,O
.,O
The,O
expression,O
patterns,O
suggest,O
that,O
RBTN,B
-,I
2,I
normally,O
interacts,O
equally,O
with,O
elf,O
-,O
2a,O
and,O
elf,O
-,O
2b,O
.,O
In,O
contrast,O
",",O
when,O
RBTN,B
-,I
2,I
is,O
inappropriately,O
expressed,O
in,O
T,B
cells,I
",",O
RBTN,B
-,I
2,I
would,O
interact,O
predominantly,O
with,O
elf,O
-,O
2b,O
;,O
this,O
interaction,O
may,O
lead,O
to,O
T,B
cell,I
proliferation,O
. When,O
immunoglobulin,B
(,O
Ig,B
),O
-,O
secreting,O
plasmacytomas,O
are,O
fused,O
to,O
a,O
T,B
-,O
cell,I
lymphoma,I
",",O
Ig,B
gene,I
expression,I
ceases,O
in,O
greater,O
than,O
95,O
%,O
of,O
the,O
resulting,O
hybrids,O
.,O
In,O
the,O
rare,O
hybrids,O
that,O
continue,O
to,O
express,O
Ig,B
",",O
all,O
other,O
tested,O
B,B
lymphocyte,I
-,I
specific,I
genes,I
also,O
remain,O
active,O
.,O
The,O
low,O
frequency,O
with,O
which,O
these,O
Ig,B
-,I
expressing,I
hybrids,I
are,O
recovered,O
",",O
along,O
with,O
the,O
fact,O
that,O
cell,B
fusions,I
can,O
lead,O
to,O
chromosome,B
loss,I
",",O
led,O
us,O
to,O
propose,O
that,O
this,O
rare,O
phenotype,O
was,O
due,O
to,O
loss,O
of,O
a,O
T,B
-,I
cell,I
-,I
derived,I
chromosome,I
encoding,O
a,O
factor,O
or,O
factors,O
with,O
gene,O
silencing,O
activity,O
.,O
To,O
identify,O
the,O
relevant,O
chromosome,B
",",O
we,O
have,O
used,O
a,O
polymerase,B
chain,I
reaction,I
(,O
PCR,B
),O
-,O
assisted,O
method,O
of,O
chromosome,B
mapping,I
to,O
analyze,O
both,O
Ig,B
-,I
silenced,I
(,O
common,O
),O
and,O
Ig,B
-,I
expressing,I
(,O
rare,O
),O
hybrids,O
.,O
Kaposi,B
',O
s,O
sarcoma,O
(,O
KS,B
),O
-,O
associated,O
herpesvirus,B
(,O
KSHV,B
),O
",",O
or,O
human,O
herpesvirus,B
8,I
",",O
is,O
a,O
lymphotropic,O
virus,O
strongly,O
linked,O
to,O
several,O
AIDS,O
-,O
related,O
neoplasms,O
.,O
Nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
and,O
AP,B
-,I
1,I
are,O
insufficient,O
for,O
IL,O
-,O
2,O
promoter,O
activation,O
:,O
requirement,O
for,O
CD28,B
up,I
-,I
regulation,I
of,I
RE,B
/,I
AP,I
.,O
Uncontrolled,O
replication,O
of,O
a,O
virus,O
",",O
which,O
is,O
harmful,O
to,O
the,O
host,O
is,O
also,O
disadvantageous,O
to,O
the,O
virus,O
.,O
Therefore,O
",",O
only,O
the,O
time,O
between,O
infection,O
and,O
eradication,O
remains,O
for,O
these,O
viruses,O
to,O
proliferate,O
.,O
Both,O
are,O
TRUE,O
for,O
the,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
),O
.,O
Disturbance,O
of,O
both,O
the,O
immune,O
surveillance,O
as,O
well,O
as,O
viral,O
gene,O
regulation,O
may,O
result,O
in,O
EBV,B
-,I
associated,I
disease,I
.,O
3BP2,B
was,O
selectively,O
expressed,O
in,O
hematopoietic,B
/,I
lymphoid,I
tissues,I
and,O
bound,O
via,O
its,O
SH2,B
domain,I
activated,O
Syk,B
-,I
family,I
kinases,I
in,O
mammalian,B
cells,I
",",O
including,O
in,O
antigen,O
receptor,O
-,O
stimulated,O
T,B
cells,I
.,O
In,O
this,O
study,O
",",O
a,O
series,O
of,O
Burkitt,B
',I
s,I
lymphoma,I
(,O
BL,B
),O
cell,O
lines,O
were,O
assayed,O
for,O
their,O
expression,O
of,O
tissue,O
inhibitor,O
of,O
metalloproteinases,O
(,O
TIMP,B
),O
-,O
1,O
.,O
Results,O
indicate,O
that,O
TIMP,B
-,O
1,O
-,O
positive,O
BL,B
lines,O
show,O
resistance,O
to,O
cold,O
-,O
shock,O
-,O
induced,O
apoptosis,O
.,O
Furthermore,O
",",O
recombinant,O
TIMP,B
-,O
1,O
",",O
but,O
not,O
TIMP,B
-,O
2,O
or,O
a,O
synthetic,O
metalloproteinase,O
inhibitor,O
(,O
BB,O
-,O
94,O
),O
",",O
confers,O
resistance,O
to,O
apoptosis,O
induced,O
by,O
both,O
CD95,O
-,O
dependent,O
and,O
-,O
independent,O
(,O
cold,O
shock,O
",",O
serum,O
deprivation,O
",",O
and,O
gamma,O
-,O
radiation,O
),O
pathways,O
in,O
TIMP,B
-,O
1,O
-,O
negative,O
BL,B
lines,O
.,O
The,O
spi,B
-,I
1,I
transfected,O
cells,O
showed,O
reduced,O
growth,O
rates,O
and,O
reduced,O
clonogenic,O
cell,O
growth,O
.,O
To,O
investigate,O
in,O
vivo,O
regulatory,O
mechanisms,O
that,O
control,O
the,O
population,O
of,O
type,O
2,O
T,B
cells,O
and,O
disease,O
susceptibility,O
",",O
we,O
have,O
created,O
lines,O
of,O
transgenic,O
mice,O
in,O
which,O
expression,O
of,O
a,O
chimeric,O
cytokine,O
receptor,O
(,O
the,O
mouse,B
interleukin,B
2,I
receptor,I
beta,I
chain,I
[,O
IL,B
-,I
2Rbeta,I
],O
extracellular,O
domain,O
fused,O
to,O
the,O
cytoplasmic,O
tail,O
of,O
IL,B
-,I
4Ralpha,I
),O
is,O
targeted,O
to,O
the,O
T,B
lymphoid,I
lineage,I
using,O
the,O
proximal,O
lck,O
promoter,O
.,O
We,O
have,O
recently,O
cloned,O
the,O
carboxylesterase,B
upstream,I
sequence,I
and,O
showed,O
its,O
basal,O
promoter,O
activity,O
in,O
CHO,B
cells,I
.,O
The,O
role,O
of,O
the,O
Ikaros,B
gene,I
in,O
lymphocyte,B
development,I
and,O
homeostasis,O
.,O
In,O
the,O
adult,O
",",O
however,O
",",O
lymphoid,B
lineages,I
rely,O
on,O
Ikaros,B
at,O
distinct,O
phases,O
of,O
their,O
development,O
.,O
Its,O
activity,O
is,O
essential,O
for,O
the,O
generation,O
of,O
B,B
cell,I
but,O
not,O
of,O
T,B
cell,I
precursors,I
",",O
although,O
the,O
differentiation,O
of,O
the,O
latter,O
is,O
not,O
normal,O
.,O
A,O
significant,O
increase,O
in,O
CD4,B
thymocytes,I
and,O
their,O
immediate,O
precursors,O
is,O
detected,O
",",O
and,O
because,O
these,O
cells,O
lack,O
markers,O
that,O
correlate,O
with,O
positive,O
selection,O
",",O
a,O
deregulation,O
in,O
their,O
maturation,O
process,O
is,O
suggested,O
. Furthermore,O
",",O
Ikaros,O
-,O
null,O
thymocytes,O
hyperproliferate,O
in,O
response,O
to,O
T,B
cell,I
receptor,I
(,O
TCR,B
),O
signaling,O
;,O
within,O
days,O
after,O
their,O
appearance,O
in,O
the,O
thymus,O
",",O
clonally,O
expanding,O
populations,O
are,O
detected,O
.,O
Deregulated,O
TCR,B
-,I
mediated,I
responses,I
and,O
the,O
fast,O
kinetics,O
of,O
tumor,O
development,O
in,O
these,O
mutant,O
thymocytes,O
implicate,O
Ikaros,B
as,O
a,O
central,O
tumor,O
suppressor,O
gene,O
for,O
the,O
T,B
cell,I
lineage,I
.,O
The,O
role,O
of,O
Aiolos,B
",",O
a,O
lymphoid,B
-,I
restricted,I
and,O
structurally,O
related,O
gene,O
",",O
in,O
lymphoid,B
differentiation,I
is,O
discussed,O
.,O
Changes,O
in,O
this,O
regulatory,O
network,O
may,O
reflect,O
differentiation,O
and,O
proliferation,O
adjustments,O
made,O
in,O
hemo,O
-,O
lymphoid,O
progenitors,O
and,O
precursors,O
as,O
they,O
give,O
rise,O
to,O
the,O
cells,O
of,O
our,O
immune,O
system,O
.,O
STAT1,B
pathway,I
is,O
involved,O
in,O
activation,O
of,O
caprine,O
arthritis,O
-,O
encephalitis,O
virus,O
long,O
terminal,O
repeat,O
in,O
monocytes,O
.,O
Substitution,O
mutations,O
in,O
this,O
consensus,O
sequence,O
eliminate,O
binding,O
of,O
the,O
inducible,O
factor,O
.,O
1,O
",",O
25,O
-,O
Dihydroxyvitamin,O
D3,O
receptors,O
in,O
peripheral,O
blood,O
mononuclear,O
cells,O
from,O
patients,O
with,O
renal,O
insufficiency,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
have,O
investigated,O
the,O
specific,O
uptake,O
of,O
[,O
3H,O
],O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
by,O
PBMC,O
of,O
11,O
women,O
with,O
advanced,O
chronic,O
renal,O
failure,O
(,O
A,O
-,O
CRF,O
),O
",",O
6,O
women,O
with,O
mild,O
-,O
moderate,O
renal,O
insufficiency,O
(,O
M,O
-,O
CRF,O
),O
",",O
and,O
23,O
healthy,O
women,O
.,O
The,O
mean,O
dissociation,O
constant,O
(,O
KD,B
),O
was,O
similar,O
in,O
both,O
groups,O
of,O
patients,O
and,O
in,O
healthy,O
women,O
(,O
A,O
-,O
CRF,O
:,O
0,O
0.24,O
7,O
+,O
/,O
-,O
0,O
0.30,O
5,O
x,O
10,O
(,O
-,O
10,O
),O
M,O
;,O
M,O
-,O
CRF,O
:,O
1,O
0.45,O
1,O
+,O
/,O
-,O
0,O
0.51,O
9,O
x,O
10,O
(,O
-,O
10,O
),O
M,O
;,O
controls,O
:,O
1,O
0.64,O
0,O
+,O
/,O
-,O
0,O
0.70,O
6,O
x,O
10,O
(,O
-,O
10,O
),O
M,O
),O
0.80,O
No,O
correlation,O
was,O
seen,O
between,O
VDR,O
and,O
serum,O
calcitriol,B
or,O
PTH,O
levels,O
",",O
when,O
considering,O
both,O
groups,O
of,O
patients,O
together,O
or,O
separately,O
.,O
Conversely,O
",",O
a,O
significant,O
negative,O
correlation,O
was,O
found,O
between,O
VDR,B
and,O
serum,O
creatinine,O
values,O
when,O
A,O
-,O
CRF,O
and,O
M,O
-,O
CRF,O
were,O
considered,O
altogether,O
(,O
r,O
=,O
-,O
0,O
.,O
63,O
;,O
p,O
<,O
0,O
.,O
1,O
.,O
These,O
data,O
are,O
well,O
in,O
line,O
with,O
the,O
long,O
-,O
standing,O
notion,O
that,O
interindividual,O
differences,O
in,O
platelet,O
monoamine,O
oxidase,O
may,O
represent,O
differences,O
in,O
expression,O
of,O
the,O
enzyme,O
rather,O
than,O
genotypic,O
variation,O
.,O
Ciprofibrate,O
",",O
an,O
hypolipidaemic,O
peroxisome,O
proliferator,O
",",O
induced,O
differentiation,O
of,O
HL,B
-,I
60,I
cells,I
.,O
In,O
particular,O
",",O
TRAF6,B
interacted,O
with,O
membrane,B
-,I
proximal,I
determinants,I
distinct,O
from,O
those,O
binding,O
TRAFs,B
1,I
",",O
2,I
",",O
3,I
",",O
and,O
5,I
.,O
The,O
molecular,O
mechanisms,O
by,O
which,O
IL,B
-,I
4,I
induces,O
expression,O
of,O
the,O
IL,B
-,I
4,I
gene,I
are,O
not,O
known,O
",",O
although,O
the,O
IL,B
-,I
4,I
-,I
activated,O
transcription,O
factor,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
6,O
(,O
Stat6,B
),O
is,O
required,O
for,O
this,O
effect,O
.,O
CONCLUSIONS,O
:,O
Intestinal,B
epithelial,I
cells,I
initiate,O
an,O
inflammatory,O
response,O
with,O
resulting,O
neutrophil,B
-,I
mediated,I
tissue,I
damage,I
in,O
response,O
to,O
E,O
.histolytica,O
infection,O
;,O
this,O
inflammatory,O
cascade,O
can,O
be,O
blocked,O
by,O
inhibiting,O
the,O
transcription,O
of,O
genes,O
regulated,O
by,O
nuclear,O
factor,O
kappaB,O
.The,O
triptolide,O
-,O
induced,O
apoptosis,O
is,O
accompanied,O
by,O
increase,O
of,O
DEVD,B
-,I
cleavable,I
caspases,I
activity,I
and,O
degradation,O
of,O
caspase,B
substrate,I
poly,I
(,I
ADP,I
-,I
ribose,I
),I
polymerase,I
(,I
PARP,I
),I
.,O
A,O
specific,O
inhibitor,O
of,O
caspases,B
",",O
zVAD,O
-,O
FMK,O
",",O
prevents,O
triptolide,O
-,O
induced,O
PARP,B
degradation,O
and,O
DNA,B
fragmentation,O
but,O
not,O
growth,O
arrest,O
.,O
A,O
novel,O
transcription,O
factor,O
regulates,O
expression,O
of,O
the,O
vacuolar,O
H,B
+,I
-,I
ATPase,I
B2,I
subunit,I
through,O
AP,O
-,O
2,O
sites,O
during,O
monocytic,O
differentiation,O
.,O
In,O
mobility,O
shift,O
assays,O
",",O
a,O
nuclear,O
factor,O
from,O
THP,O
-,O
1,O
and,O
U,O
-,O
937,O
cells,O
was,O
identified,O
that,O
binds,O
to,O
several,O
AP,O
-,O
2,O
response,O
elements,O
within,O
the,O
B2,O
promoter,O
",",O
but,O
does,O
not,O
react,O
with,O
AP,O
-,O
2,O
antibodies,O
",",O
and,O
has,O
a,O
DNA,B
sequence,I
binding,I
affinity,I
profile,I
that,O
differs,O
from,O
AP,O
-,O
2,O
.,O
These,O
findings,O
suggest,O
that,O
a,O
novel,O
AP,O
-,O
2,O
-,O
like,O
transcription,O
factor,O
is,O
responsible,O
for,O
V,O
-,O
ATPase,B
B,I
subunit,I
amplification,O
during,O
monocyte,O
differentiation,O
.,O
c,O
-,O
Jun,B
and,O
GST,B
-,I
pi,I
expression,O
in,O
human,O
plasma,O
cells,O
.,O
The,O
expression,O
of,O
these,O
two,O
proteins,O
was,O
not,O
related,O
to,O
clinical,O
or,O
laboratory,O
data,O
.,O
It,O
has,O
been,O
shown,O
that,O
eosinophil,O
stimulation,O
by,O
these,O
cytokines,O
is,O
associated,O
with,O
increases,O
in,O
tyrosine,O
phosphorylation,O
of,O
several,O
cellular,O
substrates,O
.,O
This,O
review,O
will,O
concentrate,O
on,O
this,O
topic,O
and,O
on,O
its,O
role,O
for,O
the,O
regulation,O
of,O
eosinophil,B
apoptosis,O
.,O
Time,O
-,O
course,O
experiments,O
showed,O
that,O
nuclear,O
levels,O
of,O
GATA,B
-,I
1,I
and,O
p45,B
NF,I
-,I
E2,I
proteins,O
increased,O
during,O
BA,O
treatment,O
.,O
The,O
upstream,O
regions,O
UAS3,B
(,O
-,O
1168,O
to,O
-,O
440,O
),O
and,O
UAS2,B
(,O
-,O
352,O
to,O
-,O
264,O
),O
both,O
functioned,O
in,O
a,O
cell,B
lineage,I
-,I
independent,I
manner,O
and,O
were,O
together,O
responsible,O
for,O
the,O
bulk,O
of,O
Wp,O
activity,O
in,O
non,O
-,O
B,O
cells,O
;,O
mutational,O
analysis,O
indicated,O
the,O
importance,O
of,O
a,O
YY1,B
binding,O
site,O
in,O
UAS2,B
in,O
that,O
context,O
.,O
By,O
contrast,O
",",O
UAS1,B
(,O
-,O
140,O
to,O
-,O
87,O
),O
was,O
B,O
cell,O
specific,O
and,O
was,O
the,O
key,O
determinant,O
of,O
the,O
promoter,O
',O
s,O
increased,O
activity,O
in,O
B,B
cell,I
lines,I
.,O
When,O
mutations,O
that,O
abolished,O
factor,O
binding,O
in,O
bandshift,O
assays,O
were,O
introduced,O
into,O
a,O
Wp,O
reporter,O
construct,O
",",O
the,O
loss,O
of,O
any,O
one,O
of,O
the,O
three,O
UAS1,B
binding,O
sites,O
was,O
sufficient,O
to,O
reduce,O
promoter,O
activity,O
by,O
10,O
-,O
to,O
30,O
-,O
fold,O
in,O
B,B
cells,I
.,O
Both,O
BZLF1,B
and,O
BRLF1,B
immediate,O
-,O
early,O
transcripts,O
",",O
but,O
not,O
BMLF1,B
transcript,O
",",O
could,O
be,O
detected,O
in,O
individual,O
CD4,B
+,I
and,O
CD8,B
+,I
T,B
cells,I
infected,O
with,O
EBV,B
.,O
T,B
-,I
lineage,I
precursor,I
populations,I
from,O
the,O
adult,O
mouse,O
thymus,O
",",O
prior,O
to,O
T,B
-,I
cell,I
receptor,I
gene,I
rearrangement,I
",",O
display,O
a,O
capacity,O
to,O
produce,O
DC,B
as,O
well,O
as,O
T,B
cells,I
in,O
the,O
thymus,O
",",O
and,O
are,O
very,O
efficient,O
precursors,O
of,O
DC,B
in,O
culture,O
.,O
These,O
lymphoid,B
/,I
DC,I
precursors,O
have,O
little,O
capacity,O
to,O
form,O
myeloid,B
cells,O
",",O
indicating,O
that,O
thymic,O
DC,I
are,O
a,O
lymphoid,B
-,I
related,I
rather,O
than,O
myeloid,B
-,I
related,I
lineage,O
.,O
Pharmacologic,O
blockade,O
of,O
endogenous,O
NFAT,B
activity,O
by,O
FK506,O
or,O
CsA,O
inhibited,O
synthesis,O
of,O
reverse,O
transcription,O
and,O
also,O
potently,O
blocked,O
HIV,B
-,I
1,I
replication,O
.,O
The,O
first,O
step,O
in,O
the,O
nuclear,O
import,O
process,O
is,O
recognition,O
of,O
a,O
nuclear,O
localization,O
sequence,O
(,O
NLS,B
),O
within,O
the,O
karyophilic,O
protein,B
by,O
a,O
cytoplasmic,O
receptor,O
such,O
as,O
the,O
importin,B
(,O
karyopherin,I
),O
-,O
alpha,O
subunit,O
.,O
NLS,B
peptide,O
-,O
mediated,O
disruption,O
of,O
the,O
nuclear,O
import,O
of,O
these,O
transcription,O
factors,O
results,O
in,O
inhibition,O
of,O
I,O
kappa,O
B,O
alpha,O
and,O
IL,O
-,O
2,O
gene,O
expression,O
",",O
processes,O
dependent,O
on,O
NF,O
-,O
kappa,O
B,O
or,O
the,O
combination,O
of,O
NF,O
-,O
kappa,O
B,O
",",O
AP,O
-,O
1,O
",",O
and,O
NFAT,O
.,O
Further,O
",",O
we,O
show,O
that,O
inhibitory,O
NLS,B
peptide,O
interacts,O
in,O
vitro,O
with,O
a,O
cytoplasmic,O
NLS,B
receptor,O
complex,O
comprised,O
of,O
the,O
Rch1,O
/,O
importin,O
(,O
karyopherin,O
),O
-,O
beta,O
heterodimer,O
expressed,O
in,O
Jurkat,O
T,O
cells,O
.,O
Forty,O
-,O
eight,O
hours,O
after,O
transfection,O
",",O
EC,O
were,O
stimulated,O
with,O
NK,O
cells,O
or,O
NK,O
cell,O
membrane,O
extracts,O
for,O
7,O
hr,O
and,O
activation,O
was,O
measured,O
by,O
a,O
luciferase,O
assay,O
.,O
CONCLUSIONS,O
:,O
Human,O
NK,B
cell,I
membrane,I
-,I
bound,I
LT,I
signals,O
across,O
species,O
via,O
TNFRI,O
",",O
leading,O
to,O
NF,B
-,I
kappaB,I
nuclear,I
translocation,O
and,O
transcription,O
of,O
E,B
-,I
selectin,I
and,O
IL,B
-,I
8,I
",",O
which,O
results,O
in,O
EC,B
activation,O
.,O
The,O
discrepancy,O
in,O
the,O
degree,O
of,O
inhibition,O
by,O
membrane,I
extracts,I
and,O
NK,B
cells,I
with,O
mutant,O
TNFRI,O
suggests,O
that,O
additional,O
pathways,O
are,O
utilized,O
by,O
NK,B
cells,I
to,O
activate,O
EC,B
Ras,I
-,I
dependent,I
",",O
Ca2,B
+,I
-,I
stimulated,I
activation,O
of,O
nuclear,I
factor,I
of,I
activated,I
T,I
cells,I
by,O
a,O
constitutively,O
active,O
Cbl,O
mutant,O
in,O
T,I
cells,I
.,O
Blood,O
monocytes,B
spontaneously,O
activate,O
endothelial,B
cells,I
in,O
culture,O
",",O
leading,O
to,O
adhesion,O
of,O
monocytic,B
cells,I
onto,O
the,O
endothelial,B
surface,I
and,O
overproduction,O
of,O
endothelial,B
proteins,I
such,O
as,O
von,B
Willebrand,I
factor,I
(,O
vWf,B
),O
and,O
plasminogen,B
activator,I
inhibitor,I
type,I
1,I
(,O
PAI,B
-,I
1,I
),O
.,O
Addition,O
of,O
untreated,O
THP,B
-,I
1,I
cells,I
had,O
little,O
effect,O
on,O
HUVEC,B
adhesiveness,O
.,O
Under,O
these,O
conditions,O
HUVEC,B
adhesion,I
molecules,I
",",O
E,B
-,I
selectin,I
",",O
VCAM,B
-,I
1,I
and,O
ICAM,B
-,I
1,I
",",O
were,O
increased,O
at,O
3,O
h,O
with,O
only,O
ICAM,B
-,I
1,I
remaining,O
overexpressed,O
at,O
24,O
h,O
.,O
Quantitative,O
reverse,O
transcriptase,O
-,O
polymerase,O
chain,O
reaction,O
(,O
RT,B
-,I
PCR,I
),O
showed,O
an,O
increase,O
in,O
steady,O
-,O
state,O
TNF,B
-,I
alpha,I
mRNA,I
after,O
3,O
to,O
4,O
hours,O
of,O
cross,O
-,O
linking,O
.,O
CD2,B
cross,I
-,I
linking,I
concurrently,O
increased,O
phosphorylation,O
of,O
CREB,B
detected,O
by,O
immunoblot,O
assay,O
eightfold,O
.,O
These,O
data,O
indicate,O
specific,O
modulation,O
of,O
the,O
CREB,B
/,I
ATF,I
-,I
1,I
family,O
of,O
transcription,O
factors,O
by,O
the,O
CD2,B
signalling,O
pathway,O
and,O
suggest,O
CD2,B
receptor,O
modulation,O
of,O
CRE,B
-,I
mediated,I
transcription,O
following,O
ligand,O
engagement,O
(,O
e,O
.,O
g,O
.,O
cell,B
-,I
to,I
-,I
cell,I
contact,I
.,O
),O
.,O
In,O
the,O
present,O
report,O
we,O
show,O
that,O
in,O
various,O
transiently,O
or,O
stably,O
transfected,O
cell,B
lines,I
",",O
X,O
-,O
ray,O
irradiation,O
up,O
-,O
regulates,O
HIV,B
-,I
1,I
LTR,I
transcription,O
through,O
the,O
kappaB,O
regulatory,O
elements,O
.,O
In,O
addition,O
",",O
X,O
-,O
ray,O
activation,O
of,O
HIV,B
-,I
1,I
LTR,I
in,O
transiently,O
or,O
stably,O
transfected,O
cell,B
lines,I
is,O
inhibited,O
by,O
a,O
potent,O
antioxidant,O
drug,O
",",O
pyrrolidine,O
dithiocarbamate,O
and,O
by,O
another,O
drug,O
",",O
known,O
for,O
its,O
role,O
in,O
the,O
trapping,O
of,O
growth,O
factors,O
",",O
suramin,O
.,O
The,O
importance,O
of,O
these,O
observations,O
in,O
the,O
pathophysiology,O
of,O
patients,O
with,O
AIDS,O
-,O
related,O
cancers,O
treated,O
by,O
radiotherapy,O
remains,O
to,O
be,O
established,O
.,O
Restoration,O
of,O
the,O
CCAAT,B
box,I
at,O
-,O
70,O
bp,O
",",O
or,O
insertion,O
of,O
an,O
EKLF,B
binding,I
site,I
at,O
-,O
85,O
bp,O
or,O
-,O
95,O
bp,O
in,O
the,O
promoter,O
significantly,O
increased,O
delta,B
globin,I
gene,I
expression,I
in,O
hAEC,O
.,O
Constitutive,O
association,O
of,O
JAK1,B
and,O
STAT5,B
in,O
pro,B
-,I
B,I
cells,I
is,O
dissolved,O
by,O
interleukin,B
-,I
4,I
-,I
induced,O
tyrosine,O
phosphorylation,O
of,O
both,O
proteins,O
.,O
Nuclear,B
factor,I
-,I
kappaB,I
was,O
found,O
to,O
be,O
activated,O
in,O
ventilated,O
macrophages,O
.,O
To,O
determine,O
the,O
mechanisms,O
responsible,O
for,O
these,O
differences,O
",",O
we,O
turned,O
to,O
human,O
U937,B
promonocytic,I
cells,I
.,O
Based,O
on,O
the,O
high,O
specificity,O
of,O
this,O
compound,O
for,O
PKC,B
",",O
we,O
conclude,O
that,O
PKC,B
is,O
necessary,O
for,O
FN,O
-,O
induced,O
IL,O
-,O
1beta,O
protein,B
production,O
.,O
A,O
novel,O
member,O
of,O
the,O
tumor,O
necrosis,O
factor,O
(,O
TNF,B
),O
receptor,O
family,O
",",O
designated,O
TRAMP,B
",",O
has,O
been,O
identified,O
.,O
Overexpression,O
of,O
TRAMP,B
leads,O
to,O
two,O
major,O
responses,O
",",O
NF,B
-,I
kappaB,I
activation,O
and,O
apoptosis,O
.,O
Using,O
a,O
nuclear,B
run,I
-,I
on,I
assay,I
",",O
IL,B
-,I
4,I
stimulation,O
was,O
shown,O
to,O
enhance,O
transcription,O
by,O
two,O
-,O
to,O
threefold,O
.,O
Conversely,O
",",O
IL,B
-,I
4,I
and,O
IL,B
-,I
13,I
markedly,O
and,O
significantly,O
inhibited,O
HIV,B
replication,O
at,O
the,O
transcriptional,O
level,O
in,O
monocyte,B
-,I
derived,I
macrophages,I
",",O
and,O
this,O
occurred,O
whether,O
these,O
cytokines,O
were,O
added,O
before,O
or,O
after,O
HIV,B
infection,O
.,O
Interleukin,B
-,I
10,I
(,O
IL,B
-,I
10,I
),O
protects,O
animals,O
from,O
lethal,O
endotoxemia,O
.,O
Evidence,O
suggests,O
that,O
IL,B
-,I
10,I
may,O
inhibit,O
activation,O
of,O
the,O
transcription,O
factor,O
nuclear,O
factor,O
-,I
kappaB,I
(,O
NF,B
-,I
kappaB,I
),O
through,O
an,O
unknown,O
mechanism,O
.,O
We,O
hypothesized,O
that,O
IL,B
-,I
10,I
prevents,O
human,O
monocyte,O
NF,B
-,I
kappaB,I
activation,O
and,O
resultant,O
TNF,B
-,I
alpha,I
production,O
by,O
stabilization,O
of,O
IkappaB,B
-,I
alpha,I
.,O
Cells,B
were,O
stimulated,O
with,O
endotoxin,O
(,O
LPS,B
",",O
100,O
ng,O
/,O
mL,O
),O
with,O
and,O
without,O
human,O
IL,B
-,I
10,I
(,O
10,O
ng,O
/,O
mL,O
),O
.,O
IL,B
-,I
10,I
attenuated,O
LPS,B
-,I
stimulated,I
TNF,B
-,I
alpha,I
production,O
(,O
297,O
+,O
/,O
-,O
54,O
;,O
p,O
<,O
0.001,O
versus,O
LPS,B
alone,O
),O
.,O
IL,B
-,I
10,I
appears,O
to,O
prevent,O
activation,O
of,O
NF,B
-,I
kappaB,I
by,O
preserving,O
IkappaB,B
-,I
alpha,I
protein,O
levels,O
",",O
leading,O
to,O
a,O
reduction,O
in,O
TNF,B
-,I
alpha,I
release,O
.,O
Down,O
-,O
regulation,O
of,O
human,O
granzyme,B
B,I
expression,O
by,O
glucocorticoids,O
.,O
These,O
results,O
indicate,O
that,O
dexamethasone,O
is,O
able,O
to,O
abrogate,O
the,O
transcriptional,O
activity,O
of,O
the,O
human,O
granzyme,B
B,I
gene,O
promoter,O
by,O
inhibiting,O
the,O
binding,O
of,O
nuclear,O
factors,O
at,O
the,O
AP,O
-,O
1,O
and,O
Ikaros,O
sites,O
.,O
Therefore,O
in,O
this,O
study,O
",",O
we,O
have,O
examined,O
the,O
role,O
of,O
glucocorticoid,O
receptor,O
/,O
s,O
(,O
GR,B
),O
characteristics,O
in,O
the,O
developing,O
of,O
these,O
abnormalities,O
in,O
patients,O
with,O
PCOS,O
.,O
ngal,B
gene,I
expression,I
was,O
found,O
at,O
moderate,O
levels,O
in,O
only,O
2,O
of,O
17,O
human,O
tissues,O
examined,O
",",O
breast,B
and,O
lung,B
.,O
Immuno,O
-,O
histochemical,O
analysis,O
confirmed,O
the,O
presence,O
of,O
NGAL,B
within,O
breast,B
carcinoma,I
cells,I
but,O
detected,O
only,O
low,O
levels,O
of,O
this,O
protein,B
in,O
normal,O
ductal,B
epithelium,I
.,O
In,O
contrast,O
",",O
a,O
significant,O
correlation,O
between,O
NGAL,B
expression,I
in,O
breast,B
cancer,I
was,O
found,O
with,O
several,O
other,O
markers,O
of,O
poor,O
prognosis,O
",",O
including,O
estrogen,B
and,O
progesterone,B
receptor,I
-,I
negative,I
status,I
and,O
high,O
proliferation,O
(,O
S,O
-,O
phase,O
fraction,O
),O
.,O
BASH,B
",",O
a,O
novel,O
signaling,O
molecule,O
preferentially,O
expressed,O
in,O
B,B
cells,I
of,O
the,O
bursa,O
of,O
Fabricius,O
.,O
The,O
gene,O
encodes,O
an,O
85,O
-,O
kDa,O
protein,B
",",O
designated,O
BASH,B
(,O
B,B
cell,I
adaptor,I
containing,I
SH2,I
domain,I
),O
",",O
that,O
contains,O
N,O
-,O
terminal,O
acidic,O
domains,O
with,O
SH2,I
domain,I
-,I
binding,I
phosphotyrosine,I
-,I
based,I
motifs,I
",",O
a,O
proline,O
-,O
rich,O
domain,O
",",O
and,O
a,O
C,B
-,I
terminal,I
SH2,I
domain,I
.,O
These,O
studies,O
revealed,O
that,O
the,O
major,O
protein,B
in,O
extracts,O
of,O
PMN,O
activated,O
by,O
G,O
-,O
CSF,O
to,O
bind,O
the,O
high,O
-,O
affinity,O
serum,O
-,O
inducible,O
element,O
(,O
hSIE,O
),O
is,O
a,O
72,O
-,O
kDa,O
protein,B
that,O
cross,O
-,O
reacts,O
with,O
Stat3,B
monoclonal,I
antibody,I
",",O
which,O
we,O
have,O
designated,O
Stat3gamma,O
.,O
In,O
order,O
to,O
investigate,O
the,O
factors,O
that,O
influence,O
the,O
induction,O
of,O
ICAM,B
-,I
1,I
molecules,I
",",O
Northern,O
blot,O
analysis,O
to,O
measure,O
the,O
expression,O
level,O
of,O
ICAM,B
-,I
1,I
mRNAs,I
and,O
Southern,O
blot,O
hybridization,O
to,O
analyze,O
the,O
integration,O
of,O
human,O
T,O
-,O
cell,B
-,I
leukemia,I
virus,I
type,I
1,I
(,O
HTLV,O
-,O
1,O
),O
provirus,O
were,O
done,O
.,O
These,O
sequences,O
were,O
chosen,O
for,O
study,O
because,O
mass,O
-,O
spectrometric,O
analysis,O
(,O
MS,B
),O
of,O
a,O
CTL,B
active,I
HPLC,I
peptide,I
fraction,I
eluted,O
from,O
immunoaffinity,O
precipitated,O
HLA,B
-,I
A2,I
molecule,I
",",O
revealed,O
:,O
(,O
a,O
),O
the,O
presence,O
of,O
an,O
ion,O
with,O
a,O
mass,O
-,O
to,O
-,O
charge,O
ratio,O
(,O
m,O
/,O
z,O
),O
of,O
793,O
which,O
was,O
more,O
abundant,O
than,O
other,O
ions,O
of,O
similar,O
masses,O
;,O
(,O
b,O
),O
the,O
tentatively,O
reconstituted,O
sequence,O
of,O
the,O
ion,O
793,O
matched,O
the,O
sequence,O
of,O
peptide,O
G76,B
.,O
These,O
concentrations,O
are,O
lower,O
than,O
concentrations,O
reported,O
to,O
activate,O
effector,O
function,O
of,O
CTL,B
recognizing,O
other,O
epithelial,O
tumor,O
Ag,O
.,O
Furthermore,O
",",O
analysis,O
with,O
cloned,O
CD8,B
+,I
T,I
cells,I
indicated,O
that,O
G75,B
and,O
G76,B
were,O
not,O
cross,O
-,O
reactive,O
specificities,O
",",O
suggesting,O
a,O
key,O
role,O
for,O
the,O
N,B
-,I
terminal,I
residues,I
of,O
the,O
variant,O
peptide,O
in,O
dictating,O
specificities,O
.,O
Since,O
the,O
AES,B
proteins,I
are,O
part,O
of,O
a,O
set,O
of,O
transcriptional,O
repressors,O
encoded,O
by,O
the,O
Enhancer,O
of,O
split,O
[,O
E,O
(,O
spl,O
),O
],O
genes,O
",",O
and,O
since,O
these,O
repressors,O
are,O
activated,O
to,O
suppress,O
cell,O
differentiation,O
in,O
response,O
to,O
Notch,O
receptors,O
signalling,O
",",O
the,O
AES,B
peptides,I
may,O
represent,O
a,O
novel,O
class,O
of,O
self,O
-,O
antigens,O
that,O
deserve,O
further,O
consideration,O
as,O
tumor,O
Ag,O
in,O
epithelial,O
cancers,O
.,O
Our,O
data,O
show,O
that,O
IFNs,B
and,O
IL,B
-,I
1,I
upregulate,O
PML,B
transcript,O
and,O
protein,B
expression,O
in,O
a,O
time,O
and,O
dose,O
-,O
dependent,O
manner,O
.,O
Glucocorticoid,B
receptors,I
(,O
GR,B
),O
and,O
3,O
-,O
O,O
-,O
methyl,O
-,O
D,O
glucose,O
(,O
3,O
-,O
O,O
-,O
MG,O
),O
transport,O
were,O
determined,O
in,O
mononuclear,B
leukocytes,I
(,O
MNL,O
),O
from,O
11,O
abdominal,O
obese,O
subjects,O
",",O
10,O
pituitary,B
-,I
dependent,I
Cushing,I
',I
s,I
syndrome,I
(,O
Cushing,I
',I
s,I
disease,I
),O
and,O
10,O
healthy,O
controls,O
.,O
Interleukin,B
-,I
10,I
(,O
IL,B
-,I
10,I
),O
and,O
transforming,O
growth,O
factor,O
beta,B
(,O
TGF,B
-,I
beta,I
),O
are,O
inhibitory,O
for,O
B,B
and,O
T,B
cells,I
",",O
IgE,B
production,I
",",O
and,O
mast,B
cell,I
proliferation,I
",",O
and,O
they,O
induce,O
apoptosis,O
in,O
eosinophils,B
.,O
The,O
IL,B
-,I
10,I
gene,I
polymorphism,I
was,O
a,O
C,O
-,O
to,O
-,O
A,O
exchange,O
571,O
base,O
pairs,O
upstream,O
from,O
the,O
translation,O
start,O
site,O
and,O
was,O
present,O
between,O
consensus,O
binding,O
sequences,O
for,O
Sp1,O
and,O
elevated,O
total,O
serum,O
.,O
This,O
polymorphism,O
was,O
associated,O
with,O
elevated,O
total,O
serum,O
IgE,B
in,O
subjects,O
heterozygotic,O
or,O
homozygotic,O
for,O
this,O
base,O
exchange,O
(,O
p,O
<,O
0,O
.,O
9,O
),O
.,O
This,O
polymorphism,O
represented,O
a,O
C,O
-,O
to,O
-,O
T,O
base,O
exchange,O
which,O
induced,O
a,O
YY1,O
consensus,O
sequence,O
and,O
is,O
present,O
in,O
a,O
region,O
of,O
the,O
promoter,O
associated,O
with,O
negative,O
transcription,O
regulation,O
.,O
However,O
",",O
it,O
was,O
only,O
the,O
IL,B
-,I
2,I
promoter,I
whose,O
activation,O
by,O
Tpl,O
-,O
2,O
was,O
fully,O
blocked,O
by,O
the,O
dominant,O
negative,O
mutant,O
MEK1S218,B
/,I
222A,I
and,O
the,O
MEK1,B
/,I
MEK2,I
inhibitor,O
PD098059,O
.,O
Since,O
the,O
protein,B
has,O
a,O
homeodomain,O
and,O
can,O
activate,O
transcription,O
",",O
it,O
probably,O
exerts,O
at,O
least,O
some,O
of,O
its,O
effects,O
in,O
vivo,O
by,O
regulation,O
of,O
target,O
genes,O
.,O
We,O
investigated,O
the,O
function,O
of,O
the,O
evolutionary,O
conserved,B
X2,I
box,I
in,O
the,O
promoter,O
of,O
the,O
HLA,B
-,I
DRA,I
gene,I
from,O
the,O
human,O
major,O
histocompatibility,O
complex,O
(,O
MHC,B
),O
in,O
resting,O
and,O
activated,O
B,B
cells,I
.,O
Thymocytes,O
control,O
the,O
CD4,B
gene,I
differently,O
from,O
mature,O
T,B
lymphocytes,I
.,O
Glucocorticoids,O
are,O
physiological,O
molecules,O
that,O
are,O
also,O
extensively,O
used,O
in,O
clinics,O
as,O
anti,O
-,O
inflammatory,O
",",O
immunosuppressive,O
or,O
anti,O
-,O
tumoral,O
agents,O
.,O
The,O
action,O
of,O
adenoviral,B
E1A,I
oncoprotein,I
on,O
host,O
immune,O
-,O
response,O
genes,O
has,O
been,O
attributed,O
to,O
interaction,O
with,O
p300,B
/,I
CBP,I
-,I
type,I
transcriptional,I
coactivators,I
in,O
competition,O
with,O
endogenous,O
transcription,O
factors,O
such,O
as,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
(,O
STAT,B
),O
proteins,O
.,O
Effect,O
of,O
environmental,O
estrogens,O
on,O
IL,B
-,I
1beta,I
promoter,I
activity,O
in,O
a,O
macrophage,B
cell,I
line,I
.,O
17beta,O
-,O
estradiol,B
(,O
E2,B
),O
markedly,O
enhanced,O
lipopolysaccharide,O
-,O
(,O
LPS,O
),O
induced,O
IL,B
-,I
1beta,I
promoter,I
-,I
driven,I
CAT,I
activity,I
in,O
a,O
dose,O
-,O
dependent,O
manner,O
.,O
Unlike,O
the,O
mycoestrogens,O
",",O
none,O
of,O
the,O
compounds,O
",",O
with,O
the,O
exception,O
of,O
genistein,B
",",O
synergized,O
with,O
LPS,O
to,O
enhance,O
IL,B
-,I
1beta,I
promoter,I
activity,I
.,O
Naringenin,O
",",O
a,O
plant,O
flavonoid,O
",",O
showed,O
little,O
or,O
no,O
ability,O
to,O
antagonize,O
the,O
response,O
to,O
E2,B
.,O
Isolation,O
and,O
utilization,O
of,O
human,B
dendritic,I
cells,I
from,O
peripheral,O
blood,O
to,O
assay,O
an,O
in,O
vitro,O
primary,O
immune,O
response,O
to,O
varicella,O
-,O
zoster,O
virus,O
peptides,O
.,O
Here,O
we,O
evaluated,O
whether,O
xenogeneic,O
serum,O
",",O
as,O
a,O
source,O
of,O
xenoreactive,O
natural,O
antibodies,O
and,O
complement,O
",",O
induced,O
endothelial,B
cell,I
activation,O
with,O
consequent,O
leukocyte,O
adhesion,O
under,O
flow,O
conditions,O
.,O
Adherent,O
cells,O
were,O
counted,O
by,O
digital,O
image,O
analysis,O
.,O
In,O
order,O
to,O
elucidate,O
possible,O
mechanisms,O
underlying,O
endothelial,B
cell,I
activation,O
by,O
xenogeneic,O
serum,O
",",O
we,O
focussed,O
on,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
",",O
a,O
central,O
regulator,O
for,O
the,O
induction,O
of,O
different,O
genes,O
",",O
including,O
adhesive,O
molecules,O
and,O
chemoattractants,O
.,O
Anaphylatoxins,O
C5a,B
and,O
C3a,B
induce,O
nuclear,O
factor,O
kappaB,O
activation,O
in,O
human,O
peripheral,O
blood,O
monocytes,O
.,O
These,O
results,O
imply,O
a,O
potential,O
role,O
of,O
the,O
anaphylatoxins,O
C5a,B
and,O
C3a,B
in,O
regulating,O
leukocytes,O
gene,O
expression,O
through,O
G,O
protein,B
-,I
coupled,I
transcription,I
factor,I
activation,I
.,O
Plasma,O
TPO,O
levels,O
are,O
regulated,O
by,O
the,O
platelet,O
and,O
megakaryocyte,O
mass,O
through,O
Mpl,O
receptor,O
binding,O
",",O
internalization,O
and,O
degradation,O
.,O
The,O
Mpl,B
receptor,I
is,O
a,O
member,O
of,O
the,O
hematopoietin,O
receptor,O
superfamily,O
lacking,O
intrinsic,O
kinase,O
activity,O
.,O
Promoter,O
analysis,O
revealed,O
that,O
a,O
GATA,B
site,O
in,O
a,O
cryptic,O
promoter,O
in,O
the,O
second,O
intron,O
was,O
essential,O
and,O
sufficient,O
for,O
the,O
TAL1,B
-,I
and,I
LMO,B
-,I
dependent,I
transcriptional,I
activation,I
",",O
and,O
GATA3,B
binds,O
to,O
this,O
site,O
.,O
Glucocorticoids,B
are,O
important,O
for,O
maintaining,O
cellular,O
and,O
humoral,O
homeostasis,O
and,O
are,O
key,O
mediators,O
of,O
neuroendocrine,O
-,O
immune,O
regulatory,O
interactions,O
.,O
Several,O
neuroendocrine,O
-,O
immune,O
interactions,O
could,O
be,O
responsible,O
for,O
reduced,O
GR,B
levels,O
with,O
age,O
and,O
sport,O
activity,O
in,O
man,O
.,O
Glycation,O
-,O
dependent,O
",",O
reactive,O
oxygen,O
species,O
-,O
mediated,O
suppression,O
of,O
the,O
insulin,B
gene,I
promoter,I
activity,O
in,O
HIT,B
cells,I
.,O
In,O
non,O
-,O
rheumatoid,O
arthritis,O
",",O
binding,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
synovial,O
T,B
cells,I
was,O
exclusively,O
mediated,O
by,O
p50,B
/,I
p50,I
homodimers,I
.,O
X,B
chromosome,I
inactivation,I
patterns,I
in,O
normal,O
females,O
.,O
Since,O
one,O
of,O
the,O
two,O
X,B
chromosomes,I
is,O
randomly,O
inactivated,O
at,O
an,O
early,O
stage,O
of,O
female,O
embryonic,O
development,O
",",O
X,B
-,I
linked,I
markers,I
have,O
been,O
used,O
to,O
study,O
the,O
origin,O
and,O
development,O
of,O
various,O
neoplastic,O
disorders,O
in,O
affected,O
heterozygous,O
women,O
;,O
clonality,O
assays,O
have,O
provided,O
a,O
useful,O
tool,O
to,O
the,O
understanding,O
of,O
the,O
mechanisms,O
underlying,O
the,O
development,O
of,O
neoplasia,O
.,O
Recently,O
",",O
a,O
technique,O
of,O
clonal,O
analysis,O
has,O
been,O
devised,O
that,O
takes,O
advantage,O
of,O
a,O
highly,O
polymorphic,O
short,O
tandem,O
repeat,O
within,O
the,O
X,B
-,I
linked,I
human,I
androgen,I
receptor,I
(,O
AR,B
),O
gene,O
",",O
resulting,O
in,O
a,O
heterozygosity,O
rate,O
approaching,O
90,O
%,O
.,O
The,O
rapid,O
expansion,O
of,O
the,O
number,O
of,O
women,O
now,O
suitable,O
for,O
X,B
inactivation,I
analysis,I
has,O
however,O
given,O
rise,O
to,O
new,O
controversies,O
",",O
one,O
of,O
the,O
more,O
troublesome,O
being,O
the,O
possibility,O
of,O
a,O
modification,O
of,O
the,O
pattern,O
of,O
X,B
-,I
chromosome,I
inactivation,I
pattern,I
in,O
blood,O
cells,O
of,O
elderly,O
women,O
.,O
In,O
the,O
present,O
study,O
we,O
analyze,O
with,O
the,O
AR,B
assay,I
a,O
group,O
of,O
166,O
healthy,O
females,O
aged,O
between,O
8,O
and,O
94,O
years,O
",",O
with,O
no,O
history,O
of,O
genetic,O
or,O
neoplastic,O
familial,O
disorders,O
.,O
We,O
show,O
here,O
that,O
IFN,B
-,I
alpha,I
/,I
beta,I
act,O
directly,O
on,O
human,O
T,B
cells,I
to,O
drive,O
Th1,B
development,I
",",O
bypassing,O
the,O
need,O
for,O
IL,B
-,I
12,I
-,I
induced,I
signaling,I
",",O
whereas,O
IFN,B
-,I
alpha,I
can,O
not,O
substitute,O
IL,B
-,I
12,I
for,O
mouse,O
Th1,B
development,I
.,O
Unlike,O
IL,B
-,I
12,I
",",O
which,O
acts,O
only,O
on,O
Th1,B
cells,I
",",O
IFN,B
-,I
alpha,I
/,I
beta,I
can,O
activate,O
Stat4,B
not,O
only,O
in,O
human,O
Th1,B
",",O
but,O
also,O
in,O
Th2,B
cells,I
.,O
We,O
have,O
generated,O
antibodies,O
that,O
specifically,O
immunoprecipitated,O
the,O
in,O
-,O
vitro,O
-,O
translated,O
20,O
-,O
kDa,O
protein,B
.,O
The,O
mRNA,O
levels,O
for,O
fkhrl1,B
is,O
elevated,O
in,O
T,B
helper,I
-,I
induced,I
lymphocytes,I
in,O
comparison,O
to,O
PHA,B
-,I
stimulated,I
T,B
lymphocytes,I
.,O
Further,O
characterization,O
of,O
FKHRL1,B
and,O
its,O
related,O
family,O
members,O
should,O
shed,O
light,O
on,O
the,O
transcriptional,O
mechanisms,O
of,O
this,O
fork,O
head,O
gene,O
subfamily,O
and,O
their,O
role,O
in,O
T,O
helper,O
cell,B
differentiation,O
and,O
regulation,O
of,O
cell,B
growth,O
.,O
Inhibition,O
of,O
Th1,B
development,O
mediated,O
by,O
GATA,B
-,I
3,I
through,O
an,O
IL,B
-,I
4,I
-,I
independent,I
mechanism,O
.,O
These,O
motifs,O
are,O
regulatory,O
sequences,O
within,O
the,O
so,O
-,O
called,O
AU,B
-,I
rich,I
elements,I
(,O
AREs,O
),O
often,O
found,O
in,O
3,O
',O
untranslated,O
regions,O
of,O
genes,O
such,O
as,O
cytokines,O
",",O
proto,O
-,O
oncogenes,O
",",O
and,O
transcription,O
factors,O
.,O
Copyright,O
1998,O
Academic,O
Press,O
.,O
Transcription,O
factor,O
NF,B
-,I
kappaB,I
regulation,O
of,O
renal,O
fibrosis,O
during,O
ureteral,O
obstruction,O
.,O
Irrespective,O
of,O
the,O
etiology,O
",",O
many,O
kidney,B
diseases,I
result,O
in,O
inflammation,O
and,O
fibrosis,O
of,O
the,O
tubulointerstitium,O
",",O
with,O
the,O
subsequent,O
loss,O
of,O
renal,B
function,I
. The,O
nuclear,B
factor,I
-,I
kappa,I
B,I
(,O
NF,B
-,I
kappaB,I
),O
family,O
of,O
transcription,O
factors,O
regulates,O
genes,O
involved,O
in,O
inflammation,O
",",O
cell,B
proliferation,I
",",O
and,O
cell,B
differentiation,I
.,O
Morphological,O
studies,O
demonstrated,O
characteristic,O
features,O
of,O
erythroid,B
differentiation,I
and,O
maturation,O
.,O
At,O
the,O
same,O
time,O
there,O
was,O
no,O
change,O
in,O
the,O
level,O
of,O
expression,O
of,O
the,O
cell,B
surface,I
antigenes,I
CD33,B
",",O
CD34,B
",",O
CD45,B
",",O
CD71,B
and,O
glycophorin,B
A,I
.,O
The,O
class,O
II,O
transactivator,O
(,O
CIITA,B
),O
is,O
essential,O
for,O
the,O
expression,O
of,O
major,O
histocompatibility,O
complex,O
(,O
MHC,B
),O
class,O
II,O
antigens,O
.,O
In,O
contrast,O
",",O
luciferase,B
expression,I
was,O
not,O
stimulated,O
after,O
IFN,B
-,I
gamma,I
treatment,O
when,O
the,O
construct,O
was,O
transfected,O
in,O
macrophage,B
or,O
in,O
epithelial,B
cell,I
lines,I
.,O
These,O
studies,O
investigate,O
the,O
relationship,O
between,O
leukocyte,B
populations,I
",",O
steroid,B
hormone,I
receptor,I
expression,I
",",O
proliferative,O
activity,O
",",O
bcl,B
-,I
2,I
expression,I
and,O
apoptosis,O
in,O
eutopic,O
and,O
ectopic,O
endometrium,O
from,O
women,O
with,O
endometriosis,O
or,O
adenomyosis,O
at,O
different,O
phases,O
of,O
the,O
menstrual,O
cycle,O
.,O
Here,O
",",O
we,O
demonstrate,O
through,O
the,O
use,O
of,O
intracellular,O
staining,O
that,O
interleukin,B
-,I
1beta,I
(,O
IL,B
-,I
1beta,I
),O
is,O
expressed,O
in,O
LCLs,B
and,O
investigate,O
the,O
influence,O
of,O
the,O
individual,O
latent,O
proteins,O
on,O
the,O
expression,O
of,O
IL,B
-,I
1beta,I
.,O
Electrophoretic,O
mobility,O
shift,O
assays,O
(,O
EMSAs,B
),O
demonstrated,O
that,O
the,O
-,O
300,O
region,O
of,O
the,O
IL,B
-,I
1beta,I
promoter,I
",",O
which,O
contains,O
a,O
nuclear,O
factor,O
-,O
kappaB,B
(,O
NF,B
-,I
kappaB,I
),O
binding,O
site,O
",",O
contained,O
a,O
functional,B
RBP,B
binding,I
site,I
.,O
CD27,B
/,O
CD70,B
interaction,O
augments,O
IgE,B
secretion,O
by,O
promoting,O
the,O
differentiation,O
of,O
memory,B
B,I
cells,I
into,O
plasma,B
cells,I
.,O
The,O
induction,O
of,O
IgE,B
switching,O
in,O
B,B
cells,I
requires,O
several,O
signals,O
given,O
by,O
cytokines,B
and,O
cell,B
contact,I
-,I
delivered,I
signals,I
.,O
Here,O
",",O
we,O
investigated,O
the,O
role,O
of,O
CD27,B
/,O
CD70,B
interaction,O
in,O
B,B
cell,I
IgE,B
synthesis,O
.,O
The,O
effect,O
of,O
CD70,B
transfectants,O
was,O
dose,O
dependent,O
and,O
was,O
completely,O
blocked,O
by,O
anti,O
-,O
CD70,B
mAb,O
.,O
CD27,B
/,I
CD70,I
interaction,O
enhanced,O
B,B
cell,I
proliferation,O
in,O
the,O
presence,O
of,O
IL,O
-,O
4,O
or,O
IL,O
-,O
4,O
plus,O
anti,O
-,O
CD40,B
.,O
Recent,O
studies,O
",",O
however,O
",",O
demonstrate,O
that,O
the,O
transcribed,O
5,O
',O
-,O
untranslated,O
leader,O
region,O
(,O
5,O
',O
-,O
UTR,O
),O
also,O
contains,O
important,O
transcriptional,O
elements,O
.,O
These,O
regulatory,O
elements,O
situated,O
downstream,O
of,O
transcription,O
interact,O
with,O
constitutive,O
and,O
inducible,O
transcription,O
factors,O
",",O
mediate,O
transmission,O
of,O
cellular,O
activation,O
signals,O
",",O
and,O
are,O
important,O
for,O
efficient,O
HIV,B
-,I
1,I
transcription,I
and,O
replication,O
.,O
Regulation,O
of,O
PAK,B
activation,I
and,O
the,O
T,B
cell,I
cytoskeleton,I
by,O
the,O
linker,O
protein,O
SLP,B
-,I
76,I
.,O
In,O
turn,O
",",O
assembly,O
of,O
this,O
complex,O
mediates,O
the,O
enzymatic,O
activation,O
of,O
the,O
p21,B
-,I
activated,I
protein,I
kinase,I
1,I
and,O
facilitates,O
actin,O
polymerization,O
. ,O
Copyright,O
1998,O
Academic,O
Press,O
. ,O
LOX,B
-,I
1,I
is,O
an,O
endothelial,O
receptor,O
for,O
oxidized,O
low,B
-,I
density,I
lipoprotein,I
that,O
plays,O
essential,O
roles,O
in,O
atherogenesis,O
. ,O
In,O
the,O
present,O
study,O
",",O
we,O
cloned,O
and,O
characterized,O
the,O
human,O
LOX,B
-,I
1,I
gene,I
(,O
HGMW,O
-,O
approved,O
symbol,O
OLR1,O
),O
. ,O
In,O
contrast,O
",",O
the,O
expression,O
pattern,O
of,O
LOX,B
-,I
1,I
is,O
different,O
from,O
that,O
of,O
the,O
natural,B
killer,I
cell,I
receptors,I
;,O
LOX,B
-,I
1,I
is,O
expressed,O
in,O
vascular,B
-,I
rich,I
organs,I
",",O
but,O
not,O
in,O
lymphocytes,B
.,O
These,O
results,O
demonstrate,O
that,O
the,O
human,O
LOX,B
-,I
1,I
gene,I
is,O
a,O
new,O
member,O
of,O
the,O
natural,B
killer,I
gene,I
complex,I
with,O
a,O
unique,O
expression,O
profile,O
.,O
In,O
this,O
report,O
",",O
we,O
describe,O
the,O
transcriptional,O
regulation,O
of,O
the,O
beta,B
-,I
casein,I
gene,I
by,O
cytokines,O
in,O
T,B
cells,I
.,O
Coincidentally,O
",",O
a,O
deletion,O
of,O
this,O
region,O
enhanced,O
the,O
IL,B
-,I
2,I
-,I
induced,I
expression,I
of,O
beta,B
-,I
casein,I
.,O
In,O
addition,O
",",O
Ras,B
(,O
G12V,O
),O
complemented,O
signaling,O
by,O
an,O
erythropoietin,B
receptor,I
mutant,O
defective,O
in,O
Ras,B
activation,O
and,O
augmented,O
the,O
activation,O
of,O
the,O
beta,B
-,I
casein,I
promoter,I
by,O
the,O
mutant,O
erythropoietin,B
receptor,I
signaling,O
",",O
suggesting,O
a,O
possible,O
role,O
of,O
Ras,B
in,O
Stat5,B
-,I
mediated,I
gene,I
expression,I
.,O
GATA,B
-,I
3,I
represses,O
gp91phox,B
gene,I
expression,O
in,O
eosinophil,B
-,I
committed,I
HL,B
-,I
60,I
-,I
C15,I
cells,O
.,O
An,O
81,O
%,O
increment,O
in,O
promoter,O
activity,O
was,O
obtained,O
when,O
a,O
mutation,O
was,O
introduced,O
in,O
the,O
GATA,B
-,I
3,I
binding,I
site,I
of,O
the,O
bp,O
-,O
267,O
to,O
+,O
12,O
construct,O
",",O
which,O
is,O
comparable,O
to,O
that,O
of,O
the,O
bp,O
-,O
245,O
to,O
+,O
12,O
construct,O
.,O
Ligation,O
of,O
CD3,B
also,O
induces,O
the,O
tyrosine,O
phosphorylation,O
of,O
HS1,B
",",O
a,O
75,O
-,O
kDa,O
hematopoietic,B
cell,I
-,I
specific,I
intracellular,I
signaling,I
protein,I
of,O
unknown,O
function,O
.,O
Costimulation,O
through,O
CD28,B
and,O
/,O
or,O
CD2,B
did,O
not,O
modulate,O
the,O
CD3,B
-,I
dependent,I
phosphorylation,I
of,I
HS1,B
.,O
c,O
-,O
fos,B
and,O
c,B
-,I
jun,I
mRNA,I
expression,I
in,O
activated,O
cord,O
and,O
adult,O
lymphocytes,O
:,O
an,O
analysis,O
by,O
Northern,O
hybridization,O
.,O
In,O
addition,O
",",O
Northern,O
blot,O
analysis,O
of,O
cord,O
and,O
adult,O
samples,O
revealed,O
similar,O
maximal,O
increases,O
in,O
c,B
-,I
fos,I
(,O
99,O
+,O
/,O
-,O
15,O
and,O
126,O
+,O
/,O
-,O
11,O
%,O
",",O
p,O
=,O
0,O
0.0126,O
),O
and,O
c,B
-,I
jun,I
(,O
123,O
+,O
/,O
-,O
9,O
185,O
+,O
/,O
-,O
38,O
%,O
",",O
p,O
=,O
0,O
0.0291,O
),O
mRNA,B
expression,I
",",O
respectively,O
",",O
as,O
early,O
as,O
15,O
min,O
post,O
-,O
alphaCD3,O
stimulation,O
.,O
Receptors,O
for,O
the,O
Fc,B
portion,I
of,I
immunoglobulin,I
molecules,I
(,O
FcR,B
),O
present,O
on,O
leukocyte,B
cell,I
membranes,I
mediate,O
a,O
large,O
number,O
of,O
cellular,O
responses,O
that,O
are,O
very,O
important,O
in,O
host,O
defense,O
",",O
including,O
phagocytosis,O
",",O
cell,B
cytotoxicity,I
",",O
production,O
and,O
secretion,O
of,O
inflammatory,O
mediators,O
",",O
and,O
modulation,O
of,O
the,O
immune,O
response,O
.,O
Cross,O
-,O
linking,O
of,O
FcR,B
",",O
on,O
the,O
THP,B
-,I
1,I
monocytic,I
cell,I
line,I
",",O
by,O
immune,O
complexes,O
resulted,O
in,O
both,O
activation,O
of,O
the,O
transcription,O
factor,O
NF,B
-,I
kappaB,I
and,O
interleukin,O
1,O
production,O
.,O
BCL,B
-,I
6,I
mutations,O
in,O
normal,O
germinal,O
center,O
B,B
cells,I
:,O
evidence,O
of,O
somatic,O
hypermutation,O
acting,O
outside,O
Ig,B
loci,I
.,O
Thirty,O
percent,O
of,O
GC,B
B,I
cells,I
",",O
but,O
not,O
naive,O
B,B
cells,I
",",O
displayed,O
mutations,O
in,O
the,O
742,O
bp,O
region,O
analyzed,O
within,O
the,O
first,O
intron,O
of,O
BCL,B
-,I
6,I
(,O
overall,O
frequency,O
:,O
5,O
x,O
10,O
(,O
-,O
4,O
),O
/,O
bp,O
.,O
The,O
ability,O
of,O
E2A,B
-,I
HLF,B
to,O
prolong,O
the,O
survival,O
of,O
interleukin,B
-,I
3,I
(,O
IL,B
-,I
3,I
),O
-,O
dependent,O
murine,B
pro,I
-,I
B,I
cells,I
after,O
IL,B
-,I
3,I
withdrawal,O
suggests,O
that,O
it,O
disrupts,O
signaling,O
pathways,O
normally,O
responsible,O
for,O
cell,O
suicide,O
",",O
allowing,O
the,O
cells,O
to,O
accumulate,O
as,O
transformed,O
lymphoblasts,O
.,O
Neither,O
the,O
E12,B
nor,O
the,O
E47,B
product,O
of,O
the,O
E2A,B
gene,I
nor,O
the,O
wild,O
-,O
type,O
HLF,B
protein,I
was,O
able,O
to,O
protect,O
the,O
cells,O
from,O
apoptosis,O
induced,O
by,O
IL,B
-,I
3,I
deprivation,O
.,O
Surprisingly,O
",",O
different,O
combinations,O
of,O
disabling,O
mutations,O
within,O
the,O
HLF,B
bZIP,I
domain,I
had,O
little,O
effect,O
on,O
the,O
antiapoptotic,O
property,O
of,O
the,O
chimeric,O
protein,B
",",O
so,O
long,O
as,O
the,O
amino,O
-,O
terminal,O
portion,O
of,O
E2A,O
remained,O
intact,O
.,O
These,O
results,O
suggest,O
that,O
1,O
),O
lipid,O
A,O
myristoyl,O
fatty,O
acid,O
",",O
although,O
it,O
is,O
important,O
for,O
the,O
induction,O
of,O
inflammatory,O
cytokine,O
production,O
by,O
human,O
monocytes,O
",",O
is,O
not,O
necessary,O
for,O
the,O
induction,O
of,O
Mn,B
SOD,I
",",O
2,O
),O
endotoxin,O
-,O
mediated,O
induction,O
of,O
Mn,B
SOD,I
and,O
inflammatory,O
cytokines,O
are,O
regulated,O
",",O
at,O
least,O
in,O
part,O
",",O
through,O
different,O
signal,O
transduction,O
pathways,O
",",O
and,O
3,O
),O
failure,O
of,O
the,O
mutant,O
endotoxin,O
to,O
induce,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
production,O
is,O
",",O
at,O
least,O
in,O
part,O
",",O
due,O
to,O
its,O
inability,O
to,O
activate,O
mitogen,O
-,O
activated,O
protein,O
kinase,O
.,O
Characterization,O
of,O
cytokine,B
differential,O
induction,O
of,O
STAT,B
complexes,I
in,O
primary,O
human,O
T,B
and,O
NK,B
cells,I
.,O
Finally,O
",",O
we,O
observed,O
that,O
activated,O
STAT5a,B
and,O
STAT5b,B
proteins,I
form,O
distinct,O
Fc,B
gamma,I
RI,I
GAS,I
binding,I
patterns,I
in,O
T,B
and,O
NK,B
cells,I
",",O
suggesting,O
that,O
they,O
might,O
have,O
different,O
roles,O
in,O
gene,O
regulation,O
.,O
A,O
regulatory,O
element,O
in,O
the,O
CD95,B
(,O
APO,B
-,I
1,I
/,I
Fas,I
),O
ligand,O
promoter,O
is,O
essential,O
for,O
responsiveness,O
to,O
TCR,O
-,O
mediated,O
activation,O
.,O
The,O
DNA,B
sequence,I
at,O
-,O
120,O
also,O
contains,O
two,O
DNA,B
motifs,I
homologous,O
to,O
the,O
binding,O
site,O
for,O
NF,B
-,I
AT,I
.,O
NF,B
-,I
AT,I
does,O
not,O
directly,O
bind,O
to,O
this,O
element,O
.,O
Progesterone,O
acts,O
distally,O
to,O
the,O
initial,O
steps,O
of,O
T,B
cell,I
receptor,I
(,I
TCR,I
),I
-,I
mediated,I
signal,I
transduction,I
",",O
since,O
it,O
blocks,O
sustained,O
Ca2,B
+,I
signals,I
after,O
thapsigargin,O
stimulation,O
",",O
as,O
well,O
as,O
oscillatory,O
Ca2,B
+,I
signals,I
",",O
but,O
not,O
the,O
Ca2,B
+,I
transient,I
after,O
TCR,O
stimulation,O
.,O
Progesterone,B
effectively,O
blocked,O
a,O
broad,O
spectrum,O
of,O
K,B
+,I
channels,I
",",O
reducing,O
both,O
Kv1,B
.,O
3,I
and,O
charybdotoxin,B
-,I
resistant,I
components,I
of,I
KV,B
current,I
and,O
KCa,B
current,I
in,O
T,B
cells,I
",",O
as,O
well,O
as,O
blocking,O
several,O
cloned,O
KV,B
channels,I
expressed,O
in,O
cell,B
lines,I
.,O
A,O
mouse,O
carrying,O
genetic,O
defect,O
in,O
the,O
choice,O
between,O
T,B
and,O
B,B
lymphocytes,I
.,O
The,O
present,O
study,O
shows,O
that,O
",",O
instead,O
of,O
T,B
cells,I
",",O
B,B
cells,I
are,O
generated,O
in,O
the,O
thymus,O
of,O
a,O
line,O
",",O
tg,O
epsilon26,O
",",O
of,O
the,O
human,O
CD3epsilon,O
transgenic,O
mice,O
.,O
The,O
accumulation,O
of,O
mature,O
B,B
cells,I
in,O
the,O
thymus,O
was,O
found,O
only,O
in,O
tg,O
epsilon26,O
mice,O
",",O
not,O
in,O
other,O
human,O
CD3epsilon,O
transgenic,O
mouse,O
lines,O
or,O
other,O
T,B
cell,I
-,I
deficient,I
mice,O
",",O
including,O
CD3,B
-,I
epsilon,I
knockout,I
mice,O
and,O
TCR,B
-,I
beta,I
/,I
TCR,B
-,I
delta,I
double,I
knockout,I
mice,O
.,O
The,O
chemokine,B
receptor,I
",",O
BLR1,B
",",O
is,O
a,O
major,O
regulator,O
of,O
the,O
microenvironmental,O
homing,O
of,O
B,B
cells,I
in,O
lymphoid,O
organs,O
.,O
Activation,O
of,O
the,O
CD4,B
promoter,I
occurs,O
in,O
the,O
presence,O
of,O
the,O
viral,B
DNA,I
polymerase,I
inhibitor,I
phosphonoformic,I
acid,I
",",O
which,O
limits,O
expression,O
to,O
the,O
immediate,O
-,O
early,O
and,O
early,O
classes,O
of,O
viral,B
genes,I
.,O
Both,O
Tax,B
-,I
mediated,I
apoptosis,O
and,O
oxidative,O
stress,O
can,O
be,O
potently,O
suppressed,O
by,O
antioxidants,O
",",O
as,O
is,O
seen,O
with,O
the,O
administration,O
of,O
recombinant,O
thioredoxin,B
(,O
adult,O
T,B
cell,I
leukemia,I
-,I
derived,I
factor,I
),O
or,O
pyrrolidine,O
dithiocarbamate,O
.,O
The,O
efficacy,O
of,O
o,O
",",O
o,O
',O
-,O
bismyristoyl,O
thiamine,O
disulfide,O
(,O
BMT,B
),O
was,O
examined,O
in,O
detail,O
against,O
HIV,B
-,I
1,I
laboratory,I
isolates,I
(,O
HTLV,B
-,I
IIIB,I
",",O
JRFL,B
",",O
and,O
MN,B
),O
",",O
primary,O
isolates,O
(,O
KMT,B
and,O
KMO,B
),O
",",O
and,O
simian,O
immunodeficiency,B
virus,I
(,O
SIVmac251,B
),O
in,O
vitro,O
.,O
In,O
addition,O
",",O
BMT,B
exhibited,O
antiviral,O
activity,O
against,O
SIVmac251,O
.,O
Minimizing,O
energy,O
studies,O
of,O
BMT,B
structure,O
reveal,O
that,O
a,O
trans,O
-,O
disulfide,O
of,O
thiamine,O
(,O
holo,O
drug,O
),O
disulfide,O
(,O
TDS,B
",",O
protodrug,O
),O
is,O
allosterically,O
transited,O
to,O
the,O
reactive,O
twisted,O
disulfide,O
of,O
BMT,B
(,O
allo,O
drug,O
),O
by,O
o,O
",",O
o,O
',O
-,O
bismyristoyl,O
esterification,O
of,O
TDS,B
.,O
Nor,O
was,O
fragmentation,O
observed,O
after,O
treatment,O
with,O
RU38486,O
",",O
indicating,O
that,O
repression,O
of,O
AP,B
-,I
1,I
activity,O
is,O
not,O
involved,O
.,O
Dexamethasone,O
treatment,O
completely,O
blocked,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
13,O
-,O
acetate,O
induction,O
of,O
nuclear,O
factor,O
-,O
kappaB,O
(,O
NF,B
-,I
kappaB,I
),O
activity,O
and,O
elicited,O
an,O
increase,O
in,O
the,O
amount,O
of,O
immunoreactive,O
IkappaB,O
alpha,O
in,O
sensitive,O
6TG1,O
.,O
1,O
cells,B
but,O
not,O
in,O
resistant,O
ICR27TK,B
.,O
3,O
cells,B
.,O
It,O
was,O
proposed,O
that,O
the,O
mechanism,O
of,O
antiviral,O
action,O
of,O
S9a,O
was,O
on,O
the,O
host,O
cell,B
",",O
by,O
blocking,O
TNF,B
-,I
alpha,I
transcription,O
via,O
a,O
Tat,O
-,O
induced,O
tar,O
-,O
independent,O
loop,O
",",O
which,O
decreases,O
downstream,O
NF,B
-,I
kappaB,I
activation,O
of,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
(,O
LTR,B
),O
.,O
S9a,O
was,O
superior,O
to,O
the,O
first,O
generation,O
compound,O
Canventol,O
",",O
which,O
was,O
superior,O
to,O
the,O
natural,O
compound,O
sarcophytol,O
A,O
",",O
demonstrating,O
that,O
further,O
structure,O
-,O
based,O
enhancement,O
of,O
potency,O
of,O
these,O
compounds,O
is,O
feasible,O
.,O
Intestinal,O
epithelial,O
cells,O
can,O
express,O
HLA,B
class,I
II,I
antigens,I
and,O
may,O
function,O
as,O
antigen,O
-,O
presenting,O
cells,O
to,O
CD4,B
(,O
+,O
),O
T,B
cells,O
within,O
the,O
intestinal,O
mucosa,O
.,O
These,O
data,O
indicate,O
a,O
highly,O
polarized,O
functional,B
architecture,I
for,O
antigen,B
processing,I
and,O
presentation,O
by,O
intestinal,B
epithelial,I
cells,I
",",O
and,O
suggest,O
that,O
the,O
functional,B
outcome,I
of,O
antigen,B
processing,I
by,O
the,O
intestinal,B
epithelium,I
is,O
both,O
dependent,O
on,O
the,O
cellular,B
surface,I
at,O
which,O
the,O
foreign,O
antigen,B
is,O
internalized,O
and,O
by,O
the,O
underlying,O
degree,O
of,O
mucosal,B
inflammation,I
We,O
determined,O
whether,O
Hsp70,B
induction,I
by,O
TS,O
was,O
mediated,O
by,O
the,O
activation,O
of,O
the,O
HS,B
transcription,I
factor,I
",",O
HSF,B
.,O
Thus,O
",",O
we,O
also,O
determined,O
the,O
effects,O
of,O
TS,B
on,O
NFkappaB,B
.,O
TS,B
activated,O
HSF,B
",",O
which,O
was,O
associated,O
with,O
Hsp70,B
overexpression,O
and,O
inhibition,O
of,O
NFkappaB,B
binding,O
activity,O
and,O
TNFalpha,B
release,O
.,O
[,O
Molecular,O
mechanism,O
of,O
cytokine,B
gene,I
expression,I
in,O
Th1,B
and,O
Th2,B
],O
Among,O
them,O
",",O
both,O
the,O
activation,O
of,O
PKC,B
/,I
Ras,I
-,I
and,I
CaM,B
/,I
CN,I
-,I
mediated,O
pathways,O
play,O
a,O
central,O
role,O
in,O
the,O
signal,O
transduction,O
of,O
cytokine,B
gene,I
expression,I
.,O
Activation,O
of,O
T,B
cells,I
results,O
in,O
the,O
rapid,O
calcineurin,O
-,O
dependent,O
translocation,O
of,O
NFAT,B
transcription,I
factors,I
from,O
the,O
cytoplasm,O
to,O
the,O
nucleus,O
.,O
Replication,O
of,O
human,O
immunodeficiency,O
virus,O
type,O
-,O
1,O
(,O
HIV,B
-,I
1,I
),O
is,O
highly,O
dependent,O
on,O
the,O
state,O
of,O
activation,O
of,O
the,O
infected,O
cells,O
and,O
is,O
modulated,O
by,O
interactions,O
between,O
viral,O
and,O
host,O
cellular,O
factors,O
.,O
These,O
results,O
suggest,O
that,O
secretion,O
of,O
PGE2,B
by,O
macrophages,O
in,O
response,O
to,O
infection,O
or,O
inflammatory,O
activators,O
could,O
induce,O
signaling,O
events,O
resulting,O
in,O
activation,O
of,O
proviral,B
DNA,I
present,O
into,O
T,B
cells,I
latently,O
infected,O
with,O
HIV,B
-,I
1,I
.,O
Unexpectedly,O
",",O
we,O
found,O
that,O
conventional,O
procedures,O
employed,O
to,O
prepare,O
cellular,O
extracts,O
cause,O
the,O
release,O
of,O
proteolytic,B
activities,I
that,O
are,O
normally,O
stored,O
in,O
intracellular,O
granules,O
",",O
resulting,O
in,O
the,O
degradation,O
of,O
various,O
NF,B
-,I
kappaB,I
/,I
Rel,I
and,O
STAT,B
proteins,I
.,O
In,O
addition,O
",",O
the,O
procedure,O
described,O
herein,O
could,O
prove,O
useful,O
in,O
other,O
cell,B
types,I
that,O
express,O
high,O
levels,O
of,O
endogenous,O
proteases,O
.,O
The,O
capacity,O
of,O
neonatal,B
T,I
cells,I
to,O
secrete,O
interleukin,B
-,I
2,I
(,O
IL,B
-,I
2,I
),O
has,O
been,O
reported,O
to,O
be,O
variable,O
.,O
PDBu,O
+,O
iono,O
induced,O
equally,O
high,O
IL,B
-,I
2,I
levels,O
in,O
both,O
groups,O
and,O
",",O
when,O
stimulated,O
with,O
plate,O
-,O
bound,O
anti,O
-,O
CD3,B
monoclonal,I
antibody,I
(,O
mAb,O
),O
",",O
the,O
IL,B
-,I
2,I
secretion,O
by,O
neonatal,B
cells,I
was,O
undetectable,O
and,O
adult,B
cells,I
produced,O
low,O
amounts,O
of,O
IL,B
-,I
2,I
(,O
mean,O
331,O
+,O
/,O
ml,O
),O
.,O
As,O
NF,B
-,I
kappa,I
B,I
is,O
a,O
critical,O
transcription,O
factor,O
in,O
the,O
control,O
of,O
IL,B
-,I
2,I
expression,O
",",O
we,O
next,O
analysed,O
its,O
nuclear,O
translocation,O
in,O
neonatal,O
and,O
adult,O
T,B
cells,I
using,O
the,O
electrophoretic,O
mobility,O
shift,O
assay,O
and,O
",",O
because,O
induction,O
of,O
reactive,O
oxygen,O
intermediates,O
(,O
ROI,B
),O
is,O
required,O
for,O
the,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
",",O
we,O
also,O
analysed,O
levels,O
of,O
intracellular,O
ROI,B
in,O
these,O
cells,O
using,O
the,O
ROI,B
-,I
reactive,I
fluorochrome,I
DCFH,I
-,I
DA,I
and,O
flow,O
cytometry,O
.,O
Our,O
results,O
suggest,O
that,O
reduced,O
IL,B
-,I
2,I
production,O
by,O
neonatal,O
T,B
cells,I
is,O
specific,O
for,O
anti,O
-,O
CD3,B
and,O
anti,O
-,O
CD3,B
+,I
anti,O
-,O
CD28,B
-,O
mediated,O
stimulation,O
and,O
that,O
these,O
activators,O
can,O
not,O
effectively,O
activate,O
the,O
ROI,B
-,I
NF,I
-,I
kappa,I
B,I
signalling,I
pathway,I
in,O
neonatal,O
T,B
cells,I
.,O
CL,B
-,I
1,I
cells,I
are,O
IgM,B
+,I
IgD,I
+,I
CD30,I
+,I
and,O
switch,O
to,O
IgG,B
",",O
IgA,B
",",O
and,O
IgE,B
when,O
exposed,O
to,O
CD40L,B
and,O
IL,B
-,I
4,I
.,O
Switching,O
is,O
hampered,O
by,O
CD30,B
coengagement,O
",",O
possibly,O
through,O
interference,O
with,O
the,O
CD40,B
-,I
mediated,O
NF,B
-,I
kappaB,I
-,I
dependent,I
transcriptional,O
activation,O
of,O
downstream,O
C,B
(,I
H,I
),I
genes,I
.,O
Are,O
there,O
effects,O
of,O
CyA,B
and,O
FK,B
506,I
all,O
attributable,O
to,O
CN,B
inhibition,O
",",O
and,O
how,O
much,O
of,O
them,O
are,O
mediated,O
through,O
the,O
NFATC,B
family,I
of,I
transcription,O
factors,O
To,O
investigate,O
processes,O
related,O
to,O
B,B
and,O
T,B
cell,I
activation,O
",",O
the,O
gene,O
expression,O
of,O
stimulated,O
and,O
nonstimulated,O
Ramos,B
and,O
Jurkat,B
cells,I
was,O
studied,O
using,O
cDNA,B
microarray,I
technology,I
.,O
Simultaneous,O
analysis,O
of,O
close,O
to,O
600,O
genes,O
indicated,O
highest,O
increase,O
in,O
the,O
expression,O
of,O
certain,O
transcription,B
",",O
differentiation,B
and,O
proliferation,B
factors,I
.,O
Also,O
genes,O
encoding,O
proteins,O
involved,O
in,O
DNA,B
replication,I
",",O
binding,B
",",O
transcription,B
and,O
translation,B
were,O
induced,O
.,O
Signal,O
transducer,O
and,O
activator,O
of,O
transcription,B
3,I
(,O
Stat3,B
),O
has,O
recently,O
been,O
shown,O
to,O
exist,O
in,O
two,O
alternatively,O
spliced,O
isoforms,O
",",O
a,O
short,O
form,O
",",O
Stat3beta,B
",",O
and,O
a,O
longer,O
form,O
",",O
Stat3alpha,B
",",O
displaying,O
differences,O
in,O
transcriptional,B
activity,I
.,O
It,O
is,O
unknown,O
which,O
Stat3,B
isoform,O
(,O
s,O
),O
is,O
activated,O
in,O
response,O
to,O
interleukin,B
(,O
IL,I
),O
-,O
2,O
and,O
IL,B
-,O
15,O
.,O
It,O
is,O
shown,O
here,O
that,O
during,O
monocyte,B
to,O
macrophage,I
differentiation,I
",",O
the,O
expression,O
of,O
LAL,B
-,I
mRNA,I
is,O
induced,O
.,O
Relationship,O
between,O
IkappaBalpha,B
constitutive,I
expression,I
",",O
TNFalpha,B
synthesis,I
",",O
and,O
apoptosis,O
in,O
EBV,B
-,I
infected,I
lymphoblastoid,I
cells,I
.,O
In,O
order,O
to,O
understand,O
the,O
role,O
of,O
NF,B
-,I
kappaB,I
in,O
EBV,O
transformation,O
we,O
have,O
established,O
stably,O
transfected,O
IkappaBalpha,O
into,O
lymphoblastoid,O
cells,O
.,O
Protein,B
latency,I
expression,I
was,O
determined,O
by,O
immunocytochemistry,O
.,O
Our,O
results,O
suggest,O
that,O
the,O
TNFalpha,O
gene,O
could,O
be,O
one,O
of,O
the,O
targets,O
of,O
NF,B
-,I
kappaB,I
in,O
EBV,O
infected,O
cells,O
and,O
that,O
NF,B
-,I
kappaB,I
protects,O
EBV,O
-,O
infected,O
cells,O
from,O
apoptosis,O
induced,O
by,O
TNFalpha,O
",",O
which,O
may,O
favour,O
the,O
proliferative,O
effect,O
of,O
this,O
cytokine,O
.,O
We,O
report,O
an,O
unusual,O
case,O
of,O
a,O
55,O
year,O
old,O
Japanese,O
woman,O
with,O
a,O
seminoma,B
but,O
relatively,O
normal,O
menses,O
.,O
A,O
typical,O
seminoma,B
was,O
removed,O
from,O
the,O
left,O
adnexal,O
region,O
and,O
an,O
immature,O
testis,B
was,O
identified,O
separately,O
as,O
an,O
associated,O
right,O
adnexal,O
mass,O
.,O
Repeated,O
karyotypic,O
studies,O
on,O
peripheral,O
blood,O
lymphocyte,O
cultures,O
showed,O
only,O
46,O
",",O
X,B
",",O
-,O
Y,B
",",O
t,O
(,O
Y,B
;,O
15,O
),O
(,O
q12,O
;,O
p13,O
),O
.,O
Two,O
chronically,O
HIV,B
-,I
1,I
-,I
infected,O
cell,O
lines,O
",",O
U1,B
(,O
monocytic,O
),O
and,O
ACH,B
-,I
2,I
(,O
T,B
lymphocytic,O
),O
",",O
were,O
stimulated,O
with,O
TNF,B
-,I
alpha,I
or,O
PMA,B
and,O
cultured,O
in,O
the,O
presence,O
of,O
various,O
concentrations,O
of,O
the,O
compound,O
.,O
Its,O
50,O
%,O
effective,O
and,O
cytotoxic,O
concentrations,O
were,O
0,O
.,O
16,O
and,O
2,O
.,O
2,O
microg,O
/,O
ml,O
in,O
PMA,B
-,I
stimulated,O
U1,B
cells,O
",",O
respectively,O
.,O
These,O
results,O
indicate,O
that,O
cepharanthine,O
is,O
a,O
highly,O
potent,O
inhibitor,O
of,O
HIV,B
-,I
1,I
replication,O
in,O
a,O
chronically,O
infected,O
monocytic,B
cell,I
line,I
.,O
This,O
study,O
shows,O
that,O
expression,O
of,O
LMP1,B
activates,O
transcription,O
from,O
p50,O
/,O
p65,O
-,O
and,O
c,O
-,O
Rel,O
-,O
responsive,O
promoters,O
",",O
and,O
that,O
this,O
activity,O
can,O
be,O
completely,O
inhibited,O
by,O
expression,O
of,O
a,O
dominant,O
inhibitory,O
IkappaB,B
mutant,O
.,O
Furthermore,O
",",O
LMP1,B
-,I
induced,I
cell,I
size,I
increase,I
of,I
primary,I
B,I
cells,I
was,O
unaffected,O
by,O
IkappaB,O
expression,O
. When,O
cultured,O
in,O
RPMI,O
1640,O
medium,O
containing,O
10,O
%,O
fetal,O
bovine,O
serum,O
",",O
most,O
YJ,B
cells,I
were,O
myeloblastoid,O
with,O
a,O
small,O
number,O
of,O
the,O
cells,O
having,O
eosinophilic,B
granules,I
. The,O
eosinophilic,B
characteristics,I
of,I
YJ,B
cells,I
were,O
confirmed,O
by,O
histochemical,O
staining,O
with,O
Fast,O
-,O
Green,O
/,O
Neutral,O
-,O
Red,O
and,O
by,O
the,O
expression,O
of,O
mRNAs,O
for,O
eosinophil,B
-,I
associated,I
granule,I
proteins,I
",",O
eosinophil,B
cationic,I
protein,I
(,I
ECP,I
),I
",",O
eosinophil,B
-,I
derived,I
neurotoxin,I
(,I
EDN,I
),I
",",O
eosinophil,B
peroxidase,I
(,I
EPO,I
),I
",",O
and,O
major,B
basic,I
protein,I
(,I
MBP,I
),I
",",O
and,O
for,O
the,O
Charcot,O
-,O
Leyden,O
crystal,O
(,O
CLC,O
),O
protein,O
.,O
The,O
expression,O
of,O
genes,O
for,O
transcription,O
factors,O
involved,O
in,O
myeloid,B
differentiation,I
was,O
evaluated,O
by,O
Northern,O
blot,O
analysis,O
.,O
The,O
YJ,B
cell,I
line,I
should,O
be,O
useful,O
for,O
elucidating,O
the,O
molecular,O
mechanisms,O
governing,O
lineage,O
switching,O
from,O
the,O
eosinophil,B
to,O
monocytic,B
or,O
neutrophil,B
lineages,I
.,O
To,O
examine,O
the,O
hypothesis,O
that,O
interleukin,B
-,I
6,I
(,O
IL,B
-,I
6,I
),O
contributes,O
to,O
PMN,B
infiltration,I
and,O
lung,B
damage,I
in,O
HS,O
we,O
examined,O
the,O
lungs,O
of,O
rats,O
subjected,O
to,O
unresuscitated,O
and,O
resuscitated,O
HS,O
for,O
the,O
production,O
of,O
IL,B
-,I
6,I
and,O
activation,O
of,O
Stat3,B
.,O
Electrophoretic,O
mobility,O
shift,O
assay,O
of,O
protein,B
extracts,O
from,O
shock,O
lungs,O
exhibited,O
an,O
increase,O
in,O
Stat3,B
activation,O
with,O
kinetics,O
similar,O
to,O
IL,B
-,I
6,I
mRNA,I
0.24,O
The,O
MHC,B
class,I
II,I
transactivator,I
(,O
CIITA,B
),O
requires,O
conserved,B
leucine,I
charged,I
domains,I
for,O
interactions,O
with,O
the,O
conserved,B
W,I
box,I
promoter,I
element,I
0.47,O
The,O
ability,O
of,O
mutants,O
to,O
activate,O
a,O
reporter,O
gene,O
under,O
the,O
control,O
of,O
MHC,B
class,I
II,I
conserved,B
W,I
-,I
X,I
-,I
Y,I
or,O
X,I
-,I
Y,I
regulatory,I
elements,I
was,O
determined,O
0.78,O
Two,O
mutants,O
displayed,O
differential,O
activity,O
between,O
the,O
two,O
promoters,O
",",O
activating,O
transcription,O
with,O
the,O
W,B
-,I
X,I
-,I
Y,I
but,O
not,O
the,O
X,B
-,I
Y,I
elements,I
.,O
All,O
mutants,O
were,O
tested,O
for,O
their,O
ability,O
to,O
interfere,O
with,O
wild,O
-,O
type,O
CIITA,O
activity,O
.,O
The,O
characterization,O
of,O
CIITA,O
mutants,O
that,O
are,O
able,O
to,O
discriminate,O
between,O
promoters,O
with,O
or,O
without,O
the,O
W,B
box,I
strongly,O
suggests,O
that,O
CIITA,O
requires,O
such,O
interactions,O
for,O
function,O
.,O
Recently,O
",",O
it,O
was,O
suggested,O
that,O
activation,O
of,O
the,O
alpha,B
isoform,I
of,I
PPAR,I
by,O
the,O
potent,O
proinflammatory,O
mediator,O
leukotriene,B
B4,I
(,O
LTB4,B
),O
enhanced,O
degradation,O
of,O
this,O
eicosanoid,O
",",O
offersuggesting,O
a,O
new,O
aspect,O
of,O
down,O
-,O
regulation,O
of,O
inflammation,O
.,O
Thus,O
",",O
this,O
study,O
provides,O
no,O
evidence,O
indicating,O
a,O
regulatory,O
function,O
of,O
PPARalpha,B
in,O
LTB4,B
induced,O
adhesive,O
interactions,O
between,O
endothelial,B
cells,I
and,O
neutrophils,B
We,O
determined,O
whether,O
the,O
interaction,O
of,O
SS,B
RBC,I
with,O
cultured,O
endothelial,B
cells,I
induced,O
cellular,O
oxidant,O
stress,O
that,O
would,O
culminate,O
in,O
expression,O
of,O
cell,O
adhesion,O
molecules,O
(,O
CAMs,B
),O
involved,O
in,O
the,O
adhesion,O
and,O
diapedesis,O
of,O
monocytes,B
and,O
the,O
adherence,O
of,O
SS,B
reticulocytes,I
.,O
These,O
results,O
suggest,O
that,O
the,O
adherence,O
/,O
contact,O
of,O
SS,B
RBC,I
to,O
endothelial,B
cells,I
in,O
large,O
vessel,O
can,O
generate,O
enhanced,O
oxidant,O
stress,O
leading,O
to,O
increased,O
adhesion,O
and,O
diapedesis,O
of,O
monocytes,O
",",O
as,O
well,O
as,O
heightened,O
adherence,O
of,O
SS,B
reticulocytes,I
",",O
indicating,O
that,O
injury,O
/,O
activation,O
of,O
endothelium,B
can,O
contribute,O
to,O
vaso,O
-,O
occlusion,O
in,O
SCD,O
.,O
Relative,O
levels,O
were,O
then,O
correlated,O
with,O
a,O
series,O
of,O
clinical,O
variables,O
including,O
response,O
to,O
therapy,O
",",O
performance,O
status,O
",",O
survival,O
",",O
disease,O
sites,O
",",O
age,O
",",O
and,O
others,O
.,O
Changes,O
in,O
these,O
signaling,O
molecules,O
during,O
cytokine,O
treatment,O
were,O
also,O
investigated,O
.,O
Correlations,O
of,O
TCRzeta,B
or,O
p56,B
(,O
lck,B
),O
levels,O
with,O
response,O
or,O
disease,O
variables,O
",",O
except,O
for,O
lower,O
TCRzeta,B
levels,O
(,O
P,O
<,O
0,O
.,O
1,O
),O
in,O
the,O
presence,O
of,O
bone,O
metastases,O
",",O
were,O
not,O
found,O
.,O
In,O
the,O
majority,O
of,O
patients,O
with,O
advanced,O
RCC,O
",",O
peripheral,O
blood,O
T,B
cells,I
express,O
TCRzeta,B
and,O
p56,B
(,O
lck,B
),O
",",O
and,O
in,O
a,O
subset,O
",",O
reduced,O
levels,O
of,O
these,O
TCRzeta,B
associated,O
molecules,O
are,O
seen,O
that,O
may,O
increase,O
during,O
cytokine,O
-,O
based,O
therapy,O
.,O
Identification,O
of,O
transcription,O
factors,O
expressed,O
during,O
ATRA,O
-,O
induced,O
neutrophil,O
differentiation,O
of,O
HL60,O
cells,O
.,O
In,O
order,O
to,O
understand,O
this,O
block,O
the,O
cascade,O
of,O
molecular,O
events,O
needs,O
to,O
be,O
characterized,O
.,O
CD38,B
+,O
cells,O
committed,O
towards,O
this,O
lineage,O
were,O
enriched,O
and,O
a,O
population,O
of,O
these,O
cells,O
treated,O
with,O
dihydroxyvitamin,O
D3,O
to,O
induce,O
neutrophil,O
maturation,O
.,O
The,O
differential,O
expression,O
of,O
the,O
genes,O
in,O
the,O
zinc,B
finger,I
and,O
POU,B
families,I
will,O
lead,O
to,O
a,O
better,O
understanding,O
of,O
the,O
cascade,O
of,O
gene,O
expression,O
which,O
occurs,O
following,O
ATRA,O
-,O
induced,O
differentiation,O
.,O
Interleukin,B
-,I
4,I
and,O
-,I
13,I
induce,O
upregulation,O
of,O
the,O
murine,B
macrophage,I
12,I
/,I
15,I
-,I
lipoxygenase,I
activity,O
:,O
evidence,O
for,O
the,O
involvement,O
of,O
transcription,O
factor,O
STAT6,O
.,O
Moreover,O
",",O
a,O
strong,O
induction,O
of,O
the,O
enzyme,O
was,O
observed,O
in,O
red,B
cells,I
during,O
experimental,O
anemia,O
in,O
mice,O
.,O
The,O
cytokine,O
-,O
dependent,O
upregulation,O
of,O
the,O
murine,B
macrophage,I
12,I
-,I
lipoxygenase,I
and,O
its,O
induction,O
during,O
experimental,O
anemia,O
suggests,O
its,O
close,O
relatedness,O
with,O
the,O
human,B
reticulocyte,I
-,I
type,I
15,I
-,I
lipoxygenase,I
despite,O
their,O
differences,O
in,O
the,O
positional,O
specificity,O
of,O
arachidonic,O
acid,O
oxygenation,O
.,O
Interferon,O
-,O
gamma,O
-,O
induced,O
factor,O
binding,O
to,O
the,O
interleukin,B
-,I
4,I
-,I
responsive,I
element,I
of,O
CD23b,B
promoter,I
in,O
human,O
tonsillar,O
mononuclear,O
cells,O
:,O
role,O
in,O
transient,O
up,O
-,O
regulation,O
of,O
the,O
interleukin,B
-,I
4,I
-,I
induced,I
CD23b,B
mRNA,I
.,O
Activation,O
of,O
E2F,B
-,I
mediated,I
transcription,I
by,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
Tax,I
protein,I
in,O
a,O
p16,B
(,I
INK4A,I
),I
-,I
negative,I
T,B
-,I
cell,I
line,I
.,O
Consequently,O
",",O
Tax,B
can,O
activate,O
the,O
signaling,O
pathway,O
that,O
lead,O
to,O
the,O
release,O
of,O
E2F,B
that,O
in,O
turn,O
induces,O
expression,O
of,O
factors,O
required,O
for,O
cell,B
cycle,I
progression,O
.,O
In,O
addition,O
",",O
Tax,B
also,O
stimulates,O
the,O
transcription,O
of,O
the,O
E2F,B
-,I
1,I
gene,I
itself,O
.,O
Inducible,O
nitric,O
oxide,O
:,O
an,O
autoregulatory,O
feedback,O
inhibitor,O
of,O
vascular,O
inflammation,O
.,O
These,O
studies,O
indicate,O
that,O
iNO,B
attenuates,O
iNOS,B
expression,O
in,O
macrophages,O
and,O
inhibits,O
monocyte,B
adhesion,O
to,O
endothelial,B
cells,I
",",O
and,O
suggest,O
that,O
endogenously,O
derived,O
iNO,B
may,O
be,O
an,O
important,O
autoregulatory,O
inhibitor,O
of,O
vascular,O
inflammation,O
These,O
results,O
corroborate,O
previous,O
findings,O
that,O
the,O
presence,O
of,O
ER,B
variants,O
is,O
not,O
a,O
characteristic,O
of,O
breast,B
cancer,I
.,O
p21ras,B
initiates,O
Rac,B
-,I
1,I
but,O
not,O
phosphatidyl,B
inositol,I
3,I
kinase,I
/,I
PKB,I
",",O
mediated,O
signaling,O
pathways,O
in,O
T,B
lymphocytes,I
.,O
We,O
also,O
examined,O
the,O
possibility,O
that,O
Akt,B
/,I
PKB,I
is,O
regulated,O
by,O
Ras,B
signaling,O
pathways,O
in,O
T,B
lymphocytes,I
.,O
Moreover,O
",",O
neither,O
TCR,B
or,O
Ras,B
activation,O
of,O
AP,B
-,I
1,I
is,O
dependent,O
on,O
PtdIns,B
3,I
-,I
kinase,I
.,O
The,O
present,O
data,O
thus,O
highlight,O
that,O
PtdIns,B
3,I
-,I
kinase,I
and,O
Akt,B
/,I
PKB,I
are,O
not,O
universal,O
Ras,B
effector,I
molecules,I
.,O
LNCaP,B
cells,I
treated,O
with,O
prostaglandin,O
E2,O
showed,O
neither,O
a,O
reduction,O
in,O
proliferation,O
nor,O
a,O
down,O
-,O
regulation,O
of,O
AR,B
and,O
PSA,B
levels,O
.,O
In,O
addition,O
",",O
recombinant,O
IL,B
-,I
1beta,I
was,O
able,O
to,O
replace,O
MCM,B
for,O
the,O
inhibition,O
of,O
proliferation,O
and,O
down,O
-,O
regulation,O
of,O
AR,B
and,O
PSA,B
proteins,O
.,O
LNCaP,B
cells,I
were,O
shown,O
to,O
express,O
the,O
IL,B
-,I
1beta,I
receptor,I
type,I
1,I
",",O
which,O
transduces,O
IL,B
-,I
1beta,I
signal,O
.,O
Differential,O
responsiveness,O
of,O
the,O
IL,B
-,I
5,I
and,O
IL,B
-,I
4,I
genes,I
to,O
transcription,O
factor,O
GATA,B
-,I
3,I
.,O
Here,O
",",O
we,O
show,O
that,O
ectopic,O
expression,O
of,O
GATA,B
-,I
3,I
is,O
sufficient,O
to,O
drive,O
IL,B
-,I
5,I
but,O
not,O
IL,B
-,I
4,I
gene,I
expression,O
.,O
Mutations,O
of,O
sites,O
that,O
suppress,O
NF,B
-,I
AT,I
binding,I
impair,O
the,O
induction,O
and,O
strong,O
NF,B
-,I
ATp,I
-,I
mediated,I
transactivation,I
of,O
the,O
CD25,B
promoter,I
in,O
T,B
cells,I
.,O
Antibodies,O
to,O
Duffy,B
antigens,I
are,O
responsible,O
for,O
some,O
cases,O
of,O
transfusion,O
incompatibility,O
and,O
newborn,O
hemolytic,O
disease,O
.,O
The,O
Duffy,B
protein,I
is,O
a,O
receptor,O
for,O
the,O
Plasmodium,B
vivax,I
erythrocyte,I
-,I
binding,I
protein,I
and,O
is,O
also,O
a,O
receptor,O
for,O
various,O
chemokines,B
(,O
thus,O
renamed,O
Duffy,B
Antigen,I
Receptor,I
for,I
Chemokines,I
[,O
DARC,O
],O
.,O
The,O
Fy,B
(,O
a,O
-,O
b,O
-,O
),O
phenotype,O
is,O
the,O
predominant,O
one,O
in,O
populations,O
of,O
black,O
people,O
and,O
also,O
occurs,O
in,O
other,O
populations,O
",",O
including,O
some,O
non,O
-,O
Ashkenazi,O
Jewish,O
groups,O
.,O
The,O
Fy,B
(,O
a,O
-,O
b,O
-,O
),O
phenotype,O
has,O
been,O
associated,O
with,O
a,O
mutation,O
in,O
the,O
FY,B
*,I
B,I
promoter,I
at,O
the,O
GATA,B
box,I
that,O
abolishes,O
the,O
expression,O
of,O
erythrocyte,B
Duffy,I
protein,I
.,O
The,O
271C,O
-,O
-,O
>,O
T,O
substitution,O
represents,O
a,O
considerable,O
change,O
in,O
chemical,O
nature,O
(,O
Arg91,B
-,I
-,I
>,I
Cys,I
),O
",",O
one,O
which,O
may,O
affect,O
the,O
antigenic,O
determinants,O
of,O
DARC,B
",",O
and,O
thus,O
be,O
of,O
clinical,O
significance,O
.,O
The,O
functions,O
of,O
NFAT,B
proteins,I
are,O
directly,O
controlled,O
by,O
the,O
calcium,O
-,O
and,O
calmodulin,O
-,O
dependent,O
phosphatase,O
calcineurin,O
.,O
Expression,O
of,O
the,O
IL,B
-,I
2,I
gene,I
requires,O
activation,O
of,O
T,B
cells,I
through,O
stimulation,O
of,O
the,O
TCR,B
and,O
costimulation,O
through,O
accessory,O
receptors,O
.,O
In,O
this,O
study,O
",",O
we,O
analyzed,O
whether,O
activities,O
of,O
these,O
phosphatases,O
are,O
necessary,O
for,O
the,O
expression,O
of,O
the,O
IL,B
-,I
2,I
gene,I
.,O
In,O
both,O
activated,O
peripheral,B
blood,I
T,I
lymphocytes,I
and,O
activated,O
tumorigenic,B
T,I
cell,I
lines,I
",",O
IL,B
-,I
2,I
gene,I
expression,O
was,O
blocked,O
at,O
the,O
transcriptional,O
level,O
by,O
okadaic,O
acid,O
.,O
The,O
transcription,O
factors,O
active,O
at,O
the,O
IL,B
-,I
2,I
promoter,I
were,O
differentially,O
influenced,O
:,O
upon,O
down,O
-,O
modulation,O
of,O
okadaic,O
acid,O
-,O
sensitive,O
phosphatases,O
",",O
transactivation,O
by,O
octamer,O
",",O
NF,B
-,I
kappa,I
B,I
",",O
and,O
NF,B
of,I
activated,I
T,I
cells,I
proteins,I
was,O
abrogated,O
",",O
while,O
transactivation,O
by,O
AP,B
-,I
1,I
proteins,I
was,O
even,O
enhanced,O
.,O
The,O
purpose,O
of,O
this,O
study,O
was,O
to,O
examine,O
the,O
effects,O
of,O
bis,O
[,O
4,O
-,O
[,O
2,O
",",O
4,O
-,O
dioxo,O
-,O
5,O
-,O
thiazolidinyl,O
),O
methyl,O
],O
phenyl,O
],O
methane,O
(,O
YM,O
-,O
268,O
),O
",",O
a,O
thiazolidinedione,O
derivative,O
",",O
on,O
glucose,B
uptake,I
",",O
adipocyte,O
differentiation,O
through,O
peroxisome,O
proliferator,O
-,O
activated,O
receptor,O
gamma,O
(,O
PPARgamma,O
),O
",",O
and,O
phosphatidylinositol,O
3,O
-,O
kinase,O
(,O
PI,O
3,O
-,O
kinase,O
),O
activity,O
in,O
cultured,O
cells,O
.,O
YM268,O
and,O
pioglitazone,O
dose,O
-,O
dependently,O
increased,O
the,O
2,O
-,O
deoxyglucose,O
uptake,O
in,O
3T3,B
-,I
L1,I
cells,I
.,O
The,O
nuclear,O
receptor,O
PPARgamma,B
-,I
bigger,I
than,I
fat,I
.,O
PPARgamma,B
has,O
also,O
been,O
implicated,O
recently,O
in,O
the,O
biology,O
of,O
monocytes,B
and,O
in,O
cell,O
-,O
cycle,O
regulation,O
and,O
cancer,O
.,O
Although,O
common,O
members,O
of,O
the,O
apoptotic,O
cascade,O
are,O
shared,O
between,O
different,O
cell,O
types,O
",",O
it,O
appears,O
that,O
cell,O
-,O
specific,O
factors,O
can,O
influence,O
the,O
response,O
to,O
a,O
given,O
apoptotic,O
stimuli,O
.,O
These,O
results,O
establish,O
an,O
independent,O
role,O
for,O
enhanced,O
p75TNF,B
-,I
R,I
production,O
in,O
the,O
pathogenesis,O
of,O
inflammatory,O
disease,O
and,O
implicate,O
the,O
direct,O
involvement,O
of,O
this,O
receptor,O
in,O
a,O
wide,O
range,O
of,O
human,O
inflammatory,O
pathologies,O
.,O
Molecular,O
and,O
cellular,O
analysis,O
of,O
human,O
immunodeficiency,O
virus,O
-,O
induced,O
apoptosis,O
in,O
lymphoblastoid,O
T,B
-,I
cell,I
-,I
line,I
-,I
expressing,O
wild,O
-,O
type,O
and,O
mutated,O
CD4,B
receptors,I
.,O
We,O
have,O
determined,O
how,O
the,O
phosphorylation,O
of,O
the,O
retinoblastoma,B
family,I
(,O
pRb,B
",",O
p107,B
",",O
and,O
p130,B
),O
is,O
governed,O
in,O
individual,O
cell,O
cycle,O
phases,O
of,O
Daudi,B
B,I
-,I
cells,I
during,O
cell,O
cycle,O
exit,O
triggered,O
by,O
alpha,B
-,I
interferon,I
(,O
alpha,B
-,I
IFN,I
),O
.alpha,O
-,O
IFN,O
causes,O
dephosphorylation,O
of,O
pRb,B
and,O
loss,O
of,O
p130,B
phosphorylated,O
Form,O
3,O
0.58,O
However,O
",",O
the,O
change,O
in,O
p130,B
phosphorylation,O
in,O
response,O
to,O
alpha,O
-,O
IFN,O
occurs,O
before,O
dephosphorylation,O
of,O
pRb,B
is,O
complete,O
because,O
loss,O
of,O
p130,B
Form,O
3,O
occurs,O
throughout,O
the,O
cell,O
cycle,O
prior,O
to,O
complete,O
arrest,O
in,O
G1,O
",",O
whereas,O
pRb,B
is,O
dephosphorylated,O
only,O
in,O
G1,O
.,O
p130,B
",",O
predominantly,O
in,O
Form,O
1,O
",",O
and,O
hypophosphorylated,O
pRb,B
bind,O
an,O
E2F,B
DNA,I
binding,I
site,I
;,O
p130,B
complexes,O
E2F,B
-,I
4,I
",",O
whereas,O
pRb,B
binds,O
both,O
E2F,B
-,I
4,I
and,O
E2F,B
-,I
1,I
.,O
The,O
phosphorylated,O
forms,O
of,O
E2F,B
-,I
4,I
that,O
bind,O
to,O
the,O
E2F,B
DNA,I
site,I
are,O
different,O
from,O
hyperphosphorylated,O
E2F,B
-,I
4,I
",",O
which,O
predominates,O
in,O
primary,O
hemopoietic,O
cells,O
in,O
G0,O
.,O
Macrophages,O
and,O
granulocytes,O
",",O
which,O
are,O
developed,O
from,O
a,O
common,O
progenitor,O
cell,O
",",O
are,O
the,O
cellular,O
components,O
of,O
the,O
specific,O
and,O
non,O
-,O
specific,O
immunoreaction,O
.,O
In,O
contrast,O
",",O
v,O
-,O
myb,O
reduces,O
MRP14,B
promoter,I
activity,O
.,O
Northern,O
blot,O
analysis,O
of,O
L132,B
cells,I
transfected,O
with,O
the,O
C,B
/,I
EBP,I
alpha,I
expression,O
vector,O
demonstrate,O
that,O
C,B
/,I
EBP,I
alpha,I
is,O
sufficient,O
to,O
enhance,O
MRP14,B
expression,O
in,O
the,O
context,O
of,O
the,O
whole,O
genome,O
.,O
This,O
observation,O
prompted,O
us,O
to,O
postulate,O
that,O
signal,O
2,O
(,O
costimulatory,O
signal,O
),O
alone,O
without,O
signal,O
1,O
(,O
TCR,O
signal,O
),O
can,O
activate,O
T,B
cells,I
.,O
This,O
pathway,O
resulted,O
in,O
the,O
induction,O
of,O
the,O
transcription,O
factors,O
NF,B
-,I
kappa,I
B,I
",",O
NF,B
-,I
AT,I
",",O
and,O
proteins,B
binding,O
to,O
the,O
CD28,B
response,I
element,I
of,O
the,O
IL,B
-,I
2,I
promoter,I
.,O
In,O
contrast,O
to,O
the,O
differential,O
signaling,O
of,O
BW,O
828,O
and,O
9,O
.,O
3,O
in,O
resting,O
T,B
cells,I
",",O
the,O
two,O
mAbs,O
exhibited,O
a,O
similar,O
pattern,O
of,O
early,O
signaling,O
events,O
in,O
activated,O
T,B
cells,I
and,O
Jurkat,B
cells,I
(,O
p56,B
(,O
lck,I
),O
activation,O
",",O
association,O
of,O
phosphatidylinositol,B
3,I
-,I
kinase,I
with,O
CD28,B
),O
",",O
indicating,O
that,O
the,O
signaling,O
capacity,O
of,O
CD28,B
changes,O
with,O
activation,O
.,O
IL,B
-,I
12,I
is,O
a,O
75,O
-,O
kDa,O
heterodimeric,O
cytokine,O
composed,O
of,O
two,O
covalently,O
linked,O
p35,B
and,O
p40,B
chains,O
.,O
Th1,B
cell,I
-,I
mediated,I
immune,I
responses,I
have,O
been,O
implicated,O
in,O
the,O
pathogenesis,O
of,O
chronic,O
inflammatory,O
autoimmune,O
diseases,O
.,O
This,O
was,O
associated,O
with,O
the,O
down,O
-,O
regulation,O
of,O
IL,B
-,I
12p40,I
mRNA,I
expression,I
.,O
Metabolic,O
labeling,O
combined,O
with,O
pulse,O
-,O
chase,O
experiments,O
and,O
biochemical,O
analysis,O
showed,O
that,O
the,O
majority,O
of,O
class,O
II,O
molecules,O
in,O
infected,O
cells,O
became,O
resistant,O
to,O
endoglycosidase,O
H,O
",",O
consistent,O
with,O
normal,O
Golgi,O
processing,O
.,O
However,O
",",O
results,O
of,O
intracellular,O
staining,O
and,O
dual,O
color,O
confocal,O
microscopy,O
revealed,O
a,O
significant,O
defect,O
in,O
transport,O
of,O
newly,O
synthesized,O
class,O
II,O
molecules,O
through,O
the,O
endocytic,O
compartment,O
.,O
Thus,O
",",O
compared,O
with,O
findings,O
in,O
control,O
cells,O
",",O
class,O
II,O
molecules,O
in,O
infected,O
cells,O
colocalized,O
to,O
a,O
minimal,O
extent,O
with,O
a,O
lysosomal,O
-,O
associated,O
membrane,O
protein,O
-,O
1,O
+,O
endosomal,O
compartment,O
.,O
Analyzed,O
DNA,B
sequences,I
included,O
delta,B
and,O
beta,B
5,O
',O
flanking,O
regions,O
extending,O
from,O
approximately,O
-,O
500,O
to,O
+,O
50bp,O
(,O
promoter,O
regions,O
),O
",",O
truncated,O
delta,B
and,O
beta,B
5,O
',O
flanking,O
regions,O
extending,O
from,O
approximately,O
-,O
250,O
to,O
+,O
50,O
bp,O
",",O
and,O
chimeric,O
promoter,O
constructions,O
",",O
which,O
consisted,O
of,O
a,O
distal,O
delta,B
or,O
beta,B
fragment,O
fused,O
to,O
a,O
proximal,O
beta,B
or,O
delta,B
sequence,O
.,O
In,O
CAT,B
reporter,I
constructions,I
no,O
appreciable,O
level,O
of,O
CAT,B
activity,I
was,O
supported,O
by,O
the,O
beta,B
globin,I
promoter,I
",",O
and,O
only,O
low,O
level,O
activity,O
by,O
the,O
delta,B
promoter,I
.,O
Fusion,O
of,O
the,O
upstream,O
portion,O
of,O
the,O
delta,B
promoter,I
to,O
the,O
truncated,O
beta,B
globin,I
promoter,I
yielded,O
a,O
modest,O
increase,O
in,O
promoter,I
strength,I
relative,O
to,O
the,O
truncated,O
beta,B
gene,I
promoter,I
",",O
indicating,O
the,O
presence,O
of,O
a,O
positive,O
transcriptional,O
element,O
(,O
s,O
),O
in,O
the,O
upstream,O
delta,B
globin,I
regulatory,I
region,I
.,O
The,O
induction,O
of,O
IgE,B
by,O
IL,B
-,I
4,I
and,O
IL,B
-,I
13,I
occurs,O
through,O
the,O
activation,O
of,O
the,O
intracellular,O
signal,O
-,O
transducing,O
protein,B
Stat6,I
",",O
whereas,O
the,O
inhibition,O
of,O
IgE,B
class,I
switching,I
by,O
interferon,B
-,I
y,I
(,O
IFN,B
-,I
gamma,I
),O
occurs,O
through,O
the,O
activation,O
of,O
Statl,B
.,O
NFAT,B
regulates,O
transcription,O
of,O
a,O
number,O
of,O
cytokine,B
and,O
other,O
immunoregulatory,I
genes,I
.,O
We,O
also,O
report,O
three,O
additional,O
isoforms,O
of,O
NFATx,B
",",O
designated,O
NFATx2,B
",",O
NFATx3,B
",",O
and,O
NFATx4,B
.,O
This,O
transactivation,O
sequence,O
is,O
altered,O
by,O
tissue,O
-,O
specific,O
alternative,O
splicing,O
in,O
newly,O
isolated,O
NFATx,B
isoforms,O
",",O
resulting,O
in,O
lower,O
transactivation,O
activity,O
in,O
Jurkat,B
T,I
cells,I
.,O
5,O
',O
HS3,O
contains,O
six,O
G,O
-,O
rich,O
motifs,O
that,O
are,O
essential,O
for,O
its,O
activity,O
.,O
We,O
show,O
that,O
the,O
function,O
of,O
such,O
closely,O
related,O
proteins,B
can,O
be,O
distinguished,O
in,O
vivo,O
by,O
matching,O
point,O
mutations,O
in,O
5,O
',O
HS3,O
with,O
amino,O
acid,O
changes,O
in,O
the,O
zinc,B
fingers,I
of,O
Sp1,B
and,O
EKLF,B
.,O
The,O
transition,O
of,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,B
),O
from,O
latency,O
into,O
the,O
lytic,O
cycle,O
is,O
associated,O
with,O
the,O
expression,O
of,O
two,O
immediate,O
-,O
early,O
viral,O
genes,O
",",O
BZLF1,B
and,O
BRLF1,B
.,O
In,O
HH514,B
-,I
16,I
cells,O
",",O
transfection,O
of,O
Rta,B
leads,O
to,O
synthesis,O
of,O
ZEBRA,B
",",O
viral,O
DNA,B
replication,O
",",O
and,O
late,O
gene,O
expression,O
.,O
Expression,O
of,O
either,O
BZLF1,B
or,O
BRLF1,B
triggers,O
expression,O
of,O
the,O
other,O
immediate,O
-,O
early,O
factor,O
",",O
and,O
together,O
these,O
activators,O
act,O
individually,O
or,O
in,O
synergy,O
on,O
downstream,O
targets,O
to,O
activate,O
the,O
viral,O
lytic,O
cycle,O
.,O
We,O
first,O
demonstrate,O
",",O
in,O
human,O
and,O
mouse,O
intraspecies,O
hybrids,O
",",O
the,O
coordinate,O
suppression,O
of,O
MHC,B
class,I
II,I
",",O
Ii,B
(,O
invariant,I
chain,I
),O
and,O
HLA,B
-,I
DM,I
gene,I
transcription,I
",",O
and,O
the,O
release,O
of,O
the,O
silencing,O
by,O
the,O
addition,O
of,O
interferon,O
gamma,O
. These,O
data,O
indicate,O
that,O
the,O
IFN,B
-,I
gamma,I
-,I
independent,I
component,I
of,O
the,O
target,O
cell,O
HLA,B
-,I
DR,I
expression,I
induced,I
by,O
lymphocyte,O
adhesion,O
uses,O
a,O
signaling,O
pathway,O
that,O
is,O
distinct,O
from,O
the,O
IFN,B
-,I
gamma,I
-,I
dependent,I
mechanism,I
and,O
also,O
suggest,O
that,O
CIITA,O
is,O
not,O
required,O
.,O
In,O
this,O
report,O
expression,O
profiles,O
and,O
activation,O
of,O
PKC,B
were,O
analyzed,O
in,O
human,O
Raji,B
B,I
lymphoblastoid,I
cells,I
.,O
Transient,O
transfection,O
analysis,O
with,O
target,O
plasmids,O
containing,O
either,O
DRA,B
promoter,I
(,O
wild,O
-,O
type,O
or,O
mutated,O
),O
or,O
TPA,B
response,I
elements,I
demonstrated,O
that,O
pretreatment,O
with,O
the,O
selective,O
PKC,B
inhibitor,I
GF,I
109203X,I
repressed,O
TPA,B
-,I
mediated,I
activation,I
.,O
Together,O
",",O
these,O
results,O
show,O
that,O
activated,O
HLA,B
-,I
DRA,I
expression,O
in,O
response,O
to,O
TPA,O
treatment,O
is,O
strictly,O
dependent,O
on,O
PKC,B
activation,O
acting,O
on,O
the,O
X2,O
box,O
of,O
the,O
DRA,B
promoter,I
and,O
that,O
selective,O
inhibition,O
of,O
PKC,B
enzymatic,O
activity,O
does,O
not,O
influence,O
subcellular,O
localization,O
of,O
expressed,O
PKC,B
isoenzymes,O
.,O
Multiple,O
cellular,O
DNA,B
-,I
binding,I
transcription,I
factors,I
are,O
required,O
by,O
HIV,O
type,O
1,O
for,O
RNA,B
synthesis,I
.,O
These,O
synthetic,O
ligands,O
specifically,O
inhibit,O
DNA,B
-,I
binding,I
of,O
each,O
transcription,O
factor,O
and,O
HIV,O
type,O
1,O
transcription,O
in,O
cell,O
-,O
free,O
assays,O
.,O
In,O
situ,O
hybridisation,O
revealed,O
musculin,O
expression,O
in,O
embryos,O
was,O
largely,O
restricted,O
to,O
the,O
embryonic,O
skeletal,O
muscle,O
lineage,O
.,O
While,O
all,O
skeletal,B
muscles,I
expressed,O
the,O
gene,O
",",O
only,O
a,O
subset,O
of,O
myocytes,B
within,O
each,O
muscle,O
were,O
positive,O
",",O
indicating,O
molecular,O
heterogeneity,O
within,O
fetal,O
muscle,O
.,O
All,O
Rights,O
Reserved,O
.,O
The,O
TT,B
-,I
selected,I
T,I
cell,I
line,I
could,O
be,O
rendered,O
unresponsive,O
to,O
its,O
dominant,O
epitope,O
in,O
a,O
dose,O
-,O
dependent,O
manner,O
(,O
IC50,B
=,O
0,O
.,O
3,O
microg,O
/,O
ml,O
),O
.,O
JNK,B
enzymatic,I
activity,I
was,O
blocked,O
in,O
anergized,O
T,B
cells,I
.,O
Copyright,O
1998,O
Academic,O
Press,O
.,O
Previously,O
",",O
we,O
demonstrated,O
that,O
granulocyte,B
colony,I
-,I
stimulating,I
factor,I
(,O
G,B
-,I
CSF,I
),O
receptor,O
mRNA,O
was,O
undetectable,O
and,O
granulocyte,B
maturation,I
blocked,I
in,O
CCAAT,B
enhancer,I
binding,I
protein,I
alpha,I
(,O
C,B
/,I
EBPalpha,I
),O
-,O
deficient,O
mice,O
.,O
Although,O
bacterial,O
lipopolysaccharides,B
(,O
LPS,B
),O
and,O
several,O
other,O
microbial,O
agonists,O
can,O
bind,O
to,O
mCD14,B
(,O
membrane,O
CD14,I
),O
",",O
a,O
cell,O
-,O
surface,O
receptor,O
found,O
principally,O
on,O
monocytes,B
and,O
neutrophils,B
",",O
host,O
-,O
derived,O
mCD14,B
ligands,O
are,O
poorly,O
defined,O
.,O
We,O
report,O
here,O
that,O
phosphatidylinositol,B
(,O
PtdIns,I
),O
",",O
phosphatidylinositol,B
-,I
4,I
-,I
phosphate,I
",",O
and,O
other,O
phosphatidylinositid,B
can,O
bind,O
to,O
mCD14,B
.,O
Despite,O
progress,O
in,O
understanding,O
the,O
death,O
signals,O
transduced,O
from,O
Fas,B
",",O
very,O
little,O
is,O
known,O
with,O
regard,O
to,O
the,O
mechanisms,O
by,O
which,O
Fas,B
expression,O
is,O
regulated,O
.,O
PKC,B
-,I
dependent,I
Fas,B
expression,O
was,O
also,O
observed,O
in,O
several,O
murine,B
and,O
human,B
tumor,I
cell,I
lines,I
.,O
Since,O
the,O
inhibition,O
of,O
Ca2,B
+,I
redistribution,I
by,O
an,O
inhibitor,O
of,O
intracellular,B
Ca2,I
+,I
mobilization,I
",",O
8,O
-,O
(,O
diethylamino,O
),O
-,O
octyl,O
-,O
3,O
",",O
4,O
",",O
5,O
-,O
trimethoxybenzoate,O
hydrochloride,O
",",O
inhibited,O
TCR,B
-,I
induced,I
FasL,B
but,O
not,O
Fas,B
",",O
the,O
expression,O
of,O
Fas,B
appears,O
to,O
be,O
independent,O
of,O
Ca2,B
+,I
mobilization,I
.,O
Anti,O
-,O
CD40,B
+,O
IL,B
-,I
mediated,I
proliferation,O
of,O
PBMC,B
and,O
B,B
cells,I
was,O
inhibited,O
by,O
RA,B
in,O
a,O
dose,O
-,O
dependent,O
manner,O
",",O
with,O
maximal,O
inhibition,O
of,O
62,O
%,O
+,O
/,O
-,O
5,O
%,O
in,O
PBMC,B
and,O
55,O
%,O
+,O
/,O
-,O
4,O
%,O
in,O
B,B
cells,I
by,O
all,O
-,O
trans,O
RA,B
",",O
and,O
58,O
%,O
+,O
/,O
-,O
6,O
. 7,O
%,O
and,O
51,O
%,O
+,O
/,O
-,O
4,O
. 7,O
%,O
",",O
respectively,O
by,O
13,O
-,O
cis,O
RA,B
.,O
IgE,B
synthesis,O
was,O
even,O
more,O
markedly,O
inhibited,O
by,O
RA,B
starting,O
at,O
concentrations,O
of,O
>,O
10,O
(,O
-,O
14,O
),O
mol,O
/,O
L,O
for,O
B,B
cells,I
and,O
>,O
10,O
(,O
-,O
10,O
),O
mol,O
/,O
L,O
for,O
PBMC,B
.,O
Low,O
concentrations,O
of,O
RA,B
inhibiting,O
IgE,B
synthesis,O
(,O
10,O
(,O
-,O
10,O
),O
mol,O
/,O
L,O
),O
affected,O
neither,O
B,B
-,I
cell,I
proliferation,O
nor,O
the,O
production,O
of,O
IgA,B
",",O
IgG,B
",",O
and,O
IgM,B
.,O
To,O
differentiate,O
whether,O
the,O
RA,B
effect,O
was,O
mediated,O
by,O
RA,B
receptors,O
alpha,B
",",O
beta,B
",",O
and,O
gamma,B
",",O
the,O
expression,O
of,O
the,O
retinoic,B
acid,I
receptors,I
(,O
RAR,B
),O
was,O
examined,O
by,O
reverse,O
transcriptase,O
-,O
polymerase,O
chain,O
reaction,O
(,O
RT,O
-,O
PCR,O
),O
.,O
Taken,O
together,O
",",O
this,O
study,O
shows,O
that,O
RA,B
inhibits,O
IgE,B
production,O
of,O
anti,O
-,O
CD40,B
+,O
IL,B
-,I
4,I
-,I
stimulated,O
B,B
cells,I
in,O
vitro,O
.,O
Copyright,O
1998,O
by,O
The,O
American,O
Society,O
of,O
Hematology,O
.,O
In,O
contrast,O
",",O
a,O
mutant,O
of,O
Tax,B
termed,O
M22,O
",",O
which,O
does,O
not,O
induce,O
NF,B
-,I
kappaB,I
",",O
fails,O
to,O
activate,O
either,O
IKKalpha,B
or,O
IKKbeta,B
.,O
The,O
pathological,O
alteration,O
of,O
this,O
cytokine,B
pathway,I
leading,O
to,O
NF,B
-,I
kappaB,I
activation,O
by,O
Tax,O
may,O
play,O
a,O
central,O
role,O
in,O
HTLV,B
-,I
1,I
-,I
mediated,O
transformation,O
of,O
human,B
T,I
cells,I
",",O
clinically,O
manifested,O
as,O
the,O
adult,O
T,B
-,I
cell,I
leukemia,I
Recently,O
",",O
we,O
have,O
reported,O
that,O
the,O
tumor,O
necrosis,O
factor,O
and,O
interleukin,B
1,I
signaling,O
pathways,O
activate,O
two,O
kinases,O
",",O
IKK1,B
and,O
IKK2,B
.,O
Here,O
",",O
we,O
report,O
that,O
LPS,B
induces,O
IKK,B
activity,O
in,O
human,O
monocytes,O
and,O
THP,B
-,I
1,I
monocytic,I
cells,I
.,O
In,O
contrast,O
",",O
a,O
dominant,O
negative,O
mutant,O
of,O
IKK2,B
inhibited,O
LPS,B
induction,O
of,O
kappaB,B
-,I
dependent,I
transcription,I
in,O
a,O
dose,O
-,O
dependent,O
manner,O
.,O
IL,B
-,I
7,I
did,O
not,O
maintain,O
v,O
-,O
Abl,B
-,I
mediated,I
differentiation,I
arrest,I
of,O
the,O
pre,O
-,O
B,B
cells,I
",",O
as,O
activation,O
of,O
NF,B
-,I
kappaB,I
and,O
RAG,B
gene,I
transcription,I
was,O
unaffected,O
by,O
IL,B
-,I
7,I
.,O
Functional,B
analysis,I
of,I
the,I
promoter,I
by,O
transient,O
transfection,O
assays,O
indicated,O
that,O
synergistic,O
action,O
between,O
an,O
SP,O
-,O
1,O
-,O
like,O
element,O
at,O
-,O
21,O
/,O
-,O
12,O
",",O
a,O
GATA,O
site,O
at,O
-,O
59,O
/,O
-,O
54,O
",",O
and,O
a,O
novel,O
regulatory,O
element,O
",",O
CPRE,B
(,O
-,O
GGACTACAG,O
-,O
),O
at,O
-,O
49,O
/,O
-,O
41,O
",",O
is,O
essential,O
for,O
the,O
promoter,I
activity,I
in,O
murine,O
erythroleukemia,O
(,O
MEL,B
),O
cells,O
.,O
Administration,O
of,O
the,O
cytokine,B
interleukin,I
-,I
2,I
(,O
IL,B
-,I
2,I
),O
can,O
result,O
in,O
therapeutic,O
benefits,O
for,O
individuals,O
with,O
renal,B
cell,I
carcinoma,I
and,O
melanoma,B
.,O
Here,O
we,O
report,O
an,O
analysis,O
of,O
the,O
transcription,O
factor,O
families,O
AP,B
-,I
1,I
",",O
Sp1,B
",",O
NF,B
-,I
kappaB,I
",",O
and,O
signal,O
transducers,O
and,O
activators,O
of,O
transcription,O
(,O
STAT,B
),O
in,O
cancer,B
patients,O
',O
lymphocytes,B
before,O
and,O
after,O
IL,B
-,I
2,I
immunotherapy,O
",",O
as,O
assessed,O
by,O
a,O
gel,O
-,O
shift,O
assay,O
.,O
The,O
role,O
of,O
platelets,B
for,O
monocyte,B
chemotactic,I
protein,I
-,I
1,I
(,O
MCP,B
-,I
1,I
),O
secretion,O
and,O
surface,O
expression,O
of,O
intercellular,B
adhesion,I
molecule,I
-,I
1,I
(,O
ICAM,B
-,I
1,I
),O
on,O
endothelial,B
cells,I
has,O
been,O
assessed,O
.,O
Nuclear,B
receptors,I
are,O
important,O
regulators,O
of,O
erythroid,B
cell,I
development,I
.,O
Here,O
we,O
investigated,O
the,O
impact,O
of,O
retinoid,B
X,I
receptor,I
(,O
RXR,B
),O
",",O
retinoic,B
acid,I
receptor,I
(,O
RAR,B
),O
",",O
and,O
of,O
the,O
c,B
-,I
erbA,I
/,I
thyroid,I
hormone,I
(,O
T3,B
),O
receptor,I
(,O
c,B
-,I
erbA,I
/,I
TR,I
),O
on,O
growth,O
and,O
differentiation,O
of,O
erythroid,B
cells,I
using,O
an,O
in,O
vitro,O
culture,O
system,O
of,O
stem,O
cell,O
factor,O
-,O
dependent,O
erythroid,B
progenitors,I
.,O
RXR,B
",",O
RAR,B
",",O
and,O
c,O
-,O
erbA,B
/,O
TR,B
-,O
specific,O
ligands,O
were,O
found,O
to,O
induce,O
erythroid,B
-,I
specific,I
gene,I
expression,I
and,O
to,O
accelerate,O
erythroid,B
differentiation,I
in,O
culture,O
",",O
with,O
T3,B
being,O
most,O
effective,O
.,O
Thus,O
",",O
c,O
-,O
erbA,B
/,O
TR,B
appears,O
to,O
act,O
as,O
a,O
binary,O
switch,O
affecting,O
erythroid,B
cell,I
fate,I
:,O
unliganded,O
c,O
-,O
erbA,B
/,O
TR,B
supports,O
growth,O
while,O
ligand,O
-,O
activated,O
c,O
-,O
erbA,B
/,O
TR,B
induces,O
differentiation,I
.,O
In,O
marked,O
contrast,O
",",O
expression,O
of,O
the,O
dominant,O
interfering,O
deltaDNA,B
-,I
binding,I
domain,I
RXR,B
",",O
containing,O
a,O
deletion,O
of,O
the,O
entire,O
DNA,B
-,I
binding,I
domain,I
",",O
was,O
incompatible,O
with,O
erythroid,O
cell,O
growth,O
in,O
vitro,O
",",O
suggesting,O
a,O
pivotal,O
role,O
of,O
RXR,B
for,O
erythroid,O
cell,O
development,O
.,O
We,O
examined,O
signaling,O
molecules,O
of,O
peripheral,O
blood,O
T,O
lymphocytes,O
obtained,O
from,O
women,O
with,O
breast,O
cancer,O
.,O
This,O
observation,O
was,O
made,O
despite,O
normal,O
cytoplasmic,O
levels,O
of,O
the,O
Rel,B
-,I
A,I
protein,I
.,O
T,O
lymphocytes,O
from,O
6,O
of,O
the,O
14,O
patients,O
also,O
exhibited,O
an,O
increased,O
expression,O
of,O
the,O
dual,O
specificity,O
phosphatase,O
",",O
map,O
kinase,O
phosphatase,O
-,O
1,O
(,O
MKP,B
-,I
1,I
),O
.,O
We,O
studied,O
the,O
number,O
of,O
glucocorticoid,B
receptors,I
and,O
dissociation,O
constant,O
in,O
isolated,O
human,O
lymphocytes,O
as,O
well,O
as,O
blood,O
concentrations,O
of,O
hormones,O
produced,O
by,O
the,O
hypothalamic,O
-,O
hypophyseal,O
-,O
adrenocortical,O
system,O
in,O
three,O
experimental,O
series,O
:,O
at,O
normal,O
(,O
17,O
subjects,O
),O
",",O
decreased,O
(,O
10,O
subjects,O
",",O
a,O
360,O
-,O
d,O
head,O
-,O
down,O
bed,O
rest,O
),O
and,O
increased,O
(,O
8,O
subjects,O
",",O
physical,O
exercise,O
on,O
bicycle,O
ergometer,O
),O
levels,O
of,O
motor,O
activity,O
.,O
The,O
small,O
GTP,B
-,I
binding,I
protein,I
Rho,B
potentiates,O
AP,B
-,I
1,I
transcription,I
in,O
T,B
cells,I
.,O
The,O
effect,O
of,O
Rho,B
on,O
AP,B
-,I
1,I
is,O
independent,O
of,O
the,O
mitogen,O
-,O
activated,O
protein,O
kinase,O
pathway,O
",",O
as,O
a,O
dominant,O
-,O
negative,O
MEK,B
and,O
a,O
MEK,B
inhibitor,I
(,O
PD98059,O
),O
did,O
not,O
affect,O
Rho,B
-,I
induced,I
AP,B
-,I
1,I
activity,O
.,O
These,O
cells,I
exhibit,O
many,O
alterations,O
in,O
function,O
compared,O
with,O
their,O
precursor,O
cells,I
",",O
blood,O
monocytes,B
.,O
To,O
evaluate,O
a,O
potential,O
mechanism,O
for,O
these,O
differences,O
in,O
function,O
",",O
we,O
evaluated,O
expression,O
of,O
protein,B
kinase,I
C,I
(,O
PKC,B
),O
isoforms,O
.,O
Using,O
mRNA,O
differential,O
display,O
we,O
demonstrated,O
abnormally,O
high,O
expression,O
of,O
the,O
signal,O
transducer,O
and,O
activator,O
of,O
transcription,O
(,O
STAT1alpha,B
),O
in,O
monocytes,O
from,O
the,O
proband,O
II,O
-,O
2,O
.,O
Analysis,O
of,O
monocytes,B
from,O
familial,O
hypercholesterolemic,O
(,O
FH,O
),O
subjects,O
",",O
who,O
frequently,O
develop,O
xanthomatosis,O
",",O
revealed,O
a,O
significant,O
number,O
of,O
subjects,O
with,O
elevated,O
STAT1alpha,B
and,O
IP,B
-,I
10,I
expression,O
.,O
The,O
activation,O
of,O
NF,B
-,I
kappaB,I
has,O
been,O
recognized,O
to,O
regulate,O
a,O
number,O
of,O
genes,O
necessary,O
for,O
normal,O
T,B
cell,I
responses,O
including,O
IL,B
-,I
2,I
",",O
IL,B
-,I
6,I
",",O
IL,B
-,I
8,I
",",O
and,O
several,O
T,B
cell,I
surface,I
receptors,I
.,O
Uncoupling,O
of,O
nonreceptor,B
tyrosine,I
kinases,I
from,O
PLC,B
-,I
gamma1,I
in,O
an,O
SLP,B
-,I
76,I
-,I
deficient,I
T,O
cell,O
.,O
SLP,B
-,I
76,I
was,O
not,O
required,O
for,O
TCR,O
-,O
induced,O
tyrosine,O
phosphorylation,O
of,O
most,O
proteins,O
",",O
but,O
was,O
required,O
for,O
optimal,O
tyrosine,O
phosphorylation,O
and,O
activation,O
of,O
phospholipase,B
C,I
-,I
gamma1,I
(,O
PLC,B
-,I
gamma1,I
),O
",",O
as,O
well,O
as,O
Ras,O
pathway,O
activation,O
.,O
Thus,O
",",O
coupling,O
of,O
TCR,B
-,I
regulated,I
PTKs,I
to,O
downstream,O
signaling,O
pathways,O
requires,O
SLP,B
-,I
76,I
.,O
In,O
addition,O
",",O
we,O
have,O
shown,O
that,O
Stat1alpha,B
",",O
but,O
not,O
Stat3,B
",",O
is,O
involved,O
in,O
EPO,B
-,I
induced,I
cellular,I
proliferation,I
.,O
Dominant,O
negative,O
forms,O
of,O
Stat1alpha,B
or,O
Stat3,B
promoted,O
the,O
EPO,B
-,I
induced,I
erythroid,I
differentiation,I
of,O
UT,B
-,I
7,I
/,I
GM,I
cells,I
",",O
even,O
in,O
the,O
presence,O
of,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
",",O
although,O
this,O
cytokine,O
never,O
induced,O
erythroid,O
differentiation,O
of,O
the,O
parent,O
UT,O
-,O
7,O
/,O
GM,O
cells,O
with,O
or,O
without,O
EPO,O
.,O
Taken,O
together,O
",",O
our,O
data,O
suggest,O
that,O
Stat1alpha,B
and,O
Stat3,B
act,O
as,O
negative,O
regulators,O
in,O
EPO,O
-,O
induced,O
erythroid,O
differentiation,O
.,O
Data,O
obtained,O
by,O
electrophoretic,O
mobility,O
shift,O
assay,O
suggested,O
that,O
the,O
activated,O
Stat,B
-,I
3,I
protein,I
associates,O
with,O
the,O
human,O
serum,O
-,O
inducible,O
element,O
(,O
hSIE,O
),O
DNA,B
-,I
probe,I
derived,O
from,O
the,O
interferon,O
-,O
gamma,O
activated,O
site,O
(,O
GAS,O
),O
in,O
the,O
c,O
-,O
fos,O
promoter,O
",",O
a,O
common,O
DNA,B
sequence,I
for,O
Stat,B
protein,I
binding,I
.,O
In,O
conclusion,O
",",O
our,O
data,O
suggest,O
the,O
involvement,O
of,O
the,O
Jak,B
/,I
Stat,I
signal,I
pathway,I
in,O
MHC,B
-,I
I,I
-,I
induced,I
signal,I
transduction,I
in,O
T,B
cells,I
.,O
These,O
apparent,O
inconsistencies,O
reflect,O
the,O
complexity,O
of,O
the,O
DTCs,O
biological,O
activities,O
and,O
are,O
probably,O
due,O
in,O
part,O
to,O
differences,O
in,O
dose,O
",",O
route,O
of,O
exposure,O
",",O
animal,O
species,O
used,O
and,O
/,O
or,O
specific,O
compound,O
tested,O
.,O
The,O
studies,O
described,O
herein,O
were,O
undertaken,O
to,O
investigate,O
the,O
immunotoxicity,O
of,O
one,O
member,O
of,O
this,O
family,O
",",O
dimethyldithiocarbam,O
(,O
DMDTC,B
),O
.,O
This,O
inhibition,O
is,O
not,O
accompanied,O
by,O
a,O
loss,O
in,O
viability,O
",",O
and,O
DMDTC,B
-,O
treated,O
T,O
cells,O
retain,O
other,O
active,O
signaling,O
pathways,O
throughout,O
the,O
exposure,O
duration,O
.,O
We,O
further,O
demonstrate,O
that,O
0,O
. 5,O
microM,O
DMDTC,O
inhibits,O
intracellular,O
IL,B
-,I
2,I
production,O
and,O
decreases,O
surface,O
expression,O
of,O
CD25,B
(,O
the,O
alpha,O
subunit,O
of,O
the,O
IL,B
-,I
2,I
receptor,I
),O
in,O
T,B
cells,I
stimulated,O
with,O
phorbol,O
ester,O
.,O
Using,O
deletion,O
constructs,O
",",O
we,O
have,O
defined,O
an,O
active,O
promoter,O
region,O
of,O
1056,O
bp,O
.,O
Ex,O
vivo,O
activation,O
of,O
tumor,B
-,I
draining,I
lymph,I
node,I
T,I
cells,I
reverses,O
defects,O
in,O
signal,O
transduction,O
molecules,O
.,O
To,O
determine,O
whether,O
the,O
acquisition,O
of,O
antitumor,O
function,O
during,O
ex,O
vivo,O
activation,O
is,O
associated,O
with,O
modifications,O
in,O
signal,O
transduction,O
capacity,O
",",O
the,O
protein,B
tyrosine,I
kinases,I
p56lck,I
and,O
p59fyn,B
and,O
proteins,O
of,O
the,O
NF,B
-,I
kappaB,I
family,I
were,O
analyzed,O
in,O
tumor,B
-,I
draining,I
LN,I
T,I
cells,I
.,O
In,O
contrast,O
",",O
the,O
cytoplasmic,O
levels,O
of,O
c,O
-,O
Rel,B
and,O
Rel,B
A,I
were,O
normal,O
in,O
freshly,O
isolated,O
tumor,O
-,O
draining,O
LN,O
",",O
as,O
was,O
nuclear,O
kappaB,B
DNA,I
-,I
binding,I
activity,I
induced,O
by,O
anti,O
-,O
CD3,O
mAb,O
or,O
phorbol,O
myristate,O
acetate,O
.,O
BACKGROUND,O
:,O
The,O
class,O
II,O
transactivator,O
(,O
CIITA,B
),O
is,O
a,O
bi,O
-,O
or,O
multifunctional,O
domain,O
protein,O
that,O
acts,O
as,O
a,O
transcriptional,O
activator,O
and,O
plays,O
a,O
critical,O
role,O
in,O
the,O
expression,O
of,O
MHC,B
class,I
II,I
genes,I
.,O
Porcine,B
MHC,I
class,I
II,I
antigens,I
are,O
potent,O
stimulators,O
of,O
direct,O
T,B
-,I
cell,I
recognition,I
by,O
human,O
CD4,B
+,I
T,I
cells,I
and,O
are,O
",",O
therefore,O
",",O
likely,O
to,O
play,O
an,O
important,O
role,O
in,O
the,O
rejection,O
responses,O
to,O
transgenic,O
pig,O
donors,O
in,O
clinical,O
xenotransplantation,O
.,O
Transient,O
transfectants,O
of,O
the,O
porcine,B
B,I
-,I
cell,I
line,I
L23,I
with,O
the,O
mutated,O
CIITA,B
constructs,I
were,O
tested,O
for,O
the,O
suppression,O
of,O
constitutive,O
SLA,B
-,I
DR,I
and,I
SLA,B
-,I
DQ,I
expression,I
.,O
Macrophages,B
in,O
human,O
atheroma,O
contain,O
PPARgamma,B
:,O
differentiation,O
-,O
dependent,O
peroxisomal,O
proliferator,O
-,O
activated,O
receptor,O
gamma,O
(,O
PPARgamma,B
),O
expression,O
and,O
reduction,O
of,O
MMP,B
-,I
9,I
activity,O
through,O
PPARgamma,B
activation,O
in,O
mononuclear,O
phagocytes,O
in,O
vitro,O
.,O
Mononuclear,O
phagocytes,O
play,O
an,O
important,O
role,O
in,O
atherosclerosis,O
and,O
its,O
sequela,O
plaque,O
rupture,O
in,O
part,O
by,O
their,O
secretion,O
of,O
matrix,O
metalloproteinases,O
(,O
MMPs,B
),O
",",O
including,O
MMP,B
-,I
9,I
.,O
The,O
role,O
of,O
PPARgamma,B
in,O
human,B
atherosclerosis,I
is,O
unexplored,O
.,O
In,O
addition,O
",",O
PPARgamma,B
mRNA,I
expression,I
in,O
U937,B
cells,I
increased,O
during,O
phorbol,O
12,O
-,O
myristate,O
13,O
acetate,O
-,O
induced,O
differentiation,O
.,O
We,O
examined,O
signaling,O
by,O
erythropoietin,B
in,O
highly,O
purified,O
human,B
colony,I
forming,I
unit,I
-,I
erythroid,I
cells,I
",",O
generated,O
in,O
vitro,O
from,O
CD34,B
(,I
+,I
),I
cells,I
.,O
We,O
found,O
that,O
erythropoietin,B
induces,O
tyrosine,O
phosphorylation,O
of,O
Jak2,B
",",O
STAT5A,B
",",O
and,O
STAT5B,B
.,O
Tyrosine,O
phosphorylation,O
of,O
Jak2,B
reaches,O
a,O
peak,O
around,O
10,O
minutes,O
after,O
stimulation,O
and,O
is,O
maximum,O
at,O
5,O
U,O
/,O
mL,O
of,O
erythropoietin,B
.,O
Effects,O
of,O
oxidative,O
stress,O
on,O
stimulation,O
-,O
dependent,O
signal,O
transduction,O
",",O
leading,O
to,O
IL,B
-,I
2,I
expression,O
",",O
were,O
studied,O
.,O
The,O
cells,O
were,O
then,O
stimulated,O
for,O
6,O
h,O
.,O
Eosinophils,O
infiltrating,O
hamster,O
cutaneous,O
wounds,O
were,O
found,O
to,O
express,O
TGFs,B
sequentially,O
.,O
IL,B
-,I
3,I
",",O
IL,B
-,I
4,I
",",O
and,O
IL,B
-,I
5,I
independently,O
up,O
-,O
regulated,O
TGF,B
-,I
beta1,I
mRNA,O
and,O
product,O
expression,O
by,O
eosinophils,O
in,O
all,O
donors,O
.,O
The,O
observation,O
that,O
IL,B
-,I
4,I
can,O
differentially,O
regulate,O
the,O
expression,O
of,O
TGF,B
-,I
alpha,I
and,O
TGF,B
-,I
beta1,I
suggests,O
that,O
IL,B
-,I
4,I
may,O
serve,O
as,O
a,O
physiologic,O
molecular,O
switch,O
of,O
TGF,B
expression,O
by,O
the,O
infiltrating,O
eosinophils,O
in,O
wound,O
healing,O
and,O
carcinogenesis,O
.,O
A,O
recent,O
study,O
showed,O
a,O
MLL,B
/,I
AF10,I
fusion,O
in,O
all,O
cases,O
of,O
AML,O
with,O
t,O
(,O
10,O
;,O
11,O
),O
and,O
various,O
breakpoints,O
on,O
chromosome,O
11,O
ranging,O
from,O
q13,O
to,O
q23,O
.,O
We,O
recently,O
cloned,O
CALM,B
(,O
Clathrin,I
Assembly,I
Lymphoid,I
Myeloid,I
leukemia,I
gene,I
),O
",",O
the,O
fusion,O
partner,O
of,O
AF10,O
at,O
11q14,O
in,O
the,O
monocytic,O
cell,O
line,O
U937,O
.,O
MLL,B
was,O
rearranged,O
in,O
3,O
AML,O
with,O
myelomonocytic,O
differentiation,O
(,O
2,O
AML,O
-,O
M2,O
and,O
1,O
AML,O
-,O
M5,O
),O
",",O
including,O
1,O
secondary,O
AML,O
.,O
For,O
the,O
7,O
AML,B
cases,O
that,O
were,O
uniformly,O
treated,O
according,O
to,O
the,O
AMLCG86,O
/,O
92,O
protocols,O
",",O
disease,O
-,O
free,O
and,O
overall,O
survival,O
was,O
significantly,O
worse,O
than,O
for,O
the,O
overall,O
study,O
group,O
(,O
P,O
=,O
.,O
3,O
and,O
P,O
=,O
.,O
1,O
",",O
respectively,O
),O
.,O
We,O
conclude,O
that,O
the,O
t,O
(,O
10,O
;,O
11,O
),O
(,O
p13,O
;,O
q14,O
),O
indicates,O
CALM,O
and,O
MLL,B
rearrangements,O
in,O
morphologically,O
distinct,O
subsets,O
of,O
acute,O
leukemia,O
and,O
may,O
be,O
associated,O
with,O
a,O
poor,O
prognosis,O
.,O
In,O
particular,O
",",O
one,O
class,O
of,O
helix,B
-,I
loop,I
-,I
helix,I
proteins,I
",",O
termed,O
E,B
-,I
proteins,I
",",O
have,O
been,O
implicated,O
in,O
the,O
regulation,O
of,O
gene,O
expression,O
during,O
B,B
-,I
cell,I
development,I
.,O
Dominant,O
negative,O
mutants,O
of,O
NIK,B
",",O
IKKalpha,B
",",O
or,O
IKKbeta,B
substantially,O
inhibited,O
NF,B
-,I
kappaB,I
activation,O
by,O
LMP1,B
or,O
by,O
each,O
of,O
its,O
effector,O
sites,O
.,O
MyD88,B
",",O
originally,O
isolated,O
as,O
a,O
myeloid,B
differentiation,I
primary,I
response,I
gene,I
",",O
is,O
shown,O
to,O
act,O
as,O
an,O
adaptor,O
in,O
interleukin,B
-,I
1,I
(,O
IL,B
-,I
1,I
),O
signaling,O
by,O
interacting,O
with,O
both,O
the,O
IL,B
-,I
1,I
receptor,I
complex,I
and,O
IL,B
-,I
1,I
receptor,I
-,I
associated,I
kinase,I
(,O
IRAK,B
),O
.,O
In,O
vivo,O
Th1,B
response,I
is,O
also,O
impaired,O
.,O
Furthermore,O
",",O
IL,B
-,I
18,I
-,I
induced,O
activation,O
of,O
NF,B
-,I
kappaB,I
and,O
c,B
-,I
Jun,I
N,I
-,I
terminal,I
kinase,I
(,O
JNK,B
),O
is,O
blocked,O
in,O
MyD88,B
-,I
/,I
-,I
Th1,I
-,I
developing,I
cells,I
.,O
Taken,O
together,O
",",O
these,O
results,O
demonstrate,O
that,O
MyD88,B
is,O
a,O
critical,O
component,O
in,O
the,O
signaling,O
cascade,O
that,O
is,O
mediated,O
by,O
IL,B
-,I
1,I
receptor,I
as,O
well,O
as,O
IL,B
-,I
18,I
receptor,I
.,O
In,O
addition,O
",",O
transcriptional,O
activity,O
of,O
IL,B
-,I
2,I
and,O
metallothionein,B
enhancer,I
and,O
promoter,I
regions,I
and,O
transcription,O
factors,O
AP,B
-,I
1,I
",",O
NF,B
-,I
kappaB,I
",",O
and,O
NF,B
-,I
AT,I
were,O
analyzed,O
by,O
chloramphenicol,O
acetyltransferase,O
(,O
CAT,O
),O
and,O
electrophoretic,O
mobility,O
shift,O
assays,O
",",O
respectively,O
.,O
The,O
concentration,O
of,O
c,B
-,I
fos,I
",",O
c,B
-,I
jun,I
",",O
c,B
-,I
myc,I
",",O
junB,B
",",O
and,O
fra,B
-,I
1,I
mRNAs,O
was,O
increased,O
in,O
activated,O
peripheral,O
blood,O
lymphocytes,O
incubated,O
with,O
ciprofloxacin,O
compared,O
to,O
that,O
in,O
untreated,O
controls,O
.,O
Simple,O
activation,O
of,O
RXRs,O
is,O
not,O
sufficient,O
to,O
induce,O
apoptosis,O
of,O
the,O
cells,O
.,O
Thrombopoietin,O
supports,O
in,O
vitro,O
erythroid,O
differentiation,O
via,O
its,O
specific,O
receptor,O
c,B
-,I
Mpl,I
in,O
a,O
human,O
leukemia,O
cell,O
line,O
.,O
More,O
than,O
50,O
%,O
of,O
TPO,B
-,I
treated,O
UT,B
-,I
7,I
/,I
GMT,I
cells,O
positively,O
stained,O
for,O
Hb,B
.,O
Because,O
the,O
GATA,B
-,I
1,I
gene,O
is,O
located,O
on,O
the,O
X,O
chromosome,O
",",O
which,O
is,O
randomly,O
inactivated,O
in,O
every,O
cell,O
",",O
heterozygous,O
females,O
can,O
bear,O
either,O
an,O
active,O
wild,O
-,O
type,O
or,O
mutant,O
(,O
referred,O
to,O
as,O
GATA,B
-,I
1,I
.,O
5,O
),O
GATA,B
-,I
1,I
allele,O
",",O
consequently,O
leading,O
to,O
variable,O
anemic,O
severity,O
.,O
We,O
also,O
observed,O
hematopoiesis,O
outside,O
of,O
the,O
bone,O
marrow,O
in,O
the,O
affected,O
mutant,O
mice,O
.,O
The,O
GATA,B
-,I
1,I
heterozygous,O
mutant,O
mouse,O
shows,O
a,O
phenotype,O
that,O
is,O
analogous,O
to,O
human,O
myelodysplastic,O
syndrome,O
and,O
thus,O
may,O
serve,O
as,O
a,O
useful,O
model,O
for,O
this,O
disorder,O
.,O
Differential,O
regulation,O
of,O
the,O
Janus,O
kinase,B
-,I
STAT,I
pathway,I
and,O
biologic,O
function,O
of,O
IL,B
-,I
13,I
in,O
primary,O
human,O
NK,B
and,O
T,B
cells,O
:,O
a,O
comparative,O
study,O
with,O
IL,B
-,I
4,I
.,O
We,O
observed,O
that,O
Abs,B
directed,O
against,O
unique,O
domains,O
of,O
STAT6,B
have,O
differential,O
effects,O
on,O
complexes,O
in,O
T,B
cells,I
but,O
not,O
in,O
NK,B
cells,I
",",O
suggesting,O
different,O
STAT6,B
isoforms,I
.,O
These,O
findings,O
show,O
that,O
IL,B
-,I
13,I
and,O
IL,B
-,I
4,I
have,O
the,O
ability,O
to,O
regulate,O
NK,B
and,O
T,B
cell,I
activation,I
and,O
that,O
IL,B
-,I
13,I
is,O
a,O
potent,O
regulator,O
of,O
STAT6,B
and,O
JAK3,B
in,O
these,O
cell,B
types,I
.,O
NFkappaB,B
activity,O
is,O
independent,O
from,O
FADD,O
",",O
caspases,O
",",O
and,O
apoptosis,O
induction,O
.,O
To,O
study,O
the,O
influence,O
of,O
NFkappaB,B
activity,O
on,O
apoptosis,O
mediated,O
by,O
TRAIL,O
",",O
CD95,O
",",O
TNFalpha,O
",",O
or,O
doxorubicin,O
",",O
NFkappaB,B
activation,O
was,O
inhibited,O
using,O
the,O
proteasome,O
inhibitor,O
N,O
-,O
acetyl,O
-,O
L,O
-,O
leucinyl,O
-,O
L,O
-,O
leucinyl,O
-,O
L,O
-,O
norleucinal,O
or,O
transient,O
overexpression,O
of,O
mutant,O
IkappaBalpha,O
.,O
Sensitivity,O
for,O
induction,O
of,O
apoptosis,O
was,O
markedly,O
increased,O
by,O
these,O
treatments,O
in,O
apoptosis,O
sensitive,O
cell,O
lines,O
.,O
Loss,O
-,O
and,O
gain,O
-,O
of,O
-,O
function,O
mutations,O
reveal,O
an,O
important,O
role,O
of,O
BSAP,B
(,O
Pax,B
-,I
5,I
),O
at,O
the,O
start,O
and,O
end,O
of,O
B,B
cell,I
differentiation,I
.,O
However,O
",",O
its,O
interactions,O
with,O
these,O
histone,B
acetyltransferases,I
are,O
not,O
equivalent,O
",",O
as,O
CBP,B
and,O
p300,B
",",O
but,O
not,O
P,B
/,I
CAF,I
",",O
utilize,O
EKLF,B
as,O
a,O
substrate,O
for,O
in,O
vitro,O
acetylation,O
within,O
its,O
trans,O
-,O
activation,O
region,O
.,O
We,O
conclude,O
that,O
contact,O
with,O
fibrinogen,B
-,I
derived,I
proteins,I
may,O
contribute,O
to,O
mononuclear,O
phagocyte,O
activation,O
by,O
signaling,O
through,O
CD11b,B
/,I
CD18,I
",",O
resulting,O
in,O
selective,O
activation,O
of,O
transcriptional,O
regulatory,O
factors,O
",",O
including,O
NF,B
-,I
kappa,I
B,I
.,O
OBJECTIVE,O
:,O
To,O
identify,O
and,O
characterize,O
estrogen,B
receptor,I
(,O
ER,B
),O
transcripts,O
expressed,O
in,O
immune,O
cells,O
of,O
patients,O
with,O
systemic,O
lupus,O
erythematosus,O
(,O
SLE,O
),O
and,O
healthy,O
donors,O
.,O
There,O
were,O
no,O
notable,O
differences,O
in,O
the,O
ER,B
transcripts,I
between,O
patients,O
and,O
healthy,O
controls,O
.,O
Variant,O
receptor,B
transcripts,I
lacking,O
exon,B
5,I
or,O
exon,B
7,I
",",O
which,O
encodes,O
the,O
hormone,O
binding,O
domain,O
",",O
were,O
identified,O
in,O
the,O
majority,O
of,O
the,O
cells,O
.,O
Whether,O
the,O
detected,O
transcripts,O
are,O
translated,O
into,O
functional,B
receptor,I
proteins,I
remains,O
to,O
be,O
determined,O
.,O
A,O
nondegradable,O
mutant,O
of,O
I,B
kappa,I
B,I
blocked,O
both,O
FasL,B
expression,O
and,O
apoptosis,O
induced,O
by,O
DNA,B
damage,O
but,O
not,O
Fas,B
ligation,O
.,O
These,O
stimuli,O
also,O
induced,O
the,O
stress,O
-,O
activated,O
kinase,O
pathway,O
(,O
SAPK,B
/,I
JNK,I
),O
",",O
which,O
was,O
required,O
for,O
the,O
maximal,O
induction,O
of,O
apoptosis,O
.,O
Simultaneously,O
",",O
T,B
lymphocyte,I
subsets,I
and,O
NK,B
cells,I
from,O
the,O
peripheral,O
blood,O
(,O
PB,B
),O
and,O
bone,O
marrow,O
(,O
BM,B
),O
were,O
investigated,O
by,O
flow,O
cytometric,O
analysis,O
.,O
Four,O
of,O
the,O
eight,O
patients,O
in,O
LT,O
and,O
7,O
of,O
the,O
15,O
patients,O
in,O
ST,O
remission,O
were,O
MRD,O
-,O
positive,O
.,O
Thus,O
",",O
the,O
difference,O
of,O
the,O
possible,O
T,O
/,O
NK,O
-,O
cell,B
phenotype,I
in,O
the,O
BM,O
may,O
strongly,O
influence,O
clinical,O
and,O
molecular,O
remission,O
.,O
The,O
implication,O
of,O
protein,B
tyrosine,I
kinase,I
(,I
s,I
),I
",",O
protein,B
kinase,I
A,I
and,I
/,I
or,I
protein,I
kinase,I
C,I
was,O
highlighted,O
by,O
the,O
abrogation,O
of,O
the,O
ManLAM,O
-,O
mediated,O
activation,O
of,O
HIV,O
-,O
1,O
LTR,O
-,O
driven,O
gene,O
expression,O
using,O
herbimycin,O
A,O
and,O
H7,O
.,O
These,O
findings,O
suggest,O
that,O
LTR,B
sequence,I
changes,O
can,O
significantly,O
affect,O
basal,O
LTR,B
function,I
and,O
transcription,O
factor,O
recruitment,O
",",O
which,O
may,O
",",O
in,O
turn,O
",",O
alter,O
the,O
course,O
of,O
viral,O
replication,O
in,O
cells,O
of,O
CNS,B
and,O
immune,B
system,I
origin,I
.,O
These,O
insights,O
in,O
the,O
molecular,O
events,O
that,O
are,O
involved,O
in,O
TCF,B
/,I
LEF,I
function,I
in,O
these,O
organisms,O
may,O
eventually,O
lead,O
to,O
the,O
understanding,O
of,O
the,O
function,O
of,O
these,O
HMG,B
box,I
proteins,I
in,O
lymphoid,B
development,I
Molecular,O
genetic,O
characterization,O
of,O
the,O
variant,O
allele,O
can,O
serve,O
as,O
a,O
primary,O
tool,O
for,O
diagnosis,O
and,O
subsequent,O
therapy,O
",",O
and,O
can,O
provide,O
a,O
basis,O
for,O
distinguishing,O
heterozygous,O
carriers,O
in,O
familial,O
androgen,B
resistance,I
.,O
In,O
this,O
study,O
",",O
the,O
proliferative,O
activity,O
of,O
129,O
primary,O
breast,B
cancers,I
was,O
investigated,O
",",O
and,O
the,O
results,O
were,O
related,O
to,O
prognosis,O
.,O
RESULTS,O
.,O
Elf,B
-,I
1,I
binds,O
exclusively,O
to,O
the,O
underphosphorylated,O
form,O
of,O
Rb,B
and,O
fails,O
to,O
bind,O
to,O
Rb,B
mutants,O
derived,O
from,O
patients,O
with,O
retinoblastoma,O
.,O
In,O
this,O
study,O
we,O
analyzed,O
the,O
T,B
cell,I
receptor,I
(,O
TcR,B
),O
delta,O
transcripts,O
expressed,O
by,O
CD3,B
-,I
CD16,I
+,I
cells,O
and,O
we,O
investigated,O
whether,O
these,O
cells,O
expressed,O
the,O
hGATA,B
-,I
3,I
T,B
cell,I
transcription,I
factor,I
and,O
the,O
recombination,B
-,I
activating,I
gene,I
(,O
RAG,B
),O
-,O
1,O
.,O
Sequence,O
analysis,O
of,O
nine,O
different,O
2,O
.,O
3,O
-,O
kb,O
cDNA,O
clones,O
obtained,O
from,O
NK,B
-,I
derived,I
polyA,I
+,I
RNA,I
confirmed,O
that,O
they,O
corresponded,O
to,O
an,O
unrearranged,O
TcR,B
delta,I
gene,I
.,O
However,O
",",O
only,O
that,O
located,O
at,O
the,O
3,O
',O
end,O
appeared,O
to,O
be,O
utilized,O
in,O
the,O
2,O
.,O
3,O
-,O
kb,O
cDNA,O
.,O
All,O
NK,B
clones,I
and,O
cell,B
lines,I
studied,O
were,O
found,O
to,O
express,O
hGATA,B
-,I
3,I
-,I
specific,I
mRNA,I
",",O
suggesting,O
that,O
hGATA,B
-,I
3,I
may,O
be,O
involved,O
in,O
the,O
regulation,O
of,O
the,O
unrearranged,O
TcR,B
delta,I
gene,I
expression,I
in,O
NK,B
cells,I
.,O
To,O
correlate,O
changes,O
in,O
nuclear,B
factor,I
binding,I
in,O
vitro,O
with,O
transcriptional,O
activity,O
in,O
vivo,O
and,O
define,O
the,O
structural,O
requirements,O
for,O
IL,B
-,I
2,I
promoter,I
repression,O
",",O
we,O
used,O
transient,O
DNA,B
transfections,O
.,O
Jurkat,B
cells,I
were,O
transfected,O
with,O
plasmids,O
containing,O
either,O
the,O
intact,O
IL,B
-,I
2,I
promoter,I
or,O
its,O
AP,B
-,I
1,I
",",O
NF,B
-,I
AT,I
",",O
and,O
NF,B
-,I
kB,I
motifs,O
.,O
Other,O
bacterial,O
toxins,O
",",O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
(,O
TNF,B
),O
",",O
interleukin,B
-,I
1,I
(,I
IL,I
-,I
1,I
),O
",",O
T,O
cell,O
mitogens,O
",",O
UV,O
light,O
",",O
gamma,O
rays,O
and,O
oxidative,O
stress,O
were,O
reported,O
to,O
induce,O
NF,B
-,I
kappa,I
B,I
.,O
We,O
further,O
characterize,O
which,O
AP1,B
family,I
members,I
can,O
assume,O
this,O
role,O
.,O
Antisera,O
to,O
Fos,B
inhibits,O
NF,B
-,I
AT,I
DNA,I
binding,I
as,O
does,O
an,O
oligonucleotide,O
containing,O
a,O
binding,O
site,O
for,O
AP1,B
.,O
The,O
patients,O
',O
plasma,O
cortisol,B
concentrations,I
were,O
normal,O
or,O
slightly,O
elevated,O
.,O
Despite,O
a,O
wide,O
range,O
",",O
the,O
mean,O
GR,B
count,I
and,O
affinity,O
in,O
MNC,O
from,O
septic,O
patients,O
did,O
not,O
differ,O
from,O
those,O
in,O
normal,O
controls,O
",",O
suggesting,O
that,O
glucocorticoids,O
could,O
still,O
be,O
effective,O
in,O
the,O
hemodynamic,O
compensatory,O
phase,O
of,O
sepsis,O
.,O
Activation,O
of,O
the,O
HIV,B
-,I
1,I
provirus,I
correlated,O
with,O
the,O
activation,O
of,O
binding,O
of,O
55,O
-,O
and,O
85,O
-,O
kDa,B
proteins,I
to,O
the,O
kappa,B
B,I
enhancer,I
and,O
binding,O
of,O
the,O
50,O
-,O
kDa,B
HLP,I
-,I
1,I
protein,I
to,O
the,O
LBP,B
-,I
1,I
sequences,I
of,O
the,O
HIV,B
-,I
1,I
long,I
terminal,I
repeat,I
.,O
Surprisingly,O
",",O
the,O
NF,B
-,I
kappa,I
B,I
and,O
HLP,B
-,I
1,I
binding,O
activities,O
were,O
substantially,O
inhibited,O
in,O
acyclovir,O
-,O
treated,O
cells,O
.,O
Transcriptional,O
activation,O
of,O
the,O
macrophage,B
colony,I
-,I
stimulating,I
factor,I
gene,I
by,O
IL,O
-,O
2,O
is,O
associated,O
with,O
secretion,O
of,O
bioactive,O
macrophage,B
colony,I
-,I
stimulating,I
factor,I
protein,I
by,O
monocytes,O
and,O
involves,O
activation,O
of,O
the,O
transcription,B
factor,I
NF,B
-,I
kappa,I
B,I
.,O
Transcriptional,O
activation,O
of,O
the,O
M,B
-,I
CSF,I
gene,I
by,O
IL,O
-,O
2,O
is,O
preceded,O
by,O
enhanced,O
binding,O
activity,O
of,O
the,O
transcription,B
factor,I
NF,B
-,I
kappa,I
B,I
to,O
its,O
recognition,O
sequence,O
in,O
the,O
5,O
',O
regulatory,O
enhancer,O
region,O
of,O
the,O
M,B
-,I
CSF,I
gene,I
.,O
We,O
localized,O
the,O
LAM,B
-,I
",",O
lipopolysaccharide,B
(,O
LPS,B
),O
-,O
",",O
and,O
TNF,B
-,I
alpha,I
-,I
inducible,O
promoter,O
activity,O
to,O
a,O
-,O
131,O
/,O
+,O
15,O
(,O
positions,O
-,O
131,O
to,O
+,O
15,O
),O
DNA,B
fragment,I
of,O
the,O
IL,B
-,I
1,I
beta,I
gene,I
by,O
deletion,O
analysis,O
and,O
chloramphenicol,B
acetyltransferase,I
assay,I
.,O
Site,O
-,O
directed,O
mutagenesis,O
demonstrated,O
that,O
the,O
two,O
NF,B
-,I
IL,I
-,I
6,I
motifs,I
could,O
be,O
independently,O
activated,O
by,O
LAM,B
",",O
LPS,B
",",O
or,O
TNF,B
-,I
alpha,I
and,O
that,O
they,O
acted,O
in,O
an,O
orientation,O
-,O
independent,O
manner,O
.,O
Additionally,O
",",O
Nef,B
expressing,O
cells,O
were,O
transiently,O
transfected,O
with,O
a,O
plasmid,O
in,O
which,O
HIV,B
-,I
1,I
AP,I
-,I
1,I
DNA,B
recognition,O
sequences,O
were,O
cloned,O
downstream,O
of,O
the,O
chloramphenicol,O
acetyltransferase,O
(,O
CAT,B
),O
gene,O
.,O
The,O
in,O
vitro,O
effect,O
of,O
17,O
beta,O
-,O
estradiol,O
on,O
NK,O
activity,O
was,O
studied,O
.,O
A,O
serum,O
response,O
element,O
and,O
a,O
binding,O
site,O
for,O
NF,B
-,I
Y,I
mediate,O
the,O
serum,O
response,O
of,O
the,O
human,O
thrombospondin,O
1,O
gene,O
.,O
Two,O
transcriptional,O
elements,O
in,O
the,O
TSP,B
1,I
promoter,I
",",O
a,O
distal,O
element,O
at,O
-,O
1280,O
and,O
a,O
proximal,O
element,O
at,O
-,O
65,O
",",O
were,O
required,O
for,O
the,O
response,O
of,O
the,O
human,O
TSP,B
1,I
gene,I
to,O
serum,O
.,O
Cell,O
-,O
type,O
-,O
specific,O
transactivation,O
of,O
the,O
parathyroid,B
hormone,I
-,I
related,I
protein,I
gene,I
promoter,I
by,O
the,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
(,O
HTLV,B
-,I
I,I
),O
tax,O
and,O
HTLV,B
-,I
II,I
tax,O
proteins,O
.,O
The,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
(,O
HTLV,B
-,I
I,I
),O
and,O
HTLV,B
-,I
II,I
Tax,I
proteins,O
are,O
potent,O
transactivators,O
of,O
viral,O
and,O
cellular,O
gene,O
expression,O
.,O
A,O
carboxy,O
terminal,O
Tax,B
deletion,O
mutant,O
was,O
deficient,O
in,O
transactivation,O
of,O
both,O
the,O
PTHrP,B
and,O
IL2R,B
alpha,I
promoters,O
but,O
not,O
the,O
HTLV,B
-,I
I,I
long,I
terminal,I
repeat,I
(,I
LTR,I
),O
.,O
Here,O
we,O
have,O
investigated,O
the,O
transcriptional,O
regulation,O
of,O
the,O
gamma,B
chain,I
gene,I
by,O
analyzing,O
the,O
2,O
.,O
5,O
-,O
kilobase,O
sequence,O
upstream,O
of,O
the,O
transcription,O
start,O
site,O
.,O
This,O
sequence,O
contains,O
a,O
promoter,B
specific,I
to,O
cells,O
of,O
hematopoietic,B
lineage,I
.,O
However,O
",",O
the,O
tissue,O
specificity,O
of,O
this,O
promoter,O
is,O
only,O
partial,O
because,O
it,O
is,O
active,O
in,O
all,O
of,O
the,O
hematopoietic,B
cells,O
tested,O
here,O
",",O
regardless,O
of,O
whether,O
they,O
constitutively,O
express,O
Fc,O
epsilon,O
RI,O
-,O
gamma,B
chain,I
transcripts,I
.,O
Regression,O
analysis,O
of,O
our,O
data,O
revealed,O
slight,O
trends,O
for,O
some,O
of,O
the,O
biomarkers,O
(,O
e,O
.,O
g,O
.,O
CD45R0,B
+,O
),O
.,O
HIV,B
-,I
1,I
can,O
also,O
establish,O
a,O
latent,O
or,O
persistent,O
infection,O
in,O
some,O
T,B
cell,I
lines,I
that,O
show,O
minimal,O
constitutive,O
virus,O
expression,O
.,O
On,O
the,O
basis,O
of,O
these,O
observations,O
",",O
it,O
has,O
been,O
proposed,O
that,O
reactivation,O
of,O
latent,O
HIV,B
-,I
1,I
harbored,O
in,O
chronically,O
infected,O
T,B
lymphocytes,I
",",O
monocytes,B
",",O
or,O
macrophages,B
plays,O
an,O
important,O
role,O
in,O
the,O
pathogenesis,O
of,O
AIDS,O
.,O
ACH,O
-,O
2,O
can,O
be,O
converted,O
to,O
productive,O
infection,O
by,O
stimulation,O
of,O
the,O
cells,O
with,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
(,O
TPA,O
),O
",",O
mitogen,O
or,O
cytokines,O
(,O
TNF,O
-,O
alpha,O
),O
",",O
or,O
infection,O
with,O
HSV,O
.,O
Oxidoreductive,O
regulation,O
of,O
nuclear,O
factor,O
kappa,O
B,B
.,O
The,O
promoter,O
activity,O
from,O
HIV,B
long,I
terminal,I
repeat,I
was,O
greatly,O
augmented,O
by,O
co,O
-,O
transfecting,O
the,O
Trx,O
-,O
expressing,O
plasmid,O
",",O
whose,O
effect,O
was,O
dependent,O
on,O
the,O
NF,B
kappa,I
B,I
-,I
binding,I
sites,I
.,O
These,O
results,O
may,O
also,O
provide,O
a,O
clue,O
to,O
understanding,O
of,O
the,O
molecular,O
process,O
of,O
AIDS,O
pathogenesis,O
and,O
its,O
possible,O
biochemical,O
intervention,O
.,O
Synergism,O
between,O
the,O
CD3,B
antigen,I
-,I
and,O
CD2,B
antigen,I
-,I
derived,O
signals,O
.,O
We,O
have,O
demonstrated,O
earlier,O
that,O
the,O
crosslinkage,O
of,O
the,O
CD3,B
/,I
TCR,I
complex,I
with,O
the,O
CD2,B
antigen,I
results,O
in,O
the,O
proliferation,O
of,O
normal,O
human,O
T,B
cells,I
.,O
The,O
human,O
erythroleukemia,B
cell,I
line,I
line,I
K562,O
can,O
be,O
induced,O
to,O
differentiate,O
along,O
the,O
erythroid,B
and,O
megakaryocytic,B
lineages,I
.,O
This,O
was,O
accompanied,O
by,O
downregulation,O
of,O
two,O
transcription,O
factors,O
normally,O
expressed,O
in,O
erythroid,B
",",O
mast,B
and,O
megakaryocyte,B
lineages,I
.,O
Northern,O
analysis,O
demonstrated,O
coordinate,O
downregulation,O
of,O
alpha,B
globin,I
and,O
gamma,B
globin,I
in,O
addition,O
to,O
the,O
two,O
lineage,O
-,O
restricted,O
transcription,O
factors,O
",",O
SCL,B
and,O
GATA,B
-,I
1,I
.,O
Electron,O
microscopy,O
revealed,O
a,O
marked,O
increase,O
in,O
granules,O
resembling,O
those,O
specific,O
for,O
eosinophils,B
.,O
Surface,O
marker,O
analysis,O
showed,O
that,O
HMBA,O
-,O
induced,O
cells,O
expressed,O
reduced,O
levels,O
of,O
glycophorin,B
A,I
",",O
CD5,B
",",O
CD7,B
and,O
CD11b,B
.,O
Activation,O
of,O
primary,O
human,O
T,O
-,O
lymphocytes,O
through,O
CD2,B
plus,O
CD28,B
adhesion,O
molecules,O
induces,O
long,O
-,O
term,O
nuclear,O
expression,O
of,O
NF,B
-,I
kappa,I
B,I
.,O
Long,O
-,O
lasting,O
IL,B
-,I
2,I
receptivity,O
is,O
associated,O
with,O
high,O
-,O
level,O
expression,O
of,O
the,O
inducible,O
IL,B
-,I
2,I
receptor,I
alpha,I
chain,I
(,O
IL,B
-,I
2R,I
alpha,I
),O
gene,O
that,O
is,O
regulated,O
at,O
both,O
transcriptional,O
and,O
posttranscriptional,O
levels,O
.,O
Resting,O
T,O
-,O
cell,O
nuclear,O
extracts,O
contained,O
KBF1,O
/,O
p50,O
homodimer,O
.,O
In,O
addition,O
",",O
an,O
inhibitor,O
of,O
PKC,O
blocked,O
both,O
activated,O
ras,O
and,O
phorbol,O
ester,O
stimulation,O
",",O
suggesting,O
a,O
role,O
for,O
ras,O
upstream,O
of,O
PKC,O
.,O
No,O
such,O
increase,O
was,O
observed,O
in,O
control,O
U937,B
cells,I
.,O
We,O
show,O
that,O
the,O
ability,O
to,O
detect,O
NF,B
-,I
ATp,I
in,O
a,O
gel,O
shift,O
assay,O
",",O
which,O
is,O
essential,O
for,O
purification,O
and,O
biochemical,O
studies,O
of,O
this,O
protein,B
",",O
is,O
strikingly,O
dependent,O
on,O
the,O
precise,O
sequence,O
of,O
the,O
NF,B
-,I
AT,I
oligonucleotide,I
used,O
as,O
the,O
labeled,O
probe,O
.,O
One,O
of,O
these,O
activities,O
was,O
found,O
to,O
be,O
a,O
novel,O
",",O
less,O
abundant,O
",",O
Rb,B
-,I
E2F,I
complex,I
. The,O
most,O
prominent,O
E2F,B
activity,I
in,O
resting,O
T,B
cells,I
(,O
termed,O
complex,O
X,O
),O
was,O
abundant,O
in,O
both,O
G0,O
and,O
G1,O
but,O
disappeared,O
as,O
cells,O
entered,O
S,B
phase,I
",",O
suggesting,O
a,O
possible,O
role,O
in,O
negatively,O
regulating,O
E2F,B
function,I
. The,O
present,O
studies,O
have,O
examined,O
the,O
effects,O
of,O
vincristine,O
-,O
selected,O
",",O
multidrug,O
resistance,O
on,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
(,O
TPA,O
),O
-,O
induced,O
HL,B
-,I
60,I
cell,I
differentiation,I
.,O
Since,O
TPA,O
activates,O
protein,B
kinase,I
C,I
(,O
PKC,B
),O
",",O
we,O
examined,O
translocation,O
of,O
PKC,B
from,O
the,O
cytosol,O
to,O
the,O
membrane,O
fraction,O
.,O
To,O
determine,O
whether,O
the,O
defect,O
in,O
the,O
patient,O
',O
s,O
T,O
lymphocytes,O
involved,O
a,O
trans,O
-,O
acting,O
factor,O
common,O
to,O
the,O
affected,O
lymphokine,O
genes,I
",",O
we,O
examined,O
the,O
ability,O
of,O
nuclear,O
factors,O
from,O
the,O
patient,O
',O
s,O
T,O
lymphocytes,O
to,O
bind,O
response,O
elements,O
present,O
in,O
the,O
regulatory,O
region,O
of,O
IL2,O
.,O
In,O
contrast,O
",",O
the,O
binding,O
of,O
the,O
nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
(,O
NF,B
-,I
AT,I
),O
to,O
its,O
response,O
element,O
in,O
the,O
IL2,O
enhancer,O
and,O
to,O
an,O
NF,B
-,I
AT,I
-,I
like,I
response,I
element,I
present,O
in,O
the,O
IL4,O
enhancer,O
was,O
abnormal,O
.,O
They,O
do,O
not,O
directly,O
intercept,O
intracellular,O
signalling,O
molecules,O
.,O
Instead,O
",",O
they,O
form,O
tight,O
complexes,O
with,O
two,O
different,O
classes,O
of,O
abundant,O
cytosolic,O
receptors,O
called,O
immunophilins,O
upon,O
entering,O
the,O
cell,O
",",O
and,O
consequently,O
inhibit,O
their,O
peptidyl,O
prolyl,O
cis,O
-,O
trans,O
isomerase,O
activities,O
.,O
p105,B
and,O
p98,B
precursor,I
proteins,I
play,O
an,O
active,O
role,O
in,O
NF,B
-,I
kappa,I
B,I
-,I
mediated,I
signal,I
transduction,I
.,O
Association,O
with,O
the,O
precursors,O
is,O
sufficient,O
for,O
cytoplasmic,O
retention,O
of,O
either,O
p65,B
or,O
c,B
-,I
Rel,I
",",O
both,O
of,O
which,O
are,O
otherwise,O
nuclear,O
.,O
The,O
eukaryotic,O
transcription,O
factor,O
nuclear,B
factor,I
-,I
kappa,I
B,I
(,I
NF,I
-,I
kappa,I
B,I
),I
participates,O
in,O
many,O
parts,O
of,O
the,O
genetic,O
program,O
mediating,O
T,B
lymphocyte,I
activation,I
and,O
growth,O
.,O
Transfection,O
studies,O
indicate,O
that,O
the,O
I,B
kappa,I
B,I
alpha,I
gene,I
is,O
specifically,O
induced,O
by,O
the,O
65,O
-,O
kilodalton,O
transactivating,O
subunit,O
of,O
NF,B
-,I
kappa,I
B,I
.,O
Together,O
",",O
these,O
results,O
show,O
that,O
NF,B
-,I
kappa,I
B,I
controls,O
the,O
expression,O
of,O
I,B
kappa,I
B,I
alpha,I
by,O
means,O
of,O
an,O
inducible,O
autoregulatory,O
pathway,O
.,O
A,O
cell,B
-,I
type,I
-,I
independent,I
lipopolysaccharide,I
(,O
LPS,I
)-,O
-,O
responsive,O
enhancer,O
element,O
located,O
between,O
-,O
3757,O
and,O
-,O
2729,O
bp,O
upstream,O
from,O
the,O
transcription,O
start,O
site,O
(,O
cap,O
site,O
)-,O
consisted,O
of,O
at,O
least,O
six,O
discrete,O
subregions,O
which,O
were,O
essential,O
to,O
the,O
maximal,O
induction,O
by,O
LPS,I
in,O
transfected,O
monocytes,O
.,O
The,O
assessment,O
of,O
synovial,B
lymphocyte,I
reactivity,O
to,O
adenovirus,B
antigen,O
stimulation,O
was,O
undertaken,O
in,O
patients,O
with,O
persistent,O
or,O
recurrent,O
inflammatory,O
arthritis,O
.,O
The,O
3H,O
-,O
thymidine,O
uptake,O
procedure,O
was,O
employed,O
",",O
incorporating,O
multiple,O
microbiological,O
antigens,O
.,O
Expression,O
of,O
PILOT,B
",",O
a,O
putative,O
transcription,O
factor,O
",",O
requires,O
two,O
signals,O
and,O
is,O
cyclosporin,O
A,O
sensitive,O
in,O
T,B
cells,I
.,O
Few,O
known,O
genes,I
(,O
IL,B
-,I
2,I
",",O
members,O
of,O
the,O
IL,B
-,I
8,I
family,I
",",O
interferon,B
-,I
gamma,I
),O
are,O
induced,O
in,O
T,O
cells,I
only,O
through,O
the,O
combined,O
effect,O
of,O
phorbol,O
myristic,O
acetate,O
(,O
PMA,O
),O
and,O
a,O
Ca,B
(,O
2,I
+,I
),O
-,O
ionophore,O
",",O
and,O
expression,O
of,O
only,O
these,O
genes,I
can,O
be,O
fully,O
suppressed,O
by,O
Cyclosporin,B
A,I
(,O
CyA,O
),O
.,O
The,O
PILOT,O
protein,B
has,O
a,O
calculated,O
M,O
(,O
r,O
),O
of,O
42,O
.,O
6,O
kDa,O
and,O
contains,O
three,O
zinc,B
fingers,I
of,I
the,I
C2H2,I
-,I
type,I
at,O
the,O
carboxyl,O
-,O
terminus,O
which,O
are,O
highly,O
homologous,O
to,O
the,O
zinc,B
finger,I
regions,I
of,I
the,I
transcription,I
factors,I
EGR1,O
",",O
EGR2,O
",",O
and,O
pAT,O
133,O
.,O
In,O
contrast,O
to,O
T,O
cells,O
",",O
in,O
fibroblasts,O
PILOT,O
gene,O
expression,O
requires,O
only,O
one,O
signal,O
(,O
PMA,O
),O
and,O
is,O
not,O
affected,O
by,O
CyA,O
.,O
NF,B
-,I
kappa,I
B,I
is,O
a,O
pleiotropic,O
regulator,O
of,O
a,O
variety,O
of,O
genes,O
implicated,O
in,O
the,O
cellular,B
response,I
to,I
injury,I
.,O
However,O
",",O
the,O
p65,B
antisense,I
phosphorothioate,I
oligodeoxynucleotide,I
had,O
no,O
significant,O
effect,O
on,O
the,O
production,O
of,O
reactive,O
oxygen,O
intermediates,O
or,O
on,O
phagocytosis,O
by,O
these,O
cells,O
.,O
These,O
findings,O
indicate,O
that,O
antisense,I
oligomers,I
to,O
p65,B
can,O
be,O
used,O
to,O
define,O
the,O
role,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
the,O
activation,O
pathways,O
of,O
neutrophils,O
.,O
Overexpression,O
of,O
p65,B
increases,O
endogenous,O
I,B
kappa,I
B,I
protein,I
in,O
both,O
carcinoma,O
and,O
lymphoid,O
cells,O
by,O
two,O
mechanisms,O
:,O
protein,B
stabilization,I
and,I
increased,I
transcription,I
of,I
I,I
kappa,I
B,I
mRNA,I
.,O
The,O
precise,O
molecular,O
abnormalities,O
that,O
cause,O
primary,O
cortisol,O
resistance,O
have,O
not,O
been,O
completely,O
described,O
.,O
At,O
nucleotide,O
2,O
",",O
317,O
we,O
identified,O
a,O
homozygous,O
A,O
for,O
G,O
point,O
mutation,O
that,O
predicts,O
an,O
isoleucine,O
(,O
ATT,B
),O
for,O
valine,O
(,O
GTT,B
),O
substitution,O
at,O
amino,O
acid,O
729,O
.,O
When,O
the,O
wild,O
-,O
type,O
hGR,B
and,O
hGR,B
-,I
Ile,I
729,I
were,O
expressed,O
in,O
COS,B
-,I
1,I
cells,I
and,O
assayed,O
for,O
[,O
3H,B
],I
-,I
Dexamethasone,I
binding,I
",",O
the,O
dissociation,O
constants,O
were,O
0,O
.,O
799,O
+,O
/,O
-,O
0,O
.,O
68,O
and,O
1,O
.,O
54,O
+,O
/,O
-,O
0,O
.,O
6,O
nM,O
(,O
mean,O
+,O
/,O
-,O
SEM,O
),O
(,O
P,O
<,O
0,O
.,O
1,O
),O
",",O
respectively,O
.,O
Transcriptional,O
regulation,O
of,O
interleukin,B
3,I
(,I
IL3,I
),I
in,O
primary,O
human,O
T,B
lymphocytes,I
.,O
Dimerization,O
of,O
NF,B
-,I
KB2,I
with,O
RelA,B
(,O
p65,I
),O
regulates,O
DNA,B
binding,I
",",O
transcriptional,O
activation,O
",",O
and,O
inhibition,O
by,O
an,O
I,B
kappa,I
B,I
-,I
alpha,I
(,O
MAD,B
-,I
3,I
),O
.,O
We,O
have,O
previously,O
found,O
that,O
NFKB2,B
(,O
p49,I
/,I
p52,I
),O
acts,O
in,O
concert,O
with,O
RelA,B
(,O
p65,I
),O
to,O
stimulate,O
the,O
HIV,B
enhancer,I
in,O
Jurkat,B
T,I
-,I
leukemia,I
cells,I
.,O
Transcriptional,O
activation,O
of,O
the,O
HIV,B
enhancer,I
was,O
also,O
subject,O
to,O
regulation,O
by,O
recently,O
cloned,O
I,B
kappa,I
B,I
-,I
alpha,I
(,O
MAD,B
-,I
3,I
),O
.,O
The,O
c,O
-,O
rel,B
protooncogene,I
product,I
represses,O
NF,B
-,I
kappa,I
B,I
p65,I
-,I
mediated,O
transcriptional,O
activation,O
of,O
the,O
long,O
terminal,O
repeat,O
of,O
type,O
1,O
human,O
immunodeficiency,O
virus,O
.,O
This,O
intracellular,O
signaling,O
complex,O
potently,O
stimulates,O
kappa,B
B,I
-,I
directed,O
transcription,O
from,O
either,O
the,O
HIV,B
-,I
1,I
LTR,I
or,O
the,O
IL,B
-,I
2R,I
alpha,I
promoter,I
via,O
the,O
strong,O
transactivation,O
domain,O
present,O
in,O
p65,B
.,O
We,O
now,O
demonstrate,O
that,O
nuclear,O
expression,O
of,O
human,O
c,B
-,I
Rel,I
",",O
which,O
is,O
induced,O
by,O
either,O
phorbol,O
ester,O
or,O
tumor,O
necrosis,O
factor,O
alpha,O
with,O
delayed,O
kinetics,O
relative,O
to,O
p65,O
",",O
markedly,O
represses,O
p65,O
-,O
mediated,O
activation,O
of,O
these,O
transcription,O
units,O
.,O
The,O
ras,O
-,O
transformed,O
lymphocytes,O
displayed,O
a,O
fully,O
functional,O
IL,B
-,I
2r,I
",",O
as,O
assessed,O
by,O
c,O
-,O
fos,O
induction,O
following,O
treatment,O
with,O
IL,B
-,I
2,I
;,O
nevertheless,O
",",O
they,O
were,O
not,O
growth,O
stimulated,O
by,O
this,O
lymphokine,O
.,O
Somewhat,O
unexpectedly,O
",",O
the,O
constitutive,O
p21ras,B
activity,I
did,O
not,O
cause,O
an,O
increased,O
DNA,B
binding,I
of,O
transcription,O
factors,O
PEA1,B
(,O
AP1,I
),O
",",O
PEA3,B
",",O
Oct,B
-,I
2,I
or,O
NF,B
-,I
kB,I
Competition,O
with,O
an,O
AP,B
-,I
1,I
motif,I
or,O
with,O
anti,O
-,O
Jun,B
and,O
anti,O
-,O
Fos,B
antibodies,I
abolished,O
binding,O
to,O
the,O
NFAT,B
motif,I
in,O
both,O
T,B
and,O
B,B
cells,I
",",O
indicating,O
that,O
Jun,B
and,O
Fos,B
are,O
critical,O
for,O
NFAT,B
complex,I
formation,I
in,O
both,O
cell,O
types,O
.,O
However,O
",",O
when,O
combined,O
with,O
unstimulated,O
B,B
or,O
T,B
cell,I
extracts,I
",",O
full,O
-,O
length,O
",",O
but,O
not,O
truncated,O
",",O
Jun,B
/,I
Fos,I
heterodimers,I
were,O
able,O
to,O
form,O
an,O
NFAT,B
complex,I
",",O
indicating,O
the,O
presence,O
of,O
a,O
constitutively,O
expressed,O
nuclear,O
factor,O
(,O
s,O
),O
in,O
B,B
and,O
T,B
cells,I
necessary,O
for,O
the,O
formation,O
of,O
the,O
NFAT,B
complex,I
in,O
both,O
cell,B
types,I
.,O
Differential,O
autoregulation,O
of,O
glucocorticoid,B
receptor,I
expression,O
in,O
human,O
T,B
-,I
and,O
B,B
-,I
cell,I
lines,I
.,O
In,O
contrast,O
to,O
the,O
decrease,O
in,O
GR,B
mRNA,I
seen,O
in,O
IM,O
-,O
9,O
cells,O
after,O
treatment,O
with,O
1,O
microM,O
dexamethasone,O
for,O
16,O
-,O
18,O
h,O
.,O
treatment,O
of,O
6TG1,O
.,O
1,O
cells,O
resulted,O
in,O
an,O
8,O
-,O
fold,O
increase,O
in,O
GR,B
mRNA,I
",",O
as,O
determined,O
by,O
Northern,O
blot,O
and,O
RNase,O
protection,O
analysis,O
",",O
with,O
a,O
corresponding,O
3,O
-,O
to,O
4,O
-,O
fold,O
increase,O
in,O
GR,B
protein,I
.,O
Induction,O
of,O
CD8,B
antigen,I
and,O
suppressor,O
activity,O
by,O
glucocorticoids,O
in,O
a,O
CEM,B
human,I
leukemic,I
cell,I
clone,I
.,O
It,O
has,O
been,O
thought,O
that,O
the,O
virally,O
induced,O
inhibition,O
of,O
IFN,B
-,I
MCP,I
is,O
secondary,O
to,O
the,O
shutdown,O
of,O
cellular,O
macromolecular,O
synthesis,O
that,O
accompanies,O
cytopathic,O
virus,O
infections,O
.,O
IFN,B
-,I
MCP,I
was,O
not,O
inhibited,O
by,O
infection,O
with,O
dl343,O
",",O
despite,O
the,O
production,O
of,O
large,O
amounts,O
of,O
both,O
early,O
(,O
E1B,B
",",O
p55,I
),O
and,O
late,O
(,O
hexon,B
),O
Ad,B
proteins,I
.,O
E1A,O
',O
s,O
inhibition,O
of,O
IFN,B
-,I
MCP,I
has,O
the,O
net,O
effect,O
of,O
promoting,O
the,O
selective,O
NK,B
cell,I
-,I
mediated,I
clearance,O
of,O
Ad,B
-,I
infected,I
or,O
Ad,B
-,I
transformed,I
human,I
cells,I
.,O
Nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
(,O
NF,B
-,I
AT,I
),O
is,O
a,O
transcriptional,O
activator,O
involved,O
in,O
the,O
induction,O
of,O
IL,B
-,I
2,I
gene,I
expression,I
.,O
We,O
find,O
that,O
a,O
short,O
enhancer,O
element,O
containing,O
the,O
NF,B
-,I
kappa,I
B,I
binding,I
site,I
from,O
the,O
interleukin,B
-,I
2,I
receptor,I
alpha,I
-,I
chain,I
gene,I
(,O
IL,B
-,I
2R,I
alpha,I
),O
is,O
preferentially,O
activated,O
in,O
T,I
cells,I
.,O
Serum,O
response,O
factor,O
(,O
SRF,B
),O
binds,O
to,O
a,O
site,O
adjacent,O
to,O
the,O
NF,B
-,I
kappa,I
B,I
site,O
in,O
the,O
IL,O
-,O
2R,O
enhancer,O
",",O
and,O
both,O
sites,O
together,O
have,O
strong,O
transcriptional,O
activity,O
specifically,O
in,O
T,B
cells,I
.,O
Mutual,O
regulation,O
of,O
the,O
transcriptional,O
activator,O
NF,B
-,I
kappa,I
B,I
and,O
its,O
inhibitor,O
",",O
I,O
kappa,O
B,O
-,O
alpha,O
.,O
In,O
previous,O
transfection,O
analyses,O
using,O
the,O
chloramphenicol,O
acetyltransferase,O
reporter,O
gene,O
system,O
",",O
we,O
determined,O
that,O
linker,O
substitution,O
(,O
LS,B
),O
mutations,O
between,O
-,O
201,O
and,O
-,O
130,O
(,O
relative,O
to,O
the,O
transcription,O
start,O
site,O
),O
of,O
the,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
long,O
terminal,O
repeat,O
(,O
LTR,B
),O
caused,O
moderate,O
decreases,O
in,O
LTR,B
transcriptional,O
activity,O
in,O
a,O
T,B
-,I
cell,I
line,I
(,O
S,O
.,O
L,O
.,O
Zeichner,O
",",O
J,O
.,O
Y,O
.,O
.,O
H,O
.,O
Kim,O
",",O
and,O
J,O
.,O
C,O
.,O
Alwine,O
",",O
J,O
.,O
Virol,O
.,O
65,O
:,O
2436,O
-,O
2444,O
",",O
1991,O
.,O
),O
.,O
If,O
GATA,B
-,I
1,I
-,I
red,I
cells,I
were,O
available,O
",",O
the,O
analyses,O
would,O
involve,O
the,O
actual,O
transcription,O
of,O
or,O
chromatin,O
structure,O
surrounding,O
the,O
globin,O
genes,I
.,O
G0S24,O
is,O
a,O
member,O
of,O
a,O
set,O
of,O
genes,I
(,O
putative,O
G0,O
/,O
G1,O
switch,O
regulatory,O
genes,I
),O
that,O
are,O
expressed,O
transiently,O
within,O
1,O
-,O
2,O
hr,O
of,O
the,O
addition,O
of,O
lectin,O
or,O
cycloheximide,O
to,O
human,O
blood,O
mononuclear,O
cells,I
.,O
Comparison,O
of,O
the,O
derived,O
protein,B
sequence,I
with,O
those,O
of,O
rodent,O
homologs,O
allows,O
classification,O
into,O
three,O
groups,O
.,O
Groups,O
1,O
and,O
2,O
have,O
a,O
serine,B
-,I
rich,I
region,I
and,O
an,O
`,O
`,O
arginine,B
element,I
`,O
`,O
(,O
RRLPIF,O
),O
at,O
the,O
carboxyl,O
terminus,O
.,O
All,O
groups,O
contain,O
cysteine,B
-,I
and,I
histidine,I
-,I
rich,I
putative,O
zinc,B
finger,I
domains,I
and,O
a,O
serine,B
-,I
phenylalanine,I
`,O
`,O
SFS,I
',I
domain,I
similar,O
to,O
part,O
of,O
the,O
large,O
subunit,O
of,O
eukaryotic,O
RNA,B
polymerase,I
II,I
.,O
Comparison,O
of,O
group,O
1,O
human,O
and,O
mouse,O
genomic,O
sequences,O
shows,O
high,O
conservation,O
in,O
the,O
5,O
',O
flank,O
and,O
exons,O
.,O
A,O
CpG,O
island,O
suggests,O
expression,O
in,O
the,O
germ,O
line,O
.,O
A,O
microB,B
binding,I
protein,I
is,O
encoded,O
by,O
the,O
PU,O
.,O
1,O
/,O
Spi,O
-,O
1,O
proto,O
-,O
oncogene,O
.,O
One,O
enigmatic,O
aspect,O
of,O
GATA,B
factor,I
expression,O
is,O
that,O
several,O
GATA,B
proteins,I
",",O
which,O
ostensibly,O
share,O
the,O
same,O
DNA,B
-,I
binding,I
site,I
specificity,I
",",O
are,O
coexpressed,O
in,O
erythroid,O
cells,O
.,O
Thus,O
",",O
the,O
GATA,B
-,I
2,I
transcription,O
factor,O
appears,O
to,O
play,O
a,O
role,O
in,O
regulating,O
the,O
self,O
-,O
renewal,O
capacity,O
of,O
early,O
erythroid,B
progenitor,I
cells,I
.,O
Endothelial,B
cells,I
(,O
EC,B
),O
act,O
as,O
APC,O
for,O
resting,O
PBL,O
in,O
vitro,O
",",O
and,O
may,O
have,O
important,O
roles,O
in,O
vivo,O
in,O
the,O
pathogenesis,O
of,O
allograft,O
rejection,O
and,O
delayed,O
hypersensitivity,O
.,O
PBL,O
constitutively,O
express,O
c,B
-,I
jun,I
transcripts,O
",",O
and,O
the,O
level,O
of,O
c,B
-,I
jun,I
mRNA,O
is,O
not,O
altered,O
by,O
PHA,O
activation,O
in,O
the,O
absence,O
or,O
presence,O
of,O
EC,O
.,O
In,O
contrast,O
",",O
c,B
-,I
fos,I
mRNA,O
is,O
absent,O
from,O
resting,O
T,O
cells,O
and,O
is,O
induced,O
on,O
PHA,O
activation,O
.,O
Site,O
-,O
directed,O
mutagenesis,O
demonstrated,O
that,O
this,O
HS,O
-,O
40,O
enhancer,O
-,O
zeta,O
2,O
globin,O
promoter,O
interaction,O
is,O
mediated,O
by,O
the,O
two,O
GATA,O
-,O
1,O
factor,O
binding,O
motifs,O
located,O
at,O
-,O
230,O
and,O
-,O
104,O
",",O
respectively,O
.,O
Site,O
-,O
directed,O
mutagenesis,O
further,O
demonstrated,O
that,O
the,O
enhancer,B
function,O
of,O
one,O
of,O
the,O
two,O
NF,B
-,I
E2,I
/,I
AP1,I
motifs,I
of,O
HS,B
-,I
40,I
is,O
mediated,O
through,O
its,O
binding,O
to,O
NF,B
-,I
E2,I
but,O
not,O
AP1,B
transcription,I
factor,I
.,O
We,O
report,O
the,O
characterization,O
of,O
the,O
cis,O
-,O
and,O
trans,O
-,O
acting,O
elements,O
involved,O
in,O
the,O
tissue,O
-,O
specific,O
activity,O
of,O
the,O
L,B
gene,I
erythroid,I
promoter,I
.,O
Within,O
this,O
region,O
",",O
we,O
define,O
a,O
minimal,O
promoter,O
(,O
-,O
62,O
to,O
+,O
54,O
),O
that,O
displays,O
erythroid,B
-,I
specific,I
activity,O
and,O
contains,O
two,O
DNA,B
binding,I
sites,I
.,O
Mutations,O
and,O
deletions,O
of,O
both,O
sites,O
indicate,O
that,O
only,O
the,O
association,O
of,O
CCACC,B
/,I
Sp1,I
and,O
GATA,B
binding,I
sites,I
can,O
drive,O
efficient,O
and,O
tissue,O
-,O
specific,O
expression,O
of,O
this,O
R,O
-,O
PK,O
minimal,O
promoter,O
.,O
Protease,O
treatment,O
of,O
nuclear,O
extracts,O
distinguishes,O
between,O
class,O
II,O
MHC,B
X1,I
box,I
DNA,I
-,I
binding,I
proteins,I
in,O
wild,O
-,O
type,O
and,O
class,O
II,O
-,O
deficient,O
B,O
cells,O
.,O
The,O
X,B
box,I
region,I
is,O
critical,O
for,O
directing,O
the,O
expression,O
of,O
class,O
II,O
major,O
histocompatibility,O
complex,O
genes,O
in,O
B,O
lymphocytes,O
.,O
To,O
further,O
evaluate,O
the,O
role,O
of,O
X,B
box,I
DNA,I
-,I
binding,I
proteins,I
in,O
class,O
II,O
gene,O
expression,O
",",O
the,O
role,O
of,O
the,O
X,B
box,I
region,I
was,O
examined,O
in,O
both,O
class,O
II,O
-,O
positive,O
and,O
-,O
negative,O
lymphoid,O
cells,O
.,O
To,O
determine,O
whether,O
these,O
different,O
X1,B
box,I
activities,O
represented,O
distinct,O
DNA,B
binding,I
proteins,I
or,O
multimeric,O
forms,O
of,O
the,O
same,O
factor,O
(,O
s,O
),O
",",O
protease,O
treatment,O
of,O
the,O
crude,O
nuclear,O
extracts,O
followed,O
by,O
DNA,B
-,I
binding,I
assays,O
were,O
carried,O
out,O
and,O
demonstrated,O
that,O
B,B
cell,I
extracts,I
contain,O
at,O
least,O
two,O
X1,B
-,I
specific,I
factors,I
.,O
A,O
similar,O
comparison,O
with,O
protease,B
-,I
treated,I
extracts,I
prepared,O
from,O
Jurkat,B
cells,I
demonstrated,O
the,O
presence,O
of,O
the,O
band,O
1pk,O
activity,O
despite,O
an,O
absence,O
of,O
the,O
native,O
RFX,B
activity,O
0.28,O
In,O
contrast,O
",31",O
protease,B
treatment,O
and,O
analysis,O
of,O
SJO,B
extracts,I
showed,O
no,O
detectable,O
levels,O
of,O
the,O
band,O
1pk,O
activity,O
0.48,O
Human,O
immunodeficiency,B
viruses,I
containing,O
heterologous,O
enhancer,B
/,I
promoters,I
are,O
replication,O
competent,O
and,O
exhibit,O
different,O
lymphocyte,B
tropisms,I
0.65,O
Viruses,O
containing,O
the,O
human,B
cytomegalovirus,I
immediate,I
-,I
early,I
enhancer,I
exhibited,O
infectious,O
kinetics,O
similar,O
to,O
that,O
of,O
wild,O
-,O
type,O
HIV,B
in,O
activated,O
human,B
peripheral,I
blood,I
lymphocytes,I
and,O
AA2,B
cells,I
but,O
replicated,O
less,O
efficiently,O
in,O
H9,B
and,O
CEM,B
cells,I
.,O
Our,O
report,O
expands,O
current,O
knowledge,O
of,O
the,O
radiation,O
-,O
induced,O
signaling,O
cascade,O
by,O
clarifying,O
the,O
chronological,O
sequence,O
of,O
biochemical,O
events,O
that,O
follow,O
irradiation,O
.,O
To,O
test,O
this,O
hypothesis,O
",",O
a,O
more,O
sensitive,O
and,O
specific,O
polymerase,O
chain,O
reaction,O
(,O
PCR,B
),O
assay,O
was,O
developed,O
to,O
detect,O
adenovirus,B
DNA,I
.,O
The,O
E1A,B
and,O
hexon,B
primers,O
amplified,O
DNA,B
from,O
representative,O
adenoviral,B
serotypes,O
in,O
all,O
six,O
adenoviral,B
groups,O
(,O
A,O
-,O
F,O
),O
.,O
OBJECTIVE,O
:,O
To,O
examine,O
the,O
inter,O
-,O
relationship,O
between,O
HIV,B
-,I
1,I
infection,O
and,O
the,O
cell,B
surface,I
receptors,O
for,O
tumor,O
necrosis,O
factor,O
(,O
TNF,B
),O
-,O
alpha,O
",",O
an,O
immunoregulatory,O
cytokine,O
that,O
can,O
enhance,O
HIV,B
-,I
1,I
replication,O
.,O
HIV,B
-,I
1,I
activation,O
and,O
expression,O
was,O
quantitated,O
by,O
reverse,O
transcriptase,O
assay,O
.,O
RESULTS,O
:,O
In,O
the,O
OM,O
-,O
10,O
.,O
1,O
promyelocytic,O
model,O
of,O
chronic,O
infection,O
",",O
TNF,O
-,O
alpha,O
-,O
induced,O
HIV,B
-,I
1,I
expression,O
also,O
resulted,O
in,O
a,O
substantial,O
increase,O
in,O
75,O
kd,O
TNF,O
receptor,O
(,O
TR75,B
),O
expression,O
although,O
55,O
kD,O
TNF,O
receptor,O
(,O
TR55,B
),O
levels,O
were,O
not,O
dramatically,O
altered,O
.,O
Enhanced,O
TR75,B
expression,O
on,O
OM,B
-,I
10,I
.,O
1,O
cells,O
followed,O
the,O
same,O
TNF,O
-,O
alpha,O
-,O
dose,O
dependency,O
as,O
that,O
observed,O
for,O
HIV,B
-,I
1,I
production,O
.,O
Although,O
TR55,B
expression,O
was,O
unaltered,O
during,O
TNF,O
-,O
alpha,O
-,O
induced,O
HIV,B
activation,O
",",O
this,O
receptor,O
was,O
still,O
involved,O
in,O
the,O
viral,O
activation,O
process,O
.,O
Surprisingly,O
",",O
this,O
was,O
the,O
case,O
even,O
when,O
an,O
antagonistic,O
anti,O
-,O
TR55,B
antibody,O
was,O
used,O
.,O
Anti,O
-,O
TR55,B
antibody,I
cross,O
-,O
linking,O
in,O
chronically,O
infected,O
U1,B
promonocytic,I
cultures,I
could,O
only,O
partially,O
substitute,O
for,O
TNF,B
-,I
alpha,I
-,I
induced,I
HIV,B
-,I
1,I
expression,I
.,O
We,O
have,O
used,O
in,O
situ,O
hybridization,O
to,O
define,O
these,O
rearrangements,O
at,O
the,O
molecular,O
level,O
.,O
A,O
reporter,O
gene,O
under,O
the,O
control,O
of,O
a,O
T,B
-,I
cell,I
antigen,I
receptor,I
element,I
was,O
activated,O
in,O
Jurkat,B
cells,I
by,O
antigen,O
receptor,O
triggering,O
or,O
by,O
a,O
combination,O
of,O
phorbol,B
myristate,I
acetate,I
",",O
which,O
activates,O
protein,B
kinase,I
C,I
",",O
and,O
a,O
calcium,B
ionophore,I
.,O
Both,O
these,O
signals,O
were,O
necessary,O
for,O
expression,O
of,O
the,O
reporter,O
gene,O
.,O
When,O
co,O
-,O
transfected,O
with,O
a,O
construct,O
capable,O
of,O
overexpressing,O
the,O
tyrosine,B
kinase,I
p59fyn,I
",",O
the,O
reporter,O
gene,O
was,O
activated,O
by,O
PMA,O
alone,O
.,O
Dependence,O
for,O
the,O
proliferative,O
response,O
to,O
erythropoietin,O
on,O
an,O
established,O
erythroid,O
differentiation,O
program,O
in,O
a,O
human,O
hematopoietic,O
cell,B
line,I
",",O
UT,B
-,I
7,I
.,O
UT,B
-,I
7,I
Epo,O
and,O
UT,B
-,I
7,I
expressed,O
similar,O
levels,O
of,O
GATA,B
-,I
1,I
mRNA,O
and,O
binding,O
activity,O
.,O
This,O
difference,O
in,O
the,O
number,O
of,O
binding,O
sites,O
could,O
be,O
due,O
to,O
differences,O
in,O
cell,O
surface,O
(,O
UT,B
-,I
7,I
cells,O
are,O
20,O
%,O
smaller,O
than,O
the,O
parental,O
UT,B
-,I
7,I
cells,O
),O
or,O
in,O
receptor,O
turnover,O
.,O
By,O
Northern,O
analysis,O
",",O
UT,B
-,I
7,I
cells,O
expressed,O
detectable,O
levels,O
of,O
beta,B
-,I
and,O
gamma,B
-,I
globin,I
but,O
not,O
alpha,B
-,I
globin,I
.,O
Globin,B
chains,I
(,O
alpha,B
",",O
beta,B
and,O
gamma,B
),O
were,O
clearly,O
detectable,O
by,O
affinity,O
chromatography,O
in,O
UT,B
-,I
7,I
Epo,I
but,O
not,O
in,O
UT,B
-,I
7,I
cells,I
.,O
The,O
myeloid,B
integrin,I
CD11b,I
is,O
expressed,O
selectively,O
on,O
the,O
surface,O
of,O
mature,O
macrophages,O
",",O
monocytes,O
",",O
neutrophils,O
",",O
and,O
natural,O
killer,O
cells,O
.,O
Recent,O
isolation,O
of,O
the,O
CD11b,B
promoter,I
shows,O
that,O
92,O
base,O
pairs,O
(,O
bp,O
),O
of,O
5,O
',O
-,O
flanking,O
DNA,B
are,O
sufficient,O
to,O
direct,O
myeloid,B
-,I
specific,I
expression,I
of,O
a,O
reporter,O
gene,O
.,O
Transcription,O
factor,O
jun,B
-,I
B,I
is,O
target,O
of,O
autoreactive,O
T,O
-,O
cells,O
in,O
IDDM,O
.,O
Target,O
antigens,O
defined,O
by,O
autoantibodies,O
in,O
IDDM,O
include,O
insulin,B
",",O
a,O
putative,O
glycolipid,O
that,O
reacts,O
with,O
islet,O
cell,O
antibodies,O
",",O
and,O
a,O
64,O
",",O
0,O
-,O
M,O
(,O
r,O
),O
protein,B
recently,O
identified,O
as,O
glutamic,O
acid,O
decarboxylase,O
.,O
Okadaic,O
acid,O
increased,O
the,O
synthesis,O
of,O
the,O
interleukin,B
-,I
1,I
beta,I
precursor,I
and,O
mature,O
forms,O
and,O
their,O
secretion,O
.,O
Expression,O
of,O
tal,B
-,I
1,I
and,O
GATA,B
-,I
binding,I
proteins,I
during,O
human,O
hematopoiesis,O
.,O
Because,O
the,O
GATA,B
-,I
1,I
gene,I
is,O
known,O
to,O
transactivate,O
several,O
genes,O
specific,O
for,O
the,O
erythroid,B
",",O
megakaryocytic,B
",",O
and,O
mastocytic,B
/,I
basophilic,I
lineages,I
",",O
we,O
studied,O
GATA,B
-,I
1,I
expression,I
in,O
these,O
purified,O
hematopoietic,O
cells,O
.,O
The,O
lytic,O
transition,O
of,O
Epstein,O
-,O
Barr,O
virus,O
is,O
imitated,O
by,O
recombinant,O
B,B
-,I
cells,I
.,O
We,O
developed,O
eukaryotic,B
vectors,I
suitable,O
to,O
imitate,O
the,O
processes,O
involved,O
in,O
lytic,B
transition,I
in,O
cell,B
culture,I
systems,I
.,O
R7,B
-,I
57,I
reporter,I
cells,I
",",O
on,O
the,O
other,O
hand,O
",",O
signaled,O
induced,O
activity,O
of,O
the,O
lytic,B
origin,I
of,I
EBV,I
replication,I
(,O
ori,B
Lyt,I
),O
.,O
Different,O
modes,O
",",O
like,O
chemical,O
induction,O
",",O
lytic,B
superinfection,I
with,O
EBV,B
and,O
single,O
gene,O
trans,O
-,O
activation,O
converted,O
the,O
recombinant,O
ori,B
Lyt,I
element,I
in,O
R7,B
-,I
57,I
reporter,I
cells,I
.,O
Costimulation,O
of,O
cAMP,B
and,O
protein,B
kinase,I
C,I
pathways,I
inhibits,O
the,O
CD3,B
-,I
dependent,I
T,I
cell,I
activation,I
and,O
leads,O
to,O
a,O
persistent,O
expression,O
of,O
the,O
AP,B
-,I
1,I
transcription,I
factor,I
.,O
Analysis,O
of,O
intracellular,O
Ca2,B
+,I
mobilization,I
suggested,O
that,O
the,O
CD3,B
/,I
TcR,I
-,I
dependent,I
signal,I
transduction,I
was,O
impaired,O
in,O
PMA,B
/,I
Bt2cAMP,I
-,I
treated,I
cells,I
.,O
The,O
observation,O
that,O
a,O
mutated,O
LT,B
-,I
kappa,I
B,I
construct,O
(,O
M1,B
-,I
CAT,I
),O
was,O
inactive,O
in,O
C81,B
-,I
66,I
-,I
45,I
",",O
confirmed,O
the,O
importance,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
LT,B
gene,I
expression,I
.,O
In,O
JM,B
T,I
cells,I
",",O
tax,O
induced,O
LT,B
-,I
293,I
activity,I
by,O
two,O
-,O
to,O
four,O
-,O
fold,O
",",O
though,O
there,O
was,O
no,O
induction,O
of,O
M1,B
-,I
CAT,I
.,O
We,O
combined,O
two,O
techniques,O
to,O
identify,O
the,O
productive,O
replicative,O
form,O
of,O
Epstein,B
-,I
Barr,I
viral,I
DNA,B
in,O
the,O
lytic,O
cycle,O
-,O
induced,O
cells,O
.,O
This,O
indicates,O
an,O
increase,O
in,O
either,O
episomal,B
DNA,I
or,O
concatameric,B
linear,I
DNA,I
.,O
This,O
paper,O
describes,O
how,O
the,O
expression,O
of,O
the,O
monocyte,B
-,I
macrophage,I
Ag,I
",",O
CD14,B
",",O
and,O
the,O
low,O
affinity,O
Fc,B
receptor,I
for,O
IgE,B
",",O
CD23,B
",",O
were,O
inversely,O
regulated,O
during,O
VitD3,O
-,O
and,O
RA,O
-,O
induced,O
monocytic,B
differentiation,I
of,O
human,B
U,I
-,I
937,I
monoblasts,I
.,O
The,O
results,O
suggest,O
that,O
there,O
exists,O
a,O
functional,O
antagonism,O
between,O
VitD3,B
and,O
RA,B
that,O
may,O
have,O
important,O
implications,O
for,O
the,O
regulation,O
of,O
certain,O
immune,O
and,O
inflammatory,O
responses,O
through,O
their,O
inverse,O
effects,O
on,O
CD14,B
and,O
CD23,B
gene,I
expression,I
.,O
Cell,O
-,O
specific,O
bifunctional,O
role,O
of,O
Jun,O
oncogene,O
family,O
members,O
on,O
glucocorticoid,B
receptor,I
-,I
dependent,I
transcription,I
.,O
Here,O
we,O
report,O
that,O
this,O
interference,O
is,O
cell,O
specific,O
",",O
as,O
TPA,O
augmented,O
dexamethasone,O
-,O
induced,O
transcriptional,O
activation,O
of,O
the,O
MMTV,O
LTR,O
in,O
several,O
T,B
cell,I
lines,I
but,O
was,O
inhibitory,O
in,O
NIH,B
-,I
3T3,I
fibroblasts,I
.,O
Increased,O
c,B
-,I
jun,I
",",O
jun,B
-,I
B,I
",",O
and,O
jun,B
-,I
D,I
expression,O
above,O
basal,O
levels,O
and,O
increased,O
transcriptional,O
activity,O
of,O
AP,O
-,O
1,O
/,O
TPA,O
responsive,O
elements,O
fused,O
to,O
chloramphenicol,O
acetyl,O
-,O
transferase,O
vectors,O
were,O
observed,O
in,O
T,B
cells,I
treated,O
with,O
TPA,O
alone,O
or,O
in,O
combination,O
with,O
dexamethasone,O
.,O
Studies,O
with,O
5,O
',O
deletion,O
CD20,B
promoter,I
-,I
CAT,I
constructs,I
have,O
previously,O
revealed,O
two,O
regions,O
of,O
the,O
promoter,O
between,O
bases,O
-,O
186,O
and,O
-,O
280,O
and,O
between,O
bases,O
-,O
280,O
and,O
-,O
454,O
which,O
contained,O
positive,O
regulatory,O
elements,O
.,O
Cross,O
competition,O
experiments,O
with,O
an,O
octamer,O
sequence,O
from,O
the,O
Ig,B
heavy,I
chain,I
promoter,I
",",O
the,O
BAT,B
box,I
",",O
and,O
a,O
TA,B
-,I
rich,I
sequence,I
present,O
in,O
the,O
CD21,B
promoter,I
revealed,O
that,O
all,O
three,O
sequences,O
bound,O
the,O
same,O
nuclear,O
proteins,O
suggesting,O
that,O
the,O
BAT,B
box,I
binding,I
proteins,I
were,O
Oct,B
-,I
1,I
and,O
Oct,B
-,I
2,I
.,O
Despite,O
this,O
lower,O
affinity,O
",",O
a,O
trimer,O
of,O
the,O
BAT,B
box,I
sequence,I
was,O
as,O
efficiently,O
transactivated,O
by,O
an,O
Oct,O
-,O
2,O
expression,O
vector,O
as,O
was,O
a,O
trimer,O
of,O
the,O
octamer,O
sequence,O
in,O
HeLa,B
cells,I
.,O
Control,O
peptides,O
corresponding,O
to,O
the,O
normal,O
pml,B
and,O
RAR,B
alpha,I
proteins,I
were,O
not,O
recognized,O
.,O
One,O
cDNA,O
clone,O
of,O
a,O
primary,O
response,O
gene,O
",",O
expressed,O
upon,O
macrophage,B
differentiation,I
",",O
encoded,O
for,O
Egr,B
-,I
1,I
",",O
a,O
zinc,B
finger,I
transcription,I
factor,I
.,O
HL,B
-,I
60,I
cells,O
constitutively,O
expressing,O
an,O
Egr,B
-,I
1,I
transgene,I
(,O
HL,B
-,I
60Egr,I
-,I
1,I
),O
could,O
be,O
induced,O
for,O
macrophage,O
",",O
but,O
not,O
granulocyte,O
",",O
differentiation,O
.,O
These,O
observations,O
indicate,O
that,O
expression,O
of,O
Egr,B
-,I
1,I
is,O
essential,O
for,O
and,O
restricts,O
differentiation,O
of,O
myeloblasts,O
along,O
the,O
macrophage,O
lineage,O
.,O
Electrophoretic,O
mobility,O
shift,O
assays,O
revealed,O
three,O
specific,O
protein,B
-,I
DNA,I
complexes,O
formed,O
with,O
sequences,O
of,O
the,O
EBNA2,O
responsive,O
element,O
.,O
Thus,O
",",O
these,O
experiments,O
demonstrate,O
that,O
EBNA2,O
interacts,O
with,O
an,O
EBNA2,O
responsive,O
cis,O
-,O
element,O
of,O
the,O
TP1,O
promoter,O
Agents,O
which,O
increased,O
cAMP,B
levels,O
",",O
including,O
cholera,O
toxin,O
",",O
pertussis,O
toxin,O
",",O
dibutyryl,O
cAMP,O
",",O
and,O
isoproterenol,O
mimicked,O
the,O
actions,O
of,O
MM,O
-,O
LDL,O
.,O
One,O
member,O
of,O
this,O
multigene,O
family,O
",",O
GATA,B
-,I
3,I
",",O
is,O
most,O
abundantly,O
expressed,O
in,O
T,B
lymphocytes,I
",",O
a,O
cellular,O
target,O
for,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
(,O
HIV,B
-,I
1,I
),O
infection,O
and,O
replication,O
.,O
Cotransfection,O
of,O
an,O
hGATA,B
-,I
3,I
expression,O
plasmid,O
with,O
a,O
reporter,O
plasmid,O
whose,O
transcription,O
is,O
directed,O
by,O
the,O
HIV,B
-,I
1,I
LTR,I
resulted,O
in,O
6,O
-,O
to,O
10,O
-,O
fold,O
stimulation,O
of,O
LTR,B
-,I
mediated,I
transcription,I
",",O
whereas,O
site,O
specific,O
mutation,O
of,O
these,O
GATA,B
sites,I
resulted,O
in,O
virtual,O
abrogation,O
of,O
the,O
activation,O
by,O
hGATA,B
-,I
3,I
.,O
Conversely,O
",",O
several,O
cytokines,O
modulate,O
the,O
levels,O
of,O
HIV,B
expression,O
in,O
infected,O
cells,O
of,O
both,O
T,B
lymphocytic,I
and,O
mononuclear,B
phagocytic,I
lineage,O
.,O
Cloning,O
and,O
functional,B
characterization,I
of,O
early,O
B,B
-,I
cell,I
factor,I
",",O
a,O
regulator,O
of,O
lymphocyte,B
-,I
specific,I
gene,I
expression,I
.,O
Early,O
B,B
-,I
cell,I
factor,I
(,O
EBF,B
),O
was,O
identified,O
previously,O
as,O
a,O
tissue,O
-,O
specific,O
and,O
differentiation,O
stage,O
-,O
specific,O
DNA,B
-,I
binding,I
protein,I
that,O
participates,O
in,O
the,O
regulation,O
of,O
the,O
pre,O
-,O
B,B
and,O
B,B
lymphocyte,I
-,I
specific,I
mb,I
-,I
1,I
gene,I
.,O
Partial,O
amino,B
acid,I
sequences,I
obtained,O
from,O
purified,O
EBF,B
were,O
used,O
to,O
isolate,O
cDNA,B
clones,I
",",O
which,O
by,O
multiple,O
criteria,O
encode,O
EBF,B
.,O
DNA,B
-,I
binding,I
assays,I
with,O
cotranslated,O
wild,O
-,O
type,O
and,O
truncated,O
forms,O
of,O
EBF,B
indicated,O
that,O
the,O
protein,B
interacts,O
with,O
its,O
site,O
as,O
a,O
homodimer,O
.,O
Deletions,O
delineated,O
a,O
carboxy,O
-,O
terminal,O
dimerization,O
region,O
containing,O
two,O
repeats,O
of,O
15,O
amino,B
acids,I
that,O
show,O
similarity,O
with,O
the,O
dimerization,O
domains,O
of,O
basic,O
-,O
helix,O
-,O
loop,O
-,O
helix,O
proteins,O
.,O
A,O
73,O
kDa,O
protein,B
was,O
identified,O
by,O
this,O
analysis,O
:,O
this,O
protein,B
is,O
highly,O
enriched,O
in,O
cell,B
lines,I
of,O
B,B
lymphoid,I
origin,I
as,O
compared,O
to,O
pancreatic,B
beta,I
-,I
cells,I
and,O
fibroblast,B
cells,I
.,O
The,O
detection,O
of,O
this,O
protein,B
selectively,O
in,O
extracts,O
of,O
lymphoid,B
cells,I
correlates,O
with,O
the,O
presence,O
of,O
the,O
E,B
box,I
-,I
binding,I
activity,I
LEF1,O
/,O
BCF1,O
in,O
these,O
cells,B
;,O
this,O
binding,O
activity,O
was,O
previously,O
shown,O
to,O
be,O
efficiently,O
recognized,O
by,O
antiserum,O
directed,O
against,O
E2A,O
gene,O
products,O
.,O
Pregnancy,O
-,O
induced,O
hypertension,O
(,O
PIH,B
),O
is,O
a,O
frequent,O
cause,O
of,O
maternal,O
and,O
neonatal,O
morbidity,O
and,O
mortality,O
.,O
In,O
the,O
present,O
study,O
we,O
focused,O
on,O
the,O
pathophysiology,O
of,O
PIH,B
",",O
mainly,O
on,O
the,O
role,O
of,O
mineralocorticoids,B
",",O
reversed,O
blood,O
pressure,O
patterns,O
",",O
and,O
the,O
resulting,O
necessity,O
of,O
continuous,O
monitoring,O
of,O
the,O
preeclamptic,O
mother,O
.,O
Furthermore,O
",",O
we,O
evaluated,O
the,O
mineralocorticoid,B
receptor,I
(,O
MR,B
),O
count,O
in,O
mononuclear,B
leukocytes,I
in,O
the,O
2,O
groups,O
.,O
Induction,O
by,O
hemin,O
increases,O
",",O
while,O
induction,O
with,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
(,O
TPA,B
),O
represses,O
",",O
erythroid,B
-,I
specific,I
gene,I
expression,I
in,O
the,O
human,B
cell,I
line,I
K562,I
.,O
Hemin,O
induction,O
appears,O
to,O
nonspecifically,O
increase,O
the,O
expression,O
of,O
transiently,O
transfected,O
genes,O
in,O
K562,B
cells,I
.,O
The,O
divergent,O
effects,O
of,O
hemin,B
and,O
TPA,B
on,O
gene,O
expression,O
in,O
K562,B
cells,I
are,O
mediated,O
",",O
in,O
part,O
",",O
by,O
their,O
contrasting,O
effects,O
on,O
the,O
transcription,O
factor,O
NF,B
-,I
E2,I
.,O
We,O
studied,O
the,O
effect,O
of,O
interleukin,B
-,I
4,I
(,O
IL,B
-,I
4,I
),O
on,O
the,O
lipopolysaccharide,B
(,I
LPS,I
),O
induction,O
of,O
two,O
immediate,O
early,O
genes,O
c,B
-,I
fos,I
and,O
c,B
-,I
jun,I
.,O
The,O
inhibition,O
of,O
c,B
-,I
fos,I
and,I
c,B
-,I
jun,I
expression,O
by,O
IL,O
-,O
4,O
in,O
LPS,O
-,O
treated,O
cells,O
was,O
shown,O
to,O
be,O
due,O
to,O
a,O
lower,O
transcription,O
rate,O
of,O
the,O
c,B
-,I
fos,I
and,I
c,B
-,I
jun,I
genes,I
.,O
These,O
involve,O
activation,O
of,O
the,O
sodium,B
/,I
proton,I
exchanger,I
of,O
the,O
cell,B
membrane,I
at,O
very,O
low,O
",",O
physiological,O
concentrations,O
of,O
aldosterone,O
with,O
an,O
acute,O
onset,O
within,O
1,O
-,O
2,O
min,O
.,O
The,O
unique,O
characteristics,O
of,O
this,O
new,O
pathway,O
for,O
steroid,B
action,O
include,O
its,O
rapid,O
time,O
course,O
",",O
10,O
",",O
0,O
-,O
fold,O
selectivity,O
for,O
aldosterone,B
over,O
cortisol,B
and,O
the,O
ineffectiveness,O
of,O
spironolactones,O
",",O
classical,O
mineralocorticoid,B
antagonists,O
",",O
as,O
antagonists,O
of,O
the,O
response,O
.,O
Human,O
immunodeficiency,B
virus,I
type,I
1,I
Nef,I
protein,B
inhibits,O
NF,B
-,I
kappa,I
B,I
induction,O
in,O
human,O
T,B
cells,I
.,O
These,O
results,O
indicate,O
that,O
defective,O
recruitment,O
of,O
NF,B
-,I
kappa,I
B,I
may,O
underlie,O
Nef,O
',O
s,O
negative,O
transcriptional,O
effects,O
on,O
the,O
HIV,B
-,I
1,I
and,O
interleukin,B
2,I
promoters,I
.,O
The,O
expression,O
of,O
c,B
-,I
fos,I
",",O
c,B
-,I
jun,I
and,O
jun,B
B,I
proto,I
-,I
oncogenes,I
was,O
studied,O
in,O
phytohemagglutinin,O
(,O
PHA,O
),O
activated,O
peripheral,O
blood,O
lymphocytes,O
(,O
PBL,O
),O
from,O
young,O
and,O
aged,O
humans,O
.,O
In,O
PHA,O
-,O
activated,O
PBL,O
",",O
no,O
age,O
-,O
related,O
differences,O
were,O
observed,O
in,O
c,O
-,O
fos,B
or,O
jun,B
B,I
mRNA,I
expression,I
.,O
Because,O
previous,O
work,O
has,O
demonstrated,O
that,O
T,B
cells,I
from,O
elderly,O
individuals,O
may,O
display,O
normal,O
proliferative,O
responses,O
when,O
activated,O
via,O
the,O
anti,O
-,O
CD2,O
pathway,O
",",O
c,O
-,O
jun,B
and,O
jun,B
B,I
mRNA,I
expression,I
was,O
also,O
studied,O
in,O
anti,O
-,O
CD2,O
-,O
activated,O
purified,O
T,B
cells,I
.,O
The,O
CD19,B
protein,I
is,O
expressed,O
on,O
the,O
surface,O
of,O
all,O
B,B
-,I
lymphoid,I
cells,I
with,O
the,O
exception,O
of,O
terminally,O
differentiated,O
plasma,O
cells,O
and,O
has,O
been,O
implicated,O
as,O
a,O
signal,O
-,O
transducing,O
receptor,O
in,O
the,O
control,O
of,O
proliferation,O
and,O
differentiation,O
.,O
This,O
high,O
-,O
affinity,O
site,O
has,O
been,O
conserved,O
in,O
the,O
promoters,O
of,O
both,O
human,O
and,O
mouse,O
CD19,B
genes,I
and,O
was,O
furthermore,O
shown,O
to,O
confer,O
B,B
-,I
cell,I
specificity,I
to,O
a,O
beta,O
-,O
globin,O
reporter,O
gene,O
in,O
transient,O
transfection,O
experiments,O
.,O
In,O
addition,O
",",O
BSAP,B
was,O
found,O
to,O
be,O
the,O
only,O
abundant,O
DNA,B
-,I
binding,I
activity,I
of,O
B,O
-,O
cell,B
nuclear,I
extracts,I
that,O
interacts,O
with,O
the,O
CD19,B
promoter,I
.,O
Compared,O
to,O
benign,O
tumor,O
or,O
mammary,O
reduction,O
test,O
material,O
the,O
eicosanoid,O
profile,O
of,O
tissue,O
obtained,O
from,O
malignant,O
mammary,O
tumors,O
showed,O
important,O
differences,O
.,O
The,O
implications,O
",",O
in,O
particular,O
",",O
in,O
relation,O
to,O
future,O
prognosis,O
of,O
the,O
patient,O
",",O
remain,O
obscure,O
.,O
To,O
examine,O
the,O
role,O
of,O
mineralocorticoids,O
in,O
the,O
pathophysiology,O
of,O
pregnancy,O
-,O
induced,O
hypertension,O
(,O
PIH,O
),O
",",O
we,O
studied,O
plasma,O
aldosterone,B
and,O
18,O
-,O
hydroxycorticosteron,O
levels,O
in,O
25,O
women,O
with,O
PIH,O
and,O
25,O
normal,O
pregnant,O
women,O
",",O
as,O
controls,O
.,O
Plasma,O
18,O
-,O
hydroxycorticosteron,O
was,O
also,O
significantly,O
(,O
P,O
less,O
than,O
0,O
.,O
25,O
),O
lower,O
(,O
PIH,O
",",O
1071,O
+,O
/,O
-,O
149,O
pmol,O
/,O
L,O
;,O
controls,O
",",O
1907,O
+,O
/,O
-,O
318,O
pmol,O
/,O
L,O
.,O
Small,O
apolar,O
substitutions,O
(,O
11,O
alpha,O
-,O
methyl,O
",",O
11,O
alpha,O
-,O
fluoromethyl,O
),O
did,O
not,O
markedly,O
decrease,O
the,O
affinity,O
for,O
the,O
vitamin,B
D,I
receptor,I
",",O
but,O
larger,O
(,O
11,O
alpha,O
-,O
chloromethyl,O
or,O
11,O
alpha,O
-,O
or,O
11,O
beta,O
-,O
phenyl,O
),O
or,O
more,O
polar,O
substitutions,O
(,O
11,O
alpha,O
-,O
hydroxymethyl,O
",",O
11,O
alpha,O
-,O
(,O
2,O
-,O
hydroxyethyl,O
],O
decreased,O
the,O
affinity,O
to,O
less,O
than,O
5,O
%,O
of,O
that,O
of,O
1,O
alpha,O
",",O
25,O
-,O
OH,O
),O
2D3,O
.,O
The,O
11,O
beta,O
-,O
methyl,O
analog,O
had,O
a,O
greater,O
than,O
10,O
-,O
fold,O
lower,O
activity,O
.,O
In,O
the,O
present,O
paper,O
",",O
the,O
binding,O
of,O
a,O
[,O
125I,O
],O
-,O
labeled,O
aldosterone,B
derivative,I
to,O
plasma,O
membrane,O
rich,O
fractions,O
of,O
HML,O
was,O
studied,O
.,O
This,O
variation,O
was,O
the,O
result,O
of,O
a,O
duplication,O
of,O
a,O
short,O
DNA,B
sequence,I
(,O
CTG,O
-,O
motif,O
),O
.,O
No,O
positive,O
effect,O
of,O
the,O
duplicated,O
CTG,O
-,O
motif,O
could,O
be,O
detected,O
.,O
Based,O
on,O
these,O
results,O
we,O
estimate,O
a,O
5,O
-,O
10,O
%,O
difference,O
in,O
virus,O
production,O
of,O
the,O
LTR,B
variants,I
when,O
compared,O
to,O
that,O
of,O
wild,B
-,I
type,I
.,O
The,O
helix,B
-,I
loop,I
-,I
helix,I
(,O
HLH,B
),O
proteins,O
are,O
a,O
family,O
of,O
transcription,O
factors,O
that,O
include,O
proteins,O
critical,O
to,O
differentiation,O
and,O
development,O
in,O
species,O
ranging,O
from,O
plants,O
to,O
mammals,O
.,O
Glucocorticoid,B
receptor,I
in,O
patients,O
with,O
lupus,O
nephritis,O
:,O
relationship,O
between,O
receptor,B
levels,O
in,O
mononuclear,O
leukocytes,O
and,O
effect,O
of,O
glucocorticoid,B
therapy,O
.,O
We,O
investigated,O
the,O
clinical,O
significance,O
of,O
glucocorticoid,B
receptor,I
determination,O
in,O
20,O
patients,O
with,O
systemic,O
lupus,O
erythematosus,O
(,O
SLE,O
),O
who,O
afterwards,O
developed,O
nephrotic,O
syndrome,O
.,O
Improvement,O
in,O
urinary,O
protein,B
excretion,I
and,O
in,O
disease,O
activity,O
",",O
which,O
was,O
scored,O
according,O
to,O
the,O
SLE,O
Disease,O
Activity,O
Index,O
system,O
of,O
the,O
University,O
of,O
Toronto,O
",",O
closely,O
related,O
to,O
the,O
glucocorticoid,B
receptor,I
concentrations,I
in,O
MNL,O
isolated,O
from,O
the,O
corresponding,O
patients,O
.,O
Possible,O
relationship,O
between,O
the,O
changes,O
in,O
IL,O
-,O
1,O
and,O
GR,B
in,O
aged,O
long,O
-,O
distance,O
runner,O
and,O
its,O
physiological,O
significance,O
are,O
discussed,O
.,O
Mineralocorticoid,B
effector,I
mechanism,I
in,O
preeclampsia,O
.,O
MR,B
were,O
reduced,O
before,O
delivery,O
(,O
96,O
+,O
/,O
-,O
27,O
receptors,O
/,O
cell,O
),O
",",O
and,O
SPD,B
increased,O
(,O
64,O
+,O
/,O
-,O
8,O
mV,O
),O
",",O
with,O
both,O
parameters,O
normalizing,O
after,O
delivery,O
(,O
MR,B
",",O
242,O
+,O
/,O
-,O
79,O
;,O
SPD,B
",",O
14,O
.,O
0,O
+,O
/,O
-,O
4,O
mV,O
),O
.,O
Aldosterone,B
levels,I
returned,O
to,O
normal,O
nonpregnant,O
values,O
after,O
delivery,O
.,O
Kinetics,O
of,O
nuclear,O
translocation,O
and,O
turnover,O
of,O
the,O
vitamin,B
D,I
receptor,I
in,O
human,O
HL60,B
leukemia,I
cells,I
and,O
peripheral,O
blood,O
lymphocytes,O
-,O
-,O
coincident,O
rise,O
of,O
DNA,B
-,I
relaxing,I
activity,I
in,O
nuclear,O
extracts,O
.,O
HL60,B
cells,I
",",O
expressing,O
some,O
characteristics,O
of,O
promyelocytes,O
",",O
can,O
be,O
induced,O
to,O
monocytoid,O
differentiation,O
by,O
calcitriol,O
.,O
Pulse,O
exposure,O
of,O
HL60,B
to,O
radiolabeled,O
hormone,O
for,O
3,O
h,O
followed,O
by,O
culture,O
in,O
medium,O
without,O
serum,O
and,O
calcitriol,B
lead,O
to,O
nuclear,O
retention,O
of,O
approximately,O
1600,O
radiolabeled,O
VDR,B
by,O
8,O
h,O
and,O
approximately,O
1000,O
VDR,B
by,O
24,O
h,O
.,O
No,O
specific,O
translocation,O
into,O
the,O
nuclear,O
compartment,O
was,O
seen,O
when,O
isolated,O
nuclei,O
were,O
incubated,O
in,O
[,O
3H,O
],O
calcitriol,B
.,O
Radiolabeled,O
hormone,B
/,O
receptor,O
complexes,O
of,O
nuclei,O
isolated,O
from,O
cells,O
exposed,O
for,O
3,O
h,O
to,O
radiolabeled,O
hormone,B
-,O
-,O
in,O
contrast,O
to,O
identical,O
experiments,O
with,O
intact,O
cells,O
-,O
-,O
did,O
not,O
disappear,O
from,O
the,O
nuclear,O
compartment,O
upon,O
incubation,O
of,O
nuclei,O
with,O
identical,O
concentrations,O
of,O
the,O
unlabeled,O
compound,O
.,O
We,O
conclude,O
that,O
a,O
specific,O
nuclear,O
translocation,O
mechanism,O
exists,O
for,O
calcitriol,O
in,O
both,O
cell,B
types,I
examined,O
",",O
most,O
likely,O
due,O
to,O
translocation,O
of,O
receptor,B
proteins,I
after,O
hormone,O
binding,O
.,O
Enhanced,O
activity,O
of,O
topoisomerases,B
in,O
nuclear,O
extracts,O
upon,O
translocation,O
of,O
VDR,B
might,O
reflect,O
interaction,O
of,O
both,O
within,O
the,O
nuclear,O
compartment,O
",",O
thus,O
initiating,O
DNA,B
-,I
unwinding,I
",",O
a,O
prerequisite,O
of,O
transcription,O
initiation,O
.,O
Estrogen,B
receptor,I
positive,I
(,O
ER,B
+,I
:,O
MCF,B
-,I
7,I
),O
and,O
negative,B
(,O
ER,B
-,I
:,O
MDA,B
-,I
MB,I
-,I
231,I
),O
human,O
breast,O
cancer,O
cell,O
lines,O
were,O
utilized,O
to,O
evaluate,O
the,O
effects,O
of,O
tamoxifen,O
(,O
TAM,B
),O
and,O
estradiol,O
(,O
E2,B
),O
on,O
modulation,O
of,O
breast,O
cancer,O
target,O
susceptibility,O
to,O
lysis,O
by,O
lymphokine,O
-,O
activated,O
killer,O
(,O
LAK,B
),O
cells,O
.,O
E2,O
-,O
stimulated,O
ER,B
+,I
cells,O
were,O
more,O
susceptible,O
to,O
lysis,O
by,O
LAK,O
cells,O
than,O
corresponding,O
TAM,O
-,O
treated,O
or,O
control,O
cells,O
",",O
while,O
treatment,O
of,O
ER,B
-,I
cells,O
with,O
either,O
E2,O
or,O
TAM,O
alone,O
did,O
not,O
alter,O
from,O
control,O
their,O
susceptibility,O
to,O
this,O
immune,O
-,O
mediated,O
lysis,O
.,O
Regulation,O
of,O
replicative,O
functions,O
in,O
the,O
Epstein,B
-,I
Barr,I
virus,I
(,O
EBV,O
),O
genome,O
is,O
mediated,O
through,O
activation,O
of,O
a,O
virally,O
encoded,O
transcription,O
factor,O
",",O
Z,B
(,O
BZLF1,O
),O
.,O
The,O
long,O
terminal,O
repeat,O
(,O
LTR,B
),O
region,O
of,O
HIV,B
proviral,I
DNA,I
contains,O
binding,O
sites,O
for,O
nuclear,O
factor,O
kappa,O
B,B
(,O
NF,B
-,I
kappa,I
B,I
),O
",",O
and,O
this,O
transcriptional,O
activator,O
appears,O
to,O
regulate,O
HIV,B
activation,O
.,O
The,O
inhibitory,O
action,O
of,O
alpha,B
-,I
lipoic,I
acid,I
was,O
found,O
to,O
be,O
very,O
potent,O
as,O
only,O
4,O
mM,O
was,O
needed,O
for,O
a,O
complete,O
inhibition,O
",",O
whereas,O
20,O
mM,O
was,O
required,O
for,O
N,B
-,I
acetylcysteine,I
.,O
REV,O
LTRs,O
work,O
efficiently,O
in,O
human,B
lymphoid,I
cells,I
",",O
and,O
are,O
viable,O
alternatives,O
to,O
promoters,O
commonly,O
used,O
for,O
expression,O
of,O
cloned,O
genes,O
.,O
Human,B
immunodeficiency,I
virus,I
type,I
1,I
(,O
HIV,B
-,I
1,I
),O
and,O
HIV,B
-,I
2,I
are,O
structurally,O
related,O
retroviruses,O
which,O
both,O
cause,O
AIDS,O
in,O
humans,O
.,O
Although,O
both,O
viruses,O
establish,O
latency,O
in,O
quiescent,O
human,B
-,I
peripheral,I
-,I
blood,I
T,I
cells,I
",",O
the,O
asymptomatic,O
phase,O
of,O
HIV,B
-,I
2,I
infection,O
may,O
be,O
more,O
prolonged,O
than,O
that,O
of,O
HIV,B
-,I
1,I
.,O
The,O
latent,O
phases,O
of,O
both,O
HIV,B
-,I
1,I
and,O
HIV,B
-,I
2,I
infection,O
have,O
been,O
shown,O
to,O
be,O
disrupted,O
by,O
T,B
-,I
cell,I
activation,I
",",O
a,O
process,O
that,O
requires,O
host,O
cell,O
transcription,O
factors,O
.,O
Thus,O
",",O
Elf,O
-,O
1,O
is,O
a,O
novel,O
transcription,O
factor,O
that,O
appears,O
to,O
be,O
required,O
for,O
the,O
T,B
-,I
cell,I
-,I
receptor,I
-,I
mediated,I
trans,I
activation,I
of,O
HIV,B
-,I
2,I
gene,I
expression,I
.,O
These,O
results,O
may,O
explain,O
differences,O
in,O
the,O
clinical,O
spectra,O
of,O
diseases,O
caused,O
by,O
HIV,B
-,I
1,I
and,O
HIV,B
-,I
2,I
and,O
may,O
also,O
have,O
implications,O
for,O
the,O
design,O
of,O
therapeutic,O
approaches,O
to,O
HIV,B
-,I
2,I
infection,O
.,O
Okadaic,O
acid,O
is,O
a,O
potent,O
inducer,O
of,O
AP,B
-,I
1,I
",",O
NF,B
-,I
kappa,I
B,I
",",O
and,O
tumor,O
necrosis,O
factor,O
-,O
alpha,O
in,O
human,B
B,I
lymphocytes,I
.,O
Treatment,O
of,O
human,O
B,B
lymphocytes,I
with,O
an,O
optimal,O
concentration,O
of,O
okadaic,O
acid,O
",",O
an,O
inhibitor,O
of,O
phosphatases,O
1,O
and,O
2A,O
",",O
resulted,O
in,O
the,O
induction,O
of,O
the,O
transcription,O
factor,O
",",O
AP,B
-,I
1,I
and,O
a,O
marked,O
increase,O
in,O
NF,B
-,I
kappa,I
B,I
levels,I
.,O
Although,O
okadaic,O
acid,O
provides,O
a,O
potent,O
inductive,O
signal,O
for,O
AP,B
-,I
1,I
and,O
NF,B
-,I
kappa,I
B,I
it,O
did,O
not,O
induce,O
either,O
B,B
cell,I
proliferation,I
or,O
immunoglobulin,B
secretion,I
.,O
c,O
-,O
myc,B
mRNA,I
expression,O
in,O
minor,O
salivary,O
glands,O
of,O
patients,O
with,O
Sjogren,O
',O
s,O
syndrome,O
.,O
These,O
data,O
show,O
that,O
aged,O
subjects,O
have,O
reductions,O
of,O
corticosteroid,O
receptors,O
that,O
are,O
not,O
associated,O
with,O
increase,O
of,O
related,O
steroids,O
and,O
that,O
this,O
situation,O
probably,O
represents,O
a,O
concomitant,O
of,O
the,O
normal,O
aging,O
process,O
.,O
IL,O
-,O
4,O
secreted,O
by,O
activated,O
T,B
cells,I
is,O
a,O
pleiotropic,O
cytokine,O
affecting,O
growth,O
and,O
differentiation,O
of,O
diverse,O
cell,B
types,I
such,O
as,O
T,B
cells,I
",",O
B,B
cells,I
",",O
and,O
mast,B
cells,I
.,O
A,O
novel,O
T,B
cell,I
-,I
specific,I
negative,I
regulatory,I
element,I
(,O
NRE,B
),O
composed,O
of,O
two,O
protein,B
-,I
binding,I
sites,I
were,O
mapped,O
in,O
the,O
5,O
',O
flanking,O
region,O
of,O
the,O
IL,B
-,I
4,I
gene,I
:,O
-,O
311CTCCCTTCT,O
-,O
303,O
(,O
NRE,B
-,I
I,I
),O
and,O
-,O
288CTTTTTGCTT,O
-,O
TGC,O
-,O
300,O
(,O
NRE,B
-,I
II,I
),O
.,O
A,O
T,O
cell,B
-,I
specific,I
protein,I
Neg,B
-,I
1,I
and,O
a,O
ubiquitous,O
protein,B
Neg,I
-,I
2,I
binding,O
to,O
NRE,O
-,O
I,O
and,O
NRE,O
-,O
II,O
",",O
respectively,O
",",O
were,O
identified,O
.,O
The,O
addition,O
of,O
antisense,O
oligonucleotides,O
to,O
c,O
-,O
fos,O
significantly,O
inhibited,O
IL,O
6,O
-,O
induced,O
IgM,O
production,O
by,O
SKW,B
6,I
0.4,I
cells,I
(,O
p,O
less,O
than,O
0,O
0.58,O
1,O
),O
",",O
whereas,O
control,O
oligonucleotides,O
had,O
no,O
inhibitory,O
effect,O
0.69,O
In,O
this,O
article,O
",",O
transcriptional,O
regulation,O
of,O
the,O
archetypal,O
T,B
-,I
cell,I
-,I
specific,I
gene,I
",",O
alpha,O
TCR,B
",",O
is,O
discussed,O
.,O
Sodium,O
dodecyl,O
sulfate,O
-,O
polyacrylamide,O
gel,O
electrophoresis,O
showed,O
significant,O
aldosterone,B
binding,O
at,O
a,O
molecular,O
weight,O
of,O
approximately,O
50000,O
Dalton,O
which,O
was,O
absent,O
with,O
1,O
microM,O
cold,O
aldosterone,B
",",O
but,O
not,O
cortisol,B
in,O
the,O
binding,O
media,O
.,O
We,O
used,O
phenolic,B
",",O
lipid,B
-,I
soluble,I
",",O
chain,B
-,I
breaking,I
antioxidants,I
(,O
butylated,B
hydroxyanisole,I
(,O
BHA,B
),O
",",O
nordihydroquairetic,B
acid,I
",",O
or,O
alpha,B
-,I
tocopherol,I
(,O
vitamin,B
E,I
),O
to,O
show,O
that,O
peroxyl,O
radical,O
scavenging,O
in,O
unstimulated,O
and,O
PMA,O
-,O
or,O
TNF,O
-,O
stimulated,O
cells,O
blocks,O
the,O
functions,O
depending,O
on,O
NF,B
-,I
kappa,I
B,I
activation,I
.,O
Rather,O
",",O
TNF,B
and,O
PMA,B
can,O
exert,O
their,O
effect,O
only,O
if,O
cells,O
are,O
in,O
an,O
appropriate,O
redox,O
status,O
",",O
because,O
prior,O
modification,O
toward,O
reduction,O
with,O
BHA,O
treatment,O
prevents,O
this,O
activation,O
.,O
Selection,O
of,O
optimal,O
kappa,B
B,I
/,I
Rel,I
DNA,I
-,I
binding,I
motifs,I
:,O
interaction,O
of,O
both,O
subunits,O
of,O
NF,B
-,I
kappa,I
B,I
with,O
DNA,B
is,O
required,O
for,O
transcriptional,O
activation,O
.,O
Analysis,O
of,O
the,O
p50,B
and,O
p65,B
subunits,O
of,O
the,O
NF,O
-,O
kappa,O
B,O
transcription,O
factor,O
complex,O
has,O
revealed,O
that,O
both,O
proteins,O
can,O
interact,O
with,O
related,O
DNA,B
sequences,I
through,O
either,O
homo,O
-,O
or,O
heterodimer,O
formation,O
.,O
However,O
",",O
these,O
studies,O
have,O
used,O
a,O
limited,O
number,O
of,O
known,O
kappa,O
B,O
DNA,B
motifs,I
",",O
and,O
the,O
question,O
of,O
the,O
optimal,O
DNA,B
sequences,I
preferred,O
by,O
each,O
homodimer,O
has,O
not,O
been,O
addressed,O
.,O
Using,O
purified,O
recombinant,O
p50,B
",",O
p65,B
",",O
and,O
c,B
-,I
Rel,I
proteins,O
",",O
optimal,O
DNA,B
-,I
binding,I
motifs,I
were,O
selected,O
from,O
a,O
pool,O
of,O
random,O
oligonucleotides,O
.,O
Differential,O
binding,I
affinities,O
were,O
also,O
obtained,O
with,O
p50,B
-,I
and,O
c,B
-,I
Rel,I
-,I
selected,O
sequences,O
.,O
These,O
findings,O
demonstrate,O
that,O
interaction,O
of,O
both,O
subunits,O
of,O
the,O
heterodimeric,O
NF,B
-,I
kappa,I
B,I
complex,I
with,O
DNA,B
is,O
required,O
for,O
DNA,B
binding,I
and,O
transcriptional,O
activation,O
and,O
suggest,O
that,O
transcriptional,O
activation,O
mediated,O
by,O
the,O
individual,O
rel,B
-,I
related,I
proteins,O
will,O
differ,O
dramatically,O
",",O
depending,O
on,O
the,O
specific,O
kappa,B
B,I
motifs,I
present,O
.,O
These,O
observations,O
indicate,O
that,O
during,O
chronic,O
HIV,B
infection,O
of,O
U937,B
cells,O
",",O
continuous,O
NF,B
-,I
kappa,I
B,I
(,O
p50,B
/,I
p65,I
),O
translocation,O
results,O
in,O
p105,B
promoter,I
upregulation,O
with,O
subsequent,O
cytosolic,O
NF,B
-,I
kappa,I
B,I
accumulation,O
",",O
ready,O
for,O
further,O
translocation,O
.,O
Similarly,O
",",O
IL,B
-,I
2,I
activates,O
NF,B
-,I
kappa,I
B,I
in,O
the,O
human,O
monocytic,O
cell,O
line,O
U,B
937,I
",",O
but,O
not,O
in,O
resting,O
human,O
T,B
-,I
cells,I
.,O
Blockade,O
of,O
the,O
DNA,B
-,I
binding,I
complexes,I
with,O
an,O
anti,O
-,O
Fos,B
mAb,I
demonstrated,O
a,O
direct,O
participation,O
of,O
c,O
-,O
Fos,B
in,O
the,O
AP,O
-,O
1,O
complexes,I
induced,O
by,O
anti,O
-,O
AIM,O
mAb,I
.,O
These,O
data,O
provide,O
the,O
evidence,O
that,O
activation,O
of,O
human,O
peripheral,O
blood,O
T,O
cells,O
through,O
the,O
AIM,O
activation,O
pathway,O
regulate,O
the,O
activity,O
of,O
AP,O
-,O
1,O
.,O
Gangliosides,B
suppress,O
tumor,O
necrosis,O
factor,O
production,O
in,O
human,O
monocytes,O
.,O
Both,O
normal,O
and,O
malignant,O
cells,O
contain,O
gangliosides,B
as,O
important,O
cell,O
membrane,O
constituents,O
that,O
",",O
after,O
being,O
shed,O
",",O
may,O
influence,O
cells,O
of,O
the,O
immune,O
system,O
.,O
Although,O
under,O
standard,O
culture,O
conditions,O
",",O
bovine,O
brain,O
gangliosides,B
(,O
100,O
micrograms,O
/,O
ml,O
),O
suppressed,O
LPS,O
-,O
stimulated,O
TNF,O
production,O
5,O
-,O
fold,O
in,O
PBMC,O
and,O
10,O
-,O
fold,O
in,O
Mono,O
Mac,O
6,O
cells,O
",",O
suppression,O
was,O
more,O
efficient,O
under,O
serum,O
-,O
free,O
conditions,O
.,O
The,O
suppressive,O
activity,O
was,O
lost,O
in,O
molecules,O
",",O
lacking,O
the,O
sugar,B
moiety,I
or,O
the,O
lipid,B
moiety,I
.,O
On,O
the,O
other,O
hand,O
",",O
phorbol,O
ester,O
-,O
induced,O
production,O
of,O
O2,B
-,I
was,O
similar,O
in,O
cells,O
treated,O
with,O
and,O
without,O
gangliosides,B
.,O
Taken,O
together,O
",",O
our,O
data,O
demonstrate,O
that,O
TNF,B
gene,I
expression,I
in,O
monocytes,O
induced,O
by,O
different,O
types,O
of,O
stimuli,O
can,O
be,O
blocked,O
by,O
gangliosides,B
at,O
an,O
early,O
step,O
of,O
signal,O
transduction,O
.,O
Immunoglobulin,B
molecules,I
on,O
the,O
surface,O
of,O
a,O
B,B
lymphocyte,I
are,O
the,O
endogenous,O
`,O
`,O
receptors,O
',O
',O
to,O
which,O
specific,O
antigens,O
bind,O
.,O
Because,O
of,O
the,O
efficient,O
binding,O
of,O
TG,B
by,O
surrogate,O
receptors,O
on,O
non,O
-,O
T,B
cells,I
",",O
we,O
assessed,O
the,O
ability,O
of,O
such,O
cells,O
to,O
present,O
TG,B
to,O
T,B
cells,I
.,O
Proliferation,O
in,O
response,O
to,O
TG,B
was,O
observed,O
in,O
T,B
cells,I
from,O
only,O
1,O
of,O
5,O
Hashimoto,O
patients,O
.,O
The,O
transcriptional,O
activity,O
of,O
the,O
heterodimer,O
is,O
regulated,O
by,O
signal,O
-,O
dependent,O
phosphorylation,O
and,O
dephosphorylation,O
events,O
.,O
A,O
PMA,O
responsive,O
element,O
was,O
localized,O
to,O
a,O
region,O
between,O
-,O
95,O
and,O
-,O
36,O
bp,O
relative,O
to,O
the,O
transcription,O
start,O
site,O
.,O
Within,O
this,O
region,O
",",O
single,O
AP,O
-,O
2,O
-,O
and,O
AP,O
-,O
1,O
-,O
like,O
consensus,O
sequences,O
were,O
noted,O
.,O
While,O
all,O
the,O
M10,B
-,I
expressing,I
cell,I
lines,I
remained,O
infectable,O
by,O
HIV,B
-,I
1,I
",",O
these,O
same,O
cells,O
failed,O
to,O
support,O
a,O
productive,O
replication,O
cycle,O
when,O
infected,O
with,O
a,O
cloned,O
isolate,O
of,O
HIV,B
-,I
1,I
.,O
Expression,O
of,O
M10,B
did,O
not,O
affect,O
induction,O
of,O
HIV,B
transcription,O
mediated,O
by,O
the,O
kappa,O
B,O
regulatory,O
element,O
or,O
Tat,O
.,O
The,O
inhibition,O
of,O
HIV,B
infection,O
in,O
cells,O
stably,O
expressing,O
a,O
transdominant,O
Rev,B
protein,I
",",O
in,O
the,O
absence,O
of,O
any,O
deleterious,O
effect,O
on,O
T,B
cell,I
function,I
",",O
suggests,O
that,O
such,O
a,O
strategy,O
could,O
provide,O
a,O
therapeutic,O
effect,O
in,O
the,O
T,B
lymphocytes,I
of,O
acquired,O
immunodeficiency,O
syndrome,O
patients,O
.,O
The,O
present,O
work,O
has,O
examined,O
the,O
effects,O
of,O
okadaic,O
acid,O
",",O
an,O
inhibitor,O
of,O
type,O
1,O
and,O
2A,O
protein,B
phosphatases,I
",",O
on,O
the,O
regulation,O
of,O
c,O
-,O
jun,O
expression,O
during,O
monocytic,O
differentiation,O
of,O
U,O
-,O
937,O
leukemia,O
cells,O
.,O
(,O
ABSTRACT,O
TRUNCATED,O
AT,O
250,O
WORDS,O
),O
Mitogen,O
stimulation,O
of,O
T,O
-,O
cells,O
increases,O
c,O
-,O
Fos,B
and,O
c,O
-,O
Jun,B
protein,I
levels,I
",",O
AP,O
-,O
1,O
binding,O
and,O
AP,O
-,O
1,O
transcriptional,O
activity,O
.,O
Both,O
c,O
-,O
Fos,B
and,O
c,O
-,O
Jun,B
protein,I
levels,I
were,O
increased,O
after,O
Con,O
A,O
and,O
PHA,O
stimulation,O
.,O
The,O
kinetics,O
of,O
expression,O
of,O
the,O
two,O
genes,O
were,O
also,O
slightly,O
different,O
",",O
with,O
c,O
-,O
fos,B
mRNA,I
reaching,O
a,O
peak,O
at,O
15,O
min,O
after,O
stimulation,O
and,O
c,O
-,O
jun,B
at,O
30,O
min,O
.,O
Nuclear,O
transcription,O
studies,O
in,O
vitro,O
showed,O
that,O
LTB4,B
increased,O
the,O
transcription,O
of,O
the,O
c,B
-,I
fos,I
gene,I
7,O
-,O
fold,O
and,O
the,O
c,B
-,I
jun,I
gene,I
1,O
.,O
Modulation,O
of,O
normal,O
erythroid,B
differentiation,I
by,O
the,O
endogenous,O
thyroid,B
hormone,I
and,O
retinoic,B
acid,I
receptors,I
:,O
a,O
possible,O
target,O
for,O
v,O
-,O
erbA,B
oncogene,I
action,O
.,O
Thyroid,B
hormone,I
(,O
T3,B
),O
alone,O
caused,O
similar,O
but,O
weaker,O
effects,O
.,O
Two,O
types,O
of,O
helper,O
T,B
cell,I
(,O
Th,B
1,I
and,O
Th2,B
),O
clones,O
(,O
Th1,B
and,O
Th2,B
),O
are,O
defined,O
on,O
the,O
basis,O
of,O
different,O
patterns,O
of,O
cytokine,B
(,O
lymphokine,I
),O
secretion,O
.,O
Yet,O
phorbol,O
ester,O
alone,O
or,O
calcium,O
ionophore,O
alone,O
produce,O
several,O
lymphokines,B
.,O
GM2,B
defines,O
a,O
binding,O
site,O
for,O
protein,B
(,O
s,O
),O
whose,O
binding,O
is,O
inducible,O
by,O
PMA,O
.,O
Mutations,O
in,O
the,O
Pit,B
-,I
1,I
gene,O
in,O
children,O
with,O
combined,O
pituitary,O
hormone,O
deficiency,O
.,O
Pit,B
-,I
1,I
is,O
a,O
pituitary,O
-,O
specific,O
transcription,O
factor,O
that,O
binds,O
to,O
and,O
transactivates,O
promoters,O
of,O
growth,O
hormone,O
and,O
prolactin,O
genes,O
.,O
Activation,O
of,O
protein,B
kinase,I
C,I
and,O
elevation,O
of,O
cAMP,O
interact,O
synergistically,O
to,O
raise,O
c,O
-,O
Fos,B
and,O
AP,B
-,I
1,I
activity,O
in,O
Jurkat,B
cells,I
.,O
We,O
have,O
earlier,O
found,O
that,O
in,O
Jurkat,B
cells,O
activation,O
of,O
protein,B
kinase,I
C,I
(,O
PKC,B
),O
enhances,O
the,O
cyclic,O
adenosine,B
monophosphate,I
(,O
cAMP,B
),O
accumulation,O
induced,O
by,O
adenosine,B
receptor,I
stimulation,O
or,O
activation,O
of,O
Gs,B
.,O
The,O
former,O
two,O
substances,O
interact,O
with,O
T,B
cells,O
via,O
the,O
glucocorticoid,B
and,O
beta,B
-,I
adrenergic,I
receptors,I
respectively,O
.,O
When,O
occupied,O
by,O
their,O
natural,O
ligands,O
",",O
glucocorticosteroids,B
and,O
catecholamines,B
",",O
these,O
receptors,O
have,O
a,O
role,O
in,O
modulating,O
T,B
-,I
cell,I
function,O
during,O
stress,O
.,O
3,O
.,O
Synergistic,O
suppression,O
of,O
T,B
-,I
cell,I
proliferation,O
was,O
observed,O
when,O
various,O
concentrations,O
of,O
DEX,B
and,O
PGE2,B
",",O
but,O
not,O
DEX,B
and,O
ISO,O
",",O
were,O
added,O
to,O
cultures,O
.,O
In,O
vivo,O
footprint,O
analysis,O
of,O
the,O
HLA,B
-,I
DRA,I
gene,I
promoter,I
:,O
cell,O
-,O
specific,O
interaction,O
at,O
the,O
octamer,O
site,O
and,O
up,O
-,O
regulation,O
of,O
X,B
box,I
binding,I
by,O
interferon,O
gamma,O
.,O
Danazol,O
bound,O
to,O
these,O
sites,O
in,O
high,O
concentration,O
(,O
10,O
(,O
-,O
6,O
),O
M,O
",",O
clinical,O
serum,O
concentration,O
during,O
danazol,O
therapy,O
),O
and,O
decreased,O
the,O
number,O
of,O
both,O
sites,O
.,O
Therefore,O
",",O
we,O
describe,O
a,O
microtitre,O
assay,O
system,O
for,O
glucocorticoid,B
receptors,I
which,O
is,O
a,O
whole,O
-,O
cell,O
competitive,O
binding,O
radioassay,O
using,O
[,O
3H,O
].,O
-,O
dexamethasone,O
as,O
radioligand,O
.,O
Thus,O
enabled,O
to,O
perform,O
the,O
test,O
on,O
multiple,O
blood,O
samples,O
in,O
parallel,O
",",O
we,O
investigated,O
cardiac,B
infarction,I
patients,I
over,O
a,O
12,O
-,O
day,O
period,O
to,O
test,O
if,O
glucocorticoid,B
receptor,I
binding,I
is,O
altered,O
in,O
this,O
',O
stressful,O
',O
disease,O
.,O
On,O
the,O
first,O
day,O
of,O
the,O
disease,O
",",O
glucocorticoid,B
receptor,I
capacity,I
was,O
significantly,O
decreased,O
without,O
alteration,O
of,O
the,O
receptor,B
-,I
ligand,I
affinity,I
",",O
whereas,O
on,O
days,O
4,O
and,O
12,O
the,O
number,O
of,O
receptor,B
sites,I
was,O
normal,O
again,O
.,O
CsA,O
was,O
found,O
not,O
to,O
inhibit,O
lck,B
gene,I
expression,I
",",O
nor,O
the,O
activity,O
of,O
the,O
lck,B
gene,I
product,I
.,O
The,O
IL,B
-,I
2,I
promoter,I
contains,O
binding,O
sites,O
for,O
nuclear,O
factors,O
including,O
NFAT,B
-,I
1,I
",",O
Oct,B
",",O
NF,B
-,I
kappa,I
B,I
",",O
and,O
AP,B
-,I
1,I
",",O
which,O
are,O
all,O
potentially,O
sensitive,O
to,O
activation,O
of,O
PKC,O
.,O
Our,O
results,O
indicate,O
that,O
the,O
AP,B
-,I
1,I
site,I
at,O
-,O
150,O
bp,O
represents,O
a,O
major,O
",",O
if,O
not,O
the,O
only,O
",",O
site,O
of,O
PKC,O
responsiveness,O
in,O
the,O
IL,B
-,I
2,I
promoter,I
.,O
Mice,O
transgenic,O
for,O
the,O
human,O
T,B
cell,I
leukemia,I
virus,I
(,O
HTLV,B
-,I
I,I
),O
Tax,O
gene,O
develop,O
fibroblastic,O
tumors,O
that,O
express,O
NF,B
-,I
kappa,I
B,I
-,I
inducible,I
early,I
genes,I
.,O
Mice,O
treated,O
with,O
antisense,O
to,O
NF,B
-,I
kappa,I
B,I
ODNs,I
showed,O
rapid,O
regression,O
of,O
transplanted,O
fibrosarcomas,O
.,O
Binding,O
of,O
125I,O
-,O
labeled,O
aldosterone,O
to,O
plasma,O
membranes,O
of,O
HML,O
shares,O
important,O
features,O
with,O
these,O
functional,B
data,I
.,O
Leukotriene,B
B4,I
transcriptionally,O
activates,O
interleukin,B
-,I
6,I
expression,O
involving,O
NK,B
-,I
chi,I
B,I
and,O
NF,B
-,I
IL6,I
.,O
It,O
is,O
",",O
however,O
",",O
still,O
unclear,O
whether,O
LTB4,O
acts,O
in,O
this,O
regard,O
directly,O
or,O
indirectly,O
by,O
stimulating,O
the,O
release,O
of,O
chemotactic,O
and,O
inflammatory,O
cytokines,O
.,O
We,O
furthermore,O
demonstrate,O
that,O
this,O
process,O
involves,O
activation,O
of,O
the,O
transcription,O
factor,O
NF,B
-,I
chi,I
B,I
and,O
",",O
to,O
a,O
lesser,O
extent,O
",",O
of,O
NF,B
-,I
IL6,I
",",O
while,O
the,O
activity,O
of,O
the,O
transcription,O
factor,O
AP,B
-,I
1,I
",",O
shown,O
to,O
otherwise,O
confer,O
IL,O
-,O
6,I
inducibility,O
",",O
appeared,O
to,O
be,O
unaffected,O
by,O
LTB4,O
.,O
The,O
signaling,O
events,O
mediating,O
this,O
effect,O
appeared,O
to,O
involve,O
the,O
release,O
of,O
H2O2,B
",",O
since,O
LTB4,O
failed,O
to,O
induce,O
NF,B
-,I
chi,I
B,I
or,O
NF,B
-,I
IL6,I
in,O
the,O
presence,O
of,O
the,O
scavenger,O
of,O
H2O2,B
",",O
N,B
-,I
acetyl,I
-,I
L,I
-,I
cysteine,I
.,O
The,O
insertion,O
was,O
not,O
required,O
for,O
Fc,B
gamma,I
RII,I
to,O
modulate,O
surface,O
immunoglobulin,B
-,I
triggered,I
B,I
-,I
cell,I
activation,I
.,O
[,O
Age,O
-,O
related,O
changes,O
in,O
glucocorticoid,B
and,O
mineralocorticoid,B
receptors,I
in,O
lymphocytes,B
of,O
healthy,O
persons,O
and,O
patients,O
with,O
hypertension,O
],O
Still,O
a,O
more,O
essential,O
rise,O
in,O
the,O
number,O
of,O
receptors,I
is,O
observed,O
in,O
mid,O
-,O
age,O
hypertensive,O
patients,O
than,O
in,O
elderly,O
ones,O
.,O
Here,O
",",O
Stuart,O
Schreiber,O
and,O
Gerald,O
Crabtree,O
review,O
recent,O
findings,O
that,O
indicate,O
CsA,O
and,O
FK506,O
operate,O
as,O
prodrugs,O
:,O
they,O
bind,O
endogenous,O
intracellular,O
receptors,I
",",O
the,O
immunophilins,B
",",O
and,O
the,O
resulting,O
complex,O
targets,O
the,O
protein,B
phosphatase,I
",",O
calcineurin,B
",",O
to,O
exert,O
the,O
immunosuppressive,O
effect,O
.,O
PLB,O
-,O
985,O
cells,O
represent,O
a,O
bipotential,O
myelomonoblastic,O
cell,O
population,O
capable,O
of,O
either,O
granulocytic,O
or,O
monocytic,O
differentiation,O
after,O
induction,O
with,O
appropriate,O
inducers,O
.,O
Mutations,O
affecting,O
the,O
5,O
',O
guanine,B
residues,I
of,O
the,O
kappa,B
B,I
site,I
were,O
unable,O
to,O
compete,O
for,O
these,O
NF,B
-,I
kappa,I
B,I
-,I
related,I
proteins,I
.,O
Inducibility,O
of,O
endogenous,O
IFN,B
-,I
beta,I
and,O
IFN,B
-,I
alpha,I
RNA,I
was,O
also,O
increased,O
in,O
PLB,B
-,I
IIIB,I
cells,I
.,O
In,O
the,O
present,O
study,O
we,O
report,O
on,O
6,O
patients,O
(,O
2,O
males,O
and,O
4,O
females,O
),O
with,O
the,O
syndrome,O
.,O
First,O
is,O
an,O
expansion,O
phase,O
prior,O
to,O
TCR,B
rearrangement,I
",",O
which,O
appears,O
to,O
be,O
correlated,O
with,O
programming,O
of,O
at,O
least,O
some,O
response,O
genes,O
for,O
inducibility,O
.,O
However,O
",",O
the,O
profound,O
T,B
cell,I
deficit,I
of,I
nude,I
mice,I
indicates,O
that,O
the,O
thymus,B
is,O
by,O
far,O
the,O
most,O
potent,O
site,O
for,O
inducing,O
the,O
expansion,O
per,O
se,O
",",O
even,O
if,O
other,O
sites,O
can,O
induce,O
some,O
response,O
acquisition,O
.,O
Second,O
is,O
a,O
controlled,O
phase,O
of,O
TCR,B
gene,I
rearrangement,I
.,O
It,O
seems,O
that,O
the,O
rearrangement,O
of,O
the,O
TCR,B
gamma,I
loci,I
in,O
the,O
gamma,B
delta,I
lineage,I
may,O
not,O
always,O
take,O
place,O
at,O
a,O
developmental,O
stage,O
strictly,O
equivalent,O
to,O
the,O
rearrangement,O
of,O
TCR,B
beta,I
in,O
the,O
alpha,B
beta,I
lineage,I
",",O
and,O
it,O
is,O
not,O
clear,O
just,O
how,O
early,O
the,O
two,O
lineages,O
diverge,O
.,O
The,O
genes,O
that,O
need,O
to,O
be,O
induced,O
for,O
this,O
response,O
are,O
not,O
yet,O
identified,O
",",O
but,O
it,O
is,O
unquestionably,O
a,O
form,O
of,O
activation,O
.,O
In,O
contrast,O
",",O
NF,B
-,I
kappa,I
B,I
p50,I
alone,O
fails,O
to,O
stimulate,O
kappa,O
B,O
-,O
directed,O
transcription,O
",",O
and,O
based,O
on,O
prior,O
in,O
vitro,O
studies,O
",",O
is,O
not,O
directly,O
regulated,O
by,O
I,O
kappa,O
B,O
.,O
Together,O
",",O
these,O
findings,O
suggest,O
that,O
the,O
nuclear,O
localization,O
signal,O
and,O
transactivation,O
domain,O
of,O
NF,B
-,I
kappa,I
B,I
p65,I
constitute,O
a,O
bipartite,O
system,O
that,O
is,O
critically,O
involved,O
in,O
the,O
inhibitory,O
function,O
of,O
I,O
kappa,O
B,O
/,O
MAD,O
-,O
3,O
.,O
This,O
interaction,O
is,O
functional,B
as,O
it,O
leads,O
to,O
retargeting,O
of,O
NF,B
-,I
kappa,I
B,I
p50,I
from,O
the,O
nucleus,O
to,O
the,O
cytoplasm,O
.,O
However,O
",",O
no,O
loss,O
of,O
DNA,B
binding,I
activity,I
is,O
observed,O
",",O
presumably,O
reflecting,O
the,O
unique,O
C,O
-,O
terminal,O
domain,O
that,O
is,O
distinct,O
from,O
that,O
present,O
in,O
NF,B
-,I
kappa,I
B,I
p65,I
.,O
We,O
have,O
biochemically,O
and,O
functionally,O
characterized,O
a,O
new,O
transcription,O
factor,O
",",O
NP,B
-,I
TCII,I
",",O
which,O
is,O
present,O
in,O
nuclei,O
from,O
unstimulated,O
T,B
and,O
B,B
lymphocytes,I
but,O
is,O
not,O
found,O
in,O
nonhematopoietic,O
cells,O
.,O
[,O
Mechanism,O
of,O
action,O
of,O
steroid,B
hormones,I
.,O
I,O
.,O
Estrogens,B
],O
The,O
steroid,B
hormone,I
are,O
very,O
versatile,O
molecules,O
:,O
although,O
they,O
are,O
related,O
among,O
them,O
by,O
their,O
chemical,O
structure,O
",",O
they,O
have,O
very,O
diverse,O
functions,O
and,O
including,O
antagonic,O
.,O
Their,O
action,O
mechanism,O
is,O
not,O
completely,O
cleared,O
.,O
Chloramphenicol,B
acetyl,I
transferase,I
(,O
CAT,B
),O
assays,O
using,O
the,O
HIV,B
-,I
1,I
(,O
-,O
139,O
),O
long,O
terminal,O
repeat,O
-,O
CAT,B
construct,I
showed,O
no,O
PMA,B
induction,O
of,O
CAT,B
activity,O
in,O
these,O
subclones,O
(,O
unlike,O
the,O
parental,O
line,O
and,O
other,O
subclones,O
),O
.,O
Although,O
NF,B
-,I
AT,I
has,O
not,O
been,O
cloned,O
or,O
purified,O
",",O
there,O
is,O
evidence,O
that,O
it,O
is,O
a,O
major,O
target,O
for,O
immunosuppression,O
by,O
cyclosporin,O
A,O
(,O
CsA,O
),O
and,O
FK506,O
(,O
refs,O
2,O
-,O
7,O
),O
.,O
Although,O
it,O
has,O
been,O
previously,O
shown,O
that,O
the,O
IL,B
-,I
6,I
kappa,I
B,I
motif,I
functions,O
as,O
a,O
potent,O
IL,B
-,I
1,I
/,I
tumor,I
necrosis,I
factor,I
-,I
responsive,I
element,I
in,O
nonlymphoid,O
cells,O
",",O
its,O
activity,O
was,O
found,O
to,O
be,O
repressed,O
in,O
lymphoid,O
cells,O
such,O
as,O
a,O
Jurkat,B
T,I
-,I
cell,I
line,I
.,O
Cortisol,B
resistance,I
in,O
acquired,O
immunodeficiency,O
syndrome,O
.,O
An,O
acquired,O
form,O
of,O
peripheral,O
resistance,O
to,O
glucocorticoids,O
was,O
suspected,O
.,O
[,O
3H,O
],O
Thymidine,O
incorporation,O
was,O
decreased,O
dose,O
-,O
dependently,O
by,O
dexamethasone,O
in,O
controls,O
and,O
patients,O
;,O
the,O
effect,O
was,O
significantly,O
blunted,O
(,O
P,O
less,O
than,O
0,O
.,O
5,O
),O
in,O
group,O
1,O
patients,O
",",O
which,O
suggests,O
that,O
activation,O
of,O
glucocorticoid,B
receptor,I
is,O
impaired,O
as,O
a,O
result,O
of,O
the,O
glucocorticoid,B
receptor,I
abnormality,O
.,O
After,O
the,O
DNA,B
fragment,I
containing,O
the,O
CAG,O
repeats,O
is,O
amplified,O
by,O
the,O
polymerase,O
chain,O
reaction,O
",",O
a,O
primer,O
extension,O
is,O
carried,O
out,O
;,O
the,O
extension,O
of,O
the,O
end,O
-,O
labelled,O
reverse,O
primer,O
adjacent,O
to,O
3,O
',O
end,O
of,O
CAG,O
repeats,O
stops,O
at,O
the,O
first,O
T,O
after,O
CAG,O
repeats,O
with,O
the,O
incorporation,O
of,O
dideoxy,O
ATP,O
in,O
the,O
reaction,O
mixture,O
.,O
Cells,O
of,O
monocyte,B
lineage,I
serve,O
as,O
effector,O
cells,O
in,O
the,O
cellular,O
immune,O
response,O
.,O
The,O
response,O
to,O
antigen,O
proceeds,O
at,O
the,O
T,B
helper,I
cell,I
level,I
through,O
two,O
independent,O
forms,O
of,O
cellular,O
collaboration,O
",",O
contact,O
and,O
lymphokine,O
.,O
It,O
is,O
evident,O
that,O
assembly,O
of,O
the,O
surface,O
domain,O
of,O
TF,B
with,O
VIIa,B
to,O
form,O
the,O
binary,O
TF,B
.,O
VIIa,B
complex,I
induces,O
a,O
significant,O
increase,O
in,O
the,O
Kcat,B
of,O
the,O
catalytic,O
domain,O
of,O
VIIa,B
for,O
small,O
peptidyl,O
substrates,O
and,O
more,O
profoundly,O
for,O
protein,B
substrate,I
.,O
It,O
is,O
also,O
evident,O
that,O
association,O
of,O
X,O
with,O
charged,O
phospholipid,O
surfaces,O
enhances,O
the,O
proteolytic,O
activation,O
of,O
this,O
zymogen,O
by,O
increasing,O
recognition,O
and,O
susceptibility,O
of,O
the,O
sessile,O
peptide,O
bond,O
deduced,O
from,O
the,O
markedly,O
decreased,O
Km,B
and,O
increased,O
Kcat,B
.,O
NF,B
kappa,I
B,I
is,O
a,O
potent,O
mediator,O
of,O
specific,O
gene,O
expression,O
in,O
human,B
monocytes,I
and,O
has,O
been,O
shown,O
to,O
play,O
a,O
role,O
in,O
transcription,O
of,O
the,O
HIV,B
-,I
1,I
genome,I
in,O
promonocytic,O
leukemias,O
.,O
There,O
is,O
little,O
information,O
available,O
on,O
the,O
response,O
of,O
NF,B
kappa,I
B,I
to,O
cytokines,O
in,O
normal,O
human,B
monocytes,I
.,O
In,O
THP,B
-,I
1,I
cells,I
",",O
TPA,O
also,O
induced,O
a,O
new,O
",",O
faster,O
-,O
migrating,O
NF,B
kappa,I
B,I
species,I
not,O
induced,O
in,O
monocytes,O
.,O
The,O
endothelium,B
plays,O
a,O
critical,O
role,O
in,O
inflammation,O
by,O
directing,O
circulating,O
leukocytes,B
into,O
extravascular,O
tissues,O
by,O
expressing,O
adhesive,O
molecules,O
for,O
leukocytes,B
[,O
e,O
.,O
g,O
.,O
",",O
endothelial,B
-,I
leukocyte,I
adhesion,I
molecule,I
1,I
(,I
ELAM,I
-,I
1,I
),I
and,O
intercellular,B
adhesion,I
molecule,I
1,I
(,I
ICAM,I
-,I
1,I
),I
].,O
In,O
contrast,O
",",O
sodium,O
salicylate,O
(,O
1,O
mM,O
),O
inhibited,O
neither,O
adhesion,O
nor,O
expression,O
of,O
these,O
adhesion,O
molecules,O
.,O
These,O
studies,O
suggest,O
that,O
antagonism,O
by,O
dexamethasone,B
of,O
endotoxin,O
-,O
induced,O
inflammation,O
is,O
a,O
specific,O
instance,O
of,O
the,O
general,O
biological,O
principle,O
that,O
the,O
glucocorticoid,B
receptor,I
is,O
a,O
hormone,O
-,O
dependent,O
regulator,O
of,O
transcription,O
.,O
Biochemical,O
purification,O
and,O
cDNA,B
cloning,O
has,O
now,O
revealed,O
that,O
BSAP,B
belongs,O
to,O
the,O
family,O
of,O
paired,O
domain,O
proteins,O
.,O
BSAP,B
is,O
encoded,O
by,O
the,O
Pax,B
-,I
5,I
gene,I
and,O
has,O
been,O
highly,O
conserved,B
between,O
human,O
and,O
mouse,O
.,O
Later,O
",",O
the,O
expression,O
of,O
the,O
BSAP,B
gene,I
shifts,O
to,O
the,O
fetal,O
liver,O
where,O
it,O
correlates,O
with,O
the,O
onset,O
of,O
B,B
lymphopoiesis,I
.,O
Specific,O
NF,B
-,I
kappa,I
B,I
subunits,I
act,O
in,O
concert,O
with,O
Tat,O
to,O
stimulate,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
transcription,O
.,O
NF,B
-,I
kappa,I
B,I
is,O
a,O
protein,B
complex,I
which,O
functions,O
in,O
concert,O
with,O
the,O
tat,O
-,O
I,O
gene,O
product,O
to,O
stimulate,O
human,O
immunodeficiency,O
virus,O
(,O
HIV,B
),O
transcription,O
.,O
We,O
have,O
found,O
that,O
the,O
p49,B
(,O
100,O
),O
DNA,B
binding,I
subunit,I
",",O
together,O
with,O
p65,B
",",O
can,O
act,O
in,O
concert,O
with,O
Tat,O
-,O
I,O
to,O
stimulate,O
the,O
expression,O
of,O
HIV,B
-,O
CAT,O
plasmid,O
.,O
Little,O
effect,O
was,O
observed,O
with,O
50,O
-,O
kDa,O
forms,O
of,O
p105,B
NF,I
-,I
kappa,I
B,I
or,O
rel,B
",",O
in,O
combination,O
with,O
p65,B
or,O
full,O
-,O
length,O
c,O
-,O
rel,B
",",O
which,O
do,O
not,O
stimulate,O
the,O
HIV,B
enhancer,I
in,O
these,O
cells,O
.,O
Stable,O
expression,O
of,O
HB24,B
",",O
a,O
diverged,O
human,O
homeobox,O
gene,O
",",O
in,O
T,B
lymphocytes,I
induces,O
genes,O
involved,O
in,O
T,B
cell,I
activation,I
and,O
growth,O
.,O
In,O
the,O
studies,O
described,O
in,O
this,O
report,O
",",O
we,O
have,O
identified,O
two,O
potential,O
Ets,B
binding,I
sites,I
",",O
EBS1,B
and,O
EBS2,B
",",O
which,O
are,O
conserved,O
in,O
both,O
the,O
human,B
and,O
murine,B
interleukin,B
-,I
2,I
enhancers,I
.,O
Possible,O
mechanisms,O
by,O
which,O
these,O
proteins,O
may,O
regulate,O
transcription,O
of,O
the,O
epsilon,B
-,I
globin,I
-,I
encoding,I
gene,I
in,O
erythroid,B
and,O
non,B
-,I
erythroid,I
cells,I
are,O
discussed,O
.,O
A,O
MEDLINE,O
search,O
of,O
the,O
English,O
-,O
language,O
literature,O
was,O
conducted,O
using,O
the,O
indexing,O
terms,O
',O
immunology,O
",",O
calcitriol,B
and,O
vitamin,O
D,O
',O
to,O
identify,O
studies,O
indicating,O
a,O
role,O
for,O
calcitriol,B
as,O
a,O
primary,O
immunomodulator,O
.,O
This,O
protein,B
is,O
distinct,O
from,O
other,O
members,O
of,O
the,O
steroid,B
/,I
thyroid,I
hormone,I
receptor,I
family,I
including,O
the,O
COUP,B
protein,O
which,O
has,O
a,O
closely,O
related,O
DNA,B
binding,I
specificity,I
.,O
A,O
Tat,B
-,I
responsive,I
element,I
is,O
found,O
upstream,O
within,O
the,O
viral,O
promoter,I
that,O
in,O
glial,B
-,I
derived,I
cell,I
lines,I
allows,O
transactivation,O
in,O
the,O
absence,O
of,O
TAR,B
.,O
Further,O
",",O
we,O
observe,O
that,O
TAR,B
-,I
deleted,I
mutants,I
of,O
HIV,B
-,I
1,I
demonstrate,O
normal,O
late,O
gene,O
expression,O
in,O
glial,B
cells,I
as,O
evidenced,O
by,O
syncytia,O
formation,O
and,O
production,O
of,O
viral,O
p24,B
antigen,I
.,O
At,O
least,O
two,O
21,O
bp,O
repeats,O
were,O
required,O
for,O
high,O
levels,O
of,O
AP,B
-,I
2,I
activation,O
and,O
mutagenesis,O
of,O
the,O
AP,B
-,I
2,I
consensus,O
binding,O
sequences,O
in,O
the,O
21,O
bp,O
repeats,O
eliminate,O
this,O
activation,O
0.34,O
Activation,O
of,O
the,O
human,B
immunodeficiency,I
virus,I
type,I
1,I
enhancer,I
is,O
not,O
dependent,O
on,O
NFAT,B
-,I
1,I
0.51,O
Activation,O
by,O
the,O
T,B
-,I
cell,I
antigen,I
receptor,I
is,O
minimal,O
in,O
Jurkat,B
cells,I
and,O
is,O
mediated,O
by,O
the,O
kappa,B
B,I
sites,I
0.73,O
The,O
promoter,O
of,O
the,O
major,O
histocompatibility,O
class,O
II,O
gene,O
DRA,B
contains,O
an,O
octamer,O
element,O
(,O
ATTTGCAT,O
),O
that,O
is,O
required,O
for,O
efficient,O
DRA,B
expression,O
in,O
B,O
cells,O
.,O
In,O
vitro,O
transcription,O
analysis,O
using,O
protein,B
fractions,I
enriched,O
for,O
the,O
octamer,O
-,O
binding,O
protein,O
OTF,B
-,I
2,I
demonstrate,O
a,O
positive,O
functional,B
role,I
for,I
OTF,I
-,I
2,I
in,O
DRA,B
gene,I
transcription,I
.,O
Recombinant,O
OTF,B
-,I
2,I
protein,I
produced,O
by,O
in,O
vitro,O
transcription,O
/,O
translation,O
could,O
also,O
enhance,O
DRA,B
gene,I
transcription,I
in,O
vitro,O
.,O
However,O
",",O
the,O
increase,O
in,O
ISGF3,B
activity,I
ultimately,O
correlates,O
with,O
the,O
accumulation,O
of,O
ISGF3,B
gamma,I
induced,O
by,O
IFN,O
-,O
alpha,O
or,O
IFN,O
-,O
gamma,O
.,O
(,O
ABSTRACT,O
TRUNCATED,O
AT,O
250,O
WORDS,O
),O
An,O
attempt,O
was,O
also,O
undertaken,O
to,O
use,O
a,O
cell,B
harvester,I
for,O
the,O
separation,O
of,O
cells,B
from,O
unbound,O
ligand,O
.,O
Glucocorticoid,B
receptor,I
and,O
inhibition,O
of,O
3,O
-,O
O,O
-,O
methyl,O
-,O
D,O
-,O
glucose,O
uptake,O
by,O
glucocorticoids,B
in,O
peripheral,O
blood,O
leukocytes,O
from,O
normal,O
humans,O
:,O
correlation,O
between,O
receptor,B
level,I
and,O
hormone,O
effect,O
in,O
vitro,O
.,O
It,O
was,O
found,O
that,O
lipopolysaccharide,O
induced,O
strongly,O
both,O
c,O
-,O
fos,O
and,O
c,O
-,O
jun,O
expression,O
as,O
well,O
as,O
AP1,O
formation,O
.,O
Regulation,O
of,O
interleukin,B
-,I
1,I
beta,I
production,O
by,O
glucocorticoids,B
in,O
human,B
monocytes,I
:,O
the,O
mechanism,O
of,O
action,O
depends,O
on,O
the,O
activation,O
signal,O
.,O
Nuclear,O
transcription,O
factors,O
that,O
bind,O
to,O
elements,O
of,O
the,O
IL,B
-,I
2,I
promoter,I
.,O
However,O
",",O
the,O
signaling,O
requirements,O
and,O
sensitivity,O
to,O
protein,B
synthesis,I
inhibitors,I
differ,O
considerably,O
.,O
In,O
addition,O
",",O
p65,B
gave,O
per,O
se,O
",",O
with,O
low,O
affinity,O
",",O
a,O
protein,B
-,I
DNA,I
complex,I
that,O
migrated,O
more,O
slowly,O
than,O
native,O
NF,B
-,I
GM2,I
complex,I
.,O
Furthermore,O
",",O
an,O
antiserum,O
against,O
KBF1,O
(,O
identical,O
to,O
50,O
kDa,O
NF,B
-,I
kappa,I
B,I
protein,I
),O
reacted,O
with,O
the,O
p50,O
of,O
NF,B
-,I
GM2,I
",",O
indicating,O
that,O
the,O
NF,B
-,I
GM2,I
polypeptide,I
can,O
not,O
be,O
immunologically,O
differentiated,O
from,O
the,O
50,O
kDa,O
subunit,O
of,O
NF,B
-,I
kappa,I
B,I
.,O
This,O
suggests,O
that,O
the,O
activation,O
mechanism,O
of,O
the,O
GM,B
-,I
CSF,I
gene,I
through,O
the,O
GM2,B
/,I
GC,I
-,I
box,I
sequence,I
is,O
different,O
from,O
that,O
of,O
genes,O
carrying,O
the,O
kappa,B
B,I
enhancer,I
alone,O
.,O
Characterization,O
of,O
an,O
immediate,O
-,O
early,O
gene,O
induced,O
in,O
adherent,O
monocytes,O
that,O
encodes,O
I,B
kappa,I
B,I
-,I
like,I
activity,I
.,O
The,O
C,B
-,I
terminus,I
has,O
a,O
putative,O
protein,B
kinase,I
C,I
phosphorylation,I
site,I
.,O
In,O
both,O
wild,O
-,O
type,O
and,O
highly,O
dexamethasone,B
(,O
dex,I
),O
-,O
resistant,O
clones,O
of,O
the,O
human,O
leukemic,O
cell,B
line,I
CEM,I
",",O
exposure,O
to,O
cortivazol,O
leads,O
to,O
cell,B
death,I
.,O
Permissiveness,O
to,O
replication,O
of,O
human,O
immunodeficiency,O
virus,B
(,O
HIV,I
),O
differs,O
in,O
T,B
lymphocytes,I
and,O
macrophages,B
. ,O
A,O
DNA,B
probe,I
that,O
spanned,O
a,O
domain,O
conserved,B
among,O
the,O
proto,O
-,O
oncogene,O
c,O
-,O
rel,O
",",O
the,O
Drosophila,O
morphogen,O
dorsal,O
",",O
and,O
the,O
p50,B
DNA,I
binding,I
subunit,I
of,I
NF,I
-,I
kappa,I
B,I
was,O
generated,O
from,O
Jurkat,O
T,B
cell,I
complementary,I
DNA,I
with,O
the,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
and,O
degenerate,O
oligonucleotides,O
. ,O
This,O
probe,O
was,O
used,O
to,O
identify,O
a,O
rel,O
-,O
related,O
complementary,B
DNA,I
that,O
hybridized,O
to,O
a,O
2,O
.,O
6,O
-,O
kilobase,O
messenger,O
RNA,B
present,O
in,O
human,O
T,B
and,O
B,B
lymphocytes,I
.,O
In,O
vitro,O
transcription,O
and,O
translation,O
of,O
the,O
complementary,B
DNA,I
resulted,O
in,O
the,O
synthesis,O
of,O
a,O
protein,B
with,O
an,O
apparent,O
molecular,O
size,O
of,O
65,O
kilodaltons,O
(,O
kD,O
),O
.,O
This,O
protein,B
-,I
DNA,I
complex,I
comigrated,O
with,O
the,O
complex,O
obtained,O
with,O
the,O
purified,O
human,O
p65,O
NF,B
-,I
kappa,I
B,I
subunit,I
and,O
binding,O
was,O
inhibited,O
by,O
I,O
kappa,O
B,O
-,O
alpha,B
and,O
-,O
beta,B
proteins,I
.,O
Regulation,O
of,O
M,O
-,O
CSF,B
expression,O
by,O
M,O
-,O
CSF,O
:,O
role,O
of,O
protein,B
kinase,I
C,I
and,O
transcription,O
factor,O
NF,B
kappa,I
B,I
.,O
To,O
date,O
",",O
little,O
is,O
known,O
about,O
the,O
intracellular,O
pathway,O
of,O
M,O
-,O
CSF,O
signal,O
transduction,O
.,O
The,O
pAT,B
133,I
gene,I
is,O
immediately,O
induced,O
",",O
with,O
FOS,O
-,O
like,O
kinetics,O
",",O
in,O
human,B
T,I
cells,I
and,O
in,O
fibroblasts,B
.,O
However,O
",",O
upon,O
transition,O
from,O
a,O
proliferating,O
(,O
G1,O
),O
to,O
a,O
resting,O
state,O
of,O
the,O
cell,B
cycle,I
the,O
three,O
genes,B
were,O
differently,O
regulated,O
.,O
v,O
-,O
erbA,B
overexpression,O
is,O
required,O
to,O
extinguish,O
c,B
-,I
erbA,I
function,O
in,O
erythroid,B
cell,I
differentiation,O
and,O
regulation,O
of,O
the,O
erbA,B
target,I
gene,I
CAII,I
.,O
The,O
v,O
-,O
erbA,B
oncoprotein,I
represents,O
a,O
retrovirus,O
-,O
transduced,O
oncogenic,O
version,O
of,O
the,O
thyroid,B
hormone,I
(,O
T3,B
/,I
T4,I
),O
receptor,O
c,O
-,O
erbA,B
(,O
type,O
alpha,O
),O
.,O
This,O
erbA,B
-,O
binding,O
site,O
confers,O
thyroid,B
hormone,I
responsiveness,O
to,O
a,O
heterologous,O
promoter,O
in,O
transient,O
expression,O
experiments,O
and,O
is,O
a,O
target,O
for,O
efficient,O
down,O
-,O
regulation,O
of,O
CAII,O
transcription,O
by,O
the,O
v,O
-,O
erbA,B
oncoprotein,I
.,O
The,O
CD2,B
T,I
lymphocyte,I
glycoprotein,I
surface,I
molecule,I
mediates,O
both,O
cell,O
to,O
cell,O
adhesion,O
and,O
T,B
cell,I
activation,I
",",O
two,O
processes,O
that,O
are,O
involved,O
in,O
the,O
spread,O
of,O
HIV,B
infection,I
.,O
In,O
this,O
study,O
",",O
we,O
show,O
that,O
micromolar,O
concentrations,O
of,O
H2O2,O
can,O
induce,O
the,O
expression,O
and,O
replication,O
of,O
HIV,B
-,I
1,I
in,O
a,O
human,B
T,I
cell,I
line,I
.,O
The,O
effect,O
is,O
mediated,O
by,O
the,O
NF,B
-,I
kappa,I
B,I
transcription,O
factor,O
which,O
is,O
potently,O
and,O
rapidly,O
activated,O
by,O
an,O
H2O2,O
treatment,O
of,O
cells,O
from,O
its,O
inactive,O
cytoplasmic,O
form,O
.,O
ROI,O
appear,O
to,O
serve,O
as,O
messengers,O
mediating,O
directly,O
or,O
indirectly,O
the,O
release,O
of,O
the,O
inhibitory,O
subunit,O
I,B
kappa,I
B,I
from,O
NF,B
-,I
kappa,I
B,I
.,O
Inhibition,O
of,O
transcription,O
factors,O
belonging,O
to,O
the,O
rel,B
/,I
NF,I
-,I
kappa,I
B,I
family,O
by,O
a,O
transdominant,O
negative,O
mutant,O
.,O
A,O
mutant,O
of,O
KBF1,B
/,I
p50,I
(,O
delta,O
SP,O
),O
",",O
unable,O
to,O
bind,O
to,O
DNA,B
but,O
able,O
to,O
form,O
homo,O
-,O
or,O
heterodimers,O
",",O
has,O
been,O
constructed,O
.,O
One,O
gene,O
of,O
interest,O
is,O
the,O
glycoprotein,B
IIb,I
(,O
GPIIb,B
),O
gene,O
;,O
GPIIb,B
",",O
the,O
alpha,O
subunit,O
of,O
the,O
platelet,O
cytoadhesin,O
GPIIb,I
-,I
IIIa,I
",",O
is,O
produced,O
in,O
megakaryocytes,B
at,O
an,O
early,O
stage,O
of,O
the,O
differentiation,O
",",O
whereas,O
the,O
other,O
subunit,O
of,O
this,O
complex,O
",",O
GPIIIa,B
",",O
is,O
expressed,O
in,O
other,O
cells,O
.,O
No,O
relationship,O
could,O
be,O
established,O
between,O
glucocorticoid,B
receptor,I
binding,O
and,O
antidepressant,O
medication,O
.,O
These,O
data,O
support,O
the,O
view,O
of,O
an,O
impaired,O
ligand,O
-,O
induced,O
plasticity,O
of,O
glucocorticoid,B
receptor,I
regulation,O
rather,O
than,O
the,O
hypothesis,O
of,O
decreased,O
glucocorticoid,B
receptor,I
numbers,O
during,O
depression,O
.,O
The,O
promoters,O
and,O
enhancers,O
of,O
cell,B
type,I
-,I
specific,I
genes,I
are,O
often,O
conserved,O
in,O
evolution,O
",",O
and,O
hence,O
one,O
might,O
expect,O
that,O
a,O
given,O
enhancer,O
has,O
evolved,O
to,O
work,O
best,O
with,O
its,O
own,O
promoter,O
.,O
Towards,O
a,O
molecular,O
understanding,O
of,O
T,B
-,I
cell,I
differentiation,I
.,O
Lymphoid,B
differentiation,I
is,O
one,O
of,O
the,O
best,O
studied,O
examples,O
of,O
mammalian,O
development,O
.,O
Circadian,O
rhythm,O
in,O
glucocorticoid,B
receptor,I
(,O
GR,B
),O
was,O
studied,O
in,O
the,O
rat,O
liver,O
and,O
human,O
peripheral,O
leukocytes,O
.,O
The,O
conversion,O
of,O
the,O
TCEd,O
to,O
a,O
',O
perfect,O
',O
NF,B
-,I
kB,I
binding,I
site,I
leads,O
to,O
a,O
tighter,O
binding,O
of,O
NF,B
-,I
kB,I
to,O
TCEd,O
DNA,B
and,O
",",O
as,O
a,O
functional,B
consequence,I
",",O
to,O
the,O
activity,O
of,O
the,O
',O
converted,O
',O
TCEd,O
motifs,O
in,O
HeLa,O
cells,O
.,O
A,O
region,O
upstream,O
to,O
the,O
first,O
exon,O
",",O
and,O
highly,O
conserved,B
between,O
mouse,O
and,O
man,O
",",O
acts,O
as,O
an,O
erythroid,B
specific,I
enhancer,I
in,O
transient,O
assays,O
",",O
if,O
linked,O
to,O
the,O
GATA,B
-,I
1,O
or,O
to,O
the,O
SV40,B
promoter,I
. More,O
strikingly,O
",",O
the,O
80,O
-,O
kDa,O
protein,B
was,O
downregulated,O
in,O
a,O
dose,O
-,O
dependent,O
fashion,O
by,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
;,O
this,O
effect,O
was,O
independent,O
of,O
the,O
mode,O
of,O
lymphocyte,B
activation,I
and,O
specific,O
for,O
the,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
metabolite,O
of,O
vitamin,O
D3,O
.,O
Prolonged,O
corticosteroid,O
treatment,O
resulted,O
in,O
down,O
-,O
regulation,O
of,O
GcR,B
",",O
while,O
the,O
mean,O
level,O
of,O
GcR,B
in,O
Cushing,O
',O
s,O
disease,O
was,O
normal,O
.,O
Furthermore,O
",",O
GcR,B
were,O
unaltered,O
after,O
these,O
patients,O
received,O
ketoconazole,O
",",O
in,O
spite,O
of,O
a,O
marked,O
reduction,O
in,O
morning,O
plasma,O
cortisol,O
and,O
urinary,O
free,O
cortisol,O
.,O
Human,B
T,I
-,I
cell,I
leukemia,I
virus,I
type,I
1,I
(,O
HTLV,B
-,I
1,I
),O
is,O
an,O
etiological,O
agent,O
of,O
adult,O
T,B
-,I
cell,I
leukemia,I
(,O
ATL,B
),O
.,O
Previously,O
",",O
transcription,O
of,O
the,O
c,B
-,I
fos,I
gene,I
has,O
been,O
reported,O
to,O
be,O
transactivated,O
by,O
the,O
viral,O
transcription,O
factor,O
",",O
Tax1,B
.,O
Glucocorticoid,B
receptor,I
characteristics,I
in,O
monocytes,O
of,O
patients,O
with,O
corticosteroid,B
-,I
resistant,I
bronchial,I
asthma,I
.,O
Vitamin,O
D,B
receptor,I
expression,O
in,O
human,O
lymphocytes,B
.,O
Signal,O
requirements,O
and,O
characterization,O
by,O
western,O
blots,O
and,O
DNA,B
sequencing,O
.,O
However,O
",",O
combination,O
of,O
OKT3,B
and,O
phorbol,O
myristate,O
acetate,O
produced,O
a,O
concentration,O
of,O
binding,O
sites,O
similar,O
to,O
the,O
PHA,B
-,I
activated,I
cells,I
.,O
The,O
receptor,O
from,O
OKT3,B
and,O
OKT3,B
+,I
phorbol,I
myristate,I
acetate,I
-,I
activated,I
lymphocytes,I
exhibited,O
decreased,O
binding,O
to,O
DNA,B
-,I
cellulose,I
compared,O
to,O
PHA,B
-,I
activated,I
lymphocytes,I
.,O
Example,
Text:,
These,O
findings,O
suggest,O
that,O
expression,O
of,O
the,O
1,O
",",O
25,O
-,O
(,O
OH,O
),O
2D3,O
receptor,B
in,O
lymphocytes,B
is,O
triggered,O
by,O
distinct,O
and,O
contingent,O
signals,O
",",O
and,O
that,O
the,O
protein,B
and,O
the,O
mRNA,B
encoding,O
it,O
are,O
identical,O
to,O
the,O
classical,O
vitamin,O
D,O
receptor,B
.,O
The,O
kappa,O
B,O
sequence,O
(,O
GGGACTTTCC,O
),O
binds,O
a,O
factor,O
",",O
NF,O
-,O
kappa,O
B,O
",",O
that,O
is,O
constitutively,O
found,O
in,O
its,O
functional,B
",",I
DNA,B
binding,I
form,I
only,O
in,O
B,O
lymphocytes,B
.,O
However,O
",",O
these,O
genes,O
are,O
not,O
constitutively,O
active,O
in,O
B,B
lymphocytes,I
",",O
suggesting,O
that,O
other,O
regulatory,O
mechanisms,O
must,O
play,O
a,O
role,O
in,O
determining,O
the,O
patterns,O
of,O
expression,O
.,O
We,O
have,O
investigated,O
the,O
constitutive,O
and,O
inducible,O
transcriptional,O
activity,O
mediated,O
by,O
five,O
kappa,B
B,I
-,I
related,I
sequence,I
elements,I
in,O
two,O
different,O
cell,B
types,I
.,O
However,O
",",O
in,O
either,O
EL,B
-,I
4,I
(,O
T,B
),O
cells,O
or,O
S194,B
cells,O
",",O
both,O
lower,O
-,O
affinity,O
sites,O
can,O
be,O
significantly,O
induced,O
by,O
the,O
tax,O
gene,O
product,O
of,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
I,I
",",O
showing,O
that,O
NF,B
-,I
kappa,I
B,I
activity,I
can,O
be,O
modulated,O
even,O
in,O
a,O
B,B
-,I
cell,I
line,I
that,O
constitutively,O
expresses,O
this,O
factor,O
.,O
Previously,O
",",O
a,O
nuclear,O
factor,O
",",O
IRF,B
-,I
1,I
(,O
interferon,B
regulatory,I
factor,I
1,I
),O
",",O
which,O
binds,O
to,O
type,O
I,O
IFN,B
and,O
some,O
IFN,B
-,I
inducible,I
gene,I
promoters,I
",",O
was,O
identified,O
and,O
cloned,O
.,O
A,O
dimerization,O
cofactor,O
of,O
HNF,B
-,I
1,I
alpha,I
(,O
DCoH,B
),O
was,O
identified,O
that,O
displayed,O
a,O
restricted,O
tissue,O
distribution,O
and,O
did,O
not,O
bind,O
to,O
DNA,B
",",O
but,O
",",O
rather,O
",",O
selectively,O
stabilized,O
HNF,B
-,I
1,I
alpha,I
dimers,O
.,O
Previous,O
studies,O
have,O
shown,O
that,O
treatment,O
of,O
human,O
myeloid,B
leukemia,I
cells,I
with,O
12,O
-,O
O,O
-,O
tetradecanoylphorbol,O
-,O
13,O
-,O
acetate,O
(,O
TPA,O
),O
is,O
associated,O
with,O
induction,O
of,O
monocytic,B
differentiation,I
and,O
expression,O
of,O
the,O
c,B
-,I
jun,I
and,O
c,B
-,I
fos,I
early,I
response,I
genes,I
.,O
Although,O
absent,O
in,O
nonexpressing,O
erythroleukemia,B
cell,I
lines,I
",",O
the,O
DNase,B
I,I
site,I
is,O
present,O
in,O
uninduced,O
myelomonocytic,B
cell,I
lines,I
and,O
is,O
not,O
changed,O
after,O
PMA,O
induction,O
.,O
The,O
nuclear,O
extracts,O
from,O
resting,O
and,O
induced,O
ML,B
-,I
1,I
cells,I
contain,O
proteins,B
binding,O
specifically,O
to,O
the,O
AP,B
-,I
1,I
",",O
AP,B
-,I
2,I
",",O
and,O
NF,B
kappa,I
B,I
sequence,O
located,O
within,O
the,O
TNF,B
promoter,I
.,O
Enhancement,O
of,O
human,B
immunodeficiency,I
virus,I
1,I
replication,O
in,O
monocytes,O
by,O
1,O
",",O
25,O
-,O
dihydroxycholecalcif,O
.,O
Human,B
immunodeficiency,I
virus,I
(,O
HIV,B
),O
expression,O
and,O
replication,O
are,O
under,O
tight,O
regulatory,O
control,O
.,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
is,O
therefore,O
one,O
of,O
the,O
most,O
potent,O
regulators,O
of,O
HIV,B
-,O
1,I
replication,O
described,O
to,O
date,O
.,O
Transforming,O
growth,O
factor,O
-,O
beta,O
suppresses,O
human,O
B,B
lymphocyte,I
Ig,I
production,O
by,O
inhibiting,O
synthesis,O
and,O
the,O
switch,O
from,O
the,O
membrane,O
form,O
to,O
the,O
secreted,O
form,O
of,O
Ig,B
mRNA,I
.,O
One,O
of,O
the,O
members,O
of,O
this,O
multigene,O
family,O
",",O
cGATA,O
-,O
3,O
",",O
is,O
most,O
abundantly,O
expressed,O
in,O
the,O
T,B
-,I
lymphocyte,I
cell,I
lineage,I
.,O
The,O
murine,O
and,O
human,O
factors,O
are,O
abundantly,O
expressed,O
in,O
a,O
variety,O
of,O
human,O
and,O
murine,O
T,B
-,I
cell,I
lines,I
and,O
can,O
activate,O
transcription,O
through,O
a,O
tissue,O
-,O
specific,O
GATA,O
-,O
binding,O
site,O
identified,O
within,O
the,O
human,O
T,B
-,I
cell,I
receptor,I
delta,I
gene,I
enhancer,I
.,O
The,O
expression,O
of,O
active,O
NF,B
-,I
kappa,I
B,I
might,O
therefore,O
also,O
be,O
regulated,O
by,O
the,O
extent,O
of,O
processing,O
of,O
p105,O
.,O
Levels,O
of,O
RNA,B
coding,O
for,O
the,O
receptor,O
were,O
not,O
modulated,O
by,O
exposure,O
to,O
high,O
levels,O
of,O
ligand,O
.,O
Expression,O
of,O
c,O
-,O
jun,B
",",O
jun,B
B,I
and,O
jun,B
D,I
proto,I
-,I
oncogenes,I
in,O
human,O
peripheral,O
-,O
blood,O
granulocytes,O
.,O
We,O
have,O
found,O
that,O
purified,O
human,O
peripheral,O
-,O
blood,O
granulocytes,O
express,O
constitutively,O
significant,O
levels,O
of,O
proto,B
-,I
oncogenes,I
c,B
-,I
jun,I
",",O
jun,B
B,I
and,O
jun,B
D,I
mRNA,I
.,O
The,O
29,O
-,O
kDa,O
proteins,O
phosphorylated,O
in,O
thrombin,O
-,O
activated,O
human,O
platelets,O
are,O
forms,O
of,O
the,O
estrogen,B
receptor,I
-,I
related,I
27,O
-,O
kDa,O
heat,O
shock,O
protein,O
.,O
We,O
have,O
isolated,O
a,O
human,B
cDNA,I
clone,I
encoding,O
a,O
zinc,B
finger,I
protein,I
(,O
NF,B
-,I
E1,I
),O
that,O
binds,O
to,O
the,O
negative,O
-,O
acting,O
segment,O
of,O
the,O
kappa,O
E3,O
',O
enhancer,O
.,O
This,O
protein,B
also,O
binds,O
to,O
the,O
immunoglobulin,B
heavy,I
-,I
chain,I
enhancer,I
mu,I
E1,I
site,O
.,O
NF,B
-,I
E1,I
is,O
also,O
the,O
human,B
homologue,O
of,O
the,O
mouse,O
delta,O
protein,B
",",O
which,O
binds,O
to,O
ribosomal,B
protein,I
gene,I
promoters,I
.,O
Cotransfection,O
studies,O
with,O
this,O
cDNA,B
indicate,O
that,O
it,O
can,O
repress,O
basal,O
promoter,B
activity,O
.,O
The,O
apparent,O
dual,O
function,O
of,O
this,O
protein,B
is,O
discussed,O
.,O
An,O
upstream,O
segment,O
contains,O
tandem,O
dinucleotide,O
repeats,O
(,O
CT,B
),O
19,O
/,O
(,O
CA,B
),O
16,O
.,O
There,O
is,O
a,O
suitably,O
located,O
TATA,B
box,I
",",O
but,O
potential,O
sites,O
for,O
CCAAT,B
-,I
box,I
binding,I
factors,I
are,O
far,O
upstream,O
",",O
embedded,O
in,O
a,O
42,O
-,O
nucleotide,O
repeat,O
element,O
.,O
HIV,B
-,I
TF1,I
had,O
a,O
molecular,O
weight,O
of,O
39,O
",",O
0,O
.,O
A,O
potentially,O
more,O
common,O
pharmacogenetic,O
syndrome,O
.,O
The,O
activity,O
of,O
dihydropyrimidine,B
dehydrogenase,I
(,O
DPD,B
),O
",",O
the,O
initial,O
enzyme,O
of,O
pyrimidine,B
(,O
and,O
FUra,B
),O
catabolism,O
",",O
in,O
peripheral,O
blood,O
mononuclear,O
cells,O
was,O
measured,O
in,O
each,O
subject,O
by,O
a,O
specific,O
radiometric,O
assay,O
using,O
FUra,B
as,O
the,O
substrate,O
.,O
Monitoring,O
DPD,B
activity,O
may,O
be,O
important,O
in,O
the,O
management,O
of,O
patients,O
experiencing,O
severe,O
toxicity,O
secondary,O
to,O
FUra,O
chemotherapy,O
.,O
A,O
thymus,O
-,O
specific,O
member,O
of,O
the,O
HMG,B
protein,I
family,I
regulates,O
the,O
human,O
T,B
cell,I
receptor,I
C,I
alpha,I
enhancer,I
.,O
The,O
human,O
T,B
cell,I
-,I
specific,I
transcription,I
factor,I
TCF,B
-,I
1,I
alpha,I
plays,O
a,O
key,O
role,O
in,O
the,O
tissue,O
-,O
specific,O
activation,O
of,O
the,O
T,B
cell,I
receptor,I
(,O
TCR,B
),O
C,I
alpha,I
enhancer,I
and,O
binds,O
to,O
pyrimidine,O
-,O
rich,O
elements,O
(,O
5,O
',O
-,O
PyCTTTG,O
-,O
3,O
',O
),O
present,O
in,O
a,O
variety,O
of,O
other,O
T,B
cell,I
-,I
specific,I
control,I
regions,I
.,O
TCF,B
-,I
1,I
alpha,I
is,O
currently,O
unique,O
among,O
the,O
newly,O
emerging,O
family,O
of,O
DNA,B
-,I
binding,I
regulatory,I
proteins,I
that,O
share,O
the,O
HMG,O
motif,O
in,O
that,O
it,O
is,O
a,O
highly,O
tissue,O
-,O
specific,O
RNA,B
polymerase,I
II,I
transcription,I
factor,I
.,O
Ectopic,O
expression,O
of,O
cloned,O
Oct2,O
cDNA,B
was,O
shown,O
to,O
be,O
sufficient,O
to,O
reconstitute,O
at,O
least,O
some,O
aspects,O
of,O
this,O
regulation,O
in,O
non,O
-,O
lymphoid,O
cells,O
.,O
We,O
describe,O
the,O
isolation,O
and,O
characterization,O
of,O
multiple,O
cDNAs,O
encoding,O
mouse,O
Oct2,O
from,O
a,O
mature,O
B,B
-,I
cell,I
line,I
and,O
we,O
show,O
that,O
a,O
variety,O
of,O
isoforms,O
of,O
this,O
transcription,O
factor,O
is,O
generated,O
from,O
a,O
single,O
gene,O
by,O
an,O
alternative,O
splicing,O
mechanism,O
.,O
Different,O
amounts,O
of,O
the,O
various,O
isoforms,O
are,O
present,O
within,O
the,O
same,O
B,B
-,I
cell,I
regardless,O
of,O
the,O
developmental,O
stage,O
of,O
B,B
-,I
cell,I
differentiation,I
and,O
at,O
least,O
some,O
of,O
the,O
isoforms,O
are,O
conserved,O
between,O
mouse,O
and,O
humans,O
.,O
In,O
cotransfection,O
experiments,O
we,O
show,O
that,O
all,O
the,O
isoforms,O
are,O
able,O
to,O
activate,O
an,O
octamer,O
containing,O
promoter,O
element,O
in,O
fibroblasts,O
revealing,O
an,O
unexpected,O
functional,O
redundancy,O
.,O
[,O
Regulation,O
of,O
intracellular,O
cholesterol,B
synthesis,I
in,O
hypercholesterolemia,O
by,O
glucocorticoids,O
],O
The,O
rate,O
of,O
endogenous,O
cholesterol,B
synthesis,I
in,O
blood,B
lymphocytes,I
and,O
skin,O
fibroblasts,O
from,O
patients,O
with,O
type,O
IIa,O
hyperlipidemia,O
was,O
found,O
to,O
be,O
increased,O
in,O
comparison,O
with,O
healthy,O
donors,O
.,O
The,O
decrease,O
of,O
the,O
number,O
of,O
glucocorticoid,B
receptors,I
in,O
patients,O
with,O
type,O
IIa,O
hyperlipidemia,O
seems,O
to,O
be,O
a,O
compensatory,O
response,O
of,O
cells,O
culminating,O
in,O
activation,O
of,O
endogenous,O
cholesterol,B
synthesis,I
.,O
These,O
differences,O
in,O
gene,O
expression,O
have,O
not,O
been,O
molecularly,O
defined,O
.,O
Thus,O
",",O
both,O
NF,B
-,I
kappa,I
B,I
-,I
binding,I
complexes,I
are,O
needed,O
for,O
optimal,O
viral,O
transcription,O
.,O
Binding,O
of,O
the,O
65,O
-,O
kDa,B
plus,O
50,O
-,O
kDa,B
heterodimer,O
to,O
the,O
HIV,B
-,I
1,I
enhancer,I
can,O
be,O
negatively,O
regulated,O
in,O
monocytes,O
",",O
providing,O
one,O
mechanism,O
restricting,O
HIV,B
-,I
1,I
gene,I
expression,I
.,O
An,O
age,O
-,O
related,O
decrease,O
in,O
the,O
number,O
of,O
GR,B
was,O
suggested,O
between,O
subjects,O
younger,O
than,O
20,O
years,O
and,O
elderly,O
subjects,O
;,O
there,O
was,O
no,O
apparent,O
seasonal,O
variation,O
in,O
GR,B
.,O
Eight,O
patients,O
with,O
dermatomyositis,O
/,O
polymyositis,O
were,O
examined,O
to,O
determine,O
whether,O
the,O
number,O
of,O
GR,B
in,O
MNL,O
could,O
be,O
down,O
-,O
regulated,O
by,O
their,O
cognate,O
ligands,O
.,O
Formation,O
of,O
the,O
protein,B
-,I
DNA,I
complex,I
with,O
the,O
C26,O
subfragment,O
was,O
positively,O
affected,O
by,O
p40tax,O
.,O
Human,O
tumor,O
necrosis,O
factor,O
alpha,O
gene,O
regulation,O
in,O
phorbol,O
ester,O
stimulated,O
T,B
and,O
B,B
cell,I
lines,I
.,O
Moreover,O
",",O
kappa,B
1,I
-,I
kappa,I
3,I
can,O
each,O
be,O
deleted,O
from,O
the,O
TNF,B
-,I
alpha,I
promoter,I
with,O
little,O
effect,O
on,O
the,O
gene,O
',O
s,O
inducibility,O
by,O
PMA,O
.,O
We,O
have,O
generated,O
a,O
monoclonal,O
antibody,O
",",O
BZ1,O
",",O
to,O
BZLF1,O
which,O
reacts,O
in,O
immunohistology,O
",",O
immunoblotting,O
",",O
and,O
immunoprecipitation,O
and,O
which,O
recognizes,O
both,O
the,O
active,O
",",O
dimeric,O
form,O
and,O
the,O
inactive,O
",",O
monomeric,O
form,O
of,O
the,O
protein,B
.,O
The,O
hormone,O
receptors,O
of,O
the,O
primary,O
tumor,O
were,O
known,O
in,O
15,O
(,O
ER,B
),O
and,O
14,O
(,O
PR,B
),O
patients,O
",",O
respectively,O
.,O
In,O
each,O
cohort,O
there,O
was,O
only,O
one,O
case,O
with,O
a,O
negative,O
reaction,O
of,O
the,O
primary,O
tumor,O
and,O
a,O
positive,O
reaction,O
with,O
the,O
isolated,O
tumor,O
cells,O
from,O
the,O
pleural,O
effusions,O
.,O
NF,B
-,I
kB,I
is,O
a,O
eukaryotic,O
transcription,O
regulatory,O
factor,O
.,O
Regulatory,O
effect,O
of,O
insulin,B
on,O
glucocorticoid,B
receptor,I
in,O
human,B
peripheral,I
leukocytes,I
],O
After,O
3,O
h,O
incubation,O
the,O
specific,O
binding,O
power,O
with,O
[,O
3H,B
],O
Dex,B
was,O
decreased,O
by,O
23,O
.,O
3,O
+,O
/,O
-,O
10,O
.,O
0,O
",",O
32,O
.,O
2,O
+,O
/,O
-,O
13,O
.,O
2,O
%,O
(,O
P,O
greater,O
than,O
0,O
.,O
5,O
",",O
P,O
greater,O
than,O
0,O
.,O
5,O
and,O
P,O
less,O
than,O
0,O
.,O
1,O
as,O
compared,O
with,O
the,O
control,O
value,O
of,O
100,O
in,O
the,O
absence,O
of,O
insulin,B
),O
respectively,O
in,O
the,O
presence,O
of,O
20,O
mU,O
/,O
L,O
(,O
physiological,O
testing,O
concentration,O
),O
",",O
200,O
mU,O
/,O
L,O
(,O
physiological,O
upper,O
limit,O
),O
and,O
2,O
",",O
0,O
mU,O
/,O
L,O
(,O
pharmacological,O
concentration,O
),O
insulin,B
in,O
the,O
incubation,O
medium,O
.,O
Serum,O
Ig,B
levels,I
were,O
followed,O
up,O
to,O
two,O
years,O
after,O
or,O
during,O
the,O
therapy,O
.,O
Low,O
levels,O
of,O
c,B
-,I
jun,I
transcripts,I
were,O
detectable,O
in,O
resting,O
human,O
peripheral,O
blood,O
monocytes,O
.,O
Moreover,O
",",O
M,B
-,I
CSF,I
-,I
induced,I
expression,I
of,O
the,O
fos,B
-,I
related,I
gene,I
",",O
fra,B
-,I
1,I
",",O
was,O
delayed,O
compared,O
to,O
that,O
for,O
both,O
c,B
-,I
fos,I
and,O
fos,B
-,I
B,I
.,O
Glucocorticosteroids,B
remain,O
the,O
major,O
treatment,O
modality,O
for,O
systemic,O
lupus,O
erythematosus,O
(,O
SLE,O
),O
",",O
but,O
their,O
mechanism,O
of,O
action,O
is,O
unclear,O
.,O
Over,O
the,O
past,O
decade,O
it,O
has,O
become,O
clear,O
that,O
glucocorticosteroid,B
receptors,I
play,O
a,O
significant,O
role,O
in,O
the,O
mechanism,O
of,O
glucocorticosteroid,B
action,O
.,O
Glucocorticosteroid,B
receptors,I
on,O
leukocytes,O
of,O
patients,O
with,O
SLE,O
were,O
significantly,O
higher,O
than,O
in,O
healthy,O
controls,O
(,O
4419,O
+,O
/,O
-,O
306,O
vs,O
3369,O
+,O
/,O
-,O
196,O
",",O
p,O
less,O
than,O
0,O
.,O
5,O
),O
.,O
HIV1,B
infection,O
of,O
human,O
monocytes,B
and,O
macrophages,B
promotes,O
induction,O
or,O
translocation,O
of,O
NF,B
-,I
KB,I
-,I
related,I
factors,I
.,O
The,O
insertion,O
of,O
multiple,O
copies,O
of,O
the,O
binding,O
site,O
for,O
the,O
former,O
or,O
latter,O
factor,O
into,O
a,O
heterologous,O
promoter,O
reduced,O
the,O
promoter,O
activity,O
to,O
one,O
-,O
tenth,O
or,O
one,O
-,O
third,O
",",O
respectively,O
.,O
Other,O
cellular,O
parameters,O
",",O
such,O
as,O
glycosidase,O
activities,O
",",O
cytokine,O
release,O
",",O
and,O
filament,O
expression,O
",",O
returned,O
to,O
levels,O
similar,O
to,O
that,O
observed,O
in,O
uninduced,O
cells,O
.,O
Levels,O
of,O
c,O
-,O
fos,B
and,O
c,B
-,I
jun,I
transcripts,I
remained,O
elevated,O
during,O
periods,O
of,O
PKC,O
activation,O
and,O
also,O
returned,O
to,O
levels,O
observed,O
in,O
control,O
cells,O
by,O
30,O
-,O
36,O
days,O
",",O
when,O
the,O
cells,O
entered,O
retrodifferentiation,O
.,O
DNA,B
binding,O
by,O
all,O
four,O
of,O
these,O
Rel,O
-,O
related,O
factors,O
is,O
blocked,O
by,O
selective,O
chemical,O
modification,O
of,O
lysine,O
and,O
arginine,O
residues,O
",",O
suggesting,O
that,O
both,O
of,O
these,O
basic,O
amino,O
acids,O
are,O
required,O
for,O
binding,O
to,O
the,O
kappa,O
B,O
element,O
.,O
In,O
contrast,O
",",O
mild,O
oxidation,O
with,O
glucose,O
oxidase,O
selectively,O
inhibits,O
p75,B
and,O
p85,B
binding,O
while,O
not,O
blocking,O
p50,B
and,O
p55,B
interactions,O
.,O
Changes,O
in,O
leucocytic,O
estrogen,B
receptor,I
levels,O
in,O
patients,O
with,O
climacteric,O
syndrome,O
and,O
therapeutic,O
effect,O
of,O
liuwei,O
dihuang,O
pills,O
],O
The,O
numbers,O
of,O
estrogen,B
receptor,I
(,O
ER,B
),O
in,O
human,O
peripheral,O
leucocytes,O
in,O
22,O
women,O
with,O
climacteric,O
syndrome,O
were,O
measured,O
by,O
radioligand,O
method,O
.,O
This,O
may,O
be,O
the,O
basis,O
of,O
the,O
therapeutic,O
effect,O
on,O
the,O
disease,O
.,O
In,O
addition,O
",",O
cell,O
-,O
free,O
synthesized,O
hGR,B
was,O
capable,O
of,O
specific,O
binding,O
to,O
glucocorticoid,O
response,O
element,O
(,O
GRE,B
),O
-,O
containing,O
DNA,B
fragments,I
.,O
DNA,B
binding,O
by,O
in,O
vitro,O
synthesized,O
GR,B
was,O
blocked,O
by,O
the,O
addition,O
of,O
sodium,O
molybdate,O
to,O
the,O
receptor,O
preparations,O
before,O
steroid,O
addition,O
and,O
thermal,O
activation,O
.,O
Addition,O
of,O
KCl,O
resulted,O
in,O
less,O
DNA,B
binding,O
either,O
due,O
to,O
blockage,O
of,O
DNA,B
-,I
receptor,I
complex,I
formation,O
or,O
disruption,O
of,O
the,O
complexes,O
.,O
Oligonucleotides,O
containing,O
the,O
consensus,O
GRE,B
were,O
the,O
most,O
efficient,O
competitors,O
",",O
and,O
fragments,O
containing,O
regulatory,O
sequences,O
from,O
glucocorticoid,B
-,I
repressible,I
genes,I
were,O
somewhat,O
competitive,O
",",O
whereas,O
single,O
stranded,O
oligonucleotides,O
were,O
unable,O
to,O
compete,O
for,O
mouse,O
mammary,O
tumor,O
virus,O
-,O
long,O
terminal,O
repeat,O
DNA,B
binding,O
",",O
except,O
when,O
competitor,O
was,O
present,O
at,O
extremely,O
high,O
concentrations,O
.,O
Expression,O
of,O
1,O
",",O
25,B
(,I
OH,I
),I
2D3,I
receptors,I
on,O
alveolar,O
lymphocytes,O
from,O
patients,O
with,O
pulmonary,O
granulomatous,O
diseases,O
.,O
1,O
",",O
25,B
(,I
OH,I
),I
2D3,I
receptors,I
were,O
expressed,O
to,O
a,O
greater,O
extent,O
on,O
CD8,B
+,I
T,I
-,I
lymphocytes,I
than,O
on,O
CD4,B
+,I
T,I
-,I
lymphocytes,I
in,O
sarcoidosis,O
",",O
whereas,O
a,O
greater,O
proportion,O
of,O
CD4,B
+,I
than,O
of,O
CD8,B
+,I
T,I
-,I
lymphocytes,I
from,O
patients,O
with,O
tuberculosis,O
were,O
receptor,O
-,O
positive,O
.,O
Role,O
for,O
the,O
Epstein,B
-,I
Barr,I
virus,I
nuclear,I
antigen,I
2,I
in,O
viral,O
promoter,O
switching,O
during,O
initial,O
stages,O
of,O
infection,O
.,O
These,O
studies,O
have,O
been,O
extended,O
to,O
show,O
that,O
(,O
i,O
),O
a,O
mutant,O
EBV,B
strain,I
lacking,O
the,O
gene,O
encoding,O
EBNA,B
2,I
fails,O
to,O
switch,O
from,O
Wp,O
to,O
Cp,O
usage,O
in,O
primary,O
B,B
lymphocytes,I
",",O
although,O
the,O
virus,O
contains,O
a,O
functional,O
Cp,O
;,O
(,O
ii,O
),O
a,O
region,O
from,O
-,O
429,O
to,O
-,O
245,O
base,O
pairs,O
upstream,O
of,O
Cp,O
is,O
essential,O
for,O
Cp,O
activity,O
in,O
B,B
lymphocytes,I
",",O
but,O
only,O
in,O
the,O
context,O
of,O
upstream,O
and,O
downstream,O
sequences,O
;,O
(,O
iii,O
),O
this,O
region,O
contains,O
an,O
EBNA,B
2,I
-,I
dependent,I
enhancer,I
;,O
and,O
(,O
iv,O
),O
DNase,O
I,O
protection,O
employing,O
nuclear,O
extracts,O
from,O
B,B
and,O
T,B
lymphocytes,I
revealed,O
a,O
B,B
-,I
cell,I
-,I
specific,I
footprint,I
in,O
the,O
region,O
of,O
the,O
EBNA,B
2,I
-,I
dependent,I
enhancer,I
.,O
Immune,O
response,O
of,O
peripheral,O
blood,O
mononuclear,O
cells,O
to,O
HBx,B
-,I
antigen,O
of,O
hepatitis,O
B,O
virus,O
.,O
Five,O
T,B
-,I
cell,I
clones,O
specific,O
for,O
a,O
T,B
-,I
cell,I
epitope,O
located,O
at,O
the,O
carboxyterminal,O
region,O
of,O
HBxAg,O
were,O
established,O
and,O
found,O
to,O
belong,O
to,O
the,O
CD2,B
/,I
CD4,I
-,I
positive,O
",",O
CD8,B
-,I
negative,O
subtype,O
.,O
[,O
Changes,O
in,O
leucocytic,O
estrogen,O
receptor,O
levels,O
in,O
patients,O
with,O
gynecomastia,O
],O
The,O
NF,B
kappa,I
B,I
independent,O
cis,O
-,O
acting,O
sequences,O
in,O
HIV,B
-,I
1,I
LTR,I
responsive,O
to,O
T,B
-,I
cell,I
activation,O
.,O
The,O
rate,O
of,O
transcription,O
initiation,O
directed,O
by,O
the,O
long,O
terminal,O
repeat,O
(,O
LTR,B
),O
of,O
HIV,B
-,I
1,I
increases,O
in,O
response,O
to,O
mitogenic,O
stimuli,O
of,O
T,O
cells,O
.,O
The,O
rate,O
of,O
LTR,B
-,I
directed,O
gene,O
expression,O
increased,O
in,O
response,O
to,O
treatment,O
with,O
either,O
a,O
phorbol,O
ester,O
or,O
tumor,O
necrosis,O
factor,O
alpha,O
if,O
either,O
the,O
NFAT,B
-,I
1,I
or,O
NF,B
kappa,I
B,I
binding,O
sites,O
were,O
deleted,O
",",O
but,O
failed,O
to,O
respond,O
to,O
these,O
mitogenic,O
stimuli,O
if,O
both,O
sequences,O
were,O
absent,O
.,O
Activation,O
of,O
proenkephalin,B
transcription,O
by,O
JunD,B
is,O
dependent,O
upon,O
a,O
previously,O
characterized,O
cAMP,B
-,I
",",O
phorbol,B
ester,I
-,I
",",O
and,O
Ca,B
(,O
2,O
+,O
)-,O
-,O
inducible,O
enhancer,O
",",O
and,O
JunD,B
is,O
shown,O
to,O
bind,O
the,O
enhancer,O
as,O
a,O
homodimer,O
.,O
Plasma,O
cortisol,B
concentration,O
and,O
blood,O
leukocyte,B
content,O
of,O
glucocorticoid,B
receptors,I
(,O
GCR,B
),O
were,O
assayed,O
in,O
20,O
patients,O
with,O
deficiency,O
syndromes,O
",",O
10,O
cold,O
in,O
property,O
(,O
deficiency,O
-,O
cold,O
),O
",",O
the,O
other,O
10,O
hot,O
in,O
property,O
(,O
deficiency,O
-,O
heat,O
),O
",",O
and,O
also,O
in,O
10,O
healthy,O
individuals,O
as,O
normal,O
control,O
for,O
the,O
purpose,O
of,O
investigating,O
the,O
nature,O
of,O
cold,O
and,O
heat,O
syndromes,O
.,O
Furthermore,O
",",O
the,O
ability,O
of,O
these,O
complexes,O
to,O
regulate,O
gene,O
expression,O
is,O
demonstrated,O
by,O
increased,O
transcription,O
from,O
an,O
AP,B
-,I
1,I
driven,I
reporter,I
construct,I
and,O
marked,O
increases,O
in,O
the,O
expression,O
of,O
endogenous,O
AP,B
-,I
1,I
regulated,I
genes,I
.,O
This,O
tight,O
correlation,O
between,O
c,O
-,O
jun,B
expression,O
",",O
the,O
generation,O
of,O
AP,B
-,I
1,I
activity,I
",",O
and,O
differentiation,O
suggests,O
a,O
critical,O
role,O
for,O
this,O
gene,O
and,O
transcriptional,O
complex,O
during,O
this,O
process,O
.,O
Cyclosporin,B
A,I
and,O
FK506,B
inhibit,O
T,B
-,I
and,I
B,I
-,I
cell,I
activation,I
and,O
other,O
processes,O
essential,O
to,O
an,O
effective,O
immune,O
response,O
.,O
A,O
transcription,O
factor,O
",",O
NF,B
-,I
AT,I
",",O
which,O
is,O
essential,O
for,O
early,O
T,B
-,I
cell,I
gene,I
activation,I
",",O
seems,O
to,O
be,O
a,O
specific,O
target,O
of,O
cyclosporin,O
A,O
and,O
FK506,O
action,O
because,O
transcription,O
directed,O
by,O
this,O
protein,O
is,O
blocked,O
in,O
T,B
cells,I
treated,O
with,O
these,O
drugs,O
",",O
with,O
little,O
or,O
no,O
effect,O
on,O
other,O
transcription,O
factors,O
such,O
as,O
AP,B
-,I
1,I
and,O
NF,B
-,I
kappa,I
B,I
.,O
Glucocorticoid,B
receptors,I
in,O
lymphocytes,O
in,O
anorexia,O
nervosa,O
.,O
CONCLUSIONS,O
Hypercortisolaemia,O
does,O
not,O
down,O
-,O
regulate,O
the,O
lymphocyte,O
glucocorticoid,B
receptors,I
in,O
anorexia,O
nervosa,O
and,O
a,O
post,O
-,O
receptor,O
defect,O
might,O
be,O
involved,O
in,O
peripheral,O
tissue,O
resistance,O
to,O
the,O
effects,O
of,O
glucocorticoid,B
hormones,I
in,O
undernutrition,O
.,O
The,O
induction,O
of,O
AP1,B
by,O
okadaic,O
acid,O
suggests,O
that,O
protein,B
phosphatases,I
1,I
and,I
2A,I
(,O
PP1,B
and,I
PP2A,I
),O
may,O
be,O
involved,O
in,O
T,B
cell,I
activation,O
as,O
important,O
negative,O
regulators,O
of,O
the,O
transcription,O
factor,O
AP1,B
.,O
CD3,B
-,I
epsilon,I
gene,O
expression,O
is,O
confined,O
to,O
the,O
T,B
cell,I
lineage,O
.,O
TCF,B
-,I
1,I
belonged,O
to,O
a,O
novel,O
family,O
of,O
genes,O
that,O
contain,O
the,O
so,O
-,O
called,O
high,O
mobility,O
group,O
1,O
(,O
HMG,B
),O
box,O
.,O
Two,O
splice,O
alternatives,O
were,O
identified,O
that,O
were,O
not,O
previously,O
observed,O
in,O
human,O
TCF,B
-,I
1,I
.,O
Third,O
",",O
TCF,B
-,I
1,I
bound,O
specifically,O
to,O
a,O
functional,B
T,B
cell,I
-,I
specific,I
element,I
in,O
the,O
T,B
cell,I
receptor,I
alpha,I
(,O
TCR,B
-,I
alpha,I
),O
enhancer,O
.,O
Northern,O
blot,O
analysis,O
of,O
polyadenylated,O
RNA,B
purified,O
from,O
activated,O
human,O
B,B
cells,I
revealed,O
a,O
single,O
mRNA,B
transcript,I
of,O
approximately,O
2,O
.,O
3,O
kb,O
.,O
There,O
is,O
a,O
single,O
methionine,B
codon,I
-,O
initiated,O
open,O
reading,O
frame,O
of,O
1,O
",",O
458,O
nt,O
in,O
frame,O
with,O
a,O
homeobox,B
and,O
a,O
CAX,B
repeat,I
",",O
and,O
the,O
open,O
reading,O
frame,O
is,O
predicted,O
to,O
encode,O
a,O
protein,B
of,O
51,O
",",O
659,O
daltons,O
.,O
Characterization,O
of,O
HB24,B
expression,O
in,O
lymphoid,B
and,O
select,O
developing,O
tissues,O
was,O
performed,O
by,O
in,O
situ,O
hybridization,O
.,O
Platelet,B
-,I
activating,I
factor,I
induces,O
phospholipid,O
turnover,O
",",O
calcium,O
flux,O
",",O
arachidonic,O
acid,O
liberation,O
",",O
eicosanoid,O
generation,O
",",O
and,O
oncogene,O
expression,O
in,O
a,O
human,O
B,B
cell,I
line,I
.,O
Tandem,O
copies,O
of,O
this,O
67,O
-,O
bp,O
MnlI,O
-,O
AluI,O
fragment,O
",",O
when,O
fused,O
to,O
the,O
chloramphenicol,O
acetyltransferase,O
gene,O
driven,O
by,O
the,O
conalbumin,O
promoter,O
",",O
stimulated,O
transcription,O
in,O
B,B
cells,I
but,O
not,O
in,O
Jurkat,O
T,B
cells,I
or,O
HeLa,O
cells,I
.,O
Footprinting,O
analysis,O
revealed,O
that,O
the,O
identical,O
sequence,O
CCGAAACTGAAAAGG,O
",",O
designated,O
E6,O
",",O
was,O
protected,O
by,O
nuclear,O
extracts,O
from,O
B,B
cells,I
",",O
T,B
cells,I
",",O
or,O
HeLa,B
cells,I
.,O
Gel,O
mobility,O
shift,O
assays,O
using,O
a,O
synthetic,O
E6,O
motif,O
detected,O
a,O
B,B
-,I
cell,I
-,I
specific,I
complex,I
in,O
addition,O
to,O
a,O
ubiquitous,O
band,O
found,O
also,O
in,O
T,B
cells,I
and,O
HeLa,B
cells,I
.,O
In,O
agreement,O
with,O
the,O
results,O
of,O
gel,O
retardation,O
assays,O
",",O
tandem,O
copies,O
of,O
the,O
E6,B
motif,I
stimulated,O
transcription,O
in,O
ARH77,B
and,O
Raji,B
cells,I
but,O
not,O
in,O
Jurkat,B
or,O
HeLa,B
cells,I
.,O
Interestingly,O
",",O
the,O
MnlI,B
-,I
AluI,I
fragment,I
could,O
suppress,O
the,O
basal,O
-,O
level,O
activity,O
of,O
the,O
conalbumin,B
promoter,I
in,O
both,O
Jurkat,B
and,O
HeLa,B
cells,I
.,O
Thus,O
",",O
the,O
novel,O
enhancer,B
element,I
identified,O
in,O
this,O
study,O
is,O
probably,O
a,O
target,O
site,O
for,O
both,O
positive,O
and,O
negative,O
factors,O
.,O
Charybdotoxin,O
-,O
sensitive,O
",",O
Ca,O
(,O
2,O
+,O
)-,O
dependent,O
membrane,O
potential,O
changes,O
are,O
not,O
involved,O
in,O
human,O
T,B
or,O
B,B
cell,I
activation,O
and,O
proliferation,O
.,O
The,O
involvement,O
of,O
ion,O
channels,O
in,O
B,B
and,O
T,B
lymphocyte,I
activation,O
is,O
supported,O
by,O
many,O
reports,O
of,O
changes,O
in,O
ion,O
fluxes,O
and,O
membrane,O
potential,O
after,O
mitogen,O
binding,O
.,O
However,O
",",O
blockade,O
of,O
the,O
Ca,B
(,O
2,O
+,O
),O
-,O
activated,O
K,B
+,I
channel,I
is,O
not,O
associated,O
with,O
changes,O
in,O
cell,B
-,I
cycle,I
gene,I
activation,I
",",O
IL,O
-,O
2,O
production,O
",",O
IL,O
-,O
2R,O
expression,O
or,O
B,B
and,O
T,B
cell,I
mitogenesis,I
.,O
From,O
information,O
available,O
in,O
the,O
literature,O
on,O
the,O
substrate,O
specificity,O
of,O
the,O
three,O
enzymes,O
",",O
it,O
is,O
clear,O
that,O
a,O
cysteine,O
is,O
not,O
accepted,O
in,O
any,O
of,O
the,O
S2,O
",",O
S1,O
",",O
S1,O
',O
",",O
and,O
S2,O
',O
subsites,O
of,O
cathepsin,B
B,I
and,O
L,B
",",O
and,O
not,O
in,O
the,O
S1,O
and,O
S1,O
',O
subsites,O
of,O
cathepsin,B
D,I
.,O
Starting,O
with,O
a,O
replication,O
-,O
incompetent,O
molecular,O
clone,O
of,O
human,O
immunodeficiency,O
virus,B
type,I
1,I
",",O
lacking,O
all,O
the,O
NF,B
-,I
kappa,I
B,I
and,O
Sp1,B
binding,O
sites,O
present,O
in,O
the,O
native,O
long,O
terminal,O
repeat,O
(,O
LTR,O
),O
",",O
proviruses,O
containing,O
reconstructed,O
LTRs,O
with,O
individual,O
or,O
combinations,O
of,O
NF,B
-,I
kappa,I
B,I
and,O
Sp1,B
elements,O
were,O
generated,O
and,O
evaluated,O
for,O
their,O
capacity,O
to,O
produce,O
virus,B
progeny,O
following,O
transfection,O
-,O
cocultivation,O
.,O
The,O
human,O
interferon,B
beta,I
(,O
IFN,B
-,I
beta,I
),O
regulatory,O
element,O
consists,O
of,O
multiple,O
enhanson,O
domains,O
which,O
are,O
targets,O
for,O
transcription,O
factors,O
involved,O
in,O
inducible,O
expression,O
of,O
the,O
promoter,O
.,O
A,O
2,O
-,O
4,O
-,O
fold,O
increase,O
in,O
IFN,B
-,I
beta,I
promoter,I
transcription,O
was,O
observed,O
in,O
Sendai,O
virus,O
induced,O
extracts,O
",",O
and,O
deletion,O
of,O
PRDI,B
and,O
PRDII,B
elements,I
decreased,O
this,O
induced,O
level,O
of,O
transcription,O
.,O
When,O
purified,O
PRDII,B
and,O
tetrahexamer,B
binding,I
proteins,I
were,O
added,O
to,O
the,O
induced,O
extract,O
",",O
a,O
4,O
-,O
fold,O
increase,O
in,O
transcription,O
was,O
observed,O
.,O
Human,O
and,O
mouse,O
Rhom,B
-,I
2,I
are,O
highly,O
conserved,O
and,O
",",O
like,O
rhombotin,O
",",O
encode,O
two,O
tandem,O
cysteine,B
-,I
rich,I
LIM,I
domains,I
.,O
NF,B
-,I
kappa,I
B,I
activation,O
by,O
tumor,O
necrosis,O
factor,O
alpha,O
in,O
the,O
Jurkat,B
T,I
cell,I
line,I
is,O
independent,O
of,O
protein,B
kinase,I
A,I
",",O
protein,B
kinase,I
C,I
",",O
and,O
Ca,B
(,I
2,I
+,I
),I
-,I
regulated,I
kinases,I
0.82,O
Furthermore,O
",",O
while,O
PMA,B
activation,I
was,O
inhibited,O
by,O
the,O
PKC,B
inhibitor,I
staurosporin,I
",",O
the,O
TNF,B
alpha,I
effect,O
was,O
unchanged,O
. Here,O
we,O
investigated,O
the,O
transcriptional,O
basis,O
for,O
these,O
changes,O
. Mutations,O
at,O
the,O
B2,B
site,I
abolish,O
this,O
transcriptional,O
activation,O
. The,O
purified,O
homodimer,O
(,O
two,O
p50s,B
),O
of,O
the,O
DNA,B
-,I
binding,I
subunit,I
of,I
NF,B
-,I
kappa,I
B,I
binds,O
the,O
B2,B
site,I
of,I
proenkephalin,O
relatively,O
better,O
than,O
does,O
the,O
heterotetramer,O
(,O
two,O
p65s,B
plus,I
two,I
p50s,I
),O
form,O
of,O
the,O
factor,O
.,O
However,O
",",O
as,O
NF,B
-,I
kappa,I
B,I
is,O
ubiquitous,O
and,O
the,O
transcriptional,O
activation,O
through,O
the,O
B2,O
site,O
is,O
T,B
cell,I
specific,I
",",O
yet,O
another,O
T,B
-,I
cell,I
-,I
specific,I
factor,O
which,O
synergizes,O
with,O
NF,B
-,I
kappa,I
B,I
should,O
be,O
considered,O
.,O
In,O
nuclear,O
extracts,O
from,O
monocytes,O
or,O
macrophages,O
",",O
induction,O
of,O
NF,B
-,I
KB,I
occurred,O
only,O
if,O
the,O
cells,O
were,O
previously,O
infected,O
with,O
HIV,B
-,I
1,I
.,O
These,O
results,O
indicate,O
that,O
in,O
monocytic,B
cell,I
lineage,I
",",O
HIV,B
-,I
1,I
could,O
mimic,O
some,O
differentiation,O
/,O
activation,O
stimuli,O
allowing,O
nuclear,O
NF,B
-,I
KB,I
expression,O
.,O
Disruption,O
of,O
the,O
human,O
SCL,B
locus,I
by,O
`,O
`,O
illegitimate,O
',O
',O
V,O
-,O
(,O
D,O
),O
-,O
J,O
recombinase,O
activity,O
.,O
The,O
fusion,O
cDNA,O
results,O
from,O
an,O
interstitial,O
deletion,O
between,O
a,O
previously,O
unknown,O
locus,O
",",O
SIL,B
(,O
SCL,B
interrupting,I
locus,I
),O
",",O
and,O
the,O
5,O
',O
untranslated,O
region,O
of,O
SCL,B
.,O
Thus,O
",",O
in,O
lymphocytes,B
",",O
growth,O
-,O
affecting,O
genes,O
other,O
than,O
immune,O
receptors,O
risk,O
rearrangements,O
.,O
This,O
was,O
compared,O
with,O
the,O
TREp,O
binding,O
of,O
reticulocyte,O
lysate,O
-,O
synthesized,O
TRs,B
.,O
Incubation,O
of,O
each,O
of,O
the,O
TRs,B
with,O
NE,O
from,O
COS,O
-,O
7,O
cells,O
",",O
which,O
do,O
not,O
possess,O
sufficient,O
endogenous,O
TRs,B
to,O
mediate,O
T3,O
-,O
responses,O
",",O
resulted,O
in,O
formation,O
of,O
a,O
new,O
",",O
more,O
greatly,O
shifted,O
complex,O
.,O
Cell,B
-,I
specific,I
differences,I
in,O
activation,O
of,O
NF,B
-,I
kappa,I
B,I
regulatory,I
elements,I
of,O
human,O
immunodeficiency,O
virus,O
and,O
beta,O
interferon,O
promoters,O
by,O
tumor,O
necrosis,O
factor,O
.,O
Tumor,O
necrosis,O
factor,O
alpha,O
(,O
TNF,B
-,I
alpha,I
),O
mRNA,O
production,O
was,O
analyzed,O
by,O
polymerase,O
chain,O
reaction,O
amplification,O
in,O
monocytic,O
U937,B
cells,I
and,O
in,O
a,O
chronically,O
HIV,B
infected,I
U937,B
cell,I
line,I
(,O
U9,B
-,I
IIIB,I
),O
.,O
Functional,B
analysis,I
of,I
cis,I
-,I
linked,I
regulatory,I
sequences,I
in,I
the,I
HLA,B
DRA,I
promoter,I
by,O
transcription,O
in,O
vitro,O
.,O
The,O
effect,O
of,O
LPS,O
on,O
HIV,B
-,I
1,I
replication,I
occurs,O
at,O
picogram,O
per,O
milliliter,O
concentrations,O
and,O
may,O
be,O
clinically,O
significant,O
in,O
understanding,O
the,O
variability,O
of,O
the,O
natural,O
history,O
of,O
HIV,B
-,I
1,I
infection,I
.,O
Inhibitory,O
drug,O
interactions,O
affecting,O
the,O
metabolism,O
of,O
methylprednisolone,B
(,O
MP,B
),O
may,O
produce,O
either,O
steroid,O
sparing,O
or,O
adverse,O
effects,O
partly,O
by,O
increasing,O
the,O
exposure,O
time,O
to,O
the,O
steroid,O
.,O
This,O
phenomenon,O
can,O
be,O
mimicked,O
by,O
administering,O
MP,B
in,O
divided,O
doses,O
.,O
To,O
compare,O
extra,O
-,O
renal,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
production,O
in,O
different,O
types,O
of,O
granulomatous,O
disease,O
",",O
and,O
to,O
identify,O
the,O
cell,B
types,I
responsible,O
",",O
we,O
have,O
evaluated,O
the,O
conversion,O
of,O
25,O
(,O
OH,O
),O
D3,O
in,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
by,O
uncultured,O
cells,B
recovered,O
by,O
bronchoalveolar,O
lavage,O
and,O
blood,O
mononuclear,O
cells,B
from,O
normocalcemic,O
patients,O
with,O
sarcoidosis,O
and,O
tuberculosis,O
.,O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
was,O
produced,O
both,O
by,O
lavage,O
cells,O
(,O
12,O
/,O
12,O
tuberculosis,O
patients,O
",",O
2,O
/,O
6,O
sarcoidosis,O
patients,O
),O
and,O
blood,O
mononuclear,O
cells,O
(,O
3,O
/,O
5,O
tuberculosis,O
patients,O
",",O
0,O
/,O
3,O
sarcoidosis,O
patients,O
),O
from,O
patients,O
but,O
not,O
controls,O
",",O
but,O
significantly,O
greater,O
amounts,O
were,O
produced,O
by,O
lavage,O
cells,O
from,O
tuberculosis,O
patients,O
than,O
those,O
of,O
sarcoidosis,O
patients,O
(,O
P,O
less,O
than,O
0,O
.,O
1,O
),O
.,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
production,O
by,O
lavage,O
cells,O
from,O
tuberculosis,O
patients,O
correlated,O
with,O
the,O
number,O
of,O
CD8,B
+,I
T,I
lymphocytes,I
present,O
but,O
not,O
other,O
cell,O
types,O
.,O
Because,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
can,O
improve,O
the,O
capacity,O
of,O
macrophages,O
to,O
kill,O
mycobacteria,O
",",O
our,O
results,O
support,O
the,O
conclusion,O
that,O
macrophage,O
-,O
lymphocyte,O
interactions,O
",",O
mediated,O
at,O
least,O
in,O
part,O
by,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
",",O
may,O
be,O
an,O
important,O
component,O
of,O
a,O
successful,O
antituberculous,O
immune,O
response,O
.,O
A,O
closely,O
related,O
(,O
if,O
not,O
identical,O
),O
protein,B
is,O
found,O
in,O
both,O
a,O
human,B
megakaryocytic,B
cell,I
line,I
and,O
purified,O
human,B
megakaryocytes,B
;,O
it,O
binds,O
to,O
promoter,O
regions,O
of,O
two,O
megakaryocytic,B
-,I
specific,I
genes,I
.,O
Furthermore,O
",",O
point,O
mutations,O
that,O
abolish,O
binding,O
of,O
NF,B
-,I
E1,I
result,O
in,O
a,O
70,O
%,O
decrease,O
in,O
the,O
transcriptional,O
activity,O
of,O
a,O
megakaryocytic,B
-,I
specific,I
promoter,I
.,O
Transcriptional,O
down,O
-,O
regulation,O
of,O
c,O
-,O
myc,B
expression,O
by,O
protein,B
synthesis,I
-,I
dependent,I
and,O
-,O
independent,O
pathways,O
in,O
a,O
human,O
T,O
lymphoblastic,O
tumor,O
cell,O
line,O
.,O
We,O
studied,O
49,O
cases,O
of,O
B,O
-,O
cell,O
chronic,O
lymphocytic,O
leukemia,O
(,O
CLL,O
),O
using,O
immunostaining,O
of,O
cytospin,O
preparations,O
.,O
In,O
30,O
of,O
these,O
cases,O
ER,O
enzyme,O
immunoassay,O
(,O
ER,O
-,O
EIA,O
),O
was,O
also,O
performed,O
.,O
Type,O
-,O
II,O
estrogen,B
-,I
binding,I
sites,I
(,O
type,O
-,O
II,O
EBS,O
),O
have,O
been,O
demonstrated,O
in,O
the,O
human,O
lymphoblastoid,B
cell,I
line,I
IM,O
-,O
9,O
using,O
a,O
whole,O
-,O
cell,O
assay,O
with,O
(,O
6,O
",",O
7,O
-,O
3H,O
),O
estradiol,B
(,O
3H,O
-,O
E2,O
),O
as,O
tracer,O
.,O
The,O
relative,O
binding,O
affinity,O
of,O
quercetin,O
",",O
rutin,O
",",O
DES,O
and,O
TAM,O
for,O
type,O
-,O
II,O
EBS,O
correlated,O
well,O
with,O
their,O
potency,O
as,O
cell,O
growth,O
inhibitors,O
.,O
Moreover,O
",",O
hesperidin,O
",",O
a,O
flavonoid,O
which,O
does,O
not,O
bind,O
to,O
type,O
-,O
II,O
EBS,O
",",O
was,O
ineffective,O
in,O
inhibiting,O
cell,O
growth,O
.,O
[,O
Glucocorticoid,B
receptors,I
in,O
peripheral,O
blood,O
lymphocytes,O
of,O
patients,O
with,O
bronchial,O
asthma,O
],O
Quantitation,O
of,O
glucocorticoid,B
receptors,I
(,O
GCR,B
),O
and,O
the,O
study,O
of,O
their,O
affinity,O
for,O
glucocorticosteroids,B
(,O
GCS,B
),O
were,O
made,O
in,O
peripheral,O
blood,O
lymphocytes,O
of,O
bronchial,O
asthma,O
(,O
BA,O
),O
patients,O
in,O
consideration,O
of,O
GCR,B
treatment,O
and,O
serum,O
levels,O
of,O
endogenous,O
cortisol,O
.,O
Two,O
glucocorticoid,B
binding,I
sites,I
on,O
the,O
human,O
glucocorticoid,B
receptor,I
.,O
Cortivazol,O
(,O
CVZ,O
),O
is,O
a,O
unique,O
",",O
high,O
potency,O
synthetic,O
glucocorticoid,B
",",O
which,O
has,O
a,O
phenylpyrazol,O
fused,O
to,O
the,O
A,O
-,O
ring,O
of,O
the,O
steroid,O
nucleus,O
and,O
displays,O
binding,O
consistent,O
with,O
two,O
or,O
more,O
sites,O
in,O
the,O
cytosol,O
from,O
CEM,B
C7,I
cells,I
(,O
a,O
human,O
acute,O
lymphoblastic,O
T,B
-,I
cell,I
line,I
),O
.,O
We,O
have,O
carried,O
out,O
experiments,O
to,O
define,O
the,O
nature,O
of,O
the,O
higher,O
affinity,O
CVZ,O
binding,O
site,O
.,O
These,O
data,O
indicate,O
that,O
CVZ,O
is,O
recognizing,O
two,O
glucocorticoid,B
binding,I
sites,I
on,O
the,O
human,O
GR,B
or,O
a,O
protein,B
very,O
similar,O
to,O
it,O
.,O
Retroviral,O
mediated,O
transfer,O
and,O
expression,O
of,O
exogenous,O
genes,I
in,O
primary,O
lymphoid,B
cells,I
:,O
assaying,O
for,O
a,O
viral,O
transactivator,O
activity,O
in,O
normal,O
and,O
malignant,O
cells,I
.,O
Incidence,O
of,O
HLA,B
antigens,I
was,O
determined,O
in,O
94,O
of,O
them,O
.,O
Several,O
mutants,O
derived,O
from,O
transformed,O
human,O
B,B
cell,I
lines,I
are,O
defective,O
in,O
expressing,O
major,O
histocompatibility,O
complex,O
(,O
MHC,B
),O
class,O
II,O
genes,O
.,O
There,O
was,O
evidence,O
for,O
an,O
autosomal,O
recessive,O
form,O
of,O
inheritance,O
in,O
four,O
families,O
",",O
while,O
the,O
other,O
four,O
families,O
appeared,O
to,O
have,O
an,O
autosomal,O
dominant,O
mode,O
of,O
transmission,O
.,O
These,O
parents,O
were,O
entirely,O
asymptomatic,O
.,O
ER,B
content,I
in,O
lymphocytes,B
of,O
each,O
sample,O
was,O
expressed,O
by,O
both,O
fmol,O
/,O
mg,O
of,O
lymphocyte,B
cytosolic,I
protein,I
and,O
fmol,O
/,O
micrograms,O
of,O
lymphocyte,B
DNA,I
.,O
The,O
results,O
showed,O
that,O
there,O
was,O
no,O
significant,O
difference,O
between,O
the,O
ER,B
content,I
of,O
lymphocytes,B
from,O
the,O
controls,O
and,O
that,O
from,O
patients,O
with,O
SLE,O
.,O
We,O
used,O
mouse,B
embryonic,I
stem,I
(,O
ES,B
),O
cells,O
to,O
study,O
globin,B
gene,I
expression,O
and,O
switching,O
in,O
vitro,O
.,O
We,O
show,O
that,O
ES,B
-,O
derived,O
embryoid,O
bodies,O
express,O
the,O
full,O
complement,O
of,O
mouse,B
embryonic,I
globin,I
genes,I
in,O
the,O
correct,O
temporal,O
order,O
and,O
that,O
on,O
further,O
differentiation,O
",",O
a,O
switch,O
occurs,O
to,O
the,O
fetal,B
/,I
adult,I
genes,I
.,O
When,O
the,O
human,B
epsilon,I
-,I
or,O
beta,B
-,I
globin,I
genes,I
driven,O
by,O
the,O
dominant,O
control,O
region,O
(,O
DCR,B
),O
are,O
introduced,O
into,O
this,O
system,O
",",O
the,O
human,B
epsilon,I
-,I
globin,I
gene,I
",",O
in,O
contrast,O
to,O
the,O
beta,B
-,I
globin,I
gene,I
",",O
is,O
not,O
deregulated,O
by,O
the,O
presence,O
of,O
the,O
DCR,B
and,O
is,O
expressed,O
strictly,O
as,O
an,O
embryonic,O
gene,O
.,O
These,O
effects,O
of,O
aldosterone,B
were,O
blocked,O
by,O
the,O
aldosterone,B
antagonist,O
canrenone,O
(,O
140,O
nmol,O
/,O
l,O
),O
.,O
Seventeen,O
cases,O
revealed,O
distinct,O
immunostaining,O
against,O
at,O
least,O
1,O
of,O
the,O
5,O
steroid,B
hormones,I
.,O
ZRE,O
-,O
B,O
is,O
therefore,O
not,O
part,O
of,O
the,O
R,O
-,O
inducible,O
enhancer,O
.,O
However,O
",",O
one,O
palindrome,O
",",O
either,O
alone,O
or,O
duplicated,O
",",O
or,O
the,O
overlapping,O
palindromes,O
did,O
not,O
respond,O
to,O
R,O
.,O
The,O
clinical,O
implications,O
of,O
nuclear,O
T3R,O
alterations,O
of,O
circulating,O
lymphocytes,O
in,O
hyperthyroidism,O
",",O
hypothyroidism,O
and,O
nonthyroidal,O
diseases,O
were,O
investigated,O
.,O
The,O
results,O
showed,O
that,O
in,O
hyper,O
-,O
and,O
hypothyroid,O
patients,O
the,O
nuclear,O
affinity,O
(,O
Ka,B
),O
for,O
T3,B
was,O
similar,O
to,O
that,O
of,O
normal,O
subjects,O
.,O
In,O
a,O
fourth,O
cell,O
line,O
",",O
A1,O
-,O
VDR,O
",",O
the,O
receptor,O
for,O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
had,O
a,O
low,O
binding,O
capacity,O
and,O
25,O
(,O
OH,B
),O
D3,B
-,O
24,O
-,O
hydroxylase,O
activity,O
was,O
not,O
detectable,O
.,O
Binding,O
and,O
elution,O
properties,O
to,O
DNA,B
-,I
cellulose,I
",",O
however,O
",",O
differed,O
from,O
normal,O
in,O
both,O
Ro,O
-,O
VDR,O
and,O
A1,O
-,O
VDR,O
cells,O
where,O
elution,O
from,O
DNA,B
-,I
cellulose,I
occurred,O
at,O
a,O
lower,O
salt,O
concentration,O
than,O
is,O
typical,O
of,O
the,O
1,O
",",O
25,O
(,O
OH,B
),O
2D3,B
receptor,O
.,O
We,O
studied,O
the,O
effects,O
of,O
TPA,O
on,O
the,O
regulation,O
of,O
c,O
-,O
jun,B
gene,I
expression,O
in,O
HL,B
-,I
60,I
cells,O
during,O
monocytic,O
differentiation,O
0.23,O
[,O
Hormonal,O
interactions,O
and,O
glucocorticoid,O
receptors,O
in,O
patients,O
with,O
the,O
nephrotic,O
syndrome,O
],O
These,O
studies,O
detected,O
two,O
novel,O
domains,O
referred,O
to,O
as,O
L1,O
and,O
L2,O
with,O
a,O
variety,O
of,O
lymphoid,O
but,O
not,O
HeLa,B
extracts,O
0.58,O
Characterization,O
of,O
defensin,B
resistance,O
phenotypes,O
associated,O
with,O
mutations,O
in,O
the,O
phoP,O
virulence,O
regulon,O
of,O
Salmonella,O
typhimurium,O
.,O
The,O
defensin,B
sensitivities,O
of,O
Salmonella,O
typhimurium,O
strains,O
with,O
mutations,O
in,O
the,O
phoP,O
/,O
phoQ,O
two,O
-,O
component,O
virulence,O
regulon,O
were,O
tested,O
by,O
using,O
purified,O
defensins,B
NP,O
-,O
1,O
and,O
NP,O
-,O
2,O
.,O
The,O
predicted,O
periplasmic,B
domain,I
of,O
the,O
PhoQ,B
protein,I
contained,O
a,O
markedly,O
anionic,B
domain,I
that,O
could,O
interact,O
with,O
cationic,B
proteins,I
and,O
that,O
could,O
be,O
responsible,O
for,O
resistance,O
to,O
defensin,O
.,O
This,O
implied,O
that,O
a,O
pag,O
(,O
phoP,O
-,O
activated,O
gene,O
),O
product,O
is,O
responsible,O
for,O
defensin,O
resistance,O
.,O
Stimulation,O
of,O
a,O
human,O
T,B
-,I
cell,I
clone,I
with,O
anti,O
-,O
CD3,B
or,O
tumor,O
necrosis,O
factor,O
induces,O
NF,B
-,I
kappa,I
B,I
translocation,O
but,O
not,O
human,O
immunodeficiency,O
virus,O
1,O
enhancer,O
-,O
dependent,O
transcription,O
.,O
The,O
two,O
latter,O
signals,O
were,O
nevertheless,O
able,O
to,O
induce,O
NF,B
-,I
kappa,I
B,I
translocation,O
with,O
a,O
pattern,O
in,O
the,O
band,O
-,O
shift,O
assay,O
indistinguishable,O
from,O
that,O
observed,O
using,O
phorbol,O
ester,O
.,O
However,O
",",O
the,O
resistance,O
to,O
vitamin,O
D,B
treatment,O
in,O
XLH,O
can,O
not,O
be,O
explained,O
by,O
hypophosphatemia,O
alone,O
.,O
Two,O
distinct,O
forms,O
of,O
active,O
transcription,O
factor,O
CREB,B
(,O
cAMP,B
response,I
element,I
binding,I
protein,I
),O
.,O
The,O
two,O
proteins,B
differ,O
by,O
a,O
14,O
-,O
amino,O
acid,O
serine,O
-,O
rich,O
insertion,O
present,O
in,O
one,O
of,O
the,O
CREB,B
isoforms,O
.,O
Both,O
proteins,B
impart,O
cAMP,O
-,O
regulated,O
transcriptional,O
activity,O
to,O
a,O
heterologous,O
DNA,B
-,I
binding,I
domain,I
",",O
showing,O
that,O
cAMP,O
directly,O
modulates,O
the,O
transcriptional,O
stimulatory,O
activity,O
of,O
CREB,B
.,O
Competition,O
experiments,O
did,O
not,O
reveal,O
any,O
high,O
-,O
affinity,O
binding,O
site,O
for,O
BSAP,O
in,O
known,O
regulatory,O
regions,O
of,O
immunoglobulin,B
and,O
class,O
II,O
major,O
histocompatibility,O
(,O
MHC,O
),O
genes,I
",",O
suggesting,O
that,O
BSAP,O
is,O
a,O
regulator,O
of,O
a,O
different,O
set,O
of,O
B,O
-,O
lymphoid,O
-,O
specific,O
genes,O
.,O
The,O
expression,O
of,O
the,O
antibody,B
-,I
encoding,I
genes,I
",",O
the,O
immunoglobulin,B
(,I
Ig,I
),I
genes,I
",",O
is,O
also,O
restricted,O
to,O
B,B
cells,I
.,O
It,O
appears,O
that,O
the,O
B,B
cell,I
-,I
specific,I
expression,I
of,I
Ig,I
genes,I
is,O
mediated,O
at,O
least,O
in,O
part,O
by,O
cell,B
type,I
-,I
specific,I
Oct,B
factors,I
",",O
and,O
that,O
there,O
are,O
both,O
quantitative,O
and,O
qualitative,O
differences,O
between,O
Oct,B
-,I
1,I
and,O
Oct,B
-,I
2,I
factors,I
.,O
Recently,O
",",O
a,O
number,O
of,O
other,O
octamer,O
factor,O
variants,O
were,O
identified,O
.,O
Many,O
of,O
these,O
may,O
be,O
created,O
by,O
alternative,O
splicing,O
of,O
a,O
primary,O
transcript,O
of,O
one,O
Oct,O
factor,O
gene,O
and,O
may,O
serve,O
a,O
specific,O
function,O
in,O
the,O
fine,O
tuning,O
of,O
gene,O
expression,O
.,O
We,O
find,O
that,O
the,O
factor,O
that,O
binds,O
to,O
the,O
E3,O
enhancer,O
motif,O
",",O
CATGTGGC,O
",",O
is,O
a,O
ubiquitous,O
transcription,O
factor,O
.,O
However,O
",",O
despite,O
its,O
ability,O
to,O
activate,O
transcription,O
of,O
a,O
transfected,O
reporter,O
gene,O
",",O
the,O
factor,O
is,O
apparently,O
unable,O
to,O
bind,O
to,O
the,O
endogenous,O
Ig,B
heavy,I
chain,I
enhancer,I
in,O
non,O
-,O
lymphoid,O
cells,O
:,O
In,O
previous,O
experiments,O
by,O
others,O
",",O
the,O
characteristic,O
in,O
vivo,O
footprint,O
of,O
this,O
factor,O
",",O
designated,O
NF,B
-,I
muE3,I
",",O
was,O
detected,O
in,O
B,B
cells,O
but,O
not,O
in,O
non,O
-,O
B,B
cells,O
.,O
[,O
Endocrine,O
status,O
changes,O
in,O
children,O
with,O
bronchial,O
asthma,O
],O
A,O
study,O
was,O
made,O
of,O
adrenocortical,O
function,O
by,O
measuring,O
blood,O
plasma,O
cortisol,B
concentration,O
and,O
amount,O
of,O
glucocorticoid,B
receptors,I
in,O
lymphocytes,O
as,O
well,O
as,O
thyroid,B
function,O
by,O
measuring,O
blood,O
plasma,O
triidothyronine,B
and,O
thyroxine,B
concentration,O
in,O
58,O
bronchial,O
asthma,O
children,O
aged,O
1,O
to,O
14,O
years,O
.,O
The,O
authors,O
revealed,O
alterations,O
in,O
the,O
functional,B
activity,I
of,O
the,O
indicated,O
endocrine,B
glands,I
depending,O
on,O
the,O
intensity,O
of,O
bronchial,O
patency,O
disorders,O
and,O
the,O
nature,O
of,O
the,O
therapeutic,O
measures,O
carried,O
out,O
.,O
TAR,O
independent,O
activation,O
of,O
the,O
human,B
immunodeficiency,I
virus,I
in,O
phorbol,O
ester,O
stimulated,O
T,B
lymphocytes,I
.,O
Multiple,O
regulatory,O
elements,O
in,O
the,O
human,O
immunodeficiency,B
virus,I
long,I
terminal,I
repeat,I
(,O
HIV,B
LTR,I
),O
are,O
required,O
for,O
activation,O
of,O
HIV,B
gene,I
expression,I
.,O
Results,O
in,O
all,O
cell,B
lines,I
indicated,O
that,O
mutations,O
of,O
the,O
SP1,B
",",O
TATA,B
and,O
the,O
TAR,B
loop,I
and,O
stem,I
secondary,I
structure,I
resulted,O
in,O
marked,O
decreases,O
in,O
gene,I
expression,I
while,O
mutations,O
of,O
the,O
enhancer,B
motif,I
or,O
TAR,B
primary,I
sequence,I
resulted,O
in,O
only,O
slight,O
decreases,O
.,O
The,O
clinical,O
course,O
and,O
the,O
laboratory,O
data,O
suggest,O
that,O
the,O
tachycardia,O
crises,O
are,O
the,O
consequence,O
of,O
a,O
hypersensitivity,O
of,O
the,O
heart,O
to,O
thyroid,O
hormones,O
",",O
associated,O
with,O
an,O
increased,O
number,O
of,O
T3,B
nuclear,I
receptor,I
sites,I
in,O
lymphocytes,O
.,O
Induction,O
of,O
immediate,O
early,O
response,O
genes,O
by,O
macrophage,O
colony,O
-,O
stimulating,O
factor,O
in,O
normal,O
human,O
monocytes,O
.,O
The,O
c,B
-,I
jun,I
gene,I
expression,O
was,O
very,O
transient,O
and,O
was,O
not,O
detectable,O
by,O
60,O
min,O
after,O
M,O
-,O
CSF,O
addition,O
.,O
The,O
protein,B
synthesis,I
inhibitor,I
cycloheximide,I
did,O
not,O
block,O
the,O
induction,O
of,O
any,O
of,O
these,O
genes,O
",",O
and,O
in,O
fact,O
",",O
super,O
-,O
induced,O
the,O
expression,O
of,O
c,B
-,I
jun,I
and,O
hck,B
.,O
These,O
genes,O
may,O
then,O
play,O
a,O
role,O
in,O
altering,O
the,O
physiologic,O
status,O
of,O
the,O
cells,O
in,O
response,O
to,O
CSF,O
.,O
Inducible,O
nuclear,O
factor,O
binding,O
to,O
the,O
kappa,B
B,I
elements,I
of,O
the,O
human,O
immunodeficiency,O
virus,O
enhancer,O
in,O
T,B
cells,I
can,O
be,O
blocked,O
by,O
cyclosporin,O
A,O
in,O
a,O
signal,O
-,O
dependent,O
manner,O
.,O
We,O
have,O
purified,O
a,O
new,O
T,B
-,I
cell,I
-,I
specific,I
factor,O
",",O
TCF,B
-,I
1,I
alpha,I
",",O
that,O
is,O
implicated,O
in,O
the,O
activation,O
of,O
genes,O
encoding,O
a,O
major,O
component,O
of,O
the,O
human,O
T,B
-,I
cell,I
receptor,I
(,O
TCR,B
),O
.,O
Curiously,O
",",O
the,O
TCF,B
-,I
1,I
alpha,I
binding,I
element,I
was,O
inactive,O
in,O
vivo,O
when,O
removed,O
from,O
its,O
neighboring,O
elements,O
on,O
the,O
TCR,O
alpha,O
enhancer,O
and,O
positioned,O
in,O
one,O
or,O
more,O
copies,O
upstream,O
of,O
a,O
heterologous,O
promoter,O
.,O
A,O
powerful,O
enhancer,O
has,O
been,O
mapped,O
to,O
an,O
18,O
-,O
bp,O
DNA,B
segment,I
located,O
11,O
kb,O
5,O
',O
to,O
the,O
human,O
epsilon,B
-,I
globin,I
gene,I
within,O
the,O
dominant,O
control,O
or,O
locus,O
-,O
activating,O
region,O
.,O
DNA,B
-,O
protein,B
binding,I
assays,I
with,O
nuclear,O
extracts,O
from,O
induced,O
cells,O
demonstrate,O
a,O
high,O
molecular,O
weight,O
complex,O
on,O
the,O
enhancer,O
.,O
The,O
tissue,O
-,O
specific,O
expression,O
of,O
the,O
MOPC,O
141,O
immunoglobulin,B
heavy,I
-,I
chain,I
gene,I
was,O
studied,O
by,O
using,O
in,O
vitro,O
transcription,O
.,O
Purified,O
OTF1,O
from,O
HeLa,O
cells,O
and,O
OTF1,O
and,O
OTF2,O
from,O
B,O
cells,O
bound,O
to,O
identical,O
sequences,O
within,O
the,O
heavy,I
-,I
chain,I
promoter,I
.,O
In,O
addition,O
to,O
these,O
elements,O
",",O
we,O
identified,O
a,O
second,O
regulatory,O
element,O
",",O
the,O
N,B
element,I
with,O
the,O
sequence,O
5,O
',O
-,O
GGAACCTCCCCC,O
-,O
3,O
',O
.,O
NF,B
-,I
kappa,I
B,I
as,O
inducible,O
transcriptional,O
activator,O
of,O
the,O
granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
gene,I
.,O
The,O
same,O
agents,O
induce,O
transcription,O
from,O
the,O
interleukin,B
-,I
2,I
receptor,I
alpha,I
-,I
chain,I
and,O
interleukin,B
-,I
2,I
genes,I
",",O
depending,O
on,O
promoter,O
elements,O
that,O
bind,O
the,O
inducible,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
(,O
or,O
an,O
NF,B
-,I
kappa,I
B,I
-,I
like,I
factor,I
),O
.,O
Two,O
kappa,B
B,I
-,I
like,I
motifs,I
at,O
positions,O
-,O
98,O
to,O
-,O
108,O
of,O
the,O
GM,B
-,I
CSF,I
promoter,I
were,O
also,O
recognized,O
but,O
with,O
much,O
lower,O
affinities,O
.,O
Effects,O
of,O
mitogenic,O
agents,O
upon,O
glucocorticoid,B
action,I
in,O
human,O
tonsillar,O
T,B
-,I
lymphocytes,I
.,O
PMA,B
enhanced,O
slightly,O
the,O
stimulatory,O
effect,O
of,O
PHA,B
.,O
Accordingly,O
",",O
the,O
same,O
set,O
of,O
words,O
and,O
phrases,O
(,O
oligopeptides,O
),O
appear,O
in,O
totally,O
unrelated,O
proteins,O
.,O
Two,O
distinct,O
signal,O
transmission,O
pathways,O
in,O
T,B
lymphocytes,I
are,O
inhibited,O
by,O
complexes,O
formed,O
between,O
an,O
immunophilin,O
and,O
either,O
FK506,O
or,O
rapamycin,O
.,O
After,O
in,O
vitro,O
adherence,O
",",O
human,O
monocytes,O
had,O
a,O
biphasic,O
increase,O
in,O
PDGF,B
(,O
B,I
),O
mRNA,O
with,O
peaks,O
at,O
6,O
h,O
and,O
13,O
d,O
.,O
Modulation,O
of,O
these,O
events,O
at,O
the,O
time,O
of,O
adherence,O
offers,O
a,O
mechanism,O
by,O
which,O
differential,O
priming,O
of,O
the,O
cells,O
may,O
be,O
accomplished,O
.,O
Unexpectedly,O
",",O
stimulation,O
of,O
cloned,O
stably,O
transfected,O
Jurkat,B
T,I
cells,I
leads,O
to,O
a,O
bimodal,O
pattern,O
of,O
beta,B
-,I
gal,I
expression,O
in,O
which,O
some,O
cells,O
express,O
no,O
beta,B
-,I
gal,I
and,O
others,O
express,O
high,O
levels,O
.,O
Further,O
results,O
",",O
in,O
which,O
beta,B
-,I
gal,I
activity,O
is,O
correlated,O
with,O
NF,B
-,I
AT,I
-,I
binding,I
activity,O
",",O
indicate,O
that,O
the,O
concentration,O
of,O
NF,B
-,I
AT,I
must,O
exceed,O
a,O
critical,O
threshold,O
before,O
transcription,O
initiates,O
.,O
Similar,O
constructs,O
controlled,O
by,O
NF,B
-,I
kappa,I
B,I
or,O
the,O
entire,O
interleukin,B
-,I
2,I
enhancer,I
show,O
bimodal,O
expression,O
patterns,O
during,O
induction,O
",",O
suggesting,O
that,O
thresholds,O
set,O
by,O
the,O
concentration,O
of,O
transcription,O
factors,O
may,O
be,O
a,O
common,O
property,O
of,O
inducible,O
genes,O
.,O
In,O
lymphoid,B
cells,I
",",O
Z,B
or,O
R,B
alone,O
produced,O
only,O
small,O
increases,O
in,O
EA,B
-,I
D,I
promoter,I
activity,I
",",O
whereas,O
both,O
transactivators,O
together,O
produced,O
a,O
large,O
stimulatory,O
effect,O
.,O
In,O
lymphoid,B
cells,I
",",O
only,O
the,O
upstream,O
sequences,O
are,O
required,O
for,O
transactivation,O
by,O
the,O
Z,B
/,I
R,I
combination,I
",",O
and,O
the,O
AP,B
-,I
1,I
site,I
is,O
dispensable,O
.,O
The,O
DNA,B
isolated,I
contained,O
an,O
open,O
reading,O
frame,O
encoding,O
108,O
amino,B
acid,I
residues,I
.,O
This,O
effect,O
was,O
comparable,O
to,O
or,O
even,O
stronger,O
than,O
the,O
effect,O
of,O
a,O
mutation,O
in,O
the,O
OCTA,B
site,I
.,O
DNase,B
footprinting,I
analysis,I
corroborated,O
the,O
functional,O
data,O
showing,O
that,O
a,O
lymphoid,O
-,O
specific,O
protein,B
binds,O
to,O
the,O
microB,B
DNA,I
motif,I
.,O
This,O
inducer,O
can,O
act,O
in,O
concert,O
with,O
the,O
HIV,B
-,I
2,I
tat,I
gene,I
and,O
T,O
-,O
cell,B
activation,I
in,O
enhancing,O
gene,O
expression,O
in,O
human,O
CD4,B
+,I
lymphocytes,I
.,O
Both,O
HIV,B
-,I
2,I
and,O
CMV,B
transactivators,I
enhance,O
HIV,B
-,I
2,I
gene,I
expression,I
by,O
transcriptional,O
activation,O
involving,O
transcript,O
initiation,O
as,O
well,O
as,O
elongation,O
",",O
with,O
CMV,B
transactivator,I
affecting,O
elongation,O
more,O
than,O
the,O
initiation,O
.,O
Inflammatory,O
infiltrates,O
were,O
analysed,O
in,O
tissue,O
sections,O
of,O
76,O
breast,O
carcinomas,O
by,O
counting,O
the,O
percentage,O
of,O
macrophages,O
",",O
IgA,B
+,I
and,O
IgG,B
+,I
plasma,O
cells,O
",",O
T,O
cells,O
with,O
their,O
subpopulations,O
",",O
and,O
natural,O
killer,O
cells,O
",",O
and,O
by,O
measuring,O
postcapillary,O
venules,O
(,O
PCVs,O
",",O
found,O
in,O
12,O
cases,O
),O
within,O
the,O
infiltrates,O
.,O
In,O
addition,O
",",O
a,O
direct,O
correlation,O
exists,O
between,O
the,O
diameter,O
of,O
the,O
PCVs,O
and,O
both,O
the,O
percentage,O
of,O
the,O
OKT8,B
+,I
T,I
cells,I
(,O
P,O
less,O
than,O
0,O
0.28,O
4,O
),O
and,O
the,O
Leu,B
-,I
7,I
+,I
natural,I
killer,I
cells,I
(,O
P,O
less,O
than,O
0,O
0.45,O
3,O
),O
.,O
In,O
this,O
study,O
we,O
present,O
evidence,O
for,O
reactivity,O
of,O
pregnancy,O
lymphocytes,O
",",O
but,O
not,O
nonpregnancy,O
lymphocytes,O
",",O
with,O
the,O
progesterone,B
receptor,I
-,I
specific,I
monoclonal,I
antibody,I
mPRI,I
.,O
Depletion,O
of,O
CD8,B
+,I
cells,I
was,O
accompanied,O
by,O
62,O
+,O
/,O
-,O
18,O
%,O
loss,O
of,O
progesterone,B
receptor,I
-,I
bearing,I
cells,I
",",O
while,O
depletion,O
of,O
CD4,B
+,I
cells,I
resulted,O
in,O
a,O
twofold,O
increase,O
in,O
the,O
number,O
of,O
positively,O
staining,O
lymphocytes,O
.,O
Interaction,O
of,O
fibronectin,B
with,O
VLA,B
-,I
5,I
receptor,I
on,O
CD4,B
cells,I
induces,O
the,O
AP,B
-,I
1,I
transcription,I
factor,I
.,O
Int,O
-,O
2,O
was,O
amplified,O
in,O
13,O
.,O
1,O
%,O
and,O
c,O
-,O
myc,O
was,O
amplified,O
in,O
10,O
.,O
3,O
%,O
.,O
A,O
somewhat,O
surprising,O
finding,O
however,O
was,O
a,O
very,O
strong,O
association,O
between,O
oncogene,O
amplification,O
and,O
dense,O
lymphocyte,O
infiltration,O
of,O
the,O
tumor,O
(,O
P,O
=,O
.,O
5,O
),O
.,O
This,O
correlation,O
is,O
even,O
stronger,O
when,O
only,O
high,O
levels,O
of,O
amplification,O
are,O
considered,O
",",O
either,O
for,O
each,O
oncogene,O
separately,O
(,O
P,O
=,O
48,O
),O
or,O
in,O
combination,O
(,O
P,O
=,O
.,O
7,O
),O
.,O
Suppression,O
of,O
signals,O
required,O
for,O
activation,O
of,O
transcription,O
factor,O
NF,B
-,I
kappa,I
B,I
in,O
cells,O
constitutively,O
expressing,O
the,O
HTLV,B
-,I
I,I
Tax,I
protein,I
.,O
Transcription,O
factor,O
IID,B
(,O
TFIID,B
),O
binds,O
to,O
the,O
TATA,B
box,I
promoter,I
element,I
and,O
regulates,O
the,O
expression,O
of,O
most,O
eukaryotic,O
genes,O
transcribed,O
by,O
RNA,B
polymerase,I
II,I
.,O
Complementary,O
DNA,B
(,O
cDNA,B
),O
encoding,O
a,O
human,O
TFIID,B
protein,I
has,O
been,O
cloned,O
.,O
Premenopausal,O
patients,O
with,O
neither,O
risk,O
factor,O
had,O
a,O
very,O
low,O
failure,O
rate,O
(,O
2,O
.,O
6,O
%,O
at,O
5,O
years,O
),O
",",O
regardless,O
of,O
age,O
.,O
Second,O
",",O
TRE,B
-,I
DNA,I
binding,I
proteins,I
sedimented,O
through,O
a,O
glycerol,O
density,O
gradient,O
at,O
rates,O
corresponding,O
to,O
proteins,O
of,O
native,O
molecular,O
weights,O
of,O
35,O
to,O
50,O
kD,O
and,O
110,O
kD,O
.,O
Third,O
",",O
only,O
the,O
50,B
kD,I
protein,I
was,O
retained,O
on,O
a,O
biotinylated,O
DNA,B
-,I
streptavidin,I
matrix,I
when,O
the,O
DNA,B
fragment,I
contained,O
the,O
TRE,O
-,O
DNA,B
.,O
Fourth,O
",",O
extensive,O
purification,O
by,O
several,O
cycles,O
of,O
TRE,O
-,O
DNA,B
affinity,I
chromatography,I
resulted,O
in,O
the,O
32,B
",",I
36,B
to,I
42,I
and,O
110,B
kD,I
proteins,I
and,O
to,O
less,O
extent,O
the,O
50,B
kD,I
factor,I
.,O
Two,O
abundant,O
proteins,B
of,O
75,O
and,O
80,O
kD,O
were,O
competed,O
out,O
by,O
poly,O
[,O
d,O
(,O
I,O
-,O
C,O
),O
],O
in,O
all,O
reactions,O
.,O
The,O
cAMP,O
-,O
response,O
element,B
CRE,I
",",O
TGACGTCA,O
",",O
present,O
in,O
the,O
21,O
base,O
-,O
pair,O
sequence,O
",",O
appears,O
to,O
be,O
essential,O
for,O
specific,O
protein,B
-,I
TRE,I
-,I
DNA,I
interactions,I
because,O
mutation,O
of,O
the,O
two,O
G,O
',O
s,O
destroys,O
this,O
complex,O
.,O
Activity,O
of,O
the,O
immunoglobulin,B
heavy,I
and,I
kappa,I
light,I
chain,I
gene,I
enhancers,I
depends,O
on,O
a,O
complex,O
interplay,O
of,O
ubiquitous,O
and,O
developmentally,O
regulated,O
proteins,O
.,O
Elevated,O
glucocorticoid,O
receptor,O
concentrations,O
before,O
and,O
after,O
glucocorticoid,O
therapy,O
in,O
peripheral,O
mononuclear,O
leukocytes,O
of,O
patients,O
with,O
atopic,O
dermatitis,O
.,O
Patients,O
with,O
AD,O
(,O
n,O
=,O
15,O
),O
exhibited,O
significantly,O
more,O
glucocorticoid,B
receptors,I
(,O
GR,B
),O
per,O
cell,O
than,O
the,O
control,O
group,O
(,O
n,O
=,O
22,O
),O
",",O
while,O
the,O
GR,B
affinity,I
did,O
not,O
differ,O
.,O
Methylprednisolone,O
treatment,O
resulted,O
in,O
a,O
significant,O
reduction,O
of,O
the,O
GR,B
sites,I
per,O
cell,O
in,O
the,O
steroid,O
-,O
treated,O
control,O
group,O
(,O
n,O
=,O
10,O
),O
in,O
contrast,O
to,O
the,O
patients,O
.,O
The,O
internal,O
methionine,O
codons,O
of,O
human,O
T,B
-,I
cell,I
leukemia,I
virus,I
type,I
II,I
rex,I
gene,I
are,O
not,O
required,O
for,O
p24rex,O
production,O
or,O
virus,O
replication,O
and,O
transformation,O
.,O
Human,O
T,B
-,I
cell,I
leukemia,I
virus,I
types,I
I,I
(,O
HTLV,B
-,I
I,I
),O
and,O
II,O
(,O
HTLV,B
-,I
II,I
),O
have,O
two,O
nonstructural,O
trans,O
-,O
acting,O
regulatory,O
genes,O
",",O
tax,O
and,O
rex,O
",",O
located,O
in,O
the,O
3,O
',O
region,O
of,O
the,O
viral,O
genome,O
.,O
Rex,B
acts,O
posttranscriptionall,O
to,O
facilitate,O
accumulation,O
of,O
full,O
-,O
length,O
gag,B
/,I
pol,I
and,O
singly,O
spliced,O
env,B
mRNA,I
in,O
the,O
cytoplasm,O
of,O
HTLV,B
-,I
infected,I
cells,I
.,O
By,O
using,O
an,O
infectious,O
molecular,O
clone,O
of,O
HTLV,B
-,I
II,I
",",O
we,O
investigated,O
the,O
importance,O
of,O
the,O
internal,O
ATGs,B
of,O
the,O
rex,B
gene,I
on,O
Rex,B
protein,I
production,O
and,O
function,O
.,O
The,O
',O
octamer,B
',O
sequence,O
",",O
ATGCAAAT,O
or,O
its,O
complement,O
ATTTGCAT,O
",",O
is,O
a,O
key,O
element,O
for,O
the,O
transcriptional,O
regulation,O
of,O
immunoglobulin,B
genes,I
in,O
B,O
-,O
lymphocytes,O
as,O
well,O
as,O
a,O
number,O
of,O
housekeeping,O
genes,O
in,O
all,O
cell,B
types,I
.,O
In,O
lymphocytes,O
",",O
the,O
octamer,O
-,O
binding,O
protein,O
Oct,B
-,I
2A,I
and,O
variants,O
thereof,O
are,O
thought,O
to,O
contribute,O
to,O
the,O
B,O
-,O
cell,O
specific,O
gene,O
expression,O
",",O
while,O
the,O
ubiquitous,O
protein,O
Oct,B
-,I
1,I
seems,O
to,O
control,O
general,O
octamer,O
site,O
-,O
dependent,O
transcription,O
.,O
Therefore,O
",",O
the,O
phosphorylation,O
of,O
Rex,B
is,O
required,O
for,O
the,O
viral,O
RNA,B
partition,O
of,O
HTLV,B
-,I
I,I
.,O
Cell,B
proliferation,O
of,O
CEM,B
-,I
C7,I
cells,I
cultured,O
in,O
both,O
serum,O
-,O
free,O
media,O
has,O
been,O
sustained,O
for,O
3,O
mo,O
.,O
All,O
immunoglobulin,B
genes,I
contain,O
a,O
conserved,B
octanucleotide,I
promoter,I
element,I
",",O
ATGCAAAT,O
",",O
which,O
has,O
been,O
shown,O
to,O
be,O
required,O
for,O
their,O
normal,O
B,B
-,I
cell,I
-,I
specific,I
transcription,I
.,O
Proteins,B
that,O
bind,O
this,O
octamer,O
have,O
been,O
purified,O
",",O
and,O
cDNAs,B
encoding,O
octamer,O
-,O
binding,I
proteins,I
have,O
been,O
cloned,O
.,O
Addition,O
of,O
a,O
highly,O
enriched,O
preparation,O
of,O
OTF,B
-,I
1,I
made,O
from,O
one,O
of,O
these,O
pre,O
-,O
B,O
cells,O
or,O
from,O
HeLa,B
cells,I
specifically,O
stimulated,O
in,O
vitro,O
transcription,O
of,O
an,O
immunoglobulin,B
gene,I
.,O
In,O
vitro,O
binding,O
of,O
aldosterone,B
to,O
mineralocorticoid,O
receptors,O
on,O
human,B
mononuclear,I
leukocytes,I
(,O
HML,B
),O
and,O
its,O
effects,O
on,O
the,O
intracellular,O
sodium,B
and,O
potassium,B
concentrations,O
of,O
HML,B
have,O
already,O
been,O
described,O
.,O
In,O
only,O
four,O
patients,O
sodium,B
in,O
HML,B
without,O
incubation,O
was,O
elevated,O
compared,O
with,O
the,O
range,O
for,O
normal,O
persons,O
.,O
A,O
decrease,O
of,O
intracellular,O
sodium,B
or,O
potassium,B
occurred,O
during,O
incubation,O
without,O
aldosterone,O
(,O
P,O
less,O
than,O
0,O
.,O
2,O
),O
.,O
The,O
number,O
of,O
mineralocorticoid,B
receptors,I
/,O
cell,B
were,O
within,O
or,O
close,O
to,O
the,O
normal,O
range,O
(,O
n,O
=,O
9,O
),O
.,O
It,O
is,O
proposed,O
that,O
the,O
character,O
of,O
their,O
expression,O
under,O
the,O
influence,O
of,O
vitamin,O
D,O
may,O
be,O
used,O
with,O
differential,O
diagnostic,O
purposes,O
in,O
view,O
.,O
Regulation,O
of,O
gene,O
expression,O
with,O
double,O
-,O
stranded,O
phosphorothioate,O
oligonucleotides,O
.,O
We,O
now,O
demonstrate,O
the,O
following,O
.,O
Thus,O
",",O
EBNA,B
-,I
2,I
transactivation,O
of,O
LMP1,B
amplifies,O
the,O
biological,O
impact,O
of,O
EBNA,B
-,I
2,I
and,O
underscores,O
its,O
central,O
role,O
in,O
EBV,B
-,I
induced,I
growth,I
transformation,I
.,O
Heat,O
shock,O
caused,O
an,O
increase,O
in,O
c,B
-,I
fos,I
and,O
c,B
-,I
jun,I
mRNA,I
levels,O
and,O
a,O
decrease,O
in,O
c,B
-,I
myc,I
mRNA,I
levels,O
in,O
pre,O
-,O
B,B
(,O
Hyon,B
),O
and,O
T,B
(,O
DND,B
-,I
41,I
),O
cell,B
lines,I
as,O
well,O
as,O
in,O
freshly,O
isolated,O
normal,O
human,O
thymocytes,O
.,O
Mapping,O
of,O
B,O
-,O
cell,O
epitopes,O
of,O
the,O
human,O
hepatitis,B
B,I
virus,I
X,I
protein,I
.,O
Anti,O
-,O
HBx,B
antibody,I
titers,I
as,O
revealed,O
by,O
peptide,O
ELISAs,O
were,O
highest,O
and,O
most,O
frequent,O
in,O
patients,O
with,O
chronic,O
hepatitis,B
and,O
usually,O
low,O
in,O
acutely,O
infected,O
patients,O
and,O
asymptomatic,O
carriers,O
.,O
Random,O
migration,O
(,O
RM,B
),O
and,O
chemotactic,O
migration,O
(,O
ChtM,B
),O
of,O
human,O
leukocytes,O
to,O
yeast,O
activated,O
serum,O
were,O
studied,O
with,O
the,O
modified,O
Boyden,O
chamber,O
method,O
.,O
The,O
difference,O
between,O
the,O
peak,O
(,O
0,O
:,O
0,O
),O
and,O
trough,O
values,O
(,O
8,O
:,O
0,O
),O
of,O
RM,B
and,O
ChtM,B
was,O
significant,O
statistically,O
(,O
P,O
less,O
than,O
0,O
.,O
1,O
),O
.,O
ChtM,B
was,O
inhibited,O
by,O
hydrocortisone,O
(,O
F,O
),O
of,O
physiological,O
concentration,O
(,O
10,O
(,O
-,O
9,O
),O
-,O
10,O
(,O
-,O
7,O
),O
mol,O
/,O
L,O
),O
which,O
was,O
dose,O
-,O
dependent,O
and,O
completely,O
antagonized,O
by,O
the,O
competitive,O
antagonist,O
",",O
RU38486,O
.,O
The,O
inhibitory,O
effect,O
was,O
much,O
more,O
evident,O
with,O
higher,O
dose,O
(,O
more,O
than,O
10,O
(,O
-,O
5,O
),O
mol,O
/,O
L,O
),O
and,O
it,O
was,O
also,O
reversed,O
by,O
RU38486,O
",",O
but,O
only,O
partially,O
.,O
Lt,O
-,O
4,O
reacted,O
with,O
all,O
HTLV,B
-,I
I,I
-,I
bearing,I
cell,I
lines,I
tested,O
and,O
five,O
out,O
of,O
eight,O
simian,O
cell,O
lines,O
bearing,O
STLV,B
-,I
I,I
",",O
but,O
not,O
with,O
an,O
HTLV,B
-,I
II,I
-,I
bearing,I
cell,I
line,I
.,O
In,O
the,O
STLV,B
-,I
I,I
-,I
bearing,O
T,B
cell,I
lines,I
",",O
tax1,O
-,O
related,O
antigen,O
molecules,O
detected,O
by,O
Lt,O
-,O
4,O
were,O
heterogeneous,O
",",O
having,O
molecular,O
weights,O
in,O
the,O
range,O
of,O
36,O
-,O
41,O
kd,O
.,O
The,O
transcription,O
of,O
the,O
human,O
immunodeficiency,O
virus,O
type,O
1,O
(,O
HIV,B
-,I
1,I
),O
is,O
under,O
the,O
control,O
of,O
cellular,O
proteins,O
that,O
bind,O
to,O
the,O
viral,O
long,O
terminal,O
repeat,O
(,O
LTR,B
),O
.,O
The,O
corresponding,O
region,O
in,O
the,O
second,O
AIDS,O
retrovirus,O
",",O
HIV,B
-,I
2,I
",",O
contains,O
a,O
conserved,B
and,O
a,O
divergent,B
NF,B
kappa,I
B,I
binding,I
site,I
. Instead,O
of,O
NF,B
kappa,I
B,I
",",O
the,O
activator,O
protein,O
3,O
binds,O
to,O
the,O
divergent,B
site,I
in,O
HIV,B
-,I
2,I
. Expression,O
cloning,O
of,O
c,O
-,O
Jun,O
. Whereas,O
c,O
-,O
Fos,O
/,O
c,O
-,O
Jun,O
heterodimers,O
do,O
not,O
exist,O
in,O
B,O
cells,O
",",O
they,O
form,O
and,O
bind,O
to,O
the,O
X2,O
-,O
box,O
in,O
class,O
II,O
nonexpressing,O
cells,O
.,O
11,O
beta,B
",",O
19,O
-,O
epoxy,O
-,O
4,O
",",O
21,O
-,O
dihydroxypregn,O
-,O
4,O
-,O
ene,O
-,O
3,O
",",O
20,O
-,O
dione,O
(,O
2,O
),O
was,O
hydrogenated,O
with,O
Pd,B
-,I
C,I
to,O
yield,O
a,O
mixture,O
of,O
all,O
four,O
dihydro,O
derivatives,O
5,O
",",O
accompanied,O
by,O
4,O
",",O
21,O
-,O
diacetoxy,O
-,O
11,O
beta,B
",",O
19,O
-,O
epoxy,O
-,O
3,O
-,O
hydroxypregnan,O
-,O
20,O
-,O
one,O
(,O
6,O
),O
and,O
21,O
-,O
acetoxy,O
-,O
11,O
beta,B
",",O
19,O
-,O
epoxy,O
-,O
4,O
-,O
hydroxypregnane,O
-,O
3,O
",",O
20,O
-,O
dione,O
(,O
7,O
),O
.,O
Treatment,O
of,O
10,O
with,O
warm,O
HCl,O
furnished,O
19,O
-,O
chloro,O
-,O
4,O
",",O
21,O
-,O
dihydroxypregna,O
-,O
4,O
",",O
9,O
(,O
11,O
)-,O
-,O
diene,O
-,O
3,O
",",O
20,O
-,O
dione,O
(,O
13,O
),O
.,O
When,O
tested,O
in,O
a,O
radioreceptor,O
assay,O
in,O
human,O
mononuclear,O
leukocytes,O
the,O
synthesized,O
compounds,O
showed,O
only,O
low,O
relative,O
binding,O
affinities,O
(,O
RBA,O
),O
to,O
type,O
1,O
receptor,O
",",O
the,O
highest,O
being,O
0,O
.,O
72,O
%,O
for,O
13,O
(,O
aldosterone,O
=,O
100,O
%,O
),O
.,O
We,O
have,O
developed,O
a,O
system,O
to,O
monitor,O
the,O
transcriptional,O
activity,O
of,O
NFAT,B
-,I
1,I
at,O
the,O
single,O
cell,O
level,O
in,O
whole,O
animals,O
.,O
This,O
report,O
represents,O
the,O
first,O
demonstration,O
that,O
a,O
multimerized,O
short,O
binding,O
motif,O
can,O
function,O
appropriately,O
in,O
transgenic,O
mice,O
.,O
This,O
similarity,O
in,O
expression,O
and,O
the,O
fact,O
that,O
NFAT,B
-,I
1,I
has,O
been,O
shown,O
to,O
bind,O
functional,B
sequences,I
in,O
HIV,B
-,I
LTR,I
suggest,O
a,O
role,O
for,O
NFAT,B
-,I
1,I
in,O
dermal,O
activation,O
of,O
the,O
HIV,B
-,I
LTR,I
.,O
A,O
novel,O
T,B
-,I
cell,I
protein,I
recognized,O
the,O
palindromic,O
sequence,O
within,O
site,O
B,B
and,O
also,O
bound,O
estrogen,B
-,I
or,I
thyroid,I
hormone,I
-,I
response,I
elements,I
with,O
lower,O
affinity,O
.,O
The,O
effects,O
of,O
a,O
competitive,O
progesterone,B
antagonist,I
(,O
RU486,O
),O
and,O
a,O
specific,O
glucocorticoid,B
receptor,I
blocker,I
(,O
RU43044,O
),O
were,O
tested,O
on,O
the,O
release,O
of,O
a,O
blocking,O
factor,O
by,O
progesterone,B
-,I
treated,I
pregnancy,I
lymphocytes,I
.,O
It,O
has,O
previously,O
been,O
shown,O
that,O
9S,B
",",O
untransformed,O
progestin,O
",",O
estrogen,B
",",O
androgen,B
",",O
and,O
glucocorticoid,B
receptor,I
complexes,I
in,O
rabbit,O
uterine,O
and,O
liver,O
cytosols,O
contain,O
a,O
59,O
-,O
kDa,O
protein,B
[,O
Tai,O
",",O
P,O
. ,O
K,O
. ,O
",",O
Maeda,O
",",O
Y,O
. ,O
",",O
Nakao,O
",",O
K,O
. ,O
",",O
Wakim,O
",",O
N,O
. ,O
G,O
. ,O
",",O
Duhring,O
",",O
J,O
. ,O
L,O
. ,O
",",O
&,O
Faber,O
",",O
L,O
. ,O
E,O
. ,O
( ,O
1986,O
),O
Biochemistry,O
25,O
",",O
5269,O
-,O
5275,O
],O
. ,O
Sequence,O
-,O
specific,O
DNA,B
binding,O
of,O
the,O
proto,O
-,O
oncoprotein,O
ets,B
-,I
1,I
defines,O
a,O
transcriptional,O
activator,O
sequence,O
within,O
the,O
long,O
terminal,O
repeat,O
of,O
the,O
Moloney,O
murine,O
sarcoma,O
virus,O
.,O
A,O
mutant,O
LTR,O
containing,O
four,O
base,O
pair,O
substitutions,O
in,O
the,O
ets,B
-,I
1,I
binding,O
site,O
was,O
constructed,O
and,O
was,O
shown,O
to,O
have,O
reduced,O
binding,O
in,O
vitro,O
.,O
We,O
propose,O
that,O
ets,B
-,I
1,I
functions,O
as,O
a,O
transcriptional,O
activator,O
of,O
mammalian,O
type,O
-,O
C,O
retroviruses,O
and,O
speculate,O
that,O
ets,B
-,I
related,I
genes,I
constitute,O
a,O
new,O
group,O
of,O
eukaryotic,O
DNA,B
-,I
binding,I
proteins,I
.,O
We,O
have,O
previously,O
reported,O
that,O
human,O
peripheral,O
blood,O
mononuclear,O
cells,O
(,O
PBMC,B
),O
contain,O
type,O
II,O
estrogen,O
binding,O
sites,O
(,O
type,O
II,O
EBS,O
),O
.,O
In,O
postmenopausal,O
women,O
the,O
mean,O
type,B
II,I
EBS,I
levels,O
were,O
similar,O
to,O
those,O
observed,O
in,O
the,O
follicular,O
phase,O
of,O
the,O
cycle,O
.,O
Tamoxifen,O
was,O
also,O
found,O
to,O
compete,O
with,O
17,O
beta,O
-,O
estradiol,O
for,O
type,B
II,I
EBS,I
in,O
PBMC,O
",",O
although,O
to,O
a,O
lesser,O
extent,O
than,O
diethylstilbestrol,O
.,O
These,O
results,O
do,O
not,O
lend,O
support,O
to,O
previous,O
reports,O
suggesting,O
that,O
GC,B
resistance,O
in,O
MDD,O
results,O
from,O
a,O
GC,B
receptor,I
-,I
binding,I
abnormality,I
",",O
and,O
they,O
emphasize,O
the,O
importance,O
of,O
considering,O
receptor,O
studies,O
in,O
the,O
context,O
of,O
GC,B
-,I
mediated,I
cell,I
processes,I
in,O
order,O
to,O
identify,O
the,O
exact,O
cellular,O
defect,O
(,O
s,O
),O
leading,O
to,O
GC,B
resistance,O
.,O
Proteins,B
exist,O
in,O
leukocytes,O
able,O
to,O
modify,O
GTP,B
-,I
binding,I
protein,I
function,O
in,O
this,O
manner,O
",",O
and,O
their,O
activity,O
may,O
be,O
regulated,O
by,O
signals,O
generated,O
on,O
phagocyte,O
stimulation,O
.,O
Proteins,B
of,O
the,O
Ras,B
superfamily,I
are,O
likely,O
to,O
be,O
involved,O
in,O
a,O
variety,O
of,O
normal,O
phagocyte,O
functions,O
through,O
their,O
ability,O
to,O
modulate,O
the,O
assembly,O
of,O
actin,B
filaments,I
",",O
direct,O
vesicle,B
trafficking,I
and,O
fusion,O
",",O
and,O
so,O
forth,O
.,O
The,O
effect,O
of,O
1,O
",",O
25,O
-,O
dihydroxyvitamin,B
D3,I
[,O
1,O
",",O
25,O
(,O
OH,O
),O
2,O
),O
D3,I
],O
",",O
a,O
steroid,O
hormone,O
with,O
immunomodulating,O
properties,O
",",O
on,O
nuclear,O
factor,O
kappa,O
B,B
(,O
NF,B
-,I
kappa,I
B,I
),O
proteins,O
was,O
examined,O
in,O
in,O
vitro,O
activated,O
normal,B
human,I
lymphocytes,I
by,O
Western,O
blot,O
analysis,O
.,O
Over,O
a,O
72,O
-,O
hr,O
period,O
of,O
activation,O
",",O
the,O
expression,O
of,O
the,O
50,O
-,O
kDa,O
NF,B
-,I
kappa,I
B,I
",",O
p50,B
",",O
and,O
its,O
precursor,O
",",O
p105,B
",",O
was,O
increased,O
progressively,O
.,O
When,O
cells,O
were,O
activated,O
in,O
the,O
presence,O
of,O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
",",O
the,O
levels,O
of,O
the,O
mature,B
protein,I
as,O
well,O
as,O
its,O
precursor,O
were,O
decreased,O
.,O
Further,O
",",O
1,O
",",O
25,O
(,O
OH,O
),O
2D3,O
inhibited,O
the,O
transcriptional,O
activity,O
of,O
NF,B
-,I
kappa,I
B,I
in,O
Jurkat,O
cells,O
transiently,O
transfected,O
with,O
a,O
construct,O
containing,O
four,O
tandem,O
repeats,O
of,O
the,O
NF,B
-,I
kappa,I
B,I
binding,O
sequence,O
of,O
the,O
immunoglobulin,B
kappa,I
light,I
chain,I
gene,I
linked,O
to,O
the,O
chloramphenicol,O
acetyltransferase,O
reporter,O
gene,I
.,O
These,O
observations,O
demonstrate,O
directly,O
that,O
there,O
is,O
de,O
novo,O
synthesis,O
of,O
NF,B
-,I
kappa,I
B,I
during,O
human,O
lymphocyte,O
activation,O
and,O
suggest,O
that,O
this,O
process,O
is,O
hormonally,O
regulated,O
.,O
We,O
previously,O
identified,O
the,O
DNA,B
consensus,I
binding,I
site,I
recognized,O
by,O
the,O
two,O
DNA,B
binding,I
domains,I
.,O
The,O
expression,O
vector,O
was,O
cotransfected,O
with,O
the,O
chloramphenicol,O
acetyl,O
transferase,O
(,O
CAT,B
),O
reporter,O
gene,O
regulated,O
by,O
the,O
thymidine,O
kinase,O
promoter,O
containing,O
GAL4,O
DNA,B
binding,I
sites,I
into,O
NIH,B
3T3,I
",",O
293,B
",",O
K562,B
",",O
and,O
Jurkat,B
cell,I
lines,I
.,O
In,O
contrast,O
",",O
MZF,B
-,I
1,I
activates,O
CAT,B
reporter,I
gene,I
expression,O
in,O
the,O
hematopoietic,B
cell,I
lines,I
K562,O
and,O
Jurkat,O
.,O
The,O
MZF,B
-,I
1,I
binding,O
sites,O
are,O
present,O
in,O
the,O
promoters,O
of,O
several,O
genes,O
expressed,O
during,O
myeloid,B
differentiation,I
",",O
including,O
the,O
CD34,B
promoter,I
.,O
This,O
induction,O
was,O
not,O
inhibited,O
by,O
treatment,O
of,O
the,O
cells,O
with,O
a,O
protein,B
synthesis,I
inhibitor,I
",",O
cycloheximide,O
.,O
The,O
role,O
of,O
BSAP,B
(,O
Pax,B
-,I
5,I
),O
in,O
B,B
-,I
cell,I
development,O
.,O
Analysis,O
of,O
the,O
biochemical,O
and,O
cell,O
biological,O
properties,O
of,O
these,O
HSFs,O
reveals,O
that,O
HSF3,B
has,O
properties,O
in,O
common,O
with,O
both,O
HSF1,B
and,O
HSF2,B
and,O
yet,O
has,O
features,O
which,O
are,O
distinct,O
from,O
both,O
.,O
HSF3,B
is,O
constitutively,O
expressed,O
in,O
the,O
erythroblast,B
cell,I
line,I
HD6,B
",",O
the,O
lymphoblast,B
cell,I
line,I
MSB,B
",",O
and,O
embryo,B
fibroblasts,I
",",O
and,O
yet,O
its,O
DNA,B
-,I
binding,I
activity,I
is,O
induced,O
only,O
upon,O
exposure,O
of,O
HD6,B
cells,I
to,O
heat,O
shock,O
.,O
Nuclear,B
factor,I
of,I
activated,I
T,I
cells,I
(,O
NFAT,B
),O
regulates,O
transcription,O
of,O
a,O
number,O
of,O
cytokine,O
genes,O
",",O
and,O
NFAT,B
DNA,I
binding,I
activity,I
is,O
stimulated,O
following,O
T,B
cell,I
activation,I
.,O
Treatment,O
of,O
immunoprecipitated,O
NFATp,B
from,O
untreated,O
HT,B
-,I
2,I
cells,I
with,O
calcineurin,O
resulted,O
in,O
the,O
dephosphorylation,O
of,O
NFATp,B
",",O
demonstrating,O
that,O
NFATp,B
is,O
an,O
in,O
vitro,O
substrate,O
for,O
calcineurin,O
.,O
Both,O
of,O
these,O
events,O
were,O
blocked,O
by,O
preincubation,O
of,O
the,O
cells,O
with,O
FK506,B
",",O
a,O
calcineurin,B
inhibitor,I
",",O
consistent,O
with,O
the,O
hypothesis,O
that,O
NFATp,B
is,O
a,O
calcineurin,B
substrate,I
in,O
cells,O
.,O
Activation,O
and,O
expression,O
of,O
the,O
nuclear,B
factors,I
of,I
activated,I
T,I
cells,I
",",O
NFATp,B
and,O
NFATc,B
",",O
in,O
human,O
natural,O
killer,O
cells,O
:,O
regulation,O
upon,O
CD16,O
ligand,O
binding,O
.,O
The,O
results,O
of,O
supershift,O
assays,O
using,O
NFATp,B
-,I
and,O
NFATc,B
-,I
specific,O
antibodies,O
indicate,O
that,O
NK,B
cell,I
activation,O
early,O
after,O
CD16,O
ligand,O
binding,O
involves,O
primarily,O
",",O
if,O
not,O
exclusively,O
",",O
NFATp,B
",",O
and,O
Western,O
blot,O
analysis,O
shows,O
that,O
this,O
has,O
the,O
same,O
electrophoretic,O
mobility,O
(,O
approximately,O
120,O
kD,O
),O
as,O
that,O
of,O
T,B
lymphocytes,I
.,O
Since,O
many,O
cytokines,O
that,O
activate,O
Jak,B
kinases,I
also,O
lead,O
to,O
the,O
tyrosine,O
phosphorylation,O
and,O
activation,O
of,O
members,O
of,O
the,O
Stat,B
family,I
of,I
transcription,I
factors,I
",",O
the,O
ability,O
of,O
IL,O
-,O
2,O
to,O
trigger,O
Stat,B
phosphorylation,I
was,O
examined,O
.,O
Exposure,O
of,O
activated,O
human,B
T,I
lymphocytes,I
or,O
of,O
a,O
natural,O
killer,O
cell,O
line,O
(,O
NKL,B
),O
to,O
IL,O
-,O
2,O
leads,O
to,O
the,O
phosphorylation,O
of,O
Stat1,B
alpha,I
",",O
Stat1,B
beta,I
",",O
and,O
Stat3,B
",",O
as,O
well,O
as,O
of,O
two,O
Stat,B
-,I
related,I
proteins,I
",",O
p94,B
and,O
p95,B
.,O
These,O
Stat,B
proteins,I
were,O
found,O
to,O
translocate,O
to,O
the,O
nucleus,O
and,O
to,O
bind,O
to,O
a,O
specific,O
DNA,B
sequence,I
.,O
Results,O
indicated,O
that,O
(,O
i,O
),O
constitutive,O
c,O
-,O
fos,O
transcript,O
levels,O
are,O
significantly,O
higher,O
in,O
patients,O
subsequently,O
responding,O
to,O
IFN,O
-,O
alpha,O
therapy,O
(,O
p,O
<,O
0,O
0.47,O
1,O
),O
and,O
positively,O
correlated,O
with,O
the,O
proportion,O
of,O
lymphocytes,O
(,O
r,O
=,O
0,O
0.62,O
6895,O
",",O
p,O
<,O
0,O
.,O
1,O
),O
and,O
negatively,O
with,O
the,O
proportion,O
of,O
immature,O
cells,O
(,O
r,O
=,O
-,O
0,O
.,O
568,O
",",O
p,O
<,O
0,O
.,O
1,O
),O
contained,O
in,O
the,O
pbmc,O
preparations,O
tested,O
",",O
(,O
ii,O
),O
constitutive,O
mRNA,O
levels,O
of,O
the,O
hybrid,O
bcr,B
/,I
abl,I
",",O
c,B
-,I
myc,I
and,O
p53,B
are,O
positively,O
correlated,O
with,O
each,O
other,O
",",O
but,O
failed,O
to,O
relate,O
to,O
disease,O
parameters,O
",",O
and,O
(,O
iii,O
),O
acute,O
and,O
chronic,O
in,O
vivo,O
exposure,O
to,O
IFN,B
-,I
alpha,I
is,O
accompanied,O
by,O
upregulation,O
of,O
c,B
-,I
fos,I
and,O
downregulation,O
of,O
c,B
-,I
myc,I
mRNA,O
levels,O
in,O
responder,O
patients,O
.,O
In,O
parallel,O
experiments,O
",",O
IL,B
-,I
2,I
-,I
driven,O
proliferation,O
was,O
inhibited,O
significantly,O
.,O
Yet,O
",",O
IL,B
-,I
2,I
-,I
driven,O
proliferation,O
remained,O
profoundly,O
inhibited,O
",",O
suggesting,O
that,O
signaling,O
events,O
other,O
than,O
Jak3,B
/,I
Stat,B
activation,O
had,O
also,O
been,O
changed,O
following,O
SE,O
stimulation,O
.,O
In,O
contrast,O
to,O
hematopoietic,B
cells,I
",",O
I,B
kappa,I
B,I
alpha,I
-,I
/,I
-,I
embryonic,I
fibroblasts,I
show,O
minimal,O
constitutive,O
NF,B
-,I
kappa,I
B,I
",",O
as,O
well,O
as,O
normal,O
signal,O
-,O
dependent,O
NF,B
-,I
kappa,I
B,I
activation,O
that,O
is,O
concomitant,O
with,O
I,B
kappa,I
B,I
beta,I
degradation,O
.,O
Moreover,O
",",O
the,O
induction,O
of,O
both,O
Jak,B
1,I
and,O
3,B
",",O
and,O
STAT,B
5,I
activity,O
strongly,O
correlated,O
with,O
the,O
growth,O
-,O
promoting,O
effects,O
of,O
IL,B
-,I
7,I
",",O
suggesting,O
that,O
this,O
signal,O
transduction,O
mechanism,O
may,O
play,O
a,O
key,O
role,O
in,O
IL,B
-,I
7,I
-,I
induced,O
proliferation,O
.,O
Cytokine,O
-,O
modulating,O
activity,O
of,O
tepoxalin,O
",",O
a,O
new,O
potential,O
antirheumatic,O
.,O
In,O
human,B
peripheral,I
blood,I
mononuclear,I
cells,I
(,O
PBMC,B
),O
stimulated,O
with,O
OKT3,O
/,O
PMA,O
",",O
tepoxalin,O
inhibited,O
lymphocyte,B
proliferation,I
with,O
an,O
IC50,O
of,O
6,O
microM,O
.,O
Cytotoxicity,O
was,O
not,O
demonstrated,O
at,O
these,O
concentrations,O
.,O
Tepoxalin,O
also,O
inhibits,O
the,O
activation,O
of,O
NF,B
kappa,I
B,I
",",O
a,O
transcription,O
factor,O
which,O
acts,O
on,O
several,O
cytokine,B
genes,I
.,O
Analysis,O
of,O
the,O
expression,O
of,O
human,O
I,B
kappa,I
B,I
alpha,I
protein,O
in,O
stable,O
transfectants,O
of,O
mouse,O
70Z,O
/,O
3,O
cells,O
shows,O
that,O
",",O
as,O
for,O
the,O
endogenous,O
murine,O
protein,O
",",O
exogenous,O
I,B
kappa,I
B,I
alpha,I
is,O
degraded,O
in,O
response,O
to,O
inducers,O
of,O
NF,B
-,I
kappa,I
B,I
activity,O
",",O
such,O
as,O
phorbol,O
myristate,O
acetate,O
or,O
lipopolysaccharide,O
.,O
By,O
expressing,O
mutant,O
forms,O
of,O
the,O
human,O
protein,B
in,O
this,O
cell,B
line,I
",",O
we,O
have,O
been,O
able,O
to,O
delineate,O
the,O
sequences,O
responsible,O
for,O
both,O
the,O
ligand,O
-,O
induced,O
phosphorylation,O
and,O
the,O
degradation,O
of,O
I,B
kappa,I
B,I
alpha,I
.,O
Interestingly,O
",",O
microtubule,O
disruption,O
also,O
decreased,O
monocyte,B
1,I
",",O
25,I
(,I
OH,I
),I
2D3,I
synthesis,O
",",O
not,O
by,O
decreasing,O
the,O
Vmax,O
of,O
monocyte,O
mitochondrial,O
1,O
alpha,O
-,O
hydroxylase,O
but,O
through,O
an,O
increase,O
in,O
the,O
Km,O
for,O
25,O
(,O
OH,O
),O
2D3,O
.,O
We,O
examined,O
25,O
(,O
OH,B
),O
D3,B
transport,O
.,O
Finally,O
",",O
by,O
studying,O
a,O
further,O
series,O
of,O
patients,O
",",O
we,O
could,O
confirm,O
that,O
the,O
decrease,O
in,O
Rap1,B
protein,I
expression,O
in,O
heart,O
failure,O
",",O
whatever,O
its,O
extent,O
",",O
was,O
variable,O
",",O
and,O
could,O
strictly,O
correlate,O
the,O
expression,O
of,O
Rap1,B
protein,I
with,O
the,O
stimulatory,O
effect,O
of,O
C,O
.,O
Sub,O
.,O
on,O
Ca2,B
+,I
transport,I
.,O
An,O
IRF,B
-,I
1,I
-,I
dependent,O
pathway,O
of,O
DNA,B
damage,I
-,I
induced,I
apoptosis,I
in,O
mitogen,O
-,O
activated,O
T,B
lymphocytes,I
.,O
Here,O
we,O
show,O
DNA,B
damage,I
-,I
induced,I
apoptosis,I
in,O
these,O
T,B
lymphocytes,I
is,O
dependent,O
on,O
the,O
antioncogenic,O
transcription,O
factor,O
interferon,B
regulatory,I
factor,I
(,O
IRF,B
),O
-,O
1,I
.,O
Activation,O
through,O
the,O
Ca2,B
+,I
/,I
calcineurin,I
pathway,I
is,O
essential,O
to,O
the,O
transcription,O
of,O
many,O
cytokine,B
genes,I
.,O
Results,O
from,O
site,O
-,O
directed,O
mutations,O
and,O
electrophoretic,O
mobility,O
shift,O
assays,O
strongly,O
suggest,O
that,O
this,O
sequence,O
mediates,O
the,O
ionomycin,O
-,O
induced,O
activation,O
of,O
the,O
TCRG,B
enhancer,I
.,O
Our,O
studies,O
provide,O
an,O
explanation,O
for,O
a,O
previous,O
observation,O
that,O
TCRG,B
mRNA,I
levels,I
",",O
but,O
not,O
mRNA,O
levels,O
for,O
T,O
cell,O
receptor,O
alpha,O
and,O
-,O
beta,O
",",O
are,O
increased,O
by,O
ionomycin,O
treatment,O
.,O
Coexpression,O
of,O
NF,B
-,I
kappa,I
B,I
/,O
Rel,B
and,O
Sp1,B
transcription,I
factors,I
in,O
human,O
immunodeficiency,O
virus,O
1,O
-,O
induced,O
",",O
dendritic,O
cell,O
-,O
T,O
-,O
cell,O
syncytia,O
.,O
These,O
syncytia,O
lack,O
activated,O
cells,O
as,O
determined,O
by,O
an,O
absence,O
of,O
staining,O
for,O
Ki,B
-,I
67,I
cell,I
cycle,I
antigen,I
.,O
We,O
have,O
used,O
immunolabeling,O
",",O
Western,O
blot,O
analysis,O
",",O
and,O
electrophoretic,O
mobility,O
shift,O
and,O
supershift,O
assays,O
.,O
T,O
cells,B
lack,O
active,O
NF,B
-,I
kappa,I
B,I
but,O
express,O
Sp1,B
as,O
expected,O
.,O
Therefore,O
",",O
HIV,B
-,I
1,I
-,I
induced,O
cell,O
fusion,O
brings,O
together,O
factors,O
that,O
upregulate,O
virus,O
transcription,O
.,O
Deoxycholate,O
treatment,O
of,O
the,O
cytoplasmic,O
extract,O
prepared,O
from,O
cells,B
stimulated,O
by,O
TNF,B
-,I
alpha,I
in,O
the,O
presence,O
of,O
Cu2,O
+,O
resulted,O
in,O
the,O
release,O
of,O
NF,B
kappa,I
B,I
from,O
I,B
kappa,I
B,I
alpha,I
",",O
indicating,O
that,O
Cu2,O
+,O
interferes,O
with,O
the,O
dissociation,O
of,O
the,O
NF,B
kappa,I
B,I
-,I
I,I
kappa,I
B,I
complex,I
.,O
Neither,O
phosphorylation,O
nor,O
degradation,O
of,O
I,B
kappa,I
B,I
alpha,I
was,O
observed,O
upon,O
TNF,O
-,O
alpha,O
stimulation,O
in,O
the,O
presence,O
of,O
Cu2,O
+,O
.,O
Cloning,O
a,O
cDNA,B
from,O
human,O
NK,O
/,O
T,O
cells,O
which,O
codes,O
for,O
a,O
protein,B
with,O
high,O
proline,O
content,O
.,O
The,O
present,O
study,O
verified,O
the,O
ability,O
of,O
IL,O
-,O
2,O
to,O
cause,O
tyrosine,O
phosphorylation,O
and,O
activation,O
of,O
JAK1,B
and,O
JAK3,B
",",O
but,O
demonstrated,O
that,O
IL,O
-,O
2,O
stimulated,O
JAK3,B
to,O
a,O
significantly,O
larger,O
extent,O
than,O
JAK1,B
in,O
human,O
T,O
lymphocytes,O
and,O
the,O
YT,O
cell,O
line,O
.,O
Nonetheless,O
",",O
a,O
membrane,O
-,O
proximal,O
region,O
of,O
human,O
IL,B
-,I
2R,I
beta,I
(,O
Asn240,O
-,O
Leu335,O
),O
was,O
critical,O
for,O
JAK3,B
activation,O
",",O
and,O
the,O
amount,O
of,O
JAK3,B
present,O
in,O
activated,O
IL,B
-,I
2R,I
receptor,I
complexes,I
increased,O
with,O
time,O
",",O
suggesting,O
that,O
stabilization,O
of,O
JAK3,B
binding,O
to,O
the,O
receptor,O
complex,O
relies,O
on,O
both,O
IL,B
-,I
2R,I
beta,I
and,O
IL,B
-,I
2R,I
gamma,I
.,O
DHEA,B
binding,I
sites,I
were,O
examined,O
using,O
a,O
whole,O
-,O
cell,O
binding,O
assay,O
in,O
a,O
human,O
T,B
lymphoid,I
cell,I
line,I
",",O
PEER,O
",",O
revealing,O
that,O
a,O
single,O
class,O
of,O
high,O
-,O
affinity,O
binding,O
sites,O
for,O
DHEA,B
(,O
dissociation,O
constant,O
=,O
7,O
.,O
4,O
+,O
/,O
-,O
0,O
.,O
53,O
nmol,O
/,O
L,O
",",O
mean,O
+,O
/,O
-,O
SE,O
",",O
n,O
=,O
4,O
),O
was,O
greatly,O
increased,O
when,O
treated,O
with,O
DHEA,B
",",O
phorbol,O
-,O
12,O
-,O
myristate,O
-,O
13,O
-,O
acetate,O
",",O
and,O
the,O
Ca2,B
+,I
ionophore,I
A23187,I
.,O
In,O
most,O
cases,O
",",O
the,O
transcriptional,O
factor,O
NF,B
-,I
kappa,I
B,I
is,O
a,O
heterodimer,O
consisting,O
of,O
two,O
subunits,O
",",O
p50,B
and,O
p65,B
",",O
which,O
are,O
encoded,O
by,O
two,O
distinct,O
genes,O
of,O
the,O
Rel,B
family,I
.,O
It,O
has,O
been,O
suggested,O
that,O
the,O
ubiquitin,B
-,I
proteasome,I
system,I
is,O
involved,O
in,O
the,O
process,O
;,O
however,O
",",O
the,O
specific,O
enzymes,O
involved,O
and,O
the,O
mechanism,O
of,O
limited,O
proteolysis,O
",",O
in,O
which,O
half,O
of,O
the,O
molecule,O
is,O
spared,O
",",O
have,O
been,O
obscure,O
.,O
This,O
novel,O
enzyme,B
is,O
distinct,O
from,O
E6,B
-,I
AP,I
",",O
the,O
p53,B
-,I
conjugating,I
ligase,I
",",O
and,O
from,O
E3,B
alpha,I
",",O
the,O
``,O
N,B
-,I
end,I
rule,I
',I
ligase,I
.,O
Cycles,O
remained,O
ovulatory,O
.,O
Before,O
treatment,O
",",O
the,O
number,O
of,O
androgen,B
receptors,I
was,O
higher,O
in,O
the,O
luteal,O
than,O
in,O
the,O
follicular,O
phase,O
.,O
CONCLUSIONS,O
:,O
Flutamide,O
is,O
effective,O
in,O
the,O
treatment,O
of,O
hirsutism,O
but,O
requires,O
constant,O
surveillance,O
of,O
liver,B
function,I
.,O
An,O
increased,O
growth,O
rate,O
of,O
these,O
Jurkat,B
-,I
tat,I
cell,I
lines,I
as,O
compared,O
with,O
control,O
cell,O
lines,O
was,O
observed,O
.,O
To,O
identify,O
osteoblast,B
-,I
specific,I
cis,I
-,I
acting,I
elements,I
and,O
trans,O
-,O
acting,O
factors,O
",",O
we,O
initiated,O
an,O
analysis,O
of,O
the,O
promoter,O
of,O
a,O
mouse,O
osteocalcin,B
gene,I
",",O
an,O
osteoblast,B
-,I
specific,I
gene,I
.,O
By,O
DNA,B
cotransfection,I
experiments,I
",",O
we,O
also,O
demonstrate,O
that,O
AML,B
-,I
1B,I
can,O
increase,O
the,O
activity,O
of,O
a,O
short,O
osteocalcin,B
promoter,I
through,O
its,O
binding,O
to,O
OSE2,O
.,O
A,O
variety,O
of,O
other,O
cells,O
",",O
including,O
transformed,O
erythroid,B
precursors,I
",",O
do,O
not,O
have,O
IBR,B
but,O
a,O
factor,O
referred,O
to,O
as,O
IBF,B
(,O
68,O
to,O
70,O
kDa,O
),O
that,O
recognizes,O
the,O
same,O
IBR,B
sites,I
.,O
IBR,B
is,O
a,O
503,O
-,O
amino,O
-,O
acid,O
-,O
long,O
acidic,O
protein,B
which,O
is,O
99,O
0.0,O
%,O
identical,O
to,O
the,O
recently,O
reported,O
human,O
NRF,O
-,O
1,O
/,O
alpha,O
-,O
Pal,O
factor,O
and,O
highly,O
related,O
to,O
the,O
invertebrate,O
transcription,O
factors,O
P3A2,O
and,O
erected,O
wing,O
gene,O
product,O
(,O
EWG,B
),O
.,O
We,O
present,O
evidence,O
that,O
IBR,B
and,O
IBF,B
are,O
most,O
likely,O
identical,O
proteins,O
",",O
differing,O
in,O
their,O
degree,O
of,O
glycosylation,O
.,O
Mutation,O
of,O
Jak3,B
in,O
a,O
patient,O
with,O
SCID,O
:,O
essential,O
role,O
of,O
Jak3,B
in,O
lymphoid,O
development,O
.,O
A,O
girl,O
with,O
immunological,O
features,O
indistinguishable,O
from,O
those,O
of,O
XSCID,O
was,O
therefore,O
selected,O
for,O
analysis,O
.,O
The,O
lack,O
of,O
Jak3,B
expression,O
correlated,O
with,O
impaired,O
B,B
cell,I
signaling,O
",",O
as,O
demonstrated,O
by,O
the,O
inability,O
of,O
IL,B
-,I
4,I
to,O
activate,O
Stat6,B
in,O
the,O
EBV,B
-,I
transformed,I
cell,I
line,I
from,O
the,O
patient,O
.,O
These,O
observations,O
indicate,O
that,O
the,O
functions,O
of,O
gamma,B
c,I
are,O
dependent,O
on,O
Jak3,B
and,O
that,O
Jak3,B
is,O
essential,O
for,O
lymphoid,B
development,O
and,O
signaling,O
.,O
L,B
-,I
selectin,I
is,O
an,O
adhesion,O
molecule,O
of,O
the,O
selectin,B
family,I
that,O
mediates,O
the,O
initial,O
step,O
of,O
leukocyte,B
adhesion,I
to,O
vascular,O
endothelium,O
.,O
Upon,O
cellular,O
activation,O
",",O
expression,O
of,O
the,O
L,B
-,I
selectin,I
gene,I
is,O
downregulated,O
at,O
both,O
the,O
protein,B
and,O
mRNA,B
levels,I
.,O
The,O
induction,O
of,O
Tax,O
expression,O
in,O
JPX9,O
cells,O
resulted,O
in,O
about,O
a,O
twofold,O
increase,O
in,O
the,O
mRNA,B
expression,I
levels,I
compared,O
with,O
the,O
basal,O
level,O
.,O
These,O
results,O
indicated,O
that,O
ATL,B
cells,O
constitutively,O
overexpress,O
the,O
L,B
-,I
selectin,I
gene,I
that,O
can,O
be,O
transactivated,O
by,O
HTLV,O
-,O
1,O
Tax,O
.,O
Human,O
herpesvirus,O
6,O
",",O
a,O
predominantly,O
T,B
lymphotropic,I
virus,I
",",O
has,O
been,O
recently,O
shown,O
to,O
infect,O
some,O
EBV,B
-,I
positive,I
B,I
cell,I
lines,I
",",O
and,O
to,O
induce,O
in,O
them,O
the,O
activation,O
of,O
the,O
EBV,B
lytic,I
cycle,I
.,O
Here,O
we,O
have,O
confirmed,O
and,O
extended,O
such,O
observations,O
",",O
showing,O
that,O
(,O
1,O
),O
this,O
phenomenon,O
is,O
restricted,O
to,O
the,O
variant,O
A,O
of,O
HHV,O
-,O
6,O
:,O
in,O
fact,O
two,O
isolates,O
belonging,O
to,O
the,O
HHV,O
-,O
6,O
variant,O
B,O
(,O
BA92,O
and,O
Z29,O
),O
were,O
neither,O
able,O
to,O
infect,O
any,O
B,B
cell,I
line,I
",",O
independently,O
of,O
the,O
EBV,O
status,O
",",O
nor,O
to,O
induce,O
the,O
EBV,O
genome,O
expression,O
.,O
Evidence,O
for,O
normal,O
vitamin,B
D,I
receptor,I
messenger,I
ribonucleic,I
acid,I
and,O
genotype,O
in,O
absorptive,O
hypercalciuria,O
.,O
There,O
was,O
no,O
difference,O
between,O
the,O
distribution,O
of,O
the,O
VDR,B
alleles,O
in,O
the,O
patient,O
population,O
when,O
compared,O
with,O
the,O
normal,O
population,O
.,O
Sequence,O
analysis,O
of,O
the,O
5,O
',O
-,O
flanking,O
region,O
of,O
the,O
CD69,B
gene,I
revealed,O
the,O
presence,O
of,O
a,O
potential,O
TATA,B
element,I
30,O
base,O
pairs,O
upstream,O
of,O
the,O
major,O
transcription,O
initiation,O
site,O
and,O
several,O
putative,O
binding,O
sequences,O
for,O
inducible,O
transcription,O
factors,O
(,O
NF,B
-,I
kappa,I
B,I
",",O
Egr,B
-,I
1,I
",",O
AP,B
-,I
1,I
),O
",",O
which,O
might,O
mediate,O
the,O
inducible,O
expression,O
of,O
this,O
gene,O
.,O
(,O
ABSTRACT,O
TRUNCATED,O
AT,O
250,O
WORDS,O
),O
The,O
exon,O
-,O
intron,O
structure,O
of,O
the,O
5,O
',O
portion,O
of,O
the,O
thromboxane,B
receptor,I
gene,I
was,O
determined,O
initially,O
by,O
comparing,O
the,O
nucleotide,O
sequence,O
of,O
the,O
5,O
',O
flanking,O
genomic,O
clone,O
with,O
that,O
of,O
a,O
novel,O
human,B
uterine,I
thromboxane,I
receptor,I
cDNA,I
that,O
extended,O
the,O
mRNA,O
141,O
bp,O
further,O
upstream,O
than,O
the,O
previously,O
identified,O
human,B
placental,I
cDNA,I
.,O
Promoter,O
function,O
of,O
the,O
5,O
',O
flanking,O
region,O
of,O
the,O
thromboxane,B
receptor,I
gene,I
was,O
evaluated,O
by,O
transfection,O
of,O
thromboxane,B
receptor,I
gene,I
promoter,I
/,O
chloramphenicol,O
acetyltransferase,O
(,O
CAT,B
),O
chimera,O
plasmids,O
into,O
platelet,B
-,I
like,I
K562,B
cells,I
.,O
These,O
studies,O
are,O
the,O
first,O
to,O
determine,O
the,O
structure,O
and,O
organization,O
of,O
the,O
5,O
',O
end,O
of,O
the,O
thromboxane,B
receptor,I
gene,I
and,O
demonstrate,O
that,O
thromboxane,B
receptor,I
gene,I
expression,O
can,O
be,O
regulated,O
by,O
activation,O
of,O
protein,B
kinase,I
C,I
via,O
induction,O
of,O
an,O
AP,O
-,O
2,O
-,O
like,O
nuclear,O
factor,O
binding,O
to,O
upstream,O
promoter,O
elements,O
.,O
Proteins,B
in,O
the,O
first,O
group,O
contain,O
multiple,O
HMG,B
boxes,I
",",O
are,O
non,O
-,O
sequence,O
-,O
specific,O
",",O
and,O
recognize,O
structural,O
features,O
as,O
found,O
in,O
cruciform,B
DNA,I
and,O
cross,O
-,O
over,O
DNA,B
.,O
The,O
abundant,O
chromosomal,O
protein,B
HMG,I
-,I
1,I
belongs,O
to,O
this,O
subgroup,O
.,O
As,O
in,O
HMG1B,B
",",O
the,O
overall,O
structure,O
of,O
the,O
Sox,B
-,I
4,I
HMG,I
box,I
is,O
L,O
-,O
shaped,O
and,O
is,O
maintained,O
by,O
a,O
cluster,O
of,O
conserved,B
",",O
mainly,O
aromatic,O
residues,O
.,O
Nuclear,B
factor,I
kappa,I
B,I
(,O
NF,B
-,I
kappa,I
B,I
),O
is,O
stored,O
in,O
the,O
cytoplasm,O
as,O
an,O
inactive,O
form,O
through,O
interaction,O
with,O
I,B
kappa,I
B,I
.,O
We,O
have,O
recently,O
reported,O
the,O
establishment,O
of,O
a,O
lipopolysaccharide,O
(,O
LPS,O
),O
-,O
dependent,O
cell,B
-,I
free,I
activation,I
system,I
of,O
NF,B
-,I
kappa,I
B,I
in,O
association,O
with,O
the,O
induction,O
of,O
I,B
kappa,I
B,I
alpha,I
phosphorylation,I
.,O
This,O
death,O
-,O
promoting,O
activity,O
of,O
Bik,B
can,O
be,O
suppressed,O
by,O
coexpression,O
of,O
Bcl,B
-,I
2,I
",",O
Bcl,B
-,I
XL,I
",",O
EBV,B
-,I
BHRF1,I
and,O
E1B,B
-,I
19,I
kDa,I
proteins,I
suggesting,O
that,O
Bik,B
may,O
be,O
a,O
common,O
target,O
for,O
both,O
cellular,B
and,O
viral,O
anti,O
-,O
apoptotic,O
proteins,I
.,O
TCF,B
-,I
1,I
mRNA,I
was,O
originally,O
found,O
to,O
be,O
expressed,O
in,O
a,O
T,B
cell,I
-,I
specific,I
fashion,I
within,O
a,O
set,O
of,O
human,B
and,O
mouse,B
cell,I
lines,I
.,O
In,O
contrast,O
",",O
expression,O
reportedly,O
occurs,O
in,O
multiple,O
nonlymphoid,O
tissues,O
during,O
murine,O
embryogenesis,O
.,O
Immunohistochemistry,O
on,O
a,O
panel,O
of,O
human,O
tissues,O
revealed,O
that,O
the,O
TCF,B
-,I
1,I
protein,I
was,O
found,O
exclusively,O
in,O
thymocytes,O
and,O
in,O
CD3,B
+,I
T,I
cells,I
in,O
peripheral,O
lymphoid,O
tissues,O
.,O
Signalling,O
via,O
CD28,B
of,O
human,O
naive,O
neonatal,O
T,B
lymphocytes,I
.,O
We,O
have,O
examined,O
the,O
role,O
of,O
CD28,B
in,O
modulating,O
the,O
',O
naive,O
',O
neonatal,B
T,I
cell,I
response,O
to,O
anti,O
-,O
CD2,B
-,I
mediated,I
activation,O
.,O
Costimulation,O
with,O
anti,O
-,O
CD28,B
MoAb,I
greatly,O
enhanced,O
the,O
proliferative,O
response,O
of,O
neonatal,B
T,I
cells,I
to,O
levels,O
equivalent,O
to,O
those,O
of,O
adult,O
T,I
cells,I
",",O
whereas,O
adult,O
T,I
cells,I
showed,O
only,O
slight,O
increases,O
.,O
Although,O
IL,B
-,I
2,I
secretion,O
was,O
increased,O
in,O
the,O
presence,O
of,O
anti,O
-,O
CD28,O
MoAb,O
",",O
neonatal,O
T,B
cell,I
IL,B
-,I
2,I
production,O
remained,O
lower,O
than,O
in,O
adults,O
.,O
TCL1,O
oncogene,O
activation,O
in,O
preleukemic,O
T,B
cells,I
from,O
a,O
case,O
of,O
ataxia,O
-,O
telangiectasia,O
.,O
We,O
have,O
analyzed,O
the,O
expression,O
of,O
TCL1,O
mRNA,O
and,O
protein,O
in,O
peripheral,O
blood,O
lymphocytes,O
(,O
PBLs,O
),O
from,O
four,O
AT,O
cases,O
and,O
from,O
healthy,O
controls,O
.,O
We,O
found,O
that,O
the,O
TCL1,B
gene,I
was,O
overexpressed,O
in,O
the,O
PBLs,O
of,O
an,O
AT,O
patient,O
with,O
a,O
large,O
clonal,O
T,B
-,I
cell,I
population,I
exhibiting,O
the,O
t,O
(,O
14,O
;,O
14,O
),O
translocation,O
but,O
not,O
in,O
the,O
lymphocytes,O
of,O
the,O
other,O
cases,O
.,O
Fluorescence,O
in,O
situ,O
hybridization,O
of,O
the,O
TCL1,B
genomic,I
locus,I
to,O
lymphocyte,O
metaphases,O
from,O
the,O
AT,O
patient,O
with,O
the,O
T,B
-,I
cell,I
clonal,I
expansion,I
showed,O
that,O
the,O
breakpoint,O
of,O
the,O
t,O
(,O
14,O
;,O
14,O
),O
translocation,O
lies,O
within,O
the,O
TCL1,B
locus,I
and,O
is,O
accompanied,O
by,O
an,O
inverted,O
duplication,O
of,O
the,O
distal,O
part,O
of,O
chromosome,O
14,O
.,O
Deregulation,O
of,O
TCL1,B
is,O
the,O
first,O
event,O
in,O
the,O
initiation,O
of,O
malignancy,O
in,O
these,O
types,O
of,O
leukemias,O
and,O
represents,O
a,O
potential,O
tool,O
for,O
clinical,O
evaluation,O
.,O
Inhibition,O
of,O
endogenous,O
C,B
/,I
EBP,I
proteins,I
",",O
using,O
either,O
an,O
excess,O
of,O
C,B
/,I
EBP,I
binding,I
sites,I
or,O
a,O
trans,O
-,O
dominant,O
negative,O
inhibitor,O
",",O
demonstrated,O
that,O
C,B
/,I
EBP,I
proteins,I
are,O
required,O
for,O
basal,O
and,O
activated,O
levels,O
of,O
HIV,B
-,I
1,I
LTR,I
transcription,I
in,O
the,O
promonocytic,O
cell,O
line,O
U937,B
.,O
Northern,O
(,O
RNA,B
),O
blots,O
and,O
binding,O
assays,O
showed,O
that,O
NF,B
-,I
IL6,I
is,O
the,O
only,O
known,O
C,B
/,I
EBP,I
family,I
member,I
which,O
is,O
increased,O
when,O
U937,O
cells,O
are,O
activated,O
.,O
However,O
",",O
transcription,O
from,O
crippled,O
HIV,B
-,I
1,I
LTRs,I
lacking,O
C,B
/,I
EBP,I
sites,I
can,O
still,O
be,O
induced,O
following,O
activation,O
of,O
U937,O
cells,O
.,O
Since,O
expression,O
of,O
the,O
viruses,O
is,O
in,O
large,O
part,O
regulated,O
by,O
the,O
sequence,O
elements,O
in,O
their,O
long,O
terminal,O
repeats,O
(,O
LTRs,I
),O
",",O
this,O
study,O
was,O
directed,O
to,O
an,O
analysis,O
of,O
the,O
regulatory,O
elements,O
in,O
the,O
HIV,B
-,I
2,I
LTR,I
.,O
The,O
HIV,B
-,I
2,I
LTR,I
was,O
found,O
to,O
contain,O
two,O
enhancers,B
.,O
We,O
report,O
here,O
that,O
both,O
NF,B
-,I
M,I
-,I
dependent,I
promoter,I
constructs,O
and,O
resident,O
genes,O
could,O
be,O
activated,O
by,O
addition,O
of,O
beta,O
-,O
estradiol,O
to,O
the,O
NF,B
-,I
M,I
-,I
estrogen,I
receptor,I
expressing,O
progenitors,O
.,O
In,O
addition,O
to,O
the,O
onset,O
of,O
differentiation,O
",",O
cell,B
death,I
was,O
induced,O
with,O
typical,O
apoptotic,O
features,O
.,O
A,O
comparison,O
with,O
the,O
Stat,B
proteins,I
induced,O
by,O
interferon,O
-,O
gamma,O
",",O
PRL,O
",",O
and,O
IL,O
-,O
6,O
in,O
T47D,B
mammary,I
tumor,I
cells,I
was,O
made,O
.,O
Activation,O
of,O
a,O
second,O
protein,B
related,O
to,O
Stat1,B
was,O
also,O
observed,O
.,O
Granulocyte,B
-,I
macrophage,I
colony,I
-,I
stimulating,I
factor,I
(,I
GM,I
-,I
CSF,I
),I
is,O
one,O
such,O
cytokine,O
whose,O
increased,O
expression,O
results,O
partly,O
from,O
increases,O
in,O
transcription,O
.,O
A,O
number,O
of,O
the,O
ETS,B
family,I
of,I
transcription,I
factors,I
are,O
expressed,O
in,O
T,B
cells,I
",",O
including,O
ETS1,B
and,O
ELF1,B
.,O
Other,O
unidentified,O
ETS,B
-,I
like,I
factors,I
present,O
in,O
Jurkat,B
cells,I
are,O
also,O
capable,O
of,O
binding,O
GM5,O
.,O
No,O
up,O
-,O
regulation,O
of,O
hTR,B
beta,I
1,I
was,O
seen,O
in,O
hypothyroid,O
relative,O
to,O
euthyroid,O
patients,O
.,O
Using,O
varying,O
conditions,O
",",O
three,O
distinct,O
complexes,O
were,O
shown,O
to,O
interact,O
specifically,O
with,O
the,O
NIP,O
region,O
",",O
although,O
only,O
one,O
correlates,O
with,O
repressor,O
activity,O
.,O
DNA,B
binding,I
specificity,I
of,I
complex,I
3,I
overlaps,O
with,O
that,O
of,O
upstream,O
stimulatory,O
factor,O
but,O
is,O
clearly,O
distinct,O
.,O
Functional,O
specificity,O
for,O
repression,O
matches,O
the,O
DNA,B
binding,I
specificity,I
of,I
complex,I
3,I
;,O
both,O
repressor,O
activity,O
and,O
complex,O
3,O
binding,O
require,O
the,O
consensus,O
sequence,O
CTCACNTNC,O
.,O
The,O
hematopoietic,O
transcription,O
factor,O
PU,O
.,O
1,O
is,O
downregulated,O
in,O
human,O
multiple,O
myeloma,O
cell,O
lines,O
.,O
PU,B
.,O
1,O
is,O
a,O
hematopoietic,O
transcription,O
factor,O
belonging,O
to,O
the,O
Ets,O
-,O
family,O
.,O
It,O
binds,O
the,O
so,O
-,O
called,O
Pu,B
box,I
",",O
an,O
important,O
tissue,O
-,O
specific,O
regulatory,O
DNA,B
element,I
present,O
in,O
a,O
number,O
of,O
genes,O
expressed,O
in,O
these,O
cell,O
lineages,O
.,O
We,O
have,O
analyzed,O
the,O
expression,O
and,O
activity,O
of,O
PU,B
.,O
during,O
human,O
B,B
-,I
cell,I
development,O
using,O
a,O
panel,O
of,O
B,B
-,I
cell,I
lines,I
representing,O
different,O
stages,O
of,O
maturation,O
",",O
from,O
early,O
precursors,O
to,O
differentiated,O
plasma,O
cells,O
.,O
The,O
effects,O
of,O
CsA,O
on,O
endothelial,O
cells,O
were,O
also,O
detected,O
at,O
the,O
chromatin,O
structure,O
level,O
",",O
as,O
DNasel,O
hypersensitive,O
sites,O
within,O
both,O
the,O
GM,B
-,I
CSF,I
enhancer,I
and,O
the,O
E,B
-,I
selectin,I
promoter,I
were,O
suppressed,O
by,O
CsA,O
.,O
Protein,B
phosphorylation,I
has,O
an,O
important,O
role,O
in,O
the,O
regulation,O
of,O
these,O
two,O
factors,O
:,O
(,O
1,O
),O
it,O
induces,O
the,O
transactivating,O
capacity,O
of,O
the,O
AP,B
-,I
1,I
protein,I
c,I
-,I
Jun,I
;,O
and,O
(,O
2,O
),O
it,O
is,O
involved,O
in,O
the,O
release,O
of,O
the,O
cytoplasmic,O
inhibitor,O
",",O
I,B
kappa,I
B,I
",",O
from,O
NF,B
-,I
kappa,I
B,I
",",O
allowing,O
translocation,O
of,O
the,O
latter,O
into,O
the,O
nucleus,O
.,O
We,O
have,O
recently,O
shown,O
that,O
both,O
phosphorylation,B
processes,I
require,O
T,B
-,I
cell,I
costimulation,I
.,O
According,O
to,O
our,O
results,O
",",O
however,O
",",O
the,O
kinases,O
responsible,O
for,O
the,O
two,O
processes,O
are,O
distinct,O
entities,O
.,O
We,O
",",O
therefore,O
",",O
propose,O
the,O
activation,O
scheme,O
presented,O
in,O
FIGURE,O
3,O
for,O
T,B
-,I
cell,I
costimulation,I
.,O
Integration,O
of,O
the,O
signals,O
generated,O
by,O
TCR,B
and,O
CD28,B
engagement,O
occurs,O
along,O
this,O
pathway,O
",",O
which,O
then,O
bifurcates,O
to,O
induce,O
I,O
kappa,B
B,I
phosphorylation,I
and,O
NF,B
-,I
kappa,I
B,I
activation,I
on,O
the,O
one,O
hand,O
",",O
and,O
JNK,B
activation,I
and,O
c,B
-,I
Jun,I
phosphorylation,I
on,O
the,O
other,O
.,O
We,O
are,O
currently,O
engaged,O
in,O
defining,O
where,O
the,O
two,O
signals,O
integrate,O
along,O
the,O
AP,O
-,O
1,O
/,O
NF,B
-,I
kappa,I
B,I
pathway,I
.,O
Enhancement,O
of,O
HIV,O
-,O
1,O
replication,O
is,O
related,O
in,O
part,O
to,O
increased,O
DNA,B
-,I
binding,I
activity,I
of,O
cellular,O
transcription,O
factors,O
such,O
as,O
NF,B
-,I
kappa,I
B,I
.,O
Increased,O
intracellular,O
stores,O
of,O
latent,O
NF,B
-,I
kappa,I
B,I
may,O
also,O
result,O
in,O
rapid,O
inducibility,O
of,O
NF,B
-,I
kappa,I
B,I
-,I
dependent,I
cytokine,I
gene,I
expression,I
.,O
Elevated,O
levels,O
of,O
several,O
inflammatory,O
cytokines,B
have,O
been,O
detected,O
in,O
the,O
sera,O
of,O
HIV,B
-,I
1,I
-,I
infected,O
individuals,O
.,O
We,O
measured,O
steroid,O
mediated,O
lysis,O
",",O
receptor,O
number,O
and,O
induction,O
of,O
glutamine,O
synthetase,O
in,O
the,O
transfected,O
cells,O
.,O
The,O
DNA,B
binding,I
region,I
specifying,O
high,O
affinity,O
for,O
GRE,O
sites,O
is,O
required,O
.,O
Our,O
data,O
support,O
the,O
view,O
that,O
steroid,B
-,I
mediated,I
cell,I
death,I
occurs,O
by,O
a,O
process,O
requiring,O
direct,O
interaction,O
of,O
steroid,B
-,I
receptor,I
complexes,I
with,O
the,O
genome,O
.,O
Full,O
-,O
length,O
cDNAs,O
and,O
genomic,O
clones,O
were,O
isolated,O
",",O
and,O
the,O
gene,O
structure,O
was,O
determined,O
.,O
Comparison,O
of,O
the,O
deduced,O
amino,O
acids,O
shows,O
88,O
%,O
sequence,O
identity,O
between,O
mouse,O
and,O
human,O
BOB,B
.,O
1,O
/,O
OBF,B
.,O
1,O
.,O
The,O
NH2,B
-,I
terminal,I
126,O
amino,O
acids,O
of,O
BOB,B
.,O
1,O
/,O
OBF,B
.,O
1,O
are,O
both,O
essential,O
and,O
sufficient,O
for,O
interaction,O
with,O
the,O
POU,B
domains,I
of,O
either,O
Oct1,B
or,O
Oct2,B
.,O
As,O
this,O
phosphorylation,O
was,O
independent,O
of,O
protein,O
kinase,O
C,O
activity,O
",",O
we,O
tested,O
whether,O
a,O
calcium,B
/,I
calmodulin,I
-,I
dependent,I
protein,I
kinase,I
(,O
CaM,B
kinase,I
),O
might,O
phosphorylate,O
the,O
Ets,B
-,I
1,I
protein,I
after,O
elevation,O
of,O
intracellular,O
free,O
calcium,B
concentrations,O
.,O
Furthermore,O
",",O
we,O
identified,O
a,O
repression,O
domain,O
at,O
the,O
N,O
-,O
terminus,O
of,O
Oct,B
-,I
2a,I
.,O
Whereas,O
the,O
mechanism,O
of,O
nonopsonic,O
phagocytosis,O
of,O
Pseudomonas,O
aeruginosa,O
has,O
been,O
described,O
",",O
the,O
bacterial,O
ligands,O
required,O
are,O
poorly,O
understood,O
.,O
GP,B
Ib,I
alpha,I
promoter,I
activity,O
was,O
evaluated,O
by,O
transfection,O
of,O
human,O
erythroleukemia,O
cells,O
with,O
reporter,O
plasmids,O
coding,O
for,O
the,O
enzyme,O
",",O
luciferase,O
.,O
The,O
results,O
define,O
essential,O
cis,O
-,O
acting,O
elements,O
responsible,O
for,O
the,O
expression,O
of,O
GP,B
Ib,I
alpha,I
and,O
provide,O
insights,O
into,O
molecular,O
events,O
coinciding,O
with,O
the,O
release,O
of,O
normal,O
platelets,O
into,O
the,O
bloodstream,O
.,O
CD30,B
is,O
a,O
recently,O
described,O
member,O
of,O
the,O
tumor,O
necrosis,O
factor,O
/,O
nerve,O
growth,O
factor,O
receptor,O
superfamily,O
.,O
In,O
all,O
cell,B
lines,I
investigated,O
",",O
the,O
NF,B
-,I
kappa,I
B,I
complexes,O
induced,O
following,O
CD30,O
engagement,O
were,O
shown,O
to,O
contain,O
p50,B
NF,B
-,I
kappa,I
B1,I
",",O
p65,B
RelA,I
",",O
and,O
possibly,O
other,O
transcription,O
factors,O
.,O
Estrogen,B
and,O
progesterone,B
receptors,I
in,O
vernal,O
keratoconjunctivitis,O
.,O
RESULTS,O
:,O
Both,O
the,O
epithelium,O
and,O
subepithelium,O
of,O
the,O
tarsal,O
and,O
bulbar,O
conjunctiva,O
of,O
patients,O
with,O
VKC,O
",",O
but,O
not,O
those,O
of,O
four,O
nonatopic,O
control,O
subjects,O
",",O
showed,O
intense,O
positive,O
staining,O
for,O
estrogen,B
and,O
progesterone,B
receptors,I
.,O
The,O
expression,O
of,O
MHC,B
class,I
II,I
genes,I
in,O
mouse,O
T,B
cells,I
can,O
be,O
reconstituted,O
upon,O
transfection,O
with,O
the,O
human,O
CIITA,B
cDNA,I
.,O
Because,O
HLA,B
class,I
II,I
molecules,I
present,O
antigen,O
to,O
T,B
cell,I
receptors,I
(,O
TCRs,B
),O
",",O
we,O
have,O
searched,O
for,O
a,O
TCR,B
gene,I
associated,O
with,O
the,O
production,O
of,O
anti,O
-,O
Ro,B
(,O
SSA,I
),O
antibodies,O
.,O
This,O
RFLP,O
pair,O
occurs,O
in,O
76,O
%,O
of,O
patients,O
with,O
Ro,B
(,O
SSA,I
),O
precipitins,O
",",O
84,O
%,O
of,O
anti,O
-,O
Ro,B
(,O
SSA,I
),O
-,O
positive,O
patients,O
lacking,O
La,B
(,O
SSB,I
),O
precipitins,O
",",O
but,O
only,O
41,O
%,O
of,O
the,O
patients,O
lacking,O
both,O
precipitins,O
(,O
P,O
=,O
0,O
.,O
4,O
),O
.,O
The,O
majority,O
of,O
patients,O
who,O
have,O
these,O
RFLPs,O
and,O
HLA,B
class,I
II,I
antigens,I
previously,O
associated,O
with,O
the,O
anti,O
-,O
Ro,B
(,O
SSA,I
),O
response,O
make,O
this,O
antibody,O
",",O
suggesting,O
that,O
interactions,O
between,O
products,O
of,O
these,O
loci,O
occur,O
in,O
response,O
to,O
Ro,B
(,O
SSA,I
),O
.,O
However,O
",",O
while,O
IL2,B
expression,O
requires,O
the,O
contribution,O
of,O
Ca,B
(,O
2,I
+,I
),O
-,O
and,O
protein,B
kinase,I
C,I
-,I
dependent,I
signals,I
",",O
we,O
report,O
that,O
activation,O
of,O
human,O
IL4,B
transcription,O
through,O
the,O
Ca,B
(,O
2,I
+,I
),O
-,O
dependent,I
pathway,I
is,O
diminished,O
by,O
protein,B
kinase,I
C,I
stimulation,I
in,O
Jurkat,B
T,I
cells,I
.,O
Human,O
IL4,B
promoter,I
-,I
mediated,I
transcription,I
is,O
downregulated,O
in,O
Jurkat,B
cells,I
stimulated,O
with,O
the,O
NF,B
-,I
kappa,I
B,I
-,I
activating,O
cytokine,O
tumor,O
necrosis,O
factor,O
alpha,O
and,O
suppressed,O
in,O
RelA,B
-,I
overexpressing,I
cells,I
.,O
Many,O
cytokines,O
activate,O
signal,O
transducer,O
and,O
activation,O
of,O
transcription,O
(,O
STAT,B
),O
transcription,O
factors,O
",",O
which,O
",",O
in,O
turn,O
",",O
activate,O
transcription,O
of,O
inflammatory,O
effector,O
genes,O
.,O
The,O
present,O
study,O
demonstrates,O
that,O
triggering,O
of,O
complement,B
receptors,I
CR1,B
(,O
CD35,B
),O
and,O
CR3,B
(,O
CD11b,B
/,I
CD18,I
),O
enhances,O
viral,O
replication,O
in,O
HIV,B
-,I
infected,I
human,I
monocytic,I
cells,I
.,O
Monocytic,O
cell,O
lines,O
and,O
normal,O
peripheral,O
blood,O
monocytes,O
were,O
infected,O
with,O
HIV,B
-,I
1,I
in,O
vitro,O
and,O
cultured,O
in,O
the,O
presence,O
or,O
absence,O
of,O
F,O
(,O
ab,O
',O
),O
2,O
fragments,O
of,O
monoclonal,O
anti,O
-,O
CR1,B
or,O
anti,O
-,O
CR3,B
Abs,I
or,O
with,O
C3,B
fragments,I
.,O
In,O
contrast,O
",",O
in,O
cells,O
infected,O
with,O
L,B
.donovani,I
",",O
tyrosine,O
phosphorylation,O
of,O
Jak1,B
",",O
Jak2,B
",",O
and,O
Stat1,B
was,O
markedly,O
impaired,O
0.22,O
Unresponsiveness,O
to,O
gamma,O
interferon,O
for,O
activation,O
of,O
this,O
pathway,O
may,O
explain,O
impaired,O
transcriptional,O
responses,O
in,O
leishmania,O
-,O
infected,O
cells,O
0.42,O
Mutually,O
exclusive,O
interaction,O
of,O
a,O
novel,O
matrix,O
attachment,O
region,O
binding,O
protein,B
and,O
the,O
NF,B
-,I
muNR,I
enhancer,I
repressor,I
0.61,O
Implications,O
for,O
regulation,O
of,O
immunoglobulin,B
heavy,I
chain,I
expression,I
.,O
To,O
understand,O
the,O
role,O
of,O
MARs,B
in,O
IgH,B
enhancer,I
regulation,I
",",O
we,O
have,O
identified,O
a,O
novel,O
MAR,B
-,I
binding,I
protein,I
",",O
MAR,B
-,I
BP1,I
",",O
from,O
soluble,O
nuclear,O
matrix,O
preparations,O
based,O
on,O
its,O
ability,O
to,O
bind,O
to,O
the,O
MARs,B
associated,O
with,O
the,O
IgH,B
enhancer,I
.,O
Purified,O
MAR,B
-,I
BP1,I
migrates,O
as,O
a,O
33,O
-,O
kDa,O
protein,B
",",O
and,O
it,O
can,O
be,O
found,O
in,O
nuclear,O
matrix,O
preparations,O
from,O
a,O
number,O
of,O
different,O
types,O
of,O
lymphoid,B
cell,I
lines,I
.,O
The,O
GM,B
-,I
CSF,I
receptor,I
alpha,I
promoter,I
contains,O
an,O
important,B
functional,I
site,I
between,O
positions,O
-,O
53,O
and,O
-,O
41,O
as,O
identified,O
by,O
deletion,O
analysis,O
of,O
reporter,O
constructs,O
.,O
C,O
/,O
EBP,B
alpha,I
is,O
the,O
major,O
CCAAT,O
/,O
enhancer,O
-,O
binding,O
protein,O
(,O
C,B
/,I
EBP,I
),O
form,O
binding,O
to,O
this,O
site,O
in,O
nuclear,O
extracts,O
of,O
U937,B
cells,I
.,O
Tyrosine,O
phosphorylation,O
of,O
this,O
protein,O
could,O
also,O
be,O
induced,O
in,O
Balb,B
/,I
c3T3,I
cells,I
using,O
a,O
supernatant,O
from,O
the,O
B,B
line,I
",",O
which,O
was,O
associated,O
with,O
induction,O
of,O
cell,O
proliferation,O
.,O
Regulation,O
of,O
c,O
-,O
jun,B
mRNA,I
expression,O
by,O
hydroxyurea,O
in,O
human,O
K562,B
cells,I
during,O
erythroid,O
differentiation,O
[,O
published,O
erratum,O
appears,O
in,O
Biochim,O
Biophys,O
Acta,O
1995,O
Dec,O
27,O
;,O
1264,O
(,O
3,O
),O
:,O
409,O
],O
In,O
addition,O
",",O
HU,O
stimulates,O
the,O
synthesis,O
of,O
fetal,O
hemoglobin,O
in,O
sickle,B
cell,I
anemia,I
patients,O
.,O
HU,O
induced,O
a,O
dose,O
-,O
dependent,O
stimulation,O
of,O
c,O
-,O
jun,B
synthesis,I
.,O
Glucocorticoid,B
effects,O
were,O
assessed,O
in,O
vivo,O
by,O
depletion,O
of,O
endogenous,O
glucocorticoids,B
after,O
oral,O
administration,O
of,O
1,O
.,O
5,O
g,O
metyrapone,O
(,O
MET,B
),O
and,O
subsequent,O
glucocorticoid,B
replacement,O
",",O
and,O
in,O
vitro,O
by,O
incubation,O
of,O
the,O
cells,O
with,O
different,O
doses,O
of,O
dexamethasone,B
(,O
DEX,B
),O
.,O
In,O
comparison,O
",",O
isolated,O
nuclei,O
of,O
human,O
lymphocytes,O
in,O
which,O
no,O
need,O
for,O
the,O
expression,O
of,O
this,O
gene,O
exists,O
",",O
show,O
barely,O
hybridization,O
signals,O
.,O
Because,O
NF,B
-,I
kappa,I
B,I
activates,O
many,O
immunoregulatory,O
genes,O
in,O
response,O
to,O
pro,O
-,O
inflammatory,O
stimuli,O
",",O
the,O
inhibition,O
of,O
its,O
activity,O
can,O
be,O
a,O
major,O
component,O
of,O
the,O
anti,O
-,O
inflammatory,O
activity,O
of,O
glucocorticoids,O
.,O
Transcriptional,O
repression,O
of,O
the,O
interleukin,B
-,I
2,I
gene,I
by,O
vitamin,O
D3,O
:,O
direct,O
inhibition,O
of,O
NFATp,B
/,I
AP,I
-,I
1,I
complex,I
formation,O
by,O
a,O
nuclear,O
hormone,O
receptor,O
.,O
We,O
therefore,O
examined,O
vitamin,O
D3,B
-,I
mediated,O
repression,O
of,O
activated,O
IL,B
-,I
2,I
expression,O
by,O
cotransfecting,O
Jurkat,B
cells,I
with,O
IL,B
-,I
2,I
promoter,I
/,I
reporter,I
constructs,I
and,O
a,O
VDR,B
overexpression,O
vector,O
and,O
by,O
DNA,B
binding,O
.,O
The,O
5,O
',O
flanking,O
DNA,B
also,O
contains,O
a,O
cluster,O
of,O
three,O
binding,O
sites,O
for,O
the,O
GATA,B
family,I
of,I
transcription,I
factors,I
.,O
This,O
effect,O
is,O
thought,O
to,O
be,O
largely,O
mediated,O
through,O
inactivation,O
of,O
the,O
phosphatase,O
calcineurin,O
",",O
which,O
in,O
turn,O
inhibits,O
translocation,O
of,O
an,O
NFAT,B
component,I
to,O
the,O
nucleus,O
.,O
These,O
data,O
point,O
to,O
a,O
new,O
mechanism,O
for,O
CsA,O
-,O
sensitive,O
regulation,O
of,O
NFATp,B
in,O
which,O
dephosphorylation,O
is,O
critical,O
for,O
DNA,B
binding,O
.,O
Cysteamine,O
treatment,O
inhibited,O
both,O
expression,O
of,O
the,O
IL,B
-,I
2,I
mRNA,I
and,O
secretion,O
of,O
IL,B
-,I
2,I
into,O
the,O
culture,O
medium,O
.,O
The,O
mean,O
dissociation,O
constant,O
(,O
Kd,B
),O
was,O
similar,O
in,O
both,O
sexes,O
(,O
1,O
.,O
35,O
+,O
/,O
-,O
0,O
.,O
70,O
x,O
10,O
(,O
-,O
10,O
),O
M,O
in,O
males,O
",",O
1,O
.,O
13,O
+,O
/,O
-,O
0,O
.,O
66,O
x,O
10,O
(,O
-,O
10,O
),O
M,O
in,O
females,O
(,O
2,O
.,O
32,O
+,O
/,O
-,O
0,O
.,O
92,O
fmol,O
/,O
10,O
(,O
7,O
),O
PBMC,O
vs,O
4,O
.,O
43,O
+,O
/,O
-,O
1,O
38,O
fmol,O
/,O
10,O
(,O
7,O
),O
PBMC,O
in,O
males,O
;,O
p,O
=,O
0,O
.,O
1,O
.,O
Neither,O
Kd,O
nor,O
Nmax,O
were,O
significantly,O
correlated,O
with,O
age,O
.,O
We,O
examined,O
by,O
northern,O
hybridization,O
the,O
expression,O
of,O
Id2,B
and,O
Id3,B
mRNA,I
in,O
human,O
leukemia,B
/,I
lymphoma,I
lines,I
and,O
patient,O
samples,O
",",O
as,O
well,O
as,O
resting,O
and,O
activated,O
normal,O
human,O
lymphocytes,O
from,O
peripheral,O
blood,O
(,O
PBL,O
),O
.,O
The,O
Id2,B
mRNA,I
was,O
abundantly,O
expressed,O
in,O
5,O
/,O
12,O
T,B
-,I
cell,I
and,O
3,O
/,O
4,O
B,B
-,I
cell,I
lines,I
",",O
and,O
Id3,B
mRNA,I
was,O
detected,O
in,O
4,O
/,O
12,O
T,B
-,I
cell,I
and,O
3,O
/,O
4,O
B,B
-,I
cell,I
lines,I
.,O
In,O
addition,O
",",O
resting,O
PBL,O
constitutively,O
expressed,O
prominent,O
levels,O
of,O
Id2,B
mRNA,I
",",O
but,O
not,O
Id3,B
mRNA,I
.,O
Salicylates,O
inhibit,O
lipopolysaccharide,O
-,O
induced,O
transcriptional,O
activation,O
of,O
the,O
tissue,O
factor,O
gene,O
in,O
human,O
monocytic,O
cells,O
.,O
Here,O
",",O
we,O
report,O
that,O
a,O
family,O
of,O
anti,O
-,O
inflammatory,O
agents,O
",",O
known,O
as,O
the,O
salicylates,O
",",O
inhibited,O
LPS,O
induction,O
of,O
TF,B
activity,I
and,O
TF,B
gene,I
transcription,I
in,O
human,O
monocytes,O
and,O
monocytic,O
THP,O
-,O
1,O
cells,O
at,O
clinically,O
relevant,O
doses,O
.,O
Furthermore,O
",",O
sodium,O
salicylate,O
blocked,O
the,O
LPS,O
-,O
induced,O
proteolytic,O
degradation,O
of,O
I,B
kappa,I
B,I
alpha,I
",",O
which,O
prevented,O
the,O
nuclear,O
translocation,O
of,O
c,B
-,I
Rel,I
/,I
p65,I
heterodimers,I
.,O
In,O
contrast,O
",",O
two,O
other,O
nonsteroidal,O
anti,O
-,O
inflammatory,O
drugs,O
",",O
ibuprofen,O
and,O
indomethacin,O
",",O
did,O
not,O
inhibit,O
LPS,O
induction,O
of,O
the,O
TF,B
gene,I
.,O
Critical,O
role,O
for,O
IL,B
-,I
6,I
.,O
The,O
T,B
cell,I
activation,I
is,O
initiated,O
by,O
interaction,O
of,O
specific,O
Ags,O
with,O
TCR,B
",",O
followed,O
by,O
activation,O
of,O
intracellular,O
biochemical,O
events,O
leading,O
to,O
activation,O
of,O
several,O
genes,O
.,O
As,O
neutralizing,O
anti,O
-,O
IL,B
-,I
6,I
Abs,O
effectively,O
down,O
-,O
regulated,O
the,O
early,O
induction,O
of,O
STAT,B
proteins,I
and,O
as,O
exogenously,O
added,O
IL,B
-,I
6,I
rapidly,O
activated,O
DNA,B
binding,I
similar,O
to,O
TCR,O
-,O
mediated,O
bindings,O
",",O
it,O
can,O
be,O
concluded,O
that,O
IL,B
-,I
6,I
is,O
the,O
factor,O
responsible,O
for,O
the,O
activation,O
of,O
STAT,B
proteins,I
in,O
a,O
primary,O
T,B
cell,I
response,I
.,O
Our,O
data,O
suggest,O
an,O
involvement,O
of,O
BLR2,B
in,O
the,O
regulation,O
of,O
migration,O
in,O
activated,O
lymphocytes,B
and,O
in,O
viral,O
pathogenesis,O
.,O
A,O
central,O
role,O
for,O
a,O
single,O
c,O
-,O
Myb,B
binding,I
site,I
in,O
a,O
thymic,O
locus,O
control,O
region,O
.,O
We,O
now,O
show,O
that,O
the,O
core,O
contains,O
a,O
single,O
critical,O
c,O
-,O
Myb,B
binding,I
site,I
.,O
c,O
-,O
Myb,B
protein,I
was,O
strongly,O
evident,O
in,O
T,B
lymphoblasts,I
in,O
which,O
the,O
enhancer,O
was,O
active,O
and,O
was,O
localized,O
within,O
discrete,O
nuclear,O
structures,O
.,O
Lymphoid,B
enhancer,I
-,I
binding,I
factor,I
1,I
(,O
LEF,B
-,I
1,I
),O
is,O
a,O
regulatory,O
high,O
mobility,O
group,O
(,O
HMG,B
),O
protein,O
that,O
activates,O
the,O
T,B
cell,I
receptor,I
alpha,I
(,O
TCR,B
alpha,I
),O
enhancer,O
in,O
a,O
context,O
-,O
restricted,O
manner,O
in,O
T,B
cells,I
.,O
We,O
conclude,O
that,O
transcription,O
activation,O
by,O
LEF,B
-,I
1,I
in,O
vitro,O
is,O
a,O
chromatin,O
-,O
dependent,O
process,O
that,O
requires,O
a,O
functional,O
trans,B
-,I
activation,I
domain,I
in,O
addition,O
to,O
the,O
HMG,B
domain,I
.,O
HIV,B
-,I
1,I
envelope,I
glycoproteins,I
induce,O
activation,O
of,O
activated,B
protein,I
-,I
1,I
in,O
CD4,B
+,I
T,I
cells,I
[,O
published,O
erratum,O
appears,O
in,O
J,O
Biol,O
Chem,O
1995,O
Dec,O
1,O
;,O
270,O
(,O
48,O
),O
:,O
29038,O
].,O
Immunoprecipitation,O
of,O
the,O
gp,B
160,I
-,I
induced,O
nuclear,O
extracts,O
with,O
polyclonal,O
antibodies,O
to,O
Fos,B
and,O
Jun,B
proteins,I
indicates,O
that,O
AP,B
-,I
1,I
complex,I
is,O
comprised,O
of,O
members,O
of,O
these,O
family,O
of,O
proteins,I
.,O
This,O
stimulation,O
can,O
also,O
be,O
abolished,O
by,O
inhibitors,O
of,O
protein,B
kinase,I
C,I
",",O
but,O
it,O
is,O
unaffected,O
by,O
calcium,B
channel,I
blocker,I
or,O
cyclosporine,B
A,I
.,O